Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,response to copper ion (GO:0046688),0.912855756459989,2.4048735464393074,0.0,0.0,0.0,8/20,0.13%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,response to zinc ion (GO:0010043),0.8403618362018691,2.364911720524455,0.0,0.0,0.0,8/25,0.13%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,zinc ion homeostasis (GO:0055069),0.8251233263334816,2.334939761131713,0.0,0.0,0.0,8/28,0.13%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,response to cadmium ion (GO:0046686),0.8333319280039915,2.3124473245866093,0.0,0.0,0.0,9/26,0.81%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;MAPK3
prerank,cellular response to copper ion (GO:0071280),0.9308632244044108,2.30709225849141,0.0,0.0,0.0,8/16,0.13%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,cellular response to cadmium ion (GO:0071276),0.8358795352034762,2.305956888310957,0.0,0.0,0.0,9/24,0.81%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;MAPK3
prerank,cellular zinc ion homeostasis (GO:0006882),0.8283634518231188,2.2942445508046343,0.0,0.0,0.0,8/26,0.13%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,cellular response to zinc ion (GO:0071294),0.9132974100703072,2.275984080690608,0.0,0.0,0.0,8/15,0.13%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,cellular potassium ion homeostasis (GO:0030007),-0.8348518420977555,-2.1232499375517544,0.0,0.020366378678971734,0.017,8/13,9.45%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7509528310411469,-2.021065912505635,0.0,0.0644935324834105,0.1,9/17,10.60%,ATP1A2;CACNA1C;ATP1B1;ATP1A1;GJC1;GJD3;ATP1B2;PRKACA;GJA1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.6252358861157155,-2.014001062654856,0.0,0.04789870541165575,0.111,19/32,22.20%,DLG2;LRRC7;GRIA4;GRIA2;GRIN2B;DLG4;RELN;SLC6A9;NLGN1;DLG3;ACTN2;EPHB2;DLG1;NEFL;OPRM1;DAPK1;GRIN1;CAMK2B;CAPN1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7788799221232454,-2.005718683526688,0.0,0.041864222840108566,0.126,6/14,10.09%,ANK2;ATP1B1;ATP1B3;AKAP9;ATP1B2;ACTN2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5368391682914717,-1.9614041478558408,0.0,0.07467672182289636,0.259,32/57,24.97%,DLG2;DLGAP1;LRRC7;GRIA4;GRIA2;GRIN2B;DLGAP2;SHISA9;DLG4;DLGAP4;NLGN2;RELN;SHISA6;AKAP9;NLGN1;DLG3;ACTN2;CACNG7;DLG1;NEFL;CACNG4;OPRM1;CACNG2;DAPK1;SHANK1;PRRT1;GRIN1;CAMK2B;CAPN1;CACNG3;CACNG8;CAMK2A
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5479007720227601,1.9342833252346419,0.0,0.056877913906353786,0.388,22/91,12.09%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;ISCU;ARF1;GLRX3;ATP6AP1;SLC39A10;APP;PRNP;ACO1
prerank,digestive tract development (GO:0048565),-0.6038255129310381,-1.9308589917784404,0.0,0.10409482435918888,0.378,12/33,9.91%,FGFR2;CLMP;PKD1;GLI2;GLI3;RARB;PCSK5;KIT;SMO;COBL;NIPBL;SALL1
prerank,chondrocyte differentiation (GO:0002062),-0.6046789520638302,-1.9262112158241111,0.0023752969121140144,0.09682111768812753,0.402,20/32,29.16%,SULF1;NFIB;WNT5B;SOX5;SULF2;BMP4;OSR1;SLC39A14;CREB3L2;GPLD1;TGFB1;BMPR1B;CCN3;SOX6;BMPR2;EIF2AK3;RUNX2;SNX19;BMP2;HMGA2
prerank,regulation of cellular localization (GO:0060341),-0.5447435636790077,-1.9163040603551975,0.0,0.09744746465146892,0.449,20/46,21.03%,MAP2;ADCY5;GSN;EFNA5;DYNC1H1;PARD6G;FER;LRP5;CDK16;CSNK1E;DVL3;BRSK1;CAMK2D;STXBP4;KDM1A;TTL;DVL1;PARP1;PINK1;PPM1F
prerank,regulation of potassium ion transport (GO:0043266),-0.588045836617977,-1.913414550131929,0.002457002457002457,0.09076867534702217,0.466,11/31,12.92%,ANK2;DPP6;ANK3;KCNIP4;CACNA1D;FHL1;KCNIP1;KCNIP3;ACTN2;DPP10;DLG1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6619019597739343,-1.9131992793631436,0.0,0.08180495436053646,0.467,15/20,27.98%,IGF1;LRP1;PDGFRB;IGFBP5;NRP1;SORL1;VTN;S100A11;ACE;BMPR1A;PDGFA;NDRG4;SERPINE1;CCN4;TRIB1
prerank,mesonephric tubule development (GO:0072164),-0.7311086506193283,-1.9092465885484944,0.0,0.07889400225642082,0.485,8/15,9.91%,ROBO2;FGFR2;PKD1;BMP7;BMP4;OSR1;FOXC1;SALL1
prerank,extracellular structure organization (GO:0043062),-0.4241760058017258,-1.902622334895365,0.0,0.08071120439444354,0.514,83/204,21.05%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ADAMTS2;ITGA9;ADAM12;COL1A1;THSD4;SMOC1;TNR;COL4A6;COL8A1;ITGB8;COL3A1;COL11A1;COL22A1;MMP16;TGFBR1;COL5A1;COL4A3;ADAMTS6;COL5A2;ADAMTSL5;LAMC3;COL4A4;LOXL1;FBN2;NID2;JAM3;ADAMTS17;VCAN;MMP14;ADAMTS9;ATP7A;ITGB5;ADAM19;ADAMTS5;COL6A1;DDR1;HSPG2;ITGA5;COL8A2;MFAP5;SH3PXD2A;COL15A1;COL13A1;SPARC;ADAMTS1;COL6A2;ADAMTSL4;SMOC2;THBS1;VTN;CDH1;ITGA11;FN1;ADAMTS3;SLC39A8;ITGA8;COL23A1;COL6A3;ADAMTS10;SPP1;ITGB4;COL5A3;LAMA1;LAMB1;VIT;ITGA4;TGFBI;ADAMTS15;COL14A1;ADAMTS16;MMP2;LUM;PDGFA;ITGA1;ADAMTS20;COL16A1;COL18A1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.733209333958371,-1.8925873418196928,0.0,0.08712284212671241,0.57,6/14,13.89%,CPEB4;CPEB1;CPEB2;YBX3;PKM;UNK
prerank,membrane repolarization (GO:0086009),-0.7129582376516769,-1.8906246976734526,0.0,0.08332435086515814,0.577,6/15,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP1A1;KCNJ2;ATP1B2
prerank,external encapsulating structure organization (GO:0045229),-0.4176502599218167,-1.8798046995452025,0.0,0.08953663515533129,0.632,82/205,21.05%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ADAMTS2;ITGA9;ADAM12;COL1A1;THSD4;SMOC1;TNR;COL4A6;COL8A1;ITGB8;COL3A1;COL11A1;COL22A1;MMP16;COL5A1;COL4A3;ADAMTS6;COL5A2;ADAMTSL5;LAMC3;COL4A4;LOXL1;FBN2;NID2;JAM3;ADAMTS17;VCAN;MMP14;ADAMTS9;ATP7A;ITGB5;ADAM19;ADAMTS5;COL6A1;DDR1;HSPG2;ITGA5;COL8A2;MFAP5;SH3PXD2A;COL15A1;COL13A1;SPARC;ADAMTS1;COL6A2;ADAMTSL4;SMOC2;THBS1;VTN;CDH1;ITGA11;FN1;ADAMTS3;SLC39A8;ITGA8;COL23A1;COL6A3;ADAMTS10;SPP1;ITGB4;COL5A3;LAMA1;LAMB1;VIT;ITGA4;TGFBI;ADAMTS15;COL14A1;ADAMTS16;MMP2;LUM;PDGFA;ITGA1;ADAMTS20;COL16A1;COL18A1
prerank,eye morphogenesis (GO:0048592),-0.6779022136149978,-1.8795537541293301,0.0,0.08408202864339372,0.633,10/19,7.76%,TENM3;FBN1;COL5A1;COL5A2;EFEMP1;FBN2;NKD1;SKI;MFAP5;NIPBL
prerank,cardiac muscle cell contraction (GO:0086003),-0.6749363549892895,-1.875859774838068,0.002173913043478261,0.08286320737032617,0.65,9/19,13.05%,FGF12;CACNA1C;CACNA1D;GSN;ATP1A1;KCNJ2;SCN1A;CAMK2D;CACNA1G
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7715098049678705,-1.8673461697055516,0.0,0.08649425019217626,0.682,6/11,16.22%,DDX5;EGFR;BMP4;MAP2K2;TP53;TGFB1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6523706017575137,-1.8655917043551735,0.0,0.08331158997626156,0.687,13/21,27.10%,BMP6;DAB2;TGFBR1;SMAD4;BMP4;NUP93;TGFB1;CCN3;WWTR1;BMPR1A;TGFB3;SLC2A10;SH2B1
prerank,collagen fibril organization (GO:0030199),-0.464302172447685,-1.862987995162064,0.0,0.08146551471588694,0.699,42/88,22.16%,COL1A2;COL4A5;ADAMTS2;COL1A1;COL4A6;COL8A1;COL3A1;COL11A1;PLOD2;COL25A1;COL22A1;TGFBR1;COL5A1;PLEC;COL4A3;COL5A2;COL4A4;LOXL1;COL12A1;ATP7A;COL6A1;COL8A2;P4HB;COL15A1;COL13A1;PLOD1;COL6A2;ADAMTS3;LOXL3;COL23A1;COL6A3;ITGB4;COL5A3;P4HA2;COL20A1;COL14A1;LUM;COL16A1;COL18A1;P3H1;LOX;CRTAP
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6329821951557836,-1.859274822541545,0.0,0.08211206641998128,0.721,5/21,8.13%,ANK2;CACNA1D;SNTA1;FLNA;AKAP9
prerank,ureteric bud development (GO:0001657),-0.6878901244056974,-1.8560313803493056,0.002331002331002331,0.08038547948291117,0.728,8/17,9.91%,ROBO2;FGFR2;BMP7;BMP4;OSR1;GPC3;FOXC1;SALL1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.6170967666810965,-1.8526023809562648,0.002257336343115124,0.08048163168791728,0.739,11/24,9.78%,ROBO2;FGFR2;ROBO1;PARVA;NRP1;TGFBR2;SMAD4;BMP4;SMAD6;ACVR1;NRP2
prerank,cardiac muscle cell action potential (GO:0086001),-0.5936834675544304,-1.8520231570804842,0.0,0.07774110750376016,0.74,9/30,8.73%,ANK2;ATP1A2;FGF12;CACNA1C;CACNA1D;ATP1B1;ATP1A1;KCNJ2;SCN1A
prerank,synaptic membrane adhesion (GO:0099560),-0.7284365059322268,-1.8453851247486026,0.0,0.08119396300016732,0.767,7/14,11.24%,LRRC4C;LRFN5;GPC6;NTNG1;PTPRS;PTPRF;LRRC4
prerank,embryonic digestive tract development (GO:0048566),-0.6615152681824654,-1.8377651365891912,0.006741573033707865,0.08681821680459105,0.8,8/18,9.91%,FGFR2;GLI2;GLI3;RARB;PCSK5;PDGFRA;NIPBL;SALL1
prerank,negative regulation of growth (GO:0045926),0.5031960329431003,1.8313012648355491,0.0,0.28459162251189807,0.908,18/121,5.65%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;CCDC85B;PTPRJ;FRZB;ST7L;RERG;PPT1;ING4;PPP2CA;SMARCA2;CDKN1A
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5762014819341331,-1.828837164935021,0.0,0.09366019824588852,0.827,11/29,13.20%,DPP6;FGF12;KCNIP4;CACNA1D;SNTA1;KCNIP1;WNK1;KCNIP3;DPP10;DLG1;WNK3
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5081071124579717,1.8285365076398759,0.0,0.26963051775597197,0.913,54/110,19.90%,NCBP1;RPL30;RPL17;RPL23;RPL31;SMG8;RPL3;RPS21;PPP2CA;SMG1;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;PYM1;RPL4;RPLP0;UPF2;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;RPS3;RPS15A;RPL23A;RPL21;RPL35;DCP1A;UPF3B;RPL19;RPL38;RPL36;SMG6;RPSA;RPL26;RPS8;SMG5;RPL15;RPL10;RPL32;RPS2;EIF4G1;RPL27A;EIF3E;RPL7;RPL39;RPL14;SMG7
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7595242888324502,-1.8212856573793579,0.0,0.09831626850384569,0.858,5/11,9.35%,DAB2;WNT5B;NKD1;CSNK1E;RSPO3
prerank,positive regulation of chemotaxis (GO:0050921),-0.5382610151707342,-1.807608894162995,0.0,0.11318556426761879,0.9,19/43,22.28%,NTRK3;PDGFRB;NRP1;DSCAM;IL6R;P2RX4;F3;STX3;SMOC2;THBS1;LGMN;TGFB1;SEMA5A;MET;HSPB1;PPM1F;PRKD1;P2RY12;VEGFA
prerank,receptor clustering (GO:0043113),-0.5902343272231906,-1.8044440614462132,0.004662004662004662,0.113448272345087,0.91,10/27,12.92%,MAGI2;DLG2;LRRC7;NRXN1;DLG4;FLNA;NLGN1;DLG3;NRXN2;DLG1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6688176253105991,-1.8004243964824658,0.006880733944954129,0.11519048586171109,0.917,6/16,13.52%,IGF1;IGFBP5;IGFBP2;BMP5;IGFBP6;IGFBP4
prerank,cytoplasmic translation (GO:0002181),0.512380567362139,1.7970922302368637,0.0,0.3750608443647219,0.97,45/91,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;EIF2B3;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;DRG2;RPS11;RPS3;RPS15A;RPL23A;RPL21;RPL35;EIF3M;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;FTSJ1;RPL7;RPL39;RPL14
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5113665127833489,1.7920330974430463,0.0,0.3682415562853633,0.978,43/87,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;RPS3;RPS15A;RPL23A;SEC61A2;RPL21;SRP9;RPL35;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;RPL7;RPL39;RPL14
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7825282367723126,1.788604208451728,0.0017921146953405018,0.35596683774251786,0.983,6/11,14.46%,TNFAIP3;TIRAP;LYN;PJA2;MFHAS1;CYBA
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5246214094523072,-1.7851817146906148,0.0,0.1330532690433518,0.949,20/43,26.35%,FOXP1;IGF1;PDGFRB;IGFBP5;IL6R;BMP4;ADAMTS1;THBS1;GJA1;IL18;RBPMS2;JUN;BMPR1A;DNMT1;STAT1;MMP2;CX3CL1;AKT1;MEF2D;CCN4
prerank,aorta development (GO:0035904),-0.6944453029327259,-1.7832513620590673,0.0,0.1323471745805234,0.951,6/14,5.50%,ROBO2;LRP1;ROBO1;PDGFRB;HECTD1;ADAMTS9
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5709305758283401,-1.7785123160050933,0.0,0.13537651710140033,0.96,11/30,13.05%,ANK2;FGF12;CACNA1C;CACNA1D;SNTA1;ATP1A1;GJC1;KCNJ2;SCN1A;GJA1;CACNA1G
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.7359906068354993,1.771888894796324,0.005545286506469501,0.405338483437074,0.992,8/13,14.52%,SAE1;UBA1;UBA2;DESI2;DESI1;NAE1;ATG7;UBA6
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.7665718722858447,1.765956696130084,0.007259528130671506,0.411657690390613,0.993,1/11,0.19%,RTP3
prerank,peptide biosynthetic process (GO:0043043),0.4692252881997106,1.7643932788949703,0.0,0.3937537163940225,0.993,62/153,19.87%,PCSK1;RPL30;MRPS33;RSL24D1;EEF1A1;MRPL23;RPL17;RPL23;MRPL24;RPL31;RPL3;RPS21;MRPL18;RPL35A;RPS14;RPL8;YARS2;RPL5;ABCF1;MRPS12;RPS12;HBS1L;RPS26;RPL37A;HARS1;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;DMD;RPS11;MRPL52;RPS3;MRPS15;DHPS;RPS15A;RPL23A;RPL21;RPL35;HARS2;WARS1;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;EIF4G1;MRPL13;RPL27A;FURIN;RPL7;RPL39;RPL14
prerank,melanocyte differentiation (GO:0030318),-0.7368750259907325,-1.7627317698208307,0.006493506493506494,0.15627154687960215,0.979,4/11,5.42%,LRMDA;KIT;USP13;ENPP1
prerank,endodermal cell differentiation (GO:0035987),-0.5504289492403274,-1.7596769032370243,0.0,0.15774514597185052,0.982,14/31,19.89%,COL8A1;COL11A1;MMP14;COL12A1;ITGB5;COL6A1;ITGA5;CDC73;VTN;FN1;PAF1;LAMB1;ITGA4;MMP2
prerank,response to cholesterol (GO:0070723),-0.6332690591009532,-1.7584433859141797,0.004291845493562232,0.15559179387178407,0.982,13/17,31.25%,GRAMD1B;TGFBR1;TGFBR2;SMO;GRAMD1C;GRAMD1A;LRP6;GPLD1;TGFB1;OSBPL7;PTCH1;PMVK;ABCA2
prerank,protein targeting to ER (GO:0045047),0.4910562098024664,1.7564187985900854,0.001440922190201729,0.4115314072780322,0.996,46/99,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;SGTB;RPL8;RPL5;SPCS3;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;SEC62;RPS3;RPS15A;SPCS2;RPL23A;RPL21;SRP9;RPL35;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;RPL7;RPL39;RPL14
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7034373079796046,-1.7542032169479826,0.0,0.1593579805407262,0.987,10/13,27.10%,BMP6;DAB2;TGFBR1;SMAD4;BMP4;NUP93;TGFB1;BMPR1A;TGFB3;SH2B1
prerank,respiratory tube development (GO:0030323),-0.5633053512488525,-1.7491448052698668,0.002364066193853428,0.16478779329994223,0.989,12/28,23.35%,FGFR2;GLI2;PCSK5;FGF1;PDPN;BMP4;RBP4;LOXL3;CCDC39;BAG6;VEGFA;STRA6
prerank,bone morphogenesis (GO:0060349),-0.6922643525427817,-1.7470371184183544,0.004301075268817204,0.1644302211956426,0.991,8/14,19.91%,FGFR2;SKI;LRP5;CYP26B1;LRP6;BMPR1B;SFRP4;BMPR2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.7457464593795755,-1.7442478112315625,0.008658008658008658,0.16530434727241283,0.992,4/10,8.13%,DLGAP1;DLGAP2;DLGAP4;AKAP9
prerank,cartilage development (GO:0051216),-0.4949448910921632,-1.7410766699921143,0.002531645569620253,0.16748383101477152,0.992,17/49,17.73%,SULF1;NFIB;PKD1;ITGB8;WNT5B;SOX5;SULF2;BMP4;OSR1;ATP7A;SLC39A14;CREB3L2;DDRGK1;GPLD1;TGFB1;CCN3;SOX6
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4977415038726235,-1.7405390378726857,0.0027548209366391185,0.1645098184766554,0.992,16/44,14.21%,ANK2;KCNMA1;AKAP6;ATP1B1;WNK1;FLNA;ATP1B3;GABBR2;AKAP9;KCNJ2;ATP1B2;ACTN2;WNK4;KCNJ6;WNK3;ANO6
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.48577444162220434,1.739731582425954,0.0,0.47371321191277604,1.0,31/105,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;RPS6KA5;NRAS;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,cellular response to lectin (GO:1990858),0.4863415460052852,1.7390542468623598,0.0,0.43162846262302024,1.0,31/104,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;RPS6KA5;NRAS;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4863415460052852,1.7390542468623598,0.0,0.43162846262302024,1.0,31/104,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;RPS6KA5;NRAS;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of kinase activity (GO:0033674),-0.4217995880188292,-1.737071318606499,0.003367003367003367,0.16773975773097552,0.993,28/107,10.80%,ERBB4;NTRK3;FGFR2;PRKAG2;EGFR;LMO4;EPHA6;IQGAP1;PDGFRB;EPHB1;NTRK2;RASSF2;AXL;RYK;MAPT;EPHA7;PRKAG1;ROR1;KIT;RELN;DDR1;PDGFRA;RAD50;VAC14;EPHB4;MRE11;EPHB2;EPHA3
prerank,neurotransmitter uptake (GO:0001504),-0.7007022405170322,-1.7370026010999482,0.006224066390041493,0.1641379259460833,0.993,4/12,6.01%,ATP1A2;SNAP25;SLC1A3;GLUL
prerank,odontogenesis (GO:0042476),-0.523225178113983,-1.7365009072398496,0.0024390243902439024,0.16147980196551864,0.993,8/35,8.19%,FGFR2;COL1A2;EDA;GLI2;HDAC1;BMP4;OSR1;FOXC1
prerank,positive regulation of immune effector process (GO:0002699),0.6010232744471838,1.7274642267193219,0.006745362563237774,0.47206005116626487,1.0,3/27,2.03%,PCK1;PTPRJ;PTPRC
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.4878925635312165,-1.7263816058636288,0.0,0.17602714054449328,0.996,29/50,30.71%,FGFR2;ZIC1;GLI3;TULP3;IFT81;GLIS2;MGRN1;SMO;DCDC2;VCP;GPC3;BTRC;GAS1;WDR11;RORA;RACK1;INTU;EVC;HERC4;KCTD6;GLI1;PTCH1;SFRP1;SUFU;DLG5;TTC23;FUZ;PDCL;FBXL17
prerank,lung development (GO:0030324),-0.5356611844262535,-1.718811051127948,0.002512562814070352,0.18530104490207963,0.997,14/33,23.35%,FGFR2;PKD1;GLI2;ERRFI1;FGF1;PDPN;BMP4;RBP4;LOXL3;RCN3;CCDC39;BAG6;VEGFA;STRA6
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.45508980753878087,1.718792196028137,0.0,0.500792703706171,1.0,87/168,21.53%,NCBP1;RPL30;RPL17;RPL23;PATL2;RPL31;SMG8;RPL3;RPS21;CNOT11;PPP2CA;ZFP36L1;SMG1;RPL35A;RPS14;RPL8;RPL5;CNOT2;RPS12;RPS26;RPL37A;PYM1;RPL4;CNOT7;RPLP0;EXOSC9;UPF2;XRN2;DXO;PATL1;RPS28;RPS24;RPS9;RPS23;RPL24;PAN3;RPL34;RPS11;RPS3;TUT7;PAN2;CNOT6;RPS15A;RPL23A;RPL21;RPL35;CNOT1;DCP1A;CNOT6L;TUT4;NBDY;UPF3B;PARN;CNOT10;LSM1;RPL19;RPL38;RPL36;SMG6;RPSA;RPL26;RPS8;SMG5;RPL15;RPL10;RPL32;RC3H1;RPS2;EIF4G1;DIS3L2;RPL27A;EIF3E;DCP1B;EXOSC7;RPL7;RPL39;RPL14;SMG7;AGO1;RPS27;CNOT8;CNOT4;RPS13;GSPT1;TENT2;MTPAP;RPL22
prerank,translation (GO:0006412),0.4445687202386026,1.7186938823280462,0.0,0.4803809602570377,1.0,80/208,19.87%,RPL30;MRPS2;MRPS33;RSL24D1;EEF1A1;MRPL23;RPL17;RPL23;MRPL24;FASTKD2;RPL31;RPL3;EEF1D;RPS21;MRPL18;FARS2;GARS1;RPL35A;RPS14;RPL8;YARS2;RPL5;IARS1;ABCF1;LARS2;MRPS12;RPS12;HBS1L;RPS26;RPL37A;HARS1;RPL4;RARS2;RPLP0;TSFM;RPS28;RPS24;RPS9;RPS23;RPL24;WARS2;RPL34;GTPBP2;DRG2;RPS11;MRPL52;RPS3;MRPS15;MRPS24;LARS1;DHPS;EEF1B2;RPS15A;RPL23A;RPL21;RPL35;MRPS28;GATB;HARS2;WARS1;MRPS34;RPL19;RPL38;RPL36;RPSA;IARS2;RPL26;RPS8;GFM2;RPL15;RPL10;RPL32;RPS2;EIF4G1;MRPL13;RPL27A;FTSJ1;RPL7;RPL39;RPL14
prerank,cotranslational protein targeting to membrane (GO:0006613),0.4853352952086436,1.7116701059674866,0.0,0.4969169761508068,1.0,43/91,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;SEC62;RPS3;RPS15A;RPL23A;RPL21;SRP9;RPL35;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;RPL7;RPL39;RPL14
prerank,regulation of cation channel activity (GO:2001257),-0.43064346113029917,-1.7088156076016001,0.0,0.20278632376273215,1.0,39/89,24.97%,DLG2;ANK2;ANK3;LRRC7;FGF12;GRIA4;GRIA2;AHNAK;CACNB4;GRIN2B;FGF14;SHISA9;DLG4;NLGN2;RELN;SHISA6;NLGN1;DLG3;PRKACA;ACTN2;CAMK2D;CACNG7;DLG1;VAMP2;NEFL;CACNG4;OPRM1;CACNG2;DAPK1;SELENON;SHANK1;PRRT1;GRIN1;CAMK2B;CAPN1;CACNG3;CACNG8;CACNB1;CAMK2A
prerank,positive regulation of bone mineralization (GO:0030501),-0.5271843993163483,-1.7085874797522527,0.0024449877750611247,0.19920581278998686,1.0,18/35,21.81%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CCN1;PKDCC
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6203886654726479,1.7083139664640161,0.01048951048951049,0.4946956367723409,1.0,4/22,2.51%,PHPT1;PTPRJ;SH2D1A;FCGR2B
prerank,establishment of endothelial barrier (GO:0061028),0.6044065451408992,1.7082291272593535,0.005291005291005291,0.4769797350915305,1.0,12/29,12.23%,PDE4D;PECAM1;MARVELD2;PPP1R16B;ICAM1;RAPGEF3;F11R;RAPGEF6;TJP1;RAB1A;ROBO4;RAP2C
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5978419617884133,-1.706508683652015,0.021634615384615384,0.19967037920560524,1.0,8/20,9.45%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2
prerank,heart development (GO:0007507),-0.38913688988348977,-1.7021381985768795,0.0,0.20516515444874409,1.0,41/150,14.42%,ERBB4;NTRK3;TGFBR3;FGF12;CACNA1C;FBN1;AKAP13;PDLIM5;PKD1;MICAL2;GLI2;ADAP2;COL3A1;PCSK5;FLRT2;CXADR;TGFBR1;NCOA6;TGFBR2;BMP5;BMP7;PLCE1;PDLIM7;BMP4;OSR1;GPC3;NIPBL;CDKN1B;EPHB4;RBP4;FOXC1;ACVR1;SALL1;FN1;FOXC2;SCUBE1;MTHFD1;WDR11;PDLIM1;TCF25;PTK2
prerank,positive regulation of telomerase activity (GO:0051973),0.5840305108502791,1.69945945668947,0.006462035541195477,0.5039453890645991,1.0,16/33,20.74%,MAP2K7;MAPK3;PNKP;GREM1;CCT2;MAP3K4;ACD;NEK7;TNKS;TCP1;DKC1;PARN;PARM1;NVL;PTGES3;HSP90AB1
prerank,regulation of muscle contraction (GO:0006937),-0.5554501134868346,-1.6991755214261774,0.006711409395973154,0.20748515134269002,1.0,7/26,12.21%,ATP1A2;KCNB2;CHRM2;TPM1;PLCE1;KCNA1;SRI
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6576338235807708,1.698739884536519,0.008849557522123894,0.48926432403857767,1.0,6/18,6.71%,LRP8;RPS6KA4;CAMK1D;PRKD2;RPS6KA5;EPHA5
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5545980879712282,-1.697675525361414,0.005025125628140704,0.20655530968858368,1.0,12/26,14.03%,ANK2;CACNA1D;ATP1B1;FHL1;ATP1B3;WWP2;CAB39;AKAP9;ATP1B2;ACTN2;DLG1;VAMP2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.4766162122350924,1.697501910693705,0.002789400278940028,0.47850186754183677,1.0,16/107,8.26%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;CXCL12;ATP2A2;SLC10A7;NPTN;HTR2A;ATP13A4;TRPV4;TMEM165
prerank,extracellular matrix organization (GO:0030198),-0.3690084946007367,-1.6943610435962424,0.0,0.20979427249308458,1.0,107/276,22.39%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ADAMTS2;ITGA9;ADAM12;COL1A1;GSN;THSD4;SMOC1;TNR;GPM6B;COL4A6;COL8A1;TIMP2;ITGB8;COL3A1;CAPN2;COL11A1;PLOD2;COL25A1;COL22A1;MMP16;FLRT2;TGFBR1;COL5A1;PLEC;COL4A3;ADAMTS6;COL5A2;ADAMTSL5;LAMC3;COL4A4;LOXL1;FBN2;NID2;JAM3;ADAMTS17;VCAN;MMP14;ADAMTS9;COL12A1;ATP7A;ITGB5;ADAM19;ADAMTS5;COL6A1;DDR1;HSPG2;ITGA5;COL8A2;MFAP5;SH3PXD2A;P4HB;COL15A1;COL13A1;SPARC;ADAMTS1;PLOD1;COL6A2;ADAMTSL4;SMOC2;THBS1;VTN;CDH1;ITGA11;FN1;ADAMTS3;LOXL3;SCUBE1;SLC39A8;ITGA8;COL23A1;COL6A3;ADAMTS10;SPP1;QSOX1;ITGB4;COL5A3;TGFB1;LAMA1;LAMB1;VIT;P4HA2;ITGA4;TGFBI;ADAMTS15;COL20A1;COL14A1;ADAMTS16;MMP2;LUM;FLOT1;PDGFA;ITGA1;ADAMTS20;COL16A1;COL18A1;P3H1;SH3PXD2B;LOX;CRTAP;CAPN1;KLK2
prerank,positive regulation of telomere capping (GO:1904355),0.668078470398882,1.6939681993933131,0.018315018315018316,0.4801072110581531,1.0,6/17,11.69%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6393405870227795,-1.690298119483387,0.01627906976744186,0.2146147562778152,1.0,5/16,1.32%,ERBB4;FGFR2;TGFBR3;IGF1;AKAP6
prerank,regulation of kinase activity (GO:0043549),-0.4288658427185468,-1.6891319390131898,0.0,0.21325146798069525,1.0,27/89,10.80%,ERBB4;NTRK3;FGFR2;EGFR;LMO4;EPHA6;PDGFRB;EPHB1;NTRK2;AXL;RYK;MAPT;RBL2;EPHA7;PLCE1;ROR1;KIT;DDR1;PDGFRA;LDB1;RAD50;VAC14;CDKN1B;EPHB4;MRE11;EPHB2;EPHA3
prerank,actin filament polymerization (GO:0030041),-0.5461084389790801,-1.686960867964468,0.007125890736342043,0.21408107243585808,1.0,10/29,7.49%,GSN;GAS7;SPIRE1;WASL;PSTPIP2;ARHGAP6;WASHC5;WASHC3;WASF1;COBL
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.49493815742633407,1.682489116564399,0.0014727540500736377,0.5208515407613423,1.0,27/74,14.75%,PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;STOX1;PSMD11;PSMB4;PSMC1;EP300;NOTCH1;PSMC2;PSMD2;CITED2;RBPJ;CREBBP;HIGD1A;ELOB;EGLN2;PSMD14;EPAS1;PSMC6;PSMD1;PSMB1;BACH1
prerank,regulation of hippo signaling (GO:0035330),-0.6207265947681725,-1.6793070614545258,0.0136986301369863,0.22778893215520366,1.0,9/17,16.85%,WWC2;MAPK14;MOB3B;SCHIP1;CIT;VGLL4;LIMD1;NF2;SHANK2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.5118083529469672,-1.6764667379971063,0.009925558312655087,0.23044180320095797,1.0,9/38,13.05%,ANK2;CTNNA3;CACNA1C;CACNA1D;AKAP9;KCNJ2;BIN1;CAMK2D;CACNA1G
prerank,regulation of B cell activation (GO:0050864),0.6141308331290464,1.6749674338776448,0.012152777777777778,0.5452950722367097,1.0,4/25,5.32%,TNFAIP3;FCGR2B;ZFP36L1;SAMSN1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6185476747763712,-1.6747251195770942,0.01312910284463895,0.2303737916145983,1.0,4/17,1.33%,ANK2;ATP1A2;CACNA1C;CACNA1D
prerank,myotube cell development (GO:0014904),-0.702376999842989,-1.6745153928633618,0.006493506493506494,0.22722381803931635,1.0,5/10,18.70%,IGF1;SKI;CAV2;SELENON;SIX1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6490933221589907,1.674093285207211,0.0034904013961605585,0.534124081604035,1.0,3/19,6.50%,SLC5A7;APOE;RIC3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6023602132080289,-1.671640693120819,0.0175054704595186,0.2298670905750963,1.0,7/17,9.69%,IGF1;DOCK5;PDGFRB;IGFBP5;NRP1;ADAMTS1;VTN
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7520443879481484,1.6715827181825265,0.01020408163265306,0.5313849053839228,1.0,2/10,6.32%,SAG;GNB1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.6228845136734664,-1.6702349639309186,0.019438444924406047,0.2295990971387204,1.0,6/15,9.45%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;ATP1B2
prerank,modified amino acid transport (GO:0072337),-0.6371283856896013,-1.669372399733239,0.015590200445434299,0.22838195578470866,1.0,7/15,17.59%,SLC16A12;SLC6A13;PDPN;SLC25A32;CTNS;SLC19A1;SLC5A6
prerank,positive regulation of cell projection organization (GO:0031346),-0.40798319561667246,-1.666771506044698,0.003484320557491289,0.23099039252564404,1.0,44/115,18.65%,MAGI2;NTRK3;ROBO2;TENM3;LRRC7;PLXNA2;ROBO1;CUX1;DPYSL3;NTRK2;TIAM2;DLG4;TOX;PTK7;RHOA;ROR1;RELN;CBFA2T2;PLPPR5;STMN2;ARSB;ATP1B2;DVL3;EPHA3;CUX2;RIT2;GRIP1;IL1RAPL1;OBSL1;PLXND1;CAMK1;ROR2;SETX;ARHGDIA;PLXNB2;NGF;PLXNC1;RAPGEF2;ABL2;FZD4;DVL1;TWF2;SCARF1;SNX3
prerank,regulation of synapse assembly (GO:0051963),-0.4802284225315473,-1.6664452529681344,0.0026954177897574125,0.22804940106205163,1.0,15/46,12.30%,ROBO2;LRFN5;GPC6;PDLIM5;NRXN1;GRID2;EPHB1;NLGN2;IL1RAPL2;SYNDIG1;CLSTN2;NLGN1;EPHB2;CUX2;IL1RAPL1
prerank,negative regulation of transferase activity (GO:0051348),0.5855859823373196,1.6642034976551512,0.006734006734006734,0.5560245446928856,1.0,9/28,9.76%,PHPT1;CERS1;GSK3A;SRC;ERCC4;FBXO5;SMAD7;IRS2;PARK7
prerank,respiratory system development (GO:0060541),-0.5220353036708578,-1.6585985241581183,0.0,0.2427825419157488,1.0,13/32,24.61%,FGFR2;GLI2;FGF1;PDPN;BMP4;RBP4;LOXL3;SMCHD1;CCDC39;BAG6;VEGFA;STRA6;BASP1
prerank,potassium ion transport (GO:0006813),-0.3952337259928449,-1.6576122504895123,0.0,0.24195323462820284,1.0,23/120,12.75%,ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;HCN1;NALCN;KCNH7;KCNQ5;KCNMA1;SLC1A3;KCNC2;KCND2;ATP1B3;KCNH5;KCNK5;KCNJ2;KCNA1;SLC24A2;KCNK10;KCNJ6;SLC9A2;ABCC9
prerank,ribosome assembly (GO:0042255),0.5239186377467236,1.656306758423306,0.007587253414264037,0.583092135304578,1.0,19/47,18.32%,MRPS2;MTERF3;RSL24D1;EIF2A;RPL3;RPS14;RPL5;MRPL20;RPLP0;RPS28;RRP7A;RPL24;DDX3X;EFL1;RPL23A;NPM1;EIF6;RPSA;RPL10
prerank,negative regulation of protein catabolic process (GO:0042177),-0.4850302528262434,-1.6525506982545237,0.013020833333333334,0.25092671635901365,1.0,13/40,9.26%,SNRNP70;EGFR;TIMP3;TIMP2;NELL1;FLNA;SIRT2;FMN2;ROCK1;PTPN3;IRAK3;BANP;AZIN1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5406992677138467,-1.6503540585145302,0.007518796992481203,0.2526036529267457,1.0,9/27,11.96%,DDX5;EGFR;PUM1;BMP4;PUM2;EIF4E2;MAP2K2;TP53;LIMD1
prerank,regulation of cell communication (GO:0010646),-0.49960747674833267,-1.6483949185380598,0.005249343832020997,0.2538097083673399,1.0,16/35,25.31%,ANK2;CXADR;IGFBP7;SCG5;GRK5;GRK3;SOCS2;CAMK2D;ANXA1;SRI;GRK4;MTCH1;TBX18;GRK2;TSPYL2;GLRX2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6256904650494238,-1.645500803612701,0.015555555555555555,0.2575866417548183,1.0,7/15,15.54%,COL11A1;ADGRV1;KIT;PIEZO2;SCN1A;KCNA1;WHRN
prerank,regulation of intracellular pH (GO:0051453),0.5487535829026793,1.645296608439516,0.008665511265164644,0.6298629452667903,1.0,9/34,8.26%,SLC4A4;SLC4A5;SLC9A7;CA2;GPR89B;GPR89A;SLC9A6;SLC9A8;TMEM165
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.647447663986864,-1.644250291467723,0.008791208791208791,0.2568732445996435,1.0,6/14,8.52%,KMT2A;AUTS2;CTNNB1;SMAD4;PAXIP1;SNW1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.47209787355881094,1.6398965473489662,0.001447178002894356,0.6456991543450094,1.0,28/86,14.94%,ATF3;PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;KLF2;STOX1;PSMD11;PSMB4;PSMC1;EP300;PSMC2;PSMD2;CREBBP;HIGD1A;ELOB;EGLN2;PSMD14;EPAS1;DDIT3;PSMC6;PSMD1;PSMB1;BACH1;INO80
prerank,chordate embryonic development (GO:0043009),-0.44539008407106295,-1.639186059215762,0.005154639175257732,0.26524568143235633,1.0,12/55,4.70%,FGFR2;SULF1;ARNT2;ALDH1A2;COL1A1;PKD1;PCSK5;TGFBR1;BMP5;BMP7;SULF2;FUT8
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4527240181775526,-1.636187833222395,0.002967359050445104,0.26915479542187865,1.0,17/54,12.92%,DPP6;KCNIP4;KCNMA1;AKAP6;CACNA1D;FHL1;KCNIP1;FLNA;KCNIP3;WWP2;CAB39;GABBR2;KCNJ2;BIN1;DPP10;KCNJ6;DLG1
prerank,neuron projection morphogenesis (GO:0048812),-0.39385965643611226,-1.6356387660540181,0.0,0.26720218607389756,1.0,38/137,11.06%,MAP2;FGFR2;CNTN4;DCLK1;ALCAM;ANK3;DCC;MAP1B;EPB41L3;CTNNA2;IQGAP1;NRCAM;GAS7;EPHB1;NBL1;NTNG1;SDC2;WASL;DLG4;RYK;CTNNB1;BMP7;GPM6A;ATP7A;DCDC2;MYO16;CTNND2;TAOK3;SHTN1;ROCK1;CTTN;DOCK10;NLGN1;BRSK1;SGK1;BTBD3;EPHB2;PLPPR4
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.48566199224710443,-1.6355972114147646,0.012468827930174564,0.26390707073114866,1.0,19/40,21.81%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CEBPB;CCN1;PKDCC
prerank,glutamate metabolic process (GO:0006536),0.6363234247791429,1.63541155493624,0.012433392539964476,0.6566065182011731,1.0,7/19,6.17%,GCLC;ALDH5A1;GLS2;GLS;GOT2;GCLM;MTHFS
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6475300049433005,1.6339664329676773,0.023090586145648313,0.6488414004093442,1.0,8/18,12.07%,HRH4;GNAQ;RGS8;GNB1;RGS10;GNA11;PLCB1;AGRN
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.5392163632039283,-1.6337999780204748,0.015873015873015872,0.264777245174508,1.0,4/23,5.50%,FGFR2;TGFBR3;TPM1;ADAMTS9
prerank,nuclear migration (GO:0007097),-0.6405757526279315,-1.6308234177245804,0.014767932489451477,0.26893520179211633,1.0,6/13,5.77%,SYNE2;CLMN;DYNC1H1;SYNE3;FBXW11;CEP120
prerank,regulation of telomerase activity (GO:0051972),0.5261958601504839,1.6302077088342193,0.012759170653907496,0.6559505676335396,1.0,17/45,18.05%,MAP2K7;CERS1;MAPK3;PNKP;GREM1;SRC;CCT2;ERCC4;MAP3K4;ACD;NEK7;TNKS;TCP1;DKC1;PARN;SMG6;PARM1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5528022397171313,-1.6288007902421737,0.017543859649122806,0.27019675088295625,1.0,7/22,7.58%,MAGI2;NTRK3;NTRK2;SH3GL2;MAPT;WASF1;STMN2
prerank,positive regulation of histone methylation (GO:0031062),-0.5506611547981851,-1.6283822712473388,0.008948545861297539,0.2678123602846628,1.0,14/24,22.03%,OGT;KMT2A;AUTS2;CTNNB1;SMAD4;JARID2;TET1;PAXIP1;SNW1;MTF2;PAF1;RIF1;DNMT1;PHF1
prerank,central nervous system neuron differentiation (GO:0021953),-0.5043777839195377,-1.6275015851685044,0.022277227722772276,0.2668759005342902,1.0,9/33,5.67%,MAP2;GRID2;SPOCK1;NTRK2;TOX;RYK;MAPT;CTNNB1;ATP7A
prerank,acyl-CoA biosynthetic process (GO:0071616),0.6310428869503808,1.6264328455964736,0.02443609022556391,0.6635537340103925,1.0,5/16,5.63%,SLC25A1;DIP2A;MLYCD;PPT1;ACAT1
prerank,mesenchyme development (GO:0060485),-0.6185563771848904,-1.626281630048614,0.01276595744680851,0.26650053053138606,1.0,4/15,4.74%,FGFR2;TGFBR1;BMP7;BMP4
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.7221993430525828,1.6230644532883773,0.015037593984962405,0.6680422576651642,1.0,4/10,4.52%,INSIG1;DERL2;SVIP;YOD1
prerank,peptidyl-methionine modification (GO:0018206),0.6995866708062083,1.6152182349338315,0.017509727626459144,0.6997902913792743,1.0,4/12,16.28%,NAA25;METAP2;METAP1;NAA15
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3718167079636566,-1.6144223002158293,0.0,0.29269015319818986,1.0,36/159,12.31%,LRRC4C;TENM2;ROBO2;LRFN5;CNTN4;TENM3;ALCAM;SDK1;GPC6;ROBO1;CDH10;UNC5D;CNTN6;GRID2;KIRREL3;PKD1;NTNG1;CXADR;PTPRS;TGFBR2;DSCAM;CLDN11;IGSF11;PALLD;CDH11;SDK2;CDH7;NLGN1;ACVR1;MPZL2;CDH1;PTPRF;LRRC4;CDH4;IL1RAPL1;OBSL1
prerank,cAMP biosynthetic process (GO:0006171),-0.7034885532915932,-1.613791750847834,0.016359918200409,0.29099713412241396,1.0,8/10,22.63%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;ADCY3;ADCY8;ADCY4
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6261836458306557,1.6137252845496068,0.01841620626151013,0.6944011870027428,1.0,3/17,2.14%,PHPT1;PTPRJ;SH2D1A
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.5111386304080895,-1.613360088029524,0.014814814814814815,0.2887447889083847,1.0,6/30,12.53%,LPAR1;ROBO1;AKAP13;COL3A1;PRAG1;GPR4
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6484696696442157,-1.610918408963212,0.014256619144602852,0.2914166494689989,1.0,9/12,22.50%,KHDRBS1;PTPN14;BMP4;RBM4;SIRT7;TGFB1;AAAS;NEDD4;NUP214
prerank,protein import into mitochondrial matrix (GO:0030150),0.6091460999869966,1.610464013154242,0.03429602888086643,0.6998040481779213,1.0,6/18,9.74%,TOMM20;ROMO1;TIMM17B;GRPEL2;TOMM40L;TIMM21
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4494684758470209,1.6087458123570428,0.0013850415512465374,0.6963819101707208,1.0,33/109,14.00%,PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;MAP3K7;VAV3;TAB2;PPP3CB;PSMD11;PSMB4;PSMC1;MAPK8;SYK;LCP2;TAB3;PLCG1;RELA;LYN;PSMC2;PAK1;PSMD2;PPP3CA;PPP3R1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,membrane assembly (GO:0071709),-0.48991164960863803,-1.6063880665942394,0.017632241813602016,0.29958409086764604,1.0,12/34,12.30%,ANK3;NRXN1;ANXA2;NLGN2;UBXN2A;FLOT2;NLGN1;UBXN2B;TLCD2;NSFL1C;NRXN2;IL1RAPL1
prerank,connective tissue development (GO:0061448),-0.48987795775138593,-1.6045827623393005,0.015228426395939087,0.300906959062462,1.0,11/35,13.83%,SULF1;PKD1;ITGB8;SOX5;SULF2;ATP7A;CREB3L2;SLC39A13;LRP5;DDRGK1;PGRMC2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.4531039810000726,-1.6018494168934634,0.00821917808219178,0.30527187382546644,1.0,19/46,27.98%,FOXP1;IGF1;PDGFRB;IGFBP5;CTNNB1;IL6R;BMP4;OGN;THBS1;IL18;TCF7L2;RBPMS2;APOD;STAT1;CX3CL1;AKT1;NDRG4;CCN4;TRIB1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7052719212445946,1.6016805301625832,0.01303538175046555,0.7252753574688694,1.0,2/10,2.51%,PTPRC;FCGR2B
prerank,camera-type eye development (GO:0043010),-0.5323013111399493,-1.6012698238216267,0.01699029126213592,0.30376158634777944,1.0,6/25,6.85%,TENM3;CACNA1C;FBN1;EFEMP1;FBN2;SKI
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5115247056860669,-1.6004089004037025,0.018957345971563982,0.30253927037633815,1.0,8/29,10.53%,PKD1;IFNAR2;FER;STAT2;GHR;IL31RA;STAT6;SOCS2
prerank,sulfation (GO:0051923),-0.6646036650294251,-1.5994979513979477,0.020703933747412008,0.30152351413016665,1.0,2/11,1.14%,UST;HS3ST5
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.6401973992562914,-1.5987602007784725,0.015021459227467811,0.30013610684800446,1.0,9/12,28.52%,UST;DSE;VCAN;CSPG4;DSEL;BGN;DCN;CSPG5;CHST12
prerank,regulation of protein metabolic process (GO:0051246),0.5235393848257001,1.5969565662294811,0.00641025641025641,0.7403019138951675,1.0,18/44,16.45%,KLF2;MAP2K5;SPOP;LTBP4;NEDD4L;APOE;WFS1;TMEM9;MAPK8;TRAF3;MDM2;SPOPL;APP;CHEK2;FAF1;VPS35;ODC1;FKBP1A
prerank,potassium ion transmembrane transport (GO:0071805),-0.3708635723529895,-1.5943367361147005,0.0,0.3088782905322988,1.0,36/135,19.93%,ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;HCN1;NALCN;KCNH7;KCNQ5;SLC1A3;KCNC2;KCND2;ATP1B1;ATP1B3;SLC12A2;KCNH5;ATP1A1;KCNK5;KCNJ2;KCNA1;ATP1B2;SLC24A2;KCNK10;KCNJ6;SLC9A2;ABCC9;SLC12A6;KCNJ13;KCNS3;SLC12A4;KCNQ4;ATP1A3;SLC12A9;KCNJ10;KCNA6;KCNA2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4513671760756506,1.5929596121434995,0.0057553956834532375,0.7514231476308638,1.0,31/94,14.28%,PSMB10;PSMC4;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;IL1R1;MAP3K7;TAB2;RPS6KA4;RPS6KA5;PSMD11;PSMB4;PSMC1;TAB3;RELA;PSMC2;PLCB1;PSMD2;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1;MAP3K3
prerank,"phototransduction, visible light (GO:0007603)",0.6660377692110766,1.590792025778537,0.02404809619238477,0.7515904584696134,1.0,4/14,8.84%,SAG;GNAQ;GNB1;GNA11
prerank,Fc receptor signaling pathway (GO:0038093),0.4436805802928278,1.5901624840091464,0.0013831258644536654,0.741149392715596,1.0,33/110,14.00%,PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;MAP3K7;VAV3;TAB2;PPP3CB;PSMD11;PSMB4;PSMC1;MAPK8;SYK;LCP2;TAB3;PLCG1;RELA;LYN;PSMC2;PAK1;PSMD2;PPP3CA;PPP3R1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of biosynthetic process (GO:0009889),0.7012316284736659,1.588138367694598,0.033962264150943396,0.740793576146815,1.0,2/11,7.38%,PCK1;PIKFYVE
prerank,muscle contraction (GO:0006936),-0.3740622019351421,-1.5867917395851785,0.0,0.32586205886354774,1.0,20/126,10.09%,SORBS1;CALD1;GNAO1;PABPN1;TMOD2;SNTA1;TPM1;VIM;TLN1;PXN;ROCK2;VCL;ITGB5;EDNRA;ROCK1;GLRA1;GJC1;SMTN;MYOF;ACTN2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5811786985959017,-1.584015276149498,0.022321428571428572,0.3301339183370282,1.0,6/17,7.60%,ATP1A2;TFPI;BMP7;MED1;BMP4;ATP1A1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6370149579323794,-1.5839179561589287,0.032119914346895075,0.3270963848440915,1.0,7/12,13.20%,ANK3;ATP1B1;WNK1;ATP1B3;ATP1B2;WNK4;WNK3
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.5271517710059382,-1.583813384804024,0.018306636155606407,0.3240517140920836,1.0,5/25,6.53%,CTNNA3;PARVA;CXADR;JAM3;ITGA5
prerank,retina homeostasis (GO:0001895),0.5851098729019476,1.576566326241998,0.025735294117647058,0.7995016002277325,1.0,5/23,5.45%,SOD1;POC1B;POTEF;ACTB;B2M
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5908374421887697,1.576082543379382,0.023090586145648313,0.7881473379719623,1.0,7/20,10.33%,MAPK3;DIP2A;RUVBL2;RPS6KA4;RPS6KA5;DIP2B;PRKAA2
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.5413395913471698,-1.5760526967762876,0.01948051948051948,0.341893020298976,1.0,6/22,5.85%,FGFR2;NOTCH2;MED1;KLF9;SRSF6;EPB41L4B
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5439284543020068,-1.5759356433304226,0.018223234624145785,0.33887391190844635,1.0,12/22,26.44%,KAT7;ERCC6;ELL;DDX39B;CDC73;BRD4;CCNT1;THOC5;CCNK;CDK12;THOC1;SUPT4H1
prerank,T cell proliferation (GO:0042098),0.6609040240584293,1.575276659878849,0.025390625,0.7793449302765431,1.0,3/13,2.55%,CADM1;PIK3CG;PPP3CB
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5873970326477278,1.5729523076016318,0.03315881326352531,0.7808163233487175,1.0,7/20,8.20%,BBS12;CCT2;NDUFAF1;PFDN6;LONP1;PSMG1;TMEM35A
prerank,renal system development (GO:0072001),-0.44603432552980526,-1.5721356731007317,0.014285714285714285,0.34660193100265163,1.0,25/52,24.82%,SULF1;GREB1L;PKD1;GLI2;PCSK5;TGFBR1;SULF2;BMP4;WNT4;RBP4;FOXC1;PYGO1;SALL1;ITGA8;ACE;TBX18;PYGO2;SIX1;STAT1;AGTR1;BAG6;VEGFA;STRA6;IFT88;PAX2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5205946869208387,-1.5716146375094833,0.018867924528301886,0.34489026202034345,1.0,13/25,26.44%,ELL;LDB1;CDC73;RNF168;RNF8;BRD4;NELFB;WDR43;EAF1;NELFA;CDK12;LARP7;SUPT4H1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5260855006738853,-1.571171291667884,0.02947845804988662,0.3427586100638798,1.0,10/24,17.34%,CTNNA2;BOC;CDON;CTNNA1;MAPK14;CTNNB1;RBM4;CAMK1;OLFM2;CDC42
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5664754693780292,-1.5691883609203963,0.038636363636363635,0.3451716914789879,1.0,6/19,7.87%,ERBB4;FGFR2;TGFBR3;TGFBR1;VGLL4;RBP4
prerank,neural tube development (GO:0021915),-0.5910416389477495,-1.5689844669530506,0.030837004405286344,0.3425591055583018,1.0,6/15,17.26%,ALDH1A2;PKD1;ARL13B;DACT1;TGFB1;DVL1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5338226045201291,-1.5662952667973578,0.018823529411764704,0.3466684518966948,1.0,14/23,26.13%,GLI3;TULP3;GLIS2;MGRN1;ENPP1;VCP;GPC3;BTRC;RACK1;HERC4;KCTD6;PTCH1;GPR161;SUFU
prerank,glutathione biosynthetic process (GO:0006750),0.6847032990798408,1.5656339119633265,0.04263565891472868,0.8139687181368621,1.0,5/11,13.17%,GCLC;GCLM;CNDP2;HAGH;GSS
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.672009057433144,1.5639653910400124,0.036893203883495145,0.8112225099204967,1.0,6/12,15.46%,GCLC;GCLM;CNDP2;HAGH;GSS;BDH2
prerank,regulation of lipid catabolic process (GO:0050994),0.6021149928513423,1.563704907319123,0.030249110320284697,0.7996081071414011,1.0,1/19,0.14%,CIDEA
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6411681833781603,1.5615112245975258,0.03377110694183865,0.7882375401952343,1.0,2/14,2.40%,HMOX2;ABCG2
prerank,heme catabolic process (GO:0042167),0.6411681833781603,1.5615112245975258,0.03377110694183865,0.7882375401952343,1.0,2/14,2.40%,HMOX2;ABCG2
prerank,regulation of phospholipase C activity (GO:1900274),-0.5946477242837361,-1.5598800174191674,0.031914893617021274,0.3625775947389417,1.0,5/15,6.19%,NTRK3;BICD1;PDGFRB;KIT;PDGFRA
prerank,dermatan sulfate metabolic process (GO:0030205),-0.6059742566194752,-1.55950269068369,0.01956521739130435,0.36068033756471907,1.0,9/13,28.52%,UST;DSE;VCAN;CSPG4;DSEL;BGN;DCN;CSPG5;CHST12
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5425113123780875,-1.5587260543954011,0.022271714922048998,0.3595919622913343,1.0,6/20,9.97%,KCNB2;CHRM2;PLCE1;CTTN;CHRM3;ZDHHC21
prerank,actin polymerization or depolymerization (GO:0008154),-0.43670774688968417,-1.5585604783721654,0.0223463687150838,0.3568561311785702,1.0,14/50,7.49%,SVIL;GSN;GAS7;MICAL2;SPIRE1;WASL;ABI1;MICAL3;PSTPIP2;ARHGAP6;WASHC5;WASHC3;WASF1;COBL
prerank,central nervous system neuron development (GO:0021954),-0.5886027687751887,-1.5578201260057267,0.029850746268656716,0.3557507709366699,1.0,9/15,29.30%,MAP2;NTRK2;MAPT;ATP7A;B4GALT6;RAPGEF2;LHX6;HSP90AA1;GBA2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6653683455726574,1.5574295159974398,0.03795066413662239,0.8021897945853798,1.0,6/13,16.29%,PTPRC;PTPRT;MGAT5;DOT1L;HES1;PIGU
prerank,ceramide metabolic process (GO:0006672),0.4856826657220108,1.5564801205339058,0.015552099533437015,0.7959473046227334,1.0,8/49,6.76%,CERS1;ACER2;SMPD4;ST6GALNAC3;CERS4;PPP2CA;SGMS1;PLPP1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5585973062112524,-1.5557819785137168,0.018223234624145785,0.35867455784633545,1.0,6/19,12.92%,DLG2;LRRC7;PARD3B;CLIC4;DLG3;DLG1
prerank,regulation of nervous system process (GO:0031644),-0.5546518778173718,-1.5547975228012125,0.02947845804988662,0.3585466530526994,1.0,6/18,8.13%,DLGAP1;HTR2C;DLGAP2;DLGAP4;ROCK2;AKAP9
prerank,axonal fasciculation (GO:0007413),-0.6352531651321147,-1.5531024963210611,0.035789473684210524,0.3603522480440286,1.0,4/12,10.80%,CNTN4;NRCAM;EPHB2;EPHA3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5173630171001371,-1.5520893492548538,0.02877697841726619,0.36037659139215655,1.0,12/25,14.18%,ANK2;ANK3;ATP1B1;WNK1;ATP1B3;SLC6A9;AKAP9;ATP1B2;ACTN2;WNK4;WNK3;NDUFA4
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.6013845320236695,1.5520564706044837,0.03656307129798903,0.8118534662720818,1.0,2/16,5.41%,PTPRC;CYRIB
prerank,metanephros development (GO:0001656),-0.5150144434440693,-1.5517364995162752,0.02588235294117647,0.35836771974947723,1.0,7/26,7.76%,ROBO2;PKD1;FOXD1;BMP7;BMP4;OSR1;NIPBL
prerank,ganglion development (GO:0061548),-0.6453189994296474,-1.551248995855062,0.03067484662576687,0.35672539462075703,1.0,5/11,9.78%,NRP1;CTNNB1;UNC5C;SEMA3A;NRP2
prerank,T cell receptor signaling pathway (GO:0050852),0.4182141778207724,1.5505571762073174,0.0013513513513513514,0.8095343120357759,1.0,37/138,15.09%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PTPRJ;PDE4D;PTPRC;MAP3K7;TAB2;PRKD2;PSMD11;PSMB4;FYN;PSMC1;PAK3;SPPL3;LCP2;PRAM1;PLCG1;EIF2B3;RELA;RBCK1;INPP5D;PSMC2;PAK1;PSMD2;PIK3CD;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;PAG1;DENND1B
prerank,positive regulation of ossification (GO:0045778),-0.4615706191640301,-1.549100308092105,0.016666666666666666,0.359655161264212,1.0,18/39,21.81%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CCN1;PKDCC
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6021271751537698,1.5490905849545815,0.030249110320284697,0.8072432547588946,1.0,7/19,15.11%,KLF2;MAP2K5;PAX8;WFS1;MAPK8;APP;SLCO1C1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6217083406419355,-1.5490070653948869,0.0368763557483731,0.3570194389178792,1.0,5/11,30.06%,BIN1;CAMK2D;CACNA2D1;CACNB1;NOS1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.47707196533547913,-1.5487196991878776,0.03496503496503497,0.35489064049614405,1.0,13/31,17.34%,FGFR2;CTNNA2;BOC;CDON;CTNNA1;MAPK14;CTNNB1;RBM4;CAMK1;IGF2;MEGF10;CDK9;CDC42
prerank,T cell activation involved in immune response (GO:0002286),0.6625467182625623,1.5460152428290317,0.04093567251461988,0.815033404823976,1.0,2/12,6.67%,LCP1;ICAM1
prerank,endoderm formation (GO:0001706),-0.4690041630478482,-1.5444738470769304,0.024752475247524754,0.36364196728023107,1.0,13/35,22.51%,COL8A1;COL11A1;MMP14;COL12A1;ITGB5;COL6A1;ITGA5;VTN;FN1;LAMB1;ITGA4;MMP2;DUSP1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6689716901387657,-1.5441991599526959,0.03611738148984198,0.3613481012840321,1.0,4/10,17.88%,ROCK2;ROCK1;IL18;TMBIM1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5214588704239834,1.5427426351516456,0.025817555938037865,0.8241986409515047,1.0,8/33,11.93%,PHPT1;PTPRJ;SH2D1A;PRKD2;RELA;CD81;RPS3;PRNP
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.5364286315141157,1.540966918044617,0.023769100169779286,0.8240133173076579,1.0,9/30,8.88%,CERS1;DACH1;CTC1;SRC;ERCC4;CDKN1A;HNRNPC;ACD;ACVRL1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.5445366261409854,-1.539413305802874,0.028169014084507043,0.37228835052774595,1.0,8/20,17.87%,B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;B3GALT1;ST6GALNAC6;MPDU1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.6285816399947495,-1.5383865501489344,0.035416666666666666,0.37217132466930486,1.0,4/12,10.13%,DPYD;DPYSL3;CTPS1;ALDH6A1
prerank,skin development (GO:0043588),-0.4064919004036207,-1.5374931337154614,0.014367816091954023,0.37161068288652227,1.0,12/65,6.02%,COL1A2;COL1A1;PKD1;COL3A1;ERRFI1;COL5A1;CLIC4;COL5A2;MED1;ATP7A;BCR;PIP5K1A
prerank,histone H2B ubiquitination (GO:0033523),-0.65618270816436,-1.5361890679366752,0.042105263157894736,0.37257920787325505,1.0,7/10,21.11%,WAC;UBE2E1;CDC73;RNF8;PAF1;RNF40;DTX3L
prerank,amide biosynthetic process (GO:0043604),0.4826623113247195,1.5357361999175116,0.012422360248447204,0.8451876158802057,1.0,8/47,11.71%,PCSK1;CERS1;SMPD4;CERS4;SGMS1;DMD;SLC25A2;PAM
prerank,pre-replicative complex assembly (GO:0036388),0.46086466108923485,1.5352380760958266,0.018154311649016642,0.8369601846002895,1.0,18/64,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ORC3;PSMD11;PSMB4;PSMC1;ORC4;PSMC2;PSMD2;ORC2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,circulatory system development (GO:0072359),-0.36463848857208625,-1.5323776884228424,0.010101010101010102,0.38139157799213086,1.0,34/118,14.21%,ERBB4;NTRK3;FGF12;CACNA1C;FBN1;AKAP13;PDLIM5;PKD1;MICAL2;GLI2;ADAP2;COL3A1;NXN;PCSK5;CXADR;TGFBR1;NCOA6;TGFBR2;PLCE1;PDLIM7;OSR1;HSPG2;CDKN1B;RBP4;FOXC1;ACVR1;SALL1;FN1;STK11;FOXC2;MTHFD1;WDR11;PDLIM1;TCF25
prerank,cellular response to metal ion (GO:0071248),0.42553520243773846,1.531557919962036,0.0028208744710860366,0.8495358506214984,1.0,11/123,1.88%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;CPNE5;MAPK3;SLC25A24
prerank,membrane depolarization during action potential (GO:0086010),-0.49458003277861273,-1.5304301292182025,0.034912718204488775,0.38446326725906765,1.0,7/26,8.73%,ATP1A2;CACNA1C;CACNA1D;SCN8A;SCN3A;KCNJ2;SCN1A
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6847563022062743,1.5300500734694154,0.05058365758754864,0.8476526622377811,1.0,5/10,11.64%,MAPK3;GREM1;LYN;RNF13;NBR1
prerank,regulation of bone mineralization (GO:0030500),-0.4283401278199893,-1.5299061596677388,0.00804289544235925,0.38296219857800157,1.0,24/55,22.32%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;ENPP1;OSR1;WNT4;ANKH;ACVR1;KL;ECM1;ANO6;TGFB1;BMPR1B;BCOR;BMPR1A;BMPR2;TXLNG;CCN1;PKDCC;NOTUM
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.6370232002878624,-1.5292038232303762,0.023305084745762712,0.38198103243729686,1.0,7/11,30.49%,CAT;PRDX1;PRDX2;GPX1;PRDX3;PRDX4;PRDX5
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.527212344761893,1.5291924051628865,0.03608247422680412,0.8416556766157114,1.0,3/29,6.81%,CADM1;CYRIB;AP1G1
prerank,regulation of cardiac conduction (GO:1903779),-0.4218067617016612,-1.5289188515736585,0.022284122562674095,0.3799937495629199,1.0,13/54,10.33%,ANK2;ATP1A2;ITPR1;RYR3;ATP1B1;STIM1;TMEM65;ATP1B3;ATP1A1;TRPC1;ATP1B2;PRKACA;DMPK
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.4955413362187059,1.5267098545882436,0.015698587127158554,0.8467489343630218,1.0,13/38,18.84%,MIS18A;ASF1B;HJURP;RUVBL1;RSF1;CENPC;CABIN1;CENPP;RBBP4;CENPO;NPM1;ATRX;HAT1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.58080144119971,-1.5267063056120318,0.04112554112554113,0.38342325432563323,1.0,5/16,10.68%,ANK2;ATP1A2;CACNA1C;PRKACA;CAMK2D
prerank,inorganic anion transport (GO:0015698),-0.4134785036104074,-1.5264090054182975,0.008955223880597015,0.3813792985217818,1.0,20/53,27.11%,SLC4A10;CLIC4;SLC26A7;ENPP1;SLC13A4;GLRA1;CLCN6;ANO1;CLCN2;ANO6;SLC26A11;ENPP3;CLIC5;SLC5A5;ANO10;TTYH3;SLC25A30;SLC25A11;TTYH1;FXYD1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.6364551151063937,-1.525758435608903,0.039603960396039604,0.380313835192743,1.0,5/10,16.52%,BICD1;UBXN2B;GSK3B;NSFL1C;CEP250
prerank,cellular response to drug (GO:0035690),0.5544181240051869,1.5240230654831275,0.036020583190394515,0.8541828591301859,1.0,4/25,2.08%,CERS1;RBM22;RAP2A;ACER2
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.3953416195958791,-1.5235755513010256,0.013377926421404682,0.38384760010647573,1.0,24/70,21.89%,TMEFF2;PARVA;NTNG1;NRP1;FER;LAMC3;RHOA;RILPL1;PXN;RELN;SRCIN1;RADIL;FN1;ILK;ARL13B;NTN4;UNK;ITGA8;LAMB1;ITGA4;PIK3R1;SIPA1L3;ATF4;RILPL2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.47317574870561413,1.5233986366792218,0.022727272727272728,0.8472720864979937,1.0,9/52,6.17%,PCK1;ALDH1L1;GCLC;ALDH5A1;SDHAF3;ME3;GOT2;GCLM;MTHFS
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5348740364652855,-1.5216288742943114,0.053117782909930716,0.38687100562289906,1.0,6/18,16.22%,DDX5;EGFR;BMP4;MAP2K2;TP53;TGFB1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.5824554934405306,-1.5207876620804983,0.03418803418803419,0.38644023237630054,1.0,6/14,17.45%,MALT1;PRKCZ;ANXA1;RARA;IL18;SOCS5
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6687333026224082,1.5185686250803907,0.05904761904761905,0.867140672171237,1.0,3/10,13.00%,PRKAR1A;PRNP;CD274
prerank,neuromuscular synaptic transmission (GO:0007274),0.5925515335170344,1.5180602220355477,0.05871559633027523,0.859903807932945,1.0,5/18,12.73%,SLC5A7;KIF1B;DTNA;TBC1D24;ERC1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3787870426567524,1.5169794127321663,0.0,0.8560146987422478,1.0,74/306,14.74%,POLR2J;RPL30;MRPS33;NR4A2;RSL24D1;EEF1A1;POLR2B;MRPL23;RPL17;RPL23;MRPL24;RPL31;RPL3;EEF1D;RPS21;ING4;MRPL18;PAX8;ORC3;EXT2;APOE;RAD1;RPL35A;RPS14;RPL8;YARS2;RPL5;ABCF1;PWP1;MRPS12;RPS12;POLE;CDC45;HBS1L;RPS26;RPL37A;HARS1;ORC4;RPL4;POLD3;RPLP0;POLA1;TSFM;RPS28;RPS24;EIF4G2;TERT;RPS9;RPS23;RPL24;THRB;RPL34;GTPBP2;HUS1;RPS11;ORC2;MRPL52;RPS3;TOP3A;MRPS15;NBN;DHPS;HELB;RRAGC;ING5;PPP5C;EEF1B2;RPS15A;RPL23A;RPL21;RPL35;RMI1;BAZ2A;BRIP1
prerank,embryonic digit morphogenesis (GO:0042733),-0.5438746553548515,-1.516554030721097,0.04484304932735426,0.39626345754312026,1.0,7/18,14.48%,GLI3;HDAC1;OSR1;MAP3K20;SALL1;TBX3;INTU
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.4310291681581757,-1.5153610692329464,0.033426183844011144,0.39710426135051036,1.0,17/46,20.01%,TMEFF2;PARVA;NTNG1;NRP1;FER;LAMC3;RHOA;PXN;SRCIN1;RADIL;FN1;ILK;NTN4;ITGA8;LAMB1;ITGA4;PIK3R1
prerank,regulation of chemotaxis (GO:0050920),-0.4801287499119301,-1.5150106731883513,0.02364066193853428,0.3955348347512351,1.0,14/30,21.62%,PDGFRB;ADGRA2;EFNB2;P2RX4;PDGFRA;ZSWIM8;YTHDF1;STX3;THBS1;TGFB1;PTPN2;ZSWIM4;PPM1F;P2RY12
prerank,regulation of cell cycle phase transition (GO:1901987),0.434205402621065,1.514573482871991,0.015918958031837915,0.8603038566044455,1.0,25/91,14.00%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;NEK11;PSMD11;PSMB4;PSMC1;CDKN1A;FBXO5;ANAPC7;PSMC2;TFAP4;PSMD2;ANAPC11;ANAPC10;ANAPC4;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.554361942392043,-1.5142844710467331,0.031026252983293555,0.3948023298153273,1.0,3/17,8.13%,ANK2;SNTA1;AKAP9
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5674755433505995,1.512489516399611,0.044036697247706424,0.8640579209886954,1.0,7/22,10.57%,TNFAIP3;TIRAP;IFI35;RAB7B;WDFY1;LYN;MFHAS1
prerank,embryonic organ morphogenesis (GO:0048562),-0.4486401621644157,-1.5122496081936618,0.02278481012658228,0.39807941474257136,1.0,11/42,9.13%,FGFR2;FBN1;EFEMP1;FBN2;HOXA3;DYNC2I1;PDGFRA;MFAP5;NIPBL;RBP4;ACVR1
prerank,Rap protein signal transduction (GO:0032486),0.6866101869354244,1.5106723591036617,0.04462474645030426,0.8655093914934295,1.0,4/10,12.23%,RAP2A;PLK2;RAPGEF3;RAP2C
prerank,positive regulation of protein binding (GO:0032092),0.46664521896952166,1.510419634288606,0.00949367088607595,0.8568726216554649,1.0,16/56,11.27%,TRIB3;RALB;PIN1;TIAM1;HIPK2;PPP2CA;APOE;B2M;PPP2CB;BDNF;SPPL3;EPB41;AKTIP;CLDN5;TERT;APP
prerank,negative regulation of catalytic activity (GO:0043086),0.551262557765186,1.5091691716636917,0.047038327526132406,0.8546004978165668,1.0,7/24,10.40%,PHPT1;CAND1;IFIT1;SIRT1;NOTCH1;PPP1R12A;CCAR2
prerank,nerve growth factor signaling pathway (GO:0038180),-0.6433231134804988,-1.5052696473755371,0.04182509505703422,0.4167460483171814,1.0,1/10,0.01%,MAGI2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.7091175799697761,1.5041511662923241,0.034552845528455285,0.8751523024390169,1.0,6/10,10.33%,DIP2A;DIP2B;SIRT1;SETD5;PARK7;PRKAA2
prerank,kidney development (GO:0001822),-0.4009080895624936,-1.5028896951075887,0.01744186046511628,0.42113765227271005,1.0,17/65,9.91%,ROBO2;SULF1;GREB1L;KANK2;PKD1;GLI2;PCSK5;TGFBR1;BMP7;SULF2;BMP4;OSR1;WNT4;NIPBL;FOXC1;PYGO1;SALL1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3978303725333482,1.5027459023851464,0.005263157894736842,0.8739722196448957,1.0,38/163,14.50%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PTPRJ;PDE4D;PTPRC;MAP3K7;VAV3;TAB2;PRKD2;PSMD11;PSMB4;FYN;PSMC1;PAK3;SYK;SPPL3;LCP2;PRAM1;PLCG1;EIF2B3;RELA;RBCK1;INPP5D;PSMC2;PAK1;PSMD2;PIK3CD;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;PAG1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.641891929963811,1.5021134961816551,0.047706422018348627,0.8682014503169151,1.0,4/12,10.51%,BOD1;CHAMP1;CENPC;MIS12
prerank,dopamine metabolic process (GO:0042417),-0.548014868811294,-1.501251626188178,0.04319654427645788,0.4238146420338404,1.0,5/18,13.42%,MOXD1;SNCAIP;ATP7A;COMT;MAOB
prerank,regulation of T cell cytokine production (GO:0002724),0.6031589775245982,1.4985018088640563,0.06319702602230483,0.8808821621280748,1.0,6/15,12.57%,MAP3K7;TNFRSF1B;B2M;SMAD7;TRPM4;CD55
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.5681027991059885,-1.498243681537918,0.032119914346895075,0.4299721732968199,1.0,8/16,21.76%,PID1;PPARGC1A;VCP;PPARA;ATPSCKMT;PARP1;PINK1;FLCN
prerank,negative regulation of glycolytic process (GO:0045820),-0.64099435502828,-1.4960404089917305,0.03991596638655462,0.4312014952531182,1.0,3/10,6.59%,HDAC4;NUPR1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.64099435502828,-1.4960404089917305,0.03991596638655462,0.4312014952531182,1.0,3/10,6.59%,HDAC4;NUPR1;PPARA
prerank,positive regulation of biosynthetic process (GO:0009891),-0.4332372529612499,-1.4948981934737582,0.031088082901554404,0.43184515674264123,1.0,7/40,8.00%,ZBTB20;SORBS1;VIM;BMP4;PPARA;WNT4;CREBL2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5092701879939746,-1.493628816818174,0.047058823529411764,0.4326590014465914,1.0,7/23,9.05%,IGF1;AKAP6;MAPK14;EFNB2;MAML1;MMP14;NIBAN2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.40196769772991936,-1.4933337177761588,0.020172910662824207,0.43088867832569605,1.0,23/66,17.43%,FGFR2;TGFBR3;SULF1;ROBO1;NR2F2;NFIB;MCC;MTSS1;MED1;KLF9;NUPR1;XDH;SPARC;CDC73;THBS1;CDK6;AIMP1;CAV2;MAGED1;PEX2;TGFB1;ATP5IF1;SCG2
prerank,receptor signaling pathway via STAT (GO:0097696),-0.4945313378393811,-1.4928575853893715,0.04666666666666667,0.42947931662312144,1.0,7/25,10.53%,PKD1;IFNAR2;STAT2;GHR;IL31RA;STAT6;SOCS2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5142369492323808,1.4921431036753523,0.033783783783783786,0.9113138460835576,1.0,4/32,6.03%,ROMO1;RPL30;RNASE6;FAM3A
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6021635829634296,1.4902977197563307,0.06228373702422145,0.9133446485644138,1.0,5/15,9.76%,RPL23;RPL5;FBXO5;SMAD7;PARK7
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5354164362022142,-1.4894543114009147,0.039603960396039604,0.43726396030433184,1.0,13/18,26.67%,RIMS1;NRXN1;DLG4;NLGN2;PRKCZ;RELN;NLGN1;CUX2;SHANK1;GRIN1;NLGN3;CHRNA7;STX1B
prerank,neuron development (GO:0048666),-0.3478161786682673,-1.487823940834486,0.0,0.4398354472401011,1.0,42/141,17.06%,TENM2;MAP2;CNTN4;TENM3;PLP1;PBX1;PPP1R9A;MYT1L;GPM6B;GLI2;NTRK2;HDGFL3;SH3GL2;RASGRF1;RYK;MAPT;WNK1;ATP8A2;GPM6A;ATP7A;ERCC6;ROCK1;STMN2;ETV1;TDP2;NLGN1;CDK16;STX3;B4GALT6;GSK3B;DCX;UGDH;RAB11A;UNK;BICDL1;STMN1;SRRM4;RAPGEF2;EHD1;GPRIN3;PBX4;LAMB1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.5225676898970463,-1.4869145676892679,0.0367816091954023,0.4398518011017982,1.0,11/21,22.63%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;GUCY1A1;NPR1;ADCY3;ADCY8;GUCY1B1;ADCY4
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5963591127353579,-1.4868941026992262,0.045454545454545456,0.4371108959865526,1.0,5/12,18.14%,RIMS1;UNC13C;UNC13B;SYT7;SYT2
prerank,neuron cell-cell adhesion (GO:0007158),-0.5749342673437314,-1.4864649811115536,0.0518018018018018,0.43554304928248244,1.0,7/14,11.97%,NRXN3;CNTN4;NRXN1;NCAM2;NLGN2;NLGN1;NRXN2
prerank,axonal transport of mitochondrion (GO:0019896),-0.6058728297614182,-1.485694884090355,0.04781704781704782,0.4351757677592231,1.0,4/11,16.18%,MAPT;TRAK1;NEFL;ACTR10
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.5001727884261508,-1.4851024630979794,0.024691358024691357,0.43424380213031866,1.0,4/25,8.60%,ANK2;AKAP6;CEMIP;TRPC1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.5076277968826896,1.4850225104514367,0.03672787979966611,0.9366993451305043,1.0,12/32,16.46%,MAP2K7;MAPK3;PNKP;CCT2;CCT5;MAP3K4;ACD;NEK7;TNKS;ATR;TCP1;PARN
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5904063125878648,1.48443537604248,0.07272727272727272,0.9307347207934099,1.0,7/16,18.78%,NAA25;EP300;NAA35;CREBBP;NAA80;NAA15;NAA50
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.44356592340802703,1.48351439496707,0.024279210925644917,0.9268359623192665,1.0,20/70,14.46%,PSMB10;PSMC4;PSMB6;MFSD6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;B2M;PSMC2;PSMD2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;CYBA
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5421406716492392,-1.4834572346546155,0.04783599088838269,0.4366269420836481,1.0,5/17,7.72%,HDAC4;PID1;NUPR1;PPARA;FIS1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.5042198518268705,1.4831775868620503,0.05110732538330494,0.9193900105673233,1.0,9/31,10.17%,TOMM20;ROMO1;TIMM17B;PEX1;PEX7;GRPEL2;TOMM40L;TIMM21;AIFM1
prerank,positive regulation of receptor internalization (GO:0002092),-0.5195677520975154,-1.4830446744537684,0.04367816091954023,0.43531572587446327,1.0,2/22,1.74%,MAGI2;AHI1
prerank,regulation of blood circulation (GO:1903522),-0.4559329998240337,-1.4819209253058099,0.04591836734693878,0.43609025403764373,1.0,20/34,40.00%,CELF2;TPM1;PER2;DMPK;CAMK2D;SRI;ACE;BDKRB2;AGTR1;TBX2;FXYD1;KCNQ1;KCNJ12;DES;S100A1;KCNMB4;CACNA1H;ACE2;AGT;KCNIP2
prerank,hexose metabolic process (GO:0019318),0.49073246323559644,1.4814565584368258,0.038523274478330656,0.9205575009985827,1.0,7/39,8.49%,PCK1;HECTD4;FUCA1;PPARD;OMA1;IRS2;GALM
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.553330806430124,-1.4813420422234533,0.0472972972972973,0.4353467733377776,1.0,7/16,18.54%,IGF1;AKAP6;ROCK2;ROCK1;CAMK2D;IL6ST;PARP1
prerank,plasma membrane invagination (GO:0099024),-0.45995140192763523,-1.4803193343403818,0.03881278538812785,0.4358800368612996,1.0,6/29,5.56%,GULP1;GSN;DOCK1;SPIRE1;RHOA;ARHGAP12
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.428249516133902,1.4796548716695404,0.019230769230769232,0.9221881697621482,1.0,22/84,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;PSMD11;PSMB4;PSMC1;FBXO5;ANAPC7;PSMC2;PSMD2;ANAPC11;ANAPC10;ANAPC4;CUL3;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5850749705568908,1.4780349439824547,0.06133828996282528,0.9225860304484752,1.0,2/17,6.81%,CADM1;AP1G1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5919912492753134,1.4780199137168168,0.062381852551984876,0.9135235341795264,1.0,2/16,6.81%,CADM1;AP1G1
prerank,mitochondrial fusion (GO:0008053),0.5719676396645089,1.477966077369551,0.05027932960893855,0.9048883287736578,1.0,2/18,0.19%,THG1L;MIGA1
prerank,regulation of immune effector process (GO:0002697),0.47748471156564226,1.4756651214102068,0.0492845786963434,0.9102447521229522,1.0,6/41,12.57%,C1QB;C1QC;FCGR2B;PHB2;CD81;CD55
prerank,cellular response to alcohol (GO:0097306),-0.433196444714814,-1.4756444952883705,0.03076923076923077,0.44745733436305063,1.0,20/42,21.65%,ADCY5;GRAMD1B;ADCY2;CTNNA1;SPIDR;ADCY1;CTNNB1;KLF9;SMO;GLRA1;GRAMD1C;CDH1;ADCY7;GRAMD1A;LRP6;GPLD1;OSBPL7;BLM;ADCY3;ADCY8
prerank,heterocycle biosynthetic process (GO:0018130),0.6102585582830065,1.4735900644330162,0.05740740740740741,0.9149910920634747,1.0,2/14,0.85%,GPHN;MOCS3
prerank,iron ion transmembrane transport (GO:0034755),-0.6302742690010827,-1.4718431954830977,0.046357615894039736,0.4573208371158128,1.0,5/10,22.60%,SLC39A14;SCARA5;SLC39A8;SLC11A2;SLC25A28
prerank,protein localization to cell surface (GO:0034394),-0.4821576390438506,-1.471039144546051,0.050239234449760764,0.45707188442255103,1.0,13/26,23.93%,ANK2;CTNNB1;FLNA;JAM3;VCL;USP4;GGA2;MESD;PTPRU;GGA3;PRRT1;UNC50;EMP2
prerank,bone development (GO:0060348),-0.43732747339293854,-1.4709052258946498,0.028205128205128206,0.45483581247175503,1.0,17/39,22.32%,FGFR2;RANBP3L;SULF1;AKAP13;SULF2;SKI;LRP5;GJA1;TP53;DYM;CYP26B1;LRP6;MBTPS2;SFRP4;P3H1;SH3PXD2B;NOTUM
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.5413601826943836,1.470733715830414,0.050933786078098474,0.9236563339489308,1.0,8/24,15.25%,TNFAIP3;RAMP2;TEK;KRIT1;ICAM1;TNIP2;CDH5;GAS6
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.45744275168724124,-1.4704893088006983,0.03773584905660377,0.4535720896896795,1.0,5/31,4.07%,FGFR2;TGFBR3;TGFBR1;SMAD4;TPM1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3827974235438921,-1.4703286641273996,0.018518518518518517,0.4515205102607435,1.0,22/82,11.96%,DDX5;BMP6;FGFR2;RANBP3L;IGF1;SMOC1;NELL1;BMP7;IL6R;BMP4;FBN2;CRIM1;WNT4;SKI;TMEM64;LRP5;SMAD6;ACVR1;PRKACA;CDK6;SEMA4D;LIMD1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.5520736421283179,-1.4702581870941092,0.04721030042918455,0.4491787158937379,1.0,6/15,12.55%,FGFR2;TGFBR1;TGFBR2;PDGFRA;NIPBL;MTHFD1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4093715864592737,1.4699040358251791,0.019553072625698324,0.9197461186279544,1.0,27/114,14.00%,PSMB10;PSMC4;PSMB6;EIF5A;PSMD8;PSMD5;PSMD12;BIRC2;PSMD11;PSMB4;TNFRSF1B;PSMC1;EDAR;TRAF5;ACTN4;TRAF3;RELA;PSMC2;PSMD2;CDIP1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1
prerank,striated muscle tissue development (GO:0014706),-0.4669625474722688,-1.4698321592858496,0.06234413965087282,0.4480538282621933,1.0,6/29,7.87%,SVIL;CFLAR;BMP5;BMP7;IGSF8;RBP4
prerank,microtubule-based transport (GO:0099111),0.61352132904146,1.469699117264982,0.07434944237918216,0.9125524571243837,1.0,2/13,2.17%,DYNC1I1;CABYR
prerank,regulation of cellular amine metabolic process (GO:0033238),0.4568605702701606,1.469680798513734,0.041033434650455926,0.9042039238262596,1.0,16/50,15.26%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1;ODC1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5639922350124066,1.4686426159725006,0.0544464609800363,0.9022564605842962,1.0,4/19,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.588240181483086,-1.4679842312684441,0.053418803418803416,0.4511379170488672,1.0,4/13,10.60%,ANK2;CACNA1C;GJC1;GJA1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.4595621001349557,-1.467769915089849,0.02977667493796526,0.4492946569179219,1.0,7/31,6.19%,FGFR2;TGFBR1;TGFBR2;HOXA3;OSR1;DYNC2I1;PDGFRA
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5342172671965847,1.4673360903296457,0.07017543859649122,0.9014933524837392,1.0,2/22,6.15%,CIDEA;ASXL3
prerank,positive regulation of catalytic activity (GO:0043085),0.4848965905342562,1.46724474169692,0.05218855218855219,0.8938796536456517,1.0,9/37,9.71%,MAPK3;SOD1;PSEN2;CIB1;MAPK8;CHTOP;YWHAB;SSBP1;MSH3
prerank,cellular response to light stimulus (GO:0071482),0.4394192910542033,1.4664838373923168,0.027777777777777776,0.8903717135615852,1.0,20/66,17.96%,GPR52;SAG;EIF2S1;RUVBL2;ERCC4;YY1;POLK;EP300;GNB1;USP47;CREBBP;BMF;INO80;TAF1;ATR;N4BP1;TMEM161A;USP28;NPM1;RPL26
prerank,neuron projection fasciculation (GO:0106030),-0.6296163073899325,-1.466198517114864,0.06012024048096192,0.4519021996084585,1.0,4/10,19.11%,CNTN4;NRCAM;EPHB2;SEMA5A
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3896446240501985,-1.4645521569810416,0.008450704225352112,0.45441052204233845,1.0,19/63,13.71%,MCU;GSN;PARVA;AUTS2;NRP1;CXADR;CDC42BPB;PTK7;FER;RHOA;FLNA;NEDD9;KIT;PIP5K1A;CTTN;EZR;ANXA1;GRB2;MKLN1
prerank,estrogen metabolic process (GO:0008210),0.5891887215655325,1.4640108898864508,0.07835820895522388,0.8975470529654413,1.0,4/15,11.73%,SULT1A1;HSD17B11;CYP1B1;HSD17B4
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5050485125700974,-1.4634767763313217,0.046460176991150445,0.45507668113404437,1.0,4/22,8.00%,ZBTB20;SORBS1;PPARA;CREBL2
prerank,regulation of cytokine production (GO:0001817),0.4023637584470735,1.4619748041243417,0.010554089709762533,0.9019645032964949,1.0,19/126,9.60%,CIDEA;CADM1;PIK3CG;PTPRC;SOD1;FCGR2B;RPS6KA4;HDAC9;BCL6B;RPS6KA5;TNFRSF1B;NPTN;RGCC;PPP1R11;TRAF3;CD47;POLA1;LYN;LURAP1
prerank,negative regulation of hippo signaling (GO:0035331),-0.6089241010921949,-1.4613911160073594,0.05128205128205128,0.45927441104950334,1.0,6/12,16.85%,WWC2;MAPK14;CIT;VGLL4;LIMD1;SHANK2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4313458098274839,1.4613420160708566,0.033973412112259974,0.8979322286060916,1.0,22/72,14.87%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TIRAP;BIRC2;PSMD11;TNFRSF10B;PSMB4;PSMC1;RELA;PSMC2;PSMD2;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;COPS8
prerank,regulation of mRNA processing (GO:0050684),0.5080968223936755,1.4612012177463878,0.05545927209705372,0.8909360684371184,1.0,13/32,10.59%,NCBP1;KHDRBS3;AHCYL1;ZFP36L1;SF1;QKI;HNRNPK;CPSF4;SRSF10;CDK11B;YTHDC1;PAPOLA;SRPK2
prerank,stem cell differentiation (GO:0048863),-0.4296798023097811,-1.4602271421955777,0.01837270341207349,0.46036892504999183,1.0,14/39,17.67%,FGFR2;PUM1;UFL1;JARID2;KIT;GPM6A;OSR1;TP53;NELFB;LMBR1L;MTF2;LRP6;METTL5;ACE
prerank,positive regulation of lipid localization (GO:1905954),-0.6095106530042169,-1.4601567901044075,0.05230125523012552,0.4580445812909888,1.0,4/11,14.24%,LRP1;NFKB1;IKBKE;VSTM2A
prerank,regulation of ERAD pathway (GO:1904292),-0.6243511387677262,-1.4595449553746849,0.06060606060606061,0.45734082103972684,1.0,9/11,26.03%,USP13;HERPUD1;TMEM259;USP19;RNFT1;BAG6;UBXN1;AQP11;RNF185
prerank,histone H2A acetylation (GO:0043968),0.5747023728721893,1.4589284481193048,0.0843806104129264,0.8967888384978021,1.0,7/16,13.10%,ACTL6A;RUVBL2;DMAP1;RUVBL1;YEATS4;ING3;TRRAP
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5192508219300745,1.458786872325408,0.05045045045045045,0.8900904660871258,1.0,9/25,15.70%,RPL23;PDCL3;PSME3IP1;HIPK2;RPL5;EFNA1;OPHN1;CSNK2A2;TAF1
prerank,synaptic vesicle cycle (GO:0099504),-0.45958849188385825,-1.4573655576752538,0.061068702290076333,0.4617854991775547,1.0,9/30,16.63%,RIMS1;SNAP25;PCLO;SYNDIG1;NLGN1;BRSK1;VAMP2;SYT7;STX1A
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.46064979823211755,1.4560832581550855,0.03685897435897436,0.898083048568972,1.0,5/53,6.74%,HRH4;MTNR1A;HTR1F;TSHR;HTR2A
prerank,7-methylguanosine mRNA capping (GO:0006370),0.5046861692797343,1.4558504421805136,0.05281090289608177,0.8846213441921867,1.0,6/31,8.79%,POLR2J;ERCC3;NCBP1;POLR2B;CCNH;GTF2H1
prerank,7-methylguanosine RNA capping (GO:0009452),0.5046861692797343,1.4558504421805136,0.05281090289608177,0.8846213441921867,1.0,6/31,8.79%,POLR2J;ERCC3;NCBP1;POLR2B;CCNH;GTF2H1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.4761201308811239,-1.4542207236146252,0.04186046511627907,0.46922790949831544,1.0,10/26,24.38%,SULF1;SULF2;CCBE1;IL6ST;RORA;TGFB1;SARS1;PTGS2;ATF4;EIF2AK3
prerank,cardiac myofibril assembly (GO:0055003),-0.5499707755992583,-1.4535685779151168,0.07792207792207792,0.46856053886692856,1.0,3/15,12.31%,PDGFRB;PDGFRA;OBSL1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.39871998643961015,1.4531830289912648,0.014864864864864866,0.8925516499148228,1.0,35/124,14.38%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;FRZB;LEF1;MAP3K7;TIAM1;PPP3CB;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;GNB1;CCDC88C;DAAM1;WNT5A;PSMC2;PLCB1;FZD9;FZD3;PSMD2;CELSR1;NLK;AGO4;PPP3CA;PPP3R1;PSMD14;PSMC6;PSMD1;PSMB1;AP2M1
prerank,neurogenesis (GO:0022008),-0.42950355151470504,-1.4526974489386324,0.029891304347826088,0.46886840469762286,1.0,11/43,11.85%,LPAR1;SPOCK1;EPHB1;RYK;MAPT;CIT;ERCC6;TRAK1;CDK6;BTBD3;ANXA1
prerank,cGMP-mediated signaling (GO:0019934),-0.5727351233725733,-1.4525812633910826,0.06711409395973154,0.4667295113931022,1.0,3/13,1.83%,HTR2C;IRAG1;KCNC2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.48780443117240446,1.4525804810958611,0.052969502407704656,0.8886807518833703,1.0,11/39,12.65%,TNFAIP3;RAMP2;TEK;KRIT1;ICAM1;RGCC;PLCG1;TNIP2;PRKCI;CDH5;ECSCR
prerank,import into cell (GO:0098657),-0.4321645000819019,-1.4522787847407739,0.04221635883905013,0.46512809860749815,1.0,16/41,17.59%,ATP1A2;SNAP25;SLC1A3;SLC6A13;SLC47A1;LRRC8D;GLUL;SLC39A14;SLC22A4;SLC27A1;SLC12A6;SLC19A1;SLC16A2;LRSAM1;SLC12A4;SLC5A6
prerank,neuron fate commitment (GO:0048663),-0.5532098953886233,-1.450466584693911,0.08278867102396514,0.4683492935570438,1.0,2/14,3.29%,MYT1L;TGFBR1
prerank,regulation of humoral immune response (GO:0002920),0.46390944142266605,1.4496580987552825,0.047244094488188976,0.8986795129098791,1.0,6/44,12.57%,C1QB;C1QC;FCGR2B;PHB2;CD81;CD55
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5143973046030733,-1.4490252120120504,0.06711409395973154,0.47044676055571266,1.0,6/20,10.68%,ANK2;ATP1A2;CACNA1C;ATP1B1;PRKACA;CAMK2D
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.6120555041953836,-1.447810768085886,0.05806451612903226,0.4717975338653001,1.0,3/10,13.39%,PRKCZ;RARA;IL18
prerank,metal ion export (GO:0070839),-0.4578077132440678,-1.447628361923438,0.04691358024691358,0.4699275135719679,1.0,7/31,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP7A;ATP1A1;KCNK5;ATP1B2
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.4243209637685773,-1.4466396008316436,0.038461538461538464,0.4708704417659745,1.0,9/40,6.20%,NTRK3;LPAR1;EGFR;PDGFRB;NTRK2;KIT;ARHGAP6;PDGFRA;EDNRA
prerank,skeletal system development (GO:0001501),-0.3321055570957884,-1.4459247323163888,0.004166666666666667,0.47074766445156035,1.0,27/148,8.02%,BMP6;FGFR2;IGF1;COL1A2;SULF1;FBN1;AKAP13;COL1A1;PKD1;GLI2;ITGB8;PCSK5;MMP16;TGFBR1;SOX5;BMP5;BMP7;SULF2;VCAN;MMP14;NPR3;ATP7A;CREB3L2;CDH11;ANKH;RBP4;COL13A1
prerank,regulation of heart contraction (GO:0008016),-0.3653291391459321,-1.445395253201764,0.01238390092879257,0.46997381547971845,1.0,20/90,12.75%,CELF2;ANK2;ATP1A2;ITPR1;RYR3;ATP1B1;STIM1;ASB3;TMEM65;TPM1;P2RX4;ATP1B3;ATP1A1;TRPC1;ATP1B2;PRKACA;DMPK;CAMK2D;SRI;ABCC9
prerank,embryonic eye morphogenesis (GO:0048048),-0.6018242658075512,-1.4452640794083276,0.08048289738430583,0.46805912692163637,1.0,5/11,15.41%,FBN1;EFEMP1;FBN2;MFAP5;LRP6
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5422800487814308,-1.4442129183906285,0.06952965235173825,0.46903244366235747,1.0,12/15,43.74%,ENTPD7;ENTPD5;ENTPD6;AK5;ENTPD1;ENTPD2;AK4;CMPK2;AK1;NME2;ENTPD3;AK7
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4456075962620755,1.4441304398329649,0.047839506172839504,0.9245645332298998,1.0,17/55,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;USP47;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;AVEN;PSMB1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.4477875592409718,1.4438713120183158,0.04447852760736196,0.9188287109594167,1.0,15/53,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5690105088864822,1.443722106020545,0.0599250936329588,0.9125675118482324,1.0,4/17,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.49571353678475205,-1.4424317583192539,0.07537688442211055,0.47232145260772224,1.0,6/21,6.46%,ERRFI1;MAFG;BMP4;CBFB;ROCK2;ROCK1
prerank,immunoglobulin mediated immune response (GO:0016064),0.6382023727954858,1.442257391129158,0.08795411089866156,0.9138982574353725,1.0,2/10,10.70%,FCGR2B;CD81
prerank,cellular response to hypoxia (GO:0071456),0.3945931618802757,1.442119382621219,0.017881705639614855,0.9076313845531401,1.0,36/126,14.00%,PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;HIPK2;STOX1;ZFP36L1;PSMD11;SCN2A;PSMB4;PSMC1;EP300;CARD16;RGCC;SIRT1;MDM2;PSMC2;PSMD2;BAD;TERT;HYOU1;HP1BP3;CREBBP;HIGD1A;UBQLN1;ELOB;EGLN2;BNIP3L;PSMD14;EPAS1;PSMC6;PSMD1;PSMB1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.42702179171804155,-1.4418509888838775,0.04155844155844156,0.47179281942579104,1.0,10/38,12.92%,ANK2;KCNMA1;AKAP6;FHL1;FLNA;GABBR2;KCNJ2;ACTN2;KCNJ6;DLG1
prerank,inorganic cation transmembrane transport (GO:0098662),-0.30798639693916696,-1.4414925610748153,0.0,0.4705320234985874,1.0,53/268,14.21%,TRPM3;ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;CACNA1C;HCN1;NALCN;KCNH7;KCNQ5;SLC1A3;CACNA1D;RYR3;SLC6A13;KCNC2;PKD1;KCND2;ATP1B1;SLC41A1;TRPM6;TRPC5;SLC6A1;P2RX4;SCN8A;SCN3A;ATP1B3;SLC12A2;SLC39A14;SLC30A10;KCNH5;SLC6A9;ATP1A1;SLC6A12;SLC39A13;KCNK5;KCNJ2;TRPC1;SCN1A;KCNA1;SCARA5;SLC24A2;KCNK10;SLC30A4;ATP6V0A4;SLC9A2;ABCC9;ATP6V0C;CACNA1G;TMCO1;SLC39A8;SLC6A15;ANO6
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.611022637075405,-1.4414112712113807,0.07296137339055794,0.4684547161876906,1.0,3/10,9.11%,ATP1A2;VDAC1;BIN1
prerank,protein localization to plasma membrane (GO:0072659),-0.33780370076135396,-1.441248459926096,0.00411522633744856,0.46667098731643847,1.0,39/129,16.79%,ANK2;DPP6;ANK3;KCNB2;KCNIP4;EPB41L3;MAP7;RAB3C;ATP1B1;PACS2;ASB3;FLNA;KCNIP3;ROCK2;ATP1B3;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;EZR;AFDN;ACTN2;TTC7A;CDH1;DPP10;RAMP1;DLG1;MYADM;RAB11A;WNK3;STXBP1;NECTIN3;FYB1;LRP6;RAPGEF2;EHD1;RAB8A;EHD3
prerank,cardiac muscle tissue development (GO:0048738),-0.41008641867462536,-1.4408598081288004,0.040229885057471264,0.4657089738993847,1.0,17/50,19.91%,NOTCH2;AKAP13;GJB6;BMP5;BMP7;SMAD4;MAML1;BMP4;ADAMTS9;RBP4;SIK1;GJA1;CACNA1G;SMAD5;TBX18;BMPR1A;BMPR2
prerank,skeletal muscle tissue development (GO:0007519),-0.4517424337173574,-1.4406843060288903,0.05154639175257732,0.463945002438213,1.0,7/32,18.70%,SVIL;CFLAR;IGSF8;SKI;CAV2;SELENON;SIX1
prerank,metanephric mesenchyme development (GO:0072075),-0.6224224803303209,-1.440179656163596,0.08333333333333333,0.4632142788271524,1.0,6/10,24.82%,OSR1;WNT4;SIX1;STAT1;BASP1;PAX2
prerank,positive regulation of neutrophil migration (GO:1902624),0.5587586035120444,1.4396759800064025,0.05783582089552239,0.9151274778250618,1.0,4/18,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,protein localization to membrane (GO:0072657),-0.32546747801884346,-1.4395968174687857,0.0,0.46277484822234644,1.0,56/187,18.36%,MAGI2;DLG2;ANK2;DPP6;ANK3;KCNB2;LRRC7;KCNIP4;EPB41L3;NRXN1;MAP7;RAB3C;ATP1B1;PACS2;DLG4;NLGN2;FLNA;KCNIP3;SYNE3;ROCK2;ATP1B3;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;NUP155;NLGN1;EZR;DLG3;TM9SF4;ACTN2;TTC7A;CDH1;DPP10;LRRC4;NRXN2;RAMP1;ARL5A;DLG1;MYADM;RAB11A;WNK3;WDR19;STXBP1;AP4M1;FYB1;LRP6;RAPGEF2;EHD1;RAB8A;EHD3;DVL1;ITGA4;FRMPD1;ZFYVE27
prerank,eye development (GO:0001654),-0.404201460591311,-1.439107679333992,0.030726256983240222,0.46210573418233136,1.0,21/54,21.62%,CACNA1C;FBN1;PBX1;SMOC1;COL5A1;COL5A2;EFEMP1;MEIS2;FBN2;SKI;NIPBL;RBP4;FOXC1;HIPK1;BMPR1B;PBX4;LAMA1;PBX2;SIPA1L3;SMG9;SH3PXD2B
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5682476075722492,-1.4387355671613353,0.06041666666666667,0.46106947712705626,1.0,7/13,15.76%,PLXNA2;NRP1;SEMA3A;NRP2;PLXND1;PLXNB2;PLXNC1
prerank,nervous system development (GO:0007399),-0.29513918399342604,-1.4372182341250046,0.0,0.46350752873436546,1.0,112/429,17.95%,NAV3;ERBB4;ROBO2;NOTCH2;CNTN4;DCLK1;SDK1;LPAR1;FGF12;TEAD1;ROBO1;ZIC1;ADAM22;ARNT2;ALDH1A2;ZIC4;NRXN1;CNTN6;SPOCK1;GSN;KIRREL3;MYT1L;GPM6B;NRCAM;EFNA5;AHI1;ADAM23;PKD1;GLRB;ADGRA2;CHRM2;EPHB1;NBL1;HDAC4;TMOD2;MBP;SH3GL2;NELL1;TGFBR1;MOBP;DLG4;AXL;RYK;ZEB2;TRPC5;DNER;DSCAM;JARID2;ADGRV1;NLGN2;GLIS2;IL1RAPL2;GPM6A;CRIM1;SCN8A;GMFB;VCAN;RELN;SMO;ZIC5;ERCC6;IGSF8;LDB1;FEZ1;TRAK1;MOG;SDK2;CHRM3;NLGN1;FUT10;RBFOX3;BTBD3;CDH1;EPHB2;NUMBL;NR2C2;ZIC2;FN1;DCX;TBX3;NRXN2;ALDH3A2;ACVR1B;OBSL1;APBA1;ATXN1;DPF2;COX7B;FKTN;PLXND1;VLDLR;INTU;DACT1;ATN1;ARHGAP26;SRRM4;NINJ2;DCTN1;NGF;NPAS2;TGFB1;NHEJ1;NES;WWTR1;SZT2;SHANK2;DVL1;S100B;CYP51A1;SOX6;MYLIP;GFRA2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.39761932544326944,1.4364587282421595,0.02029769959404601,0.9274509417976702,1.0,18/116,10.61%,GPR176;PRKAR1A;PTGER2;FCGR2B;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;GNB1;RXFP1;SYK;PLCG1;LYN;RHBDF2;CD163;YES1
prerank,myeloid dendritic cell activation (GO:0001773),-0.5801366806054219,-1.4357116431980856,0.0728744939271255,0.46563826387831264,1.0,3/12,9.65%,TGFBR2;CAMK4;DOCK2
prerank,protein import into peroxisome membrane (GO:0045046),-0.48226449227718465,-1.4346937119793932,0.0660377358490566,0.46662810646781383,1.0,13/22,30.43%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;GDAP1;ABCD3;PEX26;PEX19
prerank,lung epithelium development (GO:0060428),-0.6193149639877767,-1.434514215265944,0.08624229979466119,0.4650907456595439,1.0,4/10,14.40%,PKD1;ERRFI1;BMP4;RCN3
prerank,organelle fusion (GO:0048284),0.5287608413292939,1.4330469473334457,0.05714285714285714,0.9406760174439647,1.0,3/22,4.40%,THG1L;MIGA1;VPS11
prerank,SNARE complex assembly (GO:0035493),-0.6179677734413046,-1.4323280823506364,0.08213552361396304,0.46997057840509854,1.0,6/10,29.08%,UVRAG;STXBP1;VAMP2;VAMP1;VAMP8;SNCA
prerank,embryonic limb morphogenesis (GO:0030326),-0.44451198816193094,-1.4323191473667212,0.0583756345177665,0.46780045662854686,1.0,14/34,15.41%,AFF3;CACNA1C;GLI3;CTNNB1;HDAC1;OSR1;MAP3K20;SKI;NIPBL;SALL1;TBX3;CYP26B1;INTU;LRP6
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.42297159148941077,-1.4322364542681625,0.04201680672268908,0.4658809122814784,1.0,16/43,18.72%,SORBS1;OGT;TNS2;PID1;GKAP1;PRKCZ;ENPP1;SORL1;PRKCD;PIP4K2B;NUCKS1;GRB10;IGF2;PTPN2;TSC2;RPS6KB1
prerank,negative regulation of developmental growth (GO:0048640),-0.4521970875392503,-1.4318306596743429,0.06905370843989769,0.4648915317504147,1.0,7/30,7.77%,MAP2;DCC;ULK2;WWC2;PTPRS;NKD1;CDKN1B
prerank,cell-matrix adhesion (GO:0007160),-0.35951082371428666,-1.4314598578936173,0.013888888888888888,0.46390603789632323,1.0,25/95,14.05%,SORBS1;ITGBL1;ADAMTS12;PKD1;ITGB8;COL3A1;SGCE;NID2;PPFIA1;ADAMTS9;VCL;ITGB5;BCR;PIP5K1A;DDR1;CTTN;COL13A1;VTN;ACTN2;ITGA11;FN1;ILK;CD34;MKLN1;ITGA8
prerank,tRNA metabolic process (GO:0006399),0.5572090661135489,1.4314058084006214,0.06386861313868614,0.9431810324498311,1.0,4/17,8.67%,THG1L;FARS2;YARS2;POP5
prerank,regulation of glucose import (GO:0046324),-0.45879347184492636,-1.4311339663282212,0.065,0.46271255060596356,1.0,10/30,9.89%,SORBS1;PRKAG2;IGF1;PID1;OCLN;ENPP1;APPL2;AKT2;CREBL2;ARPP19
prerank,presynapse assembly (GO:0099054),-0.53201394916244,-1.431049124466906,0.06912442396313365,0.4608304618110869,1.0,7/16,17.26%,LRRTM3;PCLO;NLGN2;NLGN1;IL1RAPL1;BSN;DVL1
prerank,positive regulation of immune response (GO:0050778),0.43435825405616935,1.4299447782576538,0.043343653250773995,0.9447733475678115,1.0,9/64,14.46%,PCK1;PTPRC;FCGR2B;IFI35;SIRT1;CD81;POLR3F;POLR3B;CYBA
prerank,positive regulation of filopodium assembly (GO:0051491),-0.47702315392256067,-1.4294293568897694,0.059665871121718374,0.46372677607504864,1.0,8/24,8.48%,TENM2;DPYSL3;NRP1;WASL;GPM6A;PLPPR5;NLGN1;DOCK11
prerank,acute inflammatory response (GO:0002526),-0.4828463553883297,-1.429175647437254,0.06763285024154589,0.46239732373616377,1.0,8/23,31.90%,IL6R;F3;LBP;PLSCR1;ANO6;CEBPB;IL22;CTNNBIP1
prerank,positive regulation of synapse assembly (GO:0051965),-0.4631164157783864,-1.42855913514853,0.05995203836930456,0.462028602114062,1.0,11/27,12.30%,NRXN1;GRID2;EPHB1;NLGN2;SYNDIG1;CLSTN2;NLGN1;EPHB2;CUX2;SEMA4D;IL1RAPL1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.4064235329351646,-1.4285396590956176,0.050761421319796954,0.4600063839075587,1.0,19/45,20.13%,DDX5;EGFR;BMP4;RIOK1;LIN28B;RIOK2;MAP2K2;NFKB1;TP53;POLR2A;ZC3H18;WDR43;SETX;SIRT7;TGFB1;HABP4;GRSF1;PIK3R1;SUPV3L1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5114439275882366,-1.4283446574850287,0.052873563218390804,0.458540215669965,1.0,7/21,12.21%,ANK2;ATP1A2;CACNA1C;AKAP6;PRKACA;CAMK2D;SRI
prerank,plasma membrane organization (GO:0007009),-0.39529577869344845,-1.428233057982902,0.017241379310344827,0.45688175651071833,1.0,29/61,33.13%,ANK2;ANK3;EPB41L3;A4GALT;COL5A1;BIN1;BIN3;MYOF;PLSCR1;AHNAK2;TLCD2;SYT11;ABCD2;ANO6;SYT7;PACSIN1;ARV1;DEGS1;ANXA6;CLN3;SERP1;SPTBN1;SYTL4;ABCA7;PACSIN3;PLSCR4;CAVIN2;MICALL1;SMPD1
prerank,response to X-ray (GO:0010165),-0.558130498874622,-1.427616074728007,0.07974137931034483,0.4564441412501609,1.0,7/14,20.00%,NIPBL;IKBIP;ANXA1;NUCKS1;MSH2;ATM;BLM
prerank,regulation of telomere capping (GO:1904353),0.5356516787413809,1.4266860866395106,0.06216696269982238,0.9573674304479057,1.0,7/23,12.55%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS;NBN
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.48853097208668833,-1.4263216734051498,0.07239819004524888,0.45803509242488616,1.0,8/23,20.01%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10
prerank,organophosphate biosynthetic process (GO:0090407),0.47387302297918243,1.426236588809298,0.064891846921797,0.9531425917744263,1.0,9/37,12.03%,GPHN;MOCS3;PPIP5K2;GPAM;FITM2;TPI1;MBOAT1;AGPAT3;IP6K2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.521090856307711,-1.4259125825759458,0.0589622641509434,0.4572256954326456,1.0,2/17,1.32%,ANK3;AKAP6
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5992081198547936,1.4252092417324895,0.07854406130268199,0.9523442753747536,1.0,4/12,8.26%,PPT1;TMEM9;ATP6AP2;TMEM165
prerank,regulation of metal ion transport (GO:0010959),-0.5358339412889829,-1.424760796945544,0.05555555555555555,0.45870102588486983,1.0,9/16,22.08%,ANK2;STIM1;SLC30A10;IL16;SRI;DLG1;BCL2;CACNA2D1;CAMK2B
prerank,histone exchange (GO:0043486),0.4677579088947649,1.4245152596182136,0.06168831168831169,0.9498247048505633,1.0,12/37,17.31%,MIS18A;DMAP1;VPS72;HJURP;RUVBL1;RSF1;CENPC;ZNHIT1;CENPP;RBBP4;CENPO;NPM1
prerank,snRNA metabolic process (GO:0016073),-0.5363246196789491,-1.4240523025986587,0.068,0.45872353593596443,1.0,13/17,33.06%,INTS10;INTS8;MTREX;INTS11;RBM7;ZCCHC8;INTS7;TUT1;INTS12;INTS9;INTS3;MEPCE;INTS1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.49811839103619826,-1.4240519383796642,0.06521739130434782,0.4567462793155508,1.0,8/21,17.87%,B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;B3GALT1;ST6GALNAC6;MPDU1
prerank,retinoic acid metabolic process (GO:0042573),-0.5486373092996804,-1.4236005332676775,0.07509881422924901,0.45616512016370236,1.0,3/14,13.51%,ALDH1A2;SCPEP1;CYP26B1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5263511197699848,1.4230979354314626,0.078397212543554,0.9517371296714009,1.0,3/23,4.01%,SLC12A1;SLC9A7;CLCN3
prerank,regulation of cellular component movement (GO:0051270),-0.4054773154159319,-1.4215038478579123,0.04411764705882353,0.4607337114021419,1.0,26/49,29.60%,ERBB4;TGFBR3;EGFR;TGFBR1;PDPN;RHOA;ROCK2;ROCK1;ZSWIM8;YTHDF1;CDK6;PRAG1;RAF1;ABL2;DIAPH1;ZSWIM4;CADM4;VEGFA;ERBB2;ZSWIM5;INPP5F;DAPK3;HDAC6;HBEGF;NRG4;ARAP1
prerank,relaxation of muscle (GO:0090075),-0.5645876915939834,-1.4204309944075968,0.0863157894736842,0.46204235544889916,1.0,7/13,10.68%,ATP1A2;GSN;ATP1B1;P2RX4;ATP1A1;KCNJ2;CAMK2D
prerank,ribosomal large subunit assembly (GO:0000027),0.5172157780351115,1.4203761472542837,0.07478260869565218,0.9612403531063097,1.0,8/24,13.61%,RSL24D1;FASTKD2;RPL3;RPL5;MRPL20;RPLP0;RPL24;RPL23A
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.49624780500396937,-1.41995191494463,0.0703883495145631,0.46157079588967154,1.0,8/21,19.89%,IGF1;IGFBP5;ADAMTS1;GJA1;JUN;BMPR1A;DNMT1;MMP2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.42507723448677426,1.4198331665222106,0.043478260869565216,0.9575634648286269,1.0,19/67,14.46%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;B2M;PSMC2;PSMD2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;CYBA
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.4900257713021954,-1.4193656124311358,0.06960556844547564,0.4612512133307206,1.0,7/20,14.25%,ZC3H7A;PUM1;ZC3H7B;PUM2;TSN;AGO3;DICER1
prerank,regulation of striated muscle contraction (GO:0006942),-0.46308565516753797,-1.4180337565917152,0.06976744186046512,0.46364412862871085,1.0,6/27,12.21%,ANK2;ATP1A2;ASB3;P2RX4;PRKACA;SRI
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5745047006652388,-1.4176867516041631,0.09406952965235174,0.4627457113795377,1.0,2/12,1.68%,MAGI2;IQGAP1
prerank,regulation of immunoglobulin production (GO:0002637),0.5148755237029605,1.4164024037406595,0.08135593220338982,0.9712138935108264,1.0,4/23,10.85%,PTPRC;FCGR2B;PHB2;GPI
prerank,positive regulation of cilium assembly (GO:0045724),-0.5207193795328362,-1.4160505506503596,0.07529411764705882,0.46569233470111754,1.0,9/18,33.30%,TAPT1;CEP120;HTT;ENTR1;CCP110;FUZ;KCTD17;WRAP73;CROCC
prerank,regulation of histone methylation (GO:0031060),0.5959780036740414,1.4158496440951145,0.09807692307692308,0.9677920925604572,1.0,4/13,6.16%,CTCFL;AASS;TTLL12;CHTOP
prerank,activation of adenylate cyclase activity (GO:0007190),-0.43233793824422584,-1.4155609785756937,0.0532994923857868,0.46526705704582244,1.0,13/35,22.95%,ADCY5;LGR4;ADCY2;ADCY1;ADCY9;EDNRA;ADCY7;RAF1;LGR5;ADCY3;ADCY8;ADCY4;CAP1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4795281236027401,1.4142444546045534,0.06105610561056106,0.9710034809443714,1.0,7/33,6.17%,GCLC;ALDH5A1;GLS2;GLS;GOT2;GCLM;MTHFS
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5057688124455314,-1.4130164245101169,0.08173076923076923,0.4708860106230393,1.0,11/18,24.76%,NRXN1;TSHZ3;NLGN2;RELN;NLGN1;CACNG7;CACNG4;CACNG2;NLGN3;CACNG3;CACNG8
prerank,tRNA modification (GO:0006400),0.4283682168753911,1.4125450343325092,0.037267080745341616,0.9743649632176665,1.0,15/62,16.85%,THG1L;MOCS3;THUMPD1;TRMO;BCDIN3D;THUMPD2;PUS10;TRMT61B;ANKRD16;METTL2A;METTL2B;WDR4;SSB;NSUN6;CDKAL1
prerank,neutral amino acid transport (GO:0015804),0.49688842482521856,1.4117934037315727,0.06837606837606838,0.9720755034767862,1.0,5/28,5.53%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6
prerank,cellular response to fluid shear stress (GO:0071498),0.5985547352872523,1.4107811693368455,0.10891089108910891,0.9716480402598088,1.0,3/12,3.90%,KLF2;MAP2K5;HDAC3
prerank,embryonic skeletal system development (GO:0048706),-0.431646605467704,-1.4105784696941885,0.05808080808080808,0.47634696799150555,1.0,9/35,7.87%,SULF1;COL1A1;PCSK5;SULF2;HOXA3;OSR1;DYNC2I1;PDGFRA;RBP4
prerank,regulation of cell killing (GO:0031341),0.5735984361702755,1.4104926839035916,0.08935361216730038,0.9669504756419499,1.0,5/16,14.46%,MAPK8;ICAM1;WNT5A;CD55;CYBA
prerank,cellular response to interleukin-1 (GO:0071347),0.37844861206399416,1.4098291449752,0.02997275204359673,0.9644761695917515,1.0,34/143,14.28%,PSMB10;PSMC4;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;IL1R1;MAP3K7;TAB2;RPS6KA4;RPS6KA5;PSMD11;GBP3;PSMB4;PSMC1;TAB3;CCL25;RELA;CD47;PSMC2;PLCB1;PSMD2;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1;MAP3K3
prerank,mitochondrial gene expression (GO:0140053),0.4557963220662976,1.4095480162268221,0.05591054313099041,0.9597981277988594,1.0,15/42,18.14%,MRPS2;MRPL23;FASTKD2;LARS2;MRPS12;HARS1;RARS2;MRPS15;MRPS24;TFAM;MRPS28;GATB;MRPS34;IARS2;GFM2
prerank,regulation of aerobic respiration (GO:1903715),-0.5307962807735144,-1.4084606646075455,0.09236947791164658,0.4804833090164698,1.0,7/15,24.88%,ATP7A;VCP;COX7A2L;SLC25A33;PINK1;NOP53;UQCC2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.48413110541316456,1.408112303976919,0.05654281098546042,0.9619260668234288,1.0,6/32,8.79%,ERCC3;MAPK3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.542291964518194,-1.4081080278934157,0.07922912205567452,0.4796028176442664,1.0,3/14,9.33%,PIBF1;IRAK3;THBS1
prerank,base conversion or substitution editing (GO:0016553),0.6047656339222929,1.4079803101852368,0.10074626865671642,0.956237661843881,1.0,3/11,15.66%,ADAR;ADARB2;ADARB1
prerank,mesenchymal cell differentiation (GO:0048762),-0.3945378987379827,-1.4079507390062393,0.0335195530726257,0.4781361552783439,1.0,14/51,11.62%,DDX5;FGFR2;TGFBR3;RANBP3L;DDX17;TGFBR1;CTNNB1;BMP7;ROCK2;ROCK1;WNT4;FOXC1;GSK3B;LOXL3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.47410325466306813,-1.4079037497890186,0.0498812351543943,0.47636529131915195,1.0,9/24,24.38%,SULF1;SULF2;CCBE1;IL6ST;RORA;TGFB1;PTGS2;ATF4;EIF2AK3
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4023064836070634,-1.4078581261549952,0.029649595687331536,0.47458589671684537,1.0,19/50,16.53%,IGF1;OGT;PDGFRB;ADAP2;PLCL2;RHOA;PLCE1;PIK3C2B;PIK3C3;PDGFRA;PLCD3;EZR;PLCB3;GAB2;PLCH1;PLCL1;NGF;EXOC1;PLCD1
prerank,neuron projection extension (GO:1990138),-0.44396854531339813,-1.4074439708713873,0.07105263157894737,0.47382048281847833,1.0,10/32,9.78%,ALCAM;MAP1B;ULK2;IQGAP1;AUTS2;SH3GL2;NRP1;CTNNB1;SEMA3A;NRP2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5378274611668645,-1.4073045036095417,0.09956709956709957,0.47234610604656974,1.0,5/15,13.04%,DAB2;SNAP91;WASL;SCYL2;HIP1R
prerank,calcium ion transport (GO:0006816),-0.340058149272281,-1.4071305569298544,0.01171875,0.47096461824766045,1.0,16/113,6.12%,TRPM3;ANK2;SLC24A3;CACNA1C;NALCN;ITPR1;CALCRL;STIM2;CACNA1D;RYR3;PKD1;STIM1;TRPM6;TRPC5;P2RX4;CACNA1B
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4744215226929937,-1.4066936951356594,0.06359649122807018,0.47039330438297017,1.0,9/22,19.76%,NTRK3;FGFR2;PDGFRB;KIT;PDGFRA;ARL1;ARF4;ABL2;AGTR1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.37233741930735226,1.4059598812161294,0.024771838331160364,0.9611184845966564,1.0,36/175,14.00%,PSMB10;PSMC4;PSMB6;EIF5A;PSMD8;PSMD5;PSMD12;SMPD4;BIRC2;ZFP36L1;PSMD11;GBP3;PSMB4;TNFRSF1B;PSMC1;CIB1;EDAR;TRAF5;ACTN4;SIRT1;CCL25;ERBIN;TRAF3;RELA;PSMC2;PSMD2;NPNT;CDIP1;RPS3;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6285508347310675,1.4059270197904354,0.08687258687258688,0.9550309632595034,1.0,2/10,3.42%,PTPRC;MAP2K5
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3885870790873168,1.4057400359389038,0.026954177897574125,0.950013353755012,1.0,18/117,10.70%,GPR176;PRKAR1A;PTGER2;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;GNB1;RXFP1;SYK;PLCG1;LYN;RHBDF2;CD163;YES1;CD81
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5788923105328214,-1.4047428017939132,0.09282700421940929,0.47415111996090054,1.0,4/12,5.92%,SORBS1;GKAP1;PRKCZ;SORL1
prerank,regulation of defense response (GO:0031347),0.413408912631396,1.4045448566093088,0.03795620437956204,0.9508185825111818,1.0,17/76,11.89%,LRP8;PIK3AP1;IL1R1;SEMA7A;FCGR2B;TIRAP;BCL6B;BIRC2;SBNO2;APOE;SPATA2;WNT5A;TRAF3;RELA;PARK7;NLRP6;USP18
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4935791913315203,-1.4030850699359252,0.07068607068607069,0.4771220663926738,1.0,2/21,1.84%,MAGI2;PDGFRB
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5390964597053981,-1.402389418409442,0.09403669724770643,0.47729651157261666,1.0,6/15,18.54%,IGF1;ROCK2;ROCK1;CAMK2D;IL6ST;PARP1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.551945922350595,1.4020797963634437,0.08626760563380281,0.9594723849338882,1.0,8/20,12.21%,GNAQ;RGS8;GNB1;RGS10;GNA11;PLCB1;AGRN;LYPD1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.43719415107822585,1.401790639233839,0.0395738203957382,0.9551031582541297,1.0,18/51,18.25%,MAP2K7;MAPK3;CTC1;PNKP;SRC;CCT2;CCT5;MAP3K4;HNRNPC;ACD;NEK7;TNKS;ATR;TCP1;PARN;SMG6;TNKS2;SMG5
prerank,regulation of leukocyte migration (GO:0002685),0.5539036440281906,1.4015460244213223,0.08828828828828829,0.9504686554886286,1.0,4/16,11.04%,RAC2;HOXA7;CD81;RHOG
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.4850339576286743,1.4014238088323323,0.08768971332209106,0.9393392846705695,1.0,9/29,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,CENP-A containing chromatin organization (GO:0061641),0.4850339576286743,1.4014238088323323,0.08768971332209106,0.9393392846705695,1.0,9/29,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4305979546181643,1.4008206233592075,0.048411497730711045,0.9369589569383062,1.0,24/60,20.78%,MAP2K7;MAPK3;PNKP;GREM1;CCT2;PRKD2;CCT5;MAP3K4;RGCC;ACD;NEK7;TNKS;ATR;TCP1;DKC1;PARN;PARM1;TNKS2;NVL;CCT8;RFC5;PTGES3;HSP90AB1;PDGFB
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.45515100475289927,1.4006990433291397,0.0670926517571885,0.9320028397442217,1.0,15/40,16.34%,RPL23;PDCL3;HIPK2;UBE3A;RPL5;FOXF2;AXIN1;DESI1;GNA12;RAD23A;XPO1;CSNK2A2;UBQLN4;TAF1;PTK2B
prerank,regulation of programmed cell death (GO:0043067),0.37134356065897195,1.4003713498844816,0.022972972972972974,0.9282104461970505,1.0,28/161,12.04%,LRP8;CIDEA;MECOM;ACER2;GLS2;CHM;DNAJA3;PAX8;BIRC2;NME1;TNFRSF10B;SLK;TOX3;CASP6;WFS1;AKT1S1;CRADD;ACTN4;SIRT1;OMA1;PHLPP1;FBXO11;TARDBP;NAE1;CREBBP;RPS3;ACER3;BNIP3L
prerank,type I interferon signaling pathway (GO:0060337),0.4566758089799141,1.4000034241722978,0.0633116883116883,0.9190702355630305,1.0,13/41,12.67%,IFITM2;IFIT1;XAF1;IFI35;IRF9;IFITM3;ADAR;IFITM1;IFNAR1;IFI27;IP6K2;TYK2;IRF2
prerank,cellular response to type I interferon (GO:0071357),0.4566758089799141,1.4000034241722978,0.0633116883116883,0.9190702355630305,1.0,13/41,12.67%,IFITM2;IFIT1;XAF1;IFI35;IRF9;IFITM3;ADAR;IFITM1;IFNAR1;IFI27;IP6K2;TYK2;IRF2
prerank,sphingolipid catabolic process (GO:0030149),0.5850247618543534,1.399791333256591,0.0989010989010989,0.9148789554515756,1.0,3/15,3.22%,ACER2;SMPD4;PPT1
prerank,cellular response to BMP stimulus (GO:0071773),-0.3733844429748206,-1.3986329108658349,0.05070422535211268,0.4866185530717856,1.0,15/66,10.15%,DDX5;BMP6;TGFBR3;ADAMTS12;SMAD3;RGMA;BMP5;BMP7;SMAD4;BMP4;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,positive regulation of cellular senescence (GO:2000774),0.6331158907348212,1.3983951105642525,0.11695906432748537,0.917107652539388,1.0,3/10,7.73%,B2M;SIRT1;YPEL3
prerank,ventricular septum morphogenesis (GO:0060412),-0.4503556514327048,-1.3980976098428337,0.06053268765133172,0.4865433650992657,1.0,7/27,4.74%,ROBO2;TGFBR3;ROBO1;TGFBR1;TGFBR2;SMAD4;BMP4
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4925556086135312,1.3973806997571911,0.07705192629815745,0.9173838955138058,1.0,9/29,9.76%,TRIB3;PIN1;DCUN1D4;FBXO5;SMAD7;BMI1;AXIN1;MAGEC2;PARK7
prerank,histone ubiquitination (GO:0016574),-0.48922971699998363,-1.3967023395335236,0.10874704491725769,0.4890430632274278,1.0,12/21,25.69%,UBE2N;WAC;UBE2E1;CDC73;HUWE1;RNF8;PHC1;PAF1;RNF40;DTX3L;UBR2;UBE2B
prerank,Rho protein signal transduction (GO:0007266),-0.38766094204151025,-1.3965045217618632,0.028901734104046242,0.4876572542205613,1.0,25/53,26.96%,COL1A2;ARHGAP29;PDPN;RHOA;ROCK2;CTNNAL1;ARHGAP6;SHTN1;ROCK1;PLEKHG5;RHOJ;RHOB;ARHGDIA;CDC42EP5;CDC42EP1;CDC42;AGTR1;ARHGEF1;ARHGDIB;RHOU;EPS8L2;RIPOR1;ADRA2A;ADGRG1;CDC42EP2
prerank,relaxation of cardiac muscle (GO:0055119),-0.5564738045005135,-1.396130113010918,0.10615711252653928,0.48695663278196133,1.0,7/13,10.68%,ATP1A2;GSN;ATP1B1;P2RX4;ATP1A1;KCNJ2;CAMK2D
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5667478011447261,-1.3959911301273795,0.08791208791208792,0.48549406441820425,1.0,3/13,0.39%,ERBB4;FGFR2;TGFBR3
prerank,sphingolipid metabolic process (GO:0006665),0.3869486632002407,1.39562518570899,0.04329608938547486,0.9215238260464669,1.0,19/108,8.19%,SERINC1;CERS1;GLB1;ACER2;SMPD4;ST6GALNAC3;CERS4;PPT1;PRKD2;PPP2CA;ESYT2;SGMS1;KDSR;ELOVL6;CERKL;UGCG;PLPP1;TEX2;SGPP2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.41108494258942335,1.3943783740784377,0.05660377358490566,0.9231056256384285,1.0,18/70,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;LMO2;N4BP2L2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5694971336502165,1.3940741897891702,0.12424849699398798,0.9195519230174453,1.0,5/13,16.80%,KPNA3;NUP54;KPNA1;NUP35;KPNB1
prerank,atrial septum development (GO:0003283),-0.5553232033568378,-1.3938222784447933,0.10869565217391304,0.49017071229841574,1.0,2/13,0.30%,ANK2;NOTCH2
prerank,regulation of stress fiber assembly (GO:0051492),-0.3586287262396521,-1.3935734353055385,0.03773584905660377,0.4890512173026596,1.0,18/74,6.57%,TMEFF2;PHLDB2;LPAR1;CGNL1;WASF2;NRP1;ARHGEF10L;CCN2;TGFBR1;TPM1;ARHGAP28;RHOA;PXN;PPFIA1;ROCK2;ARHGAP6;ROCK1;PPM1E
prerank,peripheral nervous system development (GO:0007422),0.5047400222574852,1.393342065117767,0.09897610921501707,0.9183570732537354,1.0,7/23,14.16%,GFRA3;BDNF;NFASC;PMP22;NF1;ARTN;ADGRG6
prerank,chloride transport (GO:0006821),-0.3621649702951118,-1.3932117498949035,0.025806451612903226,0.4883045009280231,1.0,35/74,27.24%,GABRB1;SLC4A10;SLC1A3;GLRB;GABRA2;ANO3;CLIC4;SLC6A1;SLC26A7;SLC12A2;GLRA3;GABRG2;GLRA1;CLCN6;ANO1;CLCN2;ANO6;SLC12A6;GABRA5;SLC12A4;GABRG3;CLIC5;ANO10;GABRA4;SLC12A9;GABRG1;SLC4A8;TTYH3;GABRA1;SLC12A7;TTYH1;FXYD1;LRRC8A;SLC12A8;SLC12A5
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.568923269822793,-1.3930131154984202,0.09496124031007752,0.4870083616102461,1.0,2/11,1.47%,ST18;GSN
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5974413485234006,1.392924524519565,0.125,0.9152686469363776,1.0,2/11,7.28%,PTPRC;SMAD7
prerank,regulation of microtubule polymerization (GO:0031113),-0.4160529310214077,-1.3927453061170283,0.052083333333333336,0.4859856927380698,1.0,12/40,15.73%,NAV3;MAP2;EML2;MAPT;OCLN;STMN2;AKAP9;SLAIN2;CLIP3;STMN1;TUBB4A;DCTN1
prerank,positive regulation of viral life cycle (GO:1903902),-0.47217376336386996,-1.3921450495080991,0.09307875894988067,0.48575465851737265,1.0,8/22,21.08%,AXL;DDB1;P4HB;TSG101;CHMP2B;LGALS1;TRIM11;VPS4A
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.4408609220215926,-1.3921088538862312,0.0593607305936073,0.4840308007435222,1.0,13/31,26.43%,SYT9;SYT12;SYT11;CACNA1G;SYT4;STXBP1;SYT7;SCAMP5;STX1A;SYT2;ADRA2A;SYT10;SYT6
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.43717155081238324,-1.391218271150599,0.0951276102088167,0.48511687702613093,1.0,3/29,4.07%,FGFR2;TGFBR3;TPM1
prerank,myoblast differentiation (GO:0045445),-0.5487773769204212,-1.3910968519240405,0.10256410256410256,0.48367634994819725,1.0,3/14,2.05%,DDX5;IGF1;DDX17
prerank,regulation of acute inflammatory response (GO:0002673),-0.5031984744125733,-1.391053272227839,0.0958904109589041,0.4820335214479958,1.0,3/18,16.64%,OSMR;IL6ST;PTGES
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.4226539248970683,-1.390954791751788,0.07853403141361257,0.48054420575439005,1.0,14/37,15.11%,BICD1;PHLDB2;EFNA5;PHLDB1;CYLD;MAPT;ROCK1;STMN2;SKA2;GSK3B;EPHA3;TAOK1;TRIM36;STMN1
prerank,smooth muscle cell differentiation (GO:0051145),0.596612157679188,1.3906289030766092,0.11842105263157894,0.9222171394361823,1.0,5/12,8.25%,MRTFA;MRTFB;HEY1;HEY2;EDNRB
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4654828647253005,1.390484415440354,0.058919803600654665,0.9177831851896736,1.0,12/35,16.46%,MAP2K7;MAPK3;PNKP;CCT2;CCT5;MAP3K4;ACD;NEK7;TNKS;ATR;TCP1;PARN
prerank,regulation of cellular pH (GO:0030641),0.48254273319024577,1.390273898578088,0.07504363001745201,0.9137846026340497,1.0,7/29,10.69%,SLC4A4;SLC4A5;SLC9A7;CA2;SLC9A6;SLC9A8;ATP6AP1
prerank,protein acylation (GO:0043543),0.45482336032092374,1.3902540709631002,0.07355242566510173,0.9087276024853119,1.0,13/38,14.05%,ZDHHC17;ING4;ZDHHC13;EP300;ZDHHC14;CLOCK;SELENOK;ZDHHC15;CREBBP;NAA80;ZDHHC9;ING5;ZDHHC7
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3746247151505309,-1.3898820307541186,0.040880503144654086,0.48178877816763294,1.0,14/67,6.19%,ERBB4;FGFR2;EGFR;PDGFRB;ABI1;FER;PIBF1;EFEMP1;KIT;TEC;GHR;RELN;DDR1;PDGFRA
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4723153144435974,1.3893017702442099,0.08141592920353982,0.9084764789521653,1.0,9/33,10.93%,PIK3CG;ACER2;CIB1;NEXMIF;RET;SYK;EFNA1;LYN;CYP1B1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5091345967679303,1.389111697949946,0.08216783216783216,0.9044447036275801,1.0,2/23,6.81%,CADM1;AP1G1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.4997633041836196,1.3885795024967043,0.07413793103448275,0.9022860019610097,1.0,6/25,11.52%,PDE4D;PTPRC;MAP3K7;PRKD2;PNP;RPS3
prerank,embryonic appendage morphogenesis (GO:0035113),0.5912299747131037,1.3880045872573845,0.11895910780669144,0.9004158005092412,1.0,1/12,0.04%,TBX4
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4167437853184697,1.387108608460758,0.0832072617246596,0.9004987911045745,1.0,18/65,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;USP47;PSMC2;PSMD2;CHFR;PSMD14;PSMC6;PSMD1;AVEN;PSMB1
prerank,inner mitochondrial membrane organization (GO:0007007),0.4365086195796056,1.3871016446079778,0.06962025316455696,0.8956492495534367,1.0,16/47,14.72%,TIMM29;ROMO1;ATP5F1E;UQCC3;ATP5MG;ATP5PF;ATP5MC2;IMMT;MAIP1;CHCHD6;CHCHD3;LETM1;DNAJC11;NDUFA13;MICOS10;ATP5F1C
prerank,phagolysosome assembly (GO:0001845),0.5912194899815285,1.3868344971220303,0.10805500982318271,0.8922086208910703,1.0,4/12,8.22%,RAB7A;RAB7B;PIKFYVE;RAB14
prerank,histone H4 acetylation (GO:0043967),0.4429320223865726,1.3861837637845462,0.06891025641025642,0.8909412096628363,1.0,16/47,14.04%,JADE3;ACTL6A;LEF1;RUVBL2;DMAP1;ING4;KANSL2;BEND3;EP300;RUVBL1;KANSL3;YEATS4;ING3;TRRAP;ING5;HCFC1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.37111404951136273,-1.3855668397840974,0.043227665706051875,0.4931702905255953,1.0,8/62,3.24%,NOTCH2;LPAR1;IGF1;ROBO1;AKAP13;COL3A1;AUTS2;RASGRF1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.6004676255160427,1.385511827205528,0.11458333333333333,0.8895512109851919,1.0,2/11,0.84%,TIMM29;ROMO1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5561247238939743,-1.3850141321951468,0.09725158562367865,0.4929486524298189,1.0,4/13,6.59%,PID1;PPARGC1A;VCP;PPARA
prerank,transcription by RNA polymerase I (GO:0006360),0.46992951407909633,1.3847932838892942,0.07419354838709677,0.8886886552271054,1.0,6/34,8.79%,ERCC3;MAPK3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.39961338869843743,1.3832494361544558,0.04899135446685879,0.8921505014045079,1.0,24/87,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ZFP36L1;PSMD11;PSMB4;PSMC1;CDKN1A;RGCC;FBXO5;USP47;CDK4;WEE1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;AVEN;APC;PSMB1
prerank,response to organonitrogen compound (GO:0010243),-0.4141451453647872,-1.3830643348931126,0.05555555555555555,0.4967297447209434,1.0,11/38,17.56%,GLRB;KAT7;VCP;RHBDD1;GLRA3;HLCS;GLRA1;IRAK3;RCN3;RNF139;ERLEC1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5262149609394089,1.3826186934840141,0.10746812386156648,0.8908239400342165,1.0,6/20,11.73%,SLC25A1;PPT1;FITM2;FAR2;ACSL4;HSD17B4
prerank,positive regulation of cell killing (GO:0031343),0.5864667685321457,1.3821465407567337,0.10139165009940358,0.8885068227377886,1.0,4/13,14.46%,MAPK8;SYK;WNT5A;CYBA
prerank,regulation of stem cell differentiation (GO:2000736),0.3951621719109453,1.3821350293507806,0.051209103840682786,0.8839454816701341,1.0,20/89,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;OCIAD1;PSMD11;PSMB4;PSMC1;NOTCH1;PSMC2;PSMD2;LMO2;PSMD14;PSMC6;PSMD1;HES1;PSMB1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.4035058057285222,-1.3820008661954193,0.04871060171919771,0.4978693204302343,1.0,20/41,27.24%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;KCNJ6;ABCC9;SLC12A6;KCNJ13;SLC12A4;ATP1A3;SLC12A9;KCNJ10;SLC12A7;KCNK9;HCN2;SLC12A8;SLC12A5
prerank,regulation of axonogenesis (GO:0050770),-0.3862724436828119,-1.3816682434855265,0.056451612903225805,0.4970348782283587,1.0,15/51,15.76%,LRRC4C;ROBO2;PLXNA2;ROBO1;NTRK2;TIAM2;RHOA;BRSK1;GSK3B;GDI1;PLXND1;ARHGDIA;PLXNB2;NGF;PLXNC1
prerank,cell-cell junction assembly (GO:0007043),-0.36905944999698287,-1.381381624860503,0.03125,0.4960523112812553,1.0,28/63,22.98%,EPB41L3;CDH10;GJB6;CTNNA1;CTNNB1;RHOA;TLN1;CLDN11;JAM3;VCL;CTNND2;CDH11;TLN2;CDH7;GJC1;GJD3;ARVCF;GJA1;GJB2;WDR1;CTNND1;CDH9;CDH8;CDH19;CLDN12;FLCN;RHOC;DCHS1
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.3472189783235909,-1.3807704332080544,0.026402640264026403,0.49616781867014764,1.0,14/85,5.85%,BMP6;FGFR2;TGFBR3;IGF1;EGFR;MCC;FGF1;BMP5;MTSS1;BMP4;NUPR1;OSR1;SRSF6;EPB41L4B
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4523139353267863,1.3805481496402283,0.07993730407523511,0.8879113521111915,1.0,6/40,7.66%,ROMO1;DMBT1;TIRAP;RNASE6;GBP4;PPP1R11
prerank,protein polymerization (GO:0051258),-0.3842970489586469,-1.3788605672784662,0.04748603351955307,0.5000473446036897,1.0,14/56,9.09%,GSN;GAS7;HDGFL3;SPIRE1;WASL;MAPT;PSTPIP2;ARHGAP6;WASHC5;WASHC3;WASF1;COBL;CKAP5;RNF135
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5498114844583961,-1.3785271527074652,0.11349036402569593,0.4993293590618661,1.0,4/13,9.97%,NFAT5;RHOA;IRAK1;ZDHHC21
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5646000806965474,-1.3784822143044528,0.10429447852760736,0.4977288669265548,1.0,5/11,22.40%,KIT;VCL;ITGB5;CCN3;PLEKHA7
prerank,peptidyl-tyrosine modification (GO:0018212),-0.37775268790305117,-1.3782376921246653,0.04481792717086835,0.496685458436762,1.0,11/56,6.19%,ERBB4;FGFR2;EGFR;PDGFRB;ABI1;FER;EFEMP1;KIT;TEC;RELN;PDGFRA
prerank,positive regulation of axonogenesis (GO:0050772),-0.3976103784624157,-1.3780857352457594,0.06666666666666667,0.4954548394499639,1.0,19/43,21.58%,ROBO2;PLXNA2;ROBO1;NTRK2;TIAM2;MAPT;MACF1;RHOA;SHTN1;SEMA4D;PLXND1;ARHGDIA;PLXNB2;NGF;PLXNC1;TWF2;ZFYVE27;SLITRK1;DBNL
prerank,regulation of microtubule-based process (GO:0032886),-0.41896197731277307,-1.37790204323838,0.07874015748031496,0.49424469470938986,1.0,12/36,14.41%,BICD1;PHLDB2;EFNA5;PHLDB1;CYLD;MAPT;MACF1;ROCK1;GSK3B;EPHA3;TAOK1;TRIM36
prerank,positive regulation of wound healing (GO:0090303),-0.4177984387622134,-1.376951673439963,0.07493540051679587,0.495416300873849,1.0,18/36,33.08%,OCLN;PLPP3;RREB1;SMOC2;THBS1;VTN;FOXC2;ANXA1;PTK2;ST3GAL4;ENPP4;ADRA2A;DMTN;SERPINE1;HBEGF;MYLK;CLDN1;MTOR
prerank,intracellular pH reduction (GO:0051452),0.469894836128457,1.37609601285426,0.08013937282229965,0.9067403483500113,1.0,11/33,14.80%,ATP6V1D;CLCN3;RAB7A;ATP6V0D1;TMEM9;GPR89B;GPR89A;ATP6V0E1;DMXL2;DMXL1;ATP6V1B2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5574293900979241,-1.3756536631792025,0.07983193277310924,0.49741658389723964,1.0,10/13,39.54%,ENPP1;ENTPD7;ENTPD5;ENPP3;ENTPD6;ITPA;ENTPD1;ENTPD2;SMPDL3A;ENTPD3
prerank,signal release from synapse (GO:0099643),-0.4005770829152605,-1.3756117467084625,0.08493150684931507,0.4958089573058402,1.0,14/43,17.26%,RIMS1;SNAP25;NRXN1;SYN2;PCLO;PTPRN2;SYN1;BRSK1;NRXN2;STXBP1;SNPH;VAMP2;STX1A;DVL1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.4147674954132456,1.3755750438972838,0.07196401799100449,0.9048321013606355,1.0,17/61,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PANK2;PSMD11;PSMB4;PSMC1;SIRT1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of integrin activation (GO:0033625),0.5851915274662083,1.3753676007192783,0.13333333333333333,0.9013799928896927,1.0,3/11,13.31%,SRC;RASIP1;PLEK
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4143944369284357,-1.3749399442347892,0.06914893617021277,0.4960695818271765,1.0,7/35,3.73%,HTR2C;KSR1;AKAP6;IRAG1;ADCY2;ADCY1;NUDT4
prerank,neutrophil migration (GO:1990266),0.42261444714113977,1.3741631982432692,0.060653188180404355,0.9033168223538567,1.0,8/58,11.50%,PIK3CG;BSG;PECAM1;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3457794074351686,-1.3725243490366146,0.039603960396039604,0.5017057923031233,1.0,21/86,16.70%,NOTCH2;IGF1;AKAP13;DENND4A;OGT;KANK2;RALGPS1;RASGRF1;PLCE1;ARFGAP1;BCR;STARD13;LZTR1;EPHB2;GRB2;ARHGDIA;MADD;RAF1;NGF;RASGEF1A;RABL3
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.5319899970363053,-1.3719876717669852,0.11704312114989733,0.5015104503243143,1.0,10/14,37.63%,ENPP1;ENPP3;AK5;AK3;ITPA;AK4;SMPDL3A;CMPK2;AK1;NME2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4011594470928979,-1.3700727963271384,0.0705596107055961,0.5056801140752123,1.0,17/40,29.67%,RIMS1;SNAP25;PCLO;STX3;UNC13C;SNPH;UNC13B;VAMP2;SYT7;STX1A;SYT2;SNAP29;CPLX1;SYT10;STX1B;SNCA;CDK5
prerank,protein neddylation (GO:0045116),0.5710786808400955,1.3696606037559154,0.11873840445269017,0.9227529996838729,1.0,7/13,16.97%,RNF7;DCUN1D4;UBE2M;NAE1;UBE2F;DCUN1D2;DCUN1D1
prerank,protein localization to cell periphery (GO:1990778),-0.321930975655061,-1.3696535280801851,0.016666666666666666,0.5051685496103301,1.0,38/133,16.79%,ANK2;DPP6;ANK3;KCNB2;KCNIP4;EPB41L3;MAP7;RAB3C;ATP1B1;PACS2;FLNA;KCNIP3;ROCK2;ATP1B3;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;EZR;ACTN2;TTC7A;CDH1;DPP10;RAMP1;DLG1;MYADM;RAB11A;WNK3;WDR19;STXBP1;AP4M1;FYB1;LRP6;RAPGEF2;EHD1;RAB8A;EHD3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4450019813610572,1.3693042110117244,0.07394957983193277,0.919980217130271,1.0,20/42,19.08%,ACTL6A;DMAP1;ACTB;SMARCA2;VPS72;ACTR8;HNRNPC;ACTR5;CHD3;CECR2;ZNHIT1;INO80;PBRM1;SMARCA4;RBBP4;SMARCAD1;CHD8;HDAC2;ACTR6;SMARCB1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.4410850105915516,-1.3691221619012843,0.07192575406032482,0.5050324945715488,1.0,12/27,14.51%,PER2;PER3;CRY2;PML;BHLHE40;SIK1;MTA1;TP53;CRY1;PER1;RBM4;FBXL12
prerank,acetyl-CoA metabolic process (GO:0006084),0.5617986284080398,1.3684195197432962,0.10474308300395258,0.9198446766405731,1.0,5/15,9.96%,DIP2A;MLYCD;ACAT1;ACACB;HMGCS2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4792497235388691,1.3681910477926833,0.09154929577464789,0.9164173228079713,1.0,7/30,12.36%,NUDT14;ASGR1;ALG8;OST4;STT3B;MCFD2;MGAT5
prerank,negative regulation of DNA metabolic process (GO:0051053),0.4956272793330788,1.367681728980153,0.10430463576158941,0.9144642808518603,1.0,7/24,11.52%,ZRANB3;DACH1;ERCC4;CDKN1A;ACVRL1;MSH3;RPS3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.40308757042698395,-1.3674803147099976,0.07427055702917772,0.5083643831219611,1.0,17/43,28.26%,DDX5;TEAD1;SMAD3;NFIB;BMP4;PPARA;TP53;TGFB1;JUN;NR3C1;NFATC4;GNL3;KLF5;ATOH8;GATA2;EGR1;FOXO3
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.49560218024074504,-1.366489617889289,0.1040339702760085,0.5095785282639841,1.0,6/18,11.71%,SMAD3;ITGB8;SMAD4;LTBP1;FN1;CD34
prerank,protein targeting to mitochondrion (GO:0006626),0.4250341919258929,1.3661732199834045,0.08388157894736842,0.9179008100198827,1.0,11/52,10.17%,TOMM20;TIMM29;ROMO1;IMMP2L;TIMM17B;TSPO;GRPEL2;TOMM40L;TIMM21;FBXO7;AIFM1
prerank,organic anion transport (GO:0015711),0.3969494427997601,1.36496711539171,0.06232294617563739,0.919743679864182,1.0,13/76,10.46%,SLC4A4;SLC4A5;ABCC4;SLC25A24;ABCG2;CA2;SLC52A2;CA4;SLC52A3;LRRC8C;SLC35A1;CYB5R4;SLC35B1
prerank,positive regulation of neuron projection development (GO:0010976),-0.35573208423033564,-1.364607111422253,0.057692307692307696,0.5133929703723272,1.0,38/85,22.78%,MAGI2;NTRK3;TENM3;LRRC7;DPYSL3;NTRK2;BMP5;TOX;BMP7;PTK7;ROR1;RELN;CBFA2T2;PLPPR5;COBL;STMN2;ARSB;ATP1B2;EPHA3;CUX2;RIT2;CAMK1;VLDLR;ROR2;SETX;PLXNB2;RAPGEF2;ABL2;TWF2;SCARF1;SNX3;PACSIN1;CX3CL1;P3H1;PRKD1;DBNL;CAMK2B;SCN1B
prerank,JNK cascade (GO:0007254),0.4483207514333622,1.3636142905947755,0.07809847198641766,0.9223003965282732,1.0,11/40,12.14%,MAP2K7;MAP3K11;MAP3K7;TAB2;MAPK8;ARHGEF6;TAB3;MINK1;UBE2V1;NOD1;CRKL
prerank,histone deacetylation (GO:0016575),-0.3976304723804949,-1.363357350437198,0.05980861244019139,0.515592548311018,1.0,15/43,12.62%,PRDM5;MIER1;HDAC4;TBL1XR1;HDAC1;SIRT2;MORF4L2;PER2;MTA3;MIDEAS;MORF4L1;MTA1;TBL1X;PER1;RCOR3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.5023376893084647,-1.3631193341029213,0.12093023255813953,0.5145867297370786,1.0,7/17,30.44%,AKAP13;ADCY9;ADRA1B;RAPGEF2;ADRA1A;ADRA2A;DRD2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5643459682656926,-1.3620234745310258,0.10480349344978165,0.5161098977933075,1.0,4/12,16.22%,TMEFF2;AP2A1;SELENOS;TGFB1
prerank,endocytic recycling (GO:0032456),0.4301057538007381,1.3619968917155205,0.06416275430359937,0.9261431829720458,1.0,20/50,18.24%,VPS50;EHD4;VPS29;RAB7A;VPS26A;RAB11B;DENND1A;SNX17;RAB14;VPS53;EIPR1;ACAP2;CCDC93;ANKRD27;VPS35;DENND1B;ARF6;ANKRD50;SNX27;VPS26C
prerank,stress-activated MAPK cascade (GO:0051403),0.41319023732438265,1.3619862465186408,0.0705521472392638,0.9217349481565225,1.0,16/61,12.87%,MAP2K7;MAP3K11;MAPK3;MAP3K7;TAB2;ZFP36L1;MAPK8;ARHGEF6;TAB3;MINK1;UBE2V1;NOD1;CRKL;TNIP2;IKBKB;CHUK
prerank,dendrite morphogenesis (GO:0048813),-0.4103648943299253,-1.361876751091725,0.08,0.5148205409595631,1.0,11/35,10.62%,MAP2;CTNNA2;EPHB1;SDC2;WASL;DLG4;DCDC2;CTNND2;DOCK10;BTBD3;EPHB2
prerank,amino sugar metabolic process (GO:0006040),0.6004327831030832,1.3601814455920527,0.11623246492985972,0.9264571129815244,1.0,4/10,13.42%,CSGALNACT1;EXTL2;SLC35A3;ST3GAL1
prerank,positive regulation of ion transport (GO:0043270),-0.38293820784831967,-1.3600862116441728,0.0625,0.5184800539164851,1.0,18/48,25.09%,ANK2;ANK3;STIM2;CACNA1D;FHL1;SNX4;P2RX4;ACTN2;DLG1;WNK3;ANO6;GPD1L;TRPC6;SCN1B;VAMP8;CRACR2A;CAMK2A;ADRA2A
prerank,regulation of mitotic cell cycle (GO:0007346),0.3610004405135752,1.3597144890888488,0.02967741935483871,0.9245606004474922,1.0,38/171,14.15%,DYNLT3;PSMB10;ERCC3;PSMC4;PSMB6;CKS2;PSMD8;PSMD5;PSMD12;TAL1;BRINP3;PIN1;ANAPC2;NEK11;TTLL12;PSMD11;PSMB4;PSMC1;CDK11B;FBXO5;SIRT1;ANAPC7;MDM2;PSMC2;TFAP4;PSMD2;NEK7;USP22;APP;ANAPC11;ANAPC10;ANAPC4;PSMD14;PSMC6;NEK6;PSMD1;PSMB1;RNF20
prerank,regulation of establishment of planar polarity (GO:0090175),0.39045671060976656,1.3596135544670414,0.06417910447761194,0.9206948145544666,1.0,24/88,14.38%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TIAM1;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;DAAM1;WNT5A;PSMC2;FZD3;PSMD2;CELSR1;PSMD14;PSMC6;PSMD1;PSMB1;SPEF1;AP2M1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.5971246420054733,1.35956776772667,0.1323251417769376,0.9165511005468133,1.0,2/10,6.24%,CTCFL;PCGF3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5486639633118467,-1.3594248307632066,0.11814345991561181,0.5188029770541939,1.0,4/13,5.92%,SORBS1;GKAP1;PRKCZ;SORL1
prerank,regulation of mRNA metabolic process (GO:1903311),0.6028247363453383,1.3593222487256025,0.13409961685823754,0.9134500715207227,1.0,7/11,21.70%,NCBP1;CDK11B;SRPK2;PTCD2;SAFB;DHX9;SLTM
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5418868813530624,-1.3585022253038186,0.11839323467230443,0.5200512133862171,1.0,7/13,17.22%,RNF152;DEPDC5;CASTOR2;STK11;ATM;SZT2;ITFG2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.45780753281301145,-1.3578228885230643,0.10628019323671498,0.5203668914071117,1.0,11/23,27.72%,MTMR7;PIP4P2;SACM1L;MTMR12;MTMR9;MTMR4;MTMR11;PIP4P1;INPP5F;OCRL;INPP5K
prerank,retrograde axonal transport (GO:0008090),-0.505488503659894,-1.3577015530886976,0.1276595744680851,0.5190256985565603,1.0,9/16,16.18%,DLG2;DYNC1H1;KIF1C;FBXW11;KIF1A;MAP1A;NEFL;KIF5A;ACTR10
prerank,neuromuscular process controlling balance (GO:0050885),-0.5523604439677634,-1.3576846322803067,0.10816326530612246,0.5174140219691796,1.0,2/12,1.35%,PCDH15;NRXN1
prerank,cardiac muscle contraction (GO:0060048),-0.4131306906223948,-1.3574826333580283,0.08040201005025126,0.5162961214232894,1.0,4/34,4.07%,ATP1A2;GSN;ATP1B1;TPM1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.46072398788919644,1.355825423166983,0.10561056105610561,0.927367685368647,1.0,8/33,11.08%,PTPRR;PTPRG;PTPRM;EVL;APOE;KRIT1;ACVRL1;ADIPOR1
prerank,protein-DNA complex assembly (GO:0065004),0.3710428668674109,1.3558166068847015,0.05851063829787234,0.9230979231760771,1.0,24/116,14.00%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;NAP1L4;ORC3;PSMD11;CCNH;PSMB4;PSMC1;ORC4;GTF2H1;RSF1;PSMC2;PSMD2;ORC2;PSMD14;PSMC6;PSMD1;BRD2;PSMB1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5276851152752887,1.3557486013164965,0.11071428571428571,0.9191554527802732,1.0,2/18,4.13%,PCK1;ZFP36L1
prerank,stabilization of membrane potential (GO:0030322),-0.5056348480162771,-1.3551548113432244,0.11554621848739496,0.5217187338263259,1.0,3/16,10.34%,KCNK2;KCNK5;KCNK10
prerank,cellular response to UV-A (GO:0071492),0.5886201818195957,1.3544544023472935,0.14198782961460446,0.9215047102498175,1.0,2/11,4.44%,CERS1;MME
prerank,neurotransmitter secretion (GO:0007269),-0.3944871310539599,-1.3539582687841591,0.0856353591160221,0.5234392162266984,1.0,14/44,17.26%,RIMS1;SNAP25;NRXN1;SYN2;PCLO;PTPRN2;SYN1;BRSK1;NRXN2;STXBP1;SNPH;VAMP2;STX1A;DVL1
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5681646429408691,-1.353876493108697,0.12114989733059549,0.5219972484065512,1.0,2/10,4.74%,GLI3;BMP4
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.522982673859803,-1.3538744181292326,0.12978723404255318,0.520340370285273,1.0,9/13,28.04%,VCAN;HEXA;HEXB;ARSB;CSPG4;BGN;DCN;HYAL1;CSPG5
prerank,alanine transport (GO:0032328),0.5991112256663637,1.3536427063289767,0.14313346228239845,0.921356002670548,1.0,2/10,5.53%,SLC36A4;SLC6A6
prerank,membrane lipid biosynthetic process (GO:0046467),0.41104878465900047,1.3527244864769388,0.08062015503875969,0.921838452958968,1.0,17/58,16.13%,CERS1;ACER2;CERS4;PRKD2;SGMS1;KDSR;ELOVL6;PLPP1;SGPP2;HACD2;ACER3;SGPP1;SPNS2;ST8SIA6;CERT1;GBGT1;PPM1L
prerank,T cell mediated immunity (GO:0002456),0.5660113626914673,1.3525507126176295,0.1282051282051282,0.918546686912299,1.0,4/13,20.22%,CADM1;CD55;CD46;BTN3A3
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.39519788840638115,1.3524546481079756,0.06911764705882353,0.9148343597080844,1.0,24/80,15.69%,SURF4;VPS50;HEATR5B;PREPL;SNX8;VPS29;RAB7A;RAB7B;VPS26A;TBC1D10B;GOSR2;RAB6B;PIKFYVE;RAB6A;SNX1;VPS53;GCC2;RBSN;TBC1D14;ERC1;TRIM27;TBC1D23;VPS35;TRAPPC10
prerank,regulation of tissue remodeling (GO:0034103),-0.4840906628524769,-1.3519524072652156,0.09777777777777778,0.5242937186465654,1.0,7/18,30.86%,LEPR;IL18;SYT7;TGFB1;MDK;CEACAM1;FLT4
prerank,potassium ion homeostasis (GO:0055075),-0.4584461656102798,-1.3514250510402146,0.09230769230769231,0.5241415067397238,1.0,12/23,19.50%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;SLC12A6;SLC12A4;ATP1A3;SLC12A9
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.5163007866562485,1.3504133408059213,0.12969924812030076,0.9213012477749174,1.0,6/20,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,regulation of neuron projection development (GO:0010975),-0.3098606338304716,-1.3501896141258773,0.02459016393442623,0.5263427038379335,1.0,55/163,22.08%,MAGI2;LRRC4C;NTRK3;TENM3;DCC;LPAR1;LRRC7;CTNNA2;PDLIM5;SPOCK1;DPYSL3;NTRK2;NTNG1;PTPRS;EFNB2;TOX;PTK7;ROR1;RELN;CBFA2T2;SEMA3A;SRCIN1;PLPPR5;STMN2;ARSB;ULK4;ATP1B2;BRSK1;GSK3B;PRAG1;EPHA3;DISC1;RIT2;IL1RAPL1;KIF1A;CAMK1;ROR2;SETX;PLXNB2;PTPRO;RAPGEF2;ABL2;TWF2;MYLIP;SCARF1;SNX3;NCS1;KNDC1;MAG;PAQR3;CX3CL1;P3H1;PRKD1;RTN4IP1;CAMK2B
prerank,negative regulation of response to wounding (GO:1903035),-0.47590793508833185,-1.3499939161505567,0.09271523178807947,0.5252641113135013,1.0,8/19,28.24%,PTPRS;AJAP1;CERS2;CD109;GIT1;SERPINE1;INPP5F;MDK
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3544475253060152,-1.3495799453167319,0.045180722891566265,0.5249893095219428,1.0,19/75,13.92%,MAP2;FGFR2;CNTN4;ANK3;DCC;MAP1B;CTNNA2;NRCAM;NTNG1;SDC2;RYK;DCDC2;SHTN1;BRSK1;BTBD3;PLPPR4;AFG3L2;UNK;MAP1A
prerank,negative regulation of ion transport (GO:0043271),-0.44949179940396206,-1.3493685573867795,0.08454106280193237,0.5239430034309207,1.0,12/24,30.06%,GPM6B;WNK1;ACTN2;WNK4;SYT11;WNK3;NEDD4;ADRA2A;INPP5K;SNCA;PACSIN3;NOS1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4301497705268264,-1.3488172567014687,0.0875,0.5237978016498043,1.0,12/28,28.00%,NAV3;MAPT;OCLN;AKAP9;SLAIN2;CKAP5;DCTN1;MET;GIT1;ARL2;TOGARAM1;MAPRE1
prerank,activin receptor signaling pathway (GO:0032924),-0.5193132490184817,-1.3481596692169926,0.12345679012345678,0.5242104252572994,1.0,4/15,12.18%,SMAD3;TGFBR1;ACVR1;ACVR1B
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3892585009301044,-1.3476702422347084,0.06329113924050633,0.5240406977723343,1.0,14/47,14.44%,DOCK5;EFNA5;DOCK1;FBLN1;NRP1;PDPN;FLNA;NEDD9;RREB1;P4HB;ILK;MYADM;PTK2;TRIOBP
prerank,response to metal ion (GO:0010038),0.40235750649479496,1.3472436979500246,0.07890743550834597,0.933976248418577,1.0,14/67,14.95%,MT1X;MT1A;GPHN;AHCYL1;PPP2CA;NEDD4L;CALM3;PPP2CB;PAM;PPP3CA;SLC25A12;PPP5C;MT2A;HOMER1
prerank,epithelial cell migration (GO:0010631),-0.39817837823606356,-1.3472250068920828,0.07874015748031496,0.5236408239503629,1.0,13/37,9.86%,FSTL1;KANK2;ADGRA2;NRP1;ZEB2;RHOA;KIT;PXN;ROCK1;DPP4;STARD13;FAP;PLEKHG5
prerank,regulation of protein dephosphorylation (GO:0035304),0.447140127643084,1.3471673635536239,0.09775641025641026,0.9301508940245103,1.0,15/37,15.43%,PIN1;TIPRL;PPP1R16B;CNEP1R1;YWHAB;CALM3;SPPL3;TSC1;MFHAS1;ANKLE2;PTBP1;CDH5;PTPA;PPP6R1;PPP1R8
prerank,peptidyl-asparagine modification (GO:0018196),0.46970407120291907,1.3468787373615176,0.10387323943661972,0.9273501149919166,1.0,7/31,12.36%,NUDT14;ASGR1;ALG8;OST4;STT3B;MCFD2;MGAT5
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3805856859981222,-1.3458392922039486,0.07580174927113703,0.5263374876742011,1.0,17/52,17.38%,CELF2;DDX5;DDX17;KHDRBS1;CELF4;KHDRBS2;RBMX;SRSF6;RBM15;RBFOX3;HNRNPA1;SMU1;RBM4;SRRM4;RBM7;NOVA1;RNPS1
prerank,mitotic metaphase plate congression (GO:0007080),0.4167267306440655,1.3455714525517932,0.0804416403785489,0.9298801430311373,1.0,11/51,12.83%,KIF18A;NUDC;BOD1;CHAMP1;DCTN2;CHMP1A;CDCA8;CENPC;CHMP2A;MIS12;CUL3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5461335211010121,1.3454507638811464,0.1266540642722117,0.9264294536272203,1.0,3/15,8.70%,REEP1;ATL1;REEP3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.39456925498319545,1.3447967684205344,0.07264957264957266,0.9257609147381801,1.0,17/73,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;LMO2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of catabolic process (GO:0009894),0.5311034315076044,1.344642522504087,0.12131715771230503,0.9224383190856336,1.0,10/18,19.50%,NEDD4L;TMEM9;MDM2;CHEK2;FAF1;ZDHHC7;ODC1;HPGD;CENATAC;FURIN
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5193291083047484,1.3445422770112363,0.12430426716141002,0.9188390152832628,1.0,5/19,4.52%,NDST3;CSGALNACT1;XYLT1;EXT2;HS6ST1
prerank,acute-phase response (GO:0006953),-0.5444303198660736,-1.344177707844351,0.12337662337662338,0.5297208058594227,1.0,5/12,29.12%,IL6R;LBP;PLSCR1;CEBPB;IL22
prerank,BMP signaling pathway (GO:0030509),-0.36446219959752646,-1.3440881795144195,0.05434782608695652,0.5283735556530232,1.0,14/62,10.15%,DDX5;BMP6;TGFBR3;SMAD3;RGMA;BMP5;BMP7;SMAD4;BMP4;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,cardiac muscle cell differentiation (GO:0055007),-0.47772549261208264,-1.343485645109552,0.11086474501108648,0.5285154850392215,1.0,10/21,34.52%,AKAP13;CXADR;SIK1;ACVR1;KDM6B;VEGFA;MYH11;BMP2;CBY1;MYOCD
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.39352771149944865,-1.343290191938203,0.0741687979539642,0.5274974868010911,1.0,22/43,28.12%,BMP6;IGF1;NELL1;BMP7;IL6R;BMP4;FBN2;WNT4;LRP5;ACVR1;IL6ST;BMPR1B;WWTR1;BMPR1A;BMPR2;CCN1;PRKD1;YAP1;RUNX2;CCN4;LRP3;BMP2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.5646702698909625,1.3427175783634107,0.12195121951219512,0.9239443535696739,1.0,1/12,1.52%,IL1R1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.39425072499106545,1.3420327246762538,0.07164179104477612,0.9235972924936983,1.0,19/79,10.48%,DYNC1I1;MFSD6;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;KIF15;DCTN3;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5261928323148265,-1.3417166164612635,0.1367713004484305,0.5305059905238336,1.0,3/13,5.12%,GLI3;TGFBR2;CBFB
prerank,centromere complex assembly (GO:0034508),0.4493858665787315,1.3412357454356019,0.08925619834710743,0.9237901442815224,1.0,11/36,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;MIS12;POGZ;CENPP;RBBP4;CENPO;NPM1
prerank,positive regulation of calcium ion transport (GO:0051928),-0.40182757918099504,-1.3408930382468327,0.08888888888888889,0.5312470446594677,1.0,5/36,4.75%,ANK2;STIM2;CACNA1D;PDGFRB;P2RX4
prerank,positive regulation of dendritic spine development (GO:0060999),0.5059527525396043,1.340708274583681,0.10405643738977072,0.9224243186899582,1.0,3/20,4.59%,LRP8;SHANK3;APOE
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.566370498871647,-1.3402910705263045,0.1225296442687747,0.5313717410018124,1.0,5/10,25.75%,UFL1;TP53;LMBR1L;ACE;SFRP1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.522208746861035,-1.339947257966344,0.147239263803681,0.5309299534202893,1.0,6/13,10.98%,FBN1;FSTL1;NBL1;FBN2;LTBP1;GREM2
prerank,non-motile cilium assembly (GO:1905515),-0.42059406760628815,-1.3398949586830162,0.1016949152542373,0.5294850721223763,1.0,17/30,31.80%,PIBF1;TTC8;IFT57;CEP89;ARL13B;DISC1;DCTN1;CEP250;GORAB;TMEM80;IFT88;TOGARAM1;C2CD3;FUZ;TMEM216;BBS1;VANGL2
prerank,catecholamine metabolic process (GO:0006584),-0.5341959019380942,-1.3398872484805155,0.12474437627811862,0.5279201132025279,1.0,3/14,6.37%,SNCAIP;ATP7A;COMT
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5285790135531911,1.3398309000073554,0.14964788732394366,0.9227837315182631,1.0,1/17,0.14%,CIDEA
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.49960427804512997,-1.3397134811116997,0.10251046025104603,0.5268981437275204,1.0,11/16,40.89%,NUPR1;ATP7A;VCP;COX7A2L;SLC25A33;PINK1;UQCC2;AK4;PDE12;MLXIPL;PPIF
prerank,positive regulation of glucose import (GO:0046326),-0.46236851976883087,-1.3393674020698543,0.1258426966292135,0.5263840084661817,1.0,11/21,25.63%,SORBS1;IGF1;OCLN;AKT2;CREBL2;ARPP19;PIK3R1;OSBPL8;APPL1;AKT1;CAPN10
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5748243708832884,1.3388660198159328,0.142,0.9238249161466373,1.0,4/11,10.32%,RGS2;GSK3A;NOTCH1;GLRX3
prerank,myeloid cell differentiation (GO:0030099),0.42436564471898996,1.3388555782471672,0.08892617449664429,0.919972047072157,1.0,8/47,10.57%,PRKX;SNRK;TAL1;TIRAP;HIPK2;RPS14;LYN;MFHAS1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.34689784701230664,1.338082940796085,0.035897435897435895,0.9198960658747913,1.0,41/185,14.94%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;ALMS1;NEK11;HAUS4;HAUS5;CEP41;TUBB;ZFP36L1;PSMD11;PSMB4;DCTN2;PSMC1;RGCC;FBXO5;ODF2;CEP164;ANAPC7;DCTN3;PSMC2;TFAP4;PSMD2;DYNLL1;ANAPC11;ANAPC10;CENPJ;ANAPC4;CUL3;PSMD14;PSMC6;NEK6;PSMD1;PSMB1;DYNC1I2;INO80
prerank,epithelium development (GO:0060429),-0.3245649442082994,-1.3378566928198399,0.04697986577181208,0.529280750756535,1.0,43/107,31.88%,FGFR2;ALDH1A2;AHI1;KANK2;PKD1;ERRFI1;ANXA4;OSR1;SMO;VDAC1;VCL;MEOX2;CPT1A;WNT4;SALL1;PTER;LOXL3;CD34;MTHFD1;TOLLIP;RCN3;DACT1;ANXA7;TGFB1;DVL1;SIX1;TAGLN2;STAT1;PGK1;VEGFA;PAX2;NDRG4;PTCH1;TBX2;TAGLN;CTSB;BMP2;PCNA;ALDOC;PIH1D1;GATA6;MFSD2A;FGF10
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.5470725100357293,-1.337089559166118,0.12688172043010754,0.5298003431962756,1.0,3/12,13.42%,NUPR1;IL18;IL33
prerank,cardiac conduction system development (GO:0003161),-0.4425789338365891,-1.3367591343800058,0.11395348837209303,0.5292054306494661,1.0,10/24,19.12%,NOTCH2;GJB6;SMAD4;MAML1;BMP4;GJA1;CACNA1G;SMAD5;TBX18;BMPR1A
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3929376492744115,-1.3361316416019298,0.07427055702917772,0.5295125342946514,1.0,9/41,11.71%,ANK2;ANK3;KCNMA1;AKAP6;FLNA;GABBR2;KCNJ2;ACTN2;KCNJ6
prerank,mammary gland development (GO:0030879),-0.46651615788127354,-1.3357782168620767,0.10401891252955082,0.5290380878061147,1.0,8/21,26.12%,ERBB4;GLI2;WNT4;TBX3;PRLR;VEGFA;TGFB3;NOTCH4
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.35513888319339154,1.3350579740343596,0.0388739946380697,0.9310601324350916,1.0,32/146,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ALMS1;HAUS4;HAUS5;CEP41;STOX1;TUBB;PSMD11;PSMB4;DCTN2;PSMC1;FBXO5;ODF2;USP47;CDK4;CEP164;DCTN3;PSMC2;PSMD2;DYNLL1;RAD51B;CENPJ;PSMD14;PSMC6;PSMD1;AVEN;PSMB1
prerank,ceramide biosynthetic process (GO:0046513),0.43474688542690315,1.334678449250788,0.09046849757673667,0.9289905688561955,1.0,5/40,5.24%,CERS1;SMPD4;ST6GALNAC3;CERS4;SGMS1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5309071295235565,1.3340069056827708,0.14821428571428572,0.9285748807795031,1.0,6/16,19.12%,ZC3H12D;ZFP36L1;TARDBP;MOV10;RC3H1;DHX36
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5703837189562956,1.3337098145269954,0.18392857142857144,0.9263102106138398,1.0,5/11,18.84%,ASF1B;CABIN1;RBBP4;ATRX;HAT1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.38005205217243143,-1.3335959347673705,0.07407407407407407,0.5336944026928208,1.0,7/45,4.74%,BMP6;DAB2;TGFBR1;BMP5;BMP7;SMAD4;BMP4
prerank,positive regulation of coagulation (GO:0050820),-0.5684358696597125,-1.333354190406205,0.14046121593291405,0.5313184290479743,1.0,5/10,25.85%,THBS1;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),-0.5684358696597125,-1.333354190406205,0.14046121593291405,0.5313184290479743,1.0,5/10,25.85%,THBS1;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,sprouting angiogenesis (GO:0002040),-0.3720472546005775,-1.3333146481246005,0.07277628032345014,0.5298833231534275,1.0,14/51,10.86%,ROBO1;PARVA;ADGRA2;BMPER;NRP1;EFNB2;BMP4;PIK3R3;EPHB4;CCBE1;THBS1;RSPO3;OTULIN;RNF213
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.45899181113598897,-1.3329949992405516,0.10854503464203233,0.5293492585548925,1.0,5/22,7.83%,CACNA1C;CACNA1D;STIM1;ADGRV1;GABBR2
prerank,protein localization to cell junction (GO:1902414),-0.45665013215048517,-1.3328426101506057,0.10158013544018059,0.5282183019692644,1.0,9/22,13.66%,CGNL1;PCLO;JAK1;DLG4;NLGN2;JAM3;NLGN1;KIF3A;BSN
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3298926220873565,1.3327355463076844,0.02372479240806643,0.9274532362608852,1.0,102/341,18.09%,PSMB10;PSMC4;PSMB6;ELOC;GSK3A;RNF7;CBL;PSMD8;PSMD5;PSMD12;ARIH1;RNF149;ANAPC2;KLHL3;TNFAIP3;FEM1C;SPOP;UBXN11;UBA1;RFFL;BIRC2;PSMD11;NEDD4L;UBAP1;NHLRC1;RBBP6;PSMB4;PSMC1;UBE2I;RNF130;COP1;SIRT1;UBL7;CLOCK;RNF187;PPP1R11;TTC3;TRIM25;FBXO11;CRBN;ANAPC7;RBCK1;MDM2;RAD23A;PSMC2;UBE3D;PSMD2;RNF6;ZNRF1;FBXO7;RNF13;VPS37B;CHFR;SPOPL;UBQLN1;ANAPC11;IFI27;ANAPC10;PLAA;ANAPC4;FBXO8;RNF11;CUL3;PSMD14;USP33;UBE2R2;RNF146;RNF216;DDIT3;PSMC6;PSMD1;FAF1;APPBP2;PSMB1;RNF20;USP9X;TRIM3;UBA6;NHLRC3;UBE2G1;FBXO22;UBQLN4;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF128;RNF125;UBE2H;UFD1;UBQLN2;PSMA4;VPS37C;UBR3;ATXN3;CDC26;RNF215;RAD23B;KCTD10;AGAP3;VPS4B
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3433801739574927,-1.332586756980344,0.04516129032258064,0.5274579949444806,1.0,18/85,11.29%,PCDH15;EYA1;CACNA1D;COL1A1;EML2;COL11A1;COL4A3;ADGRV1;ROR1;CEMIP;P2RX4;PIEZO2;DCDC2;GSDME;NIPBL;TIMM9;ATP6V0A4;TBL1X
prerank,microvillus organization (GO:0032528),0.5623608714410522,1.3325805199718799,0.12922465208747516,0.9244709602497689,1.0,6/13,15.52%,RAP2A;MINK1;RAPGEF6;RAP2C;MAP4K4;FXYD5
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5520993595215634,-1.3322532923079464,0.1326530612244898,0.5269484386093646,1.0,4/12,12.92%,CTNNA3;CACNA1C;BIN1;DLG1
prerank,response to light stimulus (GO:0009416),0.41119406995481084,1.3319848743396696,0.07570977917981073,0.9236110849647976,1.0,9/55,10.40%,ERCC3;ZRANB3;MAP2K7;GPR52;ERCC4;MAPK8;CLOCK;SPRTN;CCAR2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.41998619391253916,-1.3318140313110742,0.09836065573770492,0.5268006302205074,1.0,9/29,9.75%,SMAD3;ZC3H7A;PUM1;ZC3H7B;PUM2;LIN28B;SRRT;HNRNPA2B1;AGO3
prerank,cellular metal ion homeostasis (GO:0006875),-0.3260482345868287,-1.3317232611150307,0.04460966542750929,0.5255641046914962,1.0,17/102,10.33%,ANK2;ATP1A2;SLC24A3;HTR2C;KCNMA1;STIM2;ATP1B1;STIM1;SLC41A1;ATP13A5;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;SLC24A2;DMPK
prerank,cristae formation (GO:0042407),0.46819920229818507,1.3310627526181904,0.11986301369863013,0.9246101064857445,1.0,11/27,14.72%,ATP5F1E;UQCC3;ATP5MG;ATP5PF;ATP5MC2;IMMT;CHCHD6;CHCHD3;LETM1;DNAJC11;ATP5F1C
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5839217309322082,1.33003066439773,0.13555992141453832,0.9260925859967946,1.0,4/11,10.58%,NCBP1;AHCYL1;ZFP36L1;PAPOLA
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.503348478666567,-1.3300085041680878,0.1115702479338843,0.5290533302388382,1.0,8/15,22.28%,P2RX4;SMOC2;LGMN;SEMA5A;MET;HSPB1;PRKD1;VEGFA
prerank,microvillus assembly (GO:0030033),0.5465831309251552,1.3296658280009468,0.11992263056092843,0.9241212077227617,1.0,6/14,15.52%,RAP2A;MINK1;RAPGEF6;RAP2C;MAP4K4;FXYD5
prerank,cell chemotaxis (GO:0060326),-0.3570276850322491,-1.32956302142756,0.0581039755351682,0.5286924716437384,1.0,12/60,10.71%,LPAR1;PARVA;PDGFRB;EPHB1;NRP1;KIT;PIP5K1A;PRKCD;PDGFRA;CCR9;PLEKHG5;ACKR3
prerank,positive regulation of dephosphorylation (GO:0035306),0.46974015145944015,1.3289270748212956,0.11837455830388692,0.9241491872578921,1.0,10/27,14.15%,PIN1;SRC;PPP1R16B;CNEP1R1;CALM3;SPPL3;ANKLE2;PTBP1;CDH5;PTPA
prerank,sodium ion transport (GO:0006814),-0.3375029966143851,-1.3288439626391664,0.05466237942122187,0.5292637547788652,1.0,23/85,18.15%,ATP1A2;SLC24A3;HCN1;NALCN;SLC6A13;ATP1B1;SLC6A1;SCN8A;SCN3A;ATP1B3;SLC12A2;SLC6A9;SLC6A12;SCN1A;SLC24A2;SGK1;SLC9B2;SLC6A15;ANO6;NDUFA9;SLC5A6;SLC38A7;SLC5A5
prerank,macrophage activation involved in immune response (GO:0002281),0.5630725717121087,1.3284313861731654,0.1509090909090909,0.9228441227009245,1.0,3/13,6.70%,IFI35;SBNO2;SYK
prerank,muscle organ development (GO:0007517),-0.3650782644850411,-1.3275527296071885,0.06166219839142091,0.5316326025087894,1.0,16/54,17.73%,LAMA2;IGF1;VAMP5;SGCE;FHL1;CHD2;MKX;SMTN;SPEG;ITGA11;LARGE1;SRI;FKTN;COL6A3;EVC;SOX6
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.44104656359361744,-1.327205711138217,0.1152073732718894,0.5311880828644233,1.0,5/25,11.76%,ITPR1;MAPT;P2RX4;HTT;RIT2
prerank,transition metal ion transport (GO:0000041),-0.4064687152675578,-1.326266874057027,0.10831234256926953,0.53228636788006,1.0,15/35,30.33%,CP;TRPC5;ATP7A;SLC30A10;TRPC1;SLC31A1;SLC39A8;SLC31A2;COX17;SLC11A2;TRPC6;SLC30A5;TTYH1;TRPC3;ATOX1
prerank,proteolysis (GO:0006508),0.3336040210506262,1.3262318891824327,0.024154589371980676,0.9300417854152406,1.0,31/252,9.39%,LRP8;CAPN8;PCSK1;LVRN;FBXL6;CELA1;PSMC4;PRCP;PSEN2;RSPRY1;DPP8;MME;MMP12;ATG4C;UBE3A;CASP6;METAP2;FBXW2;CNDP2;RET;SPCS3;PGPEP1;LONP1;NAPSA;SPPL3;ATG4B;DESI2;DESI1;TPP1;SPRTN;MDM2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5528424649474561,-1.3255317636855124,0.145748987854251,0.5328254265565622,1.0,7/11,24.52%,IGF1;GHR;TSC2;PIK3R1;GIGYF1;EIF2AK3;AKT1
prerank,regulation of B cell proliferation (GO:0030888),0.4258858250295718,1.32517561685624,0.08864696734059098,0.9316179918583165,1.0,7/44,10.70%,PTPRC;VAV3;FCGR2B;TIRAP;IRS2;LYN;CD81
prerank,regulation of calcium ion transport (GO:0051924),-0.37243498251069845,-1.324833816174865,0.07580174927113703,0.5335379781290204,1.0,21/54,30.06%,ANK2;STIM2;CACNA1D;STIM1;CTNNB1;P2RX4;IL16;SRI;WNK3;EFHB;BCL2;CACNA2D1;CAMK2B;TRPC6;CRACR2A;CAMK2A;ADRA2A;INPP5K;PACSIN3;MYLK;NOS1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.48894980894214046,-1.3231145076603188,0.1292372881355932,0.5371475228595161,1.0,4/17,19.42%,PLA2G4A;LPGAT1;CRLS1;LPCAT1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4215332001876879,-1.3230714390747564,0.12100456621004566,0.5357724127057721,1.0,18/29,33.65%,ZBTB20;SORBS1;LPGAT1;PPARA;CREBL2;LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2;AKT1;SLC45A3;MFSD2A;SIRT4;MTOR;CHP1;MID1IP1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.49513681861849357,1.3227537217211285,0.1271186440677966,0.9401308680073177,1.0,7/21,12.02%,NUDT11;PDE4D;MLYCD;FITM2;ACAT1;PNP;NT5C2
prerank,positive regulation of signal transduction (GO:0009967),-0.290941824672076,-1.3226195492767256,0.00546448087431694,0.5355644956851517,1.0,55/238,14.70%,SORBS1;BMP6;NTRK3;FGFR2;RIMS1;IGF1;SULF1;ROBO1;SASH1;WLS;NRXN1;NRP1;FGF1;TGFBR1;DLG4;AXL;MACF1;SULF2;NLGN2;MAML1;FLNA;GKAP1;PRKCZ;RELN;SMO;F3;DCDC2;SORL1;SLC39A14;ITGA5;SKI;HTT;PTGIS;ZDHHC5;CDC73;NLGN1;SNW1;CCBE1;SMOC2;RSPO3;VTN;SALL1;CUX2;ILK;DISC1;ADAMTS3;LOXL3;ATP6V0C;LY86;GRB10;TRIM39;IL6ST;IGF2;CAV2;DACT1
prerank,innate immune response (GO:0045087),0.3406770749691408,1.3222963276790902,0.0407911001236094,0.9386251397642349,1.0,40/217,14.46%,DMBT1;PIK3CG;CAPZA2;TRIM28;IFNLR1;IFITM2;SRC;IFIT1;TRIM8;RNASE6;FYN;PHB2;TRIM14;B2M;SYK;IFITM3;RNF187;ADAR;TRIM25;IFITM1;RELA;LYN;PJA2;MFHAS1;SRPK2;YES1;SERINC5;DDX3X;APP;SERINC3;PIK3CD;ANKHD1;IFI27;IKBKB;CHUK;NLRC5;ANKRD17;TRIM27;GCH1;CYBA
prerank,regulation of complement activation (GO:0030449),0.43170767777111124,1.3222849313321143,0.11057692307692307,0.934969141664834,1.0,5/40,12.57%,C1QB;C1QC;PHB2;CD81;CD55
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.4279276982997263,-1.322214622285644,0.10776942355889724,0.5352268108512815,1.0,2/27,0.64%,LPAR1;HTR2C
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3700190572564897,1.3219086439562957,0.06536856745479833,0.9331781230856216,1.0,19/104,10.80%,TRIB3;RALB;EZH2;MTCP1;ACTB;RPTOR;SRC;CDC37;PPP2CA;CCNH;CIB1;CDKN1A;CALM3;SIRT1;GTF2H1;CCNG2;CSF1R;BCCIP;DDX3X
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.2912876313095947,-1.3217761622273507,0.026041666666666668,0.5350805951494987,1.0,56/224,17.48%,DLG2;DLGAP1;KCNQ3;PLP1;HTR2C;GABRB1;GRIA4;SNAP25;GRIA2;SLC1A3;NRXN1;CACNB4;AMPH;GRIN2B;GRM5;GLRB;CHRM2;KCND2;SYN2;MBP;GABRA2;DLG4;NLGN2;SLC6A1;CACNA1B;GLRA3;CAMK4;CHRM3;GABRG2;GLRA1;GABBR2;AKAP9;NLGN1;SYN1;KCNA1;PRKACA;HTR4;RIT2;NRXN2;PRKAR1B;APBA1;DLG1;UNC13C;CAMK1;BSN;HTR7;UNC13B;GRIK4;SLC12A6;LRP6;KIF5A;GABRA5;SLC12A4;NOVA1;GABRG3;HCRTR2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.39861901872304434,-1.321750291918309,0.06914893617021277,0.533723117606283,1.0,14/37,23.38%,MAPK14;APPL2;PPARA;IL17RA;ADCY7;PER1;SIRPA;ABCD2;PLD3;GBP5;APOD;CHID1;APPL1;IL17D
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5261718665683706,-1.3213778991151668,0.13245033112582782,0.5334550604834067,1.0,5/13,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP1A1;ATP1B2
prerank,positive regulation of actin nucleation (GO:0051127),-0.5560556028612256,-1.3210740799303262,0.1351931330472103,0.5328370007700098,1.0,4/11,13.84%,GSN;WASF2;WASF1;FCHSD2
prerank,positive regulation of blood coagulation (GO:0030194),-0.4910811117683536,-1.320893093061191,0.14512471655328799,0.5318994634582419,1.0,7/17,25.85%,F3;THBS1;ANO6;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.46679483851287984,1.3205500658065865,0.1237785016286645,0.9362704947332264,1.0,12/30,17.99%,HSPA8;CCT2;DNAJB5;BAG1;HSPE1;SDF2;HSPA13;DNAJB14;HSPA14;GAK;ST13;UGGT1
prerank,mitochondrial translation (GO:0032543),0.3669086819221952,1.3203810584265752,0.06162464985994398,0.9333562247637575,1.0,19/104,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;FASTKD2;MRPL18;MRPL38;LARS2;MRPS12;HARS1;RARS2;MRPL20;EARS2;TSFM;MRPL52;MRPS15;MRPS24;MRPL48
prerank,endothelial cell development (GO:0001885),0.47730814515282005,1.3201527609709998,0.13448275862068965,0.9308557300017051,1.0,7/25,10.82%,PDE4D;PECAM1;MARVELD2;PPP1R16B;ICAM1;RAPGEF3;ROBO4
prerank,organelle organization (GO:0006996),0.3250269708373615,1.3200412970274846,0.016166281755196306,0.9278409369814123,1.0,67/388,11.15%,CIDEA;ROPN1;SURF4;FAM161B;CHCHD2;SEMA6A;SYNE1;SH3D19;SMPD4;TNFAIP3;LYSMD3;CYCS;KIFAP3;GORASP2;DNAJA3;SORT1;FITM2;CLASP2;GABPA;ZMYM4;MTFR1;LMAN2;ATL1;SIRT3;CFAP126;VPS11;APOE;PRPF40A;PLAAT3;RAB7A;PHB2;TMED4;SEC23IP;RAB43;CFL1;DST;PEX1;TRAPPC8;SSBP1;USP6NL;ARHGEF7;PEX7;CHMP1A;TRIP11;TTC17;LONP1;VMP1;TMED5;AGTPBP1;PIKFYVE;ODF2;TMED10;RAB14;FGD5;CDCA8;TMEM135;AUP1;RAB1A;GOLPH3L;PARK7;TRAPPC11;DOP1B;CHMP2A;TERT;TMED7;HPS3;NOS3
prerank,response to cAMP (GO:0051591),-0.39088605659348874,-1.3194000725037465,0.09042553191489362,0.5347293603503767,1.0,14/37,27.72%,HCN1;AKAP6;IGFBP5;AKAP9;EZR;RAPGEF2;SLC5A5;STAT1;DGKQ;DMTN;PDE2A;HCN2;KCNQ1;INPP5K
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.47281123244203316,1.3192274947775526,0.1524822695035461,0.9280876222466531,1.0,3/25,4.48%,NDST3;CSGALNACT1;EXT2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3890658721644756,-1.3184496871718465,0.10386473429951691,0.5361495057461558,1.0,6/40,3.36%,MAGI2;BICD1;DAB2;AHI1;ANXA2;WASL
prerank,regulation of cytoskeleton organization (GO:0051493),-0.31985461635091306,-1.3183719646955736,0.056338028169014086,0.5349391912889606,1.0,33/108,17.61%,BICD1;PHLDB2;LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;CAPN2;PHLDB1;CYLD;MAPT;CLIC4;RHOA;ROCK2;PRKCD;ROCK1;EZR;RND3;RHOBTB2;GSK3B;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;PFDN2;TRIM36;PTK2;ARHGEF5;IQGAP2;NEXN;DIAPH1;TWF2
prerank,sodium ion transmembrane transport (GO:0035725),-0.33549323988682495,-1.3178775747098395,0.03896103896103896,0.5349733044665922,1.0,17/84,9.99%,ATP1A2;SLC24A3;HCN1;NALCN;SLC6A13;ATP1B1;SLC6A1;SCN8A;SCN3A;ATP1B3;SLC12A2;SLC6A9;ATP1A1;SLC6A12;SCN1A;ATP1B2;SLC24A2
prerank,muscle cell migration (GO:0014812),-0.5575469777606934,-1.3169728105773686,0.13211382113821138,0.5361842015067567,1.0,8/10,28.88%,DDR1;ROCK1;MEGF10;CCN3;SIX1;AAMP;ITGB1BP1;ITGB3
prerank,vacuolar acidification (GO:0007035),0.5056465304011482,1.3165330185493436,0.14150943396226415,0.9378985807108416,1.0,7/21,13.75%,PPT1;ATP6V0D1;TMEM9;ATP6AP2;ATP6V0E1;DMXL2;DMXL1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5276009874234062,-1.3160952754356503,0.12814645308924486,0.5371284466069572,1.0,3/13,3.91%,NRP1;TGFBR2;CTNNB1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.37404440905993364,-1.316015979939998,0.08902077151335312,0.5359646385571059,1.0,8/49,7.05%,ERBB4;IGF1;PARP14;IL6R;PIBF1;KIT;GHR;IL31RA
prerank,spindle assembly (GO:0051225),0.3921026770783732,1.31572886992617,0.10586552217453506,0.93839303610516,1.0,23/67,17.19%,ABRAXAS1;HAUS4;HAUS5;CLASP2;HDAC3;TUBGCP5;MZT1;STARD9;KIF2A;BCCIP;NEK7;RPS3;TNKS;KIF3B;CHEK2;NEK6;ARHGEF10;RCC1;INO80;STAG2;TUBGCP2;KPNB1;CLASP1
prerank,T cell activation (GO:0042110),0.3927657411067136,1.315364495051036,0.09337349397590361,0.9365985352250191,1.0,11/69,11.89%,LCP1;JAG2;PIK3CG;PTPRC;PPP3CB;GPR89B;GPR89A;NLRC3;LFNG;PIK3CD;PPP3CA
prerank,positive regulation of cartilage development (GO:0061036),-0.48910952503772553,-1.3149038510817697,0.13449023861171366,0.5377951731665355,1.0,9/17,28.24%,SOX5;TAPT1;BMP4;BMPR1B;SOX6;BMPR2;PKDCC;BMP2;MDK
prerank,neurotrophin signaling pathway (GO:0038179),-0.4547214755530204,-1.314792818998091,0.1348314606741573,0.5367648237513611,1.0,9/21,26.27%,MAGI2;NTRK2;GRB2;NGF;RAPGEF2;ZFYVE27;CASP3;KIDINS220;DDIT4
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4692892631403446,1.3145021220941069,0.14554794520547945,0.9373662518660538,1.0,6/26,14.25%,ACER2;SPR;CYP1B1;NOS3;ACER3;GCH1
prerank,establishment of protein localization to membrane (GO:0090150),0.39678449295689633,1.314160891947172,0.09579100145137881,0.9356063244879973,1.0,19/66,17.24%,RTP3;REEP1;GORASP2;CHM;RAB11B;ZDHHC14;PIKFYVE;ZDHHC15;ICMT;VPS37B;PRKCI;ZDHHC9;NPC1;ZDHHC7;PARD3;RAB3GAP1;BRAF;VPS37C;RTP4
prerank,RNA splicing (GO:0008380),0.3703189082552557,1.3140680916423766,0.08069164265129683,0.9325675540105287,1.0,33/95,17.92%,SNRPD2;NCBP1;PRPF3;SNRPD1;PPP2CA;PPIG;SRSF10;USB1;SFPQ;HNRNPC;IVNS1ABP;SMNDC1;SF3B3;SRSF4;YJU2;RSRC1;TARDBP;U2AF1;CCAR2;SRPK2;PTBP1;RRAGC;SRSF7;USP39;FUS;TCERG1;TRA2B;LSM1;NONO;SNRPA1;DHX8;DDX23;PRPF18
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4347591264897048,1.3136293297461268,0.11609907120743033,0.9312406179622854,1.0,5/42,6.63%,ROMO1;RPL30;DMBT1;RNASE6;SELP
prerank,regulation of insulin secretion (GO:0050796),-0.320318807752635,-1.3135791447340335,0.039634146341463415,0.5388379861691793,1.0,25/101,16.67%,CACNA1C;ITPR1;SNAP25;ADCY5;MCU;CACNA1D;EFNA5;KCNC2;NLGN2;PER2;GLUD1;DPP4;ENSA;RBP4;LRP5;CDK16;STXBP4;TM7SF3;NNAT;PSMD9;SYT7;CCN3;TCF7L2;STX1A;KCNS3
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4937865801582411,1.3129062527560569,0.12432432432432433,0.9312670859539177,1.0,7/21,11.52%,PTPRC;PRKCH;PRKD2;RELA;CD81;SLC39A10;RPS3
prerank,diterpenoid metabolic process (GO:0016101),-0.3645467934763671,-1.3123109136986038,0.0856353591160221,0.5410673906507592,1.0,13/55,11.98%,GPC6;LRP1;ALDH1A1;SDC2;DHRS3;GPC3;HSPG2;ABCA4;NAPEPLD;RBP4;GPC5;RBP1;ALDH3A2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5055233987364931,-1.3114754659742123,0.14096916299559473,0.5421267980756932,1.0,11/15,40.89%,IGF1;GHITM;AKT1;BCL2L1;GPX1;FXN;PRELID1;CLU;HGF;OPA1;PPIF
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.30551404532503385,-1.31135841876953,0.023076923076923078,0.5410869877059389,1.0,33/138,15.75%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;AHI1;PDGFRB;EPHB1;NTRK2;AXL;RYK;ABI1;FER;EPHA7;MTSS1;NEDD9;ROR1;KIT;DDR1;PDGFRA;FRK;IL31RA;EPHB4;EPHB2;EPHA3;PTPRF;ACVR1B;SHC3;IL6ST;ROR2;PTK2;PTPRU;NGF
prerank,granulocyte differentiation (GO:0030851),0.510264755087211,1.3111025282191935,0.15485074626865672,0.9366102048149214,1.0,5/18,8.53%,TAL1;LEF1;CDKN1A;EP300;CDK4
prerank,somite development (GO:0061053),-0.5324263230383478,-1.3110109430902694,0.15756302521008403,0.5406302019167125,1.0,4/11,12.55%,SMO;MEOX2;LOXL3;MTHFD1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5120340548243753,-1.310785544245022,0.12857142857142856,0.5398656085451132,1.0,8/14,37.91%,SULF1;SULF2;THBS1;CREB3L1;FUZ;GPC1;SPRY4;SPRY1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5027925752615432,-1.3107467329778817,0.1336206896551724,0.5385687299365065,1.0,9/15,17.77%,WNT5B;GPC3;CSNK1E;RSPO3;ZNRF3;RNF213;DAAM2;DACT1;SFRP4
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.30082858947970154,-1.3105780560238485,0.01809954751131222,0.5376577027679426,1.0,43/182,16.22%,FOXP1;NOTCH2;SLC24A3;IGF1;ROBO1;ITGB8;SH3GL2;DLG4;MAPT;OCLN;PARP14;RBL2;HDAC1;TET1;BMP4;KDM4A;ROCK2;FLOT2;SMO;WWP2;WNT4;XDH;LDLR;MAP2K2;OPTN;SFMBT2;AGO3;LGMN;NDFIP1;NFKB1;REL;CD34;DDRGK1;MYADM;SETDB2;HINFP;RACK1;DICER1;PTPN22;ANXA7;RIN3;RBMS3;TGFB1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2976576708479965,-1.3103574540598215,0.017985611510791366,0.5368539899678059,1.0,62/151,26.25%,MAGI2;BMP6;NTRK3;ADAMTS12;EGFR;SMAD3;IQGAP1;NTRK2;NRP1;TGFBR1;MAPK14;SOX5;TGFBR2;MAPT;CTNNB1;BMP7;SMAD4;SIRT2;MED1;BMP4;APPL2;WNT4;STMN2;CLEC3B;GAS1;FOXC1;ACVR1;LGMN;ANXA1;ACVR1B;MTSS2;PDCD5;DUSP22;RACK1;VSTM2A;SETX;RAPGEF2;TGFB1;BMPR1B;EHD1;NR3C1;TWF2;SOX6;RPS6KB1;BMPR1A;CPNE3;BMPR2;HSPB1;PRKD1;VEGFA;APPL1;ITGB1BP1;EMD;AKT1;KIDINS220;ERBB2;HYAL1;RUNX2;DSTYK;SFRP1;NR4A1;PDE2A
prerank,actomyosin structure organization (GO:0031032),-0.34251442555806944,-1.310082695444542,0.04790419161676647,0.5362181569935129,1.0,19/75,14.38%,SORBS1;EPB41L3;TMOD2;EPB41L1;CDC42BPB;TPM1;RHOA;ROCK2;ITGB5;EPB41L4B;CIT;FRMD3;ROCK1;TNFAIP1;EPB41L2;ACTN2;CSRP2;PDLIM1;WDR1
prerank,cardiocyte differentiation (GO:0035051),-0.5721918589178205,-1.3094262208070409,0.147117296222664,0.5366908216575941,1.0,8/10,34.52%,AKAP13;SIK1;KDM6B;EEF1AKMT4-ECE2;BMP2;GATA6;CBY1;MYOCD
prerank,insulin secretion (GO:0030073),0.5128180947680047,1.3091135843757584,0.15858208955223882,0.9430654470044312,1.0,6/19,9.76%,SELENOT;RAB11B;RAB11FIP5;RAB11FIP2;CYB5R4;PARK7
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5429795593346075,1.3087838050278715,0.14473684210526316,0.9411825393897899,1.0,8/14,18.79%,ACD;TPP1;TERT;TNKS;TERF2IP;ATR;TNKS2;ATRX
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4695787294219451,-1.3083935554363115,0.16252821670428894,0.5380598295213175,1.0,4/18,14.13%,IGF1;IGFBP2;IL18;IGF2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.41763968995283784,1.3083718667089754,0.10873146622734761,0.9396477555114995,1.0,10/46,10.17%,TOMM20;ROMO1;TIMM17B;RALA;TSPO;GRPEL2;TOMM40L;TIMM21;FBXO7;AIFM1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.33212982465770663,-1.3077577795860715,0.04472843450479233,0.5382787465755525,1.0,25/80,17.61%,TENM2;DPYSL3;WASF2;AUTS2;NRP1;WASL;OCLN;TAPT1;PLCE1;GPM6A;CEP120;HTT;PLPPR5;ACTR3;NLGN1;DOCK11;FAM98A;ENTR1;CCP110;CDC42EP5;CDC42EP1;PLEKHM1;ACTR2;CDC42;TWF2
prerank,AMP metabolic process (GO:0046033),-0.522755206773142,-1.3075437016834148,0.16417910447761194,0.5375097670478776,1.0,11/13,42.66%,AMPD3;XDH;AK3;AMPD2;ADSS2;ADSL;AK4;NUDT2;NT5C1A;ADSS1;NT5E
prerank,cell-cell junction organization (GO:0045216),-0.33382023713610154,-1.3070504007367056,0.06948640483383686,0.5375326957745048,1.0,33/79,24.39%,SDK1;CDH10;SMAD3;CTNNA1;CXADR;OCLN;TLN1;NLGN2;CTNND2;CDH11;SDK2;TLN2;CDH7;GJC1;ARVCF;AFDN;CDH1;CSK;CDH4;MYADM;CTNND1;NECTIN3;CADM2;TGFB1;CDH9;CDH8;CADM3;CDH19;FLCN;NECTIN2;DCHS1;TGFB3;PVR
prerank,spinal cord development (GO:0021510),-0.5242916799672961,-1.3068344008834747,0.15604395604395604,0.536688914659949,1.0,5/12,17.20%,PKD1;GLI2;RELN;LOXL3;VIT
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4442821865056772,1.3064220242591522,0.11267605633802817,0.9455613193935906,1.0,7/34,6.45%,PTPRQ;PTPN18;DUSP7;PTPRJ;PTPRB;PTPN12;PTPRT
prerank,regulation of receptor internalization (GO:0002090),-0.3995649532670973,-1.3056033560078606,0.07920792079207921,0.5390054587411508,1.0,3/35,3.56%,MAGI2;AHI1;DLG4
prerank,regulation of cellular senescence (GO:2000772),0.46625458581778334,1.305127183735606,0.12935323383084577,0.9487736894996247,1.0,11/28,16.19%,B2M;FBXO5;SIRT1;YPEL3;ZKSCAN3;ING2;TERT;NEK6;YBX1;MAP3K3;RSL1D1
prerank,positive regulation of protein acetylation (GO:1901985),0.5522218639058829,1.3046572737369608,0.16205533596837945,0.9476710916160357,1.0,6/12,15.22%,DIP2A;DIP2B;RAPGEF3;PRKAA2;DDX3X;TERF2IP
prerank,regulation of hormone secretion (GO:0046883),-0.49041513093772315,-1.3045308644572997,0.1535181236673774,0.5408319070661908,1.0,7/15,35.10%,SCG5;ANXA1;VAMP2;SNX6;EDN1;SOX11;EDN3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.37415804145816095,1.303950696029781,0.08853410740203194,0.947841510926035,1.0,11/88,5.30%,FBXL6;PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;FBXL5;PSMC1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.4802696232616287,-1.303793770414081,0.15040650406504066,0.5415948107963595,1.0,2/17,1.84%,MAGI2;PDGFRB
prerank,myofibril assembly (GO:0030239),-0.38732338141297734,-1.303787207471231,0.09399477806788512,0.5402448423243555,1.0,9/42,14.38%,CFLAR;PDGFRB;TMOD2;TPM1;PDGFRA;ACTN2;CSRP2;OBSL1;WDR1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3763381590001315,1.3031366031639726,0.07771260997067449,0.948427570811932,1.0,20/87,13.09%,TTC19;IMMP2L;SDHAF3;NDUFAF1;NDUFAF5;UQCC3;NDUFB6;NDUFB4;NDUFA10;OMA1;NDUFA1;NDUFS2;TIMM21;AIFM1;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,calcium ion transmembrane transport (GO:0070588),-0.33500679585594273,-1.3027996130972608,0.0732484076433121,0.541790021758944,1.0,13/86,4.75%,TRPM3;SLC24A3;CACNA1C;NALCN;MCU;CACNA1D;GRIN2B;RYR3;PKD1;TRPM6;TRPC5;MICU2;P2RX4
prerank,regulation of osteoclast differentiation (GO:0045670),-0.40171341907943264,-1.30272733574268,0.0979381443298969,0.5406363262525705,1.0,12/33,35.42%,FBN1;CAMK4;UBASH3B;TCTA;CEBPB;PRXL2A;TLR3;GPR137B;TMEM178A;MAFB;MTOR;GPR137
prerank,chromatin organization (GO:0006325),0.35210175555097467,1.3023132396823873,0.0653950953678474,0.9490944511255391,1.0,43/132,19.08%,MECOM;EZH2;ACTL6A;RUVBL2;NUDT5;HDAC3;SMARCA2;SOX2;FAM50A;SIRT1;KDM6A;SETD5;RUVBL1;KDM4D;RSF1;PAK1;CHD1;ESR1;HP1BP3;PWWP3A;SMARCD1;HDAC5;KDM5C;DR1;HCFC1;BAZ2A;INO80;EZH1;PBRM1;TAF6L;TOP1;SMARCA4;TCF7L1;RBBP4;SETD2;SMARCAD1;NPM1;TADA2A;KDM4C;SAFB;HDAC2;ATRX;SMARCB1
prerank,regulation of innate immune response (GO:0045088),0.39953047922530815,1.3020235930241142,0.10909090909090909,0.9470712016508089,1.0,7/57,4.02%,LRP8;TNFAIP3;FCGR2B;TIRAP;CDC37;BIRC2;IFI35
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4933689258671286,1.3020129091436896,0.1445993031358885,0.9437310191425472,1.0,7/20,13.17%,GCLC;GCLM;CNDP2;GATM;MTHFS;HAGH;GSS
prerank,mesonephros development (GO:0001823),-0.5344753651690582,-1.3018818569169726,0.15271966527196654,0.5417513301880589,1.0,4/11,5.59%,FGF1;BMP7;BMP4;OSR1
prerank,positive regulation of cell division (GO:0051781),-0.3842282850362536,-1.301817996568351,0.09254498714652956,0.5405950204326507,1.0,6/38,6.06%,FGFR2;SVIL;FGF1;RHOA;SIRT2;CIT
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.4347989183285993,-1.3015135434451874,0.11576354679802955,0.5401143360609892,1.0,7/25,12.92%,ANK2;CTNNA3;CACNA1C;CXADR;AKAP9;CAMK2D;DLG1
prerank,chromatin remodeling (GO:0006338),0.3676824038204947,1.3013994381078962,0.08115942028985507,0.9432944044294235,1.0,38/100,19.08%,ACTL6A;RUVBL2;ACTB;NUDT5;SMARCA2;ACTR8;HNRNPC;SIRT1;ACTR5;KDM6A;RUVBL1;KDM4D;RSF1;PAK1;ESR1;SMARCD1;CHD3;CECR2;HDAC5;KDM5C;DR1;HCFC1;BAZ2A;INO80;EZH1;PBRM1;TAF6L;TOP1;SMARCA4;RBBP4;SMARCAD1;NPM1;TADA2A;CHD8;KDM4C;HDAC2;ATRX;SMARCB1
prerank,extracellular matrix assembly (GO:0085029),-0.43182056283893316,-1.300530470004963,0.14420803782505912,0.5415929390585892,1.0,11/23,24.77%,GPM6B;TNXB;NTNG1;ATP7A;NTN4;QSOX1;TGFB1;LAMB1;EFEMP2;EMILIN1;MYH11
prerank,negative regulation of peptidase activity (GO:0010466),-0.3707432907046254,-1.3003996550283168,0.09192200557103064,0.5405968433042518,1.0,5/47,1.97%,SPOCK3;LRP1;TIMP3;SPOCK1;TIMP2
prerank,protein heterooligomerization (GO:0051291),-0.46781351663965676,-1.2992029333324637,0.14782608695652175,0.5428352322138441,1.0,3/17,1.93%,GRIN2B;KCNC2;PKD1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5037004427403518,-1.2985452627658791,0.15163934426229508,0.5433319540243141,1.0,8/14,25.86%,GHR;PXN;STAT6;SOCS2;PTK2;PIK3R1;PRLR;STAT5A
prerank,transport across blood-brain barrier (GO:0150104),-0.33349663459567574,-1.2984472291116436,0.06875,0.5422944475195655,1.0,17/83,6.96%,ATP1A2;SLC24A3;LRP1;SLCO3A1;SLC2A13;SLC1A3;LEPR;SLC16A12;SLC6A13;SLC13A3;SLC7A2;SLC22A8;SLC6A1;SLC16A7;SLC1A5;SLC12A2;SLC6A9
prerank,spliceosomal snRNP assembly (GO:0000387),0.42401408140532465,1.2983218870431397,0.1318864774624374,0.9550292045778583,1.0,7/38,8.83%,SNRPD2;PRPF31;PRPF3;SNRPD1;SRSF10;GEMIN5;COIL
prerank,nuclear export (GO:0051168),-0.32789570853197747,-1.2977155743166762,0.040625,0.543233771825672,1.0,26/80,16.22%,RANBP3L;SRSF5;PKD1;SRSF11;CASC3;SRSF2;MALT1;SRSF6;XPO6;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;PHAX;LSG1;RANBP3;STRADA;HNRNPA1;ATXN1;THOC5;SLU7;CDC40;NUTF2;TGFB1
prerank,diol metabolic process (GO:0034311),0.502859437300386,1.2975367615046214,0.1449016100178891,0.955535673819569,1.0,7/19,14.25%,SPR;PTS;PLPP1;SGPP2;NOS3;SGPP1;GCH1
prerank,triglyceride metabolic process (GO:0006641),0.4120903930268861,1.2973571275464724,0.1171875,0.9531251716101803,1.0,7/48,7.30%,GPAM;FABP7;APOE;PLAAT3;LMF1;GPAT4;SIRT1
prerank,epithelial cell morphogenesis (GO:0003382),-0.46664244588903236,-1.296087722208104,0.1696035242290749,0.5465614555289929,1.0,7/17,21.89%,COL22A1;RILPL1;COL15A1;MET;SIPA1L3;COL18A1;RILPL2
prerank,negative regulation of cell projection organization (GO:0031345),-0.36183324427782115,-1.296046953414053,0.12368421052631579,0.5453415253564069,1.0,10/48,7.58%,DCC;LPAR1;SPOCK1;GRIN2B;DPYSL3;PTPRS;EFNB2;CBFA2T2;SEMA3A;STMN2
prerank,regulation of postsynapse organization (GO:0099175),0.4590962004233711,1.2960335879479035,0.13921901528013583,0.9562284897020201,1.0,12/28,16.30%,FCGR2B;SHANK3;CFL1;TANC2;WNT5A;ZDHHC15;PPFIA2;ABHD17B;HOMER1;VPS35;CDKL5;ABI2
prerank,negative regulation of immune response (GO:0050777),0.34609720222676155,1.2957089230898533,0.06290115532734275,0.954484148551042,1.0,22/154,10.61%,GPR176;PRKAR1A;PTGER2;TNFAIP3;FCGR2B;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;SAMSN1;GNB1;RXFP1;SYK;NLRC3;PLCG1;LYN;RHBDF2;CD163;TRAF3IP1;YES1
prerank,vascular transport (GO:0010232),-0.336521797175524,-1.295608868305198,0.06896551724137931,0.5453250680429135,1.0,17/81,6.96%,ATP1A2;SLC24A3;LRP1;SLCO3A1;SLC2A13;SLC1A3;LEPR;SLC16A12;SLC6A13;SLC13A3;SLC7A2;SLC22A8;SLC6A1;SLC16A7;SLC1A5;SLC12A2;SLC6A9
prerank,bicarbonate transport (GO:0015701),0.4624241469740523,1.2952105903091427,0.16607773851590105,0.9535313102965969,1.0,5/25,9.58%,SLC4A4;SLC4A5;CA2;CA4;CYB5R4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5655699951577868,1.2945100709109594,0.16091954022988506,0.9535574689413457,1.0,2/11,1.58%,ATF3;ATF6
prerank,Golgi organization (GO:0007030),0.35748725589921776,1.294018550779559,0.06827880512091039,0.9526773543004999,1.0,22/112,10.97%,SURF4;SYNE1;LYSMD3;GORASP2;CLASP2;LMAN2;TMED4;SEC23IP;RAB43;TRAPPC8;USP6NL;ARHGEF7;GOSR2;TRIP11;VMP1;TMED5;TMED10;RAB1A;GOLPH3L;TRAPPC11;GCC2;TMED7
prerank,positive regulation of nervous system development (GO:0051962),-0.3871671536815768,-1.2931271909857935,0.10893854748603352,0.5511445259338564,1.0,13/42,12.30%,NRXN1;GRID2;EPHB1;NLGN2;SYNDIG1;CLSTN2;SPEN;NLGN1;SNW1;EPHB2;NUMBL;CUX2;IL1RAPL1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.48350744146021124,-1.2922794404539968,0.15106382978723404,0.5521935100586743,1.0,11/17,30.38%,FGFR2;NELL1;RHOA;NPR3;EIF2AK2;MN1;CCN1;PLXNB1;SFRP1;BMP2;TMEM119
prerank,dephosphorylation (GO:0016311),0.34896667801616715,1.2915547932198155,0.07466666666666667,0.9612468476663854,1.0,22/147,6.91%,PHPT1;PTPRR;PTPN18;PTPRG;DUSP7;PTPRJ;PTPRC;CTDSP1;PPP3CB;PNKP;PTPRM;PTPRB;DUSP12;PTPRE;PPP2CA;PLPP6;PTPN12;PXYLP1;SSH2;PTPRT;PLPP1;PPP2CB
prerank,water transport (GO:0006833),-0.5258264198131907,-1.291456248158648,0.16808510638297872,0.5532483586609778,1.0,3/12,24.91%,PDPN;AQP4;AQP11
prerank,positive regulation of phagocytosis (GO:0050766),0.4103483893912094,1.2910904881305485,0.13239875389408098,0.9602557465535457,1.0,12/47,18.30%,PTPRJ;PTPRC;FCGR2B;CAMK1D;LMAN2;MERTK;CD47;CYBA;GAS6;CALR;RAB27A;MYO18A
prerank,leukotriene biosynthetic process (GO:0019370),-0.4989533643313167,-1.2909798279923101,0.16806722689075632,0.5533247906986123,1.0,3/14,13.79%,PLA2G4A;GGTA1;GGT5
prerank,nucleoside salvage (GO:0043174),0.5678630238301232,1.2909047179860853,0.1830188679245283,0.9578266166041173,1.0,3/10,9.50%,UPP1;UCK2;UPP2
prerank,photoreceptor cell development (GO:0042461),-0.5019782894597488,-1.2901882608035102,0.1735357917570499,0.554358249144052,1.0,6/14,31.51%,AHI1;DCX;TOPORS;VEGFA;RP1;MFSD2A
prerank,lymphocyte proliferation (GO:0046651),0.4794278461149596,1.2900328441760234,0.1735985533453888,0.95884621000623,1.0,3/22,2.55%,PIK3CG;PTPRC;PPP3CB
prerank,secretion (GO:0046903),-0.49767278448609215,-1.2890144561705201,0.1511879049676026,0.5562984353715457,1.0,4/14,16.74%,RIMS1;SLC22A4;SLC22A6;NPR1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4304895258240112,-1.2889078726009071,0.12740384615384615,0.5552436771031468,1.0,7/24,5.82%,TMEFF2;PHLDB2;CGNL1;WASF2;ARHGAP28;PPFIA1;ARHGAP6
prerank,cellular response to osmotic stress (GO:0071470),0.4850416055443833,1.2884778532837937,0.16477272727272727,0.9631556297990748,1.0,6/21,10.80%,OXSR1;ZFP36L1;SCN2A;ZFAND1;TRPV4;DDX3X
prerank,positive regulation of neurogenesis (GO:0050769),-0.3420894731928519,-1.2881873451502173,0.07365439093484419,0.5559249066404869,1.0,23/68,16.87%,ROBO2;PLXNA2;ROBO1;CUX1;NTRK2;TIAM2;CTNNB1;RHOA;SPEN;SNW1;SMARCD3;NUMBL;CUX2;DISC1;IL1RAPL1;OBSL1;PLXND1;ARHGDIA;KDM1A;PLXNB2;NGF;PLXNC1;OPRM1
prerank,regulation of presynapse organization (GO:0099174),-0.4756614973994385,-1.2880648094389828,0.1497695852534562,0.5537112562803523,1.0,9/18,29.15%,LRFN5;GPC6;IL1RAPL2;IL1RAPL1;SLITRK1;GPC4;LRRC4B;SNCA;MDGA1
prerank,regulation of presynapse assembly (GO:1905606),-0.4756614973994385,-1.2880648094389828,0.1497695852534562,0.5537112562803523,1.0,9/18,29.15%,LRFN5;GPC6;IL1RAPL2;IL1RAPL1;SLITRK1;GPC4;LRRC4B;SNCA;MDGA1
prerank,negative regulation of dephosphorylation (GO:0035305),0.5012429271885489,1.288056023936865,0.16007194244604317,0.9619742383948504,1.0,6/18,15.43%,PPP1R36;PPP1R16B;YWHAB;MFHAS1;PTPA;PPP1R8
prerank,chromatin remodeling at centromere (GO:0031055),0.43929662158288046,1.2878017704708873,0.14759535655058043,0.9599192367168816,1.0,9/31,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,regulation of filopodium assembly (GO:0051489),-0.38618378067597636,-1.287364448034538,0.10427807486631016,0.554324244337021,1.0,10/38,8.48%,TENM2;DPYSL3;NRP1;WASL;GPM6A;PRKCD;GAP43;PLPPR5;NLGN1;DOCK11
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4926303677276703,-1.286525237494621,0.16382978723404254,0.5552981149692477,1.0,5/16,7.45%,DDX5;DDX17;CELF4;SRSF6;SRSF1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.531030585903119,-1.2864516566745194,0.17105263157894737,0.5541779167010037,1.0,5/12,16.67%,NFIB;GLI2;EPHB1;EPHB2;SZT2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4159779110001849,-1.286358672132539,0.1360381861575179,0.5530656522257446,1.0,6/26,8.44%,NAV3;MAPT;OCLN;STMN2;AKAP9;SLAIN2
prerank,copper ion transport (GO:0006825),-0.5293259361785342,-1.2863582267188376,0.1623246492985972,0.5517700320690694,1.0,7/11,23.23%,ATP7A;STEAP3;SLC31A1;SLC31A2;COX17;SLC11A2;STEAP2
prerank,Rac protein signal transduction (GO:0016601),0.4967853882549826,1.2861055170382376,0.1725417439703154,0.9648580854748754,1.0,10/18,20.98%,RAC2;TIAM1;RHOG;ELMO1;ABI2;CDH13;CYFIP1;HACE1;EPS8;RAC1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3624396020790543,-1.2858723484898984,0.08311688311688312,0.5519166731106305,1.0,13/51,7.23%,DCLK1;EPB41L3;GAS7;NBL1;SNX2;BMP7;GPM6A;ATP7A;MYO16;TAOK3;SHTN1;CTTN;WASF1
prerank,response to hydroxyurea (GO:0072710),-0.5399450134658826,-1.2857279418642433,0.17932489451476794,0.5510580567566171,1.0,5/11,20.00%,SPIDR;KAT7;DDI2;RTF2;BLM
prerank,purine ribonucleotide transport (GO:0015868),0.5129929374695009,1.2846855915670141,0.16518650088809947,0.9687294526264834,1.0,3/16,6.46%,ABCC4;SLC25A24;LRRC8C
prerank,DNA-dependent DNA replication (GO:0006261),0.35023921407716074,1.2846572762855815,0.09491978609625669,0.9655990283126187,1.0,27/128,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PNKP;ORC3;PSMD11;PSMB4;PSMC1;SSBP1;POLE;CDC45;ORC4;POLD3;CDK2AP1;POLA1;PSMC2;PSMD2;SRPK2;ORC2;HELB;PSMD14;PSMC6;PSMD1;PSMB1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.38933833886410146,-1.2842523944566597,0.12529550827423167,0.5539196084610623,1.0,6/37,1.54%,GRIA4;GRIA2;CPEB4;GRID2;GRIN2B;GRM5
prerank,positive regulation of phosphorylation (GO:0042327),-0.276449508569944,-1.2842420050773602,0.005319148936170213,0.552647211215555,1.0,52/240,14.42%,ZBTB20;ERBB4;NTRK3;FGFR2;IGF1;SLCO3A1;DAB2;EGFR;LMO4;EPHA6;LEPR;EFNA5;PDGFRB;EPHB1;NTRK2;NRP1;FGF1;AXL;RYK;DSCAM;EPHA7;ROR1;BMP4;KIT;ROCK2;IL34;DDR1;PDGFRA;AKT2;PIK3R3;RAD50;VAC14;EPHB4;NIBAN1;PELI2;THBS1;MRE11;CCND3;DVL3;EPHB2;EPHA3;SEMA4D;ILK;PFKFB4;CLIP3;FNIP1;FAM20A;RALBP1;ROR2;IGF2;RACK1;PTK2
prerank,positive regulation of cellular respiration (GO:1901857),0.555129819415714,1.2841827196137812,0.1920152091254753,0.9648292470040751,1.0,5/11,9.96%,IFNLR1;ISCU;IL10RB;PARK7;IFNAR1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.47959580164525234,1.2839319445398594,0.16112084063047286,0.9628532695492661,1.0,12/21,16.90%,CNOT11;CNOT2;CNOT7;PAN3;TUT7;PAN2;CNOT6;CNOT1;CNOT6L;TUT4;PARN;CNOT10
prerank,ventricular septum development (GO:0003281),-0.38135204370104736,-1.283730317381362,0.1096938775510204,0.5528429602996464,1.0,9/37,9.91%,ROBO2;TGFBR3;ROBO1;TGFBR1;TGFBR2;SMAD4;HECTD1;ACVR1;SALL1
prerank,regulation of mRNA catabolic process (GO:0061013),0.3504429921049939,1.2837109490905303,0.07898259705488621,0.9608090885110926,1.0,28/121,14.69%,PSMB10;PSMC4;PSMB6;PRR5L;PSMD8;PSMD5;PSMD12;HSPA8;ZFP36L1;PSMD11;PSMB4;PSMC1;FXR1;YWHAB;CNOT7;EXOSC9;PCID2;PSMC2;PSMD2;ZC3H14;XPO1;PSMD14;EXOSC1;PSMC6;PSMD1;PSMB1;CNOT1;DCP1A
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.46707229452734855,1.2835927140987182,0.1566265060240964,0.9582172532791818,1.0,4/23,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,renal filtration (GO:0097205),-0.5431845662054537,-1.2835815061819884,0.17634854771784234,0.5519665777162062,1.0,4/10,11.71%,SULF1;SULF2;TBC1D8B;CD34
prerank,negative regulation of neuron projection development (GO:0010977),-0.34887808102086426,-1.2834893673360874,0.08192090395480225,0.5509400711182604,1.0,16/56,15.43%,DCC;LPAR1;SPOCK1;DPYSL3;PTPRS;EFNB2;RHOA;CBFA2T2;SEMA3A;STMN2;NLGN1;BCL11A;PRAG1;GDI1;ARHGDIA;PTPRO
prerank,acylglycerol biosynthetic process (GO:0046463),-0.43246208182021295,-1.283295616380639,0.15402298850574714,0.5502050719309921,1.0,6/23,7.97%,AGMO;PLA2G4A;LPGAT1;PLCE1;GK;LPIN1
prerank,activation of protein kinase A activity (GO:0034199),-0.48522123870771805,-1.283110695738698,0.17543859649122806,0.5494630477700363,1.0,11/16,22.63%,ADCY5;ADCY2;ADCY1;PRRC1;ADCY9;PRKACA;ADCY7;PRKAR1B;ADCY3;ADCY8;ADCY4
prerank,regulation of T cell migration (GO:2000404),0.5034944976481621,1.2829739800336897,0.1736745886654479,0.9580262295068006,1.0,5/18,15.24%,CXCL12;LRCH1;RIPOR2;APP;DOCK8
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.47631529741355033,1.282890239009452,0.15120274914089346,0.9552667419233501,1.0,9/21,16.45%,TIPRL;BOD1;PPP1R16B;YWHAB;PPP1R11;MFHAS1;PTPA;PPP1R8;FKBP1A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.34288607875273447,-1.2828870548877322,0.08516483516483517,0.5488074707277757,1.0,27/67,29.28%,DOCK5;RSU1;DOCK1;PLEKHA2;NRP1;FLNA;NEDD9;RREB1;P4HB;CDK6;GSK3B;FN1;ILK;MYADM;TRIOBP;VIT;CDC42;CX3CL1;PPM1F;EMP2;DMTN;SFRP1;ARL2;CSPG5;MDK;MYOC;NDNF
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3141005270010486,-1.2826992499656813,0.0641025641025641,0.5480642732329037,1.0,29/108,16.68%,ST18;UACA;ROBO1;GSN;SMAD3;CFLAR;COL4A3;MAPT;MALT1;CASP8AP2;F3;VCP;XDH;FAM162A;FIS1;IFT57;ANP32B;GRAMD4;MAP3K5;CASP12;CTSD;HIP1R;PDCD5;RACK1;HSPD1;NGF;EGLN3;TRAF2;MTCH1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4702050625671017,-1.2825730168737592,0.17511520737327188,0.5471410582625889,1.0,5/17,8.66%,ROBO2;NOTCH2;ROBO1;BMP4;SMAD6
prerank,synapse organization (GO:0050808),-0.30995662170041355,-1.2818072288858933,0.06785714285714285,0.5480803331387014,1.0,23/125,6.09%,LRRC4C;LRFN5;PDZRN3;ANK3;SDK1;GPC6;NRXN1;CACNB4;GRM5;KIRREL3;NRCAM;NTNG1;PPFIBP1;PTPRS;RYK;MAPT;DNER;DSCAM;NLGN2;SLC6A1;GPM6A;PPFIA1;CTNND2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.416800281728673,-1.2815831099604633,0.14678899082568808,0.5474672880829602,1.0,12/26,25.63%,SORBS1;IGF1;OCLN;AKT2;CREBL2;ARPP19;CLIP3;PIK3R1;OSBPL8;APPL1;AKT1;CAPN10
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.35449418770077334,-1.2812124620460625,0.07988980716253444,0.5472085216239723,1.0,12/56,10.92%,BMP6;LDLRAD4;DAB2;BMPER;TGFBR1;BMP5;BMP7;SMAD4;BMP4;SMAD6;ACVR1;SNX25
prerank,protein localization to organelle (GO:0033365),-0.30255110811509295,-1.2809672252702076,0.07666666666666666,0.546648860608474,1.0,54/133,25.34%,ANK2;BICD1;TIA1;COL1A1;TULP3;BMP7;BMP4;WDR35;LMNA;TTC21B;SORL1;UBE2J2;CYB5A;DDX1;BANP;TOR1AIP1;OPTN;RPA1;TRAM1;DDRGK1;ALDH3A2;OBSL1;BBS9;TOLLIP;RAB11A;ARL1;TOPORS;VAMP2;TOR1B;BBS2;PAF1;TRAM2;CEP250;EHD1;STX1A;ZNF423;DVL1;IFT20;SCG3;SGTA;GBP5;SIX1;PAQR3;CNTLN;MTCH2;GBP2;CTDNEP1;EMD;RAB33B;SERP1;ARFRP1;RIPOR1;DNAJA1;SEC61B
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.47834061405822625,-1.280219795114924,0.1838074398249453,0.5474147491229815,1.0,4/15,8.19%,EDA;GLI2;HDAC1;FOXC1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4397425768517512,-1.280211046769446,0.1267605633802817,0.5461920264040753,1.0,10/21,14.42%,GPM6B;EFNA5;MACF1;RHOA;ROCK2;VCL;ROCK1;LDB1;EPHA3;PTK2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5753066634807851,1.279786140260733,0.199203187250996,0.9668294526526595,1.0,3/10,7.78%,TIRAP;IFI35;WDFY1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5458809959389544,1.279563202732343,0.20335820895522388,0.9646930685606923,1.0,5/11,12.23%,F11R;RAPGEF6;TJP1;RAB1A;RAP2C
prerank,ribosomal large subunit biogenesis (GO:0042273),0.39357758525342823,1.2794448801600753,0.12018489984591679,0.9622281166523502,1.0,24/54,21.15%,RSL24D1;RPL3;RRP15;RPL35A;RPL5;MRPL20;SNU13;RPLP0;RPL24;WDR12;PAK1IP1;LTO1;RPL23A;RSL1D1;NPM1;EIF6;RPL26;RPL10;NVL;RPL7;RPL14;MDN1;GTF3A;SDAD1
prerank,L-amino acid transport (GO:0015807),0.45319744687036956,1.2794169106859548,0.1426086956521739,0.9592524082013633,1.0,8/28,13.69%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC1A2;SFXN1;SLC25A12;SLC38A5
prerank,neutrophil chemotaxis (GO:0030593),0.40037436465487664,1.2793046036310363,0.1265625,0.9566419950708616,1.0,7/53,11.50%,PIK3CG;BSG;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.40185017558309377,1.2792894628021387,0.12324492979719189,0.9536273713137918,1.0,26/52,21.01%,PATL2;CNOT11;CNOT2;HBS1L;CNOT7;EXOSC9;PATL1;PAN3;NT5C3B;TUT7;PAN2;CNOT6;EXOSC1;CNOT1;DCP1A;CNOT6L;TUT4;PARN;CNOT10;LSM1;RC3H1;DCP1B;EXOSC7;CNOT8;DDX6;CNOT4
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5344057553271501,1.2788789868021129,0.19736842105263158,0.9525467183364209,1.0,3/12,9.50%,UPP1;UCK2;UPP2
prerank,positive regulation of transporter activity (GO:0032411),-0.5084554769048986,-1.2788081657831039,0.1851063829787234,0.5488039833741095,1.0,4/13,13.20%,KMT2A;SGK1;RXRA;WNK3
prerank,RNA destabilization (GO:0050779),-0.45996584156501286,-1.2784680683197505,0.15517241379310345,0.548580637663449,1.0,6/18,13.32%,PUM1;ROCK2;ROCK1;LIN28B;YTHDF1;ZC3H18
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4910038539189956,-1.27818765469691,0.14375,0.5481431356338563,1.0,5/15,14.70%,MAGI2;SKI;ACVR1;ACVR1B;DACT1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5374218503963506,1.2779911816964284,0.2144212523719165,0.9537736632093216,1.0,5/13,14.70%,PTTG1IP;SIRT1;YJU2;MDM2;CD44
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5227579570205237,1.2779579893482218,0.16037735849056603,0.9508693679981028,1.0,6/15,16.15%,RUVBL2;CCT2;CCT5;RUVBL1;TCP1;DKC1
prerank,androgen receptor signaling pathway (GO:0030521),-0.5332230933585467,-1.2775462555048624,0.1807465618860511,0.5486142744796128,1.0,3/11,4.49%,DDX5;DDX17;RNF14
prerank,positive regulation of nuclear division (GO:0051785),-0.4291499435877525,-1.2775408860597228,0.15555555555555556,0.5474226560192706,1.0,4/25,7.89%,IGF1;PDGFRB;SIRT2;LRP5
prerank,cellular response to sterol (GO:0036315),-0.5067903545033999,-1.2773526020211963,0.16770186335403728,0.5467995520143188,1.0,9/13,19.48%,GRAMD1B;SMO;GRAMD1C;INSIG2;RORA;GRAMD1A;LRP6;GPLD1;OSBPL7
prerank,inner dynein arm assembly (GO:0036159),0.5569560799583848,1.2773189945862402,0.18003913894324852,0.9508873027280499,1.0,1/11,1.21%,CFAP73
prerank,regulation of primary metabolic process (GO:0080090),0.34698514024447263,1.2768911000135026,0.10013717421124829,0.9499038107607114,1.0,31/126,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;GPAM;HMGCR;HDAC3;PSMD11;APOE;PSMB4;PSMC1;ELOVL6;PLPP1;PPARD;SC5D;IRS2;ACACB;PSMC2;PSMD2;IDI1;CREBBP;ADIPOR1;CARM1;LSS;SP1;PSMD14;PSMC6;PSMD1;PSMB1
prerank,cellular response to organic cyclic compound (GO:0071407),-0.2981409117277586,-1.2768322372415262,0.04247104247104247,0.5470949205348663,1.0,42/141,22.86%,ATP1A2;GABRB1;HCN1;EGFR;ADCY5;AKAP6;RYR3;TFPI;ADCY2;IGFBP5;CTNNA1;SPIDR;ADCY1;CTNNB1;MED1;P2RX4;ROCK2;ATP1A1;GABRG2;AKAP9;EZR;CDH1;NCOA4;IL18;RORA;SPP1;CASP7;RAPGEF2;TGFB1;NR3C1;DIAPH1;ATP1A3;SLC5A5;MSN;RIOK3;SSH1;BLM;P2RY12;ADCY3;ADCY8;IMPACT;CASP3
prerank,in utero embryonic development (GO:0001701),-0.4273483103748697,-1.276797798320896,0.14797136038186157,0.54600218592674,1.0,11/25,24.51%,FGFR2;ARNT2;PKD1;TGFBR1;FUT8;HINFP;IGF2;FLCN;VEGFA;TGFB3;ZNF568
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4729269788992343,-1.276374318762993,0.16071428571428573,0.5459932891939152,1.0,9/17,25.89%,ROBO1;NRP1;EFNB2;PIK3R3;EPHB4;GPLD1;VEGFA;AKT1;NR4A1
prerank,membrane repolarization during action potential (GO:0086011),-0.5051171643640844,-1.2758003576736907,0.1762208067940552,0.5463732171498202,1.0,3/13,8.46%,ATP1B1;ATP1A1;KCNJ2
prerank,neuron projection development (GO:0031175),-0.2960673949675688,-1.275595578605933,0.02459016393442623,0.5457915944858847,1.0,48/168,17.34%,MAP2;CNTN4;DCLK1;PLP1;EPB41L3;PPP1R9A;GPM6B;GAS7;EPHB1;NBL1;HDGFL3;SH3GL2;RASGRF1;WASL;DLG4;RYK;MAPT;BMP7;ADGRV1;GPM6A;ATP7A;MYO16;CTNND2;TAOK3;SHTN1;ERCC6;ROCK1;CTTN;STMN2;DOCK10;NLGN1;CDK16;STX3;SGK1;GSK3B;EPHB2;RAB11A;TAOK1;DICER1;BICDL1;STMN1;WHRN;NGF;RAPGEF2;EHD1;GPRIN3;LAMB1;CDC42
prerank,regulation of fat cell differentiation (GO:0045598),0.37305890910554534,1.2754654396572414,0.10975609756097561,0.9538054339994714,1.0,15/74,12.48%,CCDC85B;PTPRQ;TRIB3;FRZB;CCDC71L;BBS12;ZFP36L1;PPARD;TRIO;SIRT1;WNT5A;AAMDC;TRPM4;CARM1;WDFY2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.30725787416176015,1.2752716112255829,0.020879120879120878,0.9517295804542458,1.0,90/532,14.00%,LRP8;CISH;LCP1;PSMB10;PSMC4;PSMB6;MAPK3;EIF5A;CBL;PSMD8;PSMD5;PSMD12;PTPRJ;IL1R1;HSPA8;MAP3K7;SOD1;TAB2;CXCL12;RPS6KA4;IFNLR1;IFITM2;CRLF1;SRC;IFIT1;TRIM8;RPS6KA5;BIRC2;XAF1;IFI35;PSMD11;IRF9;SOX2;PSMB4;FYN;TNFRSF1B;PSMC1;CFL1;B2M;RALA;EDAR;CDKN1A;UGCG;TRAF5;ICAM1;SYK;TALDO1;PIM1;ACTN4;ADIPOR2;SIRT1;IFITM3;IRS2;TAB3;ADAR;TRIM25;CCL25;RPLP0;IFITM1;TRAF3;RELA;CSF1R;SOD2;ARF1;INPP5D;IL10RB;PSMC2;PLCB1;PSMD2;PITPNA;IFNAR1;UBE2V1;ADIPOR1;CDIP1;NOD1;PIK3CD;IFI27;IP6K2;CRKL;TYK2;TNIP2;IKBKB;IRF2;CHUK;PSMD14;MID1;PSMC6;PSMD1;NFKBIA;PSMB1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4274143968178071,1.2743703921924887,0.1486725663716814,0.9531469300639107,1.0,7/34,11.11%,MT1G;SEMA6A;PRKD2;RAMP2;NOTCH1;RELA;FLT1
prerank,regulation of intracellular protein transport (GO:0033157),0.44193213021171285,1.274349523735862,0.1335676625659051,0.9502848420788165,1.0,7/32,11.88%,LCP1;PRR5L;ZFAND1;ICE1;RUFY3;GCC2;IFI27
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.3190097835182918,-1.2741626444705971,0.0744336569579288,0.5484878176153388,1.0,44/95,29.09%,UST;GPC6;HS3ST5;HS6ST2;DSE;SDC2;GLCE;B4GALT1;CEMIP;CHSY1;VCAN;OGN;HS3ST3A1;GPC3;HSPG2;HEXA;CSGALNACT2;CHST15;GPC5;B4GALT6;CHST11;SLC35D2;UGDH;CSPG4;ST3GAL4;PRELP;HS3ST3B1;DSEL;LUM;NDST2;B4GALT4;GPC4;SDC3;BGN;DCN;HYAL1;CHPF2;CHST2;XYLT2;CHST3;CSPG5;OMD;CHST12;B4GALT7
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.4720579029740022,-1.2737576670347126,0.17727272727272728,0.5483497670119111,1.0,7/18,15.36%,PABPN1;ENY2;POLDIP3;NXF1;NUP93;DDX19B;DDX19A
prerank,protein acetylation (GO:0006473),0.44444196175809864,1.2729176558043789,0.14715719063545152,0.9539950340253578,1.0,12/30,18.84%,ING4;EP300;SIRT1;CLOCK;NAA35;ESCO1;CREBBP;NAA80;ING5;NAA15;NAA50;HAT1
prerank,receptor catabolic process (GO:0032801),-0.43247127504297167,-1.2724853560297837,0.1550925925925926,0.5506877087978638,1.0,13/24,20.30%,AP2B1;RNF43;AP2A2;AP2A1;ZNRF3;LGMN;GPRASP1;UVRAG;SNX25;VLDLR;TGFB1;MYLIP;NEDD4
prerank,regulation of TORC1 signaling (GO:1903432),-0.3966985853356261,-1.2721679186232584,0.1306532663316583,0.5504000280126856,1.0,23/33,36.54%,RNF152;GPR137C;DEPDC5;KLHL22;CASTOR2;STK11;SEH1L;ATM;SZT2;ITFG2;FLCN;DGKQ;TELO2;LAMTOR5;SESN2;PIP4P1;GPR137B;SPAAR;PIH1D1;SMCR8;RRAGD;GPR137;RRAGA
prerank,positive regulation of binding (GO:0051099),0.36048933743403455,1.2721040400482548,0.0951683748169839,0.9551493028719479,1.0,18/84,11.27%,NCBP1;TRIB3;RALB;PIN1;TIAM1;HIPK2;NME1;APOE;B2M;CEBPG;SPPL3;TXN;EPB41;KDM4D;AKTIP;CLDN5;TERT;APP
prerank,translational elongation (GO:0006414),0.3583241096263205,1.2720862049502752,0.07613469985358712,0.9522850786139826,1.0,20/101,15.13%,MRPS22;MRPS2;MRPS33;EEF1A1;MRPL23;MRPL24;EEF1D;MRPL18;MRPL38;MRPS12;MRPL20;TSFM;GTPBP2;MRPL52;MRPS15;MRPS24;MRPL48;EEF1B2;MRPS28;MRPS35
prerank,bicellular tight junction assembly (GO:0070830),0.4082085271994618,1.2719359798881666,0.14173228346456693,0.9500980132294817,1.0,11/46,14.49%,PECAM1;MARVELD2;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;APC;PATJ;PARD3
prerank,TOR signaling (GO:0031929),0.44987138745997224,1.271922424149917,0.1630971993410214,0.9472277902035481,1.0,4/26,4.89%,PRR5L;TIPRL;RPTOR;SMG1
prerank,camera-type eye morphogenesis (GO:0048593),-0.5347600199905607,-1.2718574649568346,0.16041666666666668,0.55011359801353,1.0,6/10,30.04%,TENM3;SKI;LRP6;VEGFA;TBX2;KDM2B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4228001637232477,-1.271789660723593,0.17209302325581396,0.5490847359512556,1.0,14/25,26.44%,KAT7;ERCC6;ELL;LDB1;DDX39B;HTATSF1;CCNT1;WDR43;THOC5;CCNK;EAF1;THOC1;ZNF326;SUPT4H1
prerank,ncRNA processing (GO:0034470),0.32851249818462425,1.2714130397446057,0.05808080808080808,0.946751467704814,1.0,67/200,20.27%,THG1L;RPL30;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;FARS2;SMAD1;RPL35A;RPS14;RPL8;RPL5;RPL37A;PUS10;ADAR;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;AGO4;DDX27;WDR12;TUT7;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;SSB;TUT4;DKC1;INTS6;RPL19;RPL38;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;POP1;RPL14;AGO1;MDN1;INTS2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.47063930234612505,1.2708290483110116,0.16161616161616163,0.9465394297797557,1.0,10/25,17.73%,HSPA8;DNAJB5;BAG1;HSPE1;SDF2;HSPA13;DNAJB14;HSPA14;GAK;ST13
prerank,ATP transport (GO:0015867),0.5705395501951684,1.270555899739106,0.18994413407821228,0.9449731433579779,1.0,3/10,15.36%,SLC25A24;CD47;SLC25A42
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.39931304832342135,-1.2704223012563516,0.1424731182795699,0.5516873849348928,1.0,11/30,20.29%,TGFBR3;SMAD3;FSTL1;SMURF2;SMAD4;DKK3;XIAP;PCSK6;TGFB1;SFRP4;TWSG1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.40852209351516544,1.2698337717286878,0.134185303514377,0.9454062010956591,1.0,11/42,12.59%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;NARS2;RARS2;EARS2;WARS2;LARS1
prerank,regulation of receptor binding (GO:1900120),0.5635606678824372,1.2691357286355052,0.21553398058252426,0.9458008157581493,1.0,3/10,7.11%,ATP2A2;B2M;BDNF
prerank,regulation of extracellular matrix organization (GO:1903053),-0.47410156646314644,-1.26856007093918,0.18201284796573874,0.5557694910376516,1.0,4/15,9.67%,LRP1;AEBP1;DDR1;FAP
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.39425049725879807,-1.268158450516371,0.14215686274509803,0.5555958833037544,1.0,7/32,6.59%,ZBTB20;IGF1;PID1;NUPR1;PPARGC1A;VCP;PPARA
prerank,rRNA processing (GO:0006364),0.3343512468051439,1.2678891238523053,0.08549222797927461,0.9488575815654697,1.0,60/172,19.87%,RPL30;THUMPD1;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;RRP15;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;DDX27;WDR12;SRFBP1;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RSL1D1;PRKDC;RPL19;RPL38;EIF6;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;TFB1M;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;RPL14
prerank,synapse assembly (GO:0007416),-0.34430293504840503,-1.2678091567109602,0.10512129380053908,0.5553865233832664,1.0,24/67,17.26%,SDK1;NRXN1;GRID2;KIRREL3;LRRTM3;NRCAM;GABRA2;RYK;DNER;DSCAM;NLGN2;GPM6A;SDK2;GABRG2;NLGN1;CDH1;LRRC4;NRXN2;OBSL1;PLXND1;PLXNB2;LGI2;SHANK2;DVL1
prerank,muscle cell differentiation (GO:0042692),0.4311122942692022,1.2675461456265145,0.14098360655737704,0.9475058452529824,1.0,7/32,10.98%,SYNE1;MRTFA;MRTFB;TBX1;HEY2;SEMA4C;DMD
prerank,negative regulation of lymphocyte activation (GO:0051250),0.47873663825235635,1.2670446077213806,0.17513134851138354,0.9471697619318746,1.0,3/21,5.32%,TNFAIP3;FCGR2B;SAMSN1
prerank,lipid droplet organization (GO:0034389),0.46891056400907166,1.266742186979632,0.18980667838312829,0.9457440605389079,1.0,3/22,9.48%,CIDEA;FITM2;AUP1
prerank,modification-dependent protein catabolic process (GO:0019941),0.3301828501062939,1.2667131025692928,0.08571428571428572,0.9430485087322166,1.0,61/193,19.04%,ELOC;RNF7;CBL;ARIH1;RNF149;ANAPC2;KLHL3;FEM1C;UBA1;RFFL;PSMD11;NEDD4L;RBBP6;UBE2I;RNF130;LONP1;UBL7;PPP1R11;TTC3;TRIM25;FBXO11;ANAPC7;MDM2;PSMC2;RNF6;FBXO7;RNF13;CHFR;UBQLN1;ANAPC11;ANAPC10;ANAPC4;FBXO8;RNF11;CUL3;PSMD14;USP33;UBE2R2;RNF146;RNF20;UBA6;UBE2G1;FBXO22;UBQLN4;RNF114;TAF1;RNF128;RNF125;UBE2H;UFD1;UBQLN2;UBR3;ATXN3;CDC26;RNF215;KCTD10;NDFIP2;RC3H1;FBXW4;TRPC4AP;HACE1
prerank,axonogenesis (GO:0007409),-0.27609851418954573,-1.2666146603757655,0.02,0.5574749854927553,1.0,60/237,13.92%,NRXN3;NCAM1;ROBO2;FGFR2;NOTCH2;CNTN4;ANK3;LAMA2;DCC;MAP1B;ROBO1;CTNNA2;UNC5D;NRXN1;CNTN6;EPHA6;TNR;ULK2;NRCAM;EFNA5;SEMA3D;GLI2;EPHB1;NTNG1;AUTS2;NRP1;EFNB2;RYK;DSCAM;EPHA7;PDLIM7;KIF5C;UNC5C;RELN;DAB1;SHTN1;PALLD;SEMA3A;FEZ1;NOTCH3;EPHB4;EZR;NIBAN2;NRP2;B4GALT6;SPTAN1;BRSK1;EPHB2;EPHA3;PLPPR4;SEMA4D;GAB2;GRB2;NTN4;SHC3;RANBP9;AFG3L2;GRB10;VLDLR;MAP1A
prerank,wound healing (GO:0042060),-0.3400809596279526,-1.2663635149853807,0.10614525139664804,0.5569572207904668,1.0,17/62,15.31%,IGF1;SMAD3;CFLAR;COL3A1;FGF1;TGFBR1;PLEC;TPM1;MACF1;EPB41L4B;PDGFRA;FUT10;MYOF;AHNAK2;SYT11;SYT7;RAF1
prerank,positive regulation of B cell proliferation (GO:0030890),0.44836498169857475,1.265714009397912,0.1574539363484087,0.9447122389272995,1.0,5/29,10.70%,PTPRC;VAV3;TIRAP;IRS2;CD81
prerank,N-terminal protein amino acid modification (GO:0031365),0.51280051126114,1.2655797669399937,0.20224719101123595,0.9425753536112348,1.0,6/14,18.78%,METAP2;NAA35;METAP1;NTMT1;NAA15;NAA50
prerank,regulation of pH (GO:0006885),0.5527803018050903,1.2650958203819969,0.2128060263653484,0.9419494729263118,1.0,3/11,10.69%,SLC9A7;CLCN3;ATP6AP1
prerank,tight junction assembly (GO:0120192),0.40257669241878535,1.2650106027026895,0.16113744075829384,0.939583907269389,1.0,12/49,14.49%,PECAM1;MARVELD2;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;LSR;APC;PATJ;PARD3
prerank,protein heterotetramerization (GO:0051290),-0.49928407296291566,-1.26460256017734,0.18502202643171806,0.5604428981872976,1.0,2/13,1.93%,GRIN2B;PKD1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.483288858380831,1.2642707371581183,0.2033898305084746,0.9403423869148771,1.0,4/17,9.47%,CIB1;RET;SYK;PODXL
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4819996898751572,1.2637814382416022,0.18772563176895307,0.9399658693598452,1.0,2/19,0.97%,LRP8;SS18L1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.2742478440584589,-1.2636901165306291,0.004524886877828055,0.5618196557689622,1.0,79/248,17.35%,RNF220;BICC1;FGFR2;LRRK1;WLS;DAB2;EGFR;COL1A1;LGR4;ADGRA2;GLI3;IGFBP2;MCC;TBL1XR1;SMURF2;FZD6;CYLD;ZEB2;CTNNB1;WNK1;PTK7;HDAC1;PPM1B;NKD1;HECW1;VCP;SHISA6;GPC3;CTNND2;CSNK1A1;BTRC;DKK3;IGFBP6;TMEM64;PSMD4;PSMA2;CSNK1E;UBR5;GPC5;PSMA6;TLE1;DVL3;ZNRF3;CSNK1G2;OTULIN;XIAP;INVS;GSK3B;NFKB1;PSMD13;PSMA1;TBL1X;ILK;PSMF1;PSME4;STK11;DAAM2;LIMD1;PPM1A;SCYL2;USP34;SIAH2;IGFBP4;PSMA5;PSMD9;LMBR1L;CTNND1;DACT1;LRP6;PTPRU;PTPRO;RBMS3;TGFB1;TCF7L2;WWTR1;GPRC5B;FZD4;DVL1;PSMB3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.4970865984972409,-1.2631866248519,0.17684210526315788,0.5619940902446707,1.0,5/14,20.24%,UFL1;BCL2L11;TMEM33;DDRGK1;COPS5
prerank,membrane lipid catabolic process (GO:0046466),0.5671053049854365,1.2629579172103063,0.20866141732283464,0.9408357746447606,1.0,3/10,10.93%,PPT1;FUCA1;CYP1B1
prerank,motor neuron axon guidance (GO:0008045),0.5179969276669623,1.2628745470049358,0.1926782273603083,0.9385063443748071,1.0,3/15,11.04%,RAC2;TMEFF1;RHOG
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.30476512913480747,-1.2625319747985353,0.0812720848056537,0.5626770636020513,1.0,30/108,14.70%,FGFR2;TRABD2B;SULF1;LRP1;WLS;NXN;CTNNB1;PTK7;MACF1;SULF2;RNF43;CBFB;NKD1;DCDC2;GPC3;CTNND2;VGLL4;BTRC;SKI;CDC73;RSPO3;TLE1;SALL1;OTULIN;DISC1;DAAM2;ATP6V0C;GRB10;RACK1;DACT1
prerank,regulation of spindle organization (GO:0090224),-0.4466800773786712,-1.2622210731511818,0.1591928251121076,0.5623311531181578,1.0,6/18,20.56%,DYNC1H1;RNF4;PARP3;DCTN1;RAE1;MAP9
prerank,sensory perception of sound (GO:0007605),-0.32484267882217766,-1.2621595213525751,0.08099688473520249,0.5613169159661068,1.0,17/88,11.29%,PCDH15;EYA1;CACNA1D;COL1A1;EML2;COL11A1;COL4A3;ADGRV1;ROR1;CEMIP;KIT;DCDC2;GSDME;NIPBL;TIMM9;ATP6V0A4;TBL1X
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5258138065864502,1.2620055315652736,0.21223709369024857,0.9397639757084744,1.0,4/13,6.27%,FCGR2B;MANF;WFS1;LPCAT3
prerank,photoperiodism (GO:0009648),-0.40375709279494054,-1.2619201451802127,0.13286713286713286,0.5607939181234773,1.0,12/28,14.51%,PER2;PER3;CRY2;PML;BHLHE40;SIK1;MTA1;TP53;CRY1;PER1;RBM4;FBXL12
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5035611977731171,1.2618483400768985,0.21100917431192662,0.93771206793743,1.0,6/17,14.70%,RFFL;PTTG1IP;SIRT1;YJU2;MDM2;CD44
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5746620052568071,1.2618325755357502,0.17318435754189945,0.9350860088657572,1.0,3/10,13.40%,VSIR;PRNP;DDIT3
prerank,axon extension (GO:0048675),-0.4426489040413475,-1.2617195421725984,0.1670886075949367,0.560173077008078,1.0,7/23,9.78%,ALCAM;MAP1B;ULK2;AUTS2;NRP1;SEMA3A;NRP2
prerank,negative regulation of phosphatase activity (GO:0010923),0.4485547009889943,1.2616457354565056,0.19507908611599298,0.9333030952000985,1.0,4/25,7.66%,PPP1R36;TIPRL;BOD1;PPP1R11
prerank,regulation of Golgi organization (GO:1903358),0.50114720567495,1.2614274780162509,0.17272727272727273,0.9316950316700662,1.0,6/17,11.02%,MAPK3;MYO5A;USP6NL;CAMSAP2;PDE4DIP;RBSN
prerank,magnesium ion transport (GO:0015693),-0.5179552089026596,-1.2613347783009359,0.1927710843373494,0.5600397582468646,1.0,6/12,22.61%,SLC41A1;NIPA2;MRS2;NIPAL2;MAGT1;NIPAL3
prerank,peptide cross-linking (GO:0018149),-0.41480643202380696,-1.2611096183140276,0.15839243498817968,0.5594349615120066,1.0,4/25,11.85%,COL3A1;THBS1;FN1;ANXA1
prerank,regulation of lipid kinase activity (GO:0043550),-0.5286700343759172,-1.2609484163037326,0.18723404255319148,0.5587569486642625,1.0,6/11,30.73%,RBL2;PIK3R3;PIK3R1;RBL1;PIK3R2;WDR81
prerank,artery development (GO:0060840),-0.4223460780991124,-1.2608417495825073,0.15764705882352942,0.5578998819200023,1.0,5/23,4.10%,ROBO2;ROBO1;NRP1;TGFBR1;HECTD1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.45136698446629286,1.2607513329130358,0.17857142857142858,0.932063160481148,1.0,8/27,12.87%,MAP2K7;MAPK3;MAP3K7;MAPK8;CCDC88C;TNIP2;IKBKB;CHUK
prerank,axon development (GO:0061564),-0.3240177556669001,-1.2593703346128255,0.09627329192546584,0.5607990801363575,1.0,16/78,11.06%,FGFR2;CNTN4;ANK3;DCC;PLP1;MAP1B;CTNNA2;NRCAM;NTNG1;RYK;MAPT;SHTN1;GAP43;BRSK1;EPHB2;PLPPR4
prerank,negative regulation of receptor binding (GO:1900121),0.5628599536695182,1.259284467176175,0.22085889570552147,0.9359882046204414,1.0,2/10,5.45%,ATP2A2;B2M
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.4769928104583021,-1.2591273461648236,0.17721518987341772,0.5602565422416327,1.0,5/15,9.67%,LRP1;PDPN;DDR1;DPP4;FAP
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.37124756115235014,1.2584756892137046,0.13353115727002968,0.9370828654966332,1.0,19/72,14.97%,ACER2;PLK2;HIPK2;ING4;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;TFAP4;CARM1;NBN;CNOT6;CHEK2;CNOT1;CNOT6L
prerank,cellular protein-containing complex assembly (GO:0034622),0.33374090155382063,1.258280051875757,0.09283819628647215,0.9352963568480264,1.0,33/160,14.60%,HIGD2A;IMMP2L;TIAM1;AP2S1;SRC;BBS12;CCT2;NDUFAF1;SMAD1;PSMD11;SGIP1;CLTA;PFDN6;LONP1;OMA1;PSMG1;AXIN1;PDE4DIP;TMEM35A;EIF4H;TBCEL;CENPC;AIFM1;CHMP2A;MIS12;DMD;HIGD1A;EIF4B;PICALM;POGZ;AP2M1;CYBA;PIK3C2A
prerank,positive regulation of cation channel activity (GO:2001259),-0.36955219011103874,-1.2576049293931493,0.12771739130434784,0.5633007945275211,1.0,7/40,10.62%,ANK2;ANK3;AKAP6;RELN;HTT;ACTN2;EPHB2
prerank,regulation of macrophage cytokine production (GO:0010935),0.5293151816745428,1.2567548001975846,0.20192307692307693,0.9396322158073693,1.0,4/13,8.56%,SEMA7A;SIRT1;CUEDC2;WNT5A
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5022455914443391,-1.256426202003285,0.2053941908713693,0.5654750574323656,1.0,5/13,25.40%,CACNA1G;SYT4;SCAMP5;STX1A;SYT10
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.40828665297227384,-1.2561488814431696,0.16904761904761906,0.5650594723658879,1.0,4/26,2.15%,IGF1;AKAP6;FHL2;CAMTA1
prerank,carbohydrate homeostasis (GO:0033500),0.3793512869633473,1.2557927069567314,0.13970588235294118,0.9415626066183296,1.0,11/67,11.08%,PCK1;HECTD4;PYGL;SELENOT;WFS1;ADIPOR2;CYB5R4;PARK7;PRKAA2;BAD;ADIPOR1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5214995687663246,-1.2550279072597679,0.18979591836734694,0.5669271953647513,1.0,6/12,15.54%,MAP2;EML2;STMN2;CLIP3;STMN1;TUBB4A
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.525928541702333,1.25444540153911,0.19217081850533807,0.9451469247117007,1.0,3/13,4.52%,DERL2;SVIP;YOD1
prerank,isotype switching (GO:0045190),-0.5418283276291614,-1.253917043906461,0.17584745762711865,0.56875696672315,1.0,8/10,43.86%,RNF168;RNF8;MSH2;HSPD1;MSH6;EXOSC3;BATF;LIG4
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3595742541703821,-1.2537596008011378,0.12806539509536785,0.5680328454508099,1.0,20/44,24.20%,LPAR1;NRP1;ARHGEF10L;CCN2;TGFBR1;TPM1;RHOA;PXN;ROCK2;PPM1E;FHOD1;NF2;ARHGEF5;CDC42;PPM1F;PFN2;ARHGEF15;RHOC;ITGB1BP1;TGFB3
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.4585775341485358,-1.2536121268838003,0.17555555555555555,0.5672954618509484,1.0,10/17,35.38%,NLGN1;CACNA1G;SYT4;SCAMP5;STX1A;SLC4A8;SYT10;RAB3D;CACNA1H;RAB3A
prerank,mitochondrion organization (GO:0007005),0.3302091538664752,1.2529214352930231,0.08706786171574904,0.9493623865087558,1.0,26/165,11.20%,THG1L;MIGA1;TOMM20;HIGD2A;CHCHD2;DNM3;IMMP2L;CYCS;DNAJA3;GABPA;MTFR1;SIRT3;PHB2;TIMM17B;TSPO;SSBP1;LONP1;AGTPBP1;OMA1;PARK7;FBXO7;AIFM1;TERT;NOS3;CHCHD3;HIGD1A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3683558734590711,1.2528933807226466,0.13859910581222057,0.9441501178209439,1.0,18/78,10.48%,DYNC1I1;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;KIF15;DCTN3;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3683558734590711,1.2528933807226466,0.13859910581222057,0.9441501178209439,1.0,18/78,10.48%,DYNC1I1;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;KIF15;DCTN3;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,ERBB signaling pathway (GO:0038127),0.37364936722982794,1.2519758722783991,0.14285714285714285,0.9456991241152002,1.0,10/64,8.78%,FAM83B;PTPRR;PTPN18;CBL;SRC;CDC37;RPS6KA5;PTPN12;PLCG1;ERBIN
prerank,positive regulation of JNK cascade (GO:0046330),0.37191565407388266,1.2519746144773836,0.11128284389489954,0.943079759090524,1.0,14/70,11.27%,MAP3K11;FCGR2B;TIRAP;HIPK2;EDAR;TRAF5;AXIN1;MTURN;MINK1;TRAF3;PJA2;PLCB1;MFHAS1;APP
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5495329662108298,1.2513998793783505,0.21386138613861386,0.943129579702418,1.0,3/10,9.69%,HIPK2;ING4;TFAP4
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5162518973889201,-1.2513569200388868,0.21666666666666667,0.5724035283731043,1.0,3/11,8.46%,ATP1B1;ATP1A1;KCNJ2
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5339629785434281,-1.2509794475330809,0.19875776397515527,0.5723344958039972,1.0,8/10,30.44%,CTNNB1;SMARCD3;DISC1;KDM1A;CX3CL1;VEGFA;CX3CR1;DRD2
prerank,phagosome-lysosome fusion (GO:0090385),0.5625384825263846,1.2504170387455966,0.20824742268041238,0.9451608629240489,1.0,3/10,7.38%,RAB7A;RAB7B;PIKFYVE
prerank,mammary gland epithelium development (GO:0061180),-0.48882707087773386,-1.2499727981252629,0.200836820083682,0.5740332271655597,1.0,3/14,7.03%,ERBB4;WNT4;AKT2
prerank,regulation of interleukin-2 production (GO:0032663),0.4023543225245491,1.248934600489034,0.16693944353518822,0.9493300634730498,1.0,10/43,14.10%,PDE4D;PTPRC;MAP3K7;TNFAIP3;HDAC7;PRKD2;PNP;RPS3;PRNP;TRIM27
prerank,response to UV (GO:0009411),0.35208909718205267,1.248619390277298,0.11604584527220631,0.9482032731269002,1.0,28/95,17.96%,ERCC3;ZRANB3;MAP2K7;EIF2S1;RUVBL2;SDF4;ERCC4;YY1;MAP3K4;POLK;EP300;MAPK8;USP47;RELA;SPRTN;CCAR2;CREBBP;BMF;INO80;TAF1;ATR;N4BP1;TMEM161A;USP28;NPM1;UVSSA;POLH;RPL26
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3924128363001487,1.2484589625161282,0.17828200972447325,0.946263096872836,1.0,21/52,20.96%,RAC2;GSK3A;SAE1;VPS11;MAPK8;YWHAB;BAD;PPP3R1;YWHAH;CSNK2A2;ATG13;YWHAQ;LEPROT;UBE2D3;USP36;SH3GLB1;YWHAE;FBXW7;YWHAZ;UBE2L3;TFDP2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.47354537546778025,1.2481497590921458,0.1811722912966252,0.9449173232936205,1.0,6/20,15.09%,IL1R1;MAP3K7;B2M;CD81;CD55;DENND1B
prerank,regulation of sodium ion transport (GO:0002028),-0.3806083225779617,-1.2480006129446066,0.14936708860759493,0.5784548285771361,1.0,12/34,13.91%,ANK3;FGF12;SNTA1;WNK1;P2RX4;ATP1A1;SIK1;WNK4;PER1;DLG1;WNK3;NKAIN4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3042571083088674,1.2478057646559229,0.04566744730679157,0.9439926242695154,1.0,101/366,18.81%,TBX4;ONECUT1;TRAPPC2;FOXN2;EZH2;ZFAT;HES6;EIF2A;GTF2IRD1;RPS6KA4;ATXN1L;RPS6KA5;ORC3;PPP2CA;SBNO2;MYBL2;SMARCA2;SOX2;RBBP6;SPIN1;EP300;RFX3;NFX1;MED23;TGFBRAP1;SRSF10;ACTR8;CDK11B;ZNF205;SFPQ;FBXO5;ACTR5;GEMIN5;DRAP1;CLOCK;PFDN5;NOTCH1;TSC1;SOX13;ACVRL1;RELA;NAB2;ESCO1;RNF6;UBE2V1;RYBP;ING2;CCAR2;ESR1;METAP1;NLK;HP1BP3;CREBBP;CARM1;NANOS3;APP;USP37;JMJD1C;SP1;MZF1;IRF2;CHD3;ERC1;NUP35;TRRAP;CHEK2;DDIT3;ANKRD17;ZKSCAN5;HCFC1;YBX1;RNF20;BAZ2A;NSD2;BACH1;FUS;TERF2IP;RBM4B;TFEB;TAF6L;APBB2;TCF7L1;TCF3;SOX17;WTIP;CYFIP1;MYT1;CALR;NONO;ZNF219;INSR;STAT3;FOXK2;RPL10;PATZ1;ZSCAN21;NCOA2;HINT1;YAF2;ATRX;MSL3
prerank,DNA biosynthetic process (GO:0071897),0.5129864098689422,1.247739358086462,0.20309810671256454,0.941718976193915,1.0,5/16,10.58%,POLE;SIRT1;POLD3;POLA1;TERT
prerank,vasodilation (GO:0042311),0.5095799413318247,1.2477131129298578,0.21470019342359767,0.9392679187376547,1.0,4/13,11.15%,SOD1;KLF2;SOD2;NOS3
prerank,early endosome to Golgi transport (GO:0034498),0.5476319655666383,1.2476744797024564,0.20614828209764918,0.936894002669469,1.0,5/11,11.02%,SURF4;SNX8;RAB6A;SNX1;RBSN
prerank,regulation of protein modification process (GO:0031399),0.3989058523571058,1.2475317665074688,0.1554160125588697,0.9349250083744081,1.0,13/50,12.62%,ROPN1;PIN1;PPIB;PPP2CA;PPP1R16B;SPRED1;HPF1;CCDC88C;KDM4D;LYN;CCAR2;ATG7;CDH5
prerank,cellular response to UV (GO:0034644),0.36687676378885353,1.2466664955002096,0.14136904761904762,0.9363762441098603,1.0,23/76,17.96%,CERS1;EIF2S1;RUVBL2;MME;ERCC4;YY1;POLK;CDKN1A;EP300;CARD16;SIRT1;ACTR5;USP47;CREBBP;BMF;INO80;TAF1;ATR;N4BP1;TMEM161A;USP28;NPM1;RPL26
prerank,ear morphogenesis (GO:0042471),-0.44344369536068534,-1.2464987570760284,0.1721132897603486,0.5814998158543011,1.0,5/20,10.62%,FGFR2;ZIC1;OSR1;NIPBL;EPHB2
prerank,cellular response to cAMP (GO:0071320),-0.3895877812743351,-1.2463215172461999,0.15844155844155844,0.5808151301514898,1.0,12/30,27.72%,HCN1;AKAP6;IGFBP5;AKAP9;EZR;RAPGEF2;SLC5A5;DMTN;PDE2A;HCN2;KCNQ1;INPP5K
prerank,peptidyl-serine phosphorylation (GO:0018105),0.33133950788070493,1.2462433467129257,0.10198675496688742,0.9357720837692828,1.0,37/153,15.85%,PCK1;PRKX;STK32A;PLK2;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;PRKD2;RPS6KA5;PKN3;SMG1;MAPK8;CSNK1G3;SBK1;PIKFYVE;DCLK3;LATS2;PKN1;SRPK2;NLK;TNKS;PRKCI;MAST4;IKBKB;MAPK12;CHUK;TLK2;NEK6;CSNK2A2;MAP3K10;GAS6;DYRK2;TOP1;TAF1;ATR
prerank,axon guidance (GO:0007411),-0.27670622767277675,-1.2462225755011007,0.028688524590163935,0.5798612019820683,1.0,52/201,13.66%,NRXN3;NCAM1;ROBO2;NOTCH2;CNTN4;ALCAM;LAMA2;DCC;PLXNA2;ROBO1;UNC5D;NRXN1;CNTN6;EPHA6;TNR;EFNA5;NFIB;SEMA3D;GLI2;EPHB1;NRP1;EFNB2;RYK;DSCAM;EPHA7;PDLIM7;KIF5C;UNC5C;RELN;SMO;DAB1;PALLD;SEMA3A;FEZ1;GAP43;NOTCH3;EPHB4;EZR;NIBAN2;NRP2;SPTAN1;EPHB2;EPHA3;SEMA4D;GAB2;GRB2;NTN4;SHC3;PLXND1;RANBP9;GRB10;VLDLR
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5567096273551084,1.2461500732962412,0.21361058601134217,0.9336662917295914,1.0,2/10,1.01%,RSC1A1;GSK3A
prerank,positive regulation of cell cycle process (GO:0090068),-0.3141704329975817,-1.246051458260541,0.08496732026143791,0.5791917054873346,1.0,17/91,15.15%,SVIL;IGF1;PDGFRB;DYNC1H1;RHOA;SIRT2;CEP120;CIT;MAP3K20;LRP5;UBXN2B;PLSCR1;NSFL1C;USP19;CENPV;IGF2;CEP295
prerank,clathrin coat assembly (GO:0048268),0.5025834781431942,1.245543229961441,0.21616871704745166,0.9339212026337201,1.0,5/15,14.60%,AP2S1;SGIP1;CLTA;PICALM;PIK3C2A
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3237870372010498,-1.2452526144288452,0.12923076923076923,0.5802756012436561,1.0,23/72,22.04%,LPAR1;ROBO1;AKAP13;KANK2;COL3A1;NRP1;BCR;TNFAIP1;STARD13;PRAG1;RIT2;ABCA1;GPR4;RALBP1;ARHGDIA;STMN1;RAF1;ABL2;KCTD13;MET;ARHGDIB;FLCN;CCDC125
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5312449510729381,-1.2449260689616444,0.20212765957446807,0.5799919325806769,1.0,4/11,9.13%,TGFBR3;TGFBR1;TGFBR2;ACVR1
prerank,phosphatidylserine metabolic process (GO:0006658),0.42631151868204115,1.2449193757060137,0.17792421746293247,0.9342327941230767,1.0,7/32,12.52%,SERINC1;OSBPL10;PLAAT3;LPCAT3;MBOAT1;SERINC5;ABHD12
prerank,negative regulation of innate immune response (GO:0045824),0.42610418265950645,1.2448621212983892,0.16805324459234608,0.9319886650294514,1.0,9/34,13.09%,TNFAIP3;TTLL12;FAM3A;NLRC3;CNOT7;USP15;A2M;USP18;NLRC5
prerank,response to glucagon (GO:0033762),-0.44766332457501434,-1.2447378947935688,0.19004524886877827,0.5793692809818285,1.0,8/19,12.03%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;CRY1;ADCY7;PRKAR1B
prerank,neuron maturation (GO:0042551),-0.44849081950240777,-1.24453494826507,0.19665271966527198,0.5787717492990186,1.0,12/18,34.82%,ADGRB3;B4GALT6;SRRM4;MTCH1;SCARF1;CX3CL1;EPHA8;PICK1;LGI4;CLN5;B4GALT5;C1QA
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5611887138511572,1.2444166757391881,0.21485943775100402,0.9314329682912821,1.0,5/10,13.57%,PSMC4;PSMC2;ESR1;PSMC6;THRA
prerank,anterior/posterior axis specification (GO:0009948),-0.4878550828004582,-1.2443110853685315,0.1935483870967742,0.5781856366287723,1.0,3/15,11.62%,WLS;SKI;TBX3
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5298118206095139,1.2439596920040121,0.2427007299270073,0.9309593725056867,1.0,3/12,9.31%,MAPK3;CSF1R;LYN
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5143004679142519,-1.2438265554068852,0.1857451403887689,0.5784087607472822,1.0,3/12,4.40%,FOXP1;DAB2;HDAC1
prerank,digestive tract morphogenesis (GO:0048546),-0.48789256309691964,-1.243433374583663,0.1945031712473573,0.5783858093473168,1.0,6/14,23.35%,FGFR2;PDGFRA;NIPBL;RBPMS2;GLI1;STRA6
prerank,protein insertion into ER membrane (GO:0045048),-0.37741325669470266,-1.2434283267653234,0.15602836879432624,0.5772449533693391,1.0,18/37,27.56%,UBE2J2;EMC7;CYB5A;CAMLG;TRAM1;ALDH3A2;VAMP2;TRAM2;STX1A;SGTA;BAG6;EMC1;EMC8;EMD;EMC9;SERP1;SEC61B;GET4
prerank,regulation of BMP signaling pathway (GO:0030510),-0.3233966326911192,-1.243314515141519,0.11343283582089553,0.5764446944889468,1.0,26/73,21.40%,SULF1;FSTL1;FOXD1;NBL1;BMPER;SMURF2;SMAD4;VWC2L;BMP4;CRIM1;SORL1;SKI;HTRA3;SMAD6;XIAP;SPART;PCSK6;SMAD5;BMPR1B;RBPMS2;ZNF423;SFRP4;BMPR1A;BMPR2;TWSG1;CCN1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5185474506942507,-1.2432618616609714,0.21311475409836064,0.5754552942771209,1.0,5/11,15.86%,PDK1;PRKCD;MAP3K5;STK25;PRODH
prerank,adenine nucleotide transport (GO:0051503),0.49166766339186624,1.243182782927931,0.20677361853832443,0.9319358725884408,1.0,3/17,6.46%,ABCC4;SLC25A24;LRRC8C
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4264922178058616,1.243165768267879,0.15806988352745424,0.9295447350841229,1.0,2/31,0.85%,GPHN;MOCS3
prerank,supramolecular fiber organization (GO:0097435),-0.26249692822556914,-1.2429894591941786,0.01910828025477707,0.5750745842942702,1.0,125/334,28.01%,COL1A2;COL4A5;ADAMTS2;PPP1R9A;COL1A1;GSN;TNXB;COL4A6;COL8A1;CGNL1;COL3A1;COL11A1;TMOD2;PLOD2;COL25A1;HDGFL3;COL22A1;TGFBR1;DYNC1H1;COL5A1;PLEC;COL4A3;CLIP4;SNCAIP;MAPT;SHROOM3;COL5A2;TPM1;VIM;RHOA;COL4A4;LOXL1;ARHGAP12;COL12A1;ATP7A;SORL1;COL6A1;TUBGCP4;HSPG2;COL8A2;STMN2;P4HB;COL15A1;COL13A1;PLOD1;COL6A2;SLAIN2;GGA2;RND3;CEP126;CKAP5;BACE1;RHOBTB2;BIN3;UBC;ADAMTS3;LOXL3;RHOB;CLIP3;TUBGCP6;RHOBTB1;INPPL1;DLG1;HIP1R;SIAH2;FIGNL2;COL23A1;TRIOBP;NEFL;STMN1;COL6A3;KATNAL1;ERMN;DCTN1;MYO1B;TPM4;ITGB4;COL5A3;GGA3;CDC42;P4HA2;TGFBI;COL20A1;COL14A1;LUM;MYO1F;ALDOA;COL16A1;TMOD1;COL18A1;WDR73;EFEMP2;P3H1;MYO19;LOX;GFAP;CRTAP;HOOK2;EMILIN1;RHOC;COL26A1;TPPP;STMN4;EMP2;ARHGAP17;KATNAL2;MYH11;ELMO2;COL9A2;TSPAN15;MFGE8;COL27A1;APH1B;STMN3;DPT;TPPP3;HIP1;DBN1;CDC42EP2;MYO5B;MPRIP;RHOH;BFSP2;CD151;MAP7D3
prerank,nucleic acid-templated transcription (GO:0097659),0.40618349473342635,1.2428826806154263,0.1782178217821782,0.9283990629507205,1.0,10/42,14.55%,POLR2J;NR4A2;POLR2B;PAX8;PWP1;TERT;THRB;RRAGC;PPP5C;BAZ2A
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.44335712206584627,-1.2425537324839082,0.18571428571428572,0.5751608776691719,1.0,7/19,9.11%,IGF1;NTRK2;RTN1;FLOT2;SORL1;ROCK1;BIN1
prerank,myotube differentiation (GO:0014902),-0.4667300246892138,-1.2424395678350428,0.21247113163972287,0.5743710021114156,1.0,5/17,6.85%,IGF1;ADGRB3;ADAM12;ADAMTS5;SKI
prerank,negative regulation of MAPK cascade (GO:0043409),0.35324771705349717,1.2422737428418784,0.1325478645066274,0.9287217516663646,1.0,13/87,9.31%,RGS2;SEMA6A;PTPRR;DUSP7;PTPRJ;PIN1;PTPRC;PRDM15;APOE;SPRED1;CNKSR3;DAG1;LYN
prerank,epithelial structure maintenance (GO:0010669),-0.5143371560202451,-1.2420815743027545,0.2184873949579832,0.5742209507585553,1.0,2/11,7.87%,CXADR;RBP4
prerank,positive regulation of cellular protein localization (GO:1903829),-0.32419120702633236,-1.2419259054624994,0.11940298507462686,0.5735245748041508,1.0,31/69,31.62%,BICD1;MAPT;KAT7;GNL3L;STX3;TM9SF4;GSK3B;DDRGK1;SYT11;ENTR1;MAP1A;TGFB1;CEP250;WWTR1;LIMK2;GPD1L;CARD10;GNL3;DTX3L;YAP1;LAMTOR5;EIF2AK3;AKT1;SESN2;SLC5A3;ABCA7;GPR137B;ORMDL3;PARP9;CDK5RAP3;PRKAA1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4306271249661925,1.241667802270827,0.18357487922705315,0.9289717254607879,1.0,5/30,8.79%,ERCC3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,positive regulation of heart contraction (GO:0045823),0.478011086220101,1.2406367460311352,0.1978021978021978,0.9308782847529752,1.0,3/19,3.95%,RGS2;GSK3A;ATP2A2
prerank,tRNA aminoacylation (GO:0043039),0.4109383248428262,1.240351148080596,0.14309210526315788,0.9296774304998295,1.0,13/37,17.80%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;RARS2;WARS2;LARS1;GATB;HARS2;WARS1;IARS2
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5113479362109689,1.2402135235419163,0.22586520947176686,0.9278601770986276,1.0,4/13,14.25%,SPR;PTS;NOS3;GCH1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.34253367575522303,-1.239277335371011,0.1282051282051282,0.5798605903549728,1.0,16/59,12.31%,ROBO2;CNTN4;TENM3;SDK1;ROBO1;CNTN6;KIRREL3;PKD1;DSCAM;IGSF11;PALLD;SDK2;MPZL2;CDH1;CDH4;OBSL1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4968686981361664,-1.2392008668314096,0.20454545454545456,0.578946405222219,1.0,2/12,7.21%,ANK2;UBASH3B
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4764185495042462,1.2390400995525965,0.22077922077922077,0.9307437737097604,1.0,3/17,5.08%,SORT1;HDAC9;LMF1
prerank,protein prenylation (GO:0018342),0.5652699730348563,1.2384385484509874,0.2192622950819672,0.9309198900067243,1.0,2/10,2.99%,CHML;CHM
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.48571021114155244,-1.238054357512062,0.20045045045045046,0.5810141289759141,1.0,4/13,6.99%,GLI2;TOX;BMP4;CAMK4
prerank,ribosome biogenesis (GO:0042254),0.3231046706402193,1.2380434651031975,0.09975062344139651,0.9302721258125878,1.0,62/187,19.87%,RPL30;UTP20;UTP18;RPL17;RPL23;EIF2A;RPL31;RPL3;DDX54;DDX10;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;TSC1;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;LTV1;RBIS;DDX27;WDR12;PAK1IP1;XPO1;EXOSC1;UTP11;LTO1;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RPL19;NPM1;RPL38;EIF6;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;RPL14
prerank,nuclear envelope organization (GO:0006998),-0.4311288661378079,-1.237851662350986,0.16475972540045766,0.5804791416967077,1.0,13/20,26.01%,NUP155;TOR1AIP1;DMPK;NUP93;TOR1B;NEMP1;SUN1;VPS4A;CTDNEP1;EMD;LEMD2;TMEM170A;TMEM43
prerank,regulation of microtubule-based movement (GO:0060632),-0.5169178669412013,-1.237403949148647,0.2032854209445585,0.5806215988808059,1.0,2/11,5.89%,MAP2;TTC21B
prerank,gene expression (GO:0010467),0.30616617156561815,1.2367295817975879,0.055819477434679333,0.9337692443233958,1.0,100/348,18.37%,POLR2J;NCBP1;RPL30;MRPS33;NR4A2;RSL24D1;EEF1A1;POLR2B;MRPL23;RPL17;RPL23;MRPL24;FASTKD2;RPL31;RPL3;RPS21;DDX54;MRPL18;PAX8;SMG1;HNRNPK;LMF1;RPL35A;CPSF4;RPS14;RPL8;CHTOP;YARS2;RPL5;ABCF1;NUP54;PWP1;MRPS12;RPS12;HBS1L;RPS26;RPL37A;NXT1;HARS1;NUP50;ADAR;YTHDC1;FYTTD1;RPL4;SRSF4;RPLP0;SARNP;UPF2;XRN2;RPS28;U2AF1;RPS24;DUSP11;RPS9;RPS23;RPL24;THRB;ADARB2;RPL34;RPS11;MRPL52;RPS3;MRPS15;DHPS;NUP35;RRAGC;PPP5C;TSPAN17;RPS15A;RPL23A;RPL21;RPL35;SRSF7;BAZ2A;HNRNPL;NDC1;ADARB1;SLBP;UPF3B;DKC1;U2AF2;HARS2;WDR33;WARS1;NUP160;RPL19;RPL38;HNRNPF;POM121;RPL36;SMG6;RPSA;DHX8;RPL26;RPS8;SMG5;CLP1;RPL15;RPL10;NUP42
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5098581244695546,1.2367166553722608,0.20930232558139536,0.931447486553885,1.0,1/14,0.32%,SLC5A7
prerank,protein deubiquitination (GO:0016579),0.31490846886554424,1.2365756290274301,0.0691358024691358,0.9296187697638649,1.0,59/242,14.94%,TOMM20;PSMB10;PSMC4;ABRAXAS1;PSMB6;PSMD8;PSMD5;PSMD12;ACTL6A;MAP3K7;TNFAIP3;ACTB;BIRC2;SMAD1;PSMD11;YOD1;OTUD1;PSMB4;YY1;SPATA2;PSMC1;EP300;ACTR8;SMAD7;ACTR5;DESI2;RUVBL1;USP47;ATXN7L3;TRAF3;MDM2;RAD23A;PSMC2;USP48;USP31;PSMD2;ESR1;OTUD3;USP22;USP15;USP37;NFRKB;USP18;TNIP2;OTUD5;PSMD14;TRRAP;USP33;BRCC3;PSMC6;PSMD1;APC;NFKBIA;PSMB1;HCFC1;MINDY2;USP9X;UCHL5;INO80
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.3837187153516787,-1.2360118032934861,0.15328467153284672,0.5832321569343705,1.0,11/34,17.34%,DOCK5;DOCK1;NRP1;FLNA;NEDD9;RREB1;P4HB;ILK;MYADM;TRIOBP;CDC42
prerank,positive regulation of autophagy (GO:0010508),0.3551365076644775,1.2349969412868336,0.14222222222222222,0.9345540079518931,1.0,28/81,19.34%,GSK3A;ATF6;MAP3K7;PLK2;SVIP;TRIM8;EPM2A;PHB2;TRIM14;SIRT1;PARK7;FBXO7;PRKAA2;BAD;TMEM59;BNIP3L;TRIM27;SCOC;CAMKK2;PIK3C2A;TFEB;SESN3;BNIP3;ULK1;MID2;SH3GLB1;SESN1;LARP1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4755513125042235,-1.2347302030992207,0.21019108280254778,0.585546492798223,1.0,9/15,21.56%,FGF1;P2RX4;SMOC2;THBS1;LGMN;SEMA5A;MET;HSPB1;PRKD1
prerank,regulation of signal transduction (GO:0009966),-0.2777820772999691,-1.2343901878758359,0.046948356807511735,0.5853535297906134,1.0,73/190,25.74%,NCAM1;FGFR2;SULF1;ZIC1;KCTD8;OGT;TULP3;IGFBP5;IGFBP2;PLCE1;IGFBP7;IFT81;PXN;CBFB;DHRS3;POFUT1;DCDC2;IRAK1;IGFBP6;UBASH3B;CASTOR2;GAS1;SNW1;RGS12;ACVR1;ELF1;RSPO3;GRK5;GRK3;PLSCR1;SOCS2;CSK;PRAG1;ILK;NUCKS1;IGFBP4;WDR11;FRRS1L;USP20;RORA;INTU;TMEM204;TGFB1;RGS20;PTPN2;GRK4;WWTR1;MTCH1;SOCS5;TSC2;FRMPD1;SNX3;TRIM5;SEMA5A;TMEM237;CX3CL1;DTX1;GLI1;PRKD1;GRK2;DOK5;DGKQ;IRAK2;ITGB1BP1;TSPYL2;RIC8B;LLGL1;TSPAN15;FOXL1;RGS4;GLRX2;PTCH1;GIT1
prerank,central nervous system development (GO:0007417),-0.27027494889577397,-1.2340054286770215,0.02247191011235955,0.5852483447547381,1.0,34/250,6.38%,ROBO2;CNTN4;DCLK1;ZIC1;ADAM22;ARNT2;PBX1;ZIC4;CNTN6;SPOCK1;GSN;GRIN2B;NRCAM;AHI1;NFIB;ADAM23;PKD1;ADGRA2;AFF2;MBP;SH3GL2;NCOA6;TGFBR2;DNER;EPHA7;JARID2;MEIS2;GLIS2;IL1RAPL2;VCAN;RELN;SMO;ZIC5;HSPG2
prerank,positive regulation of cell adhesion (GO:0045785),0.3606127432547709,1.233797453787167,0.13834586466165413,0.9372935947537085,1.0,13/74,11.89%,FRMD5;PTPRJ;CXCL12;PRKD2;CIB1;RET;SYK;MAGI1;SMAD7;CD47;CITED2;NPNT;PPP3CA
prerank,negative regulation of inflammatory response (GO:0050728),0.3249856497592025,1.2337915920711884,0.10419313850063533,0.9349542444157622,1.0,25/182,10.61%,GPR176;PRKAR1A;PTGER2;TNFAIP3;PLK2;SRC;TSHR;INSL3;RAMP2;APOE;TEK;FYN;TNFRSF1B;LPCAT3;GNB1;RXFP1;SYK;PPARD;NLRC3;PLCG1;LYN;RHBDF2;CD163;MFHAS1;YES1
prerank,retinoid metabolic process (GO:0001523),-0.32461957979794615,-1.2337712160413974,0.12058823529411765,0.5848482097466886,1.0,14/71,10.87%,GPC6;LRP1;ALDH1A1;ALDH1A2;SDC2;DHRS3;GPC3;HSPG2;ABCA4;NAPEPLD;RBP4;SCPEP1;GPC5;RBP1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3030547480208153,-1.2328525034542726,0.08598726114649681,0.5861728167469483,1.0,33/104,19.94%,MAGI2;LDLRAD4;SMAD3;NBL1;BMPER;SMURF2;TGFBR1;TGFBR2;SMAD4;VWC2L;CRIM1;SORL1;PPARA;SKI;HTRA3;SMAD6;ACVR1;SPART;SNX25;UBC;PPM1A;SMAD5;MTMR4;TGFB1;BMPR1B;CCN3;RBPMS2;PRDM16;CD109;BMPR1A;STUB1;BMPR2;SPRED3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3294499480705271,-1.2326496287165931,0.10909090909090909,0.5856058613868858,1.0,34/67,31.19%,SULF1;CYFIP2;DOCK1;WASF2;NRP1;MAPK14;AXL;ABI1;VAV2;RHOA;PXN;ROCK2;ROCK1;NRP2;PTK2;CDC42;SHB;PIK3R1;AAMP;HSPB1;PRKD1;VEGFA;ELMO2;VEGFB;HSP90AA1;NCKAP1L;MAPKAPK2;PGF;ITGB3;NCF2;PIK3R2;CLEC14A;FLT4;NCK1
prerank,RNA transport (GO:0050658),-0.3251877888294591,-1.2324798935200851,0.11884057971014493,0.5849179907181148,1.0,30/71,24.59%,SRSF5;SRSF11;CASC3;TGFBR2;SIDT1;SRSF2;KIF5C;SRSF6;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;CKAP5;HNRNPA2B1;SIDT2;HNRNPA1;THOC5;SLU7;CDC40;RTRAF;RNPS1;RAE1;FLOT1;NUP214;EIF4A3;NCBP2;THOC1;RBM8A
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.40716344335174237,-1.2320234934321495,0.1889168765743073,0.5850926542754797,1.0,8/26,11.22%,RIMS1;NRXN1;DLG4;NLGN2;PRKCZ;RELN;NLGN1;CUX2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3223730948251615,-1.2319352508443027,0.11275964391691394,0.5842212312331356,1.0,33/71,31.40%,OTUD7A;ADAMTS12;CAPN2;NGLY1;DDB1;MALT1;VCP;RHBDD1;PSMA6;FAP;LGMN;CLPP;UBC;NEDD8;CTSO;DDI2;RNF123;HM13;CTSZ;STUB1;VPS4A;BAG6;OTUD7B;CTSK;CTSF;CLPX;CTSB;CTSC;HDAC6;CTSS;ZRANB1;FBXL17;PRPF19
prerank,rRNA metabolic process (GO:0016072),0.32712987672717614,1.2317966256982298,0.1088348271446863,0.9411442047821664,1.0,53/160,19.87%,RPL30;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;DDX27;WDR12;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RPL19;RPL38;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;RPL14
prerank,protein K48-linked ubiquitination (GO:0070936),0.3808865367428209,1.231616375216257,0.176,0.9395425500694828,1.0,17/54,16.45%,KLHL3;TNFAIP3;RFFL;NEDD4L;UBE3A;RNF187;TTC3;RNF6;ZNRF1;IFI27;CUL3;UBE2R2;RNF146;RNF216;UBE2G1;PELI1;UBE2H
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3864756900185363,-1.2315528893799295,0.17543859649122806,0.584184001715806,1.0,20/30,29.28%,DSE;CHSY1;VCAN;HEXA;CSGALNACT2;CHST15;HEXB;ARSB;CHST11;UGDH;CSPG4;DSEL;BGN;DCN;HYAL1;CHPF2;CHST3;CSPG5;CHST12;NDNF
prerank,calcium-mediated signaling (GO:0019722),-0.3070756290212058,-1.2315088897322557,0.07926829268292683,0.5832125970257691,1.0,17/93,10.71%,ANK2;CACNA1C;EGFR;MCU;PPP1R9A;GRM5;ATP1B1;NUDT4;PLCE1;P2RX4;CHRM3;FIS1;CCR9;KSR2;PRKACA;DMPK;ACKR3
prerank,positive regulation of cellular component movement (GO:0051272),0.45716427618885713,1.2313654828202996,0.1788756388415673,0.9383226457546957,1.0,5/24,9.31%,PHPT1;SPOCK2;ACTN4;CSF1R;LYN
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4649316005995835,-1.2312487136789145,0.1900647948164147,0.5817888767266306,1.0,6/15,18.41%,SORBS1;RHOA;ITGB5;TNFAIP1;PDLIM1;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.4649316005995835,-1.2312487136789145,0.1900647948164147,0.5817888767266306,1.0,6/15,18.41%,SORBS1;RHOA;ITGB5;TNFAIP1;PDLIM1;KCTD13
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5073184793520026,-1.2312315128253295,0.2012847965738758,0.5807230606061479,1.0,4/12,19.11%,PLEKHH2;LIMA1;WDR1;SEMA5A
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.38493477555116296,-1.2311229050851387,0.1590909090909091,0.5799079618318533,1.0,10/31,18.56%,DLG2;LRRC7;PARD3B;RHOA;EZR;DLG3;DLG1;WDR1;CDC42;MSN
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4560039260387508,-1.2309515079396496,0.19686800894854586,0.5793039583948961,1.0,6/17,18.98%,CTNNA2;WASF2;GMFB;WASF1;FCHSD2;ARFIP2
prerank,diol biosynthetic process (GO:0034312),0.5090319936234131,1.2307830431260312,0.23756906077348067,0.9386340883952324,1.0,4/15,14.25%,ACER2;SPR;ACER3;GCH1
prerank,homeostasis of number of cells (GO:0048872),0.5345194267630327,1.2300803113519299,0.2111111111111111,0.9393974631974528,1.0,4/12,11.15%,OCIAD1;LPCAT3;NOTCH1;NOS3
prerank,cellular response to interleukin-12 (GO:0071349),0.3913659035248794,1.2298352596846964,0.17452830188679244,0.9381259553073689,1.0,16/48,17.46%,LCP1;SOD1;CFL1;RALA;TALDO1;RPLP0;CD47;SOD2;ARF1;PLCB1;PITPNA;TYK2;TCP1;SNRPA1;HNRNPF;CAPZA1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.35772116692235145,1.2297919446956667,0.1514705882352941,0.9359605439184222,1.0,22/80,13.52%,SURF4;ARF5;KIF18A;KIFAP3;LMAN2;COPG2;TMEM115;RAB6B;NAPA;RAB6A;KDELR2;TMED10;KIF15;RAB1A;GOLPH3L;KIF2A;TMED7;SCFD1;ARCN1;COPG1;KIF3B;COG3
prerank,response to laminar fluid shear stress (GO:0034616),0.5439428122213703,1.229192240579621,0.23366336633663368,0.9362162344119267,1.0,3/10,7.28%,KLF2;MAP2K5;SMAD7
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5333579354653297,1.2291034397024214,0.23076923076923078,0.9342727748191448,1.0,2/12,1.42%,CBL;PTPRJ
prerank,regulation of cartilage development (GO:0061035),-0.4466304896217306,-1.2290159831964116,0.20518358531317496,0.5834463205411627,1.0,12/18,37.27%,SOX5;TAPT1;BMP4;BMPR1B;SOX6;BMPR2;BMP2;MDK;PTHLH;SOX9;WNT11;KAT2A
prerank,cellular response to nutrient levels (GO:0031669),0.37461542841069767,1.228989228152334,0.16129032258064516,0.9324060740231684,1.0,21/62,21.13%,RALB;GAS2L1;MAP1LC3B;HSPA8;RPTOR;SIRT1;TSC1;PRKAA2;ATG7;RRAGC;USP33;ATG14;TFEB;ZFYVE1;ULK1;LAMP2;EIF4G1;XBP1;WDR45B;STK24;LRRK2
prerank,cellular response to heat (GO:0034605),-0.37494189858307403,-1.2287366988495025,0.183206106870229,0.5831594243966424,1.0,12/35,19.23%,FGF1;MAPT;RBBP7;BAG3;VCP;THBS1;PRKACA;ANO1;HSF1;SLU7;CLPB;STUB1
prerank,intracellular protein transmembrane transport (GO:0065002),0.39560612087634933,1.2282404027484366,0.18136439267886856,0.9335287035498142,1.0,10/42,11.48%,TOMM20;ROMO1;TIMM17B;PEX1;PEX7;GRPEL2;TOMM40L;TIMM21;AIFM1;SEC62
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.42840659362695466,-1.2272209567900827,0.20232558139534884,0.586350321986105,1.0,9/21,28.31%,SIRT2;AATF;SLC30A10;PPARA;ABCD2;SIRT5;PINK1;PAX2;HDAC6
prerank,positive regulation of organelle organization (GO:0010638),-0.3836942212732084,-1.2272086911432147,0.17121588089330025,0.5852858131020865,1.0,11/32,13.50%,STX18;ANXA2;RAB3GAP2;PPARGC1A;AKT2;LMAN1;TMED9;GSK3B;UVRAG;ANXA1;PFDN2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.3024508998350167,-1.2265556544649971,0.10452961672473868,0.5860528516563012,1.0,21/107,8.70%,LRRC4C;ATP1A2;RIMS1;DLGAP1;DGKI;GRID2;GRM5;DLGAP2;DLG4;DLGAP4;SNCAIP;NLGN2;RELN;BCR;SLC12A2;CACNA1B;GRID1;CLSTN2;AKAP9;NLGN1;SYN1
prerank,regulation of integrin activation (GO:0033623),0.4875621455334843,1.2265386973601777,0.2338403041825095,0.9387284887360957,1.0,4/15,13.31%,SRC;SELP;RASIP1;PLEK
prerank,histone monoubiquitination (GO:0010390),-0.4143499031535963,-1.2258358084007588,0.17302798982188294,0.5870248642469277,1.0,10/24,21.11%,WAC;UBE2E1;DDB1;DDB2;CDC73;RNF168;PAF1;BCOR;RNF40;DTX3L
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.29201570284632034,-1.2248650324181587,0.06746031746031746,0.5887014903704996,1.0,29/121,14.13%,ERBB4;BMP6;IGF1;GRM5;EFNA5;NRP1;DLG4;PARP14;IL6R;NEDD9;PIBF1;KIT;TEC;GHR;RELN;IL34;ITGA5;IL31RA;SRCIN1;ACVR1;DLG3;VTN;TP53;SEMA4D;NOX4;CSPG4;IL18;IL6ST;IGF2
prerank,regulation of histone acetylation (GO:0035065),0.41352549408808886,1.2246021247038827,0.20297029702970298,0.944978816270418,1.0,9/33,13.20%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5;RAPGEF3;SETD5;PARK7;CTBP1;HDAC5
prerank,regulation of adaptive immune response (GO:0002819),0.47285098138622106,1.224528433755551,0.20072992700729927,0.9429866791963243,1.0,4/18,14.10%,FCGR2B;SAMSN1;SIRT1;TRIM27
prerank,stress granule assembly (GO:0034063),-0.4289118728927025,-1.2242832759575093,0.2081447963800905,0.5892906471659264,1.0,7/20,13.80%,BICD1;DYNC1H1;MAPT;OGFOD1;YTHDF1;G3BP1;ATXN2L
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.48808121209872546,-1.2235679861700097,0.227765726681128,0.5901719779823762,1.0,5/14,13.20%,ANK3;ATP1B1;WNK1;WNK4;WNK3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.4079405862865252,1.2231693253443385,0.18451400329489293,0.9467494726001559,1.0,11/36,11.96%,LEF1;MAP3K7;PPP3CB;GNB1;WNT5A;PLCB1;FZD3;NLK;AGO4;PPP3CA;PPP3R1
prerank,fluid transport (GO:0042044),-0.5002576229306257,-1.223051965263152,0.21581196581196582,0.590587474547125,1.0,2/12,9.82%,PDPN;AQP4
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.36412594610654264,-1.222695688135686,0.17391304347826086,0.5905168269014439,1.0,5/37,3.16%,TENM2;TENM3;ALCAM;GRID2;CXADR
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.3904272851926968,1.2220738418073027,0.18876755070202808,0.9492426937573682,1.0,15/46,17.46%,LCP1;SOD1;CFL1;RALA;TALDO1;RPLP0;SOD2;ARF1;PLCB1;PITPNA;TYK2;TCP1;SNRPA1;HNRNPF;CAPZA1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4365260176089294,1.2213714665410789,0.21551724137931033,0.9501629452404488,1.0,7/26,14.46%,TIRAP;IFI35;WDFY1;PJA2;MFHAS1;DDX3X;CYBA
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.45724458334612933,1.2212078588445183,0.2014260249554367,0.9485750510930253,1.0,3/19,9.22%,PIK3AP1;TIRAP;RAB11FIP2
prerank,DNA conformation change (GO:0071103),0.4804396144574857,1.220639252900718,0.22162162162162163,0.9487278397674441,1.0,5/17,19.18%,ERCC3;TOP3A;TOP1;HAT1;TOP3B
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3781847898756222,-1.2206063043326416,0.16829268292682928,0.5952484195411558,1.0,10/33,14.97%,KANK2;FHL1;RBL2;MYO16;CDC73;BRD7;CDK6;DLG1;DACT1;NACC2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5087408691956978,1.2205043851143877,0.24366471734892786,0.9470483030442287,1.0,3/13,10.12%,NCBP1;CPSF4;CPSF6
prerank,positive regulation of hormone secretion (GO:0046887),-0.44313031428433924,-1.2196827929892708,0.19457013574660634,0.5966884761971676,1.0,8/17,35.28%,SNX4;SPP1;C1QTNF3;VAMP8;EDN1;SOX11;EDN3;HFE
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2902570234623989,-1.2195190009434191,0.07835820895522388,0.5960485694310155,1.0,40/128,29.25%,BMP6;SASH1;PDGFRB;PUM1;PUM2;NAPEPLD;STX3;OPTN;THBS1;PLSCR1;IL16;IL17RA;POLR3C;GPR4;LY86;IL18;IL33;TNIP1;TGFB1;LRSAM1;GPRC5B;SCARF1;GBP5;RIOK3;AGTR1;SLC15A4;CX3CL1;SETD4;PPM1F;P2RY12;PLA2G7;TLR3;FEM1A;SERPINE1;PDE2A;CCN4;CD180;MDK;SNCA;POLR3G
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.5279930401809748,1.2189759269881808,0.23639774859287055,0.9513468330874821,1.0,4/11,14.25%,SPR;PTS;NOS3;GCH1
prerank,hyaluronan catabolic process (GO:0030214),-0.4431531376517144,-1.2189718962848919,0.214123006833713,0.5964474865436575,1.0,9/18,33.37%,CEMIP;CEMIP2;HEXA;HEXB;TGFB1;GUSB;HYAL1;SLC9A1;CHP1
prerank,chemical synaptic transmission (GO:0007268),-0.26178257082360606,-1.2187119982672556,0.04794520547945205,0.596049420941653,1.0,70/284,17.48%,DLG2;RIMS1;DLGAP1;KCNQ3;PLP1;HTR2C;GABRB1;GRIA4;SNAP25;GRIA2;SLC1A3;NRXN1;CACNB4;AMPH;GRID2;GRIN2B;GRM5;GLRB;CHRM2;KCND2;SYN2;DLGAP2;MBP;GABRA2;DLG4;PTPRN2;NLGN2;SLC6A1;SHISA6;CACNA1B;GLRA3;CAMK4;GRID1;CHRM3;GABRG2;GLRA1;GABBR2;AKAP9;NLGN1;SYN1;KCNA1;PRKACA;BRSK1;HTR4;RIT2;NRXN2;PRKAR1B;APBA1;DLG1;UNC13C;CAMK1;BSN;STXBP1;HTR7;SNPH;FCHSD2;UNC13B;VAMP2;GRIK4;SLC12A6;LRP6;KIF5A;ERC2;GABRA5;STX1A;SLC12A4;NOVA1;GABRG3;DVL1;HCRTR2
prerank,cellular protein localization (GO:0034613),0.3049363417599869,1.2185777705881118,0.09360189573459715,0.9508023520868485,1.0,62/285,13.52%,RTP3;REEP1;ARF5;RAP2A;TM9SF2;ARL5C;ARL4D;TM9SF3;EVI5L;RAB5C;TBC1D30;TBC1D8;ITSN1;SNX8;VPS29;TBC1D9;TMED4;VPS26A;SEC23IP;RAB43;CNTNAP2;TBC1D10B;TRAPPC8;LAMTOR1;USP6NL;RIC3;TBC1D4;RAB6B;NAPA;TMED5;IFT22;RABGAP1L;SNX17;HEY2;RAB6A;TMED10;RAB14;WNT5A;ACD;DNAJC27;TBC1D12;SNX1;ESAM;ARL5B;ARF1;RAB1A;ZDHHC15;CELSR1;TBC1D25;KIF13A;TMED7;DMD;SCFD1;RAB5B;RAB22A;ADPRH;ARCN1;TBC1D14;RRAGC;YWHAH;RABGAP1;COG3
prerank,V(D)J recombination (GO:0033151),0.5366958033188051,1.2172383706734573,0.2439516129032258,0.9543531278985234,1.0,4/11,16.75%,DCAF1;TCF3;XRCC4;PRKDC
prerank,establishment of spindle localization (GO:0051293),0.5066885369566475,1.2171296851593614,0.22326454033771106,0.9525874342322794,1.0,6/14,17.19%,CLASP2;CFL1;MAP4;ZBED3;KPNB1;CLASP1
prerank,negative regulation of axonogenesis (GO:0050771),-0.3926367592753324,-1.2170491029485366,0.19607843137254902,0.59950801433016,1.0,5/27,4.24%,MAP2;DCC;ULK2;PTPRS;RHOA
prerank,leukocyte cell-cell adhesion (GO:0007159),0.44964958723631543,1.2168502210361398,0.2113144758735441,0.9514910002833044,1.0,5/24,7.28%,PECAM1;SELP;ICAM1;SYK;F11R
prerank,positive regulation of rRNA processing (GO:2000234),-0.527064617804069,-1.2164858675098218,0.2318840579710145,0.60001142219649,1.0,6/10,25.26%,RIOK1;RIOK2;WDR43;SIRT7;UTP15;BUD23
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.4401829396745774,-1.2164514885127076,0.19213973799126638,0.599016684016238,1.0,5/18,14.69%,ATP1A2;CAB39;BIN1;CAMK2D;COMMD1
prerank,histone H2A ubiquitination (GO:0033522),-0.45432073308346865,-1.216409018087808,0.2360097323600973,0.5980787407345337,1.0,11/17,32.68%,DDB1;DDB2;RNF168;RNF8;BCOR;DTX3L;UBR2;UBE2B;KDM2B;RING1;TRIM37
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.4930917133949908,1.2159301233735624,0.24531835205992508,0.9533020000000895,1.0,3/14,10.12%,NCBP1;CPSF4;CPSF6
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.482018019713387,-1.2155683938022823,0.208067940552017,0.5982679800552919,1.0,3/12,2.15%,IGF1;AKAP6;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.482018019713387,-1.2155683938022823,0.208067940552017,0.5982679800552919,1.0,3/12,2.15%,IGF1;AKAP6;CAMTA1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.325717942975483,1.2154626774472055,0.12685560053981107,0.9531075517668428,1.0,31/151,16.60%,PCSK1;GPHN;CERS1;MOCS3;ACER2;CERS4;PRKD2;LPCAT2;APOE;SGMS1;KDSR;ELOVL6;LPCAT3;GPAT4;PLPP1;SLC44A1;SGPP2;DMD;SLC25A2;HACD2;ACER3;PAM;CEPT1;SGPP1;GCH1;CSNK2A2;SPNS2;CERT1;AKR1A1;PPM1L;SLC44A2
prerank,mitochondrial translational elongation (GO:0070125),0.3466149514659225,1.2152720680933238,0.145985401459854,0.9517345841247443,1.0,14/88,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;MRPL18;MRPL38;MRPS12;MRPL20;TSFM;MRPL52;MRPS15;MRPS24;MRPL48
prerank,nitric oxide biosynthetic process (GO:0006809),0.5006725244798758,1.21514515501259,0.24344569288389514,0.9499787095286657,1.0,4/13,14.25%,SPR;CYP1B1;NOS3;GCH1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5412520631024034,-1.215122596482833,0.19238476953907815,0.5984231394737354,1.0,6/10,20.30%,ATP1A2;OSR1;HECW1;CAMK2D;HECW2;NEDD4
prerank,spermatid development (GO:0007286),0.42625689668918965,1.2148998498028578,0.20481927710843373,0.9488585810403406,1.0,4/32,10.35%,SOX30;CIB1;CDYL;ING2
prerank,protein localization to synapse (GO:0035418),-0.4967389691422998,-1.2139503920319308,0.22929936305732485,0.6008122337423489,1.0,7/12,13.66%,NRXN1;PCLO;DLG4;NLGN2;NLGN1;NRXN2;BSN
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.45500969145787046,-1.2138058625367794,0.22608695652173913,0.6001451079245264,1.0,9/16,19.26%,KMT2A;AUTS2;CTNNB1;SMAD4;PAXIP1;SNW1;KDM1A;BCOR;DNMT1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4269609914438457,1.2137495196217578,0.21164021164021163,0.9516063652774743,1.0,4/30,4.40%,RAC2;GSK3A;SAE1;VPS11
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.44828988632735833,-1.2132223801134694,0.21365638766519823,0.6007717374363227,1.0,2/17,2.50%,ANK2;SNTA1
prerank,positive regulation of histone acetylation (GO:0035066),0.4358163046531537,1.2124660819464714,0.20982986767485823,0.9550529796526229,1.0,4/23,3.78%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5
prerank,cholesterol biosynthetic process (GO:0006695),0.41933044364494754,1.2120023837723892,0.21112929623567922,0.9548402139425983,1.0,8/31,11.99%,EBP;INSIG1;HMGCR;PLPP6;SC5D;IDI1;NSDHL;LSS
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.44911679278237326,1.2113718765752821,0.22625215889464595,0.955423492822803,1.0,6/20,10.80%,SMAD1;EP300;CARF;NOTCH1;RELA;RBPJ
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.28285469067413244,-1.2108728248240286,0.06870229007633588,0.6061927344403267,1.0,44/152,12.99%,RNF220;FGFR2;LRRK1;SULF1;WLS;EGFR;COL1A1;LGR4;ADGRA2;WNT5B;TBL1XR1;SMURF2;ZEB2;WNK1;PTK7;MACF1;SULF2;PPM1B;VCP;GPC3;SKI;CDC73;PSMD4;PSMA2;CSNK1E;UBR5;GPC5;RSPO3;PSMA6;SALL1;CSNK1G2;XIAP;NFKB1;PSMD13;PSMA1;TBL1X;ILK;PSMF1;DISC1;PSME4;DAAM2;PPM1A;ATP6V0C;USP34
prerank,negative regulation of secretion by cell (GO:1903531),0.39641516473184685,1.210775164585664,0.20616883116883117,0.9558690505521084,1.0,7/38,10.01%,PNKD;HMGCR;APOE;TNFRSF1B;GRM7;NOTCH1;RHBDF2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.5079353294050433,1.210675851545117,0.26045627376425856,0.9540878580141847,1.0,5/13,18.08%,HEY1;HEY2;DDIT3;TAF1;SIN3A
prerank,regulation of neuron projection arborization (GO:0150011),-0.4655957754388236,-1.2105869597345906,0.2296137339055794,0.6059229597333572,1.0,7/15,17.26%,NTNG1;DLG4;MACF1;DVL3;GRIP1;FZD4;DVL1
prerank,sympathetic nervous system development (GO:0048485),-0.46432734712730195,-1.2102322969656802,0.23076923076923078,0.6058997656994091,1.0,4/15,9.78%,NRP1;CTNNB1;SEMA3A;NRP2
prerank,negative regulation of cell motility (GO:2000146),-0.2978287161382104,-1.2097308468176422,0.1070110701107011,0.6061901684741389,1.0,12/108,4.07%,MAGI2;NAV3;SPOCK3;LDLRAD4;TMEFF2;SULF1;ROBO1;DPYSL3;IGFBP5;FBLN1;CLIC4;TPM1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5237620740870875,1.2095478814608425,0.23809523809523808,0.9566951959833008,1.0,3/11,9.69%,HIPK2;ING4;TFAP4
prerank,body fluid secretion (GO:0007589),-0.45869383766828337,-1.2093321360654836,0.22270742358078602,0.6061906566478381,1.0,5/15,22.28%,ERBB4;SLC22A4;NPR1;PRLR;VEGFA
prerank,cellular response to chemical stress (GO:0062197),0.3378141103992498,1.209257638058391,0.15492957746478872,0.9557394607222939,1.0,17/96,11.74%,CHCHD2;PRR5L;TXNRD2;SLC25A24;SOD1;EIF2S1;CYCS;STOX1;ZFAND1;LONP1;GPX7;TRPV4;SOD2;PARK7;PRKAA2;DDX3X;ATG7
prerank,protein K11-linked ubiquitination (GO:0070979),0.4351664730095498,1.209019879076866,0.22759856630824374,0.9545895503383373,1.0,11/27,21.30%,ANAPC2;ANAPC13;ANAPC7;ANAPC11;ANAPC10;ANAPC4;UBE2H;CDC26;UBE2D3;UBE2L3;UBE2A
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2971664951166724,-1.208747471500484,0.0989399293286219,0.6067919212256118,1.0,32/101,19.76%,PLD1;SAMD4A;OGT;CYFIP2;VIM;FBXW11;VGLL4;BTRC;IST1;POLDIP3;PRR16;EIF3C;YTHDF1;EZR;NIBAN1;THBS1;EEF2;RBM3;ASPSCR1;TBC1D10A;DACT1;PLXNB2;TGFB1;METTL5;NAT10;PCIF1;UPF3A;MSN;RPS6KB1;CIRBP;STUB1;AGTR1
prerank,protein deacetylation (GO:0006476),-0.3583577556551959,-1.208505556683869,0.19289340101522842,0.6064035277162035,1.0,14/41,12.62%,PRDM5;MIER1;HDAC4;TBL1XR1;HDAC1;FLNA;SIRT2;MORF4L2;MTA3;MIDEAS;MORF4L1;MTA1;TBL1X;RCOR3
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3163846197008055,-1.2079993499773367,0.1323529411764706,0.6068306804215079,1.0,32/72,26.67%,RIMS1;NRXN1;GRIN2B;TSHZ3;ADCY1;DLG4;NLGN2;PRKCZ;RELN;CLSTN2;NLGN1;SLC24A2;LGMN;EPHB2;CACNG7;VAMP2;CACNG4;SHANK2;CACNG2;NFATC4;KCTD13;CLSTN3;FLOT1;ADRA1A;ADCY8;GRIN2D;NLGN3;CACNG3;MPP2;CACNG8;CHRNA7;STX1B
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4054325226736816,1.2079419390182207,0.23825503355704697,0.9571110641437605,1.0,11/35,15.57%,CBL;PPT1;SGIP1;HNRNPK;B2M;ARF1;PICALM;SMAP1;LDLRAP1;BMP2K;ARF6
prerank,regulation of response to external stimulus (GO:0032101),0.33426259939868,1.2077964224465858,0.13580246913580246,0.9555305053111667,1.0,21/121,12.57%,LRP8;SAG;PIK3AP1;IL1R1;SEMA7A;FCGR2B;TIRAP;BCL6B;BIRC2;SBNO2;SPATA2;METAP2;CYRIB;WNT5A;TRAF3;RELA;PARK7;METAP1;NLRP6;USP18;CD55
prerank,cellular response to glucose starvation (GO:0042149),-0.35352641412630836,-1.207062804086773,0.15915119363395225,0.6084814193347717,1.0,21/41,31.62%,PRKAG2;CPEB4;PRKAG1;PIK3C3;SIK1;BRSK1;HNRNPA1;TP53;SZT2;ITFG2;ATF4;IMPACT;EIF2AK3;SESN2;PICK1;ZC3H12A;FOXO3;MYBBP1A;PRKAG3;TBL2;PRKAA1
prerank,positive regulation of histone modification (GO:0031058),0.4028503776057829,1.2069998275095148,0.2131979695431472,0.9569256817406647,1.0,8/33,11.22%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5;CHTOP;AKAP8L;ING2;CTBP1
prerank,pyruvate metabolic process (GO:0006090),0.3791841015543661,1.2067933245270204,0.1871069182389937,0.9557048427938729,1.0,5/52,5.68%,PCK1;ENO4;BSG;ME3;TPI1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.29545400089848944,1.2064960085437866,0.08490566037735849,0.9548780458904512,1.0,90/327,19.29%,TBX4;ONECUT1;TRAPPC2;FOXN2;EZH2;ZFAT;HES6;GTF2IRD1;RPS6KA4;ATXN1L;RPS6KA5;PPP2CA;SBNO2;MYBL2;SMARCA2;SOX2;SPIN1;EP300;RFX3;NFX1;MED23;TGFBRAP1;SRSF10;ACTR8;CDK11B;ZNF205;SFPQ;ACTN4;ACTR5;DRAP1;CLOCK;PFDN5;NOTCH1;SOX13;ACVRL1;RELA;NAB2;RNF6;UBE2V1;RYBP;ING2;CCAR2;ESR1;NLK;HP1BP3;CREBBP;CARM1;JMJD1C;SP1;MZF1;IRF2;CHD3;ERC1;NUP35;TRRAP;CHEK2;DDIT3;ZKSCAN5;HCFC1;YBX1;RNF20;BAZ2A;NSD2;BACH1;FUS;TERF2IP;TFEB;TAF6L;APBB2;TCF7L1;TCF3;SOX17;WTIP;MYT1;CALR;NONO;ZNF219;INSR;STAT3;FOXK2;PATZ1;ZSCAN21;NCOA2;HINT1;YAF2;ATRX;MSL3;TCF7;MYBL1;ACVR2B
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4103797790919126,-1.2053997205525304,0.19047619047619047,0.6121347569460324,1.0,5/23,7.08%,TGFBR3;SMAD3;SMURF2;SMAD4;DKK3
prerank,nitric oxide metabolic process (GO:0046209),0.4955799878472088,1.2051045862054672,0.2681992337164751,0.9586300553972027,1.0,4/14,14.25%,SPR;CYP1B1;NOS3;GCH1
prerank,I-kappaB phosphorylation (GO:0007252),0.5422888364609555,1.2050878885407366,0.26879699248120303,0.9565332076346985,1.0,3/10,12.87%,MAP3K7;ERC1;CHUK
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.32278334128051334,1.2050453451883882,0.12137203166226913,0.9545505017558616,1.0,38/173,13.84%,BCAP29;DYNC1I1;TRAPPC2;MIA2;SPTB;CAPZA2;CNIH1;LMAN2;TMED4;COG5;DCTN2;GOPC;COPG2;TRAPPC8;TMEM115;GOSR2;F8;TRIP11;NAPA;TMED5;KDELR2;TMED10;DCTN3;RAB1A;NRBP1;TRAPPC11;DYNLL1;HYOU1;TMED7;SCFD1;TRAPPC6B;MCFD2;ARCN1;CD55;COPG1;CUL3;COG3;PROC
prerank,plasma membrane repair (GO:0001778),-0.477792037252499,-1.2049497236737288,0.21906693711967545,0.6122637627797973,1.0,9/13,37.41%,MYOF;AHNAK2;SYT11;SYT7;ANXA6;SYTL4;SMPD1;RAB3A;ARL8B
prerank,positive regulation of protein secretion (GO:0050714),-0.31728934771363815,-1.204187864530006,0.14457831325301204,0.6134128153940307,1.0,27/69,28.08%,BMP6;IGF1;WLS;MCU;NLGN2;GLUD1;RBP4;EZR;PPID;TM7SF3;NNAT;UNC13B;PSMD9;EXOC1;TGFB1;PTPN23;TCF7L2;C1QTNF3;TGFB3;IER3IP1;CAPN10;APBB1;SYTL4;PPIA;AACS;LRRC8A;MYOM1
prerank,negative regulation of nervous system development (GO:0051961),-0.44517046698090534,-1.204187054764394,0.2211764705882353,0.6123404153671181,1.0,3/17,5.92%,ROBO2;APPL2;SORL1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3127680678419173,-1.2035569643925808,0.13095238095238096,0.6130074620398162,1.0,12/74,4.04%,LDLRAD4;PHLDB2;DAB2;COL1A1;SMAD3;PHLDB1;TGFBR1;TGFBR2;BMP5;CTNNB1;PDPN;SMAD4
prerank,dendritic cell chemotaxis (GO:0002407),0.4898862146753008,1.2035191339461566,0.23495145631067962,0.958810334466139,1.0,2/14,10.53%,PIK3CG;TRPM4
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5084152091593089,-1.2025652268662381,0.23275862068965517,0.6147701396885082,1.0,6/11,20.61%,PARP4;PARP14;PARP6;PARP3;PARP12;PARP16
prerank,T cell differentiation (GO:0030217),0.3914198478042534,1.2021720522793664,0.1927512355848435,0.9624298792163326,1.0,8/40,11.50%,JAG2;PTPRC;ZFP36L1;GPR89B;GPR89A;SOX13;LFNG;PIK3CD
prerank,negative regulation of viral process (GO:0048525),0.3721941634092043,1.2018569449190486,0.18799368088467613,0.9615726241193246,1.0,10/57,10.59%,ILF3;BANF1;TRIM28;IFITM2;IFIT1;TRIM8;TRIM14;IFITM3;IFITM1;SRPK2
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5049785732935537,1.2015281367428956,0.24900398406374502,0.9608331136782151,1.0,4/13,10.80%,GSK3A;HEY2;NOTCH1;RBPJ
prerank,response to interleukin-4 (GO:0070670),0.5469593402039835,1.2014181442861316,0.26908396946564883,0.9591998435125637,1.0,1/10,2.03%,LEF1
prerank,regulation of neuron migration (GO:2001222),-0.39881980643923354,-1.2013543484381417,0.19675925925925927,0.6171976945095845,1.0,14/26,25.80%,CTNNA2;COL3A1;NTNG1;SHTN1;SEMA3A;NIPBL;ULK4;PLXNB2;RAPGEF2;CX3CL1;NSMF;CAMK2B;CAMK2A;ADGRG1
prerank,sphingolipid biosynthetic process (GO:0030148),0.35353879001843985,1.2007059505754403,0.1724137931034483,0.9602489129476006,1.0,17/71,16.13%,CERS1;ACER2;SMPD4;CERS4;PRKD2;SGMS1;KDSR;ELOVL6;ST8SIA1;PLPP1;SGPP2;HACD2;ACER3;SGPP1;SPNS2;CERT1;PPM1L
prerank,dicarboxylic acid transport (GO:0006835),-0.383196381434603,-1.200638184672808,0.1926829268292683,0.6182162389167271,1.0,9/28,15.91%,SLC1A3;SLC13A3;PDPN;SLC26A7;SLC25A13;SLC25A32;GJA1;SLC22A6;SLC19A1
prerank,regulation of secretion (GO:0051046),-0.4735819372358845,-1.200579931016247,0.22661122661122662,0.6172742293550393,1.0,9/13,38.56%,SGK1;GPLD1;OAS2;KCNQ1;FGF10;POFUT2;EGF;ERBB3;OPRK1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.32411426731748494,1.1995690633634877,0.14979195561719832,0.9629602569378806,1.0,32/125,17.78%,DYNC1I1;EML1;KIF18A;NUDC;PLK2;CLASP2;NEK9;DCTN2;MAP4;CDCA8;CENPC;KIF2A;DYNLL1;BCCIP;MIS12;TNKS;XPO1;KIF3B;NEK6;PTPA;EFHC2;RCC1;DYNC1I2;CLIP1;CENPP;CENPO;SETD2;KPNB1;NUP160;CLASP1;RANGAP1;PAFAH1B1
prerank,regulation of actin filament-based process (GO:0032970),-0.3192917877574345,-1.1992371400512105,0.13392857142857142,0.6200156784881504,1.0,20/70,15.34%,LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;RHOA;ROCK2;PRKCD;ROCK1;EZR;RND3;RHOBTB2;CNN2;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;ARHGEF5;IQGAP2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.37916426476462406,-1.1987783962937875,0.20418848167539266,0.6201720595664086,1.0,5/30,4.49%,DDX5;FOXP1;DAB2;HDAC1;RNF14
prerank,glucose metabolic process (GO:0006006),0.37402705041886675,1.1983162323710863,0.18834080717488788,0.966141413105873,1.0,9/58,8.49%,PCK1;HECTD4;SLC25A1;GOT2;TPI1;PPARD;OMA1;IRS2;GALM
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5285566458940246,1.1980159465997824,0.28982725527831094,0.9651787003153277,1.0,4/12,8.83%,LY6E;IFITM2;IFITM3;IFITM1
prerank,glucose transmembrane transport (GO:1904659),0.45757829365858727,1.1979873294429926,0.24150268336314848,0.9631524347458683,1.0,3/18,8.35%,SORT1;PPARD;SLC2A1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.27452740038080786,-1.1979772025079714,0.07239819004524888,0.6213540235437399,1.0,46/166,19.11%,SORBS1;IGF1;PLD1;SAMD4A;EGFR;SMAD3;PDGFRB;GLI2;LPGAT1;ZEB2;KAT7;VIM;P2RX4;DDB1;PPARGC1A;ATP7A;LDB1;SLC6A9;AKT2;POLDIP3;LDLR;PRR16;EIF3C;YTHDF1;NIBAN1;SMOC2;THBS1;STN1;ARPP19;DDAH1;EEF2;RBM3;BRPF3;SLC27A1;ATAD5;IGF2;PLXNB2;GPLD1;PTPN2;METTL5;SREBF1;NAT10;PCIF1;UPF3A;RPS6KB1;CIRBP
prerank,nuclear pore complex assembly (GO:0051292),-0.5092401143543717,-1.1978886463438436,0.25,0.6205104710005168,1.0,5/10,27.47%,NUP205;AHCTF1;NUP93;TMEM170A;NUP153
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.43945011771876824,1.1975086920630185,0.22259696458684655,0.9630677277608797,1.0,6/24,13.40%,ATF3;ATF6;KLF2;NOTCH1;RBPJ;DDIT3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3744056450366087,-1.1973013313433085,0.20935960591133004,0.6212173198815032,1.0,9/31,14.70%,KANK2;FHL1;RBL2;MYO16;CDC73;BRD7;CDK6;DLG1;DACT1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.31951908073283297,-1.1971170281434216,0.1388888888888889,0.6207107070838738,1.0,32/63,27.24%,GABRB1;SLC1A3;GLRB;GABRA2;ANO3;SLC6A1;SLC12A2;SLC26A2;GLRA3;GABRG2;GLRA1;SLC25A3;ANO1;SLC20A1;ANO6;SLC12A6;GABRA5;SLC12A4;GABRG3;SLC5A6;SLC5A5;GABRA4;SLC12A9;GABRG1;SLC4A8;GABRA1;SLC12A7;SLC25A30;SLC25A11;LRRC8A;SLC12A8;SLC12A5
prerank,negative regulation of transmembrane transport (GO:0034763),0.5407567293342582,1.197060009328397,0.2644135188866799,0.9629214450027964,1.0,3/10,12.75%,RSC1A1;IRS2;CTTNBP2NL
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.4007212986968418,-1.1969911040490604,0.2042755344418052,0.6199946482041199,1.0,7/24,8.19%,ERRFI1;MED1;CBFB;ROCK2;SRSF6;ROCK1;FOXC1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.4288057935118069,-1.1966630324719818,0.2311111111111111,0.6198438689364506,1.0,5/18,4.40%,ST18;JAK1;SMAD4;FER;IL6R
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.28227751033121057,-1.195179086688922,0.11787072243346007,0.6229779434976177,1.0,25/128,10.15%,DDX5;BMP6;TGFBR3;COL1A2;SMAD3;COL3A1;SMURF2;TGFBR1;RGMA;TGFBR2;BMP5;BMP7;SMAD4;RHOA;BMP4;PRKCZ;PXN;APPL2;ITGB5;SKI;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.34402485886006245,-1.1951708226861206,0.16085790884718498,0.6219397827519421,1.0,14/48,14.44%,CUX1;DOCK5;DOCK1;NRP1;FLNA;NEDD9;RREB1;P4HB;CUX2;ILK;IL1RAPL1;OBSL1;MYADM;TRIOBP
prerank,response to ATP (GO:0033198),-0.4292011442546084,-1.1948717918713176,0.24273858921161826,0.621709494273335,1.0,8/18,29.76%,RYR3;P2RX4;ABCC9;SSH1;P2RY12;DGKQ;TRPC3;P2RY1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5552792014776389,1.1941001155443822,0.2781065088757396,0.9735769978491743,1.0,4/10,9.20%,CSGALNACT1;XYLT1;PXYLP1;B3GAT2
prerank,positive regulation of phospholipid transport (GO:2001140),0.5414957514254551,1.1938937575279798,0.2751004016064257,0.9722762876070805,1.0,2/10,5.62%,APOE;DBI
prerank,negative regulation of cell population proliferation (GO:0008285),-0.25338888899688355,-1.1937838712881246,0.032,0.6236776049263987,1.0,83/351,16.87%,MAGI2;ERBB4;ST18;TGFBR3;ALDH1A2;KANK2;CLMN;TNS2;IGFBP5;MCC;FBLN1;NELL1;PTPN14;COL4A3;BMP5;ABI1;CTNNB1;PDPN;MTSS1;ATP8A2;SIRT2;IGFBP7;BMP4;NUPR1;ZBTB7C;LMNA;PDS5B;OGN;APPL2;MYO16;PER2;VGLL4;FRK;PML;PODN;SKI;GSDME;IGFBP6;CDKN1B;RBP4;CDC73;ADAMTS1;SMAD6;NIBAN2;DLG3;CGRRF1;EIF2AK2;BRD7;FAP;CDK6;SPEG;CAMK2N1;DDAH1;TP53;NOX4;STK11;TBX3;WNT9A;P3H3;FKTN;PDCD5;NF2;ROR2;MAGED1;MED25;TOB1;NACC2;PEX2;RAF1;PTPRU;MN1;NGF;GPLD1;SLC16A2;RAPGEF2;TGFB1;RNF139;BMPR1B;CCN3;S100A11;PTPN2;SMYD2;OPRM1
prerank,tRNA processing (GO:0008033),0.36396352719658315,1.193746965376278,0.1834862385321101,0.9707886893620562,1.0,20/61,19.86%,THG1L;THUMPD1;FARS2;CPSF4;TRMT10B;POP5;ANKRD16;PTCD1;WDR4;SSB;TSEN2;NSUN6;CDKAL1;TSEN15;CLP1;NSUN2;TRNT1;FTSJ1;URM1;POP1
prerank,protein modification by small protein removal (GO:0070646),0.30286721606892597,1.1937367653315687,0.11491442542787286,0.9687271659366175,1.0,59/252,14.94%,TOMM20;PSMB10;PSMC4;ABRAXAS1;PSMB6;PSMD8;PSMD5;PSMD12;ACTL6A;MAP3K7;TNFAIP3;ACTB;BIRC2;SMAD1;PSMD11;YOD1;OTUD1;PSMB4;YY1;PSMC1;EP300;ACTR8;SMAD7;ACTR5;DESI2;DESI1;RUVBL1;USP47;TRAF3;MDM2;RAD23A;PSMC2;USP48;USP31;PSMD2;ESR1;OTUD3;USP22;USP15;COPS7B;USP37;NFRKB;USP18;TNIP2;OTUD5;PSMD14;TRRAP;USP33;BRCC3;PSMC6;PSMD1;APC;NFKBIA;PSMB1;HCFC1;USP9X;UCHL5;COPS8;INO80
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.41713395962376537,-1.1934682804455183,0.2336244541484716,0.6235046015066559,1.0,11/21,31.77%,CTNNB1;CSNK1A1;DVL3;FZD2;GSK3B;LRP6;DVL1;AMER1;FZD1;PPP1CA;CAV1
prerank,positive regulation of T cell migration (GO:2000406),0.450597161435845,1.193272386369237,0.25585585585585585,0.9686215618182947,1.0,5/20,15.24%,OXSR1;CXCL12;WNT5A;APP;DOCK8
prerank,presynapse organization (GO:0099172),-0.5124536585752268,-1.1932410122030017,0.24130434782608695,0.6231311617607068,1.0,6/10,27.80%,LRRTM3;NLGN2;NLGN1;DVL1;NLGN3;FZD1
prerank,regulation of phosphatase activity (GO:0010921),0.42708396997322223,1.193093459457979,0.22280701754385965,0.9673606377425664,1.0,5/24,14.98%,PPP1R36;TIPRL;TSC1;PTPA;PPP6R1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.31078843668856626,1.1927858272767005,0.13127413127413126,0.9665420789813414,1.0,30/198,12.18%,NUDT14;MAPK3;PIK3CG;PPIP5K2;NUDT11;PTPRC;PPP3CB;PNKP;PTPRB;DUSP12;NUDT5;PANK2;ACYP1;PLAAT3;CERKL;PXYLP1;PLPP1;PLCG1;INPP5D;PLCB1;PAK1;GPI;PGP;PFKFB3;PI4KA;PIK3CD;PPP3CA;INPP4B;IP6K2;PLAA
prerank,histone acetylation (GO:0016573),0.3553733849874241,1.1927809301277266,0.19369369369369369,0.9644761168723458,1.0,16/69,14.00%,JADE3;ACTL6A;LEF1;MAP3K7;RUVBL2;DMAP1;ING4;BEND3;EP300;RUVBL1;YEATS4;ING3;CREBBP;TRRAP;ING5;DR1
prerank,protein oxidation (GO:0018158),-0.4926647185129703,-1.191925629658099,0.23789473684210527,0.6257252580076836,1.0,5/11,25.70%,LOXL1;SUMF1;LOXL3;LOX;PRDX3
prerank,negative regulation of axon extension (GO:0030517),0.41662559444142216,1.1918162909041545,0.25127334465195245,0.966349948245772,1.0,8/30,9.79%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;DIP2B;SEMA6B;SEMA4C;RNF6
prerank,sulfate transport (GO:0008272),-0.4633952908888403,-1.1916210318867322,0.2420814479638009,0.6255229642682572,1.0,6/14,26.04%,SLC26A7;SLC13A4;SLC26A2;SLC26A11;SLC25A30;SLC25A11
prerank,pharyngeal system development (GO:0060037),-0.4555834212111504,-1.191200509917691,0.22657952069716775,0.6256032656110517,1.0,4/15,4.74%,TGFBR1;BMP5;BMP7;BMP4
prerank,nucleic acid metabolic process (GO:0090304),0.3572497329331468,1.191124219861536,0.1875,0.967316258475942,1.0,13/69,11.65%,POLR2J;NCBP1;POLR2B;HNRNPH2;DDX54;PCBP1;HNRNPK;HNRNPC;XRN2;DXO;EXD2;DUSP11;PTBP1
prerank,negative regulation of reproductive process (GO:2000242),-0.441566589349094,-1.1908825175524893,0.2549889135254989,0.6254360860876832,1.0,2/17,0.63%,IGF1;SULF1
prerank,retinal metabolic process (GO:0042574),0.5142878712323828,1.1907455828799625,0.25190839694656486,0.9667955433573955,1.0,4/12,14.01%,RDH13;RDH11;CYP1B1;RDH10
prerank,myoblast fusion (GO:0007520),-0.4897195894902412,-1.1900711325354272,0.2588726513569937,0.6267369555186106,1.0,3/12,6.00%,ADGRB3;ADAM12;ADAMTS5
prerank,mitochondrion morphogenesis (GO:0070584),-0.4951816191904286,-1.1899919299749053,0.27292576419213976,0.6258880415916271,1.0,3/11,7.72%,PID1;WASF1;FIS1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5336705926942535,1.188936313255153,0.27565392354124746,0.9724431354691433,1.0,4/10,11.27%,SHANK3;NETO1;NPTN;APP
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.42991916216629267,1.1888922874900665,0.25663716814159293,0.9705537187818725,1.0,6/23,13.09%,TIMM29;ROMO1;BAD;MAIP1;BMF;NDUFA13
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.49948781226949296,1.188871690461931,0.24618320610687022,0.9685754255761484,1.0,3/13,6.39%,PRPF31;PRPF3;SRSF10
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5173607610830572,-1.1887855084635905,0.28085106382978725,0.6281430904625075,1.0,5/10,22.55%,ZEB2;ATP7A;CTNS;RAPGEF2;APPL1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.37918111818876266,-1.1885546005918852,0.21212121212121213,0.6277687834285682,1.0,10/30,16.57%,ANK3;VAMP5;MACF1;RAB31;GGA2;OPTN;VAMP2;BBS2;GOLGA7;GGA3
prerank,peroxisome organization (GO:0007031),0.4249769513797353,1.1884503449772301,0.24733096085409254,0.9682402452286213,1.0,8/25,17.11%,PEX11G;PLAAT3;PEX1;PEX7;TMEM135;ACOT8;DNM1L;LONP2
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.3425582010978832,-1.1884314900106348,0.17661691542288557,0.6270902284045577,1.0,13/45,8.36%,SMAD3;BRINP1;TOM1L2;CTNNB1;BMP7;ZWINT;BMP4;TRIM35;PTPN3;CDKN1B;GAS1;FOXC1;BRINP2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4121288567260853,1.1882672036438509,0.23027375201288244,0.9668987971748768,1.0,9/31,16.30%,LRP8;SHANK3;CFL1;TANC2;EFNA1;ZDHHC15;PPFIA2;CAPRIN1;ABI2
prerank,endochondral bone morphogenesis (GO:0060350),-0.4953332322997942,-1.1882082840810928,0.2693877551020408,0.6267565715965239,1.0,6/11,19.91%,BMP4;COL13A1;FOXC1;INPPL1;BMPR1B;BMPR2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.2828226929471369,-1.1881193034068862,0.09157509157509157,0.625959784123243,1.0,34/122,19.11%,SORBS1;IGF1;PLD1;SAMD4A;EGFR;PDGFRB;GLI2;KAT7;VIM;LDB1;SLC6A9;AKT2;POLDIP3;PRR16;EIF3C;YTHDF1;NIBAN1;SMOC2;THBS1;STN1;NFKB1;EEF2;RBM3;BRPF3;IL33;ATAD5;IGF2;PLXNB2;METTL5;NAT10;PCIF1;UPF3A;RPS6KB1;CIRBP
prerank,DNA recombination (GO:0006310),-0.35941723630697586,-1.1880551328037088,0.1953727506426735,0.6250962128226097,1.0,19/37,33.54%,TSN;RAD50;MRE11;RPA1;RAD51D;MSH2;BLM;SUPV3L1;RECQL;RTEL1;DMC1;RAD21;RPAIN;RHNO1;RAD54B;RAD51C;IGHMBP2;ERCC1;HMGB1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.38661901558064704,-1.1875800785893713,0.215311004784689,0.6252976548845408,1.0,8/27,15.63%,ANK2;CTNNA3;CACNA1C;AKAP9;CAMK2D;SRI;DLG1;PDE4B
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5164741666858297,-1.1873282143688304,0.2593320235756385,0.6248980997499448,1.0,6/10,37.92%,ERRFI1;ENPP1;IMPACT;CAV1;CHP1;TESK1
prerank,cellular response to lipid (GO:0071396),-0.2640964737858925,-1.1872693102331815,0.10952380952380952,0.6240386884044156,1.0,46/191,18.85%,ATP1A2;EGFR;ADCY5;TFPI;PABPN1;ADCY2;WNT5B;BRINP1;ADCY1;MAPK14;PID1;AXL;PTK7;VIM;RHOA;MED1;ROCK2;LBP;IRAK1;ATP1A1;CDC73;BRINP2;SNW1;TRIM41;NFKB1;EPHA3;NCOA4;SIRPA;WNT9A;ATM;RORA;SETX;PAF1;PDE4B;GPLD1;SPP1;SELENOS;UPF1;DEFA6;ABL2;NR3C1;FZD4;TWF2;ATP1A3;MSN;CHMP5
prerank,antibacterial humoral response (GO:0019731),0.47576290933796855,1.1866643846416562,0.2570356472795497,0.9716271910970158,1.0,2/16,4.64%,DMBT1;RNASE6
prerank,granulocyte chemotaxis (GO:0071621),0.3692813944521295,1.1864864188201312,0.2140625,0.9703246224446697,1.0,7/55,11.50%,PIK3CG;BSG;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,positive regulation of GTPase activity (GO:0043547),0.30607633373575127,1.185939252124788,0.14157014157014158,0.9707405243365294,1.0,46/188,15.63%,EZH2;PIN1;TIAM1;EVI5L;ARHGEF26;TBC1D30;BCAR3;TBC1D8;RALGAPA2;RGS8;TBC1D9;ARHGAP25;TBC1D10B;USP6NL;ARHGEF7;TBC1D4;RALGAPB;RAPGEF3;F11R;RABGAP1L;RGS10;RAP1GDS1;CCL25;RAPGEF6;DOCK9;ITGA6;TBC1D12;TSC1;RAB11FIP2;TBC1D25;DOCK7;RHOG;PICALM;NF1;AGRN;ADPRH;MAP4K4;LARS1;TBC1D14;RABGAP1;RALGAPA1;SYDE1;ARHGEF10;DOCK8;RAB3GAP1;CDKL5
prerank,regulation of cellular component size (GO:0032535),0.4162051792748612,1.1857076239536248,0.2465277777777778,0.9696558673246654,1.0,8/30,14.38%,PEX11G;VAV3;RPTOR;HP1BP3;RAB22A;PICALM;LARS1;AP2M1
prerank,cellular response to nitrogen compound (GO:1901699),-0.4182874494211415,-1.1853180723992047,0.2300469483568075,0.6283119159874024,1.0,13/20,39.90%,SPIDR;ROCK2;HSF1;DDI2;RTF2;RIOK3;BLM;DDX11;NSMCE3;ATP2B4;PDE12;TIMELESS;NR1H4
prerank,natural killer cell mediated immunity (GO:0002228),0.4778650691018185,1.1851478024685034,0.25430210325047803,0.9699701879467257,1.0,2/15,6.48%,TUBB;CEBPG
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.41707589761100233,1.1850308589381455,0.22530329289428075,0.9684628076812618,1.0,7/29,11.62%,ACSL5;SLC25A1;PPT1;HSD17B12;ELOVL6;ACSL4;HACD2
prerank,negative regulation of lyase activity (GO:0051350),0.47666298524588735,1.184582356010371,0.2658959537572254,0.9683198855448476,1.0,4/16,14.82%,PHPT1;EDNRB;PALM;GRM3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.40933506156043575,1.1845576420206418,0.23076923076923078,0.966414131176373,1.0,9/33,15.25%,TNFAIP3;RAMP2;TEK;WFS1;KRIT1;ICAM1;TNIP2;CDH5;GAS6
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.5208939779601557,-1.1844791922028919,0.25656565656565655,0.6295693536396358,1.0,5/10,32.26%,APPL2;RAB31;ANO6;NCKAP1L;CD300A
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.258343144258743,-1.1843651477942256,0.043243243243243246,0.6288774329418997,1.0,80/260,20.08%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;NRP1;MTSS1;RILPL1;FLNA;PIBF1;IFT81;KIT;DZIP1;TTC8;WDR35;DYNC2I1;RAB8B;VCL;DCDC2;PIP5K1A;SHTN1;NUDCD3;CCDC66;CCDC57;CFAP20;EXOC6;TTC39C;IFT46;IFT52;ACTR3;CEP89;EZR;SPATA13;CEP126;IFT172;CEP20;ABLIM2;FGD1;ACTN2;IFT74;CFAP44;RP2;EMP1;ARL13B;DISC1;TTBK2;ABLIM3;KIF3A;DZIP1L;BBS9;RAB11A;WDR19;WDR11;ANO6;FGD4;INTU;RAB23;BBS2;PTPRO;CYS1;ARF4;EXOC7;EXOC1;RAPGEF2;PTPN23;CEP250;EHD1;RAB8A;EHD3;DYNLL2;ACTR2;IFT20;SNAP29;ARFIP2;BBS5;TMEM237;CCDC28B;TTLL3;ARHGEF4
prerank,motile cilium assembly (GO:0044458),-0.4891617096929857,-1.1838893604061553,0.2689243027888446,0.6291115018368091,1.0,5/12,27.78%,SPATA6;BBOF1;BBS5;CCDC39;E2F4
prerank,triglyceride homeostasis (GO:0070328),0.42663270052478797,1.183742985164032,0.23404255319148937,0.9677460080553519,1.0,5/26,11.85%,FITM2;APOE;SIRT1;PNPLA8;SCARB1
prerank,regulation of double-strand break repair (GO:2000779),-0.35043924653692676,-1.1835015868988177,0.18548387096774194,0.6291892511927795,1.0,11/39,17.13%,SPIRE1;SPIDR;FMN2;DEK;PML;UBR5;MGMT;RNF169;KDM1A;SIRT7;ACTR2
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.3353298016474234,-1.1824466794672002,0.1813186813186813,0.6310878142762347,1.0,14/51,10.98%,FBN1;FSTL1;NBL1;BMPER;SMURF2;SMAD4;VWC2L;CRIM1;SORL1;SKI;HTRA3;SMAD6;SPART;GREM2
prerank,regulation of cell adhesion (GO:0030155),0.32570734542113144,1.1824095618517394,0.17403314917127072,0.9714616969867563,1.0,19/129,10.04%,PRKX;RAC2;FRMD5;PIK3CG;PTPRJ;CXCL12;SRC;PRKD2;CD164;PPP2CA;RIPOR2;RET;MINK1;EFNA1;ACVRL1;PLXNA4;LYN;PODXL;PPP1R12A
prerank,cellular protein metabolic process (GO:0044267),0.2900479798565925,1.1823488814153442,0.11252900232018562,0.9697197423654855,1.0,104/396,18.73%,RPL30;DMBT1;MRPS33;RSL24D1;EEF1A1;MRPL23;RPL17;RPL23;MRPL24;PSEN2;RPL31;RPL3;RPS21;MRPL18;DUSP12;CDH2;SEC11A;APOE;RPL35A;WFS1;PDIA6;VWA1;UBE2I;FBXW2;RPS14;RPL8;YARS2;RPL5;ABCF1;CSNK1G3;SPCS3;MRPS12;RPS12;HBS1L;NAPSA;RPS26;RPL37A;SPPL3;HARS1;OMA1;RPL4;MAGEC2;SLC35A1;RPLP0;PIGH;FBXO11;RPS28;UBE2M;ICMT;MBTPS1;RPS24;YES1;RPS9;RPS23;RPL24;RPL34;APP;RPS11;MRPL52;RPS3;PLAT;ST3GAL6;MRPS15;ADPRH;DHPS;CHEK2;ST3GAL1;RPS15A;SPCS2;RPL23A;RPL21;RPL35;PROC;MSRA;QPCT;UBE2G1;FBXO22;GAS6;APH1A;NTAQ1;CALU;HARS2;PRKDC;WARS1;YME1L1;LCMT1;MELTF;PRSS23;RPL19;RPL38;CKAP4;RPL36;RPSA;SEPHS1;MGAT4A;RPL26;RPS8;RPL15;RPL10;MIA3;UBE2D3;MSRB3;RPL32;RPS2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4134320417455285,1.1822948811984773,0.23214285714285715,0.9679680584761969,1.0,9/29,11.12%,GPAM;SRARP;VPS11;CNOT2;AXIN1;PAK1;WBP2;ESR1;CARM1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.45458203864063496,1.1821852238265347,0.2697841726618705,0.9645163565077329,1.0,3/19,8.57%,POLR2J;POLR2B;ACD
prerank,regulation of DNA recombination at telomere (GO:0072695),0.45458203864063496,1.1821852238265347,0.2697841726618705,0.9645163565077329,1.0,3/19,8.57%,POLR2J;POLR2B;ACD
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3425706770383973,1.1812763822474917,0.1925373134328358,0.9663352152159711,1.0,18/85,9.79%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TIAM1;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;DAAM1;WNT5A;PSMC2;FZD3;PSMD2;CELSR1
prerank,sensory perception (GO:0007600),-0.3365339185245232,-1.1808128734050705,0.19553072625698323,0.6346635378712194,1.0,14/45,26.64%,PCDH15;ADGRV1;P2RX4;TTC8;GNAL;WHRN;PTGES;OPRM1;KCNA2;TMEM150C;ADORA2A;NIPSNAP1;CHRNA7;TRPV2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5076387925490216,-1.1807949777967883,0.25267665952890794,0.6336925383411256,1.0,7/10,39.45%,GALNT13;POGLUT3;POGLUT2;GALNT2;GALNT1;GALNT3;MGAT5B
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.43079122411367426,1.1804630279437422,0.25309734513274335,0.9677265249307858,1.0,6/24,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,neurotransmitter transport (GO:0006836),-0.3034591396911445,-1.1798327234724766,0.17532467532467533,0.6354089374086563,1.0,19/73,14.03%,ATP1A2;RIMS1;SNAP25;SLC1A3;NRXN1;SYN2;GABRA2;PTPRN2;PPFIA1;GLUL;SYN1;BRSK1;NRXN2;APBA1;STXBP1;SNPH;UNC13B;SLC6A15;VAMP2
prerank,apical protein localization (GO:0045176),0.528133962947976,1.1797052699941533,0.29282868525896416,0.9689854354010324,1.0,4/10,9.79%,ACTB;MAL;GOPC;CELSR1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.44635157336192344,-1.1793579056105215,0.27370689655172414,0.6357164526669188,1.0,10/15,33.68%,TAFA1;CTNNB1;SMARCD3;DISC1;KDM1A;CX3CL1;VEGFA;CX3CR1;DRD2;PTN
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.48043484586462487,1.1786485759160508,0.2546816479400749,0.9713566862880865,1.0,3/15,5.04%,SH3D19;APOE;TNFRSF1B
prerank,positive regulation of protein ubiquitination (GO:0031398),0.342098006953187,1.17844258001915,0.2145985401459854,0.9702167629250574,1.0,15/80,9.54%,GSK3A;TRIB3;PIN1;DCUN1D4;BIRC2;HDAC3;UBE3A;WFS1;PTTG1IP;SMAD7;BMI1;AXIN1;MAGEC2;SPRTN;MYCBP2
prerank,protein polyubiquitination (GO:0000209),0.2934250481491355,1.1784071567350076,0.13516746411483255,0.9683777952661122,1.0,73/297,16.67%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ARIH1;ANAPC2;KLHL3;TNFAIP3;SPOP;RFFL;BIRC2;PSMD11;NEDD4L;ANKRD39;NHLRC1;RBBP6;PSMB4;FBXL5;UBE3A;ANAPC13;TRIM14;PSMC1;FBXW2;TRAF5;RNF187;LMO7;UBE2V2;FBXO32;TTC3;AKTIP;FBXO11;TRAF3;ANAPC7;RBCK1;MDM2;PSMC2;UBE3D;PSMD2;RNF6;ZNRF1;FBXO7;UBE2V1;CHFR;ANAPC11;TNKS;IFI27;ANAPC10;ANAPC4;CUL3;PSMD14;UBE2R2;RNF146;RNF216;PSMC6;PSMD1;PSMB1;TRIM27;RNF20;TRIM3;NHLRC3;UBE2G1;FBXO22;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF125;UBE2H;PSMA4;FBXL20
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3278216909821185,-1.1783614181926556,0.15864022662889518,0.6374441797860589,1.0,22/51,24.20%,LPAR1;NRP1;ARHGEF10L;CCN2;TGFBR1;TPM1;RHOA;PXN;ROCK2;PPM1E;SYNPO2;FHOD1;NF2;ARHGEF5;CDC42;CX3CL1;PPM1F;PFN2;ARHGEF15;RHOC;ITGB1BP1;TGFB3
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.47595198230169267,1.1783338017390255,0.2764378478664193,0.9667089310938523,1.0,6/15,15.42%,ARPC3;ARPC5L;ARPC4;ARPC5;TRIM27;WHAMM
prerank,cation transmembrane transport (GO:0098655),-0.33798917200654743,-1.178110715437797,0.1842818428184282,0.637134071728109,1.0,7/44,7.66%,TRPM3;ATP1A2;SLC7A2;ATP1B1;TRPM6;SLC6A9;SFXN2
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4792219610965901,1.1779617693776925,0.2556818181818182,0.9662640731676937,1.0,2/15,3.44%,CIDEA;FITM2
prerank,response to reactive oxygen species (GO:0000302),0.3715470395393884,1.1777606704896766,0.20916030534351146,0.9651142398694484,1.0,12/54,12.87%,MAPK3;ROMO1;TXNRD2;SOD1;APOE;FYN;MAPK8;SIRT1;SOD2;APTX;RPS3;CHUK
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.39246307440703976,-1.1773051928716618,0.22115384615384615,0.6384097484668523,1.0,10/24,30.94%,TRAF3IP2;AIM2;PTPN22;MAVS;STAT1;DTX3L;HSP90AA1;ZC3H12A;TOMM70;PARP9
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.4746217903749199,-1.1772041091827703,0.25366876310272535,0.6376574468617269,1.0,8/12,33.59%,GLUD1;ACLY;IDH2;IDH3B;IDH3A;ASS1;SIRT4;IDH3G
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3627573476273652,-1.1771187377554615,0.1941031941031941,0.6369185001617597,1.0,13/34,23.81%,AMBRA1;PDGFRB;KIT;PDGFRA;PIK3R3;PIK3IP1;PTK2;TGFB1;PIK3R1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,regulation of DNA repair (GO:0006282),-0.34179782519207624,-1.176380026634013,0.21037463976945245,0.6379682624600015,1.0,18/44,19.30%,EYA2;EYA1;EGFR;UBE2N;KAT7;DEK;ERCC6;PML;UBR5;RNF168;RNF8;WRNIP1;SIRT7;NPAS2;USP1;CDK9;BABAM1;SMCHD1
prerank,error-free translesion synthesis (GO:0070987),-0.3993805918092944,-1.1762566300970831,0.22488038277511962,0.6373474230933573,1.0,6/22,11.77%,RFC1;RCHY1;VCP;RPA1;UBC;NPLOC4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3932589523442296,1.1760895420199922,0.25170068027210885,0.9703208633194579,1.0,6/34,8.56%,CCDC85B;TRIB3;BBS12;TRIO;SIRT1;WNT5A
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.29081644507955556,1.1759454673808438,0.12470023980815348,0.9689621755342361,1.0,80/314,18.05%,FBXL6;PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;ANAPC2;DERL2;FEM1C;SPOP;UBXN11;RFFL;BIRC2;PSMD11;NEDD4L;YOD1;NHLRC1;PSMB4;FBXL5;WFS1;PSMC1;FAM8A1;SGTB;COP1;FBXO5;SIRT1;CLOCK;RNF187;TRIM25;CRBN;ANAPC7;RBCK1;MDM2;RAD23A;AUP1;PSMC2;UBE3D;PSMD2;ZNRF1;RHBDD2;ERLIN2;STT3B;SPOPL;UBQLN1;ANAPC11;IFI27;ANAPC10;PLAA;ANAPC4;CUL3;PSMD14;RNF216;DDIT3;PSMC6;PSMD1;FAF1;APPBP2;PSMB1;TRIM3;NHLRC3;UBE2G1;RMND5A;DNAJC10;TAF1;PELI1;KLHL42;UFD1;UBQLN2;PSMA4;FBXL20;DNAJB14;UBR3;ATXN3;CDC26;RAD23B;UBXN4;KCTD10;AGAP3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.49210867086911675,1.1753742844606923,0.2833333333333333,0.9693121765534841,1.0,4/13,10.70%,INSIG1;TMEM30B;GCC2;CD81
prerank,regulation of peptide hormone secretion (GO:0090276),-0.31310335965495356,-1.1742907634837751,0.17575757575757575,0.6418292344960459,1.0,9/67,7.25%,HTR2C;CACNA1C;ITPR1;SNAP25;CACNA1D;KCNC2;PER2;DPP4;ENSA
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.43808751318599437,-1.1735414394728048,0.2541966426858513,0.6429964455838668,1.0,6/17,9.11%,IGF1;NTRK2;RTN1;SORL1;ROCK1;BIN1
prerank,triglyceride biosynthetic process (GO:0019432),0.45723208057739484,1.1732944754327805,0.2774774774774775,0.9760528275193306,1.0,3/18,6.73%,PCK1;GPAM;GPAT4
prerank,positive regulation of hydrolase activity (GO:0051345),0.31318533935746473,1.1731403708457446,0.1771978021978022,0.9747527734116952,1.0,27/137,13.09%,EZH2;PIN1;EVI5L;TBC1D30;BCAR3;RGS8;MAPK8;USP6NL;ARHGEF7;CALM3;RAPGEF3;F11R;RGS10;RAP1GDS1;CCL25;RAPGEF6;DOCK9;ITGA6;RAB11FIP2;RPS3;PICALM;NF1;AGRN;MAP4K4;LARS1;MAPK12;NDUFA13
prerank,muscle cell development (GO:0055001),-0.3724168473831117,-1.1727308583760605,0.21428571428571427,0.6442448778465856,1.0,11/30,24.89%,ANK2;IGF1;CXADR;BIN1;MYOF;KDM1A;MEGF10;EFEMP2;VEGFA;MYH11;SGCZ
prerank,positive regulation of T cell differentiation (GO:0045582),0.3971010875174693,1.1726127421912906,0.2387820512820513,0.9750654530303977,1.0,7/36,16.07%,PCK1;LEF1;VSIR;PNP;NKAP;BCL6;IL7
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.33113018363025865,1.1721306015423414,0.18594436310395315,0.9752825123764702,1.0,18/93,11.77%,MAP3K11;FCGR2B;TIRAP;HIPK2;MAP3K4;EDAR;TRAF5;AXIN1;KLHDC10;MTURN;MINK1;TRAF3;SEMA4C;PJA2;PLCB1;MFHAS1;APP;RELL1
prerank,negative regulation of signaling (GO:0023057),-0.3922154483084493,-1.1717759333530902,0.2611607142857143,0.6459549069671564,1.0,6/25,17.45%,UBASH3B;GLRA1;ACVR1;OPTN;OPRM1;SOCS5
prerank,nucleosome assembly (GO:0006334),0.4044052027040464,1.171577014711241,0.24302134646962234,0.9757051873801406,1.0,9/31,18.84%,ASF1B;NAP1L4;RSF1;CABIN1;BRD2;RBBP4;NPM1;ATRX;HAT1
prerank,response to exogenous dsRNA (GO:0043330),0.45009335016767404,1.1712784024560727,0.2722419928825623,0.9750054505258235,1.0,3/18,4.17%,RALB;IFIT1;SLC3A2
prerank,regulation of fatty acid oxidation (GO:0046320),-0.43744775611086406,-1.1707897270968992,0.24017467248908297,0.6475910256632631,1.0,4/16,6.59%,PRKAG2;PPARGC1A;APPL2;PPARA
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3088183931718661,1.1707359295178654,0.16817593790426907,0.9753241674390974,1.0,32/166,13.57%,POLR2J;MAZ;ERCC3;MAPK3;NR4A2;POLR2B;POLR1C;GTF3C1;HDAC7;HDAC9;HDAC3;NR5A1;CCNH;MED23;PPARD;POLR1G;NOTCH1;NRBF2;GTF2H1;RSF1;NRBP1;TAF15;ESR1;THRB;RBPJ;GTF2A2;CREBBP;E2F3;TAF4B;TBP;HDAC5;THRA
prerank,regulation of response to biotic stimulus (GO:0002831),0.417695755319285,1.1704653618068661,0.24915824915824916,0.9745073246840689,1.0,4/28,3.83%,LRP8;FCGR2B;TIRAP;BIRC2
prerank,protein localization to cell-cell junction (GO:0150105),0.47816290957232555,1.1704085038261043,0.27065026362038663,0.9728186135091925,1.0,6/15,13.38%,ACTB;F11R;ARHGEF18;TJP1;CDH5;LSR
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.49380876728262985,1.1703545500555423,0.2753623188405797,0.9711401506561524,1.0,4/14,11.77%,CRAT;ACOX3;HSD17B4;ACOT8
prerank,negative regulation of metabolic process (GO:0009892),-0.31851931342824646,-1.1703076331126443,0.18994413407821228,0.6479429723479047,1.0,21/54,24.48%,NRDC;ALDH1A1;LGR4;PLCL2;IP6K1;NPR3;ADAMTS5;ARRDC3;FIS1;ACOT11;STK11;FOXC2;RHEB;PLCL1;ZNF423;NOVA1;TFE3;ATF4;FLCN;CCDC3;NR1H2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.4987296846014432,-1.1703062137321794,0.27613412228796846,0.646923471324195,1.0,7/10,31.57%,MAPT;WWP2;NDFIP1;SNX3;PPM1F;DNAJA1;TERF1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3026574055191434,-1.1699035954718895,0.17699115044247787,0.6471283237004883,1.0,19/76,16.82%,UACA;NFAT5;SASH1;EGFR;CYLD;RASSF2;BMP7;RHOA;PPM1B;IRAK1;EZR;EIF2AK2;ILK;PPM1A;NR3C2;DLG1;PTPN22;CCN3;RTKN2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.47491076786020975,-1.169129717469408,0.28540305010893247,0.6482939154109114,1.0,8/13,42.58%,ATP7A;SZT2;ABL2;ECSIT;HDAC6;SIRT4;MT3;NOD2
prerank,regulation of vasoconstriction (GO:0019229),-0.3724895487857863,-1.1690368185441569,0.2288329519450801,0.6475235744678728,1.0,15/27,38.42%,PER2;ADRA1B;CHRM3;ZDHHC21;ACE;BDKRB2;AGTR1;BMPR2;ADRA1A;CAV1;TBXA2R;KCNMB4;ADM;ACE2;AGT
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.24271674135158958,-1.1690139440702798,0.022222222222222223,0.6465682758059993,1.0,73/390,11.20%,ERBB4;SORBS1;NTRK3;FGFR2;IGF1;SULF1;HNRNPH1;TIA1;EGFR;EPHA6;COL1A1;GRIN2B;EFNA5;AHI1;PDGFRB;CYFIP2;COL4A6;AP2B1;EPHB1;NTRK2;DOCK1;WASF2;SDC2;NRP1;FLRT2;FGF1;WASL;MAPK14;AXL;EFNB2;RYK;ABI1;SULF2;VAV2;FER;EPHA7;RHOA;MTSS1;AP2A2;SIRT2;NEDD9;ROR1;KIT;ATP6V1E1;GHR;PXN;ROCK2;ARPC1A;ATP6V0B;SLC39A14;DDR1;PDGFRA;ROCK1;FRK;AKT2;IL31RA;PIK3R3;UBASH3B;EPHB4;CEP57;AP2A1;FOXC1;ACTR3;ARPC1B;NRP2;SOCS2;GSK3B;EPHB2;KL;EPHA3;HNRNPA1;TCIRG1;ATP6V0A4
prerank,regulation of cell differentiation (GO:0045595),0.3104749274471063,1.1687922483027777,0.16533333333333333,0.9755483803354948,1.0,26/148,12.06%,SPOCK2;PTPRQ;TIAM1;OCIAD1;RPS6KA1;GREM1;LTBP4;CLASP2;BCL6B;BIRC2;PPP2CA;ZFP36L1;HEY1;CDK5RAP1;SINHCAF;SLC6A6;TBX1;BDNF;SMAD7;HEY2;DAG1;TRPS1;CREBBP;PA2G4;PTBP1;NF1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.4366376803046823,-1.1687675403298237,0.24944812362030905,0.6462467556921735,1.0,10/17,22.63%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;ADCY7;PRKAR1B;ADCY3;ADCY8;ADCY4
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4069674215842567,-1.168408213211544,0.2564705882352941,0.6461966597819901,1.0,7/19,24.20%,VIM;BMP4;WNT4;TGFB1;EMILIN1;CREB3L1;TGFB3
prerank,regulation of cell migration (GO:0030334),-0.24643814373109307,-1.1682244436813505,0.049586776859504134,0.645704437163426,1.0,76/382,14.15%,MAGI2;NAV3;ERBB4;NTRK3;LDLRAD4;TMEFF2;IGF1;SULF1;PLXNA2;ROBO1;CTNNA2;SASH1;DAB2;EGFR;LMO4;COL1A1;SYNE2;DPYSL3;PDGFRB;SEMA3D;NTNG1;IGFBP5;WNT5B;FGF1;TGFBR1;CLIC4;PDPN;TPM1;MACF1;FER;RHOA;FLNA;NEDD9;CEMIP;AMOTL2;KIT;MMP14;ROCK2;LMNA;NKD1;SMO;APPL2;VCL;F3;SORL1;PDGFRA;ROCK1;LDB1;PODN;SEMA3A;AKT2;PIK3R3;SRCIN1;DOCK10;ARSB;ULK4;SPATA13;ACVR1;THBS1;AFDN;SGK1;CDH1;EPHB2;SEMA4D;DDRGK1;ANXA1;TTBK2;RHOB;TBCCD1;MYADM;PLXND1;NF2;DUSP22;ATM;ROR2;RACK1
prerank,transport along microtubule (GO:0010970),0.48841738632804654,1.1680794741016678,0.28107074569789675,0.9766631724817044,1.0,6/13,14.75%,DYNC1I1;COPG2;APP;SPG11;COPG1;DYNC1I2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3289125811924544,-1.1679395542295805,0.20316622691292877,0.6454602680672097,1.0,18/46,21.76%,NRDC;ALDH1A1;LGR4;PLCL2;IP6K1;NPR3;ADAMTS5;ARRDC3;ACOT11;STK11;FOXC2;RHEB;PLCL1;ZNF423;NOVA1;TFE3;ATF4;FLCN
prerank,positive regulation of cell aging (GO:0090343),0.5170151600794248,1.1676777534269531,0.30434782608695654,0.9763348568207937,1.0,3/11,7.73%,B2M;SIRT1;YPEL3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4482345065749579,-1.1675429809259277,0.27056277056277056,0.6455355858645493,1.0,8/14,27.55%,LPIN1;CHKA;SLC27A1;ETNK2;PCYT2;LPIN2;CHKB;LPIN3
prerank,positive regulation of protein kinase activity (GO:0045860),0.31108550245947963,1.1671333675994047,0.17959183673469387,0.9767355727474555,1.0,26/148,12.32%,LRP8;RALB;EZH2;PTPRC;MTCP1;TAB2;RPTOR;SRC;STOX1;PPP2CA;CIB1;CDKN1A;PAK3;CALM3;LCP2;AXIN1;MINK1;EFNA1;CSF1R;NAB2;PAK1;DDX3X;MMD;PRNP;STRADB;MAP4K4
prerank,protein transport (GO:0015031),0.28910574821738894,1.1669292286453845,0.14485981308411214,0.9756856246606649,1.0,67/332,13.25%,ARF5;MIA2;ZDHHC17;ARL5C;ARL4D;EVI5L;PPT1;PREPL;RAB5C;TBC1D30;TBC1D8;ATP6V1D;SLC10A7;SNX8;VPS29;RAMP2;APOE;RAB7A;TBC1D9;TMED4;VPS26A;SEC23IP;RAB43;RAB11B;ATP6V0D1;COPG2;TBC1D10B;USP6NL;TBC1D4;RAB6B;CHMP1A;VMP1;NAPA;TMED5;IFT22;RABGAP1L;SNX17;RAB6A;TMED10;RAB14;ATP6V0E1;ACD;DNAJC27;TBC1D12;SNX1;ARL5B;ARF1;RAB1A;GOLPH3L;GCC2;CHMP2A;TBC1D25;PPY;KIF13A;ATP6AP1;TMED7;SCFD1;RAB5B;RAB22A;ADPRH;ARCN1;COPG1;TBC1D14;SCAMP1;YWHAH;KIF3B;RABGAP1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4539944707126237,1.1666465736894058,0.2736842105263158,0.9748719536264272,1.0,8/18,18.22%,TEK;CYRIB;RIPOR2;KRIT1;RUFY3;CDH5;PTK2B;ARFGEF1
prerank,negative regulation of RNA splicing (GO:0033119),0.44033085500266334,1.166269406948174,0.26629422718808193,0.9746009772561892,1.0,7/19,16.18%,SFSWAP;SRSF10;RPS26;SRSF4;PTBP1;SRSF7;U2AF2
prerank,regulation of vacuole organization (GO:0044088),0.4404119992100068,1.1660164757048488,0.26268115942028986,0.9737325448307153,1.0,7/20,16.57%,ENO4;PIKFYVE;TBC1D12;ADPRH;TBC1D14;LAPTM4B;UBQLN2
prerank,ether lipid biosynthetic process (GO:0008611),0.5240322478100383,1.1649984162218296,0.2972972972972973,0.9761396794465205,1.0,5/10,14.30%,LPCAT2;PEDS1;PEX7;AGPS;GNPAT
prerank,exit from mitosis (GO:0010458),0.49184041497489206,1.1649556269833274,0.28957528957528955,0.9744098763082338,1.0,3/12,10.23%,PPP2R2D;CLASP2;CHMP2A
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4142707014895242,1.16486199377468,0.265993265993266,0.9728675464567551,1.0,10/30,16.78%,CXCL12;PTTG1IP;FBXO5;SIRT1;YJU2;MDM2;CCAR2;RPS3;CD44;TMEM161A
prerank,nucleotide-excision repair (GO:0006289),0.32685968793430464,1.1648334403731446,0.20110192837465565,0.9711244353475774,1.0,17/101,11.27%,POLR2J;ERCC3;POLR2B;PNKP;CCNH;ERCC4;XRCC1;POLK;EP300;POLE;SIRT1;POLD3;GTF2H1;POLA1;RAD23A;COPS7B;HUS1
prerank,response to interferon-alpha (GO:0035455),0.46528156602798004,1.1643910060437306,0.2577696526508227,0.9710334003279674,1.0,6/16,9.96%,IFITM2;RO60;IFITM3;ADAR;IFITM1;IFNAR1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4874100796170974,-1.1639724193958556,0.27892561983471076,0.6545474776880605,1.0,1/11,4.87%,MALT1
prerank,dendritic cell migration (GO:0036336),0.448958699611023,1.1639589491339482,0.28623853211009176,0.970909556364477,1.0,2/16,10.53%,PIK3CG;TRPM4
prerank,regulation of ion transmembrane transport (GO:0034765),-0.35547591684718427,-1.1635449833187683,0.22704081632653061,0.6547654828219013,1.0,12/33,20.30%,AKAP6;WNK1;WWP2;CHRM3;AKAP9;KCNJ2;KCNJ6;WNK3;ANO6;KCNJ13;KCNJ10;NEDD4
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.4035800774120986,-1.1634212178857886,0.2398190045248869,0.654091030721718,1.0,11/21,30.44%,TOX;CTNNB1;SMARCD3;DISC1;KDM1A;NES;CX3CL1;VEGFA;CX3CR1;MDK;DRD2
prerank,response to chemokine (GO:1990868),0.4856708527818563,1.1633850647705288,0.27204502814258913,0.9713296397420367,1.0,4/13,5.71%,OXSR1;CXCL12;LRCH1;RIPOR2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.4954966220382297,-1.1633711119694927,0.2791666666666667,0.6532391904800413,1.0,5/10,20.49%,FGFR2;TGFBR2;LRP5;STAT1;PDGFA
prerank,aminoglycan biosynthetic process (GO:0006023),-0.3332687300098372,-1.1631799150527897,0.20270270270270271,0.6527255700948502,1.0,18/49,21.71%,GPC6;HS3ST5;HS6ST2;SDC2;HS3ST3A1;GPC3;HSPG2;HEXA;GPC5;SLC35D2;UGDH;B3GALT5;B3GALNT1;HS3ST3B1;B3GALT1;NDST2;GPC4;SDC3
prerank,cellular response to organonitrogen compound (GO:0071417),-0.2883541991029497,-1.1630394703958886,0.17763157894736842,0.6521117981481164,1.0,15/99,8.71%,GABRB1;HCN1;CPEB4;AKAP6;RYR3;CPEB1;CAPN2;IGFBP5;CTNNA1;CTNNB1;P2RX4;GABRG2;GLRA1;AKAP9;EZR
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.3342952019240719,-1.1630307531999406,0.20114942528735633,0.6511198521058154,1.0,7/47,9.69%,SPOCK3;TIMP3;SPOCK1;TIMP2;SORL1;BIN1;VTN
prerank,response to histamine (GO:0034776),-0.5080959128015674,-1.1625055971521732,0.2883435582822086,0.6515982050304713,1.0,3/10,17.47%,GABRB1;GABRG2;DIAPH1
prerank,T cell differentiation in thymus (GO:0033077),0.47372871386696014,1.1623735123438885,0.28363636363636363,0.9736830733762347,1.0,2/14,4.13%,PTPRC;ZFP36L1
prerank,negative regulation of viral life cycle (GO:1903901),0.4766922808152335,1.1620426538110376,0.2967032967032967,0.9731037329854371,1.0,4/15,8.83%,LY6E;IFITM2;IFITM3;IFITM1
prerank,negative regulation of phosphorylation (GO:0042326),-0.2964457540667092,-1.1620314969491548,0.17272727272727273,0.6519057109526281,1.0,17/85,8.75%,NTRK3;PTPN13;HDAC4;SH3GL2;FBLN1;PID1;MAPT;OCLN;BMP7;PLPP3;BMP4;NUPR1;ROCK1;PPARA;XDH;CDKN1B;NIBAN1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3401144069061323,1.1619567783155889,0.2162962962962963,0.9716242887258184,1.0,11/75,9.69%,RGS2;PRKAR1A;DUSP7;PTPRJ;CDK5RAP1;APOE;SIRT1;RASIP1;LATS2;LYN;TFAP4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.38921497275095274,-1.1619304584974948,0.26077097505668934,0.6511610000834294,1.0,4/24,6.94%,HTR2C;ITPR1;RYR3;ERO1A
prerank,regulation of interleukin-8 production (GO:0032677),0.34554097313868437,1.1617909799331407,0.21633888048411498,0.9704495158227577,1.0,11/69,13.40%,PTPRC;TIRAP;MAP2K5;PRKD2;SYK;RELA;RAB1A;PARK7;NOD1;MAPKBP1;DDIT3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.431809600431626,1.1616816294879935,0.25569176882662,0.969035932540028,1.0,5/21,4.52%,NDST3;XYLT1;SGSH;EXT2;HS6ST1
prerank,cellular component maintenance (GO:0043954),0.49125774507499304,1.1607286198332767,0.25338491295938104,0.9709787983360034,1.0,5/12,17.55%,FYN;PRNP;ITGA3;MTMR2;INSR
prerank,artery morphogenesis (GO:0048844),-0.36471819236657477,-1.1605804604744323,0.22422680412371135,0.6539818265430464,1.0,6/30,5.50%,LRP1;PDGFRB;NRP1;TGFBR1;BMP4;ADAMTS9
prerank,peptidyl-serine modification (GO:0018209),0.30413829614403187,1.1605094232896782,0.19948186528497408,0.9699769114376968,1.0,37/166,15.85%,PCK1;PRKX;STK32A;PLK2;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;PRKD2;RPS6KA5;PKN3;SMG1;HPF1;MAPK8;CSNK1G3;SBK1;DCLK3;LATS2;PKN1;SRPK2;TNKS;PRKCI;MAST4;IKBKB;MAPK12;CHUK;TLK2;NEK6;CSNK2A2;NTMT1;MAP3K10;GAS6;DYRK2;TOP1;TAF1;ATR
prerank,postsynaptic membrane organization (GO:0001941),0.4574705439968817,1.1599450690229156,0.27911275415896486,0.9704627509525023,1.0,4/17,4.59%,GPHN;SHANK3;DNAJA3;APOE
prerank,actin filament bundle assembly (GO:0051017),-0.3585947371965592,-1.1596440495222553,0.23261390887290168,0.6555929996983697,1.0,13/33,26.89%,CALD1;PAWR;DPYSL3;LIMA1;NEDD9;EZR;BAIAP2L1;MYO1B;ADD2;PLS1;DMTN;FAM107A;MICAL1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.37717070173646905,-1.15943989510412,0.24634146341463414,0.6551358679386546,1.0,7/27,5.82%,TMEFF2;PHLDB2;CGNL1;WASF2;ARHGAP28;PPFIA1;ARHGAP6
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3128819777598478,1.1591882403926013,0.1767881241565452,0.9717635340507682,1.0,31/149,14.10%,MAP3K7;TAB2;PRKCH;RPS6KA4;TIRAP;TRIM8;PRKD2;RPS6KA5;RAB7B;TRIM14;CIB1;EP300;CARD16;TRAF5;CLOCK;TAB3;TRIM25;WNT5A;RELA;RBCK1;UBE2V1;RNF25;APP;NOD1;RPS3;PRKCI;IKBKB;ERC1;CHUK;NFKBIA;TRIM27
prerank,regulation of actin filament-based movement (GO:1903115),-0.4901358811919498,-1.159129951043022,0.25656565656565655,0.6549487077153179,1.0,4/10,15.63%,ANK2;PDPN;SRI;PDE4B
prerank,response to insulin (GO:0032868),0.3375015023170885,1.1588676345204552,0.22727272727272727,0.9712580411134158,1.0,17/80,13.20%,PCK1;GSK3A;TRIB3;INSIG1;SORT1;HDAC9;ZFP36L1;MYO5A;TBC1D4;SIRT1;IRS2;EPM2AIP1;TSC1;RHOQ;ZBED3;PRKCI;HDAC5
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5206874442917853,1.1586506172620719,0.3014705882352941,0.9703143258044774,1.0,3/11,9.71%,ZRANB3;FBXO5;MSH3
prerank,bile acid biosynthetic process (GO:0006699),-0.39435418563894875,-1.158407818106022,0.2413793103448276,0.6560406412408598,1.0,5/24,10.21%,OSBPL9;OSBPL6;CYP27A1;CYP7B1;OSBP
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3438001536706672,1.1580952496994332,0.21207658321060383,0.9707601376431625,1.0,10/72,8.79%,POLR2J;ERCC3;POLR2B;CCNH;ERCC4;XRCC1;POLK;EP300;POLD3;GTF2H1
prerank,regulation of type I interferon production (GO:0032479),0.3315201377557144,1.1578615618051475,0.21145374449339208,0.9699483442311995,1.0,19/84,13.47%,LRRFIP1;PIN1;TNFAIP3;POLR1C;TIRAP;EP300;TRIM25;TRAF3;RELA;POLA1;TRAF3IP1;CREBBP;POLR3F;OTUD5;DTX4;NLRP4;NLRC5;RNF216;POLR3B
prerank,sphingosine metabolic process (GO:0006670),0.46477336777832134,1.1577351317322016,0.27547169811320754,0.9686188034214294,1.0,5/17,13.88%,ACER2;PLPP1;SGPP2;ACER3;SGPP1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.3985289778403787,-1.1567230251860148,0.25,0.6597981172135683,1.0,4/22,5.44%,MBP;WNK1;BMP7;FLOT2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3773546707576876,-1.156639535750517,0.2315270935960591,0.6590251747179565,1.0,8/26,11.86%,FOXP1;DAB2;KANK2;HDAC1;CRY2;CNOT9;CRY1;PER1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.45240838283962503,1.156586913824467,0.3016759776536313,0.9715745769199808,1.0,5/17,10.76%,SOD1;APOE;LPCAT3;MBTPS1;ERLIN2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3798537255877066,-1.156551225763088,0.23448275862068965,0.6582597516765879,1.0,4/26,6.94%,HTR2C;ITPR1;RYR3;ERO1A
prerank,intestinal absorption (GO:0050892),0.48176651371817636,1.1565002665870123,0.31316725978647686,0.9700999229265866,1.0,2/13,7.28%,UGCG;F11R
prerank,negative regulation of bone remodeling (GO:0046851),0.49764983260385065,1.1564073365975278,0.2889733840304182,0.9686948428990347,1.0,3/11,10.95%,TNFAIP3;GREM1;P2RX7
prerank,positive regulation of histone deacetylation (GO:0031065),0.4895620602377008,1.1561149333881966,0.29457364341085274,0.9681183327656107,1.0,4/12,11.22%,PRKD2;AKAP8L;ING2;CTBP1
prerank,protein kinase B signaling (GO:0043491),-0.3963393215587004,-1.155913873558159,0.2755344418052256,0.6591560232193714,1.0,9/23,24.82%,IGF1;SIRT2;PIK3R3;SETX;TGFB1;TSC2;THEM4;AKT1;PAX2
prerank,regulation of glycolytic process (GO:0006110),-0.3002262591682164,-1.1558763549177606,0.19436619718309858,0.6582742555335596,1.0,14/68,11.55%,ZBTB20;PRKAG2;IGF1;OGT;HDAC4;PRKAG1;NUPR1;NUP205;PPARA;NUP155;NUP188;PFKFB4;NUP88;NUP93
prerank,negative regulation of cell communication (GO:0010648),-0.40632070848352975,-1.1557913399799329,0.23829787234042554,0.6574963060277771,1.0,5/21,17.45%,UBASH3B;GLRA1;ACVR1;OPRM1;SOCS5
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3807642202760893,-1.1556948571140884,0.23383084577114427,0.6567463865995197,1.0,13/25,24.76%,SHISA9;NLGN2;RELN;SHISA6;NLGN1;CACNG7;CACNG4;CACNG2;SHANK1;PRRT1;NLGN3;CACNG3;CACNG8
prerank,regulation of protein neddylation (GO:2000434),0.5236662346572858,1.1555762016960431,0.3252336448598131,0.9685641160434431,1.0,5/10,16.97%,DCUN1D4;RPL5;EPAS1;DCUN1D2;DCUN1D1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.24622995823096494,-1.1552824998483153,0.05925925925925926,0.6570054294187724,1.0,63/348,13.64%,MAGI2;ANK2;BMP6;NTRK3;ANK3;RIMS1;SLC24A3;IGF1;ROBO1;GSN;SMAD3;AHI1;ITGB8;FOXD1;NTRK2;ANXA2;FGF1;TGFBR1;MAPK14;PID1;OCLN;MED26;BMP7;PRKAG1;MED1;BMP4;PPARGC1A;ROCK2;OSR1;SMO;F3;EPB41L4B;ADAM19;ROCK1;HOXA5;MPHOSPH8;FUBP3;PIK3R3;EZR;UBR5;TLE1;AGO3;AFDN;PLSCR1;GSK3B;GJA1;EPHB2;CAMK2N1;FN1;CUX2;TP53;FAM98A;CD34;DDRGK1;IFNGR1;RPS7;SNF8;SCYL2;PDCD5;SETDB2;IL33;HINFP;ATM
prerank,cellular response to hydroxyurea (GO:0072711),-0.5032842745615626,-1.1550776997001422,0.30736842105263157,0.656644200660854,1.0,7/10,38.95%,SPIDR;DDI2;RTF2;BLM;DDX11;NSMCE3;TIMELESS
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.35464603853926036,1.1546041531813158,0.25,0.9706371667200183,1.0,14/56,13.49%,RPTOR;STOX1;PHB2;RGCC;FBXO5;CDK4;ANAPC7;PLCB1;DDX3X;RAD51B;ANAPC11;ANAPC4;CUL3;ANKRD17
prerank,pulmonary valve development (GO:0003177),-0.4084384088228453,-1.1545070471297052,0.2986425339366516,0.6572996524524632,1.0,5/18,8.66%,ROBO2;NOTCH2;ROBO1;BMP4;SMAD6
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.459355214327914,1.1543457097081193,0.28413284132841327,0.9699145856194834,1.0,5/17,11.25%,SOD1;SFPQ;SIRT1;SOD2;UBQLN1
prerank,mitochondrial translational termination (GO:0070126),0.32808356724133303,1.1543428210225657,0.20760233918128654,0.9681483683372893,1.0,13/88,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;MRPL18;MRPL38;MRPS12;MRPL20;MRPL52;MRPS15;MRPS24;MRPL48
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.44684162942894456,-1.1540066380700986,0.27790432801822323,0.6577370485751728,1.0,3/14,4.07%,LRP1;IGFBP5;TPM1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.34596731452683177,-1.153724040950169,0.24274406332453827,0.6575071635248283,1.0,8/40,4.04%,DAB2;COL1A1;SMAD3;TGFBR1;TGFBR2;CTNNB1;PDPN;SMAD4
prerank,defense response to bacterium (GO:0042742),0.32206361698301184,1.1536136462853945,0.21428571428571427,0.9692531506615762,1.0,11/105,9.48%,ROMO1;RPL30;DMBT1;TIRAP;RNASE6;STAB1;GBP4;SELP;SYK;PPP1R11;RAB1A
prerank,cellular response to radiation (GO:0071478),0.37924963694742075,1.1531503196034296,0.2512396694214876,0.9693563883474257,1.0,8/40,11.27%,GPR52;EEF1D;RAD1;CDKN1A;SIRT1;CLOCK;KDM4D;HUS1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.32040975415106876,-1.1529815739495688,0.22636103151862463,0.6584450566181571,1.0,20/52,24.73%,SORBS1;LRP1;EGFR;ZDHHC5;STX3;DPP10;EPHB2;EPHA3;CLIP3;DLG1;WNK3;RACK1;CNST;ZDHHC8;PIK3R1;NKD2;CLN3;PLS1;AKT1;SPTBN1
prerank,response to peptide hormone (GO:0043434),0.3710950609539948,1.1524700318187253,0.2453125,0.9703502024733117,1.0,10/43,11.54%,PCK1;SORT1;SRC;ZFP36L1;SIRT1;EPM2AIP1;EIF2B3;TSC1;ZBED3;GNAI1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.2895325093133095,-1.152402499521776,0.19402985074626866,0.658973627103842,1.0,24/86,21.76%,BMP6;SULF1;DAB2;FOXD1;TGFBR1;BMP5;ZEB2;BMP7;SMAD4;BMP4;SNW1;ACVR1;THBS1;NUP93;STK11;ACVR1B;TGFB1;BMPR1B;ZNF423;BMPR1A;BMPR2;TWSG1;CCN1;FLCN
prerank,replicative senescence (GO:0090399),0.4884442951299599,1.15194940892434,0.2922794117647059,0.9706982813927255,1.0,5/12,15.85%,ROMO1;MME;TERT;CHEK2;ATR
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.389196600787059,-1.1518063850855935,0.2789598108747045,0.6596697452834657,1.0,5/24,5.65%,LEPR;PID1;COQ10B;PPARGC1A;SLC25A13
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.3279538026063517,-1.1517652858494054,0.21298701298701297,0.6588118201579117,1.0,20/48,22.63%,ADCY5;AMPD3;ADCY2;ADCY1;ADCY9;DCAKD;SLC26A2;SLC35B3;PANK3;ADCY7;GMPS;GUCY1A1;PAPSS2;NPR1;ACOT7;AK5;ADCY3;ADCY8;GUCY1B1;ADCY4
prerank,iron ion homeostasis (GO:0055072),0.3546539787280436,1.151631344140833,0.2363919129082426,0.9701871951855096,1.0,12/58,12.09%,CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;B2M;ISCU;GLRX3;ATP6AP1;PICALM;ACO1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.48133502669461453,-1.1515684486274331,0.3032258064516129,0.6583206795247555,1.0,3/11,19.49%,JAK1;IL6ST;STAT1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.29826441401724324,-1.151373623202904,0.2206703910614525,0.6579303405950427,1.0,16/73,11.34%,ITGBL1;DAB2;ITGB8;DOCK1;COL3A1;FBLN1;NRP1;PLPP3;NEDD9;TEC;ITGB5;ITGA5;ADAMTS1;ITGA11;FN1;ILK
prerank,positive regulation of intracellular protein transport (GO:0090316),0.30641492244452323,1.1512128222819986,0.21309192200557103,0.9701524246078411,1.0,19/144,7.75%,RAC2;GSK3A;PRR5L;RBM22;TRIM28;SAE1;DMAP1;TCAF1;HDAC3;VPS11;FYN;ZFAND1;CIB1;MAPK8;ICE1;YWHAB;RAPGEF3;TMEM30B;RUFY3
prerank,regulation of protein localization to cell surface (GO:2000008),0.38550915637184013,1.1511367122103444,0.2768166089965398,0.9687052428898785,1.0,8/33,8.20%,NEDD4L;RAB11B;GOPC;LEPROTL1;RIC3;BDNF;RAB11FIP5;TMEM35A
prerank,regulation of urine volume (GO:0035809),-0.5001583225171397,-1.1500494113498043,0.3002159827213823,0.6608044224361204,1.0,7/10,46.40%,NPR3;NPR1;INPP5K;ADCY6;ADM;HYAL2;HAS2
prerank,peptide metabolic process (GO:0006518),0.33748078311943375,1.1499474160919576,0.23851851851851852,0.9719643307140075,1.0,10/75,9.07%,PCSK1;LVRN;SOD1;PSEN2;MME;SEC11A;SPCS3;SPPL3;TPP1;CARNMT1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3844564742698432,1.149741207099559,0.252129471890971,0.9709975664188455,1.0,10/36,15.61%,MAZ;NR4A2;SGMS1;CRADD;BDNF;RPS3;PTPMT1;ING5;CSNK2A2;TPD52L1
prerank,negative regulation of cell migration (GO:0030336),-0.26863952130884955,-1.1495693070773478,0.12890625,0.6611350902686646,1.0,14/137,4.07%,MAGI2;NAV3;LDLRAD4;TMEFF2;PHLDB2;SULF1;LRP1;ROBO1;DPYSL3;COL3A1;IGFBP5;MCC;CLIC4;TPM1
prerank,regulation of JNK cascade (GO:0046328),0.320159888200198,1.149234821187932,0.215007215007215,0.9713013176138623,1.0,19/101,12.32%,MAP3K11;MECOM;RAP2A;FCGR2B;TIRAP;HIPK2;HDAC3;EDAR;TRAF5;AXIN1;MTURN;MINK1;PHLPP1;TRAF3;PJA2;PLCB1;MFHAS1;APP;MAP4K4
prerank,phospholipid homeostasis (GO:0055091),-0.47995337053650733,-1.1491787871622836,0.28316831683168314,0.6612166940611709,1.0,3/11,14.40%,TLCD2;ABCA1;RCN3
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3379612154060079,1.1491699438467842,0.24011713030746706,0.9697543703080933,1.0,14/70,10.61%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,positive regulation of response to stimulus (GO:0048584),0.38110851373411425,1.149093152919171,0.2565359477124183,0.9682865770006835,1.0,7/40,9.37%,FCGR2B;B2M;FXR1;SIRT1;YPEL3;WNT5A;BCLAF1
prerank,engulfment of apoptotic cell (GO:0043652),0.4598935361726985,1.1489093971073299,0.29143897996357016,0.9672664303645165,1.0,2/15,0.45%,RAC2;XKR8
prerank,embryonic organ development (GO:0048568),-0.30528563767992306,-1.1481601246617672,0.22,0.6629299777908461,1.0,24/61,21.81%,FGFR2;TEAD1;PBX1;GLI2;GLI3;KMT2A;RARB;PCSK5;TGFBR2;KIT;COBL;RBP4;COL13A1;SALL1;TEAD3;TGFB1;NES;PBX4;BMPR1A;TEAD2;PBX2;PDGFA;ATF4;PKDCC
prerank,negative regulation of B cell activation (GO:0050869),0.43335858083492423,1.1480883820707362,0.27827648114901254,0.9688815172881363,1.0,4/21,9.31%,TNFAIP3;FCGR2B;SAMSN1;LYN
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3342394253339016,-1.1480556423912571,0.208,0.6622382231160181,1.0,10/38,20.10%,BMP6;SASH1;PUM1;PUM2;PLSCR1;POLR3C;LY86;GBP5;RIOK3;SLC15A4
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3815150513474941,-1.1475962719550812,0.24087591240875914,0.6625715006682064,1.0,5/27,10.68%,ANK2;AHNAK;CACNB4;PRKACA;CAMK2D
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.4389221063092283,1.1475468482375393,0.2722419928825623,0.9693018216500705,1.0,4/20,6.18%,PIN1;PPIB;PPIG;PPIL3
prerank,positive regulation of growth (GO:0045927),0.3482324466791567,1.1471568464789759,0.25471698113207547,0.9691263726780822,1.0,12/64,10.80%,NCBP1;DERL2;RPS6KA1;RPTOR;WFS1;CIB1;USP47;EXOSC9;LGI1;PLCB1;EIF4G2;DDX3X
prerank,negative regulation of nuclear division (GO:0051784),-0.4826074396901017,-1.147146199947384,0.29583333333333334,0.6628321426226956,1.0,3/11,4.74%,TOM1L2;BMP7;BMP4
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.3773025552546334,-1.1467875785515746,0.27053140096618356,0.662832446490234,1.0,15/26,38.12%,B4GALT1;OGN;B4GALT6;SLC35D2;ST3GAL4;PRELP;LUM;B4GALT4;CHST2;OMD;B4GALT3;B4GALT2;B4GALT5;FMOD;CHST1
prerank,aggrephagy (GO:0035973),-0.359974919310477,-1.1467704179451128,0.23658536585365852,0.6618989996841866,1.0,8/27,11.40%,WDFY3;ACBD5;UBE2N;DYNC1H1;DYNC1LI2;VIM;UBC;ARL13B
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.3974718952554024,-1.146340873560953,0.2577565632458234,0.6620732110962243,1.0,13/21,38.61%,SMO;DCDC2;EVC;GLI1;SFRP1;DLG5;TTC23;PDCL;KIF7;GAS8;ULK3;STK36;RAB34
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4498511766129598,-1.1463334324268615,0.2888402625820569,0.6611088204451998,1.0,5/14,16.94%,SEC31A;SEC24D;SEC23A;SEC24C;SEC24A
prerank,B cell mediated immunity (GO:0019724),0.5110547249227769,1.1460865015247848,0.33852140077821014,0.9716111930995125,1.0,1/10,2.51%,FCGR2B
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4662768600937873,-1.1456351568066068,0.2880658436213992,0.6621422019473817,1.0,3/12,7.03%,SORBS1;IGF1;AKT2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.34406867333012336,1.1455984260291352,0.23845007451564829,0.9717898067880814,1.0,8/62,9.35%,POLR2J;ERCC3;NCBP1;ELOC;POLR2B;CCNH;GTF2H1;PCID2
prerank,response to cytokine (GO:0034097),-0.26688688955492484,-1.144854169138893,0.13953488372093023,0.6634120735691396,1.0,30/141,13.88%,AFF3;NFAT5;PTPN13;ALDH1A2;TIMP3;AKAP6;SMAD3;DPYSL3;TIMP2;COL3A1;HDAC4;PTPN14;OSMR;PID1;IFNAR2;RHOA;IL6R;PML;IRAK1;KLHL20;IRAK3;EIF2AK2;PLSCR1;REL;IKBKE;ANXA1;IL1RAPL1;RELB;GGT5;IL6ST
prerank,ERBB2 signaling pathway (GO:0038128),0.3892408578274878,1.1447428401917235,0.2630691399662732,0.9736473737974801,1.0,6/31,8.78%,PTPRR;PTPN18;SRC;CDC37;PTPN12;ERBIN
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3912666845217193,1.1446255880252332,0.28040540540540543,0.9724014618693874,1.0,7/31,9.48%,TRIB3;PIN1;DCUN1D4;BMI1;AXIN1;MAGEC2;RAB1A
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.2893675464998806,-1.1442084052123975,0.18789808917197454,0.6641867316968324,1.0,31/84,25.86%,FOXP1;ANXA3;SASH1;NRP1;FGF1;MAPK14;PLPP3;BMP4;P2RX4;ROCK2;SPARC;SMOC2;THBS1;NRP2;LGMN;FOXC2;RHOB;GPLD1;TGFB1;SEMA5A;MET;BMPR2;AAMP;HSPB1;PRKD1;VEGFA;ITGB1BP1;AKT1;ATOH8;GATA2;STAT5A
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3350701556090444,1.1441289279040359,0.25217391304347825,0.9727788874012961,1.0,14/71,10.61%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.42043080376131764,-1.1440577240732257,0.2927927927927928,0.6636448559511289,1.0,5/19,13.86%,ABHD5;PRKCD;PPARA;AKT2;ABCD2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4419506072724113,1.144008034437277,0.31785714285714284,0.9715983502637403,1.0,7/18,16.46%,RUVBL2;CCT2;CCT5;RUVBL1;TCP1;DKC1;PARN
prerank,positive regulation of telomere maintenance (GO:0032206),0.39829360927663615,1.1435797137346502,0.2776831345826235,0.9716423131345217,1.0,7/31,12.55%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS;NBN
prerank,regulation of phagocytosis (GO:0050764),0.35319719268366806,1.1433966169918857,0.23076923076923078,0.9706808364849046,1.0,12/53,17.51%,PTPRC;FCGR2B;CAMK1D;LMAN2;SYK;MERTK;CD47;SCARB1;CYBA;GAS6;CALR;RAB27A
prerank,regulation of steroid metabolic process (GO:0019218),0.41526933406394667,1.143073146108678,0.27726432532347506,0.970307592193059,1.0,4/23,6.46%,PANK2;NR5A1;APOE;LAMTOR1
prerank,smooth muscle contraction (GO:0006939),-0.4479611911808291,-1.1427291078068238,0.2926267281105991,0.6664627712898333,1.0,8/14,29.85%,ROCK2;EDNRA;ROCK1;SMTN;BDKRB2;ADRA1A;MYH11;MYLK
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.493279895187239,-1.1426417683189543,0.328,0.6657270294345291,1.0,2/10,3.01%,ANXA2;NELL1
prerank,protein localization to chromosome (GO:0034502),0.38454471286758124,1.1418002260029734,0.27070063694267515,0.9735678257073132,1.0,12/34,18.79%,SLF1;BOD1;ACD;TPP1;ESR1;TNKS;TERF2IP;ATR;SLF2;XRCC4;TNKS2;ATRX
prerank,regulation of cell-cell adhesion (GO:0022407),0.37343761779103396,1.1415498674992244,0.2561174551386623,0.9728675833454382,1.0,9/39,10.27%,PTPRR;PTPRG;SRC;MAGI1;SMAD7;MINK1;CD47;PODXL;CITED2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.425042544241979,1.1415069821093775,0.2677595628415301,0.9713257236561247,1.0,4/21,7.72%,OSBPL10;PLAAT3;LPCAT3;MBOAT1
prerank,oligodendrocyte development (GO:0014003),-0.4329083759401031,-1.1409289145763168,0.2841880341880342,0.6696783431824951,1.0,10/15,33.87%,PLP1;B4GALT6;TPPP;CNTNAP1;EIF2B5;EIF2B2;EIF2B4;MYRF;B4GALT5;NSUN5
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3938135098762121,1.1404387867845938,0.28407224958949095,0.9738244869990738,1.0,6/34,7.28%,RGS2;PIK3CG;PDE4D;ATP2A2;CALM3;SMAD7
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.4304053477775819,-1.1403938937497675,0.30493273542600896,0.6702467480226839,1.0,10/15,28.52%,UST;DSE;VCAN;CSGALNACT2;CSPG4;DSEL;BGN;DCN;CSPG5;CHST12
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3164840013606702,1.1401899308509946,0.2206896551724138,0.9731781465447464,1.0,22/113,13.81%,LCP1;ERCC3;PSMC4;TAL1;SLF1;TIRAP;SRC;ERCC4;ICE1;SYK;GTF2H1;RASIP1;PSMC2;PARK7;ESR1;DDX3X;RPS3;BMF;CDH5;PLEK;PSMC6;FAF1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.4020576138920948,-1.1400779511108654,0.28045977011494255,0.6692512201095518,1.0,12/20,40.22%,GSTT1;GSTZ1;ESD;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;GSTM5;GSTO1
prerank,glutathione derivative metabolic process (GO:1901685),-0.4020576138920948,-1.1400779511108654,0.28045977011494255,0.6692512201095518,1.0,12/20,40.22%,GSTT1;GSTZ1;ESD;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;GSTM5;GSTO1
prerank,cAMP metabolic process (GO:0046058),-0.4607364836091192,-1.1400391056189023,0.3311827956989247,0.6684026362898462,1.0,8/13,22.63%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;ADCY3;ADCY8;ADCY4
prerank,basement membrane organization (GO:0071711),-0.4403626135219046,-1.1399898264061685,0.2875536480686695,0.6675760305326228,1.0,5/14,17.06%,NTNG1;FLRT2;NID2;NTN4;LAMB1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.46751447729450873,1.1396471912274608,0.2873134328358209,0.9736188151870583,1.0,5/15,14.70%,PTTG1IP;SIRT1;MDM2;ING2;CD44
prerank,icosanoid biosynthetic process (GO:0046456),-0.4897606556994959,-1.1395540478365005,0.2991967871485944,0.667854003523133,1.0,1/10,1.27%,PLA2G4A
prerank,regulation of trophoblast cell migration (GO:1901163),-0.4397011337104566,-1.1395080983276447,0.29411764705882354,0.6670370501421075,1.0,5/14,22.28%,SMURF2;GJA1;ACVR1B;ARHGDIB;VEGFA
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4672957700388589,-1.1393533808923795,0.3057324840764331,0.6665077354883358,1.0,2/11,3.17%,ANK3;JAK1
prerank,cellular response to ketone (GO:1901655),0.3794412022340928,1.139014907849702,0.26917057902973396,0.9744604811512685,1.0,4/35,6.32%,PCK1;PTGER2;SRC;GNB1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.392360593982344,-1.138943477359771,0.2863961813842482,0.6666905409718715,1.0,4/22,6.92%,ANK2;AKAP6;ATP1B1;HTT
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.29972148666142295,-1.138893775299155,0.22841225626740946,0.6658690526334194,1.0,15/63,17.43%,IGF1;CFLAR;TGFBR1;CYLD;BMP4;PML;HTT;ACVR1;THBS1;DEPTOR;SIAH2;MADD;TRAF2;TCF7L2;SCG2
prerank,natural killer cell activation (GO:0030101),-0.38259712920614575,-1.1384976595683007,0.26066350710900477,0.6660619321038037,1.0,8/23,22.15%,PBX1;AXL;TOX;KAT7;ELF4;RABL3;PRDX1;BAG6
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3319136439233826,1.1384504871154297,0.2467718794835007,0.9751621348561217,1.0,14/73,10.61%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3982655091919667,-1.138359661168376,0.2968036529680365,0.6654451514160862,1.0,6/20,17.30%,LBP;IRAK1;IL18;PTPN22;TGFB1;MTDH
prerank,liver development (GO:0001889),0.3849133447462673,1.1375303520040452,0.2762237762237762,0.9771560029286197,1.0,6/32,13.38%,PCK1;GFER;CEBPG;CITED2;NF1;LSR
prerank,negative regulation of cytokine production (GO:0001818),0.2988170043031141,1.1374050614445168,0.20881971465629054,0.9760069749008145,1.0,27/163,13.40%,CIDEA;PIN1;LEF1;PTPRC;TNFAIP3;FCGR2B;RPS6KA4;MAP2K5;HDAC7;HDAC9;RPS6KA5;NPTN;RGCC;PPP1R11;NLRC3;CUEDC2;TRIM25;CD84;VSIR;TRAF3IP1;PRNP;OTUD5;MAPKBP1;CD274;NLRC5;RNF216;DDIT3
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3404648460587631,1.1372825994995162,0.24599708879184862,0.9748039058986366,1.0,17/68,18.64%,MAZ;ERCC3;NCBP1;POLR1C;CCNH;CPSF4;POLR1G;GTF2H1;PAPOLA;TBP;SCAF8;SLBP;WDR33;TAF1D;CLP1;POLR3K;SNRPD3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3395964526619861,1.1369912720105209,0.25375375375375375,0.9742966880418658,1.0,8/64,9.35%,POLR2J;ERCC3;NCBP1;ELOC;POLR2B;CCNH;GTF2H1;PCID2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3030066273129558,-1.1366927105024043,0.1952662721893491,0.6691564116635537,1.0,20/69,16.53%,IGF1;OGT;PDGFRB;PLCL2;RHOA;PLCE1;PIK3C2B;SIRT2;PIK3C3;MYO16;PDGFRA;PLCD3;EZR;PLCB3;GAB2;PLCH1;PLCL1;NGF;EXOC1;PLCD1
prerank,rRNA transcription (GO:0009303),0.45031656124033037,1.136562587897412,0.32075471698113206,0.9743114475501069,1.0,4/17,6.79%,GTF3C1;SPIN1;GTF3C5;POLR1G
prerank,protein dephosphorylation (GO:0006470),0.30793084063290754,1.1363324354238669,0.23758389261744967,0.9735385656923791,1.0,19/135,6.91%,PHPT1;PTPRR;PTPN18;PTPRG;DUSP7;PTPRJ;PTPRC;CTDSP1;PPP3CB;PTPRM;PPP2R2D;PTPRB;DUSP12;PTPRE;PPP2CA;PTPN12;SSH2;PTPRT;PPP2CB
prerank,cilium assembly (GO:0060271),-0.24196617414536278,-1.1356861972751633,0.09523809523809523,0.6710281403212502,1.0,83/297,19.85%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;DYNC1H1;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;NINL;SPATA6;DYNC2I1;RAB8B;DCDC2;TTC21B;NUDCD3;CCDC66;CCDC57;CFAP20;EXOC6;TTC39C;IFT46;CEP57;IFT57;IFT52;AKAP9;CEP70;ACTR3;CEP89;CSNK1E;CEP152;CEP126;IFT172;CKAP5;CEP20;PRKACA;IFT74;CFAP44;RP2;DCX;ARL13B;DISC1;TTBK2;ABLIM3;KIF3A;DZIP1L;BBS9;RAB11A;WDR19;WDR11;INTU;RAB23;CCP110;BBS2;TUBB4A;CYS1;DCTN1;ARF4;EXOC7;EXOC1;PTPN23;CEP250;EHD1;BBOF1;RAB8A;EHD3;GORAB;DYNLL2;ACTR2;IFT20;NDE1;TUBA1A;SNAP29;BBS5;TMEM237;TMEM80;CCDC28B;TTLL3
prerank,positive regulation of cell communication (GO:0010647),-0.36282173119689054,-1.135653383473818,0.2546419098143236,0.670179041953218,1.0,9/28,18.89%,ANK3;RIMS1;WLS;DLG4;CLSTN2;ILK;PTPN23;KCTD13;CLSTN3
prerank,regulation of cell motility (GO:2000145),-0.27203344663293477,-1.1356400653168501,0.1925925925925926,0.6692650379853065,1.0,35/121,17.47%,ERBB4;SPOCK3;PLXNA2;EGFR;LMO4;FBLN1;FGF1;MACF1;RHOA;FLNA;AMOTL2;ROCK2;LMNA;ROCK1;LDB1;CFAP20;AKT2;SRCIN1;DOCK10;CAVIN1;SPATA13;CDK6;SGK1;PRAG1;TTBK2;RHOB;TBCCD1;PLXND1;PLXNB2;RAF1;PLXNC1;TGFB1;ABL2;NEXN;DIAPH1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4610399565279638,1.135493851720811,0.3339317773788151,0.9751753214142296,1.0,2/16,2.28%,GSK3A;PRCP
prerank,negative regulation of interleukin-10 production (GO:0032693),0.45104645476978017,1.1348492358200517,0.2911392405063291,0.9760853076763312,1.0,3/16,13.00%,FCGR2B;VSIR;CD274
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.40142612765749663,1.1345326146690402,0.3,0.9756717754061309,1.0,9/27,17.21%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC1A2;SLC25A12;SLC38A5;SLC25A38;SLC7A5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4693308015608596,-1.1342791701783574,0.2997946611909651,0.6720552881449532,1.0,6/12,35.40%,WNK1;PPARA;AKT1;MDK;ASS1;SKAP1
prerank,anterograde axonal transport (GO:0008089),-0.3423765340259636,-1.1337013060681331,0.27638190954773867,0.6727201537506619,1.0,12/37,15.74%,DLG2;AP3B1;KIF5C;KIF1C;TRAK1;AP3S2;RAB27B;KIF3A;KIF1A;MAP1A;NEFL;KIF5A
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.37416042208741607,1.1333806974305196,0.2981878088962109,0.9785434432977234,1.0,4/38,4.40%,RAC2;GSK3A;SAE1;VPS11
prerank,positive regulation of dendrite development (GO:1900006),0.5085331156634467,1.1333344614467655,0.316,0.9770694515990903,1.0,1/10,0.02%,LRP8
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.37373588379320744,1.1327270484224834,0.2594417077175698,0.977801779012318,1.0,8/39,12.03%,CISH;PIK3CG;PIK3C2G;EFR3B;SMG1;PI4KA;PIK3CD;IP6K2
prerank,positive regulation of MAPK cascade (GO:0043410),-0.24407906995843096,-1.1315744897977977,0.12886597938144329,0.67770952315177,1.0,30/245,7.09%,ERBB4;NTRK3;FGFR2;NOTCH2;LPAR1;IGF1;HTR2C;ROBO1;EGFR;KSR1;IQGAP1;PDGFRB;NTRK2;BMPER;NRP1;CCN2;FGF1;RYK;ROR1;KIT;PRKCZ;ROCK2;IL34;TAOK3;PDGFRA;ROCK1;SLC30A10;ADRA1B;IRAK1;GSDME
prerank,regulation of neutrophil migration (GO:1902622),0.516375997730607,1.1314236562411593,0.33468559837728196,0.9812685856837926,1.0,2/10,11.04%,RAC2;RHOG
prerank,neuron migration (GO:0001764),-0.3227349456492312,-1.1312838947284174,0.24585635359116023,0.6775613710543388,1.0,11/48,6.81%,MAP1B;SPOCK1;NRCAM;NTRK2;AUTS2;NRP1;DNER;GPM6A;RELN;DCDC2;SEMA3A
prerank,negative regulation of cell differentiation (GO:0045596),-0.2584318202477158,-1.1305466984869041,0.12831858407079647,0.6786660454529113,1.0,38/181,14.13%,LDLRAD4;CNTN4;RANBP3L;ADAMTS12;EGFR;SMAD3;TGFBR1;COL5A1;BMP5;COL5A2;BMP7;ADGRV1;SIRT2;EFEMP1;MED1;BMP4;MEIS2;CRIM1;ENPP1;OSR1;PPARA;SKI;XDH;TMEM64;LRP5;ABCA5;CDC73;SMAD6;ANP32B;CDK6;SEMA4D;TBX3;LIMD1;ABCA1;NELFB;WNT9A;RORA;IGF2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.35024039962323894,1.1301308060013298,0.2772727272727273,0.9846390442572555,1.0,10/54,12.41%,PRCP;PRKD2;APOE;RGCC;SIRT1;PLCG1;ACVRL1;NOS3;NF1;SP1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.31794373777905416,-1.1300043203161172,0.25806451612903225,0.6792686278427804,1.0,13/52,13.20%,SORBS1;LRP1;EGFR;ZDHHC5;EPB41L2;STX3;EFCAB7;DPP10;EPHB2;EPHA3;CLIP3;DLG1;WNK3
prerank,chloride transmembrane transport (GO:1902476),-0.3229426847142715,-1.1298262231678935,0.23054755043227665,0.6787967700773571,1.0,25/48,27.24%,GABRB1;SLC1A3;GLRB;GABRA2;ANO3;SLC6A1;SLC12A2;GLRA3;GABRG2;GLRA1;ANO1;ANO6;SLC12A6;GABRA5;SLC12A4;GABRG3;GABRA4;SLC12A9;GABRG1;SLC4A8;GABRA1;SLC12A7;LRRC8A;SLC12A8;SLC12A5
prerank,positive regulation of lipid storage (GO:0010884),0.4245058158775998,1.1296407603807654,0.28620689655172415,0.9848941113696856,1.0,2/21,3.44%,CIDEA;FITM2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5059020558207175,1.129405257382536,0.31137724550898205,0.9841900146695723,1.0,2/10,8.56%,OXSR1;WNT5A
prerank,proteasomal protein catabolic process (GO:0010498),0.28979974152300236,1.1293693312961965,0.20828105395232122,0.9826617082921637,1.0,45/201,15.39%,PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FEM1C;SPOP;UBXN11;RFFL;BIRC2;PSMD11;NEDD4L;NHLRC1;PSMB4;PSMC1;COP1;SIRT1;CLOCK;RNF187;CRBN;RBCK1;MDM2;RAD23A;PSMC2;UBE3D;PSMD2;ZNRF1;SPOPL;IFI27;PLAA;CUL3;PSMD14;RNF216;DDIT3;PSMC6;PSMD1;FAF1;APPBP2;PSMB1;TRIM3;NHLRC3;UBE2G1;RMND5A
prerank,B cell differentiation (GO:0030183),0.36311048407227353,1.129246313679425,0.28874388254486133,0.981464031148719,1.0,6/46,10.07%,DCAF1;PTPRJ;PTPRC;HDAC9;CEBPG;KLF6
prerank,organic cation transport (GO:0015695),0.42748691085351587,1.1291673753013272,0.312280701754386,0.9801239185470044,1.0,3/20,7.94%,SLC5A7;SLC44A1;SLC25A26
prerank,glycogen metabolic process (GO:0005977),-0.37055306047034464,-1.1286083292826405,0.28978622327790976,0.6812388860818923,1.0,12/27,19.38%,PRKAG2;PYGB;AGL;PER2;PGM1;PHKA2;GSK3B;GYS1;PYGM;PGM2;GAA;PHKG2
prerank,regulation of defense response to virus (GO:0050688),0.46365789083282466,1.1285050797056513,0.30825688073394497,0.981054537905337,1.0,6/14,16.99%,TNFAIP3;IFNLR1;TRAF3;TRAF3IP1;RNF216;ZMPSTE24
prerank,prostanoid biosynthetic process (GO:0046457),-0.42990038609322945,-1.128448008892212,0.2926829268292683,0.6807750874076365,1.0,5/15,19.89%,PLA2G4A;PTGDS;PTGIS;PTGES;PTGS2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.35995150272302406,1.1283737374587144,0.28188976377952757,0.9798762000105401,1.0,4/48,6.48%,IL1R1;PDE4D;CYRIB;CEBPG
prerank,aerobic electron transport chain (GO:0019646),0.33696862707697806,1.1283421369340099,0.28101644245142005,0.9783845496749718,1.0,19/68,14.40%,CYCS;NDUFAF1;UQCC3;NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;SDHA;NDUFB7;COX15;UQCRB;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,hematopoietic stem cell proliferation (GO:0071425),0.499048873326027,1.128126516094241,0.348747591522158,0.9775767695204227,1.0,2/11,8.56%,MECOM;WNT5A
prerank,regulation of protein binding (GO:0043393),0.3135954344123734,1.1280631200088163,0.24854651162790697,0.9762088876546806,1.0,24/114,13.20%,TRIB3;RALB;PIN1;TIAM1;BTBD1;ACTB;PSME3IP1;HIPK2;IFIT1;PPP2CA;B2M;CDKN1A;MAPK8;CARD16;SPPL3;EPB41;AKTIP;PARK7;CLDN5;TERT;APP;LDLRAP1;USP33;HDAC5
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.47217984163691507,1.1279926722374842,0.3090551181102362,0.9748682056890882,1.0,4/14,11.52%,PRKD2;RELA;CD81;RPS3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.36414137238041966,-1.1279595268746818,0.30904522613065327,0.6812401963246927,1.0,11/28,18.72%,TNS2;PID1;PRKCZ;ENPP1;APPL2;PRKCD;PIP4K2B;GRB10;PTPN2;TSC2;RPS6KB1
prerank,retinol metabolic process (GO:0042572),0.46521230966967453,1.127900434348411,0.3159922928709056,0.9735953004683975,1.0,4/14,14.01%,RETSAT;RDH11;CYP1B1;RDH10
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.48218705681611207,1.1278358975510152,0.33072407045009783,0.9690215862735627,1.0,4/12,12.83%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.48218705681611207,1.1278358975510152,0.33072407045009783,0.9690215862735627,1.0,4/12,12.83%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.48218705681611207,1.1278358975510152,0.33072407045009783,0.9690215862735627,1.0,4/12,12.83%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.2956424883293244,-1.1277486280120443,0.22580645161290322,0.6808487020211527,1.0,16/75,9.33%,SULF1;COL4A3;CTNNB1;GTF2I;ROCK2;HSPG2;ROCK1;HOXA5;PML;WNT4;SPARC;ADAMTS1;FOXC1;THBS2;NIBAN2;THBS1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4428996801131357,1.1273696494633705,0.31504424778761064,0.9691732495995504,1.0,3/18,6.70%,IFI35;SBNO2;SYK
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3505307397353679,1.1272973203551302,0.2736318407960199,0.9678768107740671,1.0,7/46,9.31%,SEMA6A;PTPRR;PIN1;PTPRC;SPRED1;CNKSR3;LYN
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2929429510130478,-1.1270484559954932,0.2222222222222222,0.681845052582393,1.0,16/79,10.48%,SULF1;ADAMTS12;NBL1;BMPER;SMURF2;SMAD4;SULF2;VWC2L;CRIM1;SORL1;SKI;HTRA3;SMAD6;NIBAN2;THBS1;SPART
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2881475871108318,-1.126591384353195,0.2484076433121019,0.682204444464308,1.0,26/80,19.11%,PLD1;SLC2A13;SAMD4A;LRRTM3;VIM;ROCK2;PRKCD;POLDIP3;PRR16;EIF3C;YTHDF1;NIBAN1;THBS1;SMPD3;EEF2;RBM3;IFNGR1;GSAP;RACK1;PLXNB2;METTL5;NAT10;PCIF1;UPF3A;RPS6KB1;CIRBP
prerank,blood vessel endothelial cell migration (GO:0043534),-0.39015681897853427,-1.1265575325841426,0.28935185185185186,0.6813653704001483,1.0,10/22,25.89%,ROBO1;NRP1;EFNB2;PIK3R3;EPHB4;GPLD1;VEGFA;EMP2;AKT1;NR4A1
prerank,monosaccharide transmembrane transport (GO:0015749),-0.42545743991386487,-1.1264687238017792,0.32272727272727275,0.6806651529865806,1.0,7/16,36.93%,SLC2A12;SLC2A10;SLC50A1;SLC5A3;SLC45A3;SLC2A8;SLC2A9
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.45636231640027347,-1.126363144824794,0.30833333333333335,0.6800248589215823,1.0,4/12,8.17%,DOCK5;IGFBP5;TPM1;ADAMTS1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4344011366961456,1.1258320216307625,0.3118081180811808,0.9720564830363191,1.0,3/18,8.35%,RSC1A1;TRIB3;SLC2A1
prerank,intracellular protein transport (GO:0006886),0.27982034252842736,1.125744356661575,0.1936619718309859,0.9707759643202302,1.0,62/304,13.25%,SURF4;ARF5;ARL5C;ARL4D;EVI5L;RAB5C;CDC37;TBC1D30;TBC1D8;SNX8;MMP12;VPS29;RAB7A;TBC1D9;PHB2;TMED4;VPS26A;SEC23IP;RAB43;TBC1D10B;PTTG1IP;USP6NL;TBC1D4;SYK;RAB6B;NAPA;TMED5;NXT1;IFT22;RABGAP1L;SNX17;RAB6A;NUP50;DESI1;TMED10;RAB14;ACD;XPO5;RANBP17;DNAJC27;TBC1D12;SNX1;ARL5B;ARF1;AP4S1;RAB1A;CCHCR1;TBC1D25;KIF13A;MAIP1;TMED7;SCFD1;RAB5B;RAB22A;STRADB;ADPRH;ARCN1;E2F3;TBC1D14;XPO1;YWHAH;RABGAP1
prerank,transcription by RNA polymerase III (GO:0006383),0.38618739775020117,1.125210377510679,0.30357142857142855,0.9712347795225861,1.0,9/27,18.56%,GTF3C1;ICE1;GTF3C5;RO60;IVNS1ABP;TBP;GTF3C2;POLR3K;POLR3GL
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.40670629598377195,-1.1246392093145872,0.31797235023041476,0.6838026508576904,1.0,8/17,22.14%,SULF1;FSTL1;XIAP;PCSK6;TMEM204;SFRP4;TWSG1;DOK5
prerank,regulation of axon extension (GO:0030516),-0.33602555728305883,-1.1244274432945394,0.26273458445040215,0.683466100335183,1.0,8/37,6.89%,MAP2;NRCAM;PTPRS;MAPT;MACF1;SHTN1;SEMA3A;CTTN
prerank,regulation of ATP metabolic process (GO:1903578),-0.3145585324692398,-1.1242799764512827,0.2552083333333333,0.6829385192564529,1.0,23/54,24.94%,PRKAG2;OGT;PRKAG1;ATP7A;NUP205;NUP155;FIS1;NUP188;NUP88;NUP93;SEH1L;COX7A2L;ATP5IF1;NUP85;AAAS;RAE1;SLC25A33;PINK1;NUP37;NUP214;PGAM1;UQCC2;SEC13
prerank,smooth muscle tissue development (GO:0048745),-0.48427916654329095,-1.1241487540153088,0.3443298969072165,0.6823484933807376,1.0,6/10,29.85%,BMP4;SMO;EFEMP2;STRA6;PTCH1;MYLK
prerank,organelle fission (GO:0048285),0.412724931027691,1.1238347723080544,0.3102836879432624,0.9750690543276318,1.0,7/24,17.28%,PEX11G;DNM3;MTFR1;ACOT8;MIEF1;DNM1L;CORO1C
prerank,regulation of catecholamine secretion (GO:0050433),-0.36415819940608485,-1.1236556548258876,0.2541176470588235,0.6827701609708772,1.0,13/29,30.44%,SYT9;SYT12;SYT11;SYT4;SYT7;STX1A;SYT2;KCNA2;GRK2;SYT10;SYT6;SNCA;DRD2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.42301933090938754,1.12344878028141,0.29701230228471004,0.9749171655901702,1.0,7/19,17.77%,PTPRJ;PTPRC;SELP;PRNP;ADGRL1;BCAP31;RYR2
prerank,positive regulation of lyase activity (GO:0051349),-0.4334758132032346,-1.1230873749936205,0.30515463917525776,0.6834486691308783,1.0,3/14,3.09%,CACNA1C;CACNA1D;STIM1
prerank,glucose homeostasis (GO:0042593),0.32714306304109697,1.123002320567067,0.2664714494875549,0.975060459623361,1.0,12/83,11.08%,PCK1;HECTD4;PYGL;SELENOT;WFS1;ADIPOR2;SIRT1;CYB5R4;PARK7;PRKAA2;BAD;ADIPOR1
prerank,monocarboxylic acid transport (GO:0015718),-0.3208642352737595,-1.1227705229900216,0.25984251968503935,0.6834160157796731,1.0,14/51,19.18%,SLCO3A1;SLC16A12;SLC6A13;SLC16A7;SLC6A12;RXRA;SLC27A1;NCOA1;SLC16A11;STARD5;ATP8B1;SLC16A2;SLC5A6;SLC16A9
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.30861423723686116,-1.122715006786343,0.22646310432569974,0.6826410245390778,1.0,15/56,18.68%,ANK3;SON;SPIRE1;RHOA;ROCK2;CIT;ROCK1;IST1;BIN3;RHOB;MITD1;TRIM36;STMN1;JTB;SNX18
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2963120786215774,1.122606244646795,0.22356091030789826,0.9749918712487804,1.0,33/161,14.00%,PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FRZB;RUVBL2;GREM1;TPBG;PSMD11;APOE;SOX2;PSMB4;PSMC1;CCDC88C;PFDN5;AXIN1;WNT5A;SOX13;LATS2;PSMC2;PSMD2;TMEM131L;TLE4;CUL3;PSMD14;DDIT3;PSMC6;PSMD1;APC;PSMB1
prerank,regulation of gluconeogenesis (GO:0006111),-0.3650396014394157,-1.1225054926201465,0.2684729064039409,0.6823340512090339,1.0,14/27,23.88%,OGT;DDB1;PPARGC1A;SIK1;ARPP19;CRY1;SIRT7;SELENOS;USP7;PTPN2;ZNF692;DGKQ;CLK2;C1QTNF3
prerank,peptidyl-proline modification (GO:0018208),0.40352703687136615,1.1221686268816238,0.29965156794425085,0.9751139142568525,1.0,5/25,6.18%,PIN1;PPIB;PPIG;P3H2;PPIL3
prerank,fatty acid elongation (GO:0030497),-0.4443512063219512,-1.1217093048284514,0.332579185520362,0.6836385546263616,1.0,4/13,7.28%,HACD3;HACD1;HACD4;TECR
prerank,histone modification (GO:0016570),-0.2729679677728181,-1.1216256537780565,0.20655737704918034,0.682908109092306,1.0,31/109,16.65%,EYA2;EYA1;PRDM5;MIER1;HDAC4;NSD3;TBL1XR1;UBE2N;UFL1;HDAC1;SIRT2;KDM4A;PHF20;MORF4L2;PRKCD;ENY2;MTA3;HLCS;MIDEAS;MORF4L1;HUWE1;EHMT2;MTA1;TBL1X;RCOR3;PHC1;MAP3K12;SIRT7;SGF29;TAF6;USP16
prerank,small GTPase mediated signal transduction (GO:0007264),0.31552392863246387,1.1215260182893623,0.24386724386724387,0.975931121679476,1.0,24/103,12.99%,RALB;TRIM28;TIAM1;PLK2;NUCB2;RERG;NRAS;RRAD;RASGRP3;RALA;CDKN1A;KRIT1;GNB1;GRAP;CCDC88C;ARHGEF18;RAPGEF5;RAPGEF6;PARK7;NF1;CRKL;G3BP2;RIT1;RRAGC
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.32824183654141703,1.1211485140248787,0.2710843373493976,0.9758026070373297,1.0,16/73,14.62%,CTCFL;EZH2;EED;POLR1C;ACTB;EP300;TDG;POLR1G;BMI1;WBP2;TBP;HDAC5;PPHLN1;TRIM27;TASOR;AEBP2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.4608756486833806,1.1211198395266675,0.34150943396226413,0.9743407621083928,1.0,3/14,4.58%,MAP3K7;TIRAP;TNFRSF10B
prerank,actin filament bundle organization (GO:0061572),-0.3479253109971279,-1.121029218641154,0.26354679802955666,0.6836255866009464,1.0,5/33,4.60%,CALD1;PAWR;DPYSL3;LIMA1;NEDD9
prerank,response to estrogen (GO:0043627),0.3905409405574901,1.120850294208788,0.3112244897959184,0.9737210120541324,1.0,6/31,10.45%,ARID5A;EP300;TRIM25;CITED2;WBP2;ESR1
prerank,blood vessel morphogenesis (GO:0048514),0.34755483259947845,1.120770685145119,0.2785388127853881,0.9724824575135957,1.0,13/54,12.06%,SLC1A1;CDH2;EGFL7;RAMP2;TBX1;SYK;SMAD7;HEY2;RASIP1;RBPJ;CYP1B1;FLT1;NF1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4179285460417492,1.120692853689764,0.30035971223021585,0.9711996461266472,1.0,3/22,5.45%,MAP3K7;CYRIB;B2M
prerank,regulation of secretion by cell (GO:1903530),-0.3095922476453985,-1.1206429337751473,0.24866310160427807,0.6837699911178857,1.0,27/54,35.92%,RIMS1;RAB3C;SNCAIP;RAB8B;SCG5;SYN1;STXBP5;ANXA1;VAMP2;RAB8A;RHBDF1;P3H1;CPLX1;VAMP8;LLGL1;CAMK2A;RAB13;DNAJC1;KCNMB4;RAB3D;LGI3;RAB21;LLGL2;RAB3B;CPLANE2;RAB3A;CPLX2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4381622659521648,1.1205676465459642,0.3411978221415608,0.9701194383458188,1.0,5/19,11.20%,AEN;HIPK2;EP300;SIRT1;CDIP1
prerank,lymphocyte differentiation (GO:0030098),0.3342671330308777,1.1203831571872038,0.28463855421686746,0.9691971467301881,1.0,11/68,11.50%,DCAF1;JAG2;PTPRJ;PTPRC;HDAC9;GPR89B;GPR89A;CEBPG;LFNG;KLF6;PIK3CD
prerank,regulation of interleukin-1 production (GO:0032652),-0.429910708274849,-1.1203090865219123,0.3302752293577982,0.6837033907705714,1.0,3/15,12.79%,FOXP1;ANXA1;SIRPA
prerank,DNA repair (GO:0006281),0.28155458333982264,1.120044235079787,0.20668316831683167,0.9689222746331472,1.0,69/284,17.81%,ERCC3;ZRANB3;ABRAXAS1;RAD18;TRIM28;ALKBH2;PNKP;ERCC4;RAD1;HPF1;XRCC1;CIB1;TENT4A;POLK;APLF;MAPK8;TDG;ACTR8;POLE;PMS2;SIRT1;ACTR5;DCLRE1B;UBE2V2;EYA3;POLD3;USP47;MLH1;PMS1;GTF2H1;SPRTN;POLA1;RAD23A;RFWD3;EXD2;MSH3;PARK7;UBE2V1;ASCC3;RAD51B;SMUG1;APTX;HUS1;KMT5B;PWWP3A;NBN;DOT1L;TRRAP;MPG;BRCC3;PPP5C;CHEK2;FANCL;NSD2;BRIP1;BACH1;INO80;FTO;ATR;ENDOV;WDR33;XRCC4;SETD2;PRKDC;ATXN3;NPM1;DCLRE1C;POLH;RAD23B
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.34406847173525124,1.1200320969607738,0.2890262751159196,0.9674296688583374,1.0,12/62,10.96%,TXNDC12;CXCL12;BCL2L2;SRC;PTTG1IP;SIRT1;SOD2;MDM2;PARK7;CCAR2;DDX3X;HYOU1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4566523462324094,-1.1194644544322156,0.30837004405286345,0.6851292159990499,1.0,1/11,1.32%,AKAP6
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3339288851044655,1.11932626747053,0.28592814371257486,0.968601382790952,1.0,19/69,14.40%,CYCS;NDUFAF1;UQCC3;NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;SDHA;NDUFB7;COX15;UQCRB;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,regulation of neuroinflammatory response (GO:0150077),-0.3953200493787564,-1.1191643295162965,0.2857142857142857,0.6850578880702303,1.0,5/19,19.89%,IGF1;NUPR1;IL18;IL33;PTGS2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.33943935847323364,-1.11881857410918,0.2558746736292428,0.6850464651612513,1.0,14/37,25.04%,IGF1;IGFBP5;TPM1;TAFA5;CDKN1B;ADAMTS1;GJA1;JUN;BMPR1A;DNMT1;MMP2;EFEMP2;TGFB3;MEF2D
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4124716547543407,1.1185045494260593,0.29642857142857143,0.9701834450636324,1.0,3/22,4.90%,PSMB10;PSMB6;PSMB4
prerank,defense response to symbiont (GO:0140546),0.32093977043859334,1.1183117371387172,0.2733812949640288,0.9694100450467253,1.0,19/92,13.09%,PTPRC;IFNLR1;IFITM2;IFIT1;RNASE6;MLKL;IFITM3;CNOT7;IFITM1;RELA;NCBP3;SERINC5;SERINC3;ATG7;IFI27;BNIP3L;AGBL5;IRF2;NLRC5
prerank,negative regulation of cell junction assembly (GO:1901889),-0.36707271382232337,-1.118149397633977,0.28428927680798005,0.685902020325523,1.0,9/25,18.50%,ROBO2;PHLDB2;ROCK2;ARHGAP6;ROCK1;THBS1;DUSP22;ACE;APOD
prerank,gastrulation (GO:0007369),-0.4253612752360852,-1.1178830117043155,0.3068893528183716,0.6857612257742509,1.0,3/15,12.25%,GPC3;LRP5;UGDH
prerank,response to ethanol (GO:0045471),0.45413404488856846,1.1178225341437733,0.32220039292730845,0.9697085378270794,1.0,3/14,4.49%,SOD1;GOT2;SDF4
prerank,sodium ion homeostasis (GO:0055078),-0.38694697942919576,-1.1177767786100916,0.2937062937062937,0.6851633448947482,1.0,6/21,9.45%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;ATP1B2
prerank,ameboidal-type cell migration (GO:0001667),0.3503810771691381,1.1174625680716366,0.28343949044585987,0.9694570831906474,1.0,10/51,9.74%,SEMA6A;SEMA6D;SEMA7A;PKN3;SEMA3C;TBX1;AMOTL1;SEMA6B;SEMA4C;PKN1
prerank,actin nucleation (GO:0045010),0.4203754835869037,1.117462340523436,0.3067375886524823,0.9679260094463918,1.0,7/21,15.42%,ARPC3;ARPC5L;ARPC4;ARPC5;TRIM27;LMOD1;WHAMM
prerank,hyaluronan metabolic process (GO:0030212),-0.3788580050669168,-1.117415508862262,0.3185011709601874,0.6852295060697556,1.0,17/23,52.54%,CEMIP;CEMIP2;HEXA;HEXB;TGFB1;GUSB;HYAL1;SLC9A1;CHP1;HAS1;HYAL2;LYVE1;HAS2;HMMR;HAS3;HYAL3;STAB2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.40948875222650666,-1.1173097539797454,0.32027649769585254,0.6845685532355895,1.0,6/16,24.20%,VIM;BMP4;WNT4;TGFB1;CREB3L1;TGFB3
prerank,dopaminergic neuron differentiation (GO:0071542),0.4307141261672317,1.1167413860568425,0.3197879858657244,0.9690973241421994,1.0,2/19,3.05%,NR4A2;MANF
prerank,metal ion homeostasis (GO:0055065),0.37677975584411166,1.116728196964272,0.2861736334405145,0.967627578796287,1.0,4/40,5.19%,SLC12A1;SLC7A8;TMTC2;WFS1
prerank,skeletal muscle organ development (GO:0060538),-0.37024064743737894,-1.1165596515817415,0.291358024691358,0.685785025604299,1.0,7/26,24.61%,SVIL;CFLAR;IGSF8;LARGE1;SIX1;STRA6;BASP1
prerank,proteoglycan biosynthetic process (GO:0030166),0.3889689247104472,1.116290448322605,0.30256410256410254,0.9677217706469333,1.0,6/31,9.20%,NDST3;CSGALNACT1;XYLT1;EXT2;PXYLP1;B3GAT2
prerank,peptidyl-lysine acetylation (GO:0018394),0.48941252763166143,1.1161698466188,0.3090551181102362,0.9666662517022833,1.0,4/10,11.07%,EP300;SIRT1;ESCO1;CREBBP
prerank,smoothened signaling pathway (GO:0007224),-0.3428373692057092,-1.115612857664019,0.2807017543859649,0.6874699333888474,1.0,8/32,11.86%,GLI2;GLI3;CC2D2A;SMO;EVC2;HIPK1;ARL13B;TTBK2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.4368678658999168,1.1155375587478966,0.3419593345656192,0.9676023813350724,1.0,4/17,14.59%,BOD1;CHAMP1;MIS12;MTBP
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.26428217764440043,-1.1152630747654295,0.23553719008264462,0.687503873576766,1.0,14/113,5.83%,BMP6;FGFR2;NOTCH2;IGF1;EGFR;NRP1;FGF1;TGFBR1;BMP5;BMP4;RREB1;OSR1;SRSF6;F3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.2929961965110973,-1.1150842202643931,0.24545454545454545,0.6870854393535305,1.0,20/73,16.68%,ROBO1;SMAD3;CFLAR;COL4A3;MAPT;CASP8AP2;F3;VCP;XDH;FAM162A;IFT57;ANP32B;CASP12;HIP1R;RACK1;HSPD1;NGF;EGLN3;TRAF2;MTCH1
prerank,activation of protein kinase activity (GO:0032147),-0.272168726574458,-1.1149342681337604,0.19732441471571907,0.6866046757820916,1.0,40/106,25.11%,NTRK3;IGF1;ADCY5;ADCY2;FGF1;ADCY1;TGFBR2;PRRC1;PIBF1;MALT1;ADCY9;GHR;TAOK3;PRKCD;IRAK1;PRKACA;STRADA;STK11;ADCY7;PAK5;PRKAR1B;TAOK1;IL18;TOM1L1;TRAF2;CARD10;PINK1;CARD14;PRLR;OSBPL8;ADCY3;ADCY8;VEGFA;ADCY4;ITGB1BP1;EMP2;NRK;AKT1;ADRA2A;TLR3
prerank,negative regulation of cell cycle (GO:0045786),-0.28996913775649263,-1.1147422911562392,0.23303834808259588,0.6862292890712023,1.0,16/73,12.51%,NR2F2;SMAD3;BRINP1;BMP7;BMP4;TRIM35;NUPR1;PTPN3;CDKN1B;GAS1;FOXC1;BRINP2;CDK6;CAMK2N1;RHOB;SIPA1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.39131856398614423,1.1146902769743485,0.3277591973244147,0.9694305634170456,1.0,7/30,11.99%,EBP;INSIG1;HMGCR;PLPP6;IDI1;NSDHL;LSS
prerank,ethanol metabolic process (GO:0006067),-0.4511531273620448,-1.114346164047435,0.35639412997903563,0.686511784815234,1.0,6/12,31.99%,ALDH1A1;ACSS2;ALDH2;ADH5;ACSS1;ADH1A
prerank,regulation of axon guidance (GO:1902667),-0.48019084484608165,-1.114317720118207,0.3495575221238938,0.6856680821920483,1.0,6/10,25.46%,NRP1;ZSWIM8;YTHDF1;ZSWIM4;VEGFA;ZSWIM5
prerank,peroxisomal membrane transport (GO:0015919),-0.35285809761314724,-1.1141064993953438,0.28708133971291866,0.6853239844557725,1.0,10/27,18.04%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;PEX6
prerank,cell junction assembly (GO:0034329),-0.2804273868229874,-1.1140653002348937,0.23809523809523808,0.6845216105363797,1.0,41/100,23.52%,SDK1;CDH10;NRXN1;KIRREL3;NRCAM;RYK;DNER;DSCAM;RHOA;TLN1;NLGN2;FLNA;GPM6A;CTNND2;CDH11;SDK2;TLN2;CDH7;GJC1;NLGN1;ARVCF;CDH1;FN1;ILK;NRXN2;OBSL1;PLXND1;CTNND1;SHANK2;CDC42;CDH9;CDH8;CDH19;SLITRK1;DBNL;FLCN;FLNC;DCHS1;NLGN3;FARP1;RAB29
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.34511996194880373,1.1139341914086842,0.2857142857142857,0.9692992903400947,1.0,14/56,13.09%,NDUFAF1;NDUFAF5;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;TIMM21;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.34511996194880373,1.1139341914086842,0.2857142857142857,0.9692992903400947,1.0,14/56,13.09%,NDUFAF1;NDUFAF5;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;TIMM21;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,neural crest cell development (GO:0014032),0.3608933605884616,1.1133052426532555,0.28664495114006516,0.9701290147168956,1.0,8/44,9.12%,SEMA6A;SEMA6D;SEMA7A;CDH2;SEMA3C;TBX1;SEMA6B;SEMA4C
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4086472199481076,1.1132753606129098,0.2896174863387978,0.9687368761059485,1.0,5/23,13.87%,PLAAT3;LPCAT3;MBOAT1;PNPLA8;ABHD4
prerank,protein kinase A signaling (GO:0010737),0.47293354971224355,1.1132002122863656,0.3379721669980119,0.9675201684824075,1.0,1/12,0.56%,LCP1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.38455156180309275,1.1129445576493928,0.29692832764505117,0.9669482242962129,1.0,8/30,13.61%,TNFAIP3;RFFL;TNFRSF10B;ICAM1;PARK7;DDX3X;NOS3;FAIM
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4139955199617419,-1.112434436050508,0.3160270880361174,0.6880479062790393,1.0,7/16,19.16%,APPL2;PPARA;ADCY7;SIRPA;ABCD2;APOD;CHID1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.32108309309106564,-1.1120485977736736,0.266304347826087,0.6882273493540885,1.0,18/43,24.63%,CTNNA1;KAT7;BMP4;ILRUN;GLUL;GSK3B;TGFB1;WWTR1;LIMK2;CARD10;DTX3L;FLCN;YAP1;LAMTOR5;EIF2AK3;OTUD7B;AKT1;SESN2
prerank,cytosolic transport (GO:0016482),0.3124113468931825,1.1117077639987012,0.27715877437325903,0.970154564746172,1.0,35/108,18.89%,VPS50;HEATR5B;SORT1;PREPL;VPS29;RAB7A;VPS26A;TBC1D10B;GOSR2;AP1G1;RAB6B;PIKFYVE;RAB6A;RAB14;AKTIP;SNX1;VPS53;GCC2;DOP1B;RBSN;MYO1D;ERC1;TRIM27;ANKRD27;TBC1D23;CORO7;VPS35;HOOK3;SNX16;BECN1;GAK;KIF16B;HEATR5A;GOSR1;EVI5
prerank,epithelial to mesenchymal transition (GO:0001837),-0.31351978657076485,-1.1115002480776568,0.29023746701846964,0.6888128686840899,1.0,12/47,11.62%,DDX5;TGFBR3;DDX17;TGFBR1;CTNNB1;BMP7;ROCK2;ROCK1;WNT4;GSK3B;LOXL3;TBX3
prerank,cholesterol metabolic process (GO:0008203),0.33458047410460423,1.1114711090728244,0.31008902077151335,0.9696056480886135,1.0,13/68,12.68%,EBP;INSIG1;HMGCR;PLPP6;APOE;SOAT1;PPARD;SNX17;OSBPL1A;IDI1;NSDHL;LSS;LDLRAP1
prerank,heme biosynthetic process (GO:0006783),0.41012187744116657,1.1113744516304087,0.3148479427549195,0.9684822493367379,1.0,9/22,18.59%,ABCB10;ABCG2;TSPO;COX15;COX10;SLC25A38;ALAS1;FECH;NFE2L1
prerank,leukotriene metabolic process (GO:0006691),-0.3901917650615031,-1.1107130678143522,0.3,0.690074528238686,1.0,14/19,55.80%,PLA2G4A;GGT5;MAPKAPK2;ABCC10;MGST3;ALOX12;LTA4H;PTGR1;GGT1;PLA2G5;ALOX5AP;MGST2;ALOX5;DPEP1
prerank,thyroid hormone generation (GO:0006590),-0.4721650467412323,-1.1106272777894617,0.3236514522821577,0.6893710601336795,1.0,3/10,24.74%,CPQ;SLC5A5;CTSK
prerank,detection of mechanical stimulus (GO:0050982),-0.4012318900756945,-1.1105475720507232,0.31797235023041476,0.6887066625198102,1.0,3/19,5.60%,PKD1;CTNNB1;PIEZO2
prerank,negative regulation of cellular process (GO:0048523),-0.22531083620521627,-1.1102743550599523,0.08139534883720931,0.6885272255852198,1.0,178/521,27.85%,MAGI2;ERBB4;ST18;TGFBR3;PLXNA2;ADAM22;ALDH1A2;SMAD3;KANK2;CLMN;VPS13C;TNS2;FBLN1;FHL1;CCN2;PTPN14;BRINP1;PACRG;COL4A3;BMP5;ABI1;CTNNB1;PDPN;BMP7;SMAD4;DSCAM;RBBP7;ATP8A2;SIRT2;IGFBP7;BMP4;NUPR1;ZBTB7C;LMNA;PDS5B;ENPP1;PIP4P2;APPL2;SRSF6;MYO16;VGLL4;FRK;PML;PODN;SKI;GSDME;IGFBP6;CDKN1B;CDC73;ADAMTS1;NDUFS3;SMAD6;ANP32B;NIBAN2;DLG3;SERTAD2;CGRRF1;EIF2AK2;BRD7;CDK6;PLSCR1;SPEG;GJA1;EPHB2;CAMK2N1;DDAH1;TP53;SEMA4D;NOX4;STK11;CD34;RHOB;ACVR1B;SYT11;SIPA1;TNFRSF21;SIRPA;WNT9A;P3H3;FKTN;PDCD5;PLXND1;NF2;ROR2;RACK1;DUS2;ARHGDIA;TOB1;NACC2;PLXNB2;SIRT7;RAF1;PTPRU;NGF;PLXNC1;GPLD1;CBLL1;NPAS2;RAPGEF2;TAF6;TGFB1;RNF139;CCN3;S100A11;PTPN2;NPR1;SMYD2;OPRM1;SFRP4;TSC2;CRYAB;RNF167;SNX3;ORC6;SUZ12;MDM4;SEMA5A;ATF5;TGFBI;BMPR2;BLM;DNAJB2;ITGA1;PARP16;BCL2;CCN5;TMEM109;COL18A1;ADRA1A;P3H1;CCN1;PRKD1;ARHGDIB;FLCN;IFIT3;HGS;MNT;IMPACT;EMILIN1;DUSP1;TBRG1;KLF10;UBR2;OSGIN2;ANXA6;ITGB1BP1;TSPYL2;BST2;VAMP8;TGFB3;EIF2AK3;BTG2;PLXNB1;NR1H2;SESN2;AQP11;HYAL1;SFRP1;ADGRG1;APBB1;NR4A1;NOTCH4;CCN4;ZBTB17;DLG5;TEX15;VHL;PLXNA1;DCBLD2;CELF1;RBM5;SH3BP4;FGFBP1;INHBA;CHERP;KLF11;DACT3;NME6
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.4409208159278958,-1.1101616841043975,0.32537960954446854,0.6879161645280036,1.0,10/13,52.14%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;GAL3ST3;B3GNT6;B4GAT1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3940521412775011,1.1096746631027405,0.3220640569395018,0.9732162417059245,1.0,6/26,9.91%,FYN;SIRT1;TXN;SOD2;PARK7;FBXO7
prerank,cell cycle checkpoint signaling (GO:0000075),0.47306187420950074,1.109613379204181,0.3382899628252788,0.9719450392702063,1.0,4/12,10.98%,PLK2;PRCC;WEE1;CHFR
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.43870048521149774,-1.1095548578664831,0.32298136645962733,0.6886976811174262,1.0,3/13,7.03%,SORBS1;IGF1;AKT2
prerank,cytoskeleton organization (GO:0007010),-0.2704903666131295,-1.1092218048423548,0.2225705329153605,0.6887307400678565,1.0,55/114,28.79%,EPB41L3;MICAL2;PCLO;PDZD8;ARHGAP10;CDC42BPB;TPM1;RHOA;PLCE1;NEDD9;SYNE3;MICAL3;ZMYM6;PALLD;KLHL20;RND3;BIN1;FGD1;RHOBTB2;RANBP10;CNN2;SPRYD3;PAK5;LIMD1;RHOB;OBSL1;SIPA1;RHOBTB1;RANBP9;FGD4;PPP2R3C;BRWD1;STRIP2;DIAPH1;FMNL2;ARAP3;DIAPH3;CAPZB;PACSIN1;SIPA1L3;ZMYM3;CCL13;NECTIN2;RHOC;RHOU;MAST3;CNTNAP1;DMTN;FGD3;MICAL1;RHOH;CSPG5;MDK;BRWD3;AJUBA
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3715355808093981,-1.1091784862861607,0.29095354523227385,0.6879147437180729,1.0,9/25,21.40%,SULF1;FOXD1;SMAD4;BMP4;BMPR1B;ZNF423;BMPR1A;BMPR2;CCN1
prerank,phagosome maturation (GO:0090382),0.36997959023288574,1.1091342187254651,0.30204778156996587,0.9722794066575448,1.0,7/35,8.45%,ATP6V1D;RAB7A;RAB43;ATP6V0D1;PIKFYVE;RAB14;ATP6V0E1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3800002251274563,1.108878419526488,0.32229965156794427,0.9717076984307029,1.0,8/32,11.08%,PCK1;FITM2;NR5A1;APOE;ASXL3;ADIPOR2;PRKAA2;ADIPOR1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3455839362767923,1.108538982377111,0.2900158478605388,0.971574234128655,1.0,17/54,17.96%,PLK2;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;CARM1;CNOT6;CHEK2;CNOT1;CNOT6L;CNOT10;BAX;RPL26
prerank,organic acid transport (GO:0015849),-0.2791129479415209,-1.108475450902352,0.2549019607843137,0.6889472641377488,1.0,23/94,17.59%,SLC7A11;ACSL1;SLC6A13;SLC13A3;SLC7A2;PDPN;LRRC8D;SLC26A7;SLC7A14;SLC1A5;SLC6A12;SLC25A32;RXRA;SLC27A1;SLC6A15;NCOA1;SLC25A47;SLC22A6;STARD5;ATP8B1;SLC19A1;SLC16A10;SLC5A6
prerank,regulation of blood coagulation (GO:0030193),-0.35769704455199847,-1.1081669654059259,0.29195402298850576,0.6888574281795855,1.0,10/27,25.85%,TFPI;THBS1;FAP;VTN;EPHB2;CD34;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,tRNA methylation (GO:0030488),0.3740957443075413,1.1079647585796986,0.3179650238473768,0.9722069996189864,1.0,6/34,11.84%,TRMO;BCDIN3D;THUMPD2;TRMT61B;METTL2A;METTL2B
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.4892774274378523,1.1077763865686732,0.33460076045627374,0.9714684113395883,1.0,2/11,2.84%,SEMA6A;KLF2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4038124944102244,-1.107756042414159,0.3036529680365297,0.6891066765089408,1.0,2/17,2.80%,PLA2G4A;LPGAT1
prerank,regulation of T cell chemotaxis (GO:0010819),0.48589644840337487,1.1076710707265038,0.3163064833005894,0.9703989222327389,1.0,2/11,8.56%,OXSR1;WNT5A
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.38124595617003293,1.1074763756973605,0.3151618398637138,0.9696431654158039,1.0,5/29,11.52%,LPCAT2;PLAAT3;DBI;LPCAT3;PNPLA8
prerank,regulation of amyloid-beta formation (GO:1902003),-0.34154388826731297,-1.107327895587156,0.30662983425414364,0.6893596906377599,1.0,11/34,12.54%,IGF1;SLC2A13;LRRTM3;NTRK2;RTN1;ROCK2;SORL1;ROCK1;BIN1;IFNGR1;GSAP
prerank,oligosaccharide metabolic process (GO:0009311),-0.3154916660815546,-1.1072548206747168,0.29198966408268734,0.6886804253588517,1.0,13/46,18.88%,AMY1B;AMY1C;AMY1A;B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;ST6GAL2;B3GALT1;ST6GALNAC6;MPDU1;ST8SIA2
prerank,positive regulation of cell differentiation (GO:0045597),-0.24050505611935988,-1.1072093620242685,0.14948453608247422,0.6879251430371455,1.0,36/237,8.36%,BMP6;RANBP3L;IGF1;CTNNA2;DAB2;COL1A1;SMAD3;NRCAM;BOC;NBL1;CDON;NELL1;CTNNA1;CCN2;BRINP1;TGFBR1;MEDAG;MAPK14;SOX5;TGFBR2;CTNNB1;PDPN;BMP7;SMAD4;RHOA;IL6R;BMP4;ZEB1;FBN2;HOXA5;WNT4;TMEM64;LRP5;CREBL2;FOXC1;BRINP2
prerank,ketone body metabolic process (GO:1902224),-0.4701686615907508,-1.106956061314852,0.33266533066132264,0.6877756564969103,1.0,4/10,11.04%,OXCT1;HMGCLL1;ACSS3;HMGCL
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3776934506829942,-1.1068224203630388,0.3191489361702128,0.6872518411205123,1.0,4/23,10.68%,ANK2;ATP1A2;UBASH3B;CAMK2D
prerank,defense response to tumor cell (GO:0002357),-0.48073542354865406,-1.1066738476798383,0.3261802575107296,0.6868302463500863,1.0,8/10,48.43%,RBMS3;DAPK1;PRDX2;ABI3;PLK5;LAPTM5;SPI1;DLEC1
prerank,glutathione metabolic process (GO:0006749),0.36651630060253565,1.1058024369098622,0.2973856209150327,0.9743714342578426,1.0,7/38,13.17%,GCLC;SOD1;GCLM;CNDP2;PARK7;HAGH;GSS
prerank,renal water homeostasis (GO:0003091),-0.3768593950850804,-1.1057968974047183,0.2942583732057416,0.68840987854754,1.0,9/23,13.00%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;AQP4;ADCY7;PRKAR1B;RAB11A
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.3459841116162462,-1.1054110304632059,0.2989949748743719,0.6884850813048615,1.0,12/33,28.26%,TEAD1;SMAD3;TP53;TGFB1;JUN;NR3C1;GNL3;KLF5;ATOH8;GATA2;EGR1;FOXO3
prerank,regulation of mRNA stability (GO:0043488),0.2955622869798424,1.1051607197994304,0.2622739018087855,0.9753281593672762,1.0,32/145,16.61%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;HSPA8;ZFP36L1;PSMD11;PSMB4;PSMC1;FXR1;YWHAB;EXOSC9;PCID2;PSMC2;PSMD2;TAF15;ZC3H14;XPO1;PSMD14;EXOSC1;PSMC6;PSMD1;PSMB1;YBX1;DCP1A;FUS;NOCT;FTO;PARN;PSMA4
prerank,autophagosome maturation (GO:0097352),0.37571053133280785,1.105038653088479,0.32167832167832167,0.9742896588088827,1.0,12/32,18.88%,MAP1LC3B;ATP2A2;VMP1;EPG5;TECPR1;UBQLN1;ATG14;GABARAPL1;VPS33A;GABARAP;CALM1;LAMP2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.42480425033837355,1.1047531071131003,0.30654205607476637,0.9738880168413742,1.0,2/19,5.93%,CABYR;RFX3
prerank,response to amino acid (GO:0043200),-0.34961574804267237,-1.1047523317101837,0.2994791666666667,0.689470213947432,1.0,6/31,7.73%,CPEB4;CPEB1;GLRB;CAPN2;GLRA3;GLRA1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3234234193160804,-1.104625505876474,0.2857142857142857,0.6889752190897906,1.0,8/39,9.91%,PKD1;GLI2;NRP1;TGFBR2;CTNNB1;BMP4;LRP5;SALL1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3642795074139077,1.104550995572856,0.31758957654723124,0.9731643359290071,1.0,10/36,13.91%,PTPRC;OCIAD1;NOTCH1;IL10RB;NLK;CYP1B1;ADIPOR1;CENPJ;DOT1L;HES1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3751149146888103,1.1041081760282168,0.2984822934232715,0.9733822961566131,1.0,9/32,14.76%,ACER2;SRC;CLASP2;MMP12;NEXMIF;ACVRL1;HOXA7;MAP4K4;SEMA3E
prerank,cell junction organization (GO:0034330),-0.28882361960027514,-1.104004908945108,0.267741935483871,0.6898758556218716,1.0,15/71,7.34%,SDK1;GRM5;SMAD3;PPFIBP1;CXADR;MAPT;OCLN;RHOA;NLGN2;SLC6A1;FLNA;PPFIA1;RAB8B;CTNND2;SDK2
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.33760387219643745,-1.103962935839569,0.32273838630806845,0.6891277554932839,1.0,13/36,16.57%,ANK3;VAMP5;MACF1;RILPL1;RAB31;GGA2;OPTN;AFDN;VAMP2;BBS2;NECTIN3;GOLGA7;GGA3
prerank,response to calcium ion (GO:0051592),-0.27354100823538796,-1.1038684999531163,0.2251655629139073,0.688477187915375,1.0,26/102,15.95%,KCNMA1;CPNE8;RYR3;IQGAP1;SEC31A;STIM1;ADCY1;CLIC4;ADGRV1;SLC25A13;ANXA11;SYT9;NLGN1;TRPC1;THBS1;LGMN;CAMK2D;SYT12;SYT11;SYT4;RASGRP2;CPNE2;SYT7;GPLD1;PEF1;D2HGDH
prerank,nucleocytoplasmic transport (GO:0006913),0.35946695614594626,1.1034633397014144,0.30033557046979864,0.9742414142359489,1.0,7/40,9.26%,SNRPD2;NCBP1;SNRPD1;BACH2;NXT1;GEMIN5;RSRC1
prerank,positive regulation of locomotion (GO:0040017),0.4001133399091471,1.103168497210587,0.32098765432098764,0.9739285325580632,1.0,2/27,0.42%,PHPT1;SPOCK2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3473113558231852,1.1031120989378977,0.3168469860896445,0.9726745388477948,1.0,8/50,10.50%,ACTB;STOX1;CDC37;CCNH;CDKN1A;GTF2H1;CCNG2;BCCIP
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3843412542504513,-1.1028439523266031,0.32547169811320753,0.6904384679908954,1.0,5/22,3.75%,MAP2;MAP1B;AEBP1;AKAP13;MAPT
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.4387006943347507,1.1025934020017936,0.35714285714285715,0.9732004657975662,1.0,4/16,6.85%,ATP5F1E;ATP5MG;ATP5PF;ATP5MC2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3256785449442672,1.1022880848982333,0.29022556390977444,0.9729532581232169,1.0,13/72,11.82%,MAZ;PIK3CG;CBL;PIK3AP1;SRC;TEK;SELP;SIRT1;IRS2;LYN;FLT1;PIK3CD;PIK3R5
prerank,regulation of transport (GO:0051049),0.3677264874777873,1.101769924632997,0.3106796116504854,0.9735398054228563,1.0,6/36,11.58%,RSC1A1;ACTB;ICA1;EPB41;MBTPS1;SCFD1
prerank,regulation of centrosome duplication (GO:0010824),0.37942186889582485,1.101694163186444,0.3286467486818981,0.9723713592333343,1.0,9/30,18.11%,ALMS1;PLK2;CHMP1A;SIRT1;CHMP2A;CENPJ;NPM1;VPS4B;CENATAC
prerank,endomembrane system organization (GO:0010256),0.2906882036989966,1.1016526141445577,0.26745718050065875,0.9710801932232078,1.0,29/178,10.19%,SURF4;SYNE1;SMPD4;LYSMD3;GORASP2;EXOC8;CLASP2;LEMD3;LMAN2;ATL1;VPS11;TMED4;SEC23IP;RAB43;SYNGR2;TRAPPC8;LAMTOR1;USP6NL;ARHGEF7;TRIP11;VMP1;TMED5;TMED10;REEP3;AKTIP;RAB1A;GOLPH3L;TRAPPC11;DOP1B
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.4912806972270923,1.10161301013378,0.3460764587525151,0.9697671297499207,1.0,1/10,0.88%,SEMA6A
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.34581674169737314,-1.100857369803613,0.31909547738693467,0.6949712428231837,1.0,24/29,64.48%,SIRT7;BAG6;RAD21;PRDM9;P3H4;TERB1;MEI4;FANCD2;ZCWPW1;TEX11;REC8;TRIP13;SYCE2;MAJIN;MEIOB;TEX12;STAG3;IHO1;SYCP2;RAD21L1;RNF212B;ANKRD31;HORMAD1;TERB2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.39899595695968126,1.1004985270752417,0.3466666666666667,0.972437245283279,1.0,7/26,16.11%,RRM2B;ALG6;TPI1;ALG8;ST8SIA6;RRM1;GBGT1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4310267812808899,1.100047065835613,0.3493761140819964,0.9726338090627334,1.0,5/18,15.68%,PSEN2;TMCC2;APOE;LDLRAP1;APH1A
prerank,response to alcohol (GO:0097305),-0.35961701967447857,-1.0999666082848358,0.3195121951219512,0.6965800853944084,1.0,5/27,7.73%,TGFBR3;GRIN2B;TGFBR1;TGFBR2;GLRA1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3200280629655034,-1.099956903832477,0.276536312849162,0.695717225302437,1.0,7/46,5.33%,ATP1A2;DGKI;NRXN1;GRM5;TSHZ3;NLGN2;RELN
prerank,regulation of cell projection organization (GO:0031344),-0.43952547231690475,-1.0998440799420297,0.3431578947368421,0.6951833326209432,1.0,4/13,15.50%,NTNG1;MACF1;SEMA4D;ERMN
prerank,glycogen catabolic process (GO:0005980),-0.4183291628347161,-1.099707756982119,0.3574561403508772,0.6946666113570692,1.0,7/15,19.38%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.29243082308499385,-1.0996934348626202,0.3025936599423631,0.6938281308407086,1.0,12/63,8.12%,TIMP3;LEPR;TIMP2;NELL1;SIRT2;NUPR1;KDM4A;KLHL22;SORL1;ROCK1;PTPN3;GOLGA2
prerank,brain development (GO:0007420),-0.2592568810265739,-1.0996660358170718,0.21454545454545454,0.6930218908011011,1.0,58/136,31.51%,ROBO2;CNTN4;ZIC1;CTNNA2;ARNT2;PBX1;GRIN2B;NFIB;AFF2;NCOA6;TGFBR2;EPHA7;MEIS2;FBXW11;RELN;HSPG2;NIPBL;SMARCA1;ZIC2;ATXN1;SCYL2;NNAT;CTNS;CIC;BBS2;PLXNB2;RAPGEF2;NES;PBX4;SOX6;APOD;BPTF;PBX2;SMG9;GRIN2D;GRIN1;BAG6;IER3IP1;PCDH18;PAX2;NDRG4;PTCH1;ADGRG1;DDIT4;CX3CR1;POU6F1;EEF1AKMT4-ECE2;UTP3;AATK;SLC6A17;QARS1;MDGA1;TMX2;CLN5;COL4A1;CDK5RAP3;VPS51;MFSD2A
prerank,positive regulation of protein metabolic process (GO:0051247),0.3037312407523439,1.0994801942840533,0.28995756718529,0.9732264009803953,1.0,20/110,13.89%,GSK3A;ABCB10;TNFAIP3;PLK2;KLF2;MAP2K5;NEDD4L;APOE;RAB7A;WFS1;MAPK8;AXIN1;WNT5A;RAB1A;APP;ATG7;EGLN2;NDUFA13;APC;NFKBIA
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3877799508889317,-1.099230066773786,0.3270588235294118,0.6932933002009686,1.0,5/20,9.97%,AKAP13;ADCY9;ADRA1B;LMBRD2;ZDHHC21
prerank,manganese ion transport (GO:0006828),-0.4222670366806759,-1.0990805439688178,0.34743875278396436,0.6927815813612102,1.0,7/14,22.43%,TRPC5;SLC39A14;SLC30A10;TRPC1;SLC39A8;SLC11A2;TRPC6
prerank,"wound healing, spreading of cells (GO:0044319)",-0.3659636653787403,-1.0987896560405188,0.30788804071246817,0.6926711677899945,1.0,7/24,6.53%,TMEFF2;COL5A1;PDPN;RHOA;FLNA;DDR1;ITGA5
prerank,epithelial cell differentiation (GO:0030855),-0.2773157302916511,-1.0982232499449998,0.2546583850931677,0.6933785985421369,1.0,35/88,30.98%,ERBB4;FGFR2;DAB2;FSTL1;MAF;HDAC1;BMP4;ANXA4;VDAC1;CPT1A;AKT2;PTER;ANXA1;SCUBE1;TOLLIP;ANXA7;SIX1;TAGLN2;FZD7;PGK1;PCK2;GLI1;KDM6B;VEGFA;AKT1;BASP1;PAX2;TAGLN;E2F4;CTSB;PCNA;SCRIB;ALDOC;PIH1D1;GATA6
prerank,defense response to virus (GO:0051607),0.311965976789123,1.0982173672926163,0.29353932584269665,0.9765274410436187,1.0,20/100,13.09%,PTPRC;IFNLR1;IFITM2;IFIT1;RNASE6;MLKL;PHB2;IFITM3;CNOT7;IFITM1;RELA;NCBP3;SERINC5;SERINC3;ATG7;IFI27;BNIP3L;AGBL5;IRF2;NLRC5
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.32210757453219707,-1.0980918951056622,0.28835978835978837,0.6928872309737215,1.0,12/41,20.68%,ANK3;JAK1;BMP7;PLPP3;ADAM19;AFDN;DENND6A;PTPRU;MEGF10;PTPN23;FLOT1;CX3CL1
prerank,actin filament depolymerization (GO:0030042),-0.4534334936149688,-1.0978586829580033,0.3558951965065502,0.6926475875059321,1.0,5/11,17.61%,GSN;MICAL2;MICAL3;WDR1;TWF2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.47173117204865705,-1.0977559768200313,0.3649484536082474,0.6920531863954222,1.0,1/10,0.36%,ANK3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.310426741551734,1.0976143907965639,0.2994350282485876,0.9772752682155177,1.0,17/93,11.27%,PDE4D;MTCP1;RPTOR;STOX1;BCAR3;PRKD2;CNKSR3;RAPGEF3;BDNF;SMAD7;TXN;AXIN1;PAK1;PARK7;DOCK7;DMD;APP
prerank,negative regulation of viral genome replication (GO:0045071),0.3574341717113288,1.0971388517932015,0.32078559738134205,0.9776099157596742,1.0,7/40,10.59%,ILF3;BANF1;IFITM2;IFIT1;IFITM3;IFITM1;SRPK2
prerank,post-translational protein modification (GO:0043687),0.27154820803963386,1.0968807417229887,0.23563892145369286,0.9771630794542046,1.0,57/332,14.00%,CISH;PSMB10;PSMC4;PSMB6;CAND1;ELOC;RNF7;PSMD8;PSMD5;PSMD12;KLHL5;KLHL3;FEM1C;CHML;BTBD1;CHM;CDH2;PSMD11;NEURL2;PTP4A2;APOE;PSMB4;FBXL5;WFS1;RAB11B;PSMC1;PDIA6;VWA1;FBXW2;DCAF6;COP1;LMO7;KLHL2;FBXO32;FBXO11;ESCO1;RAB1A;PSMC2;PSMD2;FBXO7;UBE2M;ICMT;MBTPS1;NAE1;STT3B;COPS7B;APP;ELOB;CUL3;DCAF10;PSMD14;EPAS1;UBE2F;PSMC6;PSMD1;PROC;PSMB1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.34622755608656863,-1.0967884507894252,0.30403800475059384,0.6938083871791684,1.0,21/30,44.29%,ERCC6;UBR5;SHLD1;RNF169;HSF1;RIF1;SMCHD1;SHLD2;HMGA2;OTUB1;POLQ;TWIST1;OGG1;CYREN;FANCB;CGAS;MAD2L2;NUDT16L1;RMI2;TFIP11;PARPBP
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4758772827592661,-1.0967705383834103,0.3389473684210526,0.6929843251594316,1.0,7/10,24.43%,GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3493811305413018,-1.0962484622662572,0.324455205811138,0.6933999990038399,1.0,19/29,44.37%,CYLD;PML;THBS1;TRAF2;PPP2R1B;LTBR;TNFSF12;SFRP1;BCL10;INHBA;BID;CAV1;DEDD2;GPER1;HTRA2;AGT;HYAL2;G0S2;PYCARD
prerank,positive regulation of transferase activity (GO:0051347),0.29669988283559057,1.0960318809485563,0.2891891891891892,0.9789257097343891,1.0,28/142,11.69%,SERINC1;MAP2K7;MAPK3;GSK3A;TRIB3;PIN1;PNKP;GREM1;CCT2;DCUN1D4;TEK;MAP3K4;UBE2I;DBI;RET;EPHA5;BMI1;AXIN1;MAGEC2;EPM2AIP1;ACD;MERTK;CSF1R;TIE1;SERINC5;NEK7;FLT1;TNKS
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3540023594697872,1.096027691627822,0.3063973063973064,0.9775008213708329,1.0,6/39,6.54%,PTPN18;CBL;PTPRJ;PTPN12;EPS15L1;ARHGEF7
prerank,regulation of cytoplasmic transport (GO:1903649),0.477747426369199,1.0960231558510227,0.37058823529411766,0.9760814528532944,1.0,2/11,3.25%,MAPK3;SRC
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.3031905963841892,-1.0956478192041976,0.26822157434402333,0.6943138928076424,1.0,23/55,25.34%,GPC6;SDC2;CEMIP;VCAN;OGN;GPC3;CEMIP2;HSPG2;HEXA;HEXB;ARSB;GPC5;CSPG4;PRELP;TGFB1;GNS;LUM;GUSB;GPC4;SDC3;BGN;DCN;HYAL1
prerank,positive regulation of axon extension (GO:0045773),-0.37392692772066416,-1.0955679148827282,0.3411764705882353,0.69364060551457,1.0,10/22,22.28%,NRP1;MAPT;MACF1;DSCAM;SHTN1;TWF2;ZFYVE27;SEMA5A;DBNL;VEGFA
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.3135676595093118,-1.0943783831048532,0.3264781491002571,0.6959810655768698,1.0,21/46,23.51%,ZIC1;SMAD3;KHDRBS1;FLNA;BAG3;PRKCD;UBR5;ANP32B;EFCAB7;CDH1;GSK3B;TP53;CAMK1;TGFB1;TCF7L2;MAVS;PIK3R1;NEDD4;NRDE2;EMD;NCBP2
prerank,aminoglycan metabolic process (GO:0006022),0.49984611921442745,1.0943138452604582,0.3690248565965583,0.98086026672959,1.0,2/10,9.20%,XYLT1;B3GAT2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3027837276600163,1.0937349069558762,0.2878787878787879,0.9817019162958782,1.0,23/110,14.33%,RALB;TAL1;SLF1;HSPA8;TIRAP;SRC;SVIP;APOE;EP300;ICE1;SELP;SYK;NAPA;HJURP;PARK7;TRAF3IP1;DDX3X;RPS3;BMF;CDH5;FAF1;HCFC1;AIDA
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.36063804085643114,-1.0933570411094027,0.3485576923076923,0.6978929819719542,1.0,4/24,5.00%,ERBB4;PIBF1;KIT;GHR
prerank,T cell migration (GO:0072678),0.4483151506078721,1.0932388987715842,0.34790528233151186,0.9821795364077647,1.0,2/13,11.50%,PIK3CG;PIK3CD
prerank,pyroptosis (GO:0070269),-0.42006550392333125,-1.0927291088812379,0.33256880733944955,0.6987460781196109,1.0,9/15,51.24%,GSDME;AIM2;GSDMD;APIP;CASP8;ZBP1;CASP1;TREM2;NLRC4
prerank,negative regulation of ATPase activity (GO:0032780),0.4483108407092739,1.0927079370776547,0.3745583038869258,0.9827261118416031,1.0,3/16,8.86%,IFIT1;SIRT1;TSC1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.34457456630070915,1.0926197428302797,0.31179321486268174,0.9816169690724198,1.0,8/49,13.40%,TIRAP;PRKD2;SYK;RELA;RAB1A;PARK7;NOD1;DDIT3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.36787218305180297,-1.0923280909840019,0.319634703196347,0.6989659640886495,1.0,5/22,7.69%,NRDC;TIMP3;TIMP2;ROCK1;PTPN3
prerank,inositol phosphate biosynthetic process (GO:0032958),0.48203288654302057,1.0921352775027044,0.36186770428015563,0.9820463049667187,1.0,3/11,16.52%,PPIP5K2;IP6K2;ITPKB
prerank,glycine transport (GO:0015816),0.48078787214561447,1.091738127602105,0.36363636363636365,0.9821083186059022,1.0,3/10,16.37%,SLC7A8;SLC38A5;SLC25A38
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3091287869723468,1.0914824471150126,0.3026706231454006,0.9816132602036581,1.0,15/102,9.89%,PCK1;PRKAR1A;GSK3A;TRIB3;NR4A2;INSIG1;SRC;HDAC9;ZFP36L1;TSHR;MYO5A;TBC1D4;IRS2;RELA;RHOQ
prerank,alpha-amino acid metabolic process (GO:1901605),-0.3117466860237663,-1.0914085285677169,0.2915601023017903,0.7005596278928019,1.0,23/45,30.69%,ASPA;SRR;SLC25A13;ATP7A;GLUL;GLUD1;MTHFR;DDAH1;NOX4;MTHFD1;NAALAD2;KYAT1;GPT2;GOT1;ASPG;KYAT3;RIMKLB;OAT;MTRR;DDAH2;ALDH18A1;ASS1;RIMKLA
prerank,central nervous system myelination (GO:0022010),-0.45269818970739034,-1.0913728074737807,0.3605577689243028,0.6997798542837357,1.0,8/11,38.32%,PLP1;B4GALT6;CNTNAP1;ABCA2;MYRF;B4GALT5;CLU;SOX10
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3225316923277105,1.0910136874739529,0.3090909090909091,0.9820012026905203,1.0,11/69,9.76%,FOXQ1;SOD1;CRLF1;PPT1;APOE;TOX3;WFS1;BDNF;SOD2;FZD9;PARK7
prerank,negative regulation of proteolysis (GO:0045861),-0.33523033249890005,-1.0907853222790072,0.32917705735660846,0.7005619768310434,1.0,7/34,12.39%,TIMP3;TIMP2;ROCK1;PTPN3;GAS1;CAMK2N1;ECM1
prerank,ribosomal small subunit assembly (GO:0000028),0.43651713670675263,1.0907766950042554,0.36446886446886445,0.9814840472424432,1.0,7/16,21.79%,RPS14;RPS28;RRP7A;PRKDC;RPSA;RPS27;RPS5
prerank,regulation of lipid metabolic process (GO:0019216),0.3125367699613717,1.090768177642067,0.29777777777777775,0.9800880544761679,1.0,18/88,13.15%,PCK1;GPAM;HMGCR;HDAC3;PANK2;ELOVL6;PLPP1;PPARD;SC5D;IRS2;ACACB;IDI1;CREBBP;ADIPOR1;CARM1;LSS;SP1;NPC2
prerank,protein homotrimerization (GO:0070207),0.4535568348155383,1.0907193695453699,0.34330985915492956,0.9774470130763536,1.0,3/14,8.22%,SIGMAR1;MLKL;SLC1A2
prerank,protein trimerization (GO:0070206),0.4535568348155383,1.0907193695453699,0.34330985915492956,0.9774470130763536,1.0,3/14,8.22%,SIGMAR1;MLKL;SLC1A2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.42406336207241524,-1.09009180379186,0.34375,0.7016428643147798,1.0,7/14,26.71%,FLNA;LOXL3;PRKD1;ITGB1BP1;EMP2;DMTN;SLC2A10
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.27832374572188195,1.0900256152454715,0.27409261576971217,0.9787657132147193,1.0,43/234,14.10%,LRP8;MAP3K7;TAB2;PRKCH;RPS6KA4;CAMK1D;TIRAP;HIPK2;TRIM8;PRKD2;RPS6KA5;RAB7B;PHB2;TRIM14;CIB1;EP300;CARD16;CEBPG;TRAF5;EPHA5;RGCC;CLOCK;TAB3;TRIM25;WNT5A;RELA;RBCK1;PARK7;BUD31;UBE2V1;ESR1;RNF25;APP;NOD1;RPS3;PRKCI;IKBKB;ERC1;CHUK;HDAC5;DDIT3;NFKBIA;TRIM27
prerank,triglyceride catabolic process (GO:0019433),0.41636924944300185,1.0899467549815929,0.3469750889679715,0.977684728517909,1.0,1/19,3.33%,FABP7
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3215835547932138,1.0896636608197037,0.3282442748091603,0.9773373671773671,1.0,7/72,4.99%,POLR2J;MAPK3;NCBP1;CBL;POLR2B;SHCBP1;SPRED1
prerank,skeletal system morphogenesis (GO:0048705),-0.31803721995985496,-1.0896288171980233,0.3241758241758242,0.7020282349415763,1.0,16/42,23.67%,FGFR2;TGFBR1;FBN2;HOXA3;DYNC2I1;PDGFRA;SKI;LRP5;CYP26B1;LRP6;SFRP4;HOXC4;SIX1;HOXB3;HOXC9;RAB33B
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4638864116635403,1.089582974168461,0.37335834896810505,0.9762237498179838,1.0,2/12,3.70%,RALB;IFIT1
prerank,regulation of calcium ion import (GO:0090279),0.4069990264857977,1.0894019799127468,0.3504273504273504,0.9754554213523081,1.0,6/21,17.23%,PSEN2;CXCL12;FYN;PRNP;TRIM27;SLC30A1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3130123228725983,1.0889558766236918,0.3162518301610542,0.9757167275147769,1.0,9/87,5.97%,POLR2J;MAPK3;NCBP1;CBL;POLR2B;SHCBP1;ZFP36L1;SPRED1;TBX1
prerank,endothelial cell proliferation (GO:0001935),0.41749479101774456,1.0886943525904238,0.36541889483065954,0.9753131939075699,1.0,3/17,8.88%,PRKX;TEK;ACVRL1
prerank,myeloid cell development (GO:0061515),-0.38702536547387467,-1.0886703394541302,0.3392070484581498,0.70380640862069,1.0,4/18,4.76%,FOXP1;ANXA2;MED1;KIT
prerank,RNA modification (GO:0009451),0.33901345563118684,1.0886580662651055,0.32440944881889766,0.9740585608602664,1.0,15/54,19.84%,THG1L;THUMPD1;BCDIN3D;ADAR;ANKRD16;WDR4;SSB;ADARB1;NSUN6;PARN;CDKAL1;NSUN2;TFB1M;FTSJ1;URM1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4036558450982676,1.0886324166817456,0.33276450511945393,0.9727751629563911,1.0,8/21,16.34%,GREM1;HEY1;HEY2;NOTCH1;TRPM4;NOS3;GAS6;PTK2B
prerank,regulation of transmembrane transport (GO:0034762),0.3738943663367157,1.0885104181582546,0.3344316309719934,0.9718415416005889,1.0,5/31,8.35%,TRIB3;ACTB;NEDD4L;PIM1;SLC2A1
prerank,translational termination (GO:0006415),0.30768575387874714,1.0884069145422408,0.3072463768115942,0.9708692984200678,1.0,13/95,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;MRPL18;MRPL38;MRPS12;MRPL20;MRPL52;MRPS15;MRPS24;MRPL48
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.34537377575947037,-1.0881065942079933,0.3071593533487298,0.7044445567883225,1.0,10/32,15.54%,NAV3;MAP2;EML2;HDGFL3;STMN2;TTBK2;CLIP3;TAOK1;STMN1;TUBB4A
prerank,cytoplasmic translational initiation (GO:0002183),0.42699093506201946,1.0880964384991583,0.36007462686567165,0.9706223062801937,1.0,9/17,18.94%,MCTS1;EIF2B3;EIF4H;EIF4B;EIF5;EIF3M;EIF2S2;EIF3A;EIF4G1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.318506490916341,1.087947218527279,0.3022556390977444,0.9697767128460466,1.0,17/76,13.89%,TNFAIP3;NWD1;MAP2K5;SIRT1;NLRC3;MTURN;ERBIN;TRAF3;RBCK1;NFKBIL1;CYP1B1;G3BP2;CHUK;NLRC5;DDIT3;FAF1;NFKBIA
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4263077866547862,1.0873315180253043,0.3545966228893058,0.9692135202393223,1.0,6/17,18.41%,CISH;IRS2;SMARCA4;IL7;STAT3;IRS1
prerank,cellular response to interleukin-7 (GO:0098761),0.4263077866547862,1.0873315180253043,0.3545966228893058,0.9692135202393223,1.0,6/17,18.41%,CISH;IRS2;SMARCA4;IL7;STAT3;IRS1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.4687517017820092,-1.0873199946816303,0.36923076923076925,0.7057742098929575,1.0,5/10,38.76%,CBFB;NCKAP1L;HMGB1;ZBTB7B;SH3RF1
prerank,negative regulation of immune system process (GO:0002683),0.4364170032451129,1.0872746615502737,0.3541284403669725,0.968078941920541,1.0,3/16,9.31%,FCGR2B;HOXA7;LYN
prerank,positive regulation of developmental growth (GO:0048639),0.3445314099733007,1.08693181403261,0.3289902280130293,0.9680076938394662,1.0,9/49,12.18%,CPNE5;SEMA7A;PPIB;NEDD4L;BDNF;RUFY3;PLCB1;AGRN;PLAA
prerank,lipid biosynthetic process (GO:0008610),0.3158840177387635,1.0868587905805864,0.32568149210903874,0.9669060905601095,1.0,13/77,12.28%,ACSL5;MLYCD;GPAM;FITM2;HMGCR;GPAT4;MBOAT1;AGPS;PRKAA2;AGPAT3;PAM;LSS;PDSS2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.32728319905115055,-1.086827229504029,0.3250620347394541,0.7062096017196108,1.0,18/38,37.04%,SMAD3;P2RX4;ROCK2;PTGIS;DDAH1;CD34;SIRPA;PTGS2;AKT1;HSP90AA1;CX3CR1;DDAH2;ZC3H12A;ASS1;CAV1;EDN1;CLU;ATP2B4
prerank,histone methylation (GO:0016571),0.3866108320242442,1.0866945650095619,0.34965034965034963,0.966098329586743,1.0,5/26,11.12%,CTCFL;EZH2;SMYD3;CREBBP;CARM1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.40384371710241895,1.0862203814016278,0.36140350877192984,0.9665115163456915,1.0,6/23,11.62%,ACSL5;HSD17B12;ELOVL6;FAR2;ACSL4;HACD2
prerank,COPII vesicle coating (GO:0048208),0.3305219102812403,1.0857752307547233,0.31097560975609756,0.9640235121347376,1.0,15/61,15.69%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3305219102812403,1.0857752307547233,0.31097560975609756,0.9640235121347376,1.0,15/61,15.69%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,vesicle coating (GO:0006901),0.3305219102812403,1.0857752307547233,0.31097560975609756,0.9640235121347376,1.0,15/61,15.69%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,regulation of mitotic nuclear division (GO:0007088),-0.30211996780452166,-1.085727546072493,0.2970027247956403,0.7084126208353745,1.0,11/55,15.44%,IGF1;PDGFRB;TOM1L2;BMP7;CUL9;BMP4;LRP5;OBSL1;IGF2;CAV2;TOM1L1
prerank,negative regulation of coagulation (GO:0050819),-0.4205437870831312,-1.0855771715773157,0.3472803347280335,0.7079590614705852,1.0,4/14,11.71%,HS3ST5;TFPI;VTN;CD34
prerank,negative regulation of cellular component movement (GO:0051271),-0.4067641697737143,-1.0855564145386245,0.35181236673773986,0.7071313037864114,1.0,3/15,2.87%,SPOCK3;TGFBR3;FBLN1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.2595011480965272,-1.0855366796076107,0.2831541218637993,0.7063055699596562,1.0,17/118,5.85%,LRRC4C;FGFR2;PHLDB2;ADGRB3;PDLIM5;EFNA5;ADGRA2;PDZD8;BMPER;SDC2;PHLDB1;PID1;MAPT;CTNNB1;STAT2;ZMYM6;HECW1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.43281621527672715,-1.0851265432497577,0.36504424778761063,0.7066644343262916,1.0,7/13,21.63%,IDH2;PHYH;ADHFE1;D2HGDH;GPT2;L2HGDH;GOT1
prerank,ion homeostasis (GO:0050801),0.37022309549862525,1.0850140542418545,0.3226890756302521,0.9654541647907794,1.0,4/30,4.22%,SLC4A4;SLC4A5;KLHL3;NEDD4L
prerank,energy reserve metabolic process (GO:0006112),-0.38952895630130596,-1.0844871967666847,0.332579185520362,0.7075922956629279,1.0,8/19,24.99%,PRKAG2;LEPR;PID1;GSK3B;PYGM;PHKG2;GFPT1;GFPT2
prerank,regulation of viral genome replication (GO:0045069),0.3347203266715655,1.0843806089428427,0.3276661514683153,0.966420528035467,1.0,12/56,12.53%,ILF3;BANF1;IFITM2;IFIT1;IFITM3;ADAR;CNOT7;IFITM1;RAD23A;SRPK2;DDX3X;TMEM39A
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4884754137822941,1.0843221553965525,0.384297520661157,0.9639415226119191,1.0,4/10,15.61%,ALKBH2;ASCC3;MPG;FTO
prerank,DNA dealkylation (GO:0035510),0.4884754137822941,1.0843221553965525,0.384297520661157,0.9639415226119191,1.0,4/10,15.61%,ALKBH2;ASCC3;MPG;FTO
prerank,regulation of coagulation (GO:0050818),-0.45645793152524383,-1.0842021769416763,0.38865546218487396,0.7075587006070428,1.0,2/11,10.62%,HS3ST5;EPHB2
prerank,negative regulation of cellular component organization (GO:0051129),-0.27957455101059114,-1.083979643647235,0.27927927927927926,0.7073366097105921,1.0,24/74,22.31%,BMP6;TMEFF2;WASL;PRKCZ;SORL1;IRAK3;FAP;GSK3B;EPHA3;HSF1;SYT11;SACS;SCAMP5;RAF1;LRSAM1;PEX5;CDC42;CRYAB;RIOK3;DNAJB2;RTEL1;PRKD1;VEGFA;IMPACT
prerank,determination of bilateral symmetry (GO:0009855),0.3918919506125542,1.0832815013010164,0.34982935153583616,0.9662962691775574,1.0,5/25,17.83%,TBX1;NOTCH1;CITED2;KIF3B;BBS7
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3319411857687119,1.0825158435197666,0.3286384976525822,0.9676484897206347,1.0,13/60,11.53%,TRIM28;LEF1;CCNC;CDKN1A;MED23;MED12;HEY2;MED15;CDK4;RELA;CSF1R;AGO4;MED4
prerank,nuclear membrane disassembly (GO:0051081),0.45142023566079936,1.082170867769019,0.36617100371747213,0.9675025083995163,1.0,4/14,13.66%,NEK9;CNEP1R1;AKAP8L;NEK6
prerank,protein polyglutamylation (GO:0018095),0.47766024465344054,1.081854525660273,0.3691148775894539,0.9673644545171646,1.0,2/11,3.12%,TTLL1;CEP41
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.39700428461668424,1.0814830802910094,0.3658119658119658,0.9673933494176943,1.0,4/23,6.61%,DYNC1I1;TUBB;KIF1B;CCDC88C
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.3012482954361789,-1.0814444474796399,0.31746031746031744,0.7134955339836689,1.0,11/57,13.88%,ERBB4;IGF1;PARP14;IL6R;PIBF1;KIT;GHR;IL31RA;NF2;IL18;IL6ST
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3112053155422802,1.080709702893895,0.3323308270676692,0.9688741948063718,1.0,23/88,13.65%,SH3D19;HSPA8;SORT1;EXOC8;EXOC6B;GOPC;MYO5A;CLTA;DTNBP1;AP1G1;AP1S2;NAPA;RAB14;ARF1;AP4S1;RABEP1;DOP1B;CHMP2A;CLVS1;APP;SCFD1;SCAMP1;CCDC93
prerank,negative regulation of cellular senescence (GO:2000773),0.4633598496810637,1.0805299042549457,0.36964285714285716,0.9682302482830385,1.0,6/13,14.28%,FBXO5;SIRT1;ZKSCAN3;TERT;YBX1;MAP3K3
prerank,intraciliary retrograde transport (GO:0035721),-0.4410028789030299,-1.0805164731329442,0.3630573248407643,0.7151864237819793,1.0,6/12,27.64%,WDR35;DYNC2I1;TTC21B;WDR19;DYNLT2B;DYNC2I2
prerank,phospholipid transport (GO:0015914),0.33296062455823755,1.0804724657786355,0.33541341653666146,0.9671141169819627,1.0,12/52,13.90%,ATP8A1;ATP11A;APOE;PRELID3B;TMEM30B;PRELID2;PITPNA;SCARB1;ATP11C;NPC2;OSBPL2;ATP10A
prerank,regulation of viral entry into host cell (GO:0046596),0.37769787913695896,1.080346196240164,0.3810344827586207,0.9662401857321661,1.0,6/30,8.83%,LY6E;IFITM2;TRIM14;IFITM3;TRIM25;IFITM1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3957900724189395,1.0802722447012256,0.34285714285714286,0.9651907781072483,1.0,2/24,1.75%,PRKAR1A;PDE4D
prerank,programmed necrotic cell death (GO:0097300),0.4163429039199927,1.0801262719890334,0.35608856088560886,0.9643317991916852,1.0,5/18,16.21%,MLKL;TRPM7;ALKBH7;ITPK1;DNM1L
prerank,regulation of cholesterol esterification (GO:0010872),0.4869232370148038,1.080123475761549,0.3912175648702595,0.9630286076294943,1.0,2/10,6.46%,APOE;LAMTOR1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4662266800233336,1.0793921183518866,0.36,0.9643427177423042,1.0,4/11,11.90%,NEDD4L;GOPC;LEPROTL1;PICALM
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.4771680469286894,1.0791607120692701,0.367112810707457,0.9638013746294467,1.0,1/11,1.14%,SAG
prerank,negative regulation of protein transport (GO:0051224),0.3883147254969773,1.0790703963204962,0.3673469387755102,0.9628118248654672,1.0,3/25,4.59%,RSC1A1;HMGCR;APOE
prerank,negative regulation of chemotaxis (GO:0050922),0.3680942980926866,1.0789800546726607,0.3372093023255814,0.9618323626591423,1.0,7/31,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;NOTCH1;SEMA4C
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3741142546176004,1.0788857098970748,0.3532513181019332,0.9608863555811064,1.0,12/31,20.96%,GSK3A;MAPK8;YWHAB;ZNF205;BAD;PPP3R1;YWHAH;YWHAQ;BAX;YWHAE;YWHAZ;TFDP2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.370430376362038,1.0784954348835163,0.342512908777969,0.9609591887483965,1.0,8/32,16.58%,CDK17;NPAT;CDC45;FBXO5;POLA1;BACH1;ID2;CDK14
prerank,ribonucleoprotein complex assembly (GO:0022618),0.289964012675461,1.0783666972538022,0.3185483870967742,0.9601152144553784,1.0,38/132,18.64%,SNRPD2;NCBP1;RSL24D1;RPL3;SNRPD1;MCTS1;SF1;RPS14;RPL5;SRSF10;GEMIN5;YTHDC1;MRPL20;EIF4H;RPLP0;COIL;RPS28;CPSF6;RRP7A;SRPK2;RPL24;EIF4B;STRAP;RPL23A;USP39;EIF5;PRKDC;RPL38;EIF2S2;EIF6;EIF3A;RPSA;DDX23;PRPF18;LUC7L2;CLP1;RPL10;SNRPD3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.29121904997744996,1.0776483438165583,0.30563002680965146,0.9613349493099478,1.0,28/138,14.00%,POLR2J;MAZ;ERCC3;NR4A2;POLR2B;HDAC7;HDAC9;HDAC3;NR5A1;CCNH;MED23;PPARD;NOTCH1;NRBF2;GTF2H1;NRBP1;TAF15;ESR1;THRB;RBPJ;GTF2A2;CREBBP;E2F3;TAF4B;TBP;HDAC5;THRA;DR1
prerank,aortic valve morphogenesis (GO:0003180),-0.3401823230537475,-1.0776237515327913,0.3518987341772152,0.7222137315293251,1.0,6/30,8.66%,ROBO2;ROBO1;BMP4;ROCK2;ROCK1;SMAD6
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.28747063120588057,1.0775346927942868,0.297442799461642,0.9604351501958073,1.0,38/158,16.60%,ZDHHC17;JMJD8;MAP3K7;TAB2;PLK2;EEF1D;TIRAP;TRIM8;BIRC2;ZDHHC13;TNFRSF10B;TMED4;TRIM14;EDAR;GPR89A;CARD16;TRAF5;TAB3;TRIM25;RELA;RBCK1;LURAP1;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PPP5C;ANKRD17;NEK6;ATP2C1;TRIM27;MAP3K3;S100A13;TERF2IP;PELI1;FKBP1A;SLC44A2
prerank,positive regulation of cyclase activity (GO:0031281),-0.4179930719155108,-1.0773089258088606,0.3370288248337029,0.7221900345957841,1.0,4/14,3.50%,CACNA1C;CACNA1D;STIM1;MAPK14
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.48809849606486244,1.0769736714605418,0.3872832369942196,0.9611286344356154,1.0,4/10,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,regulation of GTPase activity (GO:0043087),0.2810232904181057,1.0767636540835606,0.316,0.9606054924004271,1.0,32/177,12.59%,EZH2;PIN1;SOD1;VAV3;EVI5L;CHN2;TBC1D30;BCAR3;PRKG1;LRCH1;RGS8;TBC1D10B;USP6NL;ARHGEF7;EPHA5;RAPGEF3;F11R;RGS10;RAP1GDS1;FGD5;CCL25;RAPGEF6;DOCK9;ITGA6;RASIP1;PLXNA4;RAB11FIP2;PICALM;NF1;AGRN;MAP4K4;LARS1
prerank,proteoglycan metabolic process (GO:0006029),-0.3487724735345552,-1.0765211228803053,0.3366093366093366,0.7234264671700319,1.0,6/26,10.38%,IGF1;SULF1;ADAMTS12;SULF2;CSGALNACT2;CHST11
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3078944560458886,-1.0758366327551454,0.31017369727047145,0.7244631365865738,1.0,16/47,16.57%,ANK3;ARFGEF2;VAMP5;MACF1;RAB31;EXOC6;GGA2;OPTN;OSBPL5;VPS35L;VAMP2;COMMD1;BBS2;GOLGA7;EXOC1;GGA3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.35764894031343325,1.0756313670723945,0.34521880064829824,0.9633911857702662,1.0,11/38,13.09%,NDUFAF1;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.33149560607129547,-1.0752650316355001,0.33098591549295775,0.7252925766169181,1.0,16/34,24.52%,GRID2;GRIN2B;GABRA2;GABRG2;GLRA1;GSK3B;GABRA5;GABRG3;GABRA4;GRIN2D;GRIN1;GABRG1;NLGN3;MPP2;GABRA1;AKT1
prerank,cellular protein modification process (GO:0006464),0.2515399843764025,1.074758805305085,0.21524201853759012,0.9651273211940105,1.0,203/983,17.11%,CISH;PHPT1;PSMB10;PSMC4;JMJD4;PSMB6;MAP3K11;MAPK3;SNRK;CAND1;ELOC;PTPRR;PTPN18;GSK3A;PTPRG;ILF3;RNF7;DUSP7;PSMD8;PSMD5;PSMD12;PTPRJ;CDK17;KLHL5;OXSR1;PTPRC;CDK19;KLHL3;CTDSP1;FEM1C;CHML;PPP3CB;PLK2;NEK11;PTPRM;BTBD1;PRKCH;RPS6KA4;ENGASE;CHM;HIPK2;PTPRB;MEX3B;PRKG1;DUSP12;PRKD2;RPS6KA5;PTPRE;PPP2CA;CDH2;PSMD11;MAP3K9;NEURL2;SIRT3;PTP4A2;APOE;PKN3;PSMB4;PTPN12;FYN;FBXL5;METAP2;WFS1;RAB11B;PSMC1;PDIA6;VWA1;UBE2I;FBXW2;DCAF6;MAPK8;UGCG;COP1;RET;SSH2;PTPRT;PAK3;ST8SIA1;CSNK1G3;SIK3;SYK;CDK11B;PPP2CB;PIM1;SIRT1;ATG4B;LMO7;KLHL2;FBXO32;PEAK1;MINK1;SLC35A1;SERP2;CDK4;MERTK;ACVRL1;PIGH;FBXO11;LATS2;CDKL4;LYN;RAB1A;NRBP1;PSMC2;ERG;PKN1;PAK1;PSMD2;PARK7;FBXO7;PIGT;UBE2M;PPP1R12A;NIM1K;ICMT;MBTPS1;DUSP11;PRKAA2;ACVR2A;SRPK2;YES1;NAE1;METAP1;SETD3;NLK;STT3B;NEK7;CTBP1;COPS7B;APP;PIK3CD;ELOB;TNKS;ATG7;PPP3CA;PLAT;ST3GAL6;STRADB;TYK2;ADPRH;PRKCI;MAP4K4;MAPK6;IKBKB;CTTNBP2NL;NAA80;CUL3;CHUK;DCAF10;PSMD14;EPAS1;UBE2F;PPP5C;CHEK2;ST3GAL1;PSMC6;TLK2;COG3;NPC1;NEK6;PSMD1;BRD2;PGGT1B;PROC;PSMB1;PTPRA;ST6GALNAC2;MSRA;B3GALNT2;CAMKK2;ST8SIA6;QPCT;COPS8;BMP2K;KLHL11;FBXO22;GAS6;DYRK2;CDKL5;PPP2R3A;TAF1;MAN2A1;NTAQ1;BRAF;PPM1L;MTMR2;CALU;KLHL42;PIGU;PTK2B;PIK3R4;CDK14;PSMA4;KLHL13;WNK2;FBXL20;PRKDC;DCUN1D1;LCMT1;MELTF;PRSS23;PPP2R5A;TIPARP
prerank,protein insertion into membrane (GO:0051205),0.36077066378567413,1.0744690093254015,0.34731543624161076,0.9648394957154768,1.0,2/32,0.33%,RTP3;REEP1
prerank,epidermis development (GO:0008544),-0.2967871016516771,-1.0744579925054545,0.31843575418994413,0.7266421279720922,1.0,8/56,11.98%,FGFR2;SVEP1;CCN2;HDAC1;FLOT2;PLOD1;EMP1;ALDH3A2
prerank,negative regulation of locomotion (GO:0040013),0.46345261126917814,1.0743376475399988,0.39571150097465885,0.9640175936999131,1.0,2/12,2.02%,FRMD5;PIN1
prerank,activation of GTPase activity (GO:0090630),0.3050648678329961,1.0738726289159868,0.3433048433048433,0.9644385294141824,1.0,24/89,14.63%,TIAM1;EVI5L;ARHGEF26;TBC1D30;TBC1D8;RALGAPA2;TBC1D9;ARHGAP25;TBC1D10B;USP6NL;TBC1D4;RALGAPB;RABGAP1L;TBC1D12;TSC1;TBC1D25;DOCK7;RHOG;ADPRH;TBC1D14;RABGAP1;RALGAPA1;SYDE1;ARHGEF10
prerank,negative regulation of multicellular organismal process (GO:0051241),0.27853144915774747,1.0736815509964994,0.3089960886571056,0.9638909129643555,1.0,28/199,11.15%,CIDEA;RGS2;PTPRR;GSK3A;PTPRG;FCGR2B;RPS6KA4;HDAC9;HMGCR;RPS6KA5;EVL;PPP2CA;HEY1;SPRED1;NPTN;RGCC;SMAD7;HEY2;PPP1R11;RAB11FIP5;NOTCH1;EFNA1;NOVA2;HOXA7;DOCK7;RBPJ;ADIPOR1;NOS3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4440797704574031,1.0736417469824417,0.3817204301075269,0.9627672492589391,1.0,2/13,2.91%,UTP20;RPS21
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.31633885871980216,1.0736007558256964,0.3391812865497076,0.9616115103055228,1.0,15/76,11.39%,GSK3A;SAE1;DCUN1D4;BIRC2;HDAC3;UBE3A;WFS1;PTTG1IP;SMAD7;UBA2;AXIN1;SPRTN;MYCBP2;UBQLN1;PIAS1
prerank,intestinal lipid absorption (GO:0098856),-0.45001168027449656,-1.0732918299485097,0.39954853273137697,0.7291661902049585,1.0,2/11,8.09%,LIMA1;LDLR
prerank,actin crosslink formation (GO:0051764),0.4607589769025329,1.0730985186328614,0.35660377358490564,0.9620503101343811,1.0,2/12,1.76%,LCP1;GAS2L1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.3980382521739414,-1.0726375118568425,0.35333333333333333,0.7300767424325546,1.0,6/17,25.95%,EGFR;PKD1;CCND3;CCNYL1;AKT1;SPDYA
prerank,cilium organization (GO:0044782),-0.23699934367177078,-1.0720440480693674,0.24644549763033174,0.7308710111007786,1.0,58/210,17.45%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;DYNC2I1;RAB8B;DCDC2;NUDCD3;CCDC66;CCDC57;CFAP20;EXOC6;TTC39C;IFT46;IFT52;ACTR3;CEP89;CEP126;IFT172;CEP20;IFT74;CFAP44;RP2;ARL13B;DISC1;TTBK2;ABLIM3;KIF3A;DZIP1L;BBS9;RAB11A;WDR19;WDR11;INTU;RAB23;CCP110;BBS2;CYS1;ARF4;EXOC7;EXOC1;PTPN23;CEP250;EHD1;RAB8A;EHD3;DYNLL2;ACTR2;IFT20
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3488012003448778,-1.0720063548663166,0.3397129186602871,0.7301018441487286,1.0,10/27,23.81%,AMBRA1;PDGFRB;KIT;PDGFRA;PTK2;TGFB1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4361980950549166,-1.071510458113532,0.3920335429769392,0.7305662585825373,1.0,4/12,15.73%,BICD1;NINL;KIF3A;DCTN1
prerank,transcription preinitiation complex assembly (GO:0070897),0.45569918313565344,1.0712116617677727,0.3815789473684211,0.9674634336799504,1.0,5/12,15.70%,BDP1;GTF2A2;TBP;DR1;TAF1
prerank,regulation of cellular response to stress (GO:0080135),0.2966608823312906,1.0711721350176322,0.3170391061452514,0.9663421956334964,1.0,34/115,19.38%,ATF3;MAPK3;CHCHD2;HSPA8;RPTOR;MANF;SMG1;AKT1S1;EP300;BAG1;NUP54;SIRT1;NUP50;ING2;CCAR2;CREBBP;FKBP4;NUP35;NEK6;CORO2B;NDC1;CAMK2G;ATR;RSL1D1;HIKESHI;NUP160;NPM1;POM121;NUP42;NUAK1;EIF4G1;YWHAE;NUP133;HSPB8
prerank,inner ear morphogenesis (GO:0042472),-0.37736263089784094,-1.071128067226692,0.3501199040767386,0.7308279012631043,1.0,6/22,18.70%,FGFR2;ZIC1;TTC39C;EPHB2;TBX18;SIX1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.27385775445382027,-1.0708980766514735,0.2925170068027211,0.7306265995228092,1.0,28/75,27.24%,ATP1A2;ATP1B1;SLC6A1;ATP1B3;SLC12A2;SLC39A14;ATP1A1;KCNJ2;ATP1B2;SLC24A2;KCNJ6;SLC9A2;ABCC9;SLC39A8;SLC12A6;KCNJ13;SLC12A4;ATP1A3;SLC12A9;KCNJ10;SLC39A6;CACNA2D1;SLC12A7;KCNK9;HCN2;TRPV2;SLC12A8;SLC12A5
prerank,positive regulation of protein maturation (GO:1903319),-0.44140346778721873,-1.0707714139374382,0.37656903765690375,0.7300963300329104,1.0,6/11,44.71%,RHBDD1;CCBE1;NKD2;SOX4;BAG2;ADAM8
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.31785941236241805,-1.0703908783545606,0.3357664233576642,0.7303292769153636,1.0,4/41,1.57%,HTR2C;ITPR1;GRIN2B;RYR3
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.3558120791435334,1.0698498189416694,0.33278418451400327,0.9697220080257547,1.0,9/39,12.23%,JAG2;TM2D3;SRC;EP300;NOTCH1;RBPJ;CREBBP;NOS3;PRKCI
prerank,heart process (GO:0003015),0.45326826064346326,1.0698354193065545,0.3578154425612053,0.9684914479269684,1.0,2/14,4.94%,SOD1;FYN
prerank,cellular protein catabolic process (GO:0044257),-0.2874920500052671,-1.0698075579299113,0.31896551724137934,0.7310735225947902,1.0,18/59,17.83%,ADAMTS12;AP2B1;CAPN2;AP2A2;AFG1L;MALT1;AP2A1;PSMA6;FAP;LGMN;CLPP;TCIRG1;CTSO;SIAH2;VLDLR;RNF123;CTSZ;MYLIP
prerank,regulation of phospholipase activity (GO:0010517),-0.47057770180782693,-1.069786877507676,0.37731958762886597,0.7302472840369241,1.0,2/10,0.70%,FGFR2;LRP1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.397795847713107,-1.0696758453295525,0.3956043956043956,0.7296998273869458,1.0,3/16,7.01%,NFAT5;RHOA;IRAK1
prerank,male meiosis I (GO:0007141),0.4226687598116171,1.0694280265699228,0.36678832116788324,0.9686639779935458,1.0,16/16,57.78%,ING2;FOXJ3;ZSCAN21;MYBL1;BRDT;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;FOXJ2;SLC25A31;DDX4;TDRD9;SYCP3;HSF2BP
prerank,cellular response to gamma radiation (GO:0071480),-0.3980413579697599,-1.0690189658262708,0.3926247288503254,0.7306891339930731,1.0,8/17,23.07%,MAP3K20;TP53;HSF1;ATM;KDM1A;CRYAB;TMEM109;YAP1
prerank,negative regulation of cell aging (GO:0090344),0.4321214153871517,1.0688550937153092,0.3904109589041096,0.9694577856292382,1.0,6/16,14.28%,FBXO5;SIRT1;ZKSCAN3;TERT;YBX1;MAP3K3
prerank,neuronal action potential (GO:0019228),-0.3637381648901341,-1.0687997994875098,0.35920177383592017,0.730423976886458,1.0,6/22,13.05%,ANK3;SCN8A;SCN3A;SCN1A;KCNA1;CACNA1G
prerank,regulation of Notch signaling pathway (GO:0008593),0.31580862994833436,1.068732085678037,0.3669590643274854,0.9686104824257631,1.0,14/76,12.23%,JAG2;TM2D3;SRC;HEY1;EGFL7;EP300;TSPEAR;NOTCH1;LFNG;BEND6;RBPJ;CREBBP;NOS3;PRKCI
prerank,bile acid metabolic process (GO:0008206),-0.3493593529410919,-1.0685488465072117,0.34615384615384615,0.7303174508344095,1.0,5/27,10.21%,OSBPL9;OSBPL6;CYP27A1;CYP7B1;OSBP
prerank,cellular response to increased oxygen levels (GO:0036295),0.47441085242984926,1.0682638003419374,0.37790697674418605,0.9689864857426831,1.0,6/11,22.61%,ATP6V0D1;ATP6AP1;ATG7;ATP6V1A;FAS;FOXO1
prerank,protein K63-linked deubiquitination (GO:0070536),0.3703372162602959,1.0679739103926449,0.39661016949152544,0.9687541500076089,1.0,9/31,13.29%,ABRAXAS1;TNFAIP3;YOD1;OTUD1;SPATA2;OTUD5;PSMD14;USP33;BRCC3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.28838849833471913,-1.0677617114805964,0.31592689295039167,0.7316061157398105,1.0,9/59,10.59%,ALDH1A2;OSBPL9;OSBPL6;CYP27A1;SRR;CYP7B1;PER2;OSBP;ACLY
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.42092449215691485,1.0676280875178863,0.3654223968565815,0.9686666144286953,1.0,2/16,0.93%,NCBP1;RBMXL1
prerank,regulation of dendrite extension (GO:1903859),0.41244832670671744,1.067412022541948,0.3650190114068441,0.968142540334696,1.0,2/18,4.22%,CPNE5;NEDD4L
prerank,regulation of endothelial cell proliferation (GO:0001936),0.30298491423133345,1.0669308266798971,0.3314366998577525,0.9684530077753443,1.0,16/88,12.06%,PTPRM;PDCL3;PRKD2;NRAS;PPP1R16B;EGFL7;APOE;TEK;KRIT1;RGCC;SIRT1;WNT5A;ACVRL1;TIE1;PIK3CD;NF1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3661815495005447,-1.0667219989301266,0.36515513126491644,0.7336050819883819,1.0,7/20,23.34%,IGF1;FOXC1;NIBAN2;DDRGK1;TGFB1;GTF2B;LAMTOR5
prerank,regulation of inclusion body assembly (GO:0090083),-0.44785012322917916,-1.0666607827349377,0.4096638655462185,0.7329054317971084,1.0,9/11,49.66%,SNCAIP;SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,fatty acid transmembrane transport (GO:1902001),-0.382578233135912,-1.0659925758027926,0.3458149779735683,0.7338506535020566,1.0,6/19,14.83%,PRKAG2;CPT1A;PRKAB2;SLC27A1;ABCD2;CPT2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.44543524289827796,1.065970127250017,0.3816793893129771,0.9705360355952705,1.0,2/13,6.81%,SYK;AP1G1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3661409697758599,-1.0656896894151253,0.35604395604395606,0.7338139351619651,1.0,5/22,25.14%,ALDH1A2;LGMN;RBP1;PIAS4;CUBN
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.339050417100916,1.0656126590666637,0.3412698412698413,0.9705343564689134,1.0,12/45,17.75%,FAM83B;CBL;SRC;RPS6KA5;PLCG1;ERBIN;PIK3C2A;BRAF;PTK2B;SHC1;PTPN11;KIF16B
prerank,cellular response to estradiol stimulus (GO:0071392),0.406267197270929,1.0653244593871884,0.36917562724014336,0.970267487178862,1.0,3/18,10.45%,RUVBL2;CCDC62;ESR1
prerank,protein methylation (GO:0006479),0.34898683240741546,1.064967579552999,0.3609271523178808,0.9702779852836818,1.0,9/40,14.58%,CTCFL;EZH2;PRMT3;RAB6A;ICMT;SETD3;CARM1;ETFBKMT;NTMT1
prerank,regulation of endopeptidase activity (GO:0052548),-0.28856913359349506,-1.0647956582142908,0.34104046242774566,0.7355017575587111,1.0,8/59,9.69%,SPOCK3;NRDC;TIMP3;SPOCK1;TIMP2;HDAC1;BIRC3;VTN
prerank,protein deacylation (GO:0035601),0.3875155574694322,1.0645988283592454,0.34523809523809523,0.9703238809938365,1.0,5/23,7.30%,PPT1;HDAC7;HDAC3;SIRT3;SIRT1
prerank,positive regulation of cellular process (GO:0048522),0.25600103464879165,1.0645006436277542,0.28820960698689957,0.9694580606432912,1.0,96/565,15.25%,FRMD5;MAZ;RAD18;ROMO1;NCBP1;PTPRJ;TAL1;EZH2;LEF1;ACER2;TIAM1;RPL23;DERL2;FCGR2B;CXCL12;RPS6KA1;RPTOR;CAMK1D;GREM1;CRLF1;STOX1;MCTS1;TBC1D8;PRKD2;ZFP36L1;TSHR;LMAN2;CSPP1;SLC35F6;MEIS1;TNFRSF1B;SINHCAF;CIB1;SLC6A6;MAPK8;TBX1;FXR1;CHTOP;FBXO5;ACTN4;SIRT1;RNF187;IRS2;NOTCH1;USP47;CNOT7;CDK4;WNT5A;TJP1;MERTK;EXOSC9;ACACB;RELA;CD47;CSF1R;LGI1;LYN;BCLAF1;MDM2;RAD23A;PAK1;CLDN5;CITED2;PRKAA2;EIF4G2;ESM1;TRPM4;SRPK2;RPS9;CD81;DDX3X;P2RX7;RHOG;FLT1;PA2G4;ACER3;PPP3CA;CRKL;DHPS;DOT1L;CUL3;TENM4;CNOT6;ANKRD17;RPS15A;FAF1;APC;HES1;HCFC1;CYBA;PARD3;INO80;CNOT6L;S100A13;VEGFC;GAS6
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.39257199491461064,1.0643415397465394,0.3586206896551724,0.9687758599247807,1.0,4/21,9.48%,RPL23;RPL5;FBXO5;RAB1A
prerank,regulation of dephosphorylation (GO:0035303),0.4425423683825535,1.0641617768227736,0.4,0.9682142251582824,1.0,7/15,19.90%,SRC;PPP1R16B;MTMR2;SMG6;SMG5;IGBP1;SMG7
prerank,negative regulation of angiogenesis (GO:0016525),-0.2730111135913844,-1.0638697570552398,0.2994011976047904,0.7371975700312151,1.0,17/84,9.33%,SULF1;COL4A3;CTNNB1;GTF2I;ROCK2;ADAMTS9;SLC12A2;HSPG2;ROCK1;HOXA5;PML;SPARC;ADAMTS1;FOXC1;THBS2;NIBAN2;THBS1
prerank,neuropeptide signaling pathway (GO:0007218),-0.29000250740820854,-1.0635071275721686,0.30446927374301674,0.7373321490910499,1.0,10/58,17.48%,SORCS1;GLRB;SORCS3;SORL1;GLRA3;GLRA1;GPR37;RAPGEF2;OPRM1;HCRTR2
prerank,metal ion transport (GO:0030001),-0.2667382839696542,-1.0632976538817094,0.3249211356466877,0.7370464193499877,1.0,16/86,13.46%,CACNA1C;ITPR1;CALCRL;CACNA1D;RYR3;SLC41A1;TRPC5;NIPA2;MRS2;CACNA1B;TRPC1;NDFIP1;CACNG7;RAMP1;NIPAL2;SLC39A8
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3875164561291055,-1.063115147229712,0.3812636165577342,0.7367018071677381,1.0,4/16,6.19%,PDGFRB;NRP1;FER;PDGFRA
prerank,cholesterol efflux (GO:0033344),0.4058478444595287,1.0630860868031728,0.3875,0.9706824868930907,1.0,5/20,13.55%,APOE;SOAT1;SCARB1;NPC2;NPC1
prerank,methylguanosine-cap decapping (GO:0110156),0.46804992832516285,1.0629820657947606,0.394990366088632,0.9698253654188619,1.0,5/10,19.40%,PATL2;PATL1;DCP1A;LSM1;DCP1B
prerank,hemopoiesis (GO:0030097),0.30616156219282104,1.0629255579144712,0.33994334277620397,0.9687384566220216,1.0,12/87,9.17%,PRKX;MECOM;SNRK;TAL1;PTPRC;TIRAP;CD164;TEK;MEIS1;BMI1;WNT5A;CSF1R
prerank,negative regulation of calcium ion transport (GO:0051926),-0.39592951328567605,-1.0627238295831731,0.3686534216335541,0.7369660306702553,1.0,1/15,0.15%,ATP1A2
prerank,sterol biosynthetic process (GO:0016126),0.36381546247329294,1.0627175053918287,0.38562091503267976,0.9681832718653054,1.0,8/33,11.99%,EBP;INSIG1;HMGCR;PLPP6;SC5D;IDI1;NSDHL;LSS
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4275808756879924,-1.062173408404195,0.36477987421383645,0.7375993112182816,1.0,8/13,26.03%,USP13;HERPUD1;TMEM259;RNFT1;SGTA;BAG6;NFE2L2;RNF185
prerank,neural crest cell migration (GO:0001755),0.35805485418495064,1.062100237611524,0.35334476843910806,0.9690716739571374,1.0,7/36,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;TBX1;SEMA6B;SEMA4C
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.42089729486203514,1.0616637762957373,0.3860294117647059,0.969453570532211,1.0,5/18,11.62%,ACSL5;HSD17B12;ELOVL6;ACSL4;HACD2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.38362449975501073,1.0616302775529947,0.3787085514834206,0.9683202562245989,1.0,6/24,11.69%,CTC1;SRC;ERCC4;HNRNPC;ACD;TNKS
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.39900272542541054,1.0616011193125099,0.37037037037037035,0.9671816947463604,1.0,11/20,20.81%,CNOT7;AGO4;HELZ;CNOT6;CNOT1;MOV10;WTIP;EIF6;AGO1;CNOT8;TNRC6A
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.38571029968723985,1.0614084552296488,0.3613595706618962,0.9666204234187407,1.0,9/24,18.59%,ABCB10;ABCG2;TSPO;COX15;COX10;SLC25A38;ALAS1;FECH;NFE2L1
prerank,phospholipid dephosphorylation (GO:0046839),-0.32717897786093425,-1.0613171041101215,0.353887399463807,0.7390500434018887,1.0,17/37,27.72%,PLPPR1;PLPP3;MTMR7;PIP4P2;SACM1L;PLPPR5;MTMR12;PLPPR4;MTMR9;MTMR4;MTMR11;PLPP5;EPHX2;PIP4P1;INPP5F;OCRL;INPP5K
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.44568192633699366,1.0611785852585969,0.388086642599278,0.9661883203769691,1.0,3/13,10.92%,TDG;UPP2;SMUG1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.4525082806849916,-1.0610144863864492,0.38306451612903225,0.7389958022280624,1.0,7/10,31.19%,SIRT2;BAG3;JUN;IMPACT;VHL;HIF1AN;NCK1
prerank,protein phosphorylation (GO:0006468),0.256106238666745,1.0606634632875118,0.2924944812362031,0.9666967113640933,1.0,103/479,16.75%,PCK1;PRKX;STK32A;MAP3K11;MAPK3;SNRK;GSK3A;ILF3;CDK17;OXSR1;MAP3K7;CDK19;PPP3CB;PLK2;NEK11;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;SRC;MEX3B;PRKG1;PRKD2;RPS6KA5;MAP3K9;TEK;CCNH;PKN3;SMG1;FYN;SLK;MAPK8;RET;PAK3;CSNK1G3;SIK3;SYK;CDK11B;SBK1;PIM1;SMAD7;PEAK1;MINK1;CDK4;DCLK3;MERTK;GTF2H1;ACVRL1;LATS2;CDKL4;CSF1R;LYN;NRBP1;ERG;PKN1;PAK1;NIM1K;PRKAA2;ACVR2A;SRPK2;NLK;NEK7;FLT1;USP15;CTBP1;APP;PIK3CD;TNKS;STRADB;TYK2;PRKCI;MAST4;MAP4K4;MAPK6;IKBKB;MAPK12;ERC1;CHUK;CHEK2;TLK2;NEK6;BRD2;MAP2K6;MAP3K3;CSNK2A2;CAMKK2;MAP3K10;COPS8;BMP2K;GAS6;DYRK2;CDKL5;TOP1;TAF1;ATR;BRAF;ABI2;PTK2B;PIK3R4;CDK14;WNK2;PRKDC
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3003024487033376,-1.0606116049125964,0.30886075949367087,0.7392495510602526,1.0,18/48,19.05%,EGFR;FLNA;SIRT2;FLOT2;FMN2;ROCK1;IRAK3;LDLR;BANP;AZIN1;EIF2AK1;NFKB1;VBP1;PFDN2;CYP51A1;CRYAB;SNX3;MDM4
prerank,histone H3 acetylation (GO:0043966),0.34933423295166477,1.0604868598405213,0.37437603993344426,0.9661080879328938,1.0,5/40,3.39%,JADE3;LEF1;MAP3K7;PHF14;ING4
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.3340409095979216,-1.0604602811671595,0.351288056206089,0.7387773109913749,1.0,9/31,11.96%,RANBP3L;CRIM1;SKI;TMEM64;LRP5;SMAD6;CDK6;SEMA4D;LIMD1
prerank,determination of left/right symmetry (GO:0007368),0.35478817388085204,1.0604116735647298,0.3723228995057661,0.9651635135831103,1.0,6/37,13.20%,RFX3;TBX1;NOTCH1;CITED2;DAND5;KIF3B
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.41350827669600587,1.0601972417031533,0.37433155080213903,0.9646753812206937,1.0,4/18,9.65%,GSK3A;SLC35F6;ZNF205;FZD9
prerank,cellular response to glucose stimulus (GO:0071333),0.3715213083819719,1.0601134881225387,0.391304347826087,0.9637073298830392,1.0,6/30,10.33%,PCK1;SELENOT;RAB11B;RAB11FIP5;RAB11FIP2;PRKAA2
prerank,mitotic spindle organization (GO:0007052),0.2792720902880692,1.0600966497734965,0.35046113306982873,0.9625435207457086,1.0,36/153,17.78%,ABRAXAS1;DYNC1I1;EML1;KIF18A;NUDC;PLK2;CLASP2;NEK9;DCTN2;MAP4;CDCA8;CENPC;MZT1;KIF2A;DYNLL1;BCCIP;MIS12;TNKS;XPO1;KIF3B;CHEK2;NEK6;PTPA;EFHC2;ARHGEF10;RCC1;DYNC1I2;CLIP1;CENPP;CENPO;STAG2;KPNB1;NUP160;CLASP1;RANGAP1;PAFAH1B1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.40910266208252755,1.0600708415162556,0.3894736842105263,0.9613964691769874,1.0,4/18,16.34%,CAMK1D;LYN;MTUS1;PTK2B
prerank,positive regulation of RNA splicing (GO:0033120),0.36513551617039897,1.059980811195243,0.3579136690647482,0.9604856622359343,1.0,4/29,6.86%,NCBP1;RBMXL1;RBM22;RBM20
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2791536708967248,-1.0598414207214135,0.2948328267477204,0.7396148337599177,1.0,23/72,17.53%,CFLAR;JAK1;CYLD;AXL;IFNAR2;CBFB;IRAK1;TAX1BP1;IRAK3;BIRC3;ELF1;OTULIN;VRK2;HIPK1;IFNGR1;CLIP3;IKBKG;RACK1;MADD;TRAF2;PTPN2;RNF31;IFNGR2
prerank,positive regulation of proteolysis (GO:0045862),-0.2921681958974178,-1.0590731083404987,0.362116991643454,0.7409263390597336,1.0,23/55,30.28%,NRDC;OGT;CYFIP2;FBXW11;RHBDD1;BTRC;IST1;CCBE1;TBC1D10A;RCN3;TNIP1;GPLD1;TANK;ATP5IF1;STUB1;PINK1;NKD2;ADRA2A;PERP;ZC3H12A;CTSC;PACSIN3;FGFR4
prerank,activation of phospholipase C activity (GO:0007202),-0.33069585995776285,-1.058819883470588,0.35324675324675325,0.7407694035202643,1.0,5/29,6.20%,LPAR1;EGFR;NTRK2;ARHGAP6;EDNRA
prerank,dendritic cell differentiation (GO:0097028),-0.3661295858182829,-1.0587011638725219,0.37054631828978624,0.7401798654333758,1.0,3/22,6.99%,TGFBR2;AXL;CAMK4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.367312903278177,-1.0582363869301248,0.3669064748201439,0.7397526542536033,1.0,2/21,0.72%,EYA2;EYA1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.367312903278177,-1.0582363869301248,0.3669064748201439,0.7397526542536033,1.0,2/21,0.72%,EYA2;EYA1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3204215367080915,-1.0580361505428342,0.3567708333333333,0.7394583162030421,1.0,10/39,13.20%,ANK3;FGF12;FGF14;WNK1;OSR1;HECW1;PTPN3;WNK4;CAMK2D;WNK3
prerank,action potential (GO:0001508),-0.30317254564473967,-1.0576904695863374,0.35537190082644626,0.7395643792792083,1.0,10/44,13.05%,ANK3;AKAP6;KCND2;SCN8A;SCN3A;KCNJ2;SCN1A;KCNA1;SRI;CACNA1G
prerank,positive regulation of protein catabolic process (GO:0045732),0.3054070904704597,1.0574195009785188,0.3630952380952381,0.9681655549961939,1.0,17/84,13.85%,GSK3A;SH3D19;TNFAIP3;PLK2;NEDD4L;VPS11;APOE;RAB7A;TNFRSF1B;PTTG1IP;AXIN1;WNT5A;ATG7;EGLN2;NDUFA13;FAF1;APC
prerank,positive regulation of cell growth (GO:0030307),0.29871374063023426,1.0573706092092787,0.3338068181818182,0.9671258250010812,1.0,15/96,10.80%,CPNE5;NCBP1;SEMA7A;DERL2;RPS6KA1;RPTOR;NEDD4L;CIB1;BDNF;RUFY3;USP47;EXOSC9;LGI1;EIF4G2;DDX3X
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.2852502805705535,-1.0573422018982932,0.3524355300859599,0.7396675974621368,1.0,25/65,23.35%,LDLRAD4;FBN1;SMAD3;SMURF2;TGFBR1;TGFBR2;FBN2;PPARA;SKI;HTRA3;SMAD6;LTBP1;SNX25;UBC;PPM1A;MTMR4;TGFB1;PRDM16;CD109;STUB1;SPRED3;SNX6;ASPN;EMILIN1;NRROS
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.31260619452593996,1.0568086576874025,0.36555891238670696,0.9678384826021375,1.0,17/73,15.96%,MTCP1;RPTOR;STOX1;BCAR3;PRKD2;RAPGEF3;BDNF;TXN;AXIN1;PAK1;PARK7;DOCK7;APP;CD44;TERF2IP;GAS6;BRAF
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3525186396387449,1.0565771354755247,0.3688663282571912,0.967452542780616,1.0,6/33,8.88%,MAP2K5;APOE;MMRN2;RGCC;NOTCH1;ACVRL1
prerank,heart looping (GO:0001947),-0.3176938299011892,-1.0565478861857254,0.3794037940379404,0.7410124626767347,1.0,10/40,25.88%,AHI1;MICAL2;TGFBR2;SMO;TBX3;SETDB2;BBS5;CCDC39;NDRG4;TBX2
prerank,establishment of spindle orientation (GO:0051294),-0.34558988921147904,-1.0562945516169984,0.36231884057971014,0.7408607608037163,1.0,9/28,24.00%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10;LLGL1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3687514149878389,1.0561510415329944,0.3723404255319149,0.9677163759450909,1.0,8/28,13.83%,MAP3K7;TNFAIP3;TAB2;TAB3;RELA;UBE2V1;NOD1;MAP2K6
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.4390908869284923,-1.0557249635584165,0.3876651982378855,0.7416270210900554,1.0,9/12,52.14%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,cellular iron ion homeostasis (GO:0006879),0.3250008443642743,1.0551905697401356,0.3621212121212121,0.9697763481689587,1.0,10/55,12.09%,CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;ISCU;GLRX3;ATP6AP1;ACO1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3532745370351256,1.055112533540744,0.39344262295081966,0.9688231507833256,1.0,6/36,8.88%,PTPRM;APOE;KRIT1;RGCC;NOTCH1;ACVRL1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.41688361167516347,1.0548821541660263,0.41100917431192663,0.9683719084127318,1.0,4/17,6.85%,ATP5F1E;ATP5MG;ATP5PF;ATP5MC2
prerank,protein ADP-ribosylation (GO:0006471),-0.34487686960421854,-1.0543324084125898,0.3592233009708738,0.7446958855385012,1.0,13/28,21.49%,PARP4;ZC3HAV1;PARP14;SIRT2;PARP6;PARP3;ART3;ARF4;PARP12;PARP1;SIRT5;PARP16;PARP2
prerank,regulation of cellular protein metabolic process (GO:0032268),0.33998447165401136,1.0542603410659892,0.36019736842105265,0.9693265674924122,1.0,17/47,20.44%,EIF2A;APOE;GEMIN5;EDNRB;TSC1;METAP1;NANOS3;APP;NFKBIA;VPS35;RBM4B;CYFIP1;RPL10;EIF4G1;NR1H3;EIF4E;MTPN
prerank,positive regulation of protein polymerization (GO:0032273),-0.27746659067902085,-1.0539494026470564,0.32831325301204817,0.7448728217359672,1.0,25/65,28.00%,NAV3;MAPT;OCLN;FER;CTTN;AKAP9;SLAIN2;BIN1;BAIAP2L1;FCHSD2;CDC42EP5;DCTN1;CDC42EP1;MET;PINK1;PFN2;TPPP;HSP90AA1;TPPP3;TTBK1;CDC42EP2;NCKAP1L;ARL2;TOGARAM1;MAPRE1
prerank,regulation of fibroblast migration (GO:0010762),0.4089088551977271,1.0537486162456948,0.3985637342908438,0.96990538542947,1.0,4/20,8.47%,PRR5L;RFFL;ARHGEF7;GNA12
prerank,Ras protein signal transduction (GO:0007265),0.28704695573113814,1.0535470170018542,0.3503448275862069,0.9694068656015461,1.0,38/137,16.91%,RAC2;RALB;TRIM28;RAP2A;TIAM1;PLK2;RERG;NRAS;CFL1;RASGRP3;RALA;CDKN1A;GNB1;GRAP;RAPGEF3;GNA12;RAPGEF6;PARK7;CELSR1;RHOG;NF1;CDC42EP3;CRKL;G3BP2;RAP2C;MYO9B;RIT1;EPS8L1;RGL2;ELMO1;GNA13;MRAS;ABI2;CDH13;SHC1;KPNB1;CYFIP1;USP28
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.25816658489109345,-1.0530085936751983,0.32142857142857145,0.7466961787295125,1.0,29/117,17.59%,IGF1;ALDH1A2;ME1;ABAT;MCCC2;VDAC1;PER2;CPT1A;PPARA;HLCS;PCCB;PDHX;DLD;SCPEP1;ACOT11;CKB;LDHB;CPT1C;ALDH4A1;ACADSB;MSMO1;CYP26B1;GGT5;PCCA;GLO1;ACSF2;ACOT7;AASDH;SLC5A6
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.27323673747133315,1.0522013887018105,0.3554140127388535,0.9727503553979646,1.0,35/186,14.00%,SOX30;PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FRZB;RUVBL2;GREM1;TPBG;PSMD11;APOE;SOX2;PSMB4;PSMC1;CCDC88C;PFDN5;AXIN1;WNT5A;SOX13;LATS2;PSMC2;PSMD2;TMEM131L;NLK;TLE4;CUL3;PSMD14;DDIT3;PSMC6;PSMD1;APC;PSMB1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3240090318685982,1.0520289110278431,0.3675344563552833,0.9721036518818843,1.0,13/59,11.53%,TRIM28;LEF1;CCNC;CDKN1A;MED23;MED12;MED15;CDK4;RELA;CSF1R;BCLAF1;AGO4;MED4
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.46400399047455987,-1.051838715576491,0.4050880626223092,0.7491694858775285,1.0,6/10,20.30%,OSR1;HECW1;CAMK2D;COMMD1;HECW2;NEDD4
prerank,positive regulation of protein phosphorylation (GO:0001934),0.25816698179306813,1.051740671125271,0.324736225087925,0.9718787248822865,1.0,52/348,12.55%,LRP8;GDF1;MAPK3;RALB;PTPRJ;LIMCH1;RAP2A;PIN1;PTPRC;MTCP1;PECAM1;TAB2;RPTOR;RPS6KA4;SRC;STOX1;BCAR3;PRKD2;RPS6KA5;HDAC3;TEK;NPTN;CIB1;CDKN1A;TBX1;FXR1;CALM3;RAPGEF3;BDNF;SIRT1;TXN;LCP2;AXIN1;EFNA1;AKTIP;ACVRL1;CDK2AP1;CSF1R;LYN;PAK1;PARK7;DOCK7;ACVR2A;CD81;DDX3X;APP;MMD;PRNP;CRKL;RAP2C;WDFY2;NBN
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.4522088616663299,1.0517284026737828,0.42533081285444235,0.9707146592449529,1.0,4/12,17.55%,JMJD4;FYCO1;BNIP3;INSR
prerank,cellular response to organic substance (GO:0071310),-0.2552014771255726,-1.0513248414078433,0.3498233215547703,0.7498149583944766,1.0,33/116,19.91%,ROBO2;NFAT5;PTPN13;AKAP6;SMAD3;DPYSL3;IGFBP5;PTPN14;TGFBR1;PID1;TGFBR2;CTNNB1;RHOA;GHR;CLEC3B;ACVR1;SOCS2;ACVR1B;RAMP1;IL1RAPL1;IL18;NCOA1;RACK1;TGFB1;BMPR1B;PTPN23;PTPN2;CDK9;TWF2;RPS6KB1;BMPR1A;CPNE3;BMPR2
prerank,ncRNA catabolic process (GO:0034661),-0.33693861475801784,-1.050865234285718,0.39097744360902253,0.7502594433178305,1.0,15/28,35.05%,LIN28B;EXOSC10;SND1;DIS3L;MTREX;DIS3;TRIR;RBM7;ZCCHC8;EXOSC8;EXOSC2;DEDD2;EXOSC3;EXOSC5;TENT4B
prerank,presynaptic endocytosis (GO:0140238),-0.3524744640794991,-1.0508020266011575,0.36683417085427134,0.7495984534468357,1.0,10/24,23.08%,AMPH;NLGN2;STON2;NLGN1;STON1;VAMP2;STX1A;SYT2;PACSIN1;NLGN3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.40371041644926514,1.0507426933480493,0.38878504672897196,0.9728974929061072,1.0,4/18,8.04%,GSK3A;HDAC3;BDNF;NOTCH1
prerank,mitotic cytokinesis (GO:0000281),-0.2992952078568011,-1.050657067238909,0.34951456310679613,0.7491495887958378,1.0,18/47,29.14%,ANK3;SON;ROCK2;CIT;ROCK1;KLHDC8B;RHOB;MITD1;TRIM36;STMN1;JTB;SNX18;RHOC;SPTBN1;CNTROB;RAB35;EFHC1;RTKN
prerank,negative regulation of cilium assembly (GO:1902018),0.45986716082009094,1.0505310567246537,0.4250474383301708,0.9724754919190375,1.0,3/12,7.53%,EVI5L;TBC1D30;MAP4
prerank,amyloid fibril formation (GO:1990000),-0.2942417115789582,-1.0505185301487547,0.34560906515580736,0.7486709538021302,1.0,14/51,25.74%,GSN;SNCAIP;MAPT;SORL1;HSPG2;GGA2;BACE1;UBC;SIAH2;GGA3;TGFBI;TSPAN15;MFGE8;APH1B
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.36920553913831183,1.0496495414859919,0.4076655052264808,0.9743180770393653,1.0,4/27,7.75%,MAP3K7;TAB2;TIRAP;TAB3
prerank,signal peptide processing (GO:0006465),0.4555121127894122,1.0495568640431707,0.4090019569471624,0.9734283973350603,1.0,4/11,13.54%,SEC11A;SPCS3;SPPL3;SPCS2
prerank,mismatch repair (GO:0006298),0.37248908953776294,1.0492586110627464,0.39152542372881355,0.9731878050812037,1.0,6/27,9.71%,TDG;PMS2;POLD3;MLH1;PMS1;MSH3
prerank,response to prostaglandin E (GO:0034695),0.462258188625375,1.0492074584976139,0.38966202783300197,0.9721930927482538,1.0,2/10,6.32%,PTGER2;GNB1
prerank,response to UV-A (GO:0070141),0.42082869781724297,1.0491138086350915,0.3918918918918919,0.9713037178795588,1.0,2/14,4.44%,CERS1;MME
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.4413058824612971,1.0484606121946913,0.4040590405904059,0.9724293631160291,1.0,3/12,10.76%,TRIB3;SIRT1;ERLIN2
prerank,inflammatory response (GO:0006954),0.2727776622877293,1.0482092977036772,0.37055837563451777,0.972106389615584,1.0,21/195,13.20%,HRH4;PTGER2;PIK3CG;TACR1;FCGR2B;HDAC9;LY75;NFX1;ABCF1;F11R;CCL25;RELA;CSF1R;PJA2;IL10RB;MFHAS1;NOD1;PIK3CD;IKBKB;CHUK;HDAC5
prerank,positive regulation of dendrite extension (GO:1903861),0.4141429273453097,1.0481003722639843,0.3932806324110672,0.9712761038991781,1.0,2/17,4.22%,CPNE5;NEDD4L
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.24268216897673878,1.0480167889594647,0.27364185110663986,0.9703699477821505,1.0,268/1645,14.92%,TBX4;SOX30;LRRFIP1;DBX2;ATF3;IRX1;PRKAR1A;TOX4;MAZ;ZBTB42;CTCFL;MAP2K7;FOXQ1;CCDC85B;GCLC;DACH1;MECOM;SIM1;ELOC;SS18L1;ARID5A;ONECUT1;ILF3;KLF8;TRAPPC2;L3MBTL4;FOXN2;TRIB3;TFCP2;NR4A2;CDK17;MTERF3;TAL1;EZH2;ACTL6A;ATF6;TRIM28;ZFAT;HSPA8;LEF1;HES6;CIPC;EED;CTDSP1;RUVBL2;PPP3CB;BTAF1;GTF2IRD1;RPS6KA1;DMAP1;PHF14;RPS6KA4;KLF2;CCNC;HIPK2;ATXN1L;ELK3;ING4;PAX8;ZHX3;ZBTB24;ZBTB33;HDAC9;GABPA;BCL6B;BACH2;RPS6KA5;BCL11B;SMAD1;HDAC3;ZKSCAN1;PHF5A;PPP2CA;PRDM15;SBNO2;HNRNPAB;HEY1;NR5A1;RLF;ZBTB41;APOE;CCNH;IRF9;MYBL2;FLI1;BBX;SMARCA2;SOX2;MEIS1;HNRNPK;YY1;PHB2;GMEB2;TOX3;ZNF83;KDM3A;KDM2A;SPIN1;ZNF740;USF2;UBE2I;ZSCAN2;CDKN1A;NPAT;IRF2BPL;EP300;VEZF1;RFX3;TBX1;ZNF260;NFX1;MED23;CARF;RET;PCGF3;TGFBRAP1;SRSF10;CEBPG;CALCOCO1;CNOT2;FOXF2;ACTR8;MAMLD1;PPARD;MED12;CDK11B;CHMP1A;ZNF205;SFPQ;CDC45;FBXO5;UXT;SMAD7;SIRT1;ACTR5;DRAP1;CLOCK;RNF187;ZNF3;PFDN5;HEY2;AXIN1;SETD5;ZBTB14;NOTCH1;CAND2;RUVBL1;USP47;CNOT7;WNT5A;LCORL;ATXN7L3;ATAD2;GTF2H1;ZXDC;SOX13;ACVRL1;RSF1;RELA;SOD2;JUND;NAB2;POLA1;HOXA7;PCID2;BCLAF1;MDM2;RAI1;PLCB1;PIAS2;TFAP4;ERG;PKN1;RNF6;TRPS1;TSFM;ZKSCAN3;KLF6;UBE2V1;CIR1;TAF15;CITED2;YEATS4;RYBP;ING2;PBXIP1;CHD1;WBP2;CCAR2;MGA;HIC2;ESR1;SETD3;RBPJ;NLK;DACH2;RHOG;HP1BP3;CREBBP;USP22;CARM1;CTBP1;PIAS1;NFIC;MED4;PA2G4;POLR3F;JMJD1C;HDGF;PICALM;LANCL2;ILF2;E2F3;SP1;IKBKB;MZF1;SMARCD1;MDFIC;IRF2;CHD3;ERC1;NUP35;CHUK;PITHD1;ACTA2;ZBTB45;ZSCAN12;RRP8;YWHAH;NDUFA13;TRRAP;TGIF1;CTBP2;HDAC5;ING5;EPAS1;EDRF1;CHEK2;DDIT3;SP110;THRA;ZKSCAN5;BRD2;CREBRF;HES1;KDM5C;HCFC1;YBX1;GRHL1;SP8;RNF20;SIX5;PHF8;PURG;NCOA7;BAZ2A;NSD2;CAMKK2;AEBP2;E2F6;TMPRSS6;BRIP1;BACH1;MAP3K10;PHF10;FUS;TSHZ1;TFAM
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.35500569839459606,-1.0479725423070736,0.3656884875846501,0.7548233037174935,1.0,7/24,19.42%,PLA2G4A;LPGAT1;CDS2;SLC27A1;CRLS1;PGS1;LPCAT1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.43067097039374386,1.0475440160366942,0.37592592592592594,0.970743164826482,1.0,2/14,8.56%,OXSR1;WNT5A
prerank,positive regulation of cell cycle (GO:0045787),-0.28533560998294166,-1.0475375826299496,0.3916913946587537,0.7551917723054462,1.0,17/62,16.39%,FGFR2;EGFR;PKD1;MEIS2;NUPR1;CCDC57;CDKN1B;SMOC2;CCND3;LGMN;TBX3;RARA;HSF1;USP19;LRP6;TTL;CCPG1
prerank,sphingoid metabolic process (GO:0046519),0.45295746915152574,1.04738268960528,0.4248496993987976,0.9700974343047677,1.0,4/12,13.88%,KDSR;PLPP1;SGPP2;SGPP1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.4149114188361316,1.0473753643299488,0.395910780669145,0.9689365651997761,1.0,4/15,19.55%,APOE;SCARB1;PLTP;ABCG1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4001305384988715,-1.0472260160616695,0.40471092077087795,0.755223164781551,1.0,6/16,24.97%,RIMS1;SNCAIP;SYN1;FLOT1;CPLX1;CAMK2A
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.32759357050658794,1.046877230006373,0.3655913978494624,0.9694751784129577,1.0,5/57,6.77%,HRH4;MTNR1A;HTR1F;INSL3;GRM7
prerank,epithelial tube morphogenesis (GO:0060562),0.3590458223699251,1.0466780817743593,0.40635451505016723,0.968971613316184,1.0,7/32,9.75%,PRKX;PRKD2;ACVRL1;RASIP1;CSF1R;PODXL;PAK1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3888375162846164,-1.0465785001926127,0.38427947598253276,0.7561522518953646,1.0,12/16,36.54%,GPR137C;KLHL22;SEH1L;FLCN;TELO2;LAMTOR5;PIP4P1;GPR137B;PIH1D1;RRAGD;GPR137;RRAGA
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3139041768882694,1.0463981094588417,0.378419452887538,0.9688007075795173,1.0,19/63,17.96%,PLK2;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;RFWD3;CARM1;CNOT6;CHEK2;CNOT1;CNOT6L;PRKDC;CNOT10;BAX;RPL26
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3664332876652872,1.0456925454765307,0.3942470389170897,0.9688073028137633,1.0,5/29,11.77%,MLYCD;DBI;ACAT1;GPAT4;ACOT8
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3664332876652872,1.0456925454765307,0.3942470389170897,0.9688073028137633,1.0,5/29,11.77%,MLYCD;DBI;ACAT1;GPAT4;ACOT8
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3474596560959689,-1.0455346750727288,0.37411764705882355,0.7581928510629578,1.0,10/24,20.87%,WASF2;AUTS2;OCLN;PLCE1;ACTR3;ACTR2;CDC42;TWF2;PIK3R1;ARPC2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.4515560247653054,1.0452106255130238,0.4149139579349904,0.9692591534084413,1.0,4/12,17.42%,CXCL12;APP;DOCK8;JAM2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4249581263539247,1.0449384386546903,0.4095427435387674,0.9689809813097641,1.0,6/14,16.18%,SFSWAP;SRSF10;SRSF4;PTBP1;SRSF7;U2AF2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.34775218101784455,1.0447708467053138,0.38980263157894735,0.9683575752072998,1.0,11/36,16.91%,TIPRL;RAD1;CDC45;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.38002687714047917,1.0446492258621352,0.379746835443038,0.9675908968997792,1.0,7/24,13.83%,MAP3K7;TNFAIP3;TAB2;TAB3;UBE2V1;NOD1;MAP2K6
prerank,cellular response to catecholamine stimulus (GO:0071870),0.38271881028684807,1.0446032904015186,0.3908256880733945,0.966557676358551,1.0,3/23,6.32%,MAPK3;GABPA;GNB1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.40681012049200405,-1.0445096805712086,0.3941299790356394,0.7602008224839935,1.0,3/14,7.78%,PUM1;PUM2;ZDHHC5
prerank,regulation of neuron apoptotic process (GO:0043523),0.2966297712332988,1.044391847408799,0.38095238095238093,0.9661155950543566,1.0,19/96,12.23%,FOXQ1;SOD1;CRLF1;PPT1;SIGMAR1;APOE;TOX3;WFS1;AKT1S1;BDNF;SOD2;FZD9;PARK7;SRPK2;NAE1;EGLN2;PRNP;NF1;PRKCI
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.45933274871025154,1.0442706631678769,0.41954022988505746,0.9653510973956866,1.0,3/11,11.50%,SIRT1;LYN;PIK3CD
prerank,negative regulation of vascular permeability (GO:0043116),0.4457867056572538,1.0441448601007481,0.4127272727272727,0.9645949844018196,1.0,3/12,9.84%,PTPRJ;RAMP2;CLDN5
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.3233266194926072,-1.043619929472332,0.3786407766990291,0.7618033635678819,1.0,14/32,20.83%,ADGRB3;CUX1;SDC2;HECW1;GSK3B;CUX2;SEMA4D;IL1RAPL1;OBSL1;RAPGEF2;HECW2;KNDC1;NEDD4;NSMF
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.45656460860278353,1.0436177536788203,0.4140625,0.9651805575381587,1.0,3/10,10.93%,ACER2;NEXMIF;CYP1B1
prerank,Notch signaling involved in heart development (GO:0061314),0.4525038072022718,1.0433034133796353,0.40117416829745595,0.9650231815680566,1.0,5/11,16.10%,HEY1;HEY2;NOTCH1;RBPJ;HEYL
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2466048141726126,-1.0431534087891963,0.3449612403100775,0.7622695666441559,1.0,24/133,14.52%,ANK2;SLC24A3;HTR2C;STIM2;MCU;PDZD8;ATP1B1;PACS2;STIM1;ATP13A5;TRPC5;MICU2;PML;HERPUD1;TRPC1;PRKACA;SLC24A2;DMPK;CAMK2D;CCL14;TMCO1;AFG3L2;SLC35G1;CAV2
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.30663688755219143,-1.0427812247074069,0.38873994638069703,0.7624578888211431,1.0,7/44,13.20%,AHI1;MICAL2;TGFBR2;SMO;ACVR1;TBX3;SETDB2
prerank,histone H4-K8 acetylation (GO:0043982),0.42354055653752676,1.0427375938361978,0.4189189189189189,0.9646552424537683,1.0,5/15,14.04%,JADE3;ING4;KANSL2;KANSL3;HCFC1
prerank,histone H4-K5 acetylation (GO:0043981),0.42354055653752676,1.0427375938361978,0.4189189189189189,0.9646552424537683,1.0,5/15,14.04%,JADE3;ING4;KANSL2;KANSL3;HCFC1
prerank,protein homooligomerization (GO:0051260),0.2923446266421576,1.042432628932123,0.3904899135446686,0.9644947167096236,1.0,18/114,12.25%,THG1L;RS1;GLS;EHD4;SIGMAR1;ATL1;MLKL;B2M;BEND3;SSBP1;SLC1A2;ACACB;SOD2;TRMT61B;CHMP2A;TRPM4;G3BP2;LETM1
prerank,mRNA splice site selection (GO:0006376),-0.3333599961109062,-1.042078134245185,0.37073170731707317,0.7635451262251493,1.0,6/30,7.45%,CELF2;SRSF5;CELF4;PSIP1;SRSF6;SRSF1
prerank,negative chemotaxis (GO:0050919),0.35519439861326624,1.0416952127764683,0.41407528641571195,0.9658095122149298,1.0,6/33,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.41985552415188643,-1.041485924279026,0.4182590233545648,0.764367651613908,1.0,4/12,20.00%,KAT7;WRNIP1;METTL4;BLM
prerank,negative regulation of DNA binding (GO:0043392),0.3647387082343226,1.0414247849097353,0.39182282793867124,0.9655657301166459,1.0,7/28,13.89%,LEF1;HEY1;HEY2;RSF1;TFAP4;TNKS;NFKBIA
prerank,positive regulation of JUN kinase activity (GO:0043507),0.3852119738595793,1.0411850417524506,0.39431616341030196,0.9651971155671956,1.0,6/23,14.82%,MAP3K11;MAP3K7;MAP3K4;PAK1;RPS3;MAP3K10
prerank,RNA catabolic process (GO:0006401),0.3356028150489047,1.0408190353145117,0.4129746835443038,0.9652613188245522,1.0,7/46,11.25%,ZC3H12D;NCBP1;NUDT12;RNASE6;XRN2;DXO;AGO4
prerank,negative regulation of protein depolymerization (GO:1901880),-0.34905383863782335,-1.0408059757418235,0.39294117647058824,0.7654110862577936,1.0,7/24,13.06%,NAV3;PLEKHH2;HDGFL3;LIMA1;STMN2;TTBK2;TAOK1
prerank,positive regulation of gene expression (GO:0010628),-0.2155269284601577,-1.040532685785683,0.26666666666666666,0.7653586499392653,1.0,83/442,15.14%,ANK2;DDX5;BMP6;NTRK3;ANK3;RIMS1;SLC24A3;IGF1;ROBO1;PLD1;SAMD4A;EGFR;GSN;SMAD3;ITGB8;FOXD1;NTRK2;FGF1;TGFBR1;MAPK14;PID1;OCLN;MED26;BMP7;VIM;ELAVL4;PRKAG1;MED1;BMP4;PPARGC1A;ROCK2;OSR1;SMO;F3;EPB41L4B;ADAM19;DEK;ERCC6;ROCK1;HOXA5;FUBP3;PLA2R1;PIK3R3;POLDIP3;PRR16;EIF3C;MAP2K2;YTHDF1;EZR;NIBAN1;UBR5;THBS1;EIF2AK2;TLE1;AGO3;AFDN;PLSCR1;GSK3B;GJA1;EPHB2;CAMK2N1;EEF2;FN1;CUX2;TP53;FAM98A;CD34;DDRGK1;RBM3;IFNGR1;RPS7;SNF8;PDCD5;POLR2A;IL33;HINFP;ATM;DDX21;VSTM2A;SETX;PTPN22;SCAMP5;PLXNB2
prerank,negative regulation of cartilage development (GO:0061037),-0.41763889623360756,-1.0403522386605129,0.4300847457627119,0.7650739761474316,1.0,3/13,4.71%,ADAMTS12;TGFBR1;EFEMP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.38430755126950744,-1.0399775211522848,0.3922902494331066,0.7652831399822538,1.0,5/18,7.87%,TGFBR3;TGFBR1;BMP5;BMP7;RBP4
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3293275895735522,-1.0397058880488539,0.38164251207729466,0.7652574809803809,1.0,12/34,14.69%,GPM6B;CTNNA1;MAPT;ROCK2;ILRUN;UBXN2B;ACTN2;GSK3B;NSFL1C;TTBK2;MAP1A;COMMD1
prerank,neuromuscular junction development (GO:0007528),-0.34191781789416165,-1.0396998458679305,0.3901345291479821,0.7644238692292908,1.0,4/24,2.47%,PDZRN3;ANK3;CACNB4;PPFIBP1
prerank,axonal transport (GO:0098930),0.35138796318062365,1.0395053830984367,0.38961038961038963,0.9684888291420747,1.0,10/36,14.02%,SOD1;KIF1B;AP3S1;DST;DTNBP1;TMEM108;AP3M2;KIF3B;AP3M1;SNAPIN
prerank,sphingoid biosynthetic process (GO:0046520),0.4657760456166219,1.0394895969893916,0.4349514563106796,0.9662492729572633,1.0,2/11,11.63%,ACER2;ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.4657760456166219,1.0394895969893916,0.4349514563106796,0.9662492729572633,1.0,2/11,11.63%,ACER2;ACER3
prerank,canonical Wnt signaling pathway (GO:0060070),-0.2771974848229875,-1.0393793306183596,0.3775811209439528,0.7643979648088338,1.0,20/68,17.77%,WNT5B;FZD6;RYK;CTNNB1;PLPP3;DIXDC1;CSNK1A1;WNT4;LRP5;CSNK1E;DVL3;FZD2;GSK3B;WNT9A;SCYL2;LRP6;TCF7L2;FZD4;DVL1;SFRP4
prerank,DNA damage checkpoint signaling (GO:0000077),0.3628316056229485,1.0391611834903987,0.38898163606010017,0.9662237994769283,1.0,10/28,16.91%,TIPRL;RAD1;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.43794354502046623,1.0391567174967278,0.41398865784499056,0.965098068117154,1.0,5/12,17.13%,EZH2;KLF2;CTBP2;CNOT1;CALR
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3465323075550792,1.038900644748563,0.3890784982935154,0.9648542081717618,1.0,13/37,18.51%,EIF5A;SOD1;SFPQ;BCLAF1;BAD;RPS3;BMF;DDIT3;DNM1L;BECN1;BCAP31;BAX;FBH1
prerank,receptor-mediated endocytosis (GO:0006898),-0.24369632605614777,-1.0387592605529206,0.35036496350364965,0.7653189824554063,1.0,31/132,14.59%,DNAJC6;LRP1;DAB2;CALCRL;AP2B1;SNAP91;AP2A2;PDLIM7;SORL1;LRP1B;HSPG2;CTTN;WASF1;GPR107;RAB31;AP2A1;SPARC;LDLR;GRK3;ACKR3;IGF2R;RAMP1;GRB2;HIP1R;DNM1;M6PR;DNAJC13;VLDLR;FCHSD2;CAV2;LMBR1L
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4475973558357074,1.0385127770851024,0.4274661508704062,0.9650468002322559,1.0,4/11,16.57%,PCBP1;NOVA2;PCBP3;ZNF445
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.4018922116440139,-1.0382041801490263,0.4156378600823045,0.7660711232234632,1.0,3/14,4.71%,ADAMTS12;TGFBR1;EFEMP1
prerank,fatty acid transport (GO:0015908),0.41090292814478546,1.0381313625041328,0.41134751773049644,0.965179036369087,1.0,3/17,6.77%,GOT2;APOE;PPARD
prerank,response to interleukin-6 (GO:0070741),0.4698414095742301,1.037859228904059,0.42359767891682787,0.9649423515612363,1.0,4/10,11.91%,SBNO2;PTPRT;RELA;ST3GAL6
prerank,neural tube closure (GO:0001843),-0.31372520856772185,-1.037637773611186,0.3691931540342298,0.7668842484794183,1.0,11/34,17.81%,LMO4;SKI;COBL;MTHFR;DVL3;MTHFD1;PLXNB2;LRP6;TGFB1;DVL1;TSC2
prerank,protein localization to nucleus (GO:0034504),-0.25372212834375185,-1.0370059029762222,0.3696369636963696,0.767820736896551,1.0,49/102,32.75%,COL1A1;TOR1AIP2;BMP7;IPO9;BMP4;LMNA;TNPO3;APPL2;PML;NUP155;NUP188;BANP;TOR1AIP1;IPO11;NUP88;NUP93;TNPO2;TOPORS;TAF8;TOR1B;FAM53C;PAF1;NUTF2;DVL1;IPO13;TSC2;NUP85;SIX1;NUP214;APPL1;TBRG1;GBP2;CTDNEP1;PPP1R10;AKT1;NOP53;SEC13;SUPT7L;RPF2;ARL2;NUP153;ABCA7;BCL3;NXT2;RPAIN;RAN;TOR1A;EIF4ENIF1;HEATR3
prerank,sarcomere organization (GO:0045214),-0.33954957167313105,-1.0367077107890437,0.40669856459330145,0.7677662173874663,1.0,4/27,14.38%,TPM1;ACTN2;CSRP2;WDR1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.24070179545260126,1.0367073245576213,0.35060975609756095,0.9674969012760211,1.0,191/1082,14.94%,SOX30;ATF3;MAZ;CTCFL;MAP2K7;MAPK3;MECOM;CHCHD2;SS18L1;ONECUT1;EIF5A;ILF3;TFCP2;NR4A2;TAL1;ATF6;TRIM28;PIN1;LEF1;RUVBL2;PPP3CB;RPS6KA1;RPTOR;RPS6KA4;KLF2;MRTFA;CCNC;GREM1;PCBP1;HIPK2;ELK3;MAP2K5;PAX8;GABPA;PRKD2;RPS6KA5;BCL11B;MRTFB;SMAD1;HDAC3;PHF5A;PRDM15;SBNO2;HNRNPAB;HEY1;NR5A1;RLF;MMP12;APOE;CCDC62;PRDM4;MYBL2;FLI1;SMARCA2;SOX2;MEIS1;YY1;TOX3;KDM3A;SPIN1;USF2;IER2;NPAT;IRF2BPL;EP300;VEZF1;DCAF6;RFX3;TBX1;ICE1;ASXL3;RET;CEBPG;CALCOCO1;FOXF2;PPARD;MED12;RGCC;SFPQ;SMAD7;SIRT1;DRAP1;PAXBP1;CLOCK;TET3;RNF187;HEY2;LMO7;AXIN1;NOTCH1;CAND2;GLMP;WNT5A;ITGA6;ATXN7L3;ATAD2;GTF2H1;ZXDC;ACVRL1;RSF1;RELA;JUND;HOXA7;PCID2;BCLAF1;RAI1;ECD;PLCB1;TFAP4;ERG;PARK7;RNF6;KANSL3;AKAP8L;RHOQ;ZKSCAN3;PPP1R12A;KLF6;LMO2;UBE2V1;TAF15;CITED2;YEATS4;RYBP;ING2;WBP2;ESR1;ACVR2A;CD81;SETD3;THRB;DDX3X;RBPJ;RHOG;CREBBP;USP22;APP;NFIC;ZBED3;MED4;ATAD2B;ZBED4;TNKS;PPP3CA;PICALM;PPP3R1;AGRN;ILF2;TNIP2;E2F3;SP1;IKBKB;SS18;MZF1;SMARCD1;MDFIC;IRF2;DOT1L;CHUK;PITHD1;ACTA2;YWHAH;NLRC5;CTBP2;HDAC5;ING5;EPAS1;EDRF1;CHEK2;DDIT3;POGZ;THRA;SSBP4;CREBRF;NFKBIA;HES1;DR1;HCFC1;YBX1;GRHL1;RNF20;PHF8;NCOA7;HEATR1;CAMKK2;SCAF8;TMPRSS6;CRTC3;PHF10;TFAM;INO80
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3067746959358669,-1.0366711174344376,0.3923705722070845,0.7670149553838673,1.0,5/41,4.74%,FGFR2;TGFBR3;TGFBR2;TPM1;BMP4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.45232028924734935,1.0366063202608005,0.437847866419295,0.9666963089210808,1.0,4/11,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.25110084120468956,1.0365842950453612,0.37341040462427744,0.9656452618605224,1.0,56/417,10.43%,CCDC85B;GCLC;DACH1;MECOM;ARID5A;ILF3;L3MBTL4;TRIB3;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;EED;BTAF1;DMAP1;ELK3;ING4;ZHX3;ZBTB33;HDAC9;RPS6KA5;HDAC3;SBNO2;HEY1;SMARCA2;PHB2;UBE2I;RFX3;PPARD;CHMP1A;SFPQ;SIRT1;CLOCK;PFDN5;HEY2;ZBTB14;NOTCH1;USP47;CNOT7;WNT5A;SOX13;RSF1;RELA;HOXA7;BCLAF1;MDM2;PLCB1;TFAP4;ZKSCAN3;CIR1;CITED2;PBXIP1;CCAR2;HIC2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4496367153946157,-1.0365025983452862,0.43776824034334766,0.7666321094505699,1.0,3/10,15.41%,RYK;CTNNB1;LRP6
prerank,telomere organization (GO:0032200),0.3394086028321009,1.0363832183799058,0.413961038961039,0.9652028323299666,1.0,13/43,16.75%,CTC1;ERCC4;DCLRE1B;POLD3;ACD;TERT;HUS1;NBN;DOT1L;LTO1;TERF2IP;ATR;PRKDC
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.43347749330408414,-1.0361094656135503,0.4578059071729958,0.7669342197304612,1.0,3/11,16.22%,IL34;HSF1;TGFB1
prerank,regulation of epithelial cell migration (GO:0010632),0.3205342623348528,1.0361054863647072,0.40031152647975077,0.9650163631704396,1.0,7/51,4.76%,PTPRR;PTPRG;SRC;CLASP2;EVL;INSL3;PFN1
prerank,morphogenesis of an epithelium (GO:0002009),0.36761312702539833,1.035990390776581,0.39661016949152544,0.9642807545029056,1.0,5/25,10.61%,PRKX;ACTB;DAG1;LIN7C;TRAF3IP1
prerank,negative regulation of cell development (GO:0010721),-0.3421284900977829,-1.035926000576764,0.37203791469194314,0.7665249207574636,1.0,5/25,10.56%,IGF1;FBN1;APPL2;SORL1;GSK3B
prerank,regulation of vasculature development (GO:1901342),-0.34193619854671264,-1.0359161600409246,0.40877598152424943,0.7657186433708981,1.0,12/26,37.61%,ADGRA2;BMPER;CTNNB1;PLXND1;EMP2;ERBB2;SFRP1;EGLN1;HTATIP2;ETS1;EPHA2;VASH1
prerank,negative regulation of heart contraction (GO:0045822),0.4433390885145704,1.0358960844392597,0.4231464737793852,0.9634589039114286,1.0,2/11,1.75%,PIK3CG;PDE4D
prerank,regulation of peptidase activity (GO:0052547),-0.36845174585749524,-1.035739274106414,0.41555555555555557,0.7653513214228563,1.0,5/19,19.92%,NRDC;HDAC1;ECM1;RCN3;PINK1
prerank,focal adhesion assembly (GO:0048041),-0.3560818239513426,-1.035621301658093,0.4036697247706422,0.7648322060423473,1.0,5/21,10.09%,SORBS1;BCR;PIP5K1A;CTTN;ACTN2
prerank,positive regulation by host of viral transcription (GO:0043923),0.40686948192391814,1.0355556270451305,0.416195856873823,0.9635111582693136,1.0,6/15,15.97%,LEF1;EP300;TFAP4;CHD1;SP1;SMARCA4
prerank,ephrin receptor signaling pathway (GO:0048013),0.30041106217916946,1.0351027054497253,0.3945086705202312,0.9638646084856866,1.0,17/82,10.61%,ARPC3;TIAM1;VAV3;PSEN2;AP2S1;ACTB;SRC;ITSN1;ARPC4;FYN;PAK3;ARHGEF7;EPHA5;EFNA1;LYN;PAK1;YES1
prerank,regulation of apoptotic process (GO:0042981),0.24492646690178152,1.0349454891428074,0.37353255069370334,0.9632647022017379,1.0,106/676,13.89%,LRP8;CIDEA;HIGD2A;ERCC3;GCLC;MAP3K11;CBL;ATF6;FRZB;LEF1;ACER2;TIAM1;SOD1;VAV3;PSEN2;PLK2;RPS6KA1;BCL2L2;GLS2;CHM;GREM1;DNAJA3;ARHGEF26;PPT1;SRC;MCF2L;ING4;PAX8;BIRC2;NME1;HDAC3;ITSN1;SIGMAR1;TNFRSF10B;TEK;CIAPIN1;HNRNPK;SLK;PHB2;TOX3;CASP6;WFS1;CFL1;CIB1;AKT1S1;MAPK8;BAG1;ARHGEF6;CRADD;ARHGEF7;PIM1;TRIO;ACTN4;SIRT1;OMA1;NAA35;ARHGEF18;USP47;WNT5A;ITGA6;TJP1;PHLPP1;FBXO11;LATS2;RELA;PCID2;BCLAF1;FZD9;TFAP4;PARK7;TARDBP;AIFM1;TMBIM4;CITED2;RYBP;PRKAA2;ING3;CCAR2;BAD;NAE1;DDX3X;CYP1B1;CREBBP;HIGD1A;ANKLE2;RPS3;PA2G4;ATG7;EGLN2;BMF;IP6K2;BNIP3L;NF1;PRKCI;MAP4K4;IKBKB;API5;ERC1;ING5;UTP11;DIABLO;AVEN;FAF1;PROC;APC;NFKBIA
prerank,anion transport (GO:0006820),-0.3191751187152493,-1.034815840739756,0.4030612244897959,0.766298320089776,1.0,9/33,15.91%,SLC13A3;LRRC8D;SLC26A7;LRRC8B;VDAC1;SLC13A4;SLC22A6;SLC4A2;SLC19A1
prerank,regulation of platelet aggregation (GO:0090330),0.4152740926716286,1.034795817328168,0.42385321100917434,0.9626334889825687,1.0,4/17,9.31%,PRKG1;SYK;F11R;LYN
prerank,telomere capping (GO:0016233),0.40753678822940714,1.0341045285531678,0.43018867924528303,0.963753732804435,1.0,7/16,17.41%,CTC1;DCLRE1B;ACD;NBN;TERF2IP;PRKDC;DCLRE1C
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.24758179617018852,1.0338636476010123,0.3794642857142857,0.9634454366564157,1.0,94/497,16.14%,CCDC85B;GCLC;DACH1;MECOM;GSK3A;ARID5A;ILF3;L3MBTL4;TRIB3;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;PATL2;EED;BTAF1;DMAP1;ELK3;ING4;ZHX3;ZBTB33;HDAC9;RPS6KA5;HDAC3;SBNO2;HEY1;SMARCA2;PHB2;UBE2I;DBI;CDKN1A;RFX3;FXR1;PAIP2B;PPARD;CHMP1A;SFPQ;SIRT1;CLOCK;PFDN5;HEY2;ZBTB14;NOTCH1;USP47;CNOT7;WNT5A;TSC1;SOX13;ACVRL1;RSF1;RELA;HOXA7;BCLAF1;MDM2;PLCB1;TFAP4;ZKSCAN3;CIR1;CITED2;PBXIP1;CCAR2;HIC2;DDX3X;RBPJ;NANOS3;CTBP1;RPS3;PA2G4;LANCL2;MDFIC;NDUFA13;CTBP2;HDAC5;DDIT3;THRA;HES1;KDM5C;YBX1;CNOT1;CAPRIN1;TMPRSS6;MAP3K10;PHF10;GAS6;NKAP;BCL6;TRIM33;ATR;SMARCA4;ID2;HEYL;ZBTB18
prerank,positive regulation of B cell activation (GO:0050871),0.33048486344893113,1.033796871473574,0.39012738853503187,0.9625450088653077,1.0,8/50,12.21%,PTPRC;VAV3;TIRAP;SYK;IRS2;CD81;KMT5B;TNIP2
prerank,negative regulation of interleukin-2 production (GO:0032703),0.3974692313359185,1.0337909534027876,0.4446529080675422,0.9614524237412028,1.0,3/18,3.58%,PTPRC;TNFAIP3;HDAC7
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.24261644033117452,1.0337450314620162,0.3655244029075805,0.9605007897594796,1.0,140/834,14.06%,SOX30;ATF3;CTCFL;MAPK3;CHCHD2;SS18L1;ONECUT1;EIF5A;TFCP2;NR4A2;TAL1;ATF6;PIN1;LEF1;RUVBL2;PPP3CB;RPS6KA1;RPS6KA4;KLF2;MRTFA;CCNC;GREM1;PCBP1;HIPK2;ELK3;MAP2K5;PAX8;GABPA;PRKD2;RPS6KA5;BCL11B;MRTFB;SMAD1;HDAC3;PRDM15;SBNO2;HEY1;NR5A1;RLF;MMP12;CCDC62;PRDM4;MYBL2;SMARCA2;SOX2;MEIS1;YY1;TOX3;USF2;IER2;NPAT;IRF2BPL;EP300;VEZF1;DCAF6;RFX3;TBX1;ASXL3;CEBPG;CALCOCO1;FOXF2;PPARD;MED12;RGCC;SFPQ;SMAD7;SIRT1;DRAP1;PAXBP1;CLOCK;TET3;HEY2;LMO7;NOTCH1;GLMP;WNT5A;ITGA6;ATAD2;ACVRL1;RSF1;RELA;JUND;HOXA7;BCLAF1;ECD;ERG;PARK7;KANSL3;AKAP8L;RHOQ;PPP1R12A;KLF6;LMO2;CITED2;YEATS4;WBP2;ESR1;ACVR2A;TERT;CD81;SETD3;THRB;DDX3X;RBPJ;CREBBP;APP;NFIC;ZBED3;MED4;ATAD2B;ZBED4;TNKS;PPP3CA;PPP3R1;AGRN;TNIP2;E2F3;SP1;IKBKB;SS18;MZF1;SMARCD1;IRF2;DOT1L;CHUK;NLRC5;CTBP2;HDAC5;EPAS1;DDIT3;POGZ;THRA;SSBP4;CREBRF;NFKBIA;HES1;DR1;HCFC1;YBX1;GRHL1
prerank,response to UV-B (GO:0010224),0.4441660578476794,1.0335327808060437,0.4386973180076628,0.9601232887733102,1.0,3/12,9.03%,MME;CDKN1A;RELA
prerank,positive regulation of inflammatory response (GO:0050729),-0.2627776468804498,-1.033349040433936,0.3738601823708207,0.7695376515757303,1.0,26/86,29.08%,OSMR;SNX4;NUPR1;LBP;NAPEPLD;IL16;IL17RA;GPR4;IL18;IL33;IL6ST;TNIP1;GPRC5B;AGTR1;CX3CL1;SETD4;PLA2G7;VAMP8;TLR3;FEM1A;SERPINE1;PDE2A;CCN4;KARS1;MDK;SNCA
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.33760723303742696,-1.0331939006706694,0.41895261845386533,0.7691801273702121,1.0,10/27,18.72%,TNS2;PID1;PRKCZ;ENPP1;PRKCD;PIP4K2B;GRB10;PTPN2;TSC2;RPS6KB1
prerank,monocyte differentiation (GO:0030224),0.451129571080086,1.0331925909164459,0.42971887550200805,0.9601327428797493,1.0,1/10,0.12%,MT1G
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4434424164363204,-1.0331263249976932,0.4068825910931174,0.7685355765173866,1.0,5/10,13.00%,PTPRS;PPM1B;REL;SIRPA;RELB
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.34329752219956844,1.0326898389762789,0.40418118466898956,0.9606615907584252,1.0,9/36,16.16%,EZH2;EED;UXT;BMI1;RYBP;MGA;APAF1;E2F6;RBBP4
prerank,negative regulation of response to external stimulus (GO:0032102),-0.25413627452080023,-1.032684536615974,0.422680412371134,0.7689140818487905,1.0,23/105,17.90%,LRFN5;CTNNA2;GRID2;PTPRS;PPM1B;SIRT2;ILRUN;PRKCD;PPARA;PTGIS;IRAK3;TRAFD1;OTULIN;SIRPA;RORA;SELENOS;AJAP1;CCN3;PTPN2;ENPP3;CERS2;TNFAIP6;CD109
prerank,protein K63-linked ubiquitination (GO:0070534),-0.3048485052727074,-1.0325695858984085,0.38242894056847543,0.7684129663746971,1.0,17/41,26.38%,RNF152;UBE2N;HECTD1;WWP2;RNF4;RNF135;RNF168;RNF8;TRAF3IP2;TRAF2;TRIM5;STUB1;NEDD4;ARIH2;UBE2B;UBE2E2;UBE2S
prerank,cellular response to oxidative stress (GO:0034599),0.2825692538312598,1.0324578399334916,0.4,0.9603175663425055,1.0,16/118,10.33%,MAPK3;ROMO1;CHCHD2;PRR5L;TXNRD2;SLC25A24;SOD1;EIF2S1;CYCS;ZFAND1;MAPK8;LONP1;GPX7;SOD2;PARK7;PRKAA2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.43994116162471897,1.0323437640251427,0.4114285714285714,0.9595728897026848,1.0,3/12,7.52%,APOE;PFDN6;PFDN5
prerank,regulation of rRNA processing (GO:2000232),-0.3903400399119282,-1.0321568230243587,0.40652173913043477,0.7687058291394095,1.0,8/16,32.21%,RIOK1;RIOK2;WDR43;SIRT7;UTP15;BUD23;KAT2B;YTHDF2
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3677435571646618,-1.031809243411457,0.4152542372881356,0.7688381742538927,1.0,10/18,33.74%,SKI;CDC73;TP53;MED25;PEX2;EMD;SFRP1;B4GALT7;CD300A;TRIM32
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.45094437726661035,1.0317411473697229,0.4046242774566474,0.9604421768805722,1.0,3/12,13.66%,NEK9;CNEP1R1;NEK6
prerank,nitrogen compound transport (GO:0071705),0.2759732252143329,1.0316260730602749,0.4050802139037433,0.9597333922433725,1.0,14/141,7.90%,SLC18A1;SLC5A7;SLC7A8;ABCG2;PPT1;SLC3A2;SLC52A2;RAMP2;RAB7A;SLC52A3;SLC6A6;CHMP1A;TMEM30B;SLC44A1
prerank,protein targeting to peroxisome (GO:0006625),-0.3216753987458879,-1.0315913006174107,0.40046296296296297,0.7685906197763911,1.0,10/29,18.04%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;PEX6
prerank,cell part morphogenesis (GO:0032990),-0.41125824480083645,-1.0315816734599563,0.425629290617849,0.7677827782962925,1.0,3/13,7.72%,PID1;WASF1;FIS1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.35590173409253445,1.0315621924489284,0.4129032258064516,0.9588599669474084,1.0,5/33,4.06%,SEMA6A;JMJD8;KLF2;SMAD1;PPP1R16B
prerank,nuclear membrane organization (GO:0071763),-0.36822098010568216,-1.0313011476922909,0.4013452914798206,0.7677085235722207,1.0,13/19,35.36%,UBXN2A;UBXN2B;TOR1AIP1;NSFL1C;TOR1B;DCTN1;NEMP1;VPS4A;EMD;TMEM43;TOR1A;GPER1;CHMP7
prerank,regulation of monocyte differentiation (GO:0045655),-0.39816285063688334,-1.0311039639521944,0.4149377593360996,0.7674409538733288,1.0,3/14,9.85%,FOXP1;IL34;CDK6
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2837586305999663,-1.0309123278882204,0.403954802259887,0.7671519449968353,1.0,13/57,13.36%,UACA;GRIN2B;CYFIP2;MALT1;FIS1;LGMN;GRAMD4;MAP3K5;CTSD;AIM2;USP50;PDCD5;TBC1D10A
prerank,gas transport (GO:0015669),0.46920393724980447,1.0308865565771461,0.4346076458752515,0.9599928044612893,1.0,1/10,3.98%,CA2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.34978548163444606,1.030785138276955,0.41086587436332767,0.9592216409261013,1.0,9/32,14.60%,MAP2K5;HDAC7;HDAC9;CIB1;MMRN2;NOTCH1;HDAC5;MAP3K3;PIK3C2A
prerank,COPII-coated vesicle budding (GO:0090114),0.3077464502440052,1.030541090766616,0.3841554559043348,0.9589223869187882,1.0,13/68,12.83%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3
prerank,regulation of cell growth (GO:0001558),0.26633341985515563,1.0302034212265652,0.3987654320987654,0.9589330996836916,1.0,29/204,12.38%,CISH;CCDC85B;NCBP1;PTPRJ;FRZB;ST7L;DERL2;RPS6KA1;RPTOR;RERG;PPT1;LTBP4;PPP2CA;SMARCA2;CIB1;CDKN1A;LAMTOR1;CDK11B;SIRT1;USP47;EXOSC9;ACVRL1;LGI1;EIF4G2;CCAR2;DDX3X;EGLN2;IP6K2;EI24
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3454162418267675,1.0300881261680603,0.4148397976391231,0.9582597928425332,1.0,11/33,18.41%,PIK3CG;PIK3C2G;ZFP36L1;HTR2A;PIK3CD;PIK3R5;NF1;PIK3C2A;PLEKHA1;NYAP2;IRS1
prerank,B cell activation (GO:0042113),0.3056642881442505,1.0298651140356487,0.4125560538116592,0.9579048546798431,1.0,9/68,13.20%,DCAF1;PTPRJ;PTPRC;HDAC9;PHB2;CEBPG;KLF6;PIK3CD;HDAC5
prerank,endothelial tube morphogenesis (GO:0061154),-0.4352122257227495,-1.029584534125003,0.4264705882352941,0.7699146070995204,1.0,5/10,12.11%,CTNNB1;RHOA;BMP4;STARD13;RHOB
prerank,cellular response to insulin stimulus (GO:0032869),0.2802325172807157,1.029540855012069,0.40304709141274236,0.9579342096748191,1.0,33/124,18.41%,PCK1;GSK3A;TRIB3;INSIG1;BCAR3;HDAC9;ATP6V1D;ZFP36L1;ATP6V0D1;MYO5A;AP3S1;TBC1D4;IRS2;ATP6V0E1;RHOQ;ATP6AP1;PRKCI;GRB14;HDAC5;APC;ZDHHC7;DENND4C;PIK3C2A;ATP6V1B2;NAMPT;SHC1;PRKDC;BAIAP2;INSR;C2CD5;SYAP1;ATP6V1A;IRS1
prerank,calcium ion import (GO:0070509),-0.32538431683858293,-1.0294016051564714,0.41148325358851673,0.7696015831052793,1.0,8/28,15.65%,CACNA1C;MCU;CACNA1D;MICU2;CACNA1B;CACNA1G;AFG3L2;MCUR1
prerank,negative regulation of protein polymerization (GO:0032272),-0.34393979580698125,-1.0290218514459268,0.4036697247706422,0.7698500894664093,1.0,13/27,21.70%,MAP2;EML2;PRKCD;STMN2;CLIP3;MYADM;HIP1R;KANK4;STMN1;TUBB4A;TWF2;SSH1;PFN2
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.4317315818200802,-1.0286806776519044,0.43829787234042555,0.770063958533435,1.0,3/10,5.56%,BMP5;BMP7;ARHGAP12
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4227779893178241,1.0286653389169205,0.43010752688172044,0.9596357554611812,1.0,4/15,13.09%,TTLL12;CNOT7;USP18;NLRC5
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.374387748648671,1.0285847978037455,0.4395796847635727,0.9588268746659157,1.0,7/23,13.91%,OCIAD1;NOTCH1;IL10RB;CYP1B1;CENPJ;MGAT5;HES1
prerank,MAPK cascade (GO:0000165),0.2584057386802648,1.0285178894341351,0.38600723763570566,0.9579458499113603,1.0,55/295,14.57%,GFRA3;PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;DUSP7;PSMD8;SPTB;PSMD5;PSMD12;MAP3K7;SHANK3;NRAS;ZFP36L1;PSMD11;TEK;PSMB4;FYN;SPRED1;PSMC1;RASGRP3;MAPK8;RET;FGF13;YWHAB;IRS2;MINK1;PSMC2;PAK1;PSMD2;ICMT;RASA2;NF1;TNIP2;MAP4K4;IKBKB;ARTN;MAPK12;PDE6D;CUL3;CHUK;ZDHHC9;NRG2;PSMD14;PPP5C;PSMC6;PSMD1;RGL2;PSMB1;PTPRA;MAP3K3;RGL3;GFRA1;CAMKK2
prerank,regulation of protein transport (GO:0051223),0.36959922735806877,1.0284351819677575,0.4305555555555556,0.9571407023747182,1.0,5/27,11.58%,LCP1;HSPA8;STXBP5L;RHBDF2;SCFD1
prerank,protein maturation (GO:0051604),-0.25647346608636024,-1.0281775266466622,0.37540453074433655,0.7706837219369221,1.0,33/95,25.93%,AEBP1;OGT;PCSK2;PCSK5;MMP16;MMP14;F3;SORL1;ADAM19;CCS;BACE1;NAA40;ADAMTS3;CPM;NNAT;AFG3L2;PCSK6;NFU1;DDI2;MMS19;HSPD1;PITRM1;ISCA1;STUB1;CASP2;NAA60;CPXM2;CIAO1;CLN3;TSPAN15;PTCH1;APH1B;CPXM1
prerank,regulation of lamellipodium organization (GO:1902743),-0.40055734590202224,-1.0280639100142805,0.4396551724137931,0.7701779804018382,1.0,6/14,25.41%,PDPN;FER;CDC42;TWF2;CAPZB;DMTN
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3002441267663773,1.0279173588527117,0.42962962962962964,0.9578011723638743,1.0,17/83,14.75%,CDK17;PLK2;CCNH;CDKN1A;NPAT;POLE;CDC45;FBXO5;CDK4;LATS2;POLA1;USP37;E2F3;CUL3;PHF8;RCC1;BACH1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3978584447500448,-1.0277533381753066,0.4264069264069264,0.7702026363273704,1.0,10/14,39.84%,ADGRV1;ULK4;MYADM;GPD1L;ADRA1A;VEGFA;FLT4;WNT11;CD40;SPHK2
prerank,mitochondrion distribution (GO:0048311),-0.40888624197148793,-1.0275854044268462,0.39819004524886875,0.7698331061933581,1.0,3/12,10.29%,MAPT;TRAK1;ARMC1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2882653450857732,-1.027573003782626,0.4098360655737705,0.7690440049008415,1.0,8/48,12.21%,ANK2;AKAP6;CEMIP;UBASH3B;TRPC1;PRKACA;CAMK2D;SRI
prerank,negative regulation of apoptotic process (GO:0043066),0.25001776942241954,1.027334843992555,0.39651162790697675,0.9585492355982355,1.0,63/444,12.44%,CIDEA;HIGD2A;MAZ;FOXQ1;GCLC;MAPK3;CBL;NR4A2;LEF1;SOD1;PSEN2;PLK2;RPS6KA1;PRKCH;BCL2L2;GREM1;CRLF1;PPT1;SRC;MAP2K5;BIRC2;HDAC3;APOE;TEK;CIAPIN1;HNRNPK;PHB2;TOX3;WFS1;CFL1;CIB1;MAPK8;TBX1;CARD16;BAG1;SFPQ;PIM1;BDNF;SIRT1;NAA35;NOTCH1;USP47;WNT5A;TJP1;MERTK;RELA;SOD2;PCID2;FZD9;FZD3;PARK7;TMBIM4;CITED2;PRKAA2;DDX3X;HIGD1A;ANKLE2;PA2G4;BNIP3L;PRKCI;MAP4K4;IKBKB;API5
prerank,eosinophil chemotaxis (GO:0048245),-0.39661505813261,-1.0272573306188073,0.4288888888888889,0.7683363833980574,1.0,3/14,22.11%,SCG2;CX3CL1;CCL13
prerank,eosinophil migration (GO:0072677),-0.39661505813261,-1.0272573306188073,0.4288888888888889,0.7683363833980574,1.0,3/14,22.11%,SCG2;CX3CL1;CCL13
prerank,tRNA wobble base modification (GO:0002097),0.42102142167774526,1.027247743933298,0.43761996161228406,0.9577338531864483,1.0,1/14,0.85%,MOCS3
prerank,positive regulation of nervous system process (GO:0031646),-0.36924216356430467,-1.0272025195630101,0.42369020501138954,0.7676757826085672,1.0,7/18,23.52%,RIMS1;NLGN2;UNC13B;DICER1;ATPSCKMT;TPPP;RNF10
prerank,negative regulation of catabolic process (GO:0009895),-0.2917251164804372,-1.0271659905699133,0.3770491803278688,0.7669731652350911,1.0,10/47,9.26%,EGFR;HDAC4;FLNA;SIRT2;NUPR1;FMN2;PPARA;IRAK3;BANP;AZIN1
prerank,lamellipodium organization (GO:0097581),-0.3263235009599302,-1.0258586985247806,0.42025316455696204,0.7697556085045181,1.0,12/29,21.62%,SNX2;KIT;VCL;CTTN;WASF1;SPATA13;ABLIM2;ABLIM3;PTPRO;ARFIP2;ARHGEF4;P2RY12
prerank,response to organophosphorus (GO:0046683),-0.38206409554595966,-1.0255879815117073,0.4314159292035398,0.769689023736272,1.0,9/16,40.76%,P2RX4;ABCC9;STAT1;DGKQ;TRIM16;TRPC3;TYMS;RFC3;VGF
prerank,regulation of lamellipodium assembly (GO:0010591),-0.31323865027346365,-1.0250535810931198,0.41075794621026895,0.770365668338392,1.0,12/34,20.87%,WASF2;AUTS2;OCLN;FER;PLCE1;ACTR3;ACTR2;CDC42;TWF2;CAPZB;PIK3R1;ARPC2
prerank,regulation of intracellular transport (GO:0032386),-0.31000302363000243,-1.0249320265748838,0.4263959390862944,0.769914215369944,1.0,16/38,29.13%,MAP2;DYNC1H1;ATP9A;TTC21B;GAS1;RBM4;ATPSCKMT;RINT1;RNF139;CRYAB;AAAS;NUP214;DYNLT2B;CAPN10;INPP5F;NEFH
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3008595076013692,-1.0248714553172436,0.40875912408759124,0.7692765421371472,1.0,21/40,40.89%,IGF1;FAM162A;BCL2L11;TP53;GHITM;PDCD5;PINK1;AKT1;BCL2L1;GPX1;BID;FXN;PRELID1;GPER1;PLSCR3;CLU;HGF;BBC3;PLAUR;OPA1;PPIF
prerank,long-chain fatty acid transport (GO:0015909),-0.3227256078372688,-1.0248560086558038,0.422279792746114,0.7685059782395869,1.0,7/30,14.83%,PRKAG2;ACSL1;CPT1A;PRKAB2;SLC27A1;ABCD2;CPT2
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3197785441129933,-1.0246105178086988,0.41005291005291006,0.7683776102793316,1.0,13/33,19.96%,DNAJC6;AMPH;SNAP91;NLGN2;STON2;NLGN1;STON1;DNM1;VAMP2;STX1A;ITSN2;SYT2;PACSIN1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.25164792752898024,-1.0244583100502345,0.37542662116040953,0.7680126953533807,1.0,42/104,28.52%,UST;DSE;GLCE;B4GALT1;CHSY1;VCAN;OGN;SLC26A2;SLC35B3;CSGALNACT2;GGTA1;CHST15;GSTT1;B4GALT6;CHST11;GSTZ1;SLC35D2;UGDH;CSPG4;GGT5;ST3GAL4;PAPSS2;PRELP;DSEL;ESD;LUM;B4GALT4;GSTA4;GSTM1;CDO1;BGN;DCN;CHPF2;CHST2;OPLAH;CHAC2;HPGDS;CHST3;MGST1;CSPG5;OMD;CHST12
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.4122995487763654,-1.0243882938791424,0.4248927038626609,0.7674095932399101,1.0,6/13,26.44%,RNF168;RNF8;NELFB;NELFA;LARP7;SUPT4H1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3825264099554395,-1.0243809632942344,0.4372093023255814,0.7666263470873445,1.0,4/16,9.91%,FOXD1;FGF1;BMP4;SALL1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.30698514337960425,-1.024328363371746,0.42424242424242425,0.7659592096582697,1.0,7/39,7.69%,ANK2;FGF12;CACNA1D;FHL1;WWP2;CHRM3;PTPN3
prerank,mRNA processing (GO:0006397),0.25535824334929497,1.0243242319149828,0.42200725513905685,0.9660045142709656,1.0,46/287,10.99%,POLR2J;ERCC3;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;CCNH;PRPF40A;HNRNPK;CPSF4;CHTOP;PPIL3;PLRG1;SRSF10;SNRNP27;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;SARNP;GTF2H1;PRMT9;SF3A1;RSRC1;AKAP8L;BUD31;SYF2;U2AF1;CPSF6;PAPOLA;EFTUD2
prerank,negative regulation of viral release from host cell (GO:1902187),0.42836870561665824,1.0241515413258202,0.4420849420849421,0.9654856742767918,1.0,2/13,3.72%,TRIM28;TRIM8
prerank,membrane organization (GO:0061024),-0.22501037023541645,-1.0240722418370092,0.40096618357487923,0.7658889848775537,1.0,81/227,26.07%,ANK2;ANK3;RIMS1;DNAJC6;DAB2;EGFR;AMPH;STX18;CHRM2;AP2B1;A4GALT;SH3GL2;TOR1AIP2;STAM2;WASL;AP2A2;STON2;UBXN2A;ARPC1A;CTTN;NUP155;SYT9;AP2A1;LDLR;ACTR3;PLEKHA8;UBXN2B;TOR1AIP1;BIN1;HUWE1;MYOF;TMEM33;DMPK;IGF2R;TLCD2;UBC;NUP93;NSFL1C;MITD1;GRB2;MYADM;HIP1R;EPN1;DNM1;M6PR;VAMP2;TOR1B;USO1;NEMP1;MTCH1;FZD4;ACTR2;SUN1;CHMP2B;SYT2;SNX3;CHMP5;SNAP29;GLTP;STAM;ARPC2;VPS4A;CNTN2;HGS;VPS33B;GCA;COX18;CTDNEP1;EMD;VAPB;CLN3;VAMP8;LEMD2;SERP1;TMEM170A;SPTBN1;SGCZ;PICK1;FNBP1;TMEM43;SYP
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.23720825461619965,1.0236888019453407,0.3659274193548387,0.9658517528722615,1.0,294/1667,16.22%,TBX4;SOX30;LRRFIP1;DBX2;ATF3;IRX1;PRKAR1A;TOX4;MAZ;ZBTB42;CTCFL;DCAF1;FOXQ1;DACH1;MAPK3;MECOM;CHCHD2;AASS;SIM1;ELOC;SS18L1;ARID5A;ONECUT1;EIF5A;KLF8;TRIB3;TFCP2;NR4A2;TAL1;EZH2;ACTL6A;ATF6;TRIM28;PIN1;LEF1;HES6;RPL23;EED;CTDSP1;RUVBL2;JAZF1;PPP3CB;GTF2IRD1;RPS6KA1;DMAP1;PHF14;RPS6KA4;KLF2;MRTFA;CCNC;GREM1;DNAJA3;PCBP1;HIPK2;ELK3;MAP2K5;PAX8;ZHX3;ZBTB24;ZBTB33;HDAC9;GABPA;BCL6B;BACH2;PRKD2;RPS6KA5;BCL11B;MRTFB;SMAD1;HDAC3;ZKSCAN1;PRDM15;SBNO2;HEY1;NEDD4L;NR5A1;RLF;MMP12;ZBTB41;APOE;CCNH;IRF9;CCDC62;PRDM4;MYBL2;FLI1;BBX;SMARCA2;SOX2;MEIS1;HNRNPK;YY1;GMEB2;TOX3;ZNF83;WFS1;KDM3A;KDM2A;VPS72;ZNF740;USF2;IER2;UBE2I;ZSCAN2;CDKN1A;NPAT;IRF2BPL;BEND3;EP300;VEZF1;DCAF6;RFX3;RPS14;TBX1;ZNF260;NFX1;MED23;CARF;ASXL3;PCGF3;CEBPG;CALCOCO1;CNOT2;FOXF2;MAMLD1;PPARD;MED12;RGCC;ZNF205;SFPQ;UXT;SMAD7;SIRT1;BMI1;DRAP1;PAXBP1;CLOCK;TET3;ZNF3;HEY2;LMO7;ZBTB14;NOTCH1;MED15;SAP130;EDNRB;GLMP;RUVBL1;CDK4;WNT5A;ITGA6;LCORL;ATXN7L3;ATAD2;EFNA1;GTF2H1;ZXDC;SOX13;ACVRL1;RSF1;RELA;CSF1R;SOD2;JUND;HOXA7;BCLAF1;MDM2;RAI1;ECD;PIAS2;TFAP4;ERG;PKN1;PARK7;TRPS1;KANSL3;AKAP8L;BUD31;RHOQ;ZKSCAN3;PPP1R12A;KLF6;LMO2;CIR1;CITED2;YEATS4;CHD1;WBP2;MGA;HIC2;ESR1;ACVR2A;CD81;SETD3;THRB;DDX3X;RBPJ;DACH2;CREBBP;CTBP1;AGO4;APP;PIAS1;ORC2;NFIC;ZBED3;MED4;ATAD2B;ZBED4;TNKS;JMJD1C;HDGF;IFI27;PPP3CA;PPP3R1;AGRN;TNIP2;N4BP2L2;E2F3;SP1;IKBKB;SS18;MZF1;SMARCD1;IRF2;CHD3;DOT1L;CHUK;ZBTB45;ZSCAN12;NLRC5;TGIF1;CTBP2;HDAC5;EPAS1;DDIT3;SP110;POGZ;THRA;SSBP4;ZKSCAN5;BRD2;CREBRF;NFKBIA;HES1;DR1;HCFC1;YBX1;GRHL1;TRIM27;SP8;SIX5;PHF8;PURG;USP9X;NCOA7;CNOT1;AEBP2;E2F6;TMPRSS6;BRIP1;BACH1;CRTC3;PHF10;FUS;TSHZ1;INO80;EZH1;PRDM10;TCF20;ZFP62;MOV10;TFEB;TAF6L;NKAP;TCERG1;NAMPT;FOXJ3;TAF1;ELK4;BCL6;WIZ;TRIM33;AKIRIN1;SMARCA4;ID2;ZNF483;TCF7L1;TCF3;HEYL;TSHZ2;ZBTB18;PURB;TAF3
prerank,endothelial cell migration (GO:0043542),-0.30532811615246225,-1.023495934940673,0.41475826972010177,0.7666303267723351,1.0,18/37,26.42%,FSTL1;ADGRA2;NRP1;RHOA;PXN;DPP4;STARD13;FAP;PLEKHG5;PLXND1;CCN3;SCG2;STAT1;TNFSF12;VEGFA;EMP2;NR4A1;RAB13
prerank,neutrophil activation involved in immune response (GO:0002283),0.24721807784919927,1.0230135710909702,0.4049493813273341,0.9669714860086603,1.0,72/428,14.81%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;GLB1;HSPA8;PTPRC;GYG1;PRCP;PECAM1;PTGES2;SVIP;RAB5C;CCT2;PTPRB;PYGL;NRAS;TUBB;ATP6V1D;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;SYK;STOM;ATP6AP2;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;DYNLL1;PNP;VAT1;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;RAP2C;GM2A;GALNS;CD55;OSTF1;SCAMP1;NDUFC2;PSMD14;NPC2;ARPC5;PSMD1;ERP44;CD93;PSMB1;APAF1;CYBA;QPCT;CD44;NHLRC3
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.4345253613059461,1.0227163525526985,0.44015444015444016,0.9668611405904236,1.0,6/13,20.76%,PRR5L;CNOT7;CNOT1;MOV10;RC3H1;CNOT8
prerank,proteasome assembly (GO:0043248),0.4488804473649799,1.0224148434624714,0.4526112185686654,0.9667398667569018,1.0,3/11,7.67%,PSMD5;PSMD11;PSMG1
prerank,pore complex assembly (GO:0046931),-0.36038460383945714,-1.0223608584586632,0.4146341463414634,0.768928253292462,1.0,10/19,31.35%,NUP205;AFDN;AHCTF1;NUP93;ANO6;GSDMD;PLEKHA7;TMEM170A;NUP153;PDZD11
prerank,negative regulation of mRNA processing (GO:0050686),0.4064033442524793,1.0222845422020583,0.42996108949416345,0.9660942249427962,1.0,6/15,16.18%,SFSWAP;SRSF10;SRSF4;PTBP1;SRSF7;U2AF2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.41347782218347245,1.0222530416333997,0.4343065693430657,0.9640498940092059,1.0,4/15,14.50%,ZFP36L1;CNOT7;NANOS3;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.41347782218347245,1.0222530416333997,0.4343065693430657,0.9640498940092059,1.0,4/15,14.50%,ZFP36L1;CNOT7;NANOS3;CNOT1
prerank,negative regulation of T cell proliferation (GO:0042130),0.3580443386232427,1.0222483840747367,0.40932642487046633,0.9629906840040096,1.0,3/28,13.00%,PRKAR1A;PRNP;CD274
prerank,regulation of TOR signaling (GO:0032006),0.3083222299297614,1.0221534771261542,0.42257597684515197,0.9621813426994827,1.0,15/67,15.25%,GSK3A;RPTOR;RFFL;HDAC3;EPM2A;AKT1S1;LAMTOR1;SIRT1;GNA12;TSC1;PRKAA2;LARS1;RRAGC;TMEM127;GAS6
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3771834630337638,-1.0220161900780842,0.42992874109263657,0.7690545949668472,1.0,2/17,1.05%,BMP6;SASH1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.4076946720094391,-1.0219346627252075,0.43067226890756305,0.768478546443339,1.0,7/13,20.92%,BMP7;RREB1;NAPEPLD;VSTM2A;SIX1;PTGS2;TFE3
prerank,cAMP-mediated signaling (GO:0019933),-0.33897354908819144,-1.0218665072529276,0.42995169082125606,0.7678551282991798,1.0,4/24,3.20%,KSR1;AKAP6;ADCY2;ADCY1
prerank,innate immune response in mucosa (GO:0002227),-0.4453180756536272,-1.0217509087691565,0.4394250513347023,0.7673845076633945,1.0,2/10,16.04%,RNASE3;DEFA6
prerank,lipoprotein catabolic process (GO:0042159),0.4557032212161098,1.0217047233820808,0.4541984732824427,0.9625322948222103,1.0,2/11,4.59%,PPT1;APOE
prerank,cellular response to interleukin-6 (GO:0071354),-0.3319030513405692,-1.0216429490606231,0.4346793349168646,0.7668983182967013,1.0,8/26,10.66%,ST18;JAK1;PID1;SMAD4;FER;IL6R;PTGIS;NFKB1
prerank,carnitine shuttle (GO:0006853),-0.4277957191683047,-1.0213292232267828,0.427734375,0.7669658849053596,1.0,4/11,14.83%,PRKAG2;CPT1A;PRKAB2;CPT2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.26127921070918725,1.0208888554476028,0.4232209737827715,0.9641172992162422,1.0,40/208,14.28%,ZDHHC17;JMJD8;MAP3K7;TNFAIP3;TAB2;PLK2;EEF1D;TIRAP;TRIM8;BIRC2;ZDHHC13;TNFRSF10B;TMED4;TRIM14;EDAR;GPR89A;CARD16;TRAF5;SIRT1;TAB3;NLRC3;TRIM25;WNT5A;TRAF3;RELA;RBCK1;LURAP1;UBE2V1;ESR1;NOD1;TNIP2;IKBKB;MAPKBP1;CHUK;PPP5C;ANKRD17;NEK6;ATP2C1;TRIM27;MAP3K3
prerank,positive regulation of response to wounding (GO:1903036),-0.33645290509306414,-1.0205030520305296,0.42596810933940776,0.7684337793493805,1.0,12/24,33.68%,OCLN;VTN;ANXA1;PTK2;SCARF1;ADRA2A;DMTN;MDK;HBEGF;MYLK;CLDN1;PTN
prerank,sulfur amino acid metabolic process (GO:0000096),0.37409032133688924,1.0203699872218115,0.4369449378330373,0.9646787947302002,1.0,2/24,2.94%,GCLC;MTR
prerank,import into nucleus (GO:0051170),0.2957369090943379,1.0201459717640802,0.4200298953662182,0.9643318211762687,1.0,11/73,8.71%,SNRPD2;SNRPD1;BACH2;MMP12;PHB2;PTTG1IP;SYK;NXT1;GEMIN5;NUP50;RANBP17
prerank,cellular response to peptide (GO:1901653),0.3110364495651747,1.0196403198598265,0.447900466562986,0.964860693592198,1.0,11/56,11.93%,CACNA1A;RPL23;FCGR2B;SRC;ZFP36L1;FYN;ICAM1;MDM2;APP;NOD1;PRNP
prerank,positive regulation of signaling (GO:0023056),-0.3063542860268449,-1.0194630400754092,0.43169398907103823,0.7704997067173764,1.0,19/37,35.10%,RIMS1;WLS;ANXA2;DLG4;CLSTN2;ILK;PTPN23;KCTD13;CLSTN3;RAB29;INPP5F;CD80;SNCA;SCRIB;CDKN2AIP;NMU;EDN1;SOX11;EDN3
prerank,negative regulation of MAP kinase activity (GO:0043407),0.32911712365318657,1.019195162677485,0.4333868378812199,0.9652348516354444,1.0,4/44,4.59%,RGS2;DUSP7;PTPRJ;APOE
prerank,double-strand break repair (GO:0006302),0.2677833503345588,1.019027389176671,0.4038961038961039,0.9646829067359642,1.0,34/158,14.94%,ABRAXAS1;ZSWIM7;ERCC4;YY1;HPF1;XRCC1;KDM2A;CIB1;TENT4A;APLF;MAPK8;ACTR8;SFPQ;ACTR5;DCLRE1B;UBE2V2;EYA3;KDM4D;POLA1;SEM1;RFWD3;EXD2;RAD51B;APTX;HUS1;NBN;PSMD14;BRCC3;PPP5C;CHEK2;RMI1;NSD2;BRIP1;INO80
prerank,cellular component assembly (GO:0022607),-0.22121785834124214,-1.0190174681864206,0.39267015706806285,0.7709424323239644,1.0,61/253,20.01%,CALD1;ANK3;RIMS1;TEAD1;PAWR;GSN;PARVA;DPYSL3;GPM6B;LRRTM3;KMT2A;PCLO;LIMA1;WASL;DLG4;WIPF1;OCLN;RHOA;NLGN2;FLNA;NEDD9;PPARGC1A;TAPBP;TUBGCP4;PEX14;PML;WASF1;DARS1;YTHDF1;NLGN1;EZR;PPID;TLCD2;RHOJ;DCX;TP53;ILK;STK25;BAIAP2L1;RANBP9;IKBKG;AFG3L2;WDR19;BSN;VAMP2;MYO1B;QSOX1;TGFB1;TRAF2;DVL1;CDC42;CARD10;CLDN14;ADD2;ZFYVE27;MDM4;TEAD2;SHANK1;SPG7;TTLL3;ZW10
prerank,gluconeogenesis (GO:0006094),0.344713525230836,1.0185158101119105,0.4435612082670906,0.965204638298523,1.0,4/39,5.68%,PCK1;SLC25A1;GOT2;TPI1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.38621399857153926,-1.0182245209205094,0.4063157894736842,0.7723663307230626,1.0,4/15,25.22%,GSTZ1;KYAT1;QDPR;FAH
prerank,negative regulation of cell adhesion (GO:0007162),-0.2630123075135235,-1.018182321318677,0.37175792507204614,0.7716500593310326,1.0,34/72,28.32%,PLXNA2;ADAM22;SPOCK1;FBLN1;DSCAM;RHOA;JAM3;CDH1;EPHB2;SEMA4D;SIPA1;PLXND1;NF2;PTK2;ARHGDIA;PLXNB2;PTPRO;PLXNC1;CBLL1;TGFB1;FZD4;SEMA5A;TGFBI;FZD7;CX3CL1;ARHGDIB;DUSP1;ITGB1BP1;PLXNB1;DMTN;SERPINE1;PLXNA1;MDK;LPXN
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.31215371532818575,1.0180032747535908,0.4444444444444444,0.9658322500005836,1.0,13/59,13.89%,MAP3K7;TAB2;BIRC2;TAB3;NLRC3;RELA;RBCK1;NFKBIL1;IKBKB;ERC1;CHUK;FAIM;NFKBIA
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.36190124427871384,1.0175297732415,0.42882882882882883,0.966260648044733,1.0,7/26,13.83%,MAP3K7;TNFAIP3;TAB2;TAB3;UBE2V1;NOD1;MAP2K6
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.31895142333012216,-1.0174712335103375,0.43765903307888043,0.7728120512675979,1.0,7/30,15.08%,ACSL1;HACD3;HACD1;HACD4;TECR;ABCD2;PEX2
prerank,ion transport (GO:0006811),-0.2477754605709588,-1.0174459336214798,0.4115384615384615,0.7720756974336614,1.0,23/111,14.67%,TRPM3;SLC24A3;GABRB1;SLC1A3;GLRB;WNK1;SLC26A7;PIEZO2;VDAC1;SLC12A2;SLC26A2;GLRA1;SLC24A2;WNK4;ANO1;LASP1;SLC20A1;SLC9A2;CTNS;ANO6;SLC26A11;SLC12A6;SLC4A2
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.39281748519237486,-1.0173958978632525,0.4276595744680851,0.7714076316330082,1.0,9/16,46.37%,SOX5;FOXC1;SOX6;PTN;SOX9;TGFB2;SP7;LTBP3;RBM24
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25771083657218535,1.0173401868563694,0.43016069221260816,0.9657948362386535,1.0,53/241,16.18%,POLR2J;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;PRPF40A;HNRNPK;CPSF4;PPIL3;PLRG1;SRSF10;SNRNP27;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;SF3A1;RSRC1;BUD31;SYF2;U2AF1;PAPOLA;EFTUD2;PTBP1;RBM10;YBX1;SRSF7;SNRPA;USP39;FUS;RBM4B;SF3B6;HNRNPL;TRA2B;GTF2F2;RBM41;UPF3B;U2AF2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.44383424886559564,1.0173081768058603,0.45213849287169044,0.9648275720912136,1.0,3/11,11.25%,FYN;PARK7;UBQLN1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.39749486406014567,1.017241473247107,0.44609665427509293,0.9639819324098905,1.0,5/17,11.08%,PANK2;PPARD;ADIPOR2;PRKAA2;ADIPOR1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3687554323153776,-1.016965068334819,0.437219730941704,0.7717647658618231,1.0,10/19,28.76%,TAPT1;PML;TOPORS;TAF8;PINK1;HK2;AKT1;SUPT7L;ARL2;BCL3
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.43843139900359923,1.0169318963020724,0.4596622889305816,0.9638822463505338,1.0,3/12,10.58%,BCDIN3D;ESR1;TERT
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.41552393720987174,-1.0160362299529846,0.4357894736842105,0.7735401695399052,1.0,1/12,5.55%,ZBTB1
prerank,protein import into nucleus (GO:0006606),0.30029205728850306,1.0158937422349104,0.43302180685358255,0.9660732640163228,1.0,18/66,17.67%,RPL23;MMP12;PHB2;KPNA3;PTTG1IP;NUP54;SYK;NXT1;NUP50;RANBP17;KPNA1;E2F3;NUP35;IPO8;HIKESHI;KPNB1;POM121;STAT3
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.392003584593397,1.0153649538731555,0.45251396648044695,0.9666593970170588,1.0,4/18,10.81%,STOX1;FBXO5;CDK4;RAD51B
prerank,acidic amino acid transport (GO:0015800),-0.3773544919553616,-1.015190828838419,0.42483660130718953,0.7750853821850707,1.0,6/17,10.60%,SLC1A3;SLC6A13;LRRC8D;SLC6A1;SLC25A13;GJA1
prerank,cytosolic calcium ion transport (GO:0060401),-0.32602248669656086,-1.014707076445887,0.44941176470588234,0.7756055905130539,1.0,10/28,22.24%,CACNA1C;MCU;MICU2;AFG3L2;SLC35G1;MCUR1;ADRA1A;MCUB;CACNA2D1;ATP2B3
prerank,maintenance of blood-brain barrier (GO:0035633),0.3545869988314649,1.014324026162646,0.43373493975903615,0.9689675410227989,1.0,10/30,13.38%,SLC1A1;PECAM1;ACTB;F11R;TJP1;ESAM;CLDN5;DMD;CDH5;LSR
prerank,negative regulation of RNA metabolic process (GO:0051253),0.3967662053201756,1.0142005339681839,0.42704626334519574,0.9683220695205743,1.0,4/18,11.65%,RPS26;ESR1;TERT;PTBP1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.3246768006459503,1.014142832449579,0.426517571884984,0.9674445095288038,1.0,4/42,8.51%,OXSR1;CXCL12;CIB1;CCL25
prerank,ncRNA transcription (GO:0098781),0.43121385732925077,1.01404728067136,0.45871559633027525,0.966695360011531,1.0,3/13,6.79%,GTF3C1;SPIN1;POLR1G
prerank,regulation of chromatin binding (GO:0035561),0.4539645086038925,1.0137874802538065,0.444015444015444,0.9664799540364273,1.0,2/10,8.54%,BTAF1;KDM4D
prerank,nucleotide-sugar metabolic process (GO:0009225),0.43879362724906423,1.0137399290138842,0.4564393939393939,0.9655934411788338,1.0,4/12,12.62%,CSGALNACT1;EXTL2;UGP2;SLC35A3
prerank,epiboly involved in wound healing (GO:0090505),-0.37882612570622054,-1.0134144495787776,0.4510739856801909,0.7784016414110625,1.0,5/16,6.18%,TMEFF2;PDPN;RHOA;FLNA;DDR1
prerank,regulation of endothelial cell migration (GO:0010594),-0.25671784982677365,-1.0133205720312843,0.4077669902912621,0.7778592378057431,1.0,18/85,12.11%,FOXP1;ANXA3;SASH1;NR2F2;BMPER;NRP1;FGF1;BMP4;ROCK2;ADAMTS9;GLUL;SPARC;SMOC2;THBS1;NRP2;RHOJ;FOXC2;RHOB
prerank,negative regulation of binding (GO:0051100),0.29418155565608156,1.0128454364090647,0.43478260869565216,0.9673833696109945,1.0,13/81,9.76%,RALB;PIN1;LEF1;BTAF1;ACTB;PSME3IP1;IFIT1;CDKN1A;MAPK8;CARD16;RSF1;TFAP4;PARK7
prerank,regulation of dopamine secretion (GO:0014059),-0.3428293557911454,-1.0127617703355092,0.41723356009070295,0.7785703523211869,1.0,11/25,30.44%,SYT9;SYT12;SYT11;SYT4;SYT7;SYT2;KCNA2;SYT10;SYT6;SNCA;DRD2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4395787797958848,-1.0126912593002837,0.4364754098360656,0.7780033325512811,1.0,8/10,49.66%,SORL1;SACS;DNAJB2;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.34834999654709853,1.0126584754412866,0.4200988467874794,0.9668904235672133,1.0,14/31,20.90%,HBS1L;CNOT7;EXOSC9;PATL1;NT5C3B;CNOT6;EXOSC1;DCP1A;LSM1;DIS3L2;DCP1B;EXOSC7;CNOT8;DDX6
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3186515382381478,1.0124729189780737,0.4255639097744361,0.9664408106518025,1.0,8/50,10.80%,RPS6KA1;SRC;MAP2K5;RFFL;CARD16;USP47;PARK7;DDX3X
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.36878924176591515,-1.0121102797694532,0.43953488372093025,0.778860221212836,1.0,7/18,35.42%,FBN1;TCTA;TLR3;GPR137B;TMEM178A;MAFB;GPR137
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3863999232947132,1.011805196391853,0.43772893772893773,0.9675052750760638,1.0,3/18,4.40%,MAPK3;SRC;VPS11
prerank,positive regulation of secretion (GO:0051047),-0.42050754696102965,-1.0117066894480136,0.45621181262729127,0.7792261342485748,1.0,2/11,16.74%,GPLD1;NPR1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4391365826055983,-1.0112846607920067,0.44930417495029823,0.7787953270308638,1.0,3/10,12.99%,MBP;WNK1;MYADM
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4391365826055983,-1.0112846607920067,0.44930417495029823,0.7787953270308638,1.0,3/10,12.99%,MBP;WNK1;MYADM
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3899033442981238,-1.010711682867162,0.4557235421166307,0.7795207746789725,1.0,6/15,33.91%,GNAL;ADCY3;SYT10;SLC24A4;DRD2;MKKS
prerank,neutrophil degranulation (GO:0043312),0.24404574011050476,1.010665264349552,0.44256756756756754,0.9701632691283368,1.0,71/425,14.81%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;GLB1;HSPA8;PTPRC;GYG1;PRCP;PECAM1;PTGES2;SVIP;RAB5C;CCT2;PTPRB;PYGL;NRAS;TUBB;ATP6V1D;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;STOM;ATP6AP2;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;DYNLL1;PNP;VAT1;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;RAP2C;GM2A;GALNS;CD55;OSTF1;SCAMP1;NDUFC2;PSMD14;NPC2;ARPC5;PSMD1;ERP44;CD93;PSMB1;APAF1;CYBA;QPCT;CD44;NHLRC3
prerank,nucleotide biosynthetic process (GO:0009165),0.3908647067728945,1.0104130143186107,0.4656084656084656,0.9699055799181847,1.0,9/18,20.58%,RRM2B;PRPS1L1;PRPS1;PNP;RRM1;NMNAT1;HPRT1;GART;PPAT
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4212405991351323,1.010361766189094,0.44204322200392926,0.9690122722059257,1.0,4/13,13.31%,SOD1;APOE;ERLIN2;PLEK
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.33095196109106284,1.0102569548086842,0.41318327974276525,0.9682831797534311,1.0,7/38,12.23%,LRP8;PTPRC;EFNA1;CSF1R;APP;PRNP;RAP2C
prerank,protein O-linked glycosylation (GO:0006493),-0.2538762731004479,-1.0100167325660994,0.4275618374558304,0.780572635900182,1.0,19/96,17.33%,GALNT13;GXYLT2;OGT;PLOD2;TMTC4;TET1;POFUT1;TRAK1;PLOD1;TMTC1;DPM1;RXYLT1;XXYLT1;LARGE1;FKTN;ST3GAL4;GALNT14;GALNTL6;POGLUT3
prerank,positive regulation of vascular permeability (GO:0043117),-0.41089139590843643,-1.0097050087186672,0.44759825327510916,0.7806523603294003,1.0,2/12,3.92%,BMP6;OCLN
prerank,regulation of amyloid fibril formation (GO:1905906),0.4094628551081907,1.0095014326681393,0.4459203036053131,0.9696036373888997,1.0,4/15,11.27%,APOE;PFDN6;PFDN5;APP
prerank,gland development (GO:0048732),-0.27148836652013475,-1.0094592926650878,0.4207650273224044,0.7805395041227936,1.0,12/59,11.85%,FGFR2;TGFBR3;GLI2;TGFBR1;ZBTB1;WNT4;DKK3;COBL;EZR;SALL1;TBX3;ANXA1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.40567060790687337,1.0094542335600447,0.4521575984990619,0.9676752509370794,1.0,6/15,16.44%,AP3S1;DTNBP1;AP3M2;AP3M1;SNAPIN;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),0.40567060790687337,1.0094542335600447,0.4521575984990619,0.9676752509370794,1.0,6/15,16.44%,AP3S1;DTNBP1;AP3M2;AP3M1;SNAPIN;BLOC1S5
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2820365320068588,1.0093553921086869,0.4215686274509804,0.9669468184818403,1.0,16/100,11.82%,MAZ;MAPK3;PIK3CG;CBL;PIK3AP1;SRC;PPP1R16B;TEK;SELP;SIRT1;IRS2;NLRC3;LYN;FLT1;PIK3CD;PIK3R5
prerank,endosome organization (GO:0007032),0.327337315862204,1.009246452532075,0.4377952755905512,0.9662899603907424,1.0,14/41,19.20%,EXOC8;CLCN3;VPS11;TMEM9;LAMTOR1;AKTIP;RAB22A;LAPTM4B;HOOK3;VPS18;CORO1C;RAB27A;ALS2;PI4K2B
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.4126664204442455,1.009018388720672,0.4456140350877193,0.9659599277096094,1.0,4/14,12.65%,RGCC;PLCG1;PRKCI;ECSCR
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.24346064875396214,1.008814289272668,0.43867403314917125,0.965571406791888,1.0,83/509,14.28%,RAC2;MAZ;PIK3CG;CBL;TRIB3;ZDHHC17;PIK3AP1;JMJD8;PTPRJ;PTPRC;MAP3K7;RPL23;TAB2;PLK2;RPTOR;EEF1D;TIRAP;SRC;BCAR3;TRIM8;PRKD2;BIRC2;HDAC3;IFI35;ZDHHC13;TNFRSF10B;TEK;SOX2;FYN;PHB2;TMED4;TRIM14;EDAR;GPR89A;EP300;TBX1;CARD16;RET;LAMTOR1;TRAF5;SELP;ACTN4;SIRT1;TXN;IRS2;VWF;TAB3;TRIM25;WNT5A;RELA;RBCK1;LYN;BCLAF1;LURAP1;PARK7;UBE2V1;RNF13;ESR1;BAD;MFHAS1;DDX3X;RHOG;FLT1;USP15;APP;NOD1;PIK3CD;RPS3;PIK3R5;BMF;TNIP2;IKBKB;LARS1;CHUK;RRAGC;NRG2;PPP5C;DDIT3;ANKRD17;NEK6;ATP2C1;TRIM27;MAP3K3
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3037761565185842,-1.0087690332099981,0.4435483870967742,0.7815951760716405,1.0,16/41,22.87%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;LACC1;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,cellular response to calcium ion (GO:0071277),-0.26837011472815897,-1.008743248558666,0.38526912181303113,0.7808664142387257,1.0,17/67,15.86%,CPNE8;RYR3;IQGAP1;ADCY1;CLIC4;ADGRV1;SYT9;NLGN1;LGMN;CAMK2D;SYT12;SYT11;SYT4;RASGRP2;CPNE2;SYT7;GPLD1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.35448028558058114,1.0086715583190897,0.4336734693877551,0.9650043868719044,1.0,13/29,20.90%,HBS1L;CNOT7;EXOSC9;PATL1;NT5C3B;CNOT6;EXOSC1;DCP1A;LSM1;DCP1B;EXOSC7;CNOT8;DDX6
prerank,cellular response to cytokine stimulus (GO:0071345),0.24664772824531156,1.0084394856771788,0.4415137614678899,0.9647184148118759,1.0,55/416,13.09%,LRP8;MT1X;PTPN18;GSK3A;CBL;PTPRJ;IL1R1;HSPA8;OXSR1;LEF1;SMPD4;CXCL12;IFNLR1;IFITM2;CRLF1;LRCH1;IFIT1;SBNO2;ZFP36L1;GBP3;MME;SOX2;PTPN12;FYN;TNFRSF1B;CIB1;CDKN1A;RIPOR2;MAPK8;GBP4;PTPRT;ICAM1;SYK;RO60;PIM1;SIRT1;CCL25;WNT5A;ERBIN;RELA;CD47;CSF1R;INPP5D;IL10RB;IFNAR1;NPNT;PIK3CD;RPS3;ST3GAL6;CRKL;TYK2;IKBKB;LDLRAP1;CHUK;NDUFA13
prerank,regulation of macroautophagy (GO:0016241),0.2836185442094326,1.0084208075444934,0.4395448079658606,0.963752089670008,1.0,32/105,19.34%,MAP3K7;RPTOR;EXOC8;ATP6V1D;EPM2A;SMG1;VPS26A;ATP6V0D1;MAPK8;LAMTOR1;SIRT1;ATP6V0E1;TSC1;TBC1D25;PRKAA2;UBQLN1;BNIP3L;RRAGC;SCOC;ATP6V1B2;VPS35;ATG13;SESN3;BNIP3;UBQLN2;ATP6V1A;USP36;ULK1;SH3GLB1;LZTS1;SESN1;LARP1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.37149639163791975,-1.0084205581920858,0.43243243243243246,0.7810052488496874,1.0,8/18,25.54%,FLNA;WDR43;SIRT7;ATF4;UTP15;EIF2AK3;ERBB2;POLR2K
prerank,synaptic vesicle recycling (GO:0036465),-0.3143808685741788,-1.008181000310109,0.4151898734177215,0.780862656774693,1.0,10/31,19.96%,AMPH;NLGN2;STON2;NLGN1;STON1;VAMP2;SYT7;STX1A;SYT2;PACSIN1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3349304824455337,1.0081793626402904,0.4292929292929293,0.963453562525137,1.0,7/35,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;PLXNA4;SEMA4C
prerank,regulation of protein phosphorylation (GO:0001932),0.2558381117014684,1.0081293749394293,0.4484472049689441,0.9626083887512749,1.0,42/256,12.62%,ROPN1;ATF3;MAPK3;PRR5L;RALB;LIMCH1;RAP2A;PIN1;SOD1;PECAM1;SMG8;PDCL3;HDAC3;PPP2CA;TEK;FYN;NPTN;CIB1;TBX1;FXR1;CCDC88C;SIRT1;AXIN1;KDM4D;EFNA1;AKTIP;CDK2AP1;MOB1B;CSF1R;LYN;PAK1;PARK7;AKAP8L;TARDBP;ACVR2A;TRAF3IP1;APP;ZBED3;PRNP;CRKL;WDFY2;CDH5
prerank,Wnt signaling pathway (GO:0016055),-0.251643342041626,-1.0074204966746392,0.4144736842105263,0.7821200692973419,1.0,26/92,18.65%,WLS;NXN;WNT5B;FZD6;RYK;CTNNB1;PLPP3;DIXDC1;CSNK1A1;BTRC;WNT4;LRP5;CSNK1E;DVL3;CSNK1G2;FZD2;GSK3B;UBC;WNT9A;USP34;LRP6;TCF7L2;FZD4;DVL1;SFRP4;SNX3
prerank,regulation of interferon-gamma production (GO:0032649),0.29980245665733063,1.007377279097368,0.4582701062215478,0.9639248102979316,1.0,11/71,15.25%,IL1R1;PDE4D;CYRIB;CEBPG;CD47;VSIR;PRNP;CD274;DDIT3;TRIM27;GAS6
prerank,establishment of vesicle localization (GO:0051650),-0.36221520943503616,-1.0072803914379351,0.44541484716157204,0.7817017875947999,1.0,7/18,16.96%,KIF5C;CCDC186;SYT11;RAB11A;IKBKG;KIF5A;LIMK2
prerank,stem cell development (GO:0048864),0.40855472625654726,1.0072150497289982,0.4696132596685083,0.9634305609338321,1.0,2/16,4.12%,PTPRC;CDH2
prerank,transepithelial transport (GO:0070633),0.4123090093416937,1.006979623830242,0.4635514018691589,0.9631778968621911,1.0,3/15,8.22%,SLC1A1;ABCG2;SLC1A2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3735386911646058,1.0066555890762126,0.4612676056338028,0.9631449068769729,1.0,7/22,16.45%,TIPRL;BOD1;PPP1R11;MGAT5;IKBKB;PTPA;FKBP1A
prerank,regulation of cellular respiration (GO:0043457),0.3932576917337427,1.0066369246260547,0.42988929889298894,0.9621825855280036,1.0,3/17,9.96%,IFNLR1;IL10RB;IFNAR1
prerank,cellular response to chemokine (GO:1990869),0.3212634724777046,1.0065492331448662,0.4453376205787781,0.9614198715158252,1.0,5/46,8.51%,OXSR1;CXCL12;LRCH1;RIPOR2;CCL25
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3667881757868553,1.006380467319703,0.4404332129963899,0.9609529020980331,1.0,6/25,12.08%,KIF18A;PIN1;FGF13;TRPV4;KIF2A;CENPJ
prerank,autophagosome assembly (GO:0000045),0.3110318068611875,1.006224513494781,0.4230171073094868,0.9604275760037987,1.0,19/52,18.80%,MAP1LC3B;ATP2A2;RAB7A;RAB43;TRAPPC8;VMP1;RAB1A;UBQLN1;ATG7;ATG16L1;ATG14;TMEM41B;GABARAPL1;ATG13;TP53INP2;UBQLN2;BECN1;GABARAP;ULK1
prerank,regulation of protein acetylation (GO:1901983),0.43095614218687095,1.0062017560611343,0.4601941747572815,0.9594769400473867,1.0,5/12,15.22%,RAPGEF3;SIRT1;PARK7;DDX3X;TERF2IP
prerank,regulation of macromolecule metabolic process (GO:0060255),0.26394346546785225,1.0060829678137622,0.4498714652956298,0.9588788164529454,1.0,25/170,9.91%,CAVIN4;PIN1;PTPRC;SORT1;PCBP1;STOX1;ZFP36L1;HNRNPAB;APOE;PRDM4;SOX2;HNRNPK;TRIM14;NPAT;LAMTOR1;RO60;BMI1;RNF187;KDM6A;CDK4;TOB2;NOVA2;ARF1;MARF1;TARDBP
prerank,regulation of gastrulation (GO:0010470),-0.3919747833874248,-1.0060480845263984,0.4539614561027837,0.7842154079435341,1.0,3/14,5.59%,PHLDB2;PHLDB1;OSR1
prerank,regulation of hydrolase activity (GO:0051336),0.295029359750029,1.0059643146260386,0.44462025316455694,0.9582285196121205,1.0,12/71,8.96%,CFAP73;SOD1;VAV3;CHN2;PRKG1;TBC1D10B;TDG;EPHA5;FGD5;RAPGEF6;RASIP1;PLXNA4
prerank,activation of protein kinase B activity (GO:0032148),-0.3233219682388564,-1.005930409619631,0.4447058823529412,0.7837558534459242,1.0,3/29,3.14%,NTRK3;IGF1;FGF1
prerank,membrane fusion (GO:0061025),-0.32226776996417794,-1.0057495572458872,0.4538653366583541,0.7834479362365498,1.0,12/33,22.61%,RIMS1;UBXN2A;UBXN2B;HUWE1;MYOF;NSFL1C;DNM1;VAMP2;USO1;SNAP29;VPS33B;GCA
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3470917916216296,1.0054137451713767,0.4393162393162393,0.9588853058071214,1.0,14/32,20.79%,EIF2A;GEMIN5;TMED10;TSC1;METAP1;NANOS3;APP;PICALM;RBM4B;CYFIP1;RPL10;EIF4E;MTPN;SAMD8
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.375746806586102,1.004813719994375,0.4385026737967914,0.9597320850368204,1.0,3/22,4.99%,EIF5A;RPL23;SPRED1
prerank,regulation of lymphocyte migration (GO:2000401),-0.4354376567175575,-1.0047805636698077,0.4716599190283401,0.7852279199009465,1.0,3/10,24.52%,WASL;MSN;AKT1
prerank,transcription by RNA polymerase II (GO:0006366),-0.21652650881773192,-1.0047648223071302,0.4339622641509434,0.7844804554179872,1.0,87/305,20.05%,DDX5;NOTCH2;TEAD1;GLIS3;PRRX1;PABPN1;RARB;MAF;TBL1XR1;CCN2;ELP4;SOX5;MED26;RPRD1B;MAML1;HDAC1;GTF2I;MED1;PPARGC1A;CBFB;RREB1;POU2F1;ZBTB1;RBMX;DEK;ERCC6;PPARA;ELL;PIR;NOTCH3;CSTF3;MED17;RNGTT;CDC73;PHAX;SNW1;SRRT;GTF2A1;ELP2;RXRA;SYMPK;NFKB1;NR2C2;ESRRA;TBL1X;RARA;CDK7;NELFB;NR3C2;CCNT1;CSTF2;NFYA;ELOA;POLR2A;SNAPC3;DDX21;TAF8;RORA;SETX;INTS10;INTS8;CCNK;PAF1;TEAD3;MLLT1;INTS11;TAF6;CTDP1;RPAP1;WWTR1;NR3C1;CDK9;GTF2E2;EAF1;MAML2;TAF5L;TAF12;KLF13;PARP1;COPS2;MED20;NR2F1;NELFA;CDK12;TEAD2;CPSF3;NABP2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3505473733294358,1.0043599001031096,0.45563139931740615,0.9601310333323961,1.0,9/29,15.69%,COG5;COPG2;GOSR2;RAB6B;NAPA;RAB6A;COPG1;COG3;TRAPPC10
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4294807919420909,1.0041968140686728,0.4570383912248629,0.9596455619639889,1.0,1/12,0.61%,IMPDH1
prerank,positive regulation of protein modification process (GO:0031401),0.25874262360736916,1.00404554211474,0.4624203821656051,0.9590899215579443,1.0,43/203,15.37%,MAPK3;RALB;LIMCH1;RAP2A;PIN1;PECAM1;SVIP;HDAC3;PPP1R16B;TEK;NPTN;CIB1;TBX1;FXR1;CNEP1R1;CALM3;RAPGEF3;SIRT1;SPPL3;TXN;AXIN1;EFNA1;AKTIP;CDK2AP1;CSF1R;LYN;PAK1;ACVR2A;DDX3X;ANKLE2;APP;PTBP1;ATG7;CRKL;WDFY2;CDH5;PTPA;CAMKK2;VEGFC;TERF2IP;GAS6;ATG14;RAB3GAP1
prerank,microtubule anchoring (GO:0034453),0.4253255278829322,1.0040050116801926,0.4753787878787879,0.958211185994854,1.0,6/12,17.19%,CLASP2;DAG1;GCC2;BCCIP;BICD2;CLASP1
prerank,regulation of synapse organization (GO:0050807),-0.32576245677900856,-1.0037536766266597,0.42035398230088494,0.7864959991731549,1.0,10/26,29.16%,CTNNA2;PDLIM5;ARHGAP22;IL1RAPL1;NEDD4;CAMK2B;CLN3;SLITRK4;MDGA1;ABHD17A
prerank,embryonic axis specification (GO:0000578),-0.3834385175202345,-1.0036600899569237,0.45454545454545453,0.7859932501960841,1.0,3/15,11.62%,COBL;SMAD6;TBX3
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.31592527332881076,-1.003614503504772,0.4523809523809524,0.7853301974032371,1.0,3/32,2.15%,MAGI2;PDGFRB;CAMTA1
prerank,negative regulation of protein kinase activity (GO:0006469),0.28900140535276,1.0035988390975223,0.45689655172413796,0.9584348384569945,1.0,11/88,7.80%,PTPRQ;TRIB3;PTPRC;GNAQ;PTPRB;SPRED1;CDKN1A;AKT1S1;DTNBP1;PTPRT;ADAR
prerank,negative regulation of DNA recombination (GO:0045910),0.32861598077037224,1.003010058928196,0.4601328903654485,0.9591954317227622,1.0,8/43,15.33%,POLR2J;ZRANB3;POLR2B;ACD;MSH3;HELB;TERF2IP;UBQLN4
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3208154762890867,-1.00289796146182,0.4674698795180723,0.7864116351682549,1.0,6/26,7.94%,DNAJC6;AP2B1;SNAP91;AP2A2;GPR107;AP2A1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.35079344264356394,-1.002860963152385,0.4503464203233256,0.785723416057295,1.0,6/20,8.63%,CFLAR;OGT;CYLD;NUPR1;FLOT2;BIRC3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.33296037395374944,-1.0027734890153173,0.47235023041474655,0.7851860777089658,1.0,14/23,41.85%,DDB1;DDB2;UBC;PARP1;XPC;COPS2;COPS5;COPS7A;COPS6;RBX1;XPA;GPS1;UBA52;CETN2
prerank,chemical homeostasis (GO:0048878),0.3023902022393306,1.0027185393387243,0.4528301886792453,0.95916429474136,1.0,10/61,11.52%,SLC4A4;SLC4A5;KLHL3;FITM2;NEDD4L;ACOX3;USF2;IRS2;DDX3X;PNPLA8
prerank,sterol metabolic process (GO:0016125),0.30832717350273764,1.0026892987403906,0.458528951486698,0.958257974236961,1.0,11/60,12.68%,EBP;INSIG1;HMGCR;APOE;SOAT1;PPARD;SC5D;OSBPL1A;NSDHL;CYP1B1;LDLRAP1
prerank,glucan catabolic process (GO:0009251),-0.37900961524161353,-1.0026829965164672,0.46710526315789475,0.7846566028302262,1.0,7/15,19.38%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,regulation of G0 to G1 transition (GO:0070316),0.32923228225194084,1.0022474153822218,0.4614065180102916,0.9586287315044651,1.0,9/38,16.16%,EZH2;EED;UXT;BMI1;RYBP;MGA;APAF1;E2F6;RBBP4
prerank,regulation of nervous system development (GO:0051960),0.3329390844469944,1.0021211584822733,0.4644628099173554,0.9580112780270739,1.0,9/37,16.10%,HES6;HEY1;TNFRSF1B;HEY2;PRUNE1;DOCK7;TENM4;HES1;HEYL
prerank,positive regulation of programmed cell death (GO:0043068),0.2523821072276897,1.0015870985360005,0.4722222222222222,0.9587034273422941,1.0,54/272,16.60%,ERCC3;MAP3K11;ATF6;FRZB;TIAM1;SOD1;VAV3;PSEN2;ARHGEF26;MCF2L;ING4;ITSN1;TNFRSF10B;MAPK8;ARHGEF6;CRADD;ARHGEF7;SYK;TRIO;SIRT1;OMA1;ARHGEF18;ITGA6;LATS2;BCLAF1;FZD9;TFAP4;AIFM1;RYBP;ING3;CCAR2;BAD;DDX3X;CYP1B1;ATG7;BMF;IP6K2;BNIP3L;NF1;ING5;UTP11;DIABLO;FAF1;APC;PTPA;APAF1;MAP3K10;GNA13;APH1A;BCL6;DNM1L;BNIP3;QRICH1;RASGRF2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3995823113630343,1.0014265172279848,0.4664179104477612,0.9582310345556326,1.0,1/15,0.77%,ZC3H12D
prerank,cation transport (GO:0006812),-0.22755709030026214,-0.999884095434611,0.4026548672566372,0.7915556180944079,1.0,44/167,23.74%,TRPM3;ATP1A2;KCNB2;KCNMA1;ATP1B1;SLC41A1;TRPM6;SLC47A1;SCN8A;SCN3A;PIEZO2;SLC12A2;SLC6A9;KCNK5;KCNJ2;SCN1A;KCNA1;SLC22A4;SGK1;ANO1;NDFIP1;KCNJ6;SLC9B2;ABCC9;ANO6;KCNJ13;NDUFA9;KCNS3;KCNQ4;SLC5A6;SLC38A7;SLC5A5;ANO10;KCNJ10;KCNA6;KCNA2;SLC11A2;GRIN1;SLC22A18;TRPC6;MCOLN1;KCNC1;PANX1;CLN3
prerank,regulation of isotype switching (GO:0045191),-0.4002015825417877,-0.9998422814867326,0.48643006263048016,0.7908785631344498,1.0,5/14,20.10%,PAXIP1;SHLD1;PARP3;RIF1;SLC15A4
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.37744861427364196,0.9993580243836742,0.45989304812834225,0.963544741104036,1.0,7/20,17.08%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;LZTFL1;PPP2R5A
prerank,positive regulation of protein import (GO:1904591),-0.31866840269647184,-0.9993554283078425,0.4373522458628842,0.7914448756777658,1.0,13/30,20.01%,ZIC1;SMAD3;FLNA;BAG3;PRKCD;UBR5;EFCAB7;CDH1;PDCD5;ARHGEF5;TGFB1;MAVS;PIK3R1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.34266860253718623,0.999296616296932,0.45611015490533563,0.9627558643969288,1.0,4/33,3.01%,LRP8;CACNA1A;GRIK5;GRIK2
prerank,regulation of axon regeneration (GO:0048679),-0.4077887513048094,-0.9990082461009867,0.44466403162055335,0.791653941490553,1.0,5/12,33.68%,PTPRS;CERS2;SCARF1;INPP5F;PTN
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4234708357685335,-0.9988355318262402,0.4810126582278481,0.7913492098988697,1.0,3/11,15.11%,NRP1;SIRT2;STMN1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2573950372640825,-0.9987181221366517,0.45483870967741935,0.7908741271241786,1.0,17/76,25.09%,LPAR1;HTR2C;GRM5;CHRM2;PLCE1;ADRA1B;ACTN2;ANO1;GPR4;OPRM1;GNA14;AGTR1;ADRA1A;P2RY12;CMKLR1;LPAR6;ADRA2A
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.35850621520376647,0.9986654293223148,0.4842105263157895,0.9637064781708854,1.0,5/25,8.21%,PRPF3;SRSF10;SMNDC1;SF3B3;SRSF4
prerank,negative regulation of neuron death (GO:1901215),0.28234978262067323,0.9984475286941503,0.4565868263473054,0.9634022389881935,1.0,13/93,9.91%,FOXQ1;SOD1;CRLF1;PPT1;APOE;TNFRSF1B;TOX3;WFS1;BDNF;SOD2;FZD9;PARK7;FBXO7
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.37535716350260956,0.9983430864772452,0.47627416520210897,0.962735678792189,1.0,5/21,11.16%,FCGR2B;PRKCH;LYN;CD81;SLC39A10
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3361901178652452,0.9983160257382001,0.45569620253164556,0.96184621613149,1.0,7/35,13.19%,PNKP;XRCC1;TDG;POLE;POLD3;SMUG1;MPG
prerank,primary alcohol metabolic process (GO:0034308),-0.32841893776149955,-0.9981235747455066,0.459954233409611,0.7917022406348687,1.0,5/25,11.98%,IGF1;DHRS3;NAPEPLD;RBP4;ALDH3A2
prerank,positive regulation of cell motility (GO:2000147),0.2568746816798657,0.9981176467263364,0.46675031367628605,0.9615158851509127,1.0,31/205,12.62%,PHPT1;SPOCK2;MAZ;SEMA6A;SEMA6D;SEMA7A;LEF1;TIAM1;PECAM1;CXCL12;SEMA3C;CIB1;RET;SEMA6B;ACTN4;RUFY3;NOTCH1;ITGA6;TJP1;SEMA4C;CSF1R;SOD2;PODXL;PAK1;VSIR;FLT1;PIK3CD;PPP3CA;MAP4K4;MGAT5;CDH5
prerank,positive regulation of viral process (GO:0048524),0.30708798523302866,0.9980063348550888,0.4503105590062112,0.9608896801676649,1.0,12/60,12.67%,POLR2J;POLR2B;IFIT1;RAB7A;ADAR;CNOT7;RSF1;RAD23A;SRPK2;DDX3X;TMEM39A;MDFIC
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.35727984807800095,0.9979098334452963,0.46416938110749184,0.9602219049416708,1.0,5/27,9.20%,CSGALNACT1;XYLT1;CHSY3;PXYLP1;B3GAT2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.27061357139686254,0.9974541192962931,0.46837146702557203,0.9606136380301936,1.0,39/132,18.85%,SLC4A4;GSK3A;PRR5L;ATF6;SH3D19;PLK2;SVIP;TRIM8;VPS11;APOE;TNFRSF1B;TRIM14;PTTG1IP;IRS2;CNOT7;DXO;PRKAA2;BAD;P2RX7;PFKFB3;APP;TMEM59;FAF1;TRIM27;CNOT1;PIK3C2A;VPS35;DAGLB;MOV10;TFEB;BNIP3;ADAM9;INSR;IRS1;RDX;RC3H1;ULK1;MID2;SH3GLB1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4281109133294108,0.997321679660298,0.4708097928436911,0.9600181672129866,1.0,5/12,16.81%,ACTB;CELSR1;TRAF3IP1;ZDHHC7;LAMA5
prerank,regulation of cellular protein localization (GO:1903827),-0.2856153239483606,-0.9971571711722865,0.43669250645994834,0.7935602753271942,1.0,11/45,9.77%,MAP2;GPC6;SPIDR;MAPT;CTNNB1;VCP;GPC3;CCDC66;CSNK1E;GPC5;DVL3
prerank,UV-damage excision repair (GO:0070914),0.4329988288352936,0.997101107379846,0.48120300751879697,0.9597480438390148,1.0,5/12,14.94%,SIRT1;ACTR5;POLD3;POLA1;INO80
prerank,lysine metabolic process (GO:0006553),0.4351510013183464,0.9968579335931345,0.4625984251968504,0.9586023634328787,1.0,3/12,15.27%,AASS;PHYKPL;SLC25A21
prerank,lysine catabolic process (GO:0006554),0.4351510013183464,0.9968579335931345,0.4625984251968504,0.9586023634328787,1.0,3/12,15.27%,AASS;PHYKPL;SLC25A21
prerank,protein-containing complex assembly (GO:0065003),0.24875687205185384,0.9968484990017159,0.4631449631449631,0.9576558188969375,1.0,57/259,16.83%,SH3BGR;CAND1;TRAPPC2;CAPZA2;LEF1;TIAM1;CNIH1;CXCL12;KIFAP3;SKAP2;NDUFAF1;ANKRD28;SEC23IP;EP300;KPNA3;GOSR2;F8;MAGI1;NAPA;GEMIN5;AXIN1;PDE4DIP;TMED10;CAND2;SLC2A1;RUVBL1;MDM2;RAB1A;TFAP4;BAD;TERT;P2RX7;DMD;CREBBP;TLE4;SCFD1;ELOB;TRAPPC6B;PICALM;MCFD2;HGSNAT;CUL3;TRRAP;APC;HES1;AP2M1;PARD3;PPP6R1;TRAPPC10;SMARCA4;TCF7L1;DNM1L;PTK2B;TUBGCP2;LIN7A;DNAJB14;CD2AP
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2846971162530639,0.9968394048571342,0.46074074074074073,0.9567075003380354,1.0,14/86,12.23%,LRP8;PTPRJ;PTPRC;PECAM1;PDCL3;SRC;FYN;SAMSN1;CNOT7;EFNA1;CD81;APP;PRNP;RAP2C
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.40980870359673033,0.9968173414184097,0.49080882352941174,0.9558128545312782,1.0,2/14,6.21%,RFFL;CARD16
prerank,neutrophil mediated immunity (GO:0002446),0.24108216050499207,0.9965577732822161,0.47565118912797283,0.9556621853475876,1.0,71/432,14.81%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;GLB1;HSPA8;PTPRC;GYG1;PRCP;PECAM1;PTGES2;SVIP;RAB5C;CCT2;PTPRB;PYGL;NRAS;TUBB;ATP6V1D;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;STOM;ATP6AP2;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;DYNLL1;PNP;VAT1;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;RAP2C;GM2A;GALNS;CD55;OSTF1;SCAMP1;NDUFC2;PSMD14;NPC2;ARPC5;PSMD1;ERP44;CD93;PSMB1;APAF1;CYBA;QPCT;CD44;NHLRC3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.23424998316475112,0.9964651277379105,0.49631966351209256,0.9549640655781791,1.0,143/807,16.22%,SOX30;LRRFIP1;ATF3;IRX1;MAZ;DCAF1;CCDC85B;GCLC;DACH1;MECOM;AASS;ARID5A;ILF3;KLF8;L3MBTL4;TRIB3;NR4A2;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;RPL23;EED;JAZF1;BTAF1;GTF2IRD1;DMAP1;KLF2;DNAJA3;ELK3;ING4;MAP2K5;ZHX3;ZBTB33;HDAC9;BCL6B;RPS6KA5;HDAC3;SBNO2;HEY1;NEDD4L;SMARCA2;SOX2;YY1;PHB2;WFS1;KDM2A;VPS72;UBE2I;IRF2BPL;BEND3;EP300;RFX3;RPS14;NFX1;CNOT2;PPARD;CHMP1A;ZNF205;SFPQ;UXT;SMAD7;SIRT1;BMI1;DRAP1;CLOCK;ZNF3;PFDN5;HEY2;ZBTB14;NOTCH1;SAP130;EDNRB;USP47;CNOT7;WNT5A;EFNA1;SOX13;RSF1;RELA;NAB2;HOXA7;BCLAF1;MDM2;PLCB1;TFAP4;TRPS1;ZKSCAN3;CIR1;CITED2;PBXIP1;CCAR2;HIC2;ESR1;THRB;RBPJ;CREBBP;CTBP1;ORC2;NFIC;PA2G4;HDGF;IFI27;LANCL2;N4BP2L2;MZF1;MDFIC;IRF2;CHD3;NDUFA13;TGIF1;CTBP2;HDAC5;DDIT3;THRA;HES1;KDM5C;DR1;HCFC1;TRIM27;USP9X;CNOT1;E2F6;TMPRSS6;BACH1;MAP3K10;PHF10;EZH1;GAS6;NKAP;TCERG1;TAF1;ELK4;BCL6;TRIM33;SMARCA4;ID2;TCF3;HEYL;ZBTB18;TAF3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4094815932757916,-0.9962836236756321,0.47198275862068967,0.7952004448297493,1.0,4/12,33.39%,IL18;IL17D;CD80;PAEP
prerank,protein targeting (GO:0006605),0.2728738235668191,0.996217071106123,0.45989304812834225,0.9547445493915669,1.0,21/118,14.49%,RTP3;TOMM20;CHM;CDC37;TIMM17B;TSPO;PEX1;SPCS3;ZDHHC14;PIKFYVE;AP4S1;ZDHHC15;FBXO7;ICMT;VPS37B;PRKCI;ZDHHC9;SPCS2;GIPC1;ZDHHC7;PARD3
prerank,kinetochore organization (GO:0051383),0.42283660215247193,0.9961661146891186,0.45131086142322097,0.9539447797588985,1.0,3/13,13.56%,CENPC;MIS12;POGZ
prerank,regulation of feeding behavior (GO:0060259),-0.4128066400527965,-0.9961169023647256,0.4725050916496945,0.7948545012209801,1.0,2/11,6.86%,LEPR;CFAP20
prerank,sodium ion import across plasma membrane (GO:0098719),0.38832725950827757,0.9960108016775457,0.49029982363315694,0.953428868297427,1.0,3/17,10.53%,SLC9A7;SLC9A6;TRPM4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.40633041559698446,-0.9959129355803412,0.47368421052631576,0.7946580895571621,1.0,2/12,2.74%,FOXP1;MBP
prerank,apoptotic process (GO:0006915),0.2569912653901758,0.9959126042744602,0.489171974522293,0.9527606225009615,1.0,36/203,14.82%,ERCC3;SEMA6A;BNIPL;AHCYL1;MAP3K7;FASTKD2;MAL;MAGI3;ING4;PPP2CA;TNFRSF10B;SCN2A;CASP6;CIB1;EP300;TBX1;FXR1;ARHGEF6;BCL2L13;PPARD;CDK11B;BCLAF1;MDM2;AIFM1;BAD;NAE1;CDIP1;APP;IFI27;BMF;RRAGC;DIABLO;NFKBIA;ELMO1;APAF1;MAP3K10
prerank,tRNA wobble uridine modification (GO:0002098),0.4116460191126068,0.995746707567039,0.47036328871892924,0.9523203468144924,1.0,2/14,8.03%,MOCS3;ELP1
prerank,negative regulation of translation (GO:0017148),-0.25290136362231613,-0.9954360667236068,0.4391025641025641,0.7951507841782665,1.0,21/87,18.44%,SAMD4A;CPEB4;CPEB1;CPEB2;IGFBP5;PUM1;ROCK2;ROCK1;SYNCRIP;EIF4E2;YTHDF1;CNOT9;EIF2AK2;PUS7;RBM4;UNK;RACK1;TOB1;RNF139;PCIF1;DAPK1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3407402799867361,0.9953223572215998,0.4606164383561644,0.9526178818472573,1.0,9/33,18.64%,MAZ;NCBP1;CPSF4;PAPOLA;SCAF8;SLBP;WDR33;CLP1;SNRPD3
prerank,regulation of protein catabolic process (GO:0042176),0.27988669579496367,0.9951286928941616,0.45863570391872277,0.9522738640527592,1.0,19/99,13.85%,GSK3A;EEF1A1;PIN1;TNFAIP3;PLK2;HMGCR;NEDD4L;RAB7A;TMEM9;AXIN1;SF3B3;WNT5A;MDM2;ATG7;EGLN2;NDUFA13;CHEK2;FAF1;APC
prerank,secondary palate development (GO:0062009),-0.3810582322831074,-0.9950925825158913,0.45233265720081134,0.7952638616348139,1.0,3/14,4.04%,TGFBR3;TGFBR2;SMAD4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.27713772843624446,0.9949426413661978,0.46573426573426574,0.9518765695674809,1.0,16/101,11.82%,PIK3CG;RALB;EZH2;MTCP1;RPTOR;SRC;PPP2CA;CIB1;RGCC;CALM3;SIRT1;WNT5A;CSF1R;DDX3X;FLT1;PIK3R5
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.41411575869422224,-0.9948656227915609,0.448692152917505,0.795067627362098,1.0,7/11,45.24%,CAMK4;MAVS;TICAM1;TYROBP;ITGB2;SPI1;ITGAM
prerank,detection of calcium ion (GO:0005513),0.41267017596259237,0.9946208817011576,0.4634146341463415,0.9519177874315885,1.0,5/13,18.82%,CALM3;KCNMB2;KCNMB3;RYR2;CALM1
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.25288625303592616,-0.9942615277506133,0.45565749235474007,0.7959285573707989,1.0,22/87,15.34%,NOTCH2;LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;RHOA;ROCK2;PRKCD;PDGFRA;ROCK1;EZR;RND3;RHOBTB2;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;ARHGDIA;ARHGEF5;IQGAP2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.2963321510920115,-0.9942300776464644,0.43283582089552236,0.7952275730088988,1.0,13/37,17.45%,IFT81;WDR35;DYNC2I1;TTC21B;IFT46;IFT57;IFT52;IFT172;IFT74;KIF3A;WDR19;DYNLL2;IFT20
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4011659308919896,0.9938458305044653,0.45692883895131087,0.9532579649568697,1.0,2/16,6.48%,TUBB;CEBPG
prerank,peptide hormone secretion (GO:0030072),0.35798571021053177,0.9937501580820867,0.4780316344463972,0.9525991422456286,1.0,4/26,9.76%,LTBP4;RAB1A;CYB5R4;PARK7
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3828954481625449,0.9935961613993602,0.46285714285714286,0.9520956090502298,1.0,8/19,19.52%,GSK3A;PARK7;FBXO7;CSNK2A2;CAMKK2;DNM1L;USP36;FBXW7
prerank,regulation of cholesterol transport (GO:0032374),-0.34193526729919793,-0.9935059228228699,0.490280777537797,0.7964482320992511,1.0,5/20,12.78%,LRP1;OSBPL6;ABCA5;NFKB1;TTC39B
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.3647894506820907,-0.9934450109535523,0.45806451612903226,0.795838142627381,1.0,7/16,19.38%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,cardiac muscle cell development (GO:0055013),-0.35074308162756634,-0.993348850450411,0.4340909090909091,0.7953569429586441,1.0,4/20,6.19%,PDLIM5;PDGFRB;CXADR;PDGFRA
prerank,aerobic respiration (GO:0009060),0.37410112204467627,0.9931645539905887,0.4603448275862069,0.9525086933797914,1.0,3/20,4.37%,ME3;MTFR1;SIRT3
prerank,regulation of centriole replication (GO:0046599),0.3720243774733978,0.9930827216912226,0.45571955719557194,0.9518080437261427,1.0,2/18,2.58%,ALMS1;PLK2
prerank,striated muscle cell development (GO:0055002),0.4115425199976764,0.9930135907030803,0.45506692160611856,0.9510715524386012,1.0,2/14,4.82%,PGM5;FLII
prerank,phosphorylation (GO:0016310),0.2443368207228971,0.9929341373999225,0.49372862029646525,0.9503555870883823,1.0,81/385,16.75%,MAP3K11;MAPK3;SNRK;GSK3A;ILF3;PIK3CG;CDK17;DGKB;OXSR1;CDK19;PPP3CB;PLK2;NEK11;PNKP;PRKCH;RPS6KA4;HIPK2;MEX3B;PRKG1;PRKD2;RPS6KA5;PANK2;MAP3K9;PKN3;FYN;CERKL;MAPK8;RET;PAK3;SIK3;SYK;CDK11B;PIM1;PEAK1;MINK1;CDK4;MERTK;ACVRL1;LATS2;CDKL4;LYN;NRBP1;ERG;PKN1;PAK1;NIM1K;PRKAA2;ACVR2A;SRPK2;NLK;NEK7;CTBP1;APP;PI4KA;PIK3CD;STRADB;TYK2;PRKCI;MAP4K4;MAPK6;IKBKB;CHUK;CHEK2;TLK2;NEK6;BRD2;CAMKK2;COPS8;BMP2K;GAS6;DYRK2;CDKL5;TOP1;TAF1;CERK;BRAF;PTK2B;PIK3R4;CDK14;WNK2;PRKDC
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4098072455578577,0.9928943473243451,0.46964285714285714,0.9495277345291683,1.0,14/14,59.06%,ATP6AP1;CSF1;POU4F2;IFNG;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;TRAF6;TYROBP
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.32405214889258416,-0.9927739675995415,0.46774193548387094,0.7961002225312462,1.0,8/25,21.10%,ERRFI1;PPARA;SLC6A9;EPHB2;ZGPAT;TSG101;SOCS5;SNX6
prerank,protein import (GO:0017038),-0.25344406059325697,-0.9926942444670745,0.43312101910828027,0.7955310533040966,1.0,41/84,32.75%,ACBD5;IPO9;TNPO3;RAB8B;APPL2;PEX14;HSPA4;NUP155;FIS1;NUP188;IPO11;NUP88;NUP93;ALDH3A2;TNPO2;PXMP4;ABCD2;FAM53C;PEX2;NUTF2;PEX5;IPO13;TSC2;NUP85;GDAP1;NUP214;APPL1;PPP1R10;AKT1;SEC13;SAMM50;ABCD3;HSP90AA1;NUP153;NXT2;PEX26;PEX19;RPAIN;RAN;EIF4ENIF1;HEATR3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4302673818738065,0.992334322249972,0.49224806201550386,0.9503379790944947,1.0,1/11,0.14%,CIDEA
prerank,rRNA methylation (GO:0031167),-0.3373528348058378,-0.9921956740299378,0.46952595936794583,0.7960911420659686,1.0,17/22,44.84%,METTL15;NSUN4;NSUN3;METTL5;BUD23;MTERF4;FTSJ3;NOP2;NSUN5;ZCCHC4;FBL;MRM1;FDXACB1;MRM2;MRM3;TRMT112;METTL16
prerank,lipid catabolic process (GO:0016042),0.38877720746075356,0.9920836472053178,0.49355432780847147,0.9501532343424591,1.0,2/18,4.71%,PPT1;PLAAT3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3570150191270078,0.9920620625620793,0.47469458987783597,0.949276534189826,1.0,7/28,11.08%,FITM2;TNFRSF1B;ADIPOR2;SIRT1;CD47;PRKAA2;ADIPOR1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.35242529241452936,0.9918888123351779,0.4626865671641791,0.9488367817176353,1.0,6/27,11.69%,DACH1;PRKD2;CDKN1A;RGCC;ACVRL1;TNKS
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.20881605186862973,-0.9918636010316527,0.4774193548387097,0.7962431179490919,1.0,52/308,13.61%,LRP1;DAB2;LEPR;COL1A1;SMAD3;ACSL1;OGT;FOXD1;SMURF2;EBF2;TGFBR1;DYNC1H1;SOX5;TGFBR2;SNX4;CTNNB1;PDPN;SMAD4;TAPT1;MED1;BMP4;GHR;PPARGC1A;RREB1;SMO;APPL2;SORL1;PER2;ROCK1;LBP;ADRA1B;PLA2R1;STAT6;LPIN1;FOXC1;PAXIP1;NLGN1;SHLD1;NIBAN2;ACVR1;KSR2;EIF2AK2;GJA1;NR2C2;PRKAB2;HSF1;ABCA1;ACVR1B;SLC27A1;IL18;IL33;GRB10
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.38826737095776326,-0.9918328313146654,0.46487603305785125,0.7955616671473333,1.0,9/14,30.04%,DDB1;PPARGC1A;AKT2;ARPP19;GPLD1;PTPN2;AKT1;NNMT;SLC45A3
prerank,fatty acid beta-oxidation (GO:0006635),0.3143447827875944,0.9913126124069654,0.4848,0.9495615104503989,1.0,12/51,16.59%,CRAT;ACOX3;ACAT1;PPARD;ETFA;HSD17B4;ACOT8;BDH2;ECHDC1;ECHS1;ACAA2;ACADL
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.3579377767781316,-0.9911132413152309,0.46004319654427644,0.7967691615905562,1.0,7/18,20.70%,KMT2A;SETD7;EHMT2;KMT2B;SMYD2;KMT2D;SETD4
prerank,mitochondrial transport (GO:0006839),0.3091286571336251,0.991092286415264,0.46322378716744916,0.9493079796246535,1.0,8/53,10.66%,TOMM20;ABCB10;SLC25A24;TIMM17B;TSPO;FBXO7;BAD;MAIP1
prerank,actin filament organization (GO:0007015),-0.23174374367128175,-0.9909307634621217,0.4600760456273764,0.7964998681794503,1.0,53/151,27.75%,SVIL;MCU;PPP1R9A;GSN;DPYSL3;CGNL1;TMOD2;SPIRE1;WASL;SHROOM3;ABI1;TPM1;RHOA;FLNA;NEDD9;GAS2;ARHGAP12;COBL;RND3;RHOBTB2;BIN3;FHOD1;RHOB;BAIAP2L1;RHOBTB1;INPPL1;DLG1;HIP1R;TRIOBP;ERMN;MYO1B;TPM4;CDC42;MYO1F;ALDOA;TMOD1;VILL;MYO19;RHOC;GAS2L3;EMP2;ARHGAP17;PLS1;ELMO2;EFS;DMTN;CAPG;HIP1;DBN1;CDC42EP2;MYO5B;MPRIP;RHOH
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3624970411877652,-0.9908833624930786,0.455531453362256,0.79585320955553,1.0,2/17,3.00%,NTRK3;NRP1
prerank,amino acid import across plasma membrane (GO:0089718),0.36085172818853745,0.9907370196671039,0.47971781305114636,0.9494789620197353,1.0,5/24,8.22%,SLC7A8;SLC1A1;SLC3A2;SLC6A6;SLC1A2
prerank,sensory perception of light stimulus (GO:0050953),-0.2500765990582207,-0.9907193203769129,0.47096774193548385,0.7955236948135448,1.0,9/87,6.49%,PCDH15;SLC4A10;COL1A1;EML2;COL11A1;ADGRV1;EFEMP1;DHRS3;DNAJC19
prerank,regulation of epithelial cell differentiation (GO:0030856),0.39438659113963725,0.9906269584228471,0.4729241877256318,0.9488788669838989,1.0,1/17,0.25%,PRKX
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3812259187051609,0.9906211211468811,0.46605504587155966,0.9479645995250955,1.0,3/20,11.01%,GSK3A;EP300;PGP
prerank,regulation of cell division (GO:0051302),0.2901389805711954,0.9899026424107801,0.4766214177978884,0.9491892513066787,1.0,8/72,6.88%,TAL1;PIN1;PLK2;PRDM15;CSPP1;PRPF40A;CIB1;CALM3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.2674672733293307,0.9898043983169988,0.47249647390691113,0.9485544533329593,1.0,30/129,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PIN1;PRDM15;PSMD11;PSMB4;PSMC1;TMEM9;CSNK1G3;ATP6AP2;AXIN1;RUVBL1;USP47;PSMC2;FZD9;PSMD2;CCAR2;TRPM4;DDX3X;ZBED3;TNKS;PSMD14;RNF146;PSMC6;PSMD1;PSMB1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4220212709165202,-0.9894640281778848,0.4789915966386555,0.7980009428897998,1.0,2/10,7.08%,WNK1;DPP4
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.26582856393426474,-0.9892193559098015,0.501466275659824,0.7979182461042408,1.0,14/66,12.92%,EGFR;KANK2;PKD1;FHL1;RBL2;APPL2;MYO16;CDC73;ADAMTS1;BRD7;CCND3;CDK6;ANXA1;DLG1
prerank,protein palmitoylation (GO:0018345),0.3378999386228287,0.9890857752926663,0.488,0.9498110471250268,1.0,7/30,14.05%,ZDHHC17;ZDHHC13;ZDHHC14;SELENOK;ZDHHC15;ZDHHC9;ZDHHC7
prerank,"transcription, DNA-templated (GO:0006351)",0.2549012012714574,0.9890197281736138,0.48195876288659795,0.9490524929121917,1.0,41/207,16.22%,POLR2J;ERCC3;NCBP1;ELOC;NR4A2;POLR2B;POLR1C;GTF3C1;PAX8;CCNH;IRF9;GMEB2;NFX1;GTF3C5;PWP1;RO60;TRIP11;IVNS1ABP;DRAP1;GTF2H1;RSF1;TAF15;THRB;GTF2A2;NFIC;MED4;ELOB;TSC22D1;TAF4B;TBP;RRAGC;RNMT;PPP5C;THRA;BAZ2A;TFAM;NOCT;TAF1;GTF3C2;GTF2F2;TAF3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.33357485791397495,0.988870465438024,0.48223350253807107,0.9485502317725536,1.0,13/37,16.68%,RPL23;PDCL3;HIPK2;RPL5;PARK7;RYBP;CCAR2;TLK2;GIPC1;CSNK2A2;UCHL5;TAF1;N4BP1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3822870238050974,0.9887120891741041,0.4729241877256318,0.9481195171522818,1.0,4/19,8.57%,CTC1;SRC;HNRNPC;ACD
prerank,regulation of immune response (GO:0050776),0.26668330490081077,0.9885463739028866,0.48641655886157825,0.9476753713393422,1.0,12/135,10.70%,LRP8;SH2D1A;FCGR2B;TIRAP;BIRC2;B2M;ICAM1;SYK;IFITM1;TRAF3;LYN;CD81
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3292329165974255,0.9881674565102208,0.480865224625624,0.9478320154694878,1.0,9/35,11.76%,DDX54;SRC;UBE3A;KDM3A;CALCOCO1;PLPP1;WBP2;ESR1;EGLN2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.3921088745970476,-0.9881647746662765,0.45670995670995673,0.7999724345634407,1.0,3/12,8.48%,NOTCH2;DOCK10;DOCK11
prerank,mitochondrial fission (GO:0000266),0.39677344146388915,0.987959584823552,0.5044722719141324,0.9475065721673271,1.0,2/16,3.85%,DNM3;MTFR1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.31348989431009144,-0.9879272524740185,0.44730679156908665,0.799835361381325,1.0,10/29,23.81%,AMBRA1;PDGFRB;KIT;PDGFRA;PTK2;TGFB1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,mesenchyme morphogenesis (GO:0072132),0.38920763123672986,0.9879040263153852,0.4755639097744361,0.9467476088477895,1.0,5/17,16.10%,HEY1;NOTCH1;ACVRL1;NOS3;HEYL
prerank,cell cycle G1/S phase transition (GO:0044843),0.3003884446928712,0.9877585578818214,0.48484848484848486,0.9462505465848886,1.0,12/61,14.65%,MAP3K11;PLK2;CCNH;CDKN1A;POLE;CDK4;LATS2;USP37;E2F3;CUL3;PHF8;RCC1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3524784454088998,-0.9875295731311698,0.48853211009174313,0.799389117234609,1.0,2/20,0.57%,ZBTB20;IGF1
prerank,positive regulation of glycolytic process (GO:0045821),-0.3524784454088998,-0.9875295731311698,0.48853211009174313,0.799389117234609,1.0,2/20,0.57%,ZBTB20;IGF1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3294124920005479,0.9875101446772497,0.4596774193548387,0.9460652299940864,1.0,4/34,10.85%,PTPRC;PHB2;WNT5A;GPI
prerank,vitamin D metabolic process (GO:0042359),-0.3970237213861612,-0.9871511755024497,0.464,0.7997372940481207,1.0,4/13,33.88%,LGMN;PIAS4;CUBN;CYP2R1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.34561930509185995,-0.9871364355899314,0.4426229508196721,0.7974695163382385,1.0,14/20,49.42%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;MAD2L1;BUB1B;TTK;IK;CENPF;KNTC1;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.34561930509185995,-0.9871364355899314,0.4426229508196721,0.7974695163382385,1.0,14/20,49.42%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;MAD2L1;BUB1B;TTK;IK;CENPF;KNTC1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.34561930509185995,-0.9871364355899314,0.4426229508196721,0.7974695163382385,1.0,14/20,49.42%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;MAD2L1;BUB1B;TTK;IK;CENPF;KNTC1;TRIP13
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.23085947108076152,-0.9869498667150632,0.48148148148148145,0.7972083632418654,1.0,48/150,22.40%,NTRK3;LDLRAD4;PRKAG2;PTPN13;DNAJC3;ERRFI1;SH3GL2;FBLN1;RASSF2;PID1;OCLN;PLPP3;SIRT2;PRKCZ;ENPP1;PRKCD;PPM1E;XDH;UBASH3B;SMAD6;NIBAN1;EPHB2;CAMK2N1;SNX25;SEMA4D;DEPTOR;SIRPA;MYADM;TAB1;RACK1;LRP6;TGFB1;WWTR1;RTRAF;DVL1;TSC2;GPD1L;PPP1R15B;SPRED3;PAQR3;CADM4;FKBP8;HSPB1;PPM1F;DBNDD2;DGKQ;IMPACT;EMILIN1
prerank,protein K48-linked deubiquitination (GO:0071108),0.3664846116461515,0.9868584508074306,0.4766187050359712,0.9470804696985992,1.0,9/23,17.18%,TNFAIP3;YOD1;OTUD3;USP37;OTUD5;USP33;MINDY2;OTUD4;ATXN3
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.40588175116533043,0.9867739921344247,0.48455598455598453,0.9464046383602498,1.0,2/15,3.56%,AMDHD2;EXTL2
prerank,acyl-CoA metabolic process (GO:0006637),0.33162383872118667,0.9866823584229987,0.48519736842105265,0.9457602245181385,1.0,6/35,11.77%,MLYCD;DBI;GPAT4;ACACB;HMGCS2;ACOT8
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.34175379052466337,-0.9861666267191035,0.4387990762124711,0.7985382917234908,1.0,5/22,15.63%,AHNAK;CACNB4;SRI;GNB5;PDE4B
prerank,positive regulation of translational initiation (GO:0045948),-0.3540551996354715,-0.9857555817155966,0.46770601336302897,0.7988570196052962,1.0,9/18,33.08%,KHDRBS1;YTHDF1;HABP4;RPS6KB1;EIF2B5;RPS6KB2;POLR2G;YTHDF2;MTOR
prerank,membrane depolarization (GO:0051899),-0.3052775762061819,-0.9854538959971156,0.4896907216494845,0.7988873829875456,1.0,10/32,17.72%,CACNB4;P2RX4;SCN8A;SCN3A;CACNA1B;SCN1A;CACNA1G;CACNG4;ATP5IF1;CACNG2
prerank,glycine metabolic process (GO:0006544),-0.3995754427079976,-0.9851736247710272,0.4935897435897436,0.7988851435977629,1.0,8/12,51.26%,DLD;RIDA;AMT;GCSH;SHMT2;GCAT;GLDC;SHMT1
prerank,long-term synaptic potentiation (GO:0060291),-0.33917897760564014,-0.9847030343252019,0.4851694915254237,0.7993738604744556,1.0,9/21,23.76%,GRIN2B;TSHZ3;PRKCZ;SLC24A2;VAMP2;SHANK2;NFATC4;GRIN2D;MPP2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.394865180808912,-0.9843472306582511,0.5,0.7995638879335898,1.0,4/13,7.04%,ASPA;DDO;GLUL;GLUD1
prerank,membrane lipid metabolic process (GO:0006643),0.3669732289919052,0.984172506055313,0.5008665511265165,0.9523838958988081,1.0,5/22,11.91%,SERINC1;CERKL;TEX2;CYP1B1;ST3GAL6
prerank,peptidyl-lysine modification (GO:0018205),-0.24613171341650522,-0.9838878801891856,0.44871794871794873,0.8000629202426102,1.0,38/99,23.26%,EYA1;HDAC4;PLOD2;LOXL1;SIRT2;SENP3;ATP7A;NUP205;NUP155;NUP188;IFIH1;PLOD1;USPL1;BCL11A;NUP88;NUP93;LOXL3;P3H3;NNAT;SEH1L;TOPORS;PIAS3;SIRT7;ATPSCKMT;SENP7;EEF1AKMT1;STX1A;NUP85;AAAS;NSMCE2;RAE1;SIRT5;PIAS4;NUP37;LOX;VPS33B;NUP214;METTL21A
prerank,positive regulation of DNA repair (GO:0045739),-0.2822596044046905,-0.9838533490357413,0.46685082872928174,0.7993841455079859,1.0,10/46,9.48%,EYA2;EYA1;EGFR;SPIRE1;SPIDR;UBE2N;FMN2;ERCC6;MGMT;RNF168
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.38210231402901607,0.9836765525678278,0.4892086330935252,0.9529516597646811,1.0,3/19,9.17%,MAPK3;CAMK1D;CSF1R
prerank,limb development (GO:0060173),0.3443648319492193,0.983572040608661,0.47715736040609136,0.9522877596770767,1.0,2/28,3.08%,TBX4;GREM1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3210328316614875,0.9829793006705245,0.5007923930269413,0.9530802816822307,1.0,6/41,9.17%,LRP8;SRC;FYN;BDNF;EFNA1;CSF1R
prerank,negative regulation of wound healing (GO:0061045),-0.32119353750484647,-0.982910945601433,0.5097560975609756,0.8011844459938179,1.0,7/28,17.90%,PHLDB2;TFPI;SLC12A2;VTN;CD34;AJAP1;CD109
prerank,cellular response to ATP (GO:0071318),-0.3845308136230931,-0.9828569203295557,0.47489539748953974,0.8005565910889171,1.0,4/14,21.62%,RYR3;P2RX4;SSH1;P2RY12
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.3083538412524075,-0.9826989693604764,0.48370927318295737,0.8001820872627176,1.0,4/32,8.60%,AKAP6;CEMIP;P2RX4;TRPC1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.38530696818779153,0.9820425640397349,0.4789473684210526,0.9549584772868488,1.0,8/18,18.42%,VPS11;APOE;PTTG1IP;CD81;FAF1;VPS35;RNF128;RDX
prerank,positive regulation of mitochondrial translation (GO:0070131),0.4014244785030289,0.9820222453640249,0.45540796963946867,0.9541000401169618,1.0,2/14,8.85%,FASTKD2;NGRN
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.30218127551334006,-0.9819792594184492,0.4760705289672544,0.8013208641311843,1.0,11/35,19.49%,SULF1;NR2F2;COL4A3;XDH;SPARC;THBS1;AIMP1;CAV2;ATP5IF1;SCG2;STAT1
prerank,atrial septum morphogenesis (GO:0060413),-0.4264840405122005,-0.981829036485936,0.5074626865671642,0.8009452702566274,1.0,2/10,9.13%,NOTCH2;ACVR1
prerank,response to hydrogen peroxide (GO:0042542),0.3192552012748053,0.9817900430570237,0.4892205638474295,0.9538420944673317,1.0,9/45,11.52%,SOD1;TNFAIP3;FYN;SIRT1;RELA;PARK7;CYP1B1;APTX;RPS3
prerank,regulation of cell junction assembly (GO:1901888),-0.32314736421691226,-0.981378229065007,0.48372093023255813,0.8014385987916988,1.0,6/27,9.54%,PDLIM5;OCLN;CBFB;ROCK2;ROCK1;PRKACA
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2787999918778007,-0.9811770207537799,0.5028089887640449,0.8011945725090894,1.0,10/47,12.24%,PDGFRB;MAPK14;PID1;TGFBR2;MAPT;PRKCD;XDH;THBS1;TP53;GRB2
prerank,detection of visible light (GO:0009584),0.39430145354486135,0.9811232108652072,0.46111111111111114,0.9549735418789845,1.0,2/16,8.84%,GNAQ;GNA11
prerank,regulation of chemokine production (GO:0032642),-0.29490825647350466,-0.9807513664380568,0.4781420765027322,0.8015633944187845,1.0,5/36,13.42%,FOXP1;IL6R;EIF2AK2;IL18;IL33
prerank,negative regulation of response to stimulus (GO:0048585),0.30239772369676354,0.9807363310267017,0.4884437596302003,0.955232182921796,1.0,13/60,14.28%,FCGR2B;MAP2K5;WFS1;LPCAT3;FBXO5;SIRT1;LYN;ZKSCAN3;TERT;MCTP1;HHIP;YBX1;MAP3K3
prerank,protein ubiquitination (GO:0016567),0.2367096126467189,0.9806734776528615,0.5384615384615384,0.9544916534421991,1.0,96/471,16.75%,PSMB10;PSMC4;PSMB6;RAD18;CAND1;ELOC;RNF7;CBL;PSMD8;PSMD5;PSMD12;ARIH1;KLHL3;RNF38;SPOP;UBA1;BIRC2;PSMD11;NEDD4L;VPS11;NHLRC1;RBBP6;PSMB4;FBXL5;UBE3A;TRIM14;PSMC1;FBXW2;NFX1;SIRT1;RNF187;LMO7;UBE2V2;KLHL2;FBXO32;CAND2;TRIM25;AKTIP;FBXO11;CRBN;ANAPC7;RBCK1;MDM2;PJA2;RFWD3;MYCBP2;PSMC2;KLHL24;UBE3D;PSMD2;RNF6;ZNRF1;FBXO7;EIPR1;UBE2V1;RNF13;RNF25;CHFR;USP22;ANAPC11;ELOB;TNKS;DTX4;RNF11;CUL3;PSMD14;UBE2R2;EPAS1;RNF146;PSMC6;TSPAN17;PSMD1;PSMB1;TRIM27;RNF20;FANCL;USP9X;TRIM3;UBA6;NHLRC3;UBE2G1;FBXO22;RMND5A;RNF114;TAF1;TRIM33;KLHL7;PELI1;KLHL42;RNF125;UBE2H;PSMA4;KLHL13;VPS18;FBXL20;PRKDC
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3905690468144649,-0.9806497684919456,0.4948453608247423,0.801102205033958,1.0,3/13,6.59%,NFIB;BMP4;PPARA
prerank,embryonic hemopoiesis (GO:0035162),-0.3975964534928449,-0.9806147626763272,0.4989384288747346,0.8004299392189527,1.0,3/12,4.76%,KMT2A;TGFBR2;KIT
prerank,neuron projection organization (GO:0106027),-0.3719458071921212,-0.9802791939292564,0.4598698481561822,0.8006016614300117,1.0,9/15,26.54%,LGMN;GSK3B;ABCD2;MAP1A;DCTN1;ATP1A3;PLS1;PICK1;CHRNA7
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.38044548348873136,-0.979979977372009,0.4876543209876543,0.8006972009275144,1.0,9/14,37.63%,ME1;NMNAT2;NMNAT3;AK5;AK3;AK4;CMPK2;AK1;NME2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.235624019897386,0.9793193582656254,0.5333333333333333,0.9576391508284091,1.0,84/476,14.24%,MAZ;CTCFL;MAP2K7;MECOM;SS18L1;ILF3;TAL1;TRIM28;LEF1;PPP3CB;RPS6KA1;KLF2;HIPK2;PAX8;PHF5A;HNRNPAB;HEY1;RLF;APOE;FLI1;SMARCA2;SOX2;KDM3A;SPIN1;NPAT;EP300;RFX3;TBX1;RET;CALCOCO1;FOXF2;PPARD;MED12;CLOCK;RNF187;HEY2;AXIN1;NOTCH1;CAND2;WNT5A;ATXN7L3;ATAD2;GTF2H1;ZXDC;ACVRL1;RSF1;RELA;PCID2;RAI1;PLCB1;TFAP4;RNF6;ZKSCAN3;KLF6;UBE2V1;TAF15;CITED2;YEATS4;RYBP;ING2;WBP2;ESR1;SETD3;RHOG;CREBBP;USP22;MED4;PICALM;ILF2;SP1;IKBKB;MDFIC;CHUK;PITHD1;ACTA2;YWHAH;ING5;EDRF1;CHEK2;DDIT3;HES1;HCFC1;RNF20;PHF8
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.358102253643392,0.9791338116125066,0.4893238434163701,0.9572512742929191,1.0,8/24,16.16%,EZH2;EED;BMI1;PPHLN1;TRIM27;TASOR;AEBP2;RBBP4
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.32516400787008504,-0.9790527785295962,0.46534653465346537,0.8023371172869965,1.0,10/26,26.93%,LGR4;FLOT2;APPL2;IRAK3;BIRC3;FLOT1;GPR108;APPL1;TLR3;LRRC14
prerank,B cell receptor signaling pathway (GO:0050853),0.3331153522406239,0.9790308205849076,0.4819672131147541,0.9566219715202563,1.0,4/32,11.50%,PTPRC;VAV3;SYK;PIK3CD
prerank,apical junction assembly (GO:0043297),0.30689807051749896,0.9787355904070074,0.49133858267716535,0.9565913024444069,1.0,11/53,14.49%,PECAM1;MARVELD2;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;APC;PATJ;PARD3
prerank,lipoprotein transport (GO:0042953),0.4451775433934213,0.978684043083303,0.49907235621521334,0.9558277169321501,1.0,5/10,21.07%,ZDHHC17;VMP1;UNC119B;MIA3;PPARG
prerank,necroptotic process (GO:0070266),0.38638713172422356,0.9782631295063083,0.4718045112781955,0.9561753372374334,1.0,4/16,16.21%,MLKL;TRPM7;ITPK1;DNM1L
prerank,protein export from nucleus (GO:0006611),-0.3090381926686021,-0.9780494386090767,0.4785553047404063,0.804168029768095,1.0,8/27,16.22%,RANBP3L;PKD1;XPO6;DUSP16;RANBP3;STRADA;NUTF2;TGFB1
prerank,positive regulation of DNA replication (GO:0045740),-0.35804131348959645,-0.9779734146610607,0.48997772828507796,0.8036047140317353,1.0,6/16,14.06%,EGFR;GLI2;KAT7;STN1;BRPF3;ATAD5
prerank,T-helper cell differentiation (GO:0042093),-0.37748878075500286,-0.9777318253609745,0.5150115473441108,0.803512926399411,1.0,2/14,5.67%,FOXP1;ATP7A
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.426335814518794,0.9776721332709758,0.5,0.956999554677188,1.0,3/12,8.19%,PCGF3;YTHDC1;CDYL
prerank,protein stabilization (GO:0050821),0.2583845258824995,0.9773956431393607,0.5247395833333334,0.9569399288794221,1.0,37/168,16.43%,ZSWIM7;CDC37L1;PIN1;RPL23;GNAQ;PDCL3;CCT2;CDC37;PPIB;CCNH;CCT5;PFN1;PHB2;WFS1;CDKN1A;EP300;RPL5;BAG1;SMAD7;GLMP;EFNA1;TSC1;PARK7;OTUD3;NLK;ZBED3;TNIP2;USP33;CHEK2;COG3;HCFC1;USP9X;TAF1;WIZ;TCP1;NAA15;SOX17
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.2677913782895509,-0.9773750137296161,0.47041420118343197,0.8036818461152023,1.0,19/61,19.30%,EYA2;EYA1;EGFR;PDGFRB;UBE2N;TOX;ERCC6;PML;RAD50;SMOC2;RNF168;MRE11;RNF8;PARP3;USP7;NPAS2;BABAM1;GNL3;SMCHD1
prerank,cellular response to interleukin-4 (GO:0071353),0.44368499090863583,0.97697711231691,0.49221789883268485,0.9572489802687327,1.0,1/10,2.03%,LEF1
prerank,dendrite self-avoidance (GO:0070593),-0.37023530831132506,-0.9766621905949908,0.5241090146750524,0.8048055542150641,1.0,4/16,6.72%,CNTN4;CNTN6;DSCAM;PALLD
prerank,Notch signaling pathway (GO:0007219),0.3003100851466328,0.9763246787636799,0.496206373292868,0.9582374161591954,1.0,14/59,16.10%,SORBS2;JAG2;PSEN2;HEY1;EP300;HEY2;NOTCH1;RBPJ;CREBBP;DTX4;HES1;YBX1;APH1A;HEYL
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3141849082997577,0.9763146387071984,0.5174603174603175,0.957352565672364,1.0,6/48,7.30%,AEN;BCL2L2;HIPK2;TNFRSF1B;EP300;SIRT1
prerank,regulation of protein polymerization (GO:0032271),-0.3015164574045158,-0.9762838643947674,0.49748743718592964,0.8050398133850104,1.0,17/35,29.30%,MAP2;MAPT;ARHGAP28;PLEKHG2;CTTN;FCHSD2;DBNL;PFN2;TPPP;HSP90AA1;TPPP3;DBN1;TTBK1;ARL2;HAX1;COTL1;GBA2
prerank,response to peptide (GO:1901652),0.32899675853181093,0.9760168994865123,0.4956217162872154,0.9573049654512846,1.0,7/33,11.93%,CACNA1A;MMP12;FYN;EIF2B3;ERBIN;GNAI1;PRNP
prerank,macroautophagy (GO:0016236),0.26575176403347306,0.9752367429164955,0.5152354570637119,0.9586975163513848,1.0,34/118,18.88%,TOMM20;MTERF3;MAP1LC3B;KLHL3;MTMR14;SRC;YOD1;ATG4B;EPG5;TECPR1;CHMP2A;PRKAA2;DYNLL1;VPS37B;UBQLN1;NBR1;ATG7;PLAA;EI24;CSNK2A2;ATG16L1;ATG14;GABARAPL1;ATG13;PIK3R4;ZFYVE1;VPS37C;BECN1;PIP4K2A;VPS33A;GABARAP;VPS4B;ULK1;LAMP2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3302401685513361,-0.9751539101288068,0.5314685314685315,0.8072820642183877,1.0,7/24,15.92%,SORBS1;IGF1;ENPP1;AKT2;GSK3B;IGF2;SELENOS
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.42938757475740186,0.9750554366908968,0.5103578154425612,0.95833901498737,1.0,3/10,15.25%,CXCL12;LYN;GAS6
prerank,selective autophagy (GO:0061912),0.29431165645925556,0.9749104572300894,0.4938080495356037,0.9578498223346856,1.0,16/56,15.94%,DYNC1I1;MAP1LC3B;KLHL3;UFC1;RAB7A;PHB2;AUP1;PARK7;UBE2V1;DYNLL1;UBQLN1;NBR1;LGALS8;DYNC1I2;ATG14;ATG13
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.2851397125925541,0.974896938742664,0.48005908419497784,0.9569773127708873,1.0,13/72,7.52%,HSPA8;SHANK3;CLASP2;APOE;PFN1;CYRIB;CIB1;KANK3;PFDN6;FGF13;SSH2;CAMSAP2;PFDN5
prerank,DNA strand elongation (GO:0022616),0.3793407333320383,0.9748310884558191,0.48717948717948717,0.9562608740748514,1.0,5/18,12.55%,DCLRE1B;POLD3;POLA1;TERT;NBN
prerank,regulation of DNA binding (GO:0051101),0.31310357776938313,0.9747934341474226,0.5098684210526315,0.9554673663570421,1.0,11/44,13.91%,LEF1;NME1;MAPK8;CEBPG;TXN;HJURP;RSF1;TFAP4;DOT1L;NFKBIA;HES1
prerank,regulation of ion transport (GO:0043269),-0.2526891166999882,-0.9745692276329784,0.5060975609756098,0.8080814174614588,1.0,22/76,21.10%,ANK3;WNK1;P2RX4;WWP2;ATP1A1;SYT9;KCNJ2;SIK1;KCNJ6;PER1;SYT12;SYT11;SYT4;NKAIN4;VAMP2;SYT7;KCNJ13;SYT2;KCNJ10;KCNA2;NEDD4;SNX6
prerank,blood vessel diameter maintenance (GO:0097746),0.3376807387405155,0.9744494188543652,0.4895833333333333,0.9555811558204517,1.0,6/34,11.15%,GCLC;KLF2;GCLM;EDNRB;KCNMB2;NOS3
prerank,osteoclast differentiation (GO:0030316),-0.33561907310077954,-0.9743269400579393,0.4894117647058824,0.8079626717203943,1.0,3/22,3.50%,FOXP1;ANXA2;MAPK14
prerank,regulation of viral transcription (GO:0046782),0.32020132323004974,0.9741384436923584,0.509493670886076,0.9555416131968126,1.0,11/39,18.83%,POLR2J;POLR2B;TRIM14;IFITM3;RSF1;MDFIC;TRIM27;GTF2F2;UBP1;HEXIM1;MID2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3018800922862976,0.9739191382281108,0.49453978159126366,0.9553019066181471,1.0,16/53,17.81%,PSME3IP1;APOE;FOXF2;DESI1;GNA12;RAD23A;PSMC2;OPHN1;ECSCR;XPO1;PSMD14;PSMC6;UCHL5;UBQLN4;TMTC3;RAD23B
prerank,glycerol metabolic process (GO:0006071),0.4429880818030735,0.9737230035088232,0.5106382978723404,0.954949319910077,1.0,3/10,11.01%,TPI1;COQ2;PGP
prerank,regulation of T cell mediated immunity (GO:0002709),0.42954848469772167,0.9732681084519349,0.5149700598802395,0.9553376557696934,1.0,2/10,10.53%,TNFRSF1B;TRPM4
prerank,establishment of mitotic spindle localization (GO:0040001),-0.31493655178023994,-0.9732011329350585,0.46543778801843316,0.810188502115257,1.0,8/28,20.01%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10
prerank,serine family amino acid catabolic process (GO:0009071),-0.42561831324316535,-0.973155874137717,0.5228215767634855,0.8095609113465443,1.0,8/10,51.26%,DLD;AMT;CBS;GCSH;THNSL2;SHMT2;GLDC;SHMT1
prerank,chromosome condensation (GO:0030261),0.3178177650078962,0.9730170400101009,0.4738675958188153,0.9551579496881941,1.0,7/36,14.34%,BANF1;TENT4A;CHMP1A;AKAP8L;AIFM1;PHF8;CSNK2A2
prerank,glycoprotein catabolic process (GO:0006516),-0.35096152493827304,-0.9728958439813714,0.49191685912240185,0.8095551087168714,1.0,3/17,5.50%,ADAMTS12;NGLY1;ADAMTS9
prerank,regulation of interleukin-13 production (GO:0032656),-0.37855723461492996,-0.9727557924851411,0.5218390804597701,0.8091697012704977,1.0,4/13,13.39%,PRKCZ;RARA;TNFRSF21;IL18
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.3929548127073268,-0.9727499525199697,0.49786324786324787,0.8084352475250679,1.0,4/13,19.94%,DDX5;PLA2R1;ATM;SPRED3
prerank,negative regulation of B cell proliferation (GO:0030889),0.4267660728488395,0.9726865669032889,0.49615384615384617,0.9552457029252109,1.0,2/11,9.31%,FCGR2B;LYN
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2963417176841077,-0.9722859857184486,0.49878934624697335,0.8089346681862487,1.0,14/36,22.47%,ERRFI1;RASSF2;EPHA7;ENPP1;RAD50;TNKS1BP1;MRE11;PPP2R5E;TOM1L1;PDGFD;PDGFA;VEGFA;IMPACT;PPP2R5D
prerank,positive regulation of protein import into nucleus (GO:0042307),0.33930971378923647,0.9719593339496124,0.49822695035460995,0.9563802410240126,1.0,4/28,3.90%,RBM22;TRIM28;DMAP1;HDAC3
prerank,positive regulation of catabolic process (GO:0009896),0.2893151188875986,0.9718797810977203,0.4856687898089172,0.9557069879219161,1.0,12/65,13.85%,GSK3A;TNFAIP3;PLK2;NEDD4L;RAB7A;AXIN1;WNT5A;VSIR;ATG7;EGLN2;NDUFA13;APC
prerank,regulation of platelet activation (GO:0010543),0.37294444636831026,0.9717814116411025,0.4990791896869245,0.9551058599787705,1.0,6/21,13.31%,APOE;SELP;SYK;LYN;NOS3;PLEK
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.4052505433725656,-0.9717754943223772,0.4847250509164969,0.8095814288025062,1.0,3/11,7.89%,FGFR2;TGFBR2;LRP5
prerank,positive regulation of chromosome organization (GO:2001252),-0.3759069969928176,-0.971703297862583,0.5177777777777778,0.8090062243198706,1.0,7/15,26.91%,PML;RAD50;MRE11;GNL3;RTEL1;PPP1R10;RAD21
prerank,cellular respiration (GO:0045333),0.31431375928998984,0.9714172172309316,0.5039001560062403,0.9552752154335892,1.0,9/41,14.40%,CYCS;ME3;MTFR1;SIRT3;ETFA;SDHA;COX15;UQCRB;COX10
prerank,positive regulation of establishment of protein localization (GO:1904951),0.36707860453944274,0.9711939670210222,0.4834782608695652,0.9550428932855092,1.0,6/19,16.15%,CCT2;CCT5;CENPJ;CORO2B;TCP1;DKC1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.35794117575832723,0.9708053976920831,0.5016722408026756,0.9552324228766929,1.0,6/24,13.49%,TTLL1;CEP41;AGTPBP1;AGBL5;NAA80;TTLL7
prerank,regulation of dendrite development (GO:0050773),0.3231160290092843,0.9707784388916678,0.4956521739130435,0.9544298560731902,1.0,6/37,9.64%,LRP8;RAP2A;CAMK1D;NEDD4L;CAMSAP2;ZDHHC15
prerank,response to ionizing radiation (GO:0010212),0.2923369185570085,0.9706746247244618,0.5022761760242792,0.9538599228970567,1.0,11/70,9.53%,AEN;ABRAXAS1;EEF1D;RAD1;CDKN1A;COP1;SIRT1;CLOCK;EYA3;KDM4D;RFWD3
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2887689239833886,-0.9704821825315868,0.4946808510638298,0.8116060680997881,1.0,15/41,22.87%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,negative regulation of protein binding (GO:0032091),0.2893218320707837,0.9703855821310532,0.5130168453292496,0.953824202221574,1.0,10/71,6.21%,RALB;PIN1;ACTB;PSME3IP1;IFIT1;ATP2A2;B2M;CDKN1A;MAPK8;CARD16
prerank,apoptotic cell clearance (GO:0043277),-0.3034982627395804,-0.97027907874491,0.48333333333333334,0.8113844883647333,1.0,9/30,12.67%,XKR4;LRP1;TXNDC5;XKR6;THBS1;RHOBTB2;ANXA1;RARA;RHOBTB1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.38970128000979176,0.9700174999153036,0.5,0.954001438899083,1.0,2/16,2.31%,RBM22;SFSWAP
prerank,negative regulation of protein modification process (GO:0031400),0.2821285473227532,0.9697274471856147,0.49099099099099097,0.9539478579428238,1.0,27/79,17.28%,PRR5L;PNKP;PPP1R16B;XRCC1;CIB1;DBI;YWHAB;SIRT1;CDYL;LYN;PARK7;TARDBP;PRKAA2;MFHAS1;TRAF3IP1;DMD;ZBED3;PRNP;CRKL;PTPA;TERF2IP;ATG14;PPP1R8;DNAJC10;PRKDC;WARS1;CORO1C
prerank,regulation of organelle organization (GO:0033043),0.28337217432320083,0.9695664478473389,0.5161290322580645,0.9535506609411425,1.0,13/80,11.02%,SURF4;MAPK3;STOX1;VPS11;MYO5A;EP300;USP6NL;F11R;CAMSAP2;PDE4DIP;TJP1;TBC1D25;RBSN
prerank,cellular response to dsRNA (GO:0071359),0.39631075090478585,0.9694968423884393,0.49635036496350365,0.9528683214382768,1.0,2/15,3.70%,RALB;IFIT1
prerank,cardiac ventricle development (GO:0003231),0.37136464561190863,0.969287953240068,0.5,0.9525962385057896,1.0,7/20,16.10%,HEY1;HEY2;NOTCH1;MATR3;DAND5;HES1;HEYL
prerank,acylglycerol metabolic process (GO:0006639),0.3213919065662,0.9686939741600352,0.49666666666666665,0.9534542439291263,1.0,4/37,5.08%,DGKB;APOE;PLAAT3;LMF1
prerank,regulation of protein processing (GO:0070613),-0.338640533511941,-0.9686351159581342,0.4908675799086758,0.8149736337390343,1.0,6/21,23.74%,RHBDD1;GAS1;CCBE1;RNF139;NKD2;CLN3
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.32100330250832554,-0.9675848578370727,0.5123042505592841,0.8170049529012011,1.0,7/24,17.73%,ADAMTS12;TGFBR1;SOX5;EFEMP1;WNT9A;BMPR1B;SOX6
prerank,hexose biosynthetic process (GO:0019319),0.3218451094553264,0.967522708804867,0.5166402535657686,0.9558760995186893,1.0,4/42,5.68%,PCK1;SLC25A1;GOT2;TPI1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.24279103599433194,-0.9674979076410146,0.5207667731629393,0.8164935171382097,1.0,20/95,12.13%,LDLRAD4;TGFBR3;DAB2;SMAD3;SMURF2;TGFBR1;TGFBR2;ZEB2;SMAD4;PPARA;SKI;HTRA3;DKK3;SNW1;SMAD6;THBS1;SNX25;UBC;STK11;PPM1A
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.42300401396648635,0.9672008496183019,0.48065173116089616,0.9559365245748188,1.0,2/12,6.88%,PDE4D;CALM3
prerank,keratan sulfate metabolic process (GO:0042339),-0.305305253837868,-0.967156926695729,0.4836272040302267,0.8166621140944549,1.0,11/31,20.22%,B4GALT1;OGN;HEXA;HEXB;B4GALT6;SLC35D2;ST3GAL4;PRELP;GNS;LUM;B4GALT4
prerank,amino acid transport (GO:0006865),0.3053702672123616,0.9670871322987774,0.5198098256735341,0.955390678792309,1.0,5/49,5.53%,SLC7A8;SLC36A4;SLC25A44;SLC3A2;SLC6A6
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.40863051757567087,-0.9668298098092875,0.5180467091295117,0.8168262248368245,1.0,5/10,31.59%,GFPT1;HK2;GFPT2;PFKM;PFKL
prerank,regulation of interleukin-12 production (GO:0032655),-0.27278256426496694,-0.9665845328872998,0.4970588235294118,0.8167418406425674,1.0,6/47,11.35%,FOXP1;MAPK14;PIBF1;IRAK3;THBS1;IL16
prerank,snRNA processing (GO:0016180),-0.37184397871193375,-0.9665165476393379,0.5142857142857142,0.8161700189922654,1.0,10/16,37.24%,INTS10;INTS8;INTS11;INTS7;TUT1;INTS12;INTS9;INTS3;INTS1;TOE1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.38836923956252195,-0.9665073956759151,0.5070422535211268,0.815445195273831,1.0,4/12,18.86%,SNAP25;STX3;STX1A;SNAP29
prerank,regulation of mitochondrial translation (GO:0070129),0.36241405430583395,0.9662712546683504,0.4818181818181818,0.9568308592267618,1.0,5/21,17.58%,FASTKD2;NGRN;TSFM;MTG2;RCC1L
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.2402981456134189,-0.9657906242945024,0.5324675324675324,0.8166071331055824,1.0,18/92,13.00%,FOXP1;ANXA3;SASH1;DOCK5;DOCK1;NRP1;FGF1;BMP4;RREB1;ROCK2;EPB41L4B;SPARC;SMOC2;THBS1;NRP2;FOXC2;RHOB;RAB11A
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24297989486454888,0.965740117323516,0.5625,0.9574835082043276,1.0,56/264,16.18%,POLR2J;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;PRPF40A;HNRNPK;CPSF4;PPIL3;PLRG1;SRSF10;SNRNP27;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;COIL;SF3A1;RSRC1;BUD31;SYF2;U2AF1;PAPOLA;SRPK2;EFTUD2;PTBP1;RBM10;STRAP;YBX1;SRSF7;SNRPA;USP39;FUS;RBM4B;SF3B6;HNRNPL;TRA2B;GTF2F2;RBM41;UPF3B;U2AF2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.277636367997585,-0.9653723865949808,0.5188172043010753,0.8169752228445211,1.0,16/48,22.87%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;PRDM16;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,multivesicular body assembly (GO:0036258),-0.3069427997266318,-0.965267424939726,0.5104895104895105,0.8164862527648687,1.0,10/30,22.01%,STAM2;IST1;SNF8;RAB11A;TSG101;CHMP2B;CHMP5;STAM;VPS4A;HGS
prerank,regulation of angiogenesis (GO:0045765),-0.21730405732808522,-0.9652379840331521,0.5398230088495575,0.8158063173561226,1.0,33/192,12.39%,SULF1;ANXA3;SASH1;ADAM12;ITGB8;ADGRA2;BMPER;STIM1;FGF1;COL4A3;CTNNB1;GTF2I;ROCK2;F3;GLUL;CEMIP2;HSPG2;ROCK1;HOXA5;PML;PTGIS;SPARC;ADAMTS1;FOXC1;THBS2;NIBAN2;SMOC2;THBS1;HIPK1;RHOJ;CD34;RHOB;ECM1
prerank,positive regulation of cytokine production (GO:0001819),0.24164496755407738,0.9648007725953812,0.564958283671037,0.9593615422418231,1.0,33/292,11.57%,LRRFIP1;CADM1;PIK3CG;IL1R1;PDE4D;PTPRC;MAP3K7;SOD1;POLR1C;TIRAP;PRKD2;RAB7B;CYRIB;EP300;CEBPG;SYK;RGCC;TMED10;WNT5A;RELA;CSF1R;RAB1A;PLCB1;LURAP1;PARK7;PNP;CYP1B1;CREBBP;APP;NOD1;PIK3CD;RPS3;POLR3F
prerank,cardiolipin metabolic process (GO:0032048),-0.39339505037137357,-0.9647212274835322,0.5085470085470085,0.8164507787345032,1.0,5/13,21.46%,PLA2G4A;SLC27A1;CRLS1;PGS1;PLA2G6
prerank,regulation of exit from mitosis (GO:0007096),0.3143299060328753,0.9647089820836884,0.5066006600660066,0.958708864656481,1.0,7/38,12.42%,ANAPC2;PHB2;RGCC;ANAPC7;ANAPC11;ANAPC10;ANAPC4
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.25808935897281826,0.9646418139270273,0.5403556771545828,0.9580196798146362,1.0,18/150,11.82%,RAC2;MAZ;PIK3CG;TRIB3;PIK3AP1;PTPRJ;SRC;TEK;FYN;RET;TXN;IRS2;PARK7;ESR1;MFHAS1;RHOG;PIK3CD;PIK3R5
prerank,response to molecule of bacterial origin (GO:0002237),0.2855824186134138,0.9645923743995408,0.5426829268292683,0.9572932513289579,1.0,13/69,16.05%,TNFAIP3;TAB2;FCGR2B;TIRAP;CYRIB;SELP;ERBIN;IFNAR1;NOS3;OTUD5;GCH1;NOCT;PELI1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2508309782589703,-0.9638363933696399,0.4984423676012461,0.8180474732202188,1.0,24/84,17.38%,CELF2;DDX5;TIA1;SON;DDX17;KHDRBS1;CELF4;KHDRBS2;RBM39;RBMX;SRSF6;RBM15;SNW1;RBFOX3;HNRNPA1;SMU1;RBM3;RBM4;DAZAP1;SRRM4;RBM7;NOVA1;SRPK1;RNPS1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2456723570983786,0.9637483997142872,0.5566750629722922,0.9588366548823483,1.0,28/214,11.27%,MAP2K7;MAPK3;SEMA6A;PTPRR;ZDHHC17;SEMA7A;PIN1;PTPRC;TIRAP;PRKD2;APOE;TEK;PHB2;SPRED1;CIB1;ICAM1;SYK;HTR2A;CNKSR3;MTURN;NOTCH1;CCL25;CSF1R;LYN;MFHAS1;ATP6AP1;NPNT;APP
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3304745422698148,0.9631879680135629,0.5362563237774031,0.9595264816810708,1.0,7/33,11.52%,TNFAIP3;SIGMAR1;SIRT1;RELA;PARK7;CYP1B1;RPS3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3730001358766248,0.9630570040623467,0.5008818342151675,0.9590185873632092,1.0,5/18,14.60%,HDAC7;HDAC9;CIB1;MAP3K3;PIK3C2A
prerank,vasculogenesis (GO:0001570),0.3271676750119275,0.9630515616022225,0.5016835016835017,0.9581504320883332,1.0,6/32,8.95%,EGFL7;RAMP2;SPRED1;HEY2;NOTCH1;RASIP1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3368483404489966,-0.9629298098379467,0.5128805620608899,0.8197384678579932,1.0,7/20,20.15%,GSN;PLA2R1;THBS1;ANO6;SFRP4;ITGA4;PIAS4
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.3922827492990044,-0.9628250736183702,0.5,0.8192585067232945,1.0,3/12,3.66%,NBL1;WASL;BMP5
prerank,regulation of embryonic development (GO:0045995),0.3204543134459911,0.9627803240966823,0.5060869565217392,0.9579880905325135,1.0,12/34,19.65%,CLASP2;CFL1;TDG;DAG1;RAB14;PLCB1;ZBED3;SOX17;CLASP1;INSR;DHX36;POGLUT1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.25762619145137766,0.962715172158154,0.5401069518716578,0.9572831676941048,1.0,24/140,12.28%,RAC2;TIAM1;VAV3;ARHGEF26;CHN2;SRC;MCF2L;ITSN1;ARAP2;CYRIB;ARHGAP25;ARHGEF6;ARHGEF7;TRIO;ARHGEF18;MYO9A;FAM13A;RHOQ;OPHN1;ARHGAP39;RHOG;A2M;ARHGAP23;MYO9B
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3318158163190411,-0.962459333257775,0.5124716553287982,0.8195474965384134,1.0,8/21,23.27%,MCU;PDZD8;MICU2;FIS1;AFG3L2;MCUR1;MCUB;ANXA6
prerank,blood circulation (GO:0008015),0.3058180798138385,0.9624183690344421,0.5132605304212169,0.9573107520913572,1.0,5/49,4.35%,GCLC;SOD1;CXCL12;TBC1D8;GCLM
prerank,vasculature development (GO:0001944),-0.36297853388930823,-0.9623352471603107,0.5327510917030568,0.819098495652185,1.0,7/16,26.12%,PDGFRB;ERRFI1;PDGFRA;STK11;BMPR2;STRA6;NOTCH4
prerank,epidermal cell differentiation (GO:0009913),-0.28160529070251833,-0.9619975801070602,0.4868421052631579,0.8192253196665217,1.0,6/41,6.02%,CLIC4;CTNNB1;HDAC1;MED1;BCR;PIP5K1A
prerank,regulation of endocytosis (GO:0030100),-0.26036908224536176,-0.9617758210686397,0.5693215339233039,0.8190821731582414,1.0,22/61,21.56%,LRP1;DAB2;RUFY2;ARFGAP1;STON2;GPC3;ROCK1;ZFYVE16;STON1;EPHA3;RIT2;CLIP3;SYT11;HIP1R;SCAMP5;CBLL1;LRSAM1;ABL2;TSC2;PACSIN1;FLOT1;PRKD1
prerank,peptidyl-threonine modification (GO:0018210),-0.2620341830564938,-0.961676256561494,0.5168195718654435,0.8186019044816579,1.0,17/66,14.49%,GALNT13;TGFBR1;TGFBR2;WNK1;CDC42BPB;ROCK2;CIT;PRKCD;HIPK3;ROCK1;ACVR1;GSK3B;CAMK2D;HIPK1;ACVR1B;WNK3;MAP3K12
prerank,regulation of cellular component biogenesis (GO:0044087),0.31953858236976534,0.9616050927360734,0.520066889632107,0.9587586594089833,1.0,7/39,9.82%,HSPA8;VPS11;APOE;HJURP;NOTCH1;TJP1;TIE1
prerank,limb morphogenesis (GO:0035108),0.3687253955108512,0.9609259122399005,0.5168738898756661,0.9598269411073956,1.0,1/20,0.04%,TBX4
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3554818325900302,0.9608005837417793,0.5342465753424658,0.9593286532750116,1.0,3/23,10.71%,SAG;METAP2;METAP1
prerank,negative regulation of viral transcription (GO:0032897),0.4101875254702263,0.9607204691708761,0.5119705340699816,0.9586903709539001,1.0,6/13,18.83%,TRIM14;IFITM3;TRIM27;UBP1;HEXIM1;MID2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.31285682816751276,0.9605206899145832,0.5214626391096979,0.9583579869021291,1.0,9/44,15.25%,RPS6KA1;SRC;MAP2K5;CARD16;USP47;PCID2;DDX3X;CD44;GAS6
prerank,mitotic recombination (GO:0006312),-0.3727560143086609,-0.9601154077486485,0.49658314350797267,0.822023546347901,1.0,8/15,33.41%,SMC6;RAD50;TPRKB;RAD51D;NSMCE2;DMC1;RAD54B;ERCC1
prerank,regulation of myoblast fusion (GO:1901739),-0.4029021042410851,-0.9596397339561582,0.5110619469026548,0.8225199616719225,1.0,4/11,20.44%,CFLAR;MAPK14;EHD1;FLOT1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3851222129158125,-0.9595691898303645,0.5234899328859061,0.8219588953302343,1.0,4/13,7.28%,HACD3;HACD1;HACD4;TECR
prerank,organophosphate ester transport (GO:0015748),0.3519274677731037,0.9592702567930528,0.5271186440677966,0.961102229946486,1.0,7/24,13.79%,PRELID3B;EPG5;PRELID2;PITPNA;SCARB1;NPC2;OSBPL2
prerank,negative regulation of cell growth (GO:0030308),0.26454680395916746,0.9591229595799416,0.5370121130551817,0.9606417908331625,1.0,20/121,13.09%,CCDC85B;GSK3A;PTPRJ;FRZB;ST7L;RERG;PPT1;PPP2CA;SMARCA2;CDKN1A;DIP2B;FGF13;SIRT1;ACVRL1;RNF6;CCAR2;DDX3X;IP6K2;EI24;NDUFA13
prerank,calcium import into the mitochondrion (GO:0036444),-0.41273067126643864,-0.959013086857435,0.5123809523809524,0.8226860923746715,1.0,5/10,21.71%,MCU;MICU2;AFG3L2;MCUR1;MCUB
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.296360814660377,0.9588874064500322,0.5408,0.9604357178145483,1.0,12/52,13.86%,GSK3A;EXTL2;WFS1;ATP6V0D1;PDIA6;GOSR2;TPP1;HYOU1;HDGF;TATDN2;FKBP14;PDIA5
prerank,regulation of protein import into nucleus (GO:0042306),-0.2934460309711403,-0.9588430882798539,0.4940047961630695,0.8223808549081323,1.0,14/36,20.01%,ZIC1;SMAD3;FLNA;BMP4;BAG3;PRKCD;UBR5;EFCAB7;CDH1;RAB23;TGFB1;MAVS;APOD;PIK3R1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.36956014104124973,-0.9582108566918245,0.48322147651006714,0.8233273287974892,1.0,7/15,27.67%,NTRK3;F3;IL16;SCG2;VEGFA;VEGFB;PGF
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3804076672274115,-0.957956773712907,0.5414937759336099,0.8232714561151943,1.0,3/13,6.03%,SLC4A10;SHISA9;SHISA6
prerank,monoacylglycerol metabolic process (GO:0046462),-0.38063917675633807,-0.9579153988226612,0.5164113785557987,0.822642803297403,1.0,1/13,1.27%,PLA2G4A
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.32827562625313694,-0.9578321851420075,0.514218009478673,0.8220948642877673,1.0,7/22,13.88%,IGF1;SMAD4;P2RX4;ROCK2;ROCK1;CAMK2D;IL6ST
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3309728185947561,0.9577983696978977,0.5033222591362126,0.9627069096367706,1.0,6/29,13.09%,TTLL12;CDC37;CNOT7;WNT5A;USP18;NLRC5
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.38927610320040523,0.9574431243350743,0.5177935943060499,0.9628290708805917,1.0,4/15,15.56%,SYK;PNP;CD55;NKAP
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.36865326871163323,0.9574240238828305,0.5073529411764706,0.9620047110589731,1.0,5/17,13.19%,KLHDC10;SEMA4C;LYN;RNF13;MID1
prerank,regulation of protein kinase activity (GO:0045859),0.26494067787224185,0.956852945248075,0.5550847457627118,0.9627699248591328,1.0,22/106,16.82%,TRIB3;PTPRC;SOD1;TAB2;GNAQ;SMG8;SPRED1;CDKN1A;AKT1S1;DTNBP1;SIRT1;LCP2;PARK7;MMD;NF1;RAP2C;TRIM27;CAMKK2;GAS6;PRKRIP1;PTK2B;WARS1
prerank,intracellular lipid transport (GO:0032365),-0.3355283300315553,-0.9567893150520872,0.5209302325581395,0.824094219559634,1.0,6/21,14.83%,PRKAG2;CPT1A;PLEKHA8;PRKAB2;ABCD2;CPT2
prerank,regulation of biomineral tissue development (GO:0070167),0.33805537155804477,0.9567808751927295,0.5108514190317195,0.9621041295963618,1.0,8/26,15.25%,HEY1;FBXO5;HEY2;NOTCH1;NOS3;NBR1;BMP2K;GAS6
prerank,regulation of DNA replication (GO:0006275),0.3005624102373702,0.9562300532825622,0.5339652448657188,0.9627569883544563,1.0,11/49,13.81%,CTC1;BCAR3;ORC3;PPP2CA;RBBP6;FBXO5;ACVRL1;ESCO1;USP37;ANKRD17;FAF1
prerank,sensory perception of smell (GO:0007608),-0.41269759280286666,-0.9561708449710579,0.5269709543568465,0.824982952248551,1.0,5/11,33.91%,ADCY3;SYT10;SLC24A4;DRD2;MKKS
prerank,lysosome organization (GO:0007040),0.3184139476923484,0.9560505906134602,0.520259319286872,0.9623861857613771,1.0,15/36,21.13%,LAMTOR1;TMEM165;TPP1;AKTIP;ZKSCAN3;MBTPS1;CLVS1;SNAPIN;TFEB;HOOK3;VPS18;VPS33A;GRN;TPCN2;LRRK2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.35888920038569927,0.9558868455847939,0.5,0.9620004743093126,1.0,3/22,10.53%,TNFRSF1B;WNT5A;TRPM4
prerank,dendritic spine morphogenesis (GO:0060997),-0.3635994859036325,-0.9557810518432083,0.5323275862068966,0.8252707760936071,1.0,6/15,10.62%,EPHB1;WASL;DLG4;CTNND2;DOCK10;EPHB2
prerank,keratinocyte differentiation (GO:0030216),-0.30335823146388546,-0.955721872059319,0.515,0.82468178152598,1.0,5/29,11.85%,CLIC4;MED1;BCR;PIP5K1A;ANXA1
prerank,RNA 3'-end processing (GO:0031123),-0.2500432087422093,-0.9556310181119085,0.5750708215297451,0.8241923651817871,1.0,25/69,24.59%,SRSF5;SRSF11;PABPN1;CASC3;RPRD1B;SRSF2;SRSF6;LIN28B;SRSF1;POLDIP3;DDX39B;CSTF3;SYMPK;CSTF2;THOC5;SLU7;CDC40;RNPS1;CPSF3;SUPV3L1;EIF4A3;NCBP2;TUT1;THOC1;RBM8A
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.31063419354925953,-0.9556219510242411,0.5311004784688995,0.8234653564110284,1.0,9/26,21.65%,ADCY5;EFNA5;LRP5;CDK16;ANO1;STXBP4;GPLD1;PLA2G6;ADCY8
prerank,determination of heart left/right asymmetry (GO:0061371),-0.28431059349615256,-0.9555660143721014,0.5472222222222223,0.8228623273364019,1.0,10/43,25.88%,AHI1;MICAL2;TGFBR2;SMO;TBX3;SETDB2;BBS5;CCDC39;NDRG4;TBX2
prerank,regulation of mitochondrial depolarization (GO:0051900),0.4156595363148085,0.955127489103753,0.5174418604651163,0.9632488104370703,1.0,2/10,9.65%,SRC;FZD9
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3923866329623282,0.9548183534699723,0.5155038759689923,0.9632705783069662,1.0,3/14,8.56%,SEMA7A;SIRT1;WNT5A
prerank,regulation of neuron differentiation (GO:0045664),-0.24470371053362283,-0.9548008784279279,0.5511363636363636,0.8240755849244336,1.0,12/76,9.11%,CNTN4;NRCAM;NBL1;BRINP1;BMP7;RHOA;MED1;ZEB1;ROCK1;BRINP2;NLGN1;BIN1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.424983893085295,0.9547992913517075,0.5084745762711864,0.962453387413376,1.0,3/10,10.09%,RAP2A;MYO9A;OPHN1
prerank,sensory perception of taste (GO:0050909),0.4380767057937357,0.9547989702390016,0.5177865612648221,0.9615902832708852,1.0,10/10,56.22%,ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;CD36;ASIC1;PKD1L3;PKD2L1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3687331765080586,-0.9547693315793208,0.5171673819742489,0.8234245106677787,1.0,4/14,18.54%,ERCC6;MMS19;ACTR2;PARP1
prerank,cognition (GO:0050890),-0.2780937424771343,-0.9546598997851262,0.5564102564102564,0.822995028568072,1.0,20/42,35.66%,GRM5;SOBP;TTC8;NIPBL;CUX2;CTNS;ST3GAL4;MAGT1;CHMP2B;DGCR2;LINS1;STRA6;FAM107A;CHRNA7;SLC1A4;MFSD2A;JAKMIP1;NSUN5;SLC8A2;METTL23
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.36567152686175275,-0.9542640877523141,0.5204301075268817,0.8232249879492323,1.0,3/14,6.98%,ZEB1;OSR1;XDH
prerank,regulation of focal adhesion assembly (GO:0051893),-0.26622290889746747,-0.954132560800823,0.5549295774647888,0.8228146181292731,1.0,11/54,6.65%,PHLDB2;GPM6B;EFNA5;NRP1;MACF1;RHOA;ROCK2;VCL;ARHGAP6;ROCK1;LDB1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.42521640347778616,0.9540428768562745,0.549718574108818,0.9619016624140955,1.0,4/11,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.42521640347778616,0.9540428768562745,0.549718574108818,0.9619016624140955,1.0,4/11,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.39312200892841576,-0.9540331590850702,0.5,0.8223384230132507,1.0,5/12,25.48%,RNF168;RNF8;NELFB;NELFA;LARP7
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.32563734024158464,-0.9538278297094367,0.5219399538106235,0.8221764203773578,1.0,2/23,0.57%,ZBTB20;IGF1
prerank,protein modification by small protein conjugation (GO:0032446),0.2344117129565659,0.953742721241847,0.5780346820809249,0.961884618121406,1.0,79/361,17.51%,RAD18;MOCS3;CAND1;ELOC;RNF7;CBL;TRIM28;ARIH1;KLHL3;SAE1;RNF38;UFC1;UBA1;DCUN1D4;NEDD4L;VPS11;FBXL5;TRIM14;UBE2I;NFX1;NUP54;SIRT1;RNF187;UBA2;NUP50;LMO7;UBE2V2;KLHL2;FBXO32;CAND2;FBXO11;CRBN;ANAPC7;MDM2;PJA2;RFWD3;MYCBP2;KLHL24;PIAS2;RNF6;FBXO7;EIPR1;UBE2M;RNF25;TRPM4;NAE1;CHFR;ANAPC11;PIAS1;ELOB;ATG7;DTX4;CUL3;NUP35;UBE2R2;EPAS1;UBE2F;TSPAN17;TRIM27;RNF20;USP9X;UBA6;UBE2G1;NDC1;TRIM33;KLHL7;UBE2H;KLHL13;VPS18;PRKDC;DCUN1D2;NUP160;DCUN1D1;UBR3;MSL2;UVSSA;POM121;PEX13;RANGAP1
prerank,nuclear membrane reassembly (GO:0031468),-0.26652908555921806,-0.9537415504891409,0.5321637426900585,0.821637215294365,1.0,22/54,25.20%,SIRT2;PPP2R2A;UBXN2A;LMNA;NUP205;IST1;NUP155;NUP188;UBXN2B;AHCTF1;NUP93;NSFL1C;SEH1L;CHMP2B;NUP85;CC2D1B;NUP37;VPS4A;EMD;LEMD2;SEC13;LBR
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3029816526582419,0.9536113107618089,0.5267295597484277,0.961387344129829,1.0,8/43,15.25%,CIDEA;TNFAIP3;NLRC3;VSIR;NFKBIL1;CD274;TRIM27;GAS6
prerank,histone lysine demethylation (GO:0070076),0.3461831599015395,0.9534583033395523,0.5307557117750439,0.9609161711567771,1.0,7/25,14.24%,KDM3A;KDM2A;KDM6A;KDM4D;JMJD1C;KDM5C;PHF8
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.35589862370128367,-0.9532277960490588,0.5422222222222223,0.8222062963500654,1.0,3/16,3.24%,OGT;AUTS2;RASGRF1
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.3160153714931727,-0.9531281745925336,0.5204545454545455,0.8217534350505338,1.0,11/27,26.43%,RIMS1;SYT9;SYT12;SYT11;SYT4;VAMP2;SYT7;SYT2;ARHGAP17;SYT10;SYT6
prerank,glucose import (GO:0046323),0.40335622593793913,0.952714661503449,0.530214424951267,0.9621391851306393,1.0,3/13,14.05%,SORT1;SLC2A1;ZDHHC7
prerank,positive regulation of mRNA processing (GO:0050685),0.3505122555116956,0.9526765966347601,0.49544626593806923,0.9613856688880008,1.0,2/21,0.93%,NCBP1;RBMXL1
prerank,negative regulation by host of viral process (GO:0044793),-0.41112813238292983,-0.9524483065005587,0.5310077519379846,0.8228123406305564,1.0,3/10,27.68%,CCNK;PSMC3;ZC3H12A
prerank,regulation of actin filament bundle assembly (GO:0032231),0.33239385565145196,0.9521810114447448,0.5088028169014085,0.9619077285378764,1.0,4/26,8.86%,ALMS1;SHANK3;PFN1;TSC1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.358048546018657,-0.9520729197595562,0.5257270693512305,0.8230669109296463,1.0,2/16,2.05%,DDX5;DDX17
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2971645813763515,0.9517586870521464,0.5539906103286385,0.9621849353527391,1.0,9/48,12.95%,POLR1C;ACTB;EP300;POLR1G;ATAD2;WBP2;ATAD2B;SMARCD1;TBP
prerank,cell-substrate junction assembly (GO:0007044),-0.2950671636428418,-0.9515548184310519,0.5255102040816326,0.8237068710161901,1.0,7/33,11.11%,SORBS1;PLEC;BCR;PIP5K1A;CTTN;ACTN2;FN1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3404715595286833,-0.9515014365326734,0.5195652173913043,0.8231171071498227,1.0,4/20,9.33%,SULF1;SULF2;SMOC2;THBS1
prerank,response to interferon-gamma (GO:0034341),0.2826150075277955,0.9513710920130759,0.5474006116207951,0.9624405975439998,1.0,8/67,9.09%,IFITM2;GBP3;GBP4;IFITM3;CCL25;WNT5A;IFITM1;CD47
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.24606689067478066,-0.9506706464174669,0.5579937304075235,0.824668266531982,1.0,29/78,25.51%,SORBS1;LRP1;DAB2;EGFR;PID1;PPFIA1;MMP14;STX8;ZDHHC5;STX3;DPP10;EPHB2;EPHA3;CLIP3;DLG1;WNK3;TGFB1;TMBIM1;ZDHHC8;PIK3R1;VPS4A;APPL1;NKD2;CLN3;VAMP8;PLS1;AKT1;SPTBN1;BCL2L1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.25730942418689057,-0.9504903625873393,0.5426997245179064,0.8244115381230157,1.0,12/56,12.30%,NRXN1;GRID2;EPHB1;NRP1;NLGN2;SYNDIG1;ROCK1;CLSTN2;NLGN1;EPHB2;CUX2;IL1RAPL1
prerank,GTP metabolic process (GO:0046039),0.38149234761972045,0.9500524074922317,0.5111524163568774,0.9652965178897408,1.0,3/15,12.35%,IMPDH1;RHOQ;EFL1
prerank,mRNA export from nucleus (GO:0006406),-0.23331650212987165,-0.9499824560495869,0.5728155339805825,0.8250300764564978,1.0,38/102,24.94%,SRSF5;SRSF11;PABPN1;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;ENY2;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;DDX19A;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,regulation of fibroblast proliferation (GO:0048145),-0.2716825587540774,-0.9499077461932346,0.5282051282051282,0.8244831321670935,1.0,10/45,15.08%,IGF1;CTNNB1;PDGFRA;SKI;CDC73;CDK6;FN1;TP53;MED25;PEX2
prerank,regulation of neurogenesis (GO:0050767),0.2930141167639408,0.9497355459352688,0.5429447852760736,0.9653857009113509,1.0,12/55,16.22%,HES6;HEY1;MME;B2M;HEY2;NOTCH1;PRUNE1;DOCK7;FAIM;HES1;HEYL;HOOK3
prerank,glycogen biosynthetic process (GO:0005978),0.4140671683122277,0.9495291250794649,0.518095238095238,0.9642566123642684,1.0,4/12,15.56%,GYG1;NHLRC1;UGP2;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),0.4140671683122277,0.9495291250794649,0.518095238095238,0.9642566123642684,1.0,4/12,15.56%,GYG1;NHLRC1;UGP2;PGM2L1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.409942750690309,-0.9491153949685461,0.52,0.825834225499838,1.0,5/10,33.65%,LPGAT1;ABCD2;NR1H2;SLC45A3;MID1IP1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3545286242422507,-0.9490995155787264,0.5337837837837838,0.8251560631610407,1.0,3/15,8.46%,ATP1B1;ATP1A1;KCNJ2
prerank,myeloid leukocyte differentiation (GO:0002573),0.2847206610349234,0.9490263592617523,0.5296875,0.9648422084878006,1.0,8/65,9.17%,MT1G;LEF1;SBNO2;CDKN1A;EP300;SIRT1;CDK4;CSF1R
prerank,regulation of fibrinolysis (GO:0051917),-0.3732662825261927,-0.9485739773988046,0.5255319148936171,0.8257936635545368,1.0,2/13,9.67%,THBS1;FAP
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3689903433820141,0.9482701917377193,0.5052083333333334,0.9660782941435853,1.0,5/17,14.40%,CYCS;COX6B1;COX5A;COX15;COX10
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3517457855121852,0.9478512438109522,0.5142348754448398,0.9663989304477583,1.0,3/25,3.83%,EVI5L;TBC1D30;EVL
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3448772408752761,-0.9476662257560737,0.5164835164835165,0.8273548032253849,1.0,8/17,27.56%,EMC7;CAMLG;SGTA;BAG6;EMC1;EMC8;EMC9;GET4
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.34475601849701293,0.947634899758161,0.5334507042253521,0.9661297232262334,1.0,3/25,10.80%,CBL;BCAR3;RBPJ
prerank,regulation of ossification (GO:0030278),-0.2860563935723586,-0.9474392439945157,0.556872037914692,0.8271886853401486,1.0,18/36,35.15%,BMP4;CHSY1;ENPP1;ANKH;SMAD6;ACVR1;ECM1;LRP6;BMPR2;TXLNG;NOTUM;SFRP1;BMP2;MDK;PTN;TWIST1;SOX11;SOX9
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2473184197111881,0.9474121946196371,0.5931558935361216,0.9659099876986028,1.0,36/190,13.40%,GSK3A;TRIB3;PTPRJ;PDE4D;TNFAIP3;BCL2L2;SRC;HDAC7;RFFL;IFI35;PRDM15;EPM2A;SPRED1;CYRIB;CIB1;AKT1S1;ARHGAP25;SIRT1;NLRC3;DAG1;PHLPP1;TSC1;RELA;LYN;MDM2;PRKAA2;ESR1;OTUD3;DDX3X;P2RX7;ADIPOR1;NF1;MAPKBP1;NDUFA13;PLEK;DDIT3
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3013445558430756,0.9473481209709907,0.5397815912636506,0.9652372246061681,1.0,12/54,12.35%,XYLT1;SGSH;GLB1;EXT2;HS6ST1;PXYLP1;FUCA1;HS3ST2;B3GAT2;HGSNAT;AGRN;IDS
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2553900430239827,0.9473080012636003,0.5439276485788114,0.9644966934563037,1.0,10/152,4.57%,MTNR1A;HTR1F;PTGER2;ADGRE1;ADGRL4;GNAQ;ADGRL3;TSHR;INSL3;RAMP2
prerank,neuron remodeling (GO:0016322),-0.4115453273399737,-0.9468456726763943,0.5406976744186046,0.8279498665743094,1.0,4/10,21.74%,ADGRB3;SCARF1;CX3CL1;EPHA8
prerank,aortic valve development (GO:0003176),-0.28763333905748395,-0.9467934029685234,0.5686274509803921,0.8273362870238362,1.0,6/34,8.66%,ROBO2;ROBO1;BMP4;ROCK2;ROCK1;SMAD6
prerank,rRNA catabolic process (GO:0016075),-0.35026650977702173,-0.9461878616548476,0.5239130434782608,0.8282386775971211,1.0,9/16,34.80%,EXOSC10;DIS3L;DIS3;TRIR;EXOSC8;EXOSC2;DEDD2;EXOSC3;EXOSC5
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.38017573891079937,0.9456520255211833,0.5280898876404494,0.9682844330733945,1.0,1/16,1.01%,GSK3A
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2936019492043796,-0.9443265943782904,0.5183374083129584,0.8322190947092241,1.0,4/35,6.92%,MAGI2;PDGFRB;CRY2;HTT
prerank,regulation of protein secretion (GO:0050708),-0.22609739796452208,-0.9441783987535687,0.6082089552238806,0.8319001053293507,1.0,34/119,26.14%,BMP6;IGF1;CACNA1C;ITPR1;SNAP25;CACNA1D;KCNC2;SERGEF;SLC12A2;PER2;DPP4;ENSA;EZR;STXBP5;PPID;UNC13B;SYT7;EXOC1;TGFB1;STX1A;KCNS3;CYP51A1;ITPR2;RHBDF1;P3H1;LLGL1;TGFB3;IER3IP1;UQCC2;ADRA2A;PICK1;APBB1;SYTL4;PPIA
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.29902013956803597,-0.9436406030989068,0.5735294117647058,0.8325491008279048,1.0,14/30,24.86%,OGT;WAC;FHIT;CAMLG;DDRGK1;TRIM39;MAP1A;USP7;SGTA;STYX;EIF3H;BAG6;UBXN1;NOP53
prerank,ERK1 and ERK2 cascade (GO:0070371),0.34767757928314313,0.9433874211411518,0.5462633451957295,0.973766324225037,1.0,2/21,4.13%,MAPK3;ZFP36L1
prerank,regulation of viral release from host cell (GO:1902186),0.3561480395224583,0.9432200488903054,0.543859649122807,0.9733864999229096,1.0,5/21,10.51%,TRIM28;TRIM8;TRIM25;CHMP2A;VPS37B
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.34558645657393094,-0.9430375593799596,0.5206971677559913,0.8333924524996453,1.0,12/18,35.81%,CTNNA1;ILRUN;GSK3B;RAB23;APOD;FLCN;CABP1;OTUD7B;SUFU;CHP1;POLR1A;LATS1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.2882767776143675,0.9426171006618772,0.5692068429237948,0.9742409671449842,1.0,7/63,13.00%,PTPRC;VAV3;TIRAP;IRS2;PNP;CD81;CD274
prerank,maturation of SSU-rRNA (GO:0030490),-0.2931799507552271,-0.9425001911892791,0.5443037974683544,0.8340252048814447,1.0,18/34,28.33%,RIOK1;BMS1;RIOK2;UTP6;NOL11;DDX52;RPS16;UTP4;NAT10;NOB1;RIOK3;NOP14;WDR3;LSM6;RRP36;TSR2;NOL10;UTP3
prerank,protein modification process (GO:0036211),0.27605481235189167,0.9423698580452854,0.5671641791044776,0.9740785246280742,1.0,22/76,18.51%,DUSP12;UBE2I;FBXW2;CSNK1G3;SLC35A1;PIGH;FBXO11;UBE2M;ICMT;YES1;PLAT;ST3GAL6;ADPRH;ST3GAL1;MSRA;QPCT;FBXO22;NTAQ1;PRKDC;LCMT1;SEPHS1;UBE2D3
prerank,positive regulation of neuron differentiation (GO:0045666),-0.2774281120711687,-0.9423182652688142,0.5484633569739953,0.8337648895227188,1.0,9/40,16.71%,NRCAM;NBL1;BRINP1;RHOA;ZEB1;BRINP2;NGF;TCF4;GPRC5B
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4140157799641718,0.9422142577550542,0.5437616387337058,0.973668320479009,1.0,2/12,6.27%,SOAT1;LPCAT3
prerank,anterior/posterior pattern specification (GO:0009952),-0.2628879488104472,-0.9422007103972738,0.5552763819095478,0.833357316381915,1.0,9/53,8.39%,WLS;PCSK5;TGFBR1;HOXC6;HOXA3;HOXA5;SKI;LRP5;BHLHE40
prerank,regulation of regulated secretory pathway (GO:1903305),-0.2893877999902131,-0.9420925030939343,0.5700712589073634,0.83291404839193,1.0,8/34,14.53%,RIMS1;SYT9;SYN1;GSK3B;SYT12;SYT11;SYT4;SYT7
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.26779813263797375,-0.9416972302640104,0.5562130177514792,0.8332274993348426,1.0,16/53,19.94%,EYA2;DDX5;EYA1;EGFR;UBE2N;PRKCD;ERCC6;PLA2R1;RNF168;RNF8;ATM;NACC2;NPAS2;BABAM1;SMCHD1;SPRED3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.282025143742192,-0.9407679687470424,0.558974358974359,0.8349026826752179,1.0,16/38,27.75%,OTUD7A;PPM1B;TLE1;PER1;PPM1A;TRIM39;RORA;TNIP1;USP10;TANK;RIOK3;STAT1;OTUD7B;TRIM59;ZC3H12A;RHOH
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3851138076615296,0.9407347436506731,0.5445920303605313,0.9768862264555034,1.0,6/15,18.60%,GRM7;GRM3;HOMER1;DAGLB;GRM8;HOMER3
prerank,lipoprotein localization (GO:0044872),0.41572270916130016,0.9407066623576024,0.544954128440367,0.9761088351575887,1.0,2/11,7.15%,ZDHHC17;VMP1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.334443590303529,-0.9406777922590664,0.5648351648351648,0.8344003483441632,1.0,8/19,24.35%,ROBO1;XDH;CCBE1;SMOC2;ADAMTS3;JCAD;CADM4;DCN
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.37695531026658363,-0.9402479740747212,0.5278969957081545,0.8347744467204186,1.0,5/11,18.56%,DAB2;SORL1;EZR;PTPN23;MSN
prerank,regulation of autophagy (GO:0010506),0.24226583410592395,0.9399227512497169,0.6116883116883117,0.9774416326689885,1.0,57/216,18.94%,GSK3A;TRIB3;ATF6;EEF1A1;ACER2;TAB2;PLK2;RPTOR;EXOC8;SVIP;TRIM8;ATP6V1D;VPS29;VPS26A;ATP6V0D1;TRIM14;EP300;MAPK8;LAMTOR1;TAB3;DRAM2;ATP6V0E1;RASIP1;ZKSCAN3;PRKAA2;EIF4G2;BAD;CISD2;UBQLN1;BMF;TMEM59;TBC1D14;RRAGC;USP33;DDIT3;TLK2;TRIM27;CSNK2A2;PIK3C2A;ATP6V1B2;VPS35;TFEB;ATG13;DNM1L;BNIP3;UBQLN2;WDR41;DAPL1;PIP4K2A;STAT3;FOXK2;ATP6V1A;USP36;ULK1;MID2;SH3GLB1;EIF4G1
prerank,platelet degranulation (GO:0002576),0.2583261817089217,0.9395426381682868,0.5646067415730337,0.9776681384432204,1.0,18/118,11.43%,ABCC4;CDC37L1;SOD1;PECAM1;MANF;NHLRC2;CYRIB;SELP;SELENOP;F8;ACTN4;VWF;LGALS3BP;LYN;GTPBP2;APP;A2M;OLA1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.3883479237615979,-0.9394862272562606,0.5582329317269076,0.8353445220394973,1.0,2/12,10.56%,FHL2;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.3883479237615979,-0.9394862272562606,0.5582329317269076,0.8353445220394973,1.0,2/12,10.56%,FHL2;GSK3B
prerank,DNA packaging (GO:0006323),0.37293612404629833,0.9393181927824651,0.5632582322357019,0.977428114996003,1.0,4/16,18.84%,BANF1;AIFM1;RBBP4;HAT1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3189260977624313,0.9391636781424257,0.5562913907284768,0.97700364782909,1.0,2/33,4.13%,LEF1;ZFP36L1
prerank,positive regulation of heart rate (GO:0010460),0.3704011281654541,0.9390601811399462,0.5519713261648745,0.9764499163509289,1.0,3/17,10.53%,PDE4D;ATP2A2;TRPM4
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.34281153861729,0.9385659112722678,0.5391304347826087,0.9760630814427065,1.0,9/23,20.96%,MAPK8;YWHAB;BAD;PPP3R1;YWHAH;YWHAQ;YWHAE;YWHAZ;TFDP2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.34281153861729,0.9385659112722678,0.5391304347826087,0.9760630814427065,1.0,9/23,20.96%,MAPK8;YWHAB;BAD;PPP3R1;YWHAH;YWHAQ;YWHAE;YWHAZ;TFDP2
prerank,regulation of necroptotic process (GO:0060544),-0.31968460240272667,-0.9383752866446746,0.5576036866359447,0.8375230718217461,1.0,6/23,8.63%,CFLAR;OGT;CYLD;FLOT2;YBX3;BIRC3
prerank,actin filament network formation (GO:0051639),0.40133854402957225,0.9380756975859299,0.5378787878787878,0.976574235342495,1.0,1/11,0.56%,LCP1
prerank,positive regulation of cell migration (GO:0030335),0.23562236568204553,0.937796372522423,0.6383495145631068,0.9764612264153956,1.0,39/253,12.62%,MAZ;SEMA6A;SEMA6D;SEMA7A;LEF1;PTPRC;TIAM1;PECAM1;CXCL12;SRC;CLASP2;INSL3;PFN1;SEMA3C;CIB1;RET;SEMA6B;ARHGEF7;FBXO5;ACTN4;RUFY3;NOTCH1;PLCG1;ITGA6;TJP1;SEMA4C;CSF1R;SOD2;PODXL;PAK1;VSIR;FLT1;PIK3CD;PPP3CA;CRKL;PLAA;MAP4K4;MGAT5;CDH5
prerank,DNA duplex unwinding (GO:0032508),-0.25878996486293265,-0.9375640621511259,0.5424657534246575,0.8388419317404883,1.0,17/50,22.62%,DDB1;DDX1;DDB2;RAD50;MRE11;RPA1;UBC;ANXA1;PURA;MCM9;PARP1;XPC;BLM;SUPV3L1;RECQL;RTEL1;MCM6
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.33814599551660485,-0.936821755434716,0.5473441108545035,0.8399076213842054,1.0,6/17,24.20%,VIM;BMP4;WNT4;TGFB1;CREB3L1;TGFB3
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.34810883300625894,0.9367687698420146,0.5473684210526316,0.9784210352695811,1.0,6/22,12.55%,RAP2A;GREM1;CALM3;DDX3X;RAP2C;NBN
prerank,calcium ion transport into cytosol (GO:0060402),-0.32904997880881515,-0.9366673907920073,0.5273972602739726,0.8395815268112219,1.0,2/21,1.54%,CACNA1C;GRIN2B
prerank,lipoprotein biosynthetic process (GO:0042158),0.40955416662905697,0.9364435550722372,0.539622641509434,0.9784288512961394,1.0,3/11,11.74%,APOE;UGCG;ATG7
prerank,icosanoid secretion (GO:0032309),0.39898927394450034,0.9359057644317352,0.5237154150197628,0.9790543686067898,1.0,2/12,11.52%,ABCC4;PNPLA8
prerank,regulation of cell development (GO:0060284),0.3150265818760789,0.9358744743985565,0.5505050505050505,0.9782988071569467,1.0,10/36,16.10%,HES6;HDAC9;HEY1;CLOCK;HEY2;PRUNE1;DOCK7;HES1;FBXO22;HEYL
prerank,heart contraction (GO:0060047),-0.2677949964286839,-0.9353750720108612,0.5679347826086957,0.8421465423237231,1.0,3/41,4.07%,ATP1A2;ATP1B1;TPM1
prerank,regulation of establishment of cell polarity (GO:2000114),0.3693709993386709,0.9352362901165102,0.5406871609403255,0.9791766201230686,1.0,7/16,18.22%,CYRIB;RIPOR2;KRIT1;RUFY3;CDH5;PTK2B;ARFGEF1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3564310697980146,0.9351481703400005,0.5753176043557169,0.9785825742368746,1.0,4/19,12.32%,PTPRJ;TEK;TSC1;MAP4K4
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3366511919081946,-0.9350077214948497,0.543046357615894,0.8424286324839941,1.0,13/18,43.67%,COX16;COX19;COX17;COX18;PET100;COX20;COX14;BCS1L;COA5;SCO1;COA3;SURF1;FASTKD3
prerank,protein N-linked glycosylation (GO:0006487),0.27905328053595374,0.934946272008434,0.5641421947449768,0.9782894930869623,1.0,10/66,13.42%,NUDT14;ALG6;ASGR1;ALG8;TMEM165;OST4;STT3B;MCFD2;MGAT5;ST3GAL1
prerank,regulation of gene expression (GO:0010468),0.21929866602397127,0.9345911359185761,0.7304890738813735,0.9784895852624552,1.0,164/903,16.10%,TBX4;MAZ;CTCFL;MAPK3;GSK3A;ONECUT1;CAVIN4;TRAPPC2;FOXN2;EZH2;ZFAT;DIP2A;PIN1;LEF1;PTPRC;HES6;RPL23;GTF2IRD1;RPS6KA4;PDCL3;NWD1;HNRNPH2;SORT1;PCBP1;ATXN1L;STOX1;GABPA;BCL6B;RPS6KA5;SMAD1;PPP2CA;SBNO2;ZFP36L1;HNRNPAB;HEY1;NR5A1;RAMP2;APOE;PRDM4;MYBL2;SMARCA2;SOX2;HNRNPK;YY1;TRIM14;FAM50A;SPIN1;NPAT;CPSF4;EP300;RFX3;MAPK8;TDG;DTNBP1;NFX1;MED23;RPL5;TGFBRAP1;SRSF10;CALCOCO1;ACTR8;RO60;RGCC;CDK11B;RBM20;ZNF205;SFPQ;SIRT1;BMI1;ACTR5;DRAP1;CLOCK;RNF187;PFDN5;KDM6A;HEY2;YTHDC1;NOTCH1;CNOT7;CDK4;WNT5A;TOB2;NOVA2;SOX13;ACVRL1;TRAF3;RELA;NAB2;LYN;MARF1;PARK7;RNF6;CLDN5;TARDBP;VSIR;UBE2V1;CITED2;RYBP;PRKAA2;ING2;CCAR2;ESR1;TERT;SRPK2;DDX3X;RBPJ;NLK;P2RX7;HP1BP3;CREBBP;CARM1;NOS3;MATR3;AGO4;APP;PIK3CD;RPS3;PTBP1;JMJD1C;PICALM;PCBP3;CRKL;SP1;MZF1;CDH5;IRF2;CHD3;ERC1;NUP35;ACTA2;TRRAP;HDAC5;CHEK2;DDIT3;POGZ;ZKSCAN5;HCFC1;YBX1;TRIM27;RNF20;BAZ2A;NSD2;BACH1;FUS;VPS35;PRDM10;TERF2IP;GAS6;ATG14;MOV10;HNRNPL;NOCT;TFEB;TAF6L;NKAP;TRA2B;APBB2;TAF1;BCL6;BRAF;TDRD7;ID2;TCF7L1;TCF3
prerank,maintenance of protein location in nucleus (GO:0051457),0.35016513250096837,0.9343502267910806,0.5497287522603979,0.9783083929104542,1.0,10/20,21.81%,SYNE1;ARL2BP;PARK7;TAF3;RANGAP1;MORC3;SP100;BBS4;SKP1;SUN2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3355991054807911,0.9342030472144978,0.5294117647058824,0.9778306984284735,1.0,8/25,19.40%,SORT1;LEPROTL1;CHMP1A;CHMP2A;LAPTM4B;VPS4B;LEPROT;DENND10
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.36693344880272527,0.9338205155363668,0.5620300751879699,0.978000152239181,1.0,4/17,10.56%,VEZF1;RFX3;TMEM100;BAD
prerank,angiogenesis involved in wound healing (GO:0060055),0.40479174256704,0.9337247921483844,0.5386064030131826,0.9774281641574964,1.0,2/11,7.27%,PRCP;ADIPOR2
prerank,protein homotetramerization (GO:0051289),0.2962031421586938,0.9333715460466437,0.57,0.9775086235075886,1.0,7/49,10.53%,THG1L;GLS;B2M;SSBP1;ACACB;SOD2;TRPM4
prerank,Golgi to lysosome transport (GO:0090160),0.4163906519820655,0.9333447173020653,0.5633270321361059,0.9767515088377202,1.0,3/11,11.02%,SORT1;AP1G1;RBSN
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.2961053347436909,-0.9333441007479902,0.5743073047858942,0.8458857348140558,1.0,4/30,5.33%,NOTCH2;IGF1;RASGRF1;RELN
prerank,cell differentiation in spinal cord (GO:0021515),0.41774388749526326,0.933322470554367,0.5531914893617021,0.9759684000726285,1.0,2/10,10.16%,SOX13;ZC4H2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3860342925659969,-0.9325667905252283,0.5366876310272537,0.8471575623883835,1.0,4/11,13.86%,MPV17L;SLC30A10;PPARA;ABCD2
prerank,membrane protein proteolysis (GO:0033619),0.3044154389802045,0.9318941086052348,0.573109243697479,0.9790877102786678,1.0,12/37,18.20%,PSEN2;RET;NAPSA;SPPL3;DAG1;RELA;MBTPS1;TMPRSS6;APH1A;MYH9;ADAM9;SPPL2A
prerank,heterochromatin organization (GO:0070828),0.38716367064296786,0.9316891030457094,0.5564053537284895,0.9787873644151684,1.0,4/14,15.04%,MECOM;SIRT1;HP1BP3;EZH1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.29753472622209437,0.9306883401956013,0.5517774343122102,0.9806840159539004,1.0,10/48,14.60%,HDAC7;HDAC9;PRKD2;CIB1;SIRT1;PLCG1;NOS3;SP1;MAP3K3;PIK3C2A
prerank,multivesicular body organization (GO:0036257),-0.2920512060307069,-0.9306496172164236,0.5655172413793104,0.8512262482154587,1.0,10/31,22.01%,STAM2;IST1;SNF8;RAB11A;TSG101;CHMP2B;CHMP5;STAM;VPS4A;HGS
prerank,positive regulation of superoxide anion generation (GO:0032930),0.3890141420463932,0.9301951613409232,0.538878842676311,0.9811785970292788,1.0,2/13,6.70%,SOD1;SYK
prerank,negative regulation of gene expression (GO:0010629),0.23186995423144666,0.9298308654676672,0.6623067776456599,0.9813042898307321,1.0,61/302,17.21%,CIDEA;ZC3H12D;ILF3;EZH2;DIP2A;PATL2;EED;FCGR2B;RPS6KA4;STOX1;HDAC9;RPS6KA5;NUDT12;APOE;YY1;NPTN;FXR1;PAIP2B;RGCC;RPS26;SIRT1;BMI1;HEY2;PPP1R11;NOTCH1;CNOT7;TSC1;ACVRL1;DXO;PARK7;CLDN5;TARDBP;CITED2;PRKAA2;ESR1;TERT;DDX3X;NANOS3;AGO4;APP;RPS3;PTBP1;PICALM;CRKL;PPHLN1;YBX1;TRIM27;CNOT1;TASOR;CAPRIN1;AEBP2;MOV10;NOCT;TAF1;ID2;RBBP4;N4BP1;CNOT10;TIPARP;CALR;SLC7A5
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.39987332489523775,-0.9298021341698443,0.5538793103448276,0.852619404499131,1.0,6/10,22.24%,OGT;SIRT7;SELENOS;USP7;ZNF692;DGKQ
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2116760860096002,-0.9297232542107849,0.6582278481012658,0.8520875544728624,1.0,48/172,22.54%,PTPN13;PLD1;PLA2G4A;PLEKHA2;AGPAT4;ABHD5;PIK3C2B;MTMR7;PIK3C3;AGPAT5;PIP5K1A;DGKH;SACM1L;PIK3R3;VAC14;LPIN1;PLEKHA8;PLSCR1;PIP4K2B;MTMR12;HDHD5;PITPNM3;CHKA;AGK;PCYT1B;INPPL1;CDS2;SLC27A1;ETNK2;MTMR9;CDS1;PTDSS2;CRLS1;MTMR4;PCYT2;PGS1;ABHD3;INPP4A;GPD1L;LPCAT1;CPNE3;PIK3R1;SBF1;BMX;LPIN2;DGKQ;PIP5K1B;CHKB
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.24752599009063886,-0.9296902169931581,0.5670731707317073,0.8514423061359409,1.0,11/62,9.85%,KMT2A;HDAC1;MEIS2;CBFB;HOXA5;CDC73;RBM15;THBS1;AGO3;RBBP5;CDK6
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2732085776544167,0.9290227739546293,0.5632716049382716,0.9826881168611615,1.0,21/69,19.57%,DERL2;YOD1;WFS1;FAM8A1;SGTB;TRIM25;AUP1;RHBDD2;ERLIN2;STT3B;UBQLN1;PSMC6;DNAJC10;UFD1;UBQLN2;DNAJB14;UBXN4;EDEM2;DNAJB9;DERL1;SEL1L
prerank,regulation of protein localization to membrane (GO:1905475),-0.30464529676926116,-0.9289811537385972,0.5527638190954773,0.8524774539566156,1.0,12/28,24.73%,GPC6;GSN;MMP14;GPC3;STX8;GPC5;VPS4A;GPC4;APPL1;CLN3;VAMP8;SPTBN1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.32115660749261665,-0.9288685636795359,0.5599078341013825,0.8520505648766832,1.0,13/21,28.52%,CHSY1;VCAN;CSGALNACT2;CHST15;CHST11;UGDH;CSPG4;BGN;DCN;CHPF2;CHST3;CSPG5;CHST12
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.22868292055196776,-0.9287133677190895,0.6302250803858521,0.8517065351854302,1.0,18/98,13.20%,SORBS1;ANK3;LRP1;EGFR;CEMIP;AKT2;FIS1;ZDHHC5;STX3;EFCAB7;DPP10;EPHB2;EPHA3;TP53;CLIP3;DLG1;PDCD5;WNK3
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.33452404496787835,0.9281050674816075,0.5651438240270727,0.9843238301188794,1.0,2/23,2.43%,SURF4;DERL2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3165072105928364,0.927746997441463,0.5544554455445545,0.9844093476603654,1.0,6/33,12.90%,TAL1;ABCB10;RAB7B;MTURN;ACVR2A;PITHD1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.3478171153053185,0.9276821375116389,0.5721830985915493,0.983754947792831,1.0,6/24,16.78%,CXCL12;SIRT1;ING2;CCAR2;CD44;TMEM161A
prerank,cellular response to mechanical stimulus (GO:0071260),0.2943141614680506,0.9275500033120738,0.5397815912636506,0.9832825807380614,1.0,6/46,10.56%,MAPK3;TNFRSF10B;MAPK8;CRADD;F11R;BAD
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.33235727616248817,0.9273062336947324,0.5609756097560976,0.9830813931036936,1.0,7/26,16.98%,FBXO5;ANAPC7;ANAPC11;ANAPC4;CUL3;NEK6;LCMT1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.271884587574957,0.9271267403003399,0.5994194484760522,0.9827238616475268,1.0,11/78,10.50%,ACTB;CDC37;CDK5RAP1;CCNH;CDKN1A;RGCC;GTF2H1;LATS2;CCNG2;TFAP4;BCCIP
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.27577127511646615,-0.9270996794968451,0.574468085106383,0.8551677900714769,1.0,15/39,28.12%,BMP6;MBP;WNK1;PPARA;CDH1;MYADM;NF2;PTK2;TGFB1;PPM1F;VEGFA;AKT1;NOTCH4;AKNA;BMP2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3427385195209858,0.9269886923822268,0.5636363636363636,0.982263596617055,1.0,6/22,13.44%,PSMC4;MED12;PSMC2;ESR1;MED4;PSMC6
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.40167760456016877,-0.9268688736074578,0.569672131147541,0.8549789178463626,1.0,4/10,21.81%,SOX5;BMPR1B;SOX6;PKDCC
prerank,steroid catabolic process (GO:0006706),0.4103811053634735,0.9268175736481588,0.5635673624288425,0.981900429325044,1.0,2/10,13.07%,HSD17B11;YWHAH
prerank,telomere maintenance via recombination (GO:0000722),-0.38861020617999464,-0.9267517221003108,0.5621052631578948,0.854538823520401,1.0,5/11,19.16%,SMC6;RAD50;TPRKB;RAD51D;NSMCE2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4271723504389548,0.9267245364532378,0.5638506876227898,0.9813192286934723,1.0,4/10,18.79%,SSBP1;INO80;WIZ;ATRX
prerank,autophagosome organization (GO:1905037),0.2882937789272584,0.9267183576285125,0.5996884735202492,0.9805059325990048,1.0,18/50,18.80%,MAP1LC3B;ATP2A2;RAB7A;RAB43;VMP1;RAB1A;UBQLN1;ATG7;ATG16L1;ATG14;TMEM41B;GABARAPL1;ATG13;TP53INP2;UBQLN2;BECN1;GABARAP;ULK1
prerank,dendritic spine organization (GO:0097061),0.32634300926578624,0.9264617340976715,0.5440677966101695,0.9803642193331218,1.0,7/26,12.25%,DIP2A;SHANK3;FYN;PAK3;ARF1;PRNP;ITGA3
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3315597282264339,-0.9258789961882988,0.5529953917050692,0.8560292287815974,1.0,8/19,22.28%,BMP6;ADAM19;AFDN;DENND6A;PTPRU;FLOT1;PPM1F;VEGFA
prerank,negative regulation of type I interferon production (GO:0032480),-0.270331029285422,-0.9256688906215335,0.5843828715365239,0.8558362573354259,1.0,12/40,13.00%,CYLD;PTPRS;PPM1B;ILRUN;TAX1BP1;IFIH1;RNF135;REL;IKBKE;NPLOC4;SIRPA;RELB
prerank,regulation of water loss via skin (GO:0033561),0.3680392165491688,0.9254011846109929,0.5705882352941176,0.9816229955409786,1.0,3/15,13.38%,UGCG;HRNR;LSR
prerank,establishment of skin barrier (GO:0061436),0.3680392165491688,0.9254011846109929,0.5705882352941176,0.9816229955409786,1.0,3/15,13.38%,UGCG;HRNR;LSR
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.25696315574341216,0.9251032357452007,0.5961538461538461,0.9815611963644436,1.0,31/119,17.22%,CISH;PIK3CG;PIK3C2G;MTMR14;EFR3B;SMG1;PIKFYVE;RAB14;PIGH;ARF1;INPP5D;PIGB;PI4KA;PIK3CD;PIK3R5;PGAP2;INPP4B;IP6K2;SYNJ2;RUFY1;PIK3C2A;IMPA1;PIGN;MTMR2;PIGU;MBOAT7;PLEKHA1;ITPKB;PIK3R4;PIP4K2A;PLEKHA3
prerank,positive regulation of endocytosis (GO:0045807),0.29618224216422817,0.9245174195420833,0.5712050078247262,0.9822900101938672,1.0,7/45,5.45%,CBL;PPT1;NEDD4L;SGIP1;APOE;HNRNPK;B2M
prerank,cellular amino acid catabolic process (GO:0009063),0.26245257928541166,0.9242567095418788,0.5904628330995793,0.9821810671121595,1.0,8/87,5.63%,AASS;BCKDHB;ALDH5A1;SLC25A44;GLS2;GLS;GOT2;ACAT1
prerank,glycolipid metabolic process (GO:0006664),0.2941819970707949,0.9241076158147046,0.5727848101265823,0.9817633650466744,1.0,11/47,16.11%,GLB1;SMPD4;ST6GALNAC3;ESYT2;FUCA1;UGCG;ST3GAL6;GM2A;ST8SIA6;CERK;GBGT1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.33362374876691325,-0.924087835434076,0.5899772209567198,0.8592619961847189,1.0,8/18,22.90%,ASPA;SLC25A13;MTHFR;MTHFD1;NAALAD2;SMS;GOT1;ASPG
prerank,regulation of actomyosin structure organization (GO:0110020),-0.36619724374804347,-0.9239532652432098,0.5711340206185567,0.8588994815989822,1.0,5/13,17.34%,AKAP13;ROCK2;ROCK1;FHOD1;CDC42
prerank,regulation of cilium movement (GO:0003352),-0.40033521839915476,-0.9238232068384143,0.5592233009708738,0.8584982349898382,1.0,9/10,56.06%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,"phagocytosis, engulfment (GO:0006911)",0.3068920371232319,0.9236568321863181,0.5546218487394958,0.9820813963888448,1.0,4/36,5.90%,RAC2;XKR8;FCGR2B;ARHGAP25
prerank,positive regulation of apoptotic process (GO:0043065),0.23067614030903666,0.9236162245694984,0.6518072289156627,0.9813713244872482,1.0,58/293,16.60%,ERCC3;MAP3K11;ATF6;FRZB;TIAM1;SOD1;VAV3;PSEN2;ARHGEF26;MCF2L;ING4;ITSN1;TNFRSF10B;MAPK8;ARHGEF6;CRADD;ARHGEF7;TRIO;SIRT1;OMA1;ARHGEF18;ITGA6;LATS2;BCLAF1;FZD9;TFAP4;AIFM1;RYBP;ING3;CCAR2;BAD;SRPK2;DDX3X;CYP1B1;RPS3;ATG7;PRNP;BMF;IP6K2;BNIP3L;NF1;ING5;UTP11;DDIT3;DIABLO;FAF1;APC;PTPA;APAF1;MAP3K10;GNA13;TPD52L1;APH1A;BCL6;DNM1L;BNIP3;QRICH1;RASGRF2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.3821968916114611,-0.9235008903652595,0.5819327731092437,0.8585953214980351,1.0,7/11,26.49%,OGFOD1;P4HB;P4HTM;EGLN3;P4HA2;CRTAP;EGLN1
prerank,alcohol catabolic process (GO:0046164),0.41146965144239656,0.923460775344862,0.5459770114942529,0.9809416228894062,1.0,2/10,7.62%,APOE;SNX17
prerank,reticulophagy (GO:0061709),-0.3783606875646408,-0.9232769028733085,0.5591182364729459,0.8584326101072621,1.0,4/12,14.46%,ULK2;UFL1;DDRGK1;TEX264
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2501708634060944,0.9230296909495015,0.6299319727891156,0.981245824689867,1.0,30/136,16.22%,HES6;TNFAIP3;NWD1;MAP2K5;PHB2;WFS1;CEBPG;PIM1;SMAD7;SIRT1;NLRC3;MTURN;ERBIN;TRAF3;RBCK1;NFKBIL1;ESR1;CYP1B1;PRNP;CHUK;NLRC5;DDIT3;NFKBIA;HES1;MAP3K10;GAS6;TAF1;ID2;HEYL;TAF3
prerank,positive regulation of metabolic process (GO:0009893),0.25772958771901583,0.9224574705458956,0.601123595505618,0.9819607302910922,1.0,13/103,8.89%,ALMS1;UCP2;CAMK1D;HDAC3;TSHR;KDM3A;ELOVL6;BEND3;GATM;SYK;ADIPOR2;OMA1;ACACB
prerank,positive regulation of fat cell differentiation (GO:0045600),0.29254851210312727,0.9222878438258102,0.5909822866344605,0.9816191141461429,1.0,10/47,12.48%,FRZB;CCDC71L;ZFP36L1;PPARD;PIM1;AAMDC;SOX13;TRPM4;CARM1;WDFY2
prerank,response to tumor necrosis factor (GO:0034612),0.26282518250361897,0.9221588820917955,0.6072931276297335,0.9811473092266703,1.0,13/91,12.87%,MAP2K7;SMPD4;ZFP36L1;GBP3;CIB1;SIRT1;CCL25;ERBIN;RELA;NPNT;RPS3;IKBKB;CHUK
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.30783035396526165,0.9220927398593438,0.5840407470288624,0.9805031043508285,1.0,9/35,16.87%,SLC25A1;PPT1;ACAT1;FAR2;HMGCS2;PAM;BDH2;HPGD;ACACA
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.21584098602601037,-0.9220787330518001,0.6937984496124031,0.860624043423279,1.0,16/142,10.71%,ATP1A2;LPAR1;CACNA1C;ADCY5;SMAD3;DLG4;TRPC5;PLCE1;PDGFRA;EDNRA;ADRA1B;FIS1;CCR9;TRPC1;PRKACA;ACKR3
prerank,snRNA transcription (GO:0009301),-0.24302018737845388,-0.9215955855700172,0.624633431085044,0.861094966674107,1.0,41/70,33.06%,RPRD1B;POU2F1;ELL;PHAX;SRRT;USPL1;GTF2A1;CDK7;CCNT1;POLR2A;SNAPC3;TAF8;INTS10;INTS8;CCNK;INTS11;TAF6;CDK9;GTF2E2;NABP2;GTF2B;INTS7;SNAPC4;NCBP2;TAF13;POLR2K;INTS12;GTF2E1;INTS9;TAF11;POLR2H;INTS3;ZC3H8;NABP1;POLR2G;POLR2F;POU2F2;POLR2C;TAF5;GTF2F1;INTS1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24951137491324127,-0.9215849505525785,0.6072423398328691,0.8603896700013163,1.0,16/55,19.92%,PDGFRB;MAPK14;PID1;TGFBR2;SIRT2;AATF;XDH;THBS1;TP53;GRB2;MPV17;ARF4;SIRT5;AGTR1;SLC25A33;PINK1
prerank,regulation of MAP kinase activity (GO:0043405),0.26332707812146483,0.9214705039481006,0.6101449275362318,0.9813012468468111,1.0,6/92,1.51%,RGS2;PIK3CG;TRIB3;DUSP7;PTPRJ;EZH2
prerank,regulation of autophagosome assembly (GO:2000785),0.31349778838442416,0.9214275145288402,0.5815126050420169,0.9805882217360721,1.0,15/33,21.39%,RALB;PIKFYVE;TBC1D12;SCFD1;ADPRH;FEZ2;TMEM39A;TBC1D14;RAB3GAP1;UBQLN2;PIP4K2A;SH3GLB1;RAB5A;LRRK2;PIP4K2C
prerank,RNA metabolic process (GO:0016070),-0.2217030213117038,-0.9212207316406559,0.6754716981132075,0.860562091392638,1.0,30/127,15.31%,CELF2;RBMS1;BICD1;HNRNPH1;DDX17;PABPN1;ELAVL4;RBM39;RBMX;SYNCRIP;SNRNP40;DDX39B;RNGTT;DDX24;HNRNPA2B1;SIDT2;AGO3;HNRNPA1;RNASEH2B;RBM3;RBM4;ATXN1;TP53RK;SND1;POLR2A;DICER1;SETX;PABPC4;MTREX;RNASE3
prerank,secondary alcohol metabolic process (GO:1902652),0.2989126933526524,0.920948959667271,0.5803858520900321,0.981065971921028,1.0,7/42,12.68%,EBP;APOE;SOAT1;PPARD;OSBPL1A;NSDHL;LDLRAP1
prerank,protein lipidation (GO:0006497),0.2792513759348002,0.9206538831132444,0.5898203592814372,0.9810455329834844,1.0,14/59,16.29%,ZDHHC17;ZDHHC13;UGCG;ZDHHC14;SELENOK;PIGH;ZDHHC15;PIGB;ATG7;PGAP2;ZDHHC9;ZDHHC7;PIGN;PIGU
prerank,tryptophan metabolic process (GO:0006568),-0.3964848961245807,-0.9204509635850968,0.5920502092050209,0.8617760098022912,1.0,2/11,17.80%,ATP7A;KYAT1
prerank,UV protection (GO:0009650),-0.39643710271580124,-0.9202527618981884,0.5967741935483871,0.8615609209131911,1.0,3/10,8.37%,SCARA3;ERCC5;CAT
prerank,T cell homeostasis (GO:0043029),-0.39774387433183467,-0.9202346102268656,0.5967078189300411,0.860877607411762,1.0,4/10,28.10%,PPP2R3C;AKT1;NCKAP1L;ZC3H8
prerank,regulation of macrophage differentiation (GO:0045649),0.3749521193389572,0.9198944923620109,0.553030303030303,0.9822452624603691,1.0,1/15,0.75%,C1QC
prerank,phosphatidylcholine metabolic process (GO:0046470),0.27197138015341726,0.9197955173803488,0.5780525502318392,0.981713706033377,1.0,13/70,16.60%,LPCAT2;PLAAT3;DBI;LPCAT3;GPAT4;MBOAT1;SLC44A1;PNPLA8;CEPT1;ABHD4;CSNK2A2;MBOAT7;SLC44A2
prerank,regulation of vasculogenesis (GO:2001212),0.378134173267629,0.9193052288863235,0.5773584905660377,0.982182892769561,1.0,3/14,7.63%,HEY1;TMEM100;HEY2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3251114676723281,0.9191900964632259,0.5843270868824532,0.981646233915399,1.0,8/29,14.33%,SHANK3;PFN1;CYRIB;KANK3;SSH2;TJP1;FKBP4;TWF1
prerank,regulation of membrane repolarization (GO:0060306),-0.3597055813905562,-0.9190274568232226,0.5827814569536424,0.8631463890215161,1.0,3/13,8.46%,AKAP6;AKAP9;KCNJ2
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.3786198098747528,-0.9189577976888332,0.5755693581780539,0.8625969560174646,1.0,3/12,10.62%,EPHB1;B4GALT6;EPHB2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.24708662963572509,0.9189263520283552,0.6072874493927125,0.9815575449577403,1.0,21/151,12.14%,MAP2K7;MAPK3;SEMA7A;PTPRC;TIRAP;PRKD2;APOE;TEK;PHB2;CIB1;ICAM1;HTR2A;MTURN;NOTCH1;CCL25;CSF1R;MFHAS1;ATP6AP1;NPNT;APP;CRKL
prerank,anion transmembrane transport (GO:0098656),0.27638333067495,0.9184363257962488,0.589041095890411,0.98200083586403,1.0,17/67,17.21%,SLC7A8;SLC1A1;SLC36A4;SLC25A1;SLC3A2;LRRC8C;SLC1A2;SLC35A1;SLC35B1;SFXN1;SLC25A12;SLC35A3;SLC38A5;SLC25A21;SLC25A42;SLC25A38;SLC7A5
prerank,regulation of inflammatory response (GO:0050727),0.23906482568578408,0.9182152219151963,0.6474358974358975,0.9817735069298976,1.0,26/190,13.89%,PIK3AP1;IL1R1;SEMA7A;TNFAIP3;BCL6B;BIRC2;IFI35;SBNO2;APOE;TEK;TNFRSF1B;SPATA2;LPCAT3;PPARD;NLRC3;WNT5A;RELA;CD47;PARK7;MFHAS1;NLRP6;APP;USP18;CDH5;PROC;NFKBIA
prerank,regulation of phosphorylation (GO:0042325),-0.22360882143880867,-0.9175817967976985,0.6475095785440613,0.8652613896185272,1.0,26/120,13.34%,PRKAG2;EGFR;GRM5;OGT;NRP1;BMP7;DSCAM;FER;PRKAG1;SIRT2;STAT2;BMP4;NUP205;ROCK1;LDB1;PML;NUP155;CDKN1B;NUP188;THBS1;FN1;ILK;NUP88;NUP93;FNIP1;SEH1L
prerank,cellular response to retinoic acid (GO:0071300),-0.2679475239785963,-0.9174808474291493,0.6055979643765903,0.8647974828093485,1.0,12/42,17.61%,WNT5B;BRINP1;PTK7;BRINP2;SNW1;EPHA3;WNT9A;ATM;SETX;ABL2;FZD4;TWF2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3005825307154308,-0.9174729223517458,0.6063348416289592,0.8640877644228484,1.0,9/24,22.40%,ITGA5;NIBAN2;VTN;GRB10;TMEM204;NEDD4;CADM4;HGS;EMILIN1
prerank,DNA metabolic process (GO:0006259),0.23003805994147544,0.9174555782720468,0.6662621359223301,0.9829664400115183,1.0,50/270,16.84%,ERCC3;ZRANB3;RAD18;TRIM28;CTC1;PNKP;ORC3;ERCC4;RAD1;XRCC1;POLK;TDG;POLE;CDC45;LONP1;DCLRE1B;ORC4;UBE2V2;POLD3;ACD;GTF2H1;POLA1;EXD2;MSH3;PARK7;TERT;SRPK2;RAD51B;SMUG1;HUS1;ORC2;TOP3A;KMT5B;PWWP3A;NBN;DOT1L;HELB;TRRAP;MPG;LTO1;FANCL;BACH1;INO80;TERF2IP;TOP1;ATR;ENDOV;ZNF445;PRKDC;SMARCAD1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.30819428713718994,0.9172150344052287,0.5941780821917808,0.9828100752945149,1.0,7/35,9.17%,PHPT1;TEK;RAPGEF3;F11R;TJP1;ESAM;CSF1R
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.37395777863148516,-0.9169549064777694,0.5870841487279843,0.8647002255329236,1.0,8/12,32.78%,WAC;TP53;SDE2;FBXO31;CDK2;RPS27L;CCND1;PLK5
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.30404308941098335,-0.9169244807228423,0.5906862745098039,0.864066576156583,1.0,2/26,0.72%,EYA2;EYA1
prerank,RNA processing (GO:0006396),0.23762130902009437,0.9167619931237093,0.6649550706033376,0.9831953072938309,1.0,50/176,17.92%,SNRPD2;NCBP1;FASTKD2;PRPF3;SNRPD1;DDX54;PPP2CA;HNRNPK;PPIG;TENT4A;USB1;SFPQ;HNRNPC;IVNS1ABP;ADAR;SF3B3;SRSF4;YJU2;PRMT9;SF3A1;XRN2;RSRC1;AKAP8L;TARDBP;U2AF1;CPSF6;DUSP11;CCAR2;SRPK2;ADARB2;PTBP1;TUT7;RRAGC;SRSF7;USP39;FUS;TUT4;HNRNPL;TCERG1;ADARB1;TSEN2;DKC1;U2AF2;LSM1;NONO;SNRPA1;HNRNPF;DHX8;DDX23;PRPF18
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.25823304936200525,0.9166753166608627,0.6013888888888889,0.9826159008264843,1.0,25/94,18.69%,TRIB3;BCL2L2;HIPK2;TNFRSF10B;SCN2A;TNFRSF1B;CDKN1A;SELENOK;AIFM1;BAD;DDX3X;CYP1B1;CUL3;RRP8;CHEK2;DDIT3;DIABLO;APAF1;DNAJC10;BNIP3;QRICH1;PRKDC;BAX;GSKIP;HINT1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2227391191388234,-0.9166344396467593,0.6716417910447762,0.8640612118249146,1.0,23/109,15.30%,PTPN13;PLA2G4A;PDGFRB;PLEKHA2;LPGAT1;PIK3C2B;MTMR7;PIK3C3;PIP4P2;PIP5K1A;SACM1L;PIK3R3;VAC14;PLEKHA8;PIP4K2B;MTMR12;PLCB3;PITPNM3;INPPL1;SLC27A1;MTMR9;CDS1;MTMR4
prerank,cellular response to arsenic-containing substance (GO:0071243),0.37490203212812667,0.9163483844531506,0.5766283524904214,0.9827030751683136,1.0,3/15,10.80%,ATF3;ZFAND1;DDX3X
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3752642438867959,0.9162664217439108,0.5783582089552238,0.9820995640379523,1.0,2/14,7.30%,PRKAR1A;SIRT1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.27726558576014615,0.9160138074996538,0.5879629629629629,0.981949794685914,1.0,18/64,17.28%,LIMCH1;ACER2;SLK;CIB1;NEXMIF;PEAK1;MINK1;CCL25;TSC1;HOXA7;NF1;MAP4K4;PTPRA;SEMA3E;PTK2B;CDH13;CLASP1;CORO1C
prerank,chromatin assembly or disassembly (GO:0006333),-0.37279625087414414,-0.915940320242696,0.5692640692640693,0.865093742086463,1.0,7/11,43.70%,TP53;MTA2;NOC2L;CDAN1;HIRIP3;SUV39H2;CHAF1A
prerank,mucosal immune response (GO:0002385),0.37178428136686514,0.9156050283711201,0.5872727272727273,0.9821711452272577,1.0,1/15,2.81%,IFNLR1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3182468557765762,0.9154619120329374,0.5901360544217688,0.9817144991051009,1.0,8/28,18.07%,SORT1;TNFRSF10B;CRADD;DDX3X;DIABLO;DELE1;BAX;GABARAP
prerank,entry into host (GO:0044409),0.39492353589715645,0.9153714609214788,0.5975609756097561,0.9811346836201263,1.0,2/13,3.25%,CBL;SRC
prerank,polarized epithelial cell differentiation (GO:0030859),0.3839535539117682,0.9147344615701913,0.5714285714285714,0.9819588362083865,1.0,4/13,14.05%,RAP2A;MYO9A;OPHN1;ZDHHC7
prerank,positive regulation of viral transcription (GO:0050434),0.32977782451910675,0.9146925257716386,0.5797872340425532,0.9812530738087135,1.0,2/25,2.00%,POLR2J;POLR2B
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3102016800874647,-0.9142348679523952,0.5632183908045977,0.8685310377804266,1.0,6/22,16.59%,TAFA1;TOX;APPL2;KDM1A;SLC16A2;NES
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.329950350682507,0.9132098012282786,0.5641025641025641,0.9843120144818305,1.0,4/25,12.57%,MAP3K7;B2M;WNT5A;CD55
prerank,negative regulation of defense response to virus (GO:0050687),-0.38734052393852975,-0.91311475636428,0.5637860082304527,0.8706367374828726,1.0,2/10,5.90%,PPM1B;ILRUN
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.34358940182376835,-0.9130111841579474,0.5871743486973948,0.870174272592907,1.0,3/15,6.18%,EGFR;TEC;DDR1
prerank,regulation of translation (GO:0006417),0.2379922283339573,0.9126444080422819,0.6432225063938619,0.9849611544803608,1.0,56/173,21.42%,NCBP1;ILF3;PATL2;EIF2A;RPS6KA1;LARP4B;EIF3B;FXR1;RPL5;PAIP2B;GEMIN5;PYM1;CNOT7;EIF4H;TSC1;TSFM;EIF4G2;METAP1;DDX3X;NANOS3;APP;EIF4B;RPS3;YBX1;CNOT1;CAPRIN1;EIF5;RBM4B;UPF3B;LARP4;PRKDC;MTG2;CYFIP1;CNOT10;CALR;NPM1;EIF6;RPL26;RPL10;EIF4G1;MRPL13;DHX36;EIF3E;LARP1;MTIF2;METTL14;EIF4E;EIF1;MTPN;CNOT8;DDX6;TRAP1;EIF2AK4;GLE1;DHX9;GSPT1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3253376334815823,0.9125868832364898,0.5972222222222222,0.9843029926249355,1.0,6/23,11.08%,HDAC7;IFI35;NLRC3;RELA;DDX3X;ADIPOR1
prerank,primary neural tube formation (GO:0014020),-0.2843914936632098,-0.9122507198627768,0.596244131455399,0.8713593735585655,1.0,9/30,17.81%,LMO4;SKI;COBL;MTHFR;MTHFD1;PLXNB2;LRP6;TGFB1;TSC2
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.397119719934274,-0.9109979718270751,0.5944798301486199,0.8737586868378893,1.0,6/10,24.25%,DDX39B;CRY1;THOC5;WDR76;ETAA1;THOC1
prerank,receptor recycling (GO:0001881),-0.3858396079397553,-0.9108610560022736,0.5815450643776824,0.8733559149667564,1.0,8/10,37.76%,ARFGEF2;SORL1;EHD3;LMTK2;NSG1;PHETA1;PLEKHJ1;REP15
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.33605737465283314,-0.9107801095220206,0.5848623853211009,0.8728250656642991,1.0,5/16,17.60%,LRP1;HDAC1;ROCK1;IFNGR1;CYP51A1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.3568045382342408,-0.9107357301884619,0.5550561797752809,0.8722030778401428,1.0,3/13,13.39%,AXL;ZBTB1;IL18
prerank,tube closure (GO:0060606),-0.28184734763211605,-0.9105170398177426,0.5843230403800475,0.8720474671758556,1.0,9/31,17.81%,LMO4;SKI;COBL;MTHFR;MTHFD1;PLXNB2;LRP6;TGFB1;TSC2
prerank,axoneme assembly (GO:0035082),-0.28693646213797386,-0.9103376418305109,0.58679706601467,0.8717674375490171,1.0,19/31,51.72%,DCX;SPAG1;TTLL3;CCDC39;CFAP74;RP1;TOGARAM1;SPAG16;GAS8;RSPH9;CFAP46;DNAAF3;LRGUK;DRC1;SPAG17;JHY;FOXJ1;CCDC65;DNAAF2
prerank,cellular response to starvation (GO:0009267),0.24436886577259248,0.9098499809160353,0.6635761589403973,0.9906783898844469,1.0,38/147,19.05%,MAPK3;RALB;GAS2L1;MAP1LC3B;HSPA8;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;XPR1;CDKN1A;MAPK8;LAMTOR1;SIRT1;ATP6V0E1;NIM1K;PRKAA2;ATG7;LARS1;RRAGC;RRP8;USP33;ATP6V1B2;ATG14;TFEB;GABARAPL1;KPTN;SESN3;PIK3R4;ZFYVE1;DAPL1;BECN1;ATP6V1A;GABARAP;SH3GLB1;LAMP2;NUAK1;SESN1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3629432080954773,-0.9098383633842569,0.6138613861386139,0.8722212634948517,1.0,4/13,13.42%,IGF1;GOLGA2;RAMP1;IL33
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2501691900587727,0.909721237765447,0.6296809986130375,0.9902363371374613,1.0,12/112,11.27%,CIDEA;PTPRJ;PTPRC;TNFAIP3;TIRAP;SYK;NLRC3;WNT5A;CD47;VSIR;NFKBIL1;APP
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.32074225067612006,0.9096714726837466,0.5927272727272728,0.9895465594622123,1.0,8/27,15.68%,GSK3A;FCGR2B;MBOAT1;FBXO7;EFHC2;HOMER1;VPS35;CAMK2G
prerank,regulation of cellular response to heat (GO:1900034),0.26533161508190234,0.9094464571886356,0.6238670694864048,0.9893484650658185,1.0,23/77,19.38%,MAPK3;HSPA8;RPTOR;AKT1S1;EP300;BAG1;NUP54;SIRT1;NUP50;CCAR2;CREBBP;FKBP4;NUP35;NDC1;CAMK2G;ATR;HIKESHI;NUP160;POM121;NUP42;YWHAE;NUP133;HSPB8
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2565934767466626,0.9092361425719212,0.634453781512605,0.9890736893942557,1.0,14/95,13.00%,TNFAIP3;FCGR2B;TIRAP;SBNO2;TNFRSF1B;CYRIB;MAPK8;CARD16;WNT5A;RELA;NFKBIL1;PLAA;TNIP2;CD274
prerank,regulation of cellular component organization (GO:0051128),0.2447330066652396,0.9091707728784387,0.6550802139037433,0.9884583039945116,1.0,20/135,11.90%,CISH;HSPA8;AP2S1;RPTOR;RAB5C;LTBP4;APOE;LAMTOR1;CDK11B;CAMSAP2;HJURP;SNX17;SETD5;WNT5A;TJP1;PARK7;OPHN1;EGLN2;RAB5B;PICALM
prerank,receptor metabolic process (GO:0043112),-0.2549129106444215,-0.908455500350627,0.6629213483146067,0.874919488150217,1.0,15/53,16.79%,LRP1;ARFGEF2;CALCRL;RAB31;GRK3;LGMN;ACKR3;UVRAG;SNX25;RAMP1;GRB2;DNM1;TGFB1;GRK4;EHD3
prerank,water-soluble vitamin metabolic process (GO:0006767),0.26991317182737107,0.9081556962593158,0.6344605475040258,0.9902633804554437,1.0,8/68,8.35%,ALDH1L1;MTR;FLAD1;PANK2;SLC52A2;SLC52A3;MTHFS;SLC2A1
prerank,regulation of cell cycle (GO:0051726),0.23034336708355443,0.9080849148385757,0.7177914110429447,0.9896628007810854,1.0,54/271,16.16%,DYNLT3;FBXL6;MECOM;CKS2;GAS2L1;PTPRC;RPL23;TTLL12;HIPK2;ING4;BIRC2;MYBL2;SOX2;CDKN1A;EP300;RGCC;CDK11B;CHMP1A;PRCC;FBXO5;SIRT1;NOTCH1;CDK4;TSC1;JUND;MDM2;RAD23A;FZD9;TFAP4;TARDBP;CITED2;EIF4G2;SRPK2;NEK7;NANOS3;CTBP1;WDR12;NBN;MAPK12;RRP8;ANKRD17;RPS15A;NEK6;MAP2K6;APC;HCFC1;RNF20;CSNK2A2;WHAMM;APBB2;ADARB1;HPGD;ID2;RBBP4
prerank,axonemal dynein complex assembly (GO:0070286),0.31420706373313256,0.9079324166201802,0.6017094017094017,0.9892344162939054,1.0,2/28,6.62%,CFAP73;DNAL1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.304925129911022,0.9079185694153163,0.5814696485623003,0.9884667762201044,1.0,5/37,8.79%,ERCC3;ERCC4;POLK;POLD3;GTF2H1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2619436625037339,0.9078751429651101,0.6103896103896104,0.9877747993226537,1.0,16/91,11.90%,MAPK3;PTPRC;AP2S1;SRC;RAB5C;STXBP5L;RAB11B;RALA;SYK;SNX17;OPHN1;MBTPS1;SCFD1;RAB5B;SCARB1;PICALM
prerank,regulation of exosomal secretion (GO:1903541),-0.32449645484232875,-0.9078735676728976,0.6111111111111112,0.8756093434026145,1.0,7/19,22.01%,ATP9A;SMPD3;SNF8;TSG101;STAM;VPS4A;HGS
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3469214816588965,0.907791380255531,0.6007194244604317,0.9871862783708433,1.0,5/21,16.34%,MAPK3;CSF1R;MTUS1;AKIRIN1;PTK2B
prerank,regulated exocytosis (GO:0045055),0.2383059949556649,0.9075755329135594,0.6458055925432756,0.9869591683114993,1.0,25/173,11.43%,ABCC4;CDC37L1;SOD1;PECAM1;PPP3CB;MANF;SDF4;NHLRC2;RAB11B;SYNGR2;CYRIB;SELP;SELENOP;F8;ACTN4;VWF;RAB11FIP5;TMED10;LGALS3BP;RAB11FIP2;LYN;GTPBP2;APP;A2M;OLA1
prerank,cellular response to amino acid stimulus (GO:0071230),-0.28594999599265114,-0.9071796714778607,0.570694087403599,0.8767016869934025,1.0,6/33,7.73%,CPEB4;CPEB1;CAPN2;KLHL22;CASTOR2;GLRA1
prerank,regulation of MAPK cascade (GO:0043408),0.24177660970854448,0.9069349518944956,0.6509433962264151,0.9878019015080276,1.0,26/157,12.32%,MAPK3;ZDHHC17;PTPRJ;PTPRC;GREM1;BCAR3;PRDM15;TEK;SOX2;SPRED1;TBX1;RET;LAMTOR1;PAK3;SYK;ATP6AP2;DAG1;MINK1;PHLPP1;LYN;PAK1;P2RX7;FLT1;NBR1;NF1;MAP4K4
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.3548544343925618,-0.9065639733972922,0.5895691609977324,0.8775429695520786,1.0,5/15,10.65%,BMPER;FGF1;JAK1;ITGA5;PKM
prerank,regulation of mitochondrial fission (GO:0090140),-0.3116825577637202,-0.9065409180216365,0.6116279069767442,0.8768801519814179,1.0,5/24,7.72%,MCU;SPIRE1;MAPT;STAT2;FIS1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.29254838230506464,0.9064452504027762,0.603225806451613,0.9882378616277921,1.0,5/41,10.28%,CIDEA;TNFAIP3;NLRC3;VSIR;NFKBIL1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4093604013228518,0.9062681448215528,0.5810526315789474,0.9878563445310784,1.0,2/10,8.36%,RUVBL2;RUVBL1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.21667363843129891,0.9062591017727335,0.7768147345612134,0.9870846169193271,1.0,99/572,16.22%,SOX30;LRRFIP1;ATF3;IRX1;MAZ;DCAF1;DACH1;AASS;ARID5A;KLF8;TRIB3;NR4A2;EZH2;RPL23;EED;JAZF1;GTF2IRD1;DMAP1;KLF2;DNAJA3;MAP2K5;HDAC9;BCL6B;HDAC3;HEY1;NEDD4L;SMARCA2;SOX2;YY1;WFS1;VPS72;UBE2I;IRF2BPL;BEND3;EP300;RPS14;NFX1;CNOT2;PPARD;ZNF205;SFPQ;UXT;SMAD7;SIRT1;BMI1;DRAP1;ZNF3;HEY2;NOTCH1;SAP130;EDNRB;EFNA1;SOX13;RELA;HOXA7;MDM2;TRPS1;ZKSCAN3;CIR1;CITED2;ESR1;THRB;RBPJ;CREBBP;CTBP1;ORC2;NFIC;HDGF;IFI27;N4BP2L2;MZF1;IRF2;CHD3;TGIF1;CTBP2;HDAC5;DDIT3;THRA;HES1;DR1;HCFC1;TRIM27;USP9X;CNOT1;E2F6;TMPRSS6;BACH1;EZH1;NKAP;TCERG1;TAF1;ELK4;BCL6;TRIM33;SMARCA4;ID2;TCF3;ZBTB18;TAF3
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.28053651679674746,-0.9062533751635686,0.6365914786967418,0.8768754965195446,1.0,6/31,12.77%,PACRG;BAG3;RHBDD1;OPTN;HSF1;TM7SF3
prerank,nuclear body organization (GO:0030575),-0.37328489652974606,-0.9062311803506993,0.5756385068762279,0.8762096631305819,1.0,5/12,17.03%,AFF2;PML;USPL1;USP50;HABP4
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3082529747316439,0.9060635532981453,0.6233333333333333,0.986778643221784,1.0,2/33,3.56%,CBL;BCAR3
prerank,response to gamma radiation (GO:0010332),-0.3045904726841609,-0.9058938883594783,0.6122448979591837,0.8763302512331695,1.0,15/24,40.92%,MAP3K20;TP53;HSF1;ATM;KDM1A;CRYAB;TMEM109;YAP1;PRKAA1;MEN1;DCUN1D3;TRIM13;HRAS;TSPYL5;FANCD2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.26458790834249235,0.9055631273309207,0.6230215827338129,0.9872557514955019,1.0,14/75,16.35%,PDCL3;PRKD2;NRAS;PPP1R16B;EGFL7;TEK;SIRT1;PLCG1;WNT5A;PIK3CD;SP1;VEGFC;ANG;CDH13
prerank,response to progesterone (GO:0032570),0.3573813448117075,0.9055500779284272,0.5981481481481481,0.9864929530241902,1.0,3/18,10.39%,SRC;UBE3A;WBP2
prerank,regulation of JUN kinase activity (GO:0043506),0.30857576518499136,0.9051997134503074,0.6066666666666667,0.9866289249428593,1.0,7/33,14.82%,MAP3K11;MAP3K7;MAP3K4;PAK1;RPS3;AIDA;MAP3K10
prerank,barbed-end actin filament capping (GO:0051016),-0.3276151896951095,-0.9049791932953337,0.5827814569536424,0.8770659656759299,1.0,8/18,20.96%,SVIL;GSN;TRIOBP;ADD3;TWF2;ADD2;CAPZB;VILL
prerank,actin filament capping (GO:0051693),-0.3276151896951095,-0.9049791932953337,0.5827814569536424,0.8770659656759299,1.0,8/18,20.96%,SVIL;GSN;TRIOBP;ADD3;TWF2;ADD2;CAPZB;VILL
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.29103183888656536,0.904614288302228,0.6260032102728732,0.9873365127102415,1.0,19/45,20.75%,EIF2A;GEMIN5;YTHDC1;TSC1;METAP1;NANOS3;MATR3;APP;RBM4B;ATG14;TDRD7;LARP4;CYFIP1;RPL10;RC3H1;LARP1;EIF4E;MTPN;GCNT2
prerank,mitotic cell cycle phase transition (GO:0044772),0.23363094297424897,0.9044900666275252,0.6791044776119403,0.9868848897768796,1.0,33/204,14.75%,FBXL6;ALMS1;PLK2;PPP2R2D;HAUS4;HAUS5;CEP41;CLASP2;TUBB;CCNH;DCTN2;CDKN1A;POLE;ODF2;CDK4;WEE1;LATS2;CCNG2;CEP164;ANAPC7;DCTN3;PLCB1;PPP1R12A;CHMP2A;DYNLL1;USP37;CENPJ;E2F3;CUL3;CHEK2;PHF8;RCC1;DYNC1I2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.33793538756800656,0.9043293449831212,0.6114081996434938,0.9865316960278679,1.0,5/21,15.56%,TALDO1;RPIA;GPI;PGLS;PGM2L1
prerank,mitotic nuclear division (GO:0140014),0.26638096240114767,0.904283829988337,0.6554878048780488,0.9858636033651674,1.0,17/71,17.19%,ABRAXAS1;KIF18A;PPP2R2D;CLASP2;CDCA8;MZT1;KIF2A;CHMP2A;BCCIP;MIS12;KIF3B;CHEK2;ARHGEF10;INO80;STAG2;KPNB1;CLASP1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2920877294180833,0.9042819697241749,0.6261682242990654,0.9850801048094586,1.0,9/48,16.27%,PTPRC;TTLL12;RFFL;CARD16;CNOT7;USP18;NLRC5;GAS6;OTUD4
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.28487180219734254,0.9039980978759429,0.6025848142164781,0.9850099753746058,1.0,9/47,13.19%,MAPK3;RAP2A;GREM1;KLHDC10;PHLPP1;SEMA4C;NBR1;MAP4K4;MID1
prerank,intermediate filament organization (GO:0045109),-0.3323190112513867,-0.9038637325469997,0.5974304068522484,0.8791004136824171,1.0,10/17,44.04%,VIM;NEFL;GFAP;BFSP2;DES;PKP2;BFSP1;MTM1;DSP;TCHH
prerank,response to lipid (GO:0033993),0.25087856270302944,0.903862114933965,0.6490984743411928,0.984578007035197,1.0,12/105,12.24%,PCK1;ACER2;TAB2;TIRAP;PAQR8;SELP;PPARD;ERBIN;IFNAR1;ESR1;NOS3;OTUD5
prerank,positive regulation of angiogenesis (GO:0045766),0.25190766578577906,0.9038610533255517,0.6457461645746164,0.9837952340200354,1.0,19/108,12.62%,JMJD8;PDCL3;HIPK2;PRKD2;SMAD1;RAMP2;TEK;RAPGEF3;SIRT1;PLCG1;WNT5A;TJP1;TIE1;CYP1B1;FLT1;NOS3;PIK3CD;SP1;CDH5
prerank,regulation of small molecule metabolic process (GO:0062012),0.31504328583414254,0.9038057405443315,0.6038062283737025,0.983143601644558,1.0,5/28,11.08%,MLYCD;PANK2;APOE;SIRT1;ADIPOR1
prerank,response to thyroid hormone (GO:0097066),0.376970887629395,0.9037571872797577,0.5641025641025641,0.9824719815105831,1.0,3/13,10.75%,GAS2L1;LMO2;THRB
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3366998716180418,0.9034622863193352,0.593128390596745,0.9824462302416961,1.0,4/21,10.81%,STOX1;FBXO5;CDK4;RAD51B
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3954698308124476,0.9034160848947427,0.6038095238095238,0.9817870935375218,1.0,3/11,12.03%,CYCS;UQCC3;UQCRB
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.3331927835584496,-0.9031832610577362,0.591324200913242,0.8800139725069193,1.0,7/17,19.49%,PBX1;MAML1;NOTCH3;SNW1;PLXND1;MAML2;STAT1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2607483306881283,-0.903079509760202,0.6045918367346939,0.8795610483069509,1.0,6/46,6.34%,PLD1;PLA2G4A;AGPAT4;ABHD5;AGPAT5;DGKH
prerank,positive regulation of defense response (GO:0031349),-0.2329765498816136,-0.9024848707211983,0.7214285714285714,0.8802773673859452,1.0,28/89,29.25%,NAPEPLD;OPTN;PLSCR1;IL16;IL17RA;POLR3C;GPR4;IL18;IL33;TNIP1;NPAS2;LRSAM1;GPRC5B;GBP5;RIOK3;AGTR1;SLC15A4;CX3CL1;SETD4;PLA2G7;TLR3;FEM1A;SERPINE1;PDE2A;CCN4;MDK;SNCA;POLR3G
prerank,mononuclear cell differentiation (GO:1903131),0.325729974878928,0.9024498909782048,0.5859106529209622,0.9835558113607207,1.0,3/24,9.31%,MT1G;CSF1R;LYN
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.39010713256144053,-0.9022246181133636,0.6050955414012739,0.8801885547052017,1.0,4/10,16.42%,PARP14;PIBF1;NF2;PTPN2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.3636583544446989,0.9018371180375999,0.5930018416206262,0.9843691129193788,1.0,4/15,10.80%,PTPN18;PTPN12;RHBDF2;RBPJ
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.386186920063627,0.9016076907517234,0.5722326454033771,0.9841339456150822,1.0,3/12,10.75%,GAS2L1;LMO2;THRB
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3289195219453547,0.9011490999954882,0.5961871750433275,0.9844944862658158,1.0,4/24,9.76%,TXNDC12;WFS1;LPCAT3;PARK7
prerank,lipid droplet formation (GO:0140042),0.4017041441043807,0.9002725178228943,0.6161417322834646,0.9859598178777861,1.0,4/10,20.57%,FITM2;AUP1;ZFYVE1;BSCL2
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.34961667569061644,-0.9002402609531502,0.5635964912280702,0.8843632194992188,1.0,3/14,19.89%,OSMR;IL6ST;PTGS2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3758144232226389,0.8999674933425519,0.5985790408525755,0.9859444142427384,1.0,3/14,11.13%,UPP1;UPP2;ERH
prerank,substrate-dependent cell migration (GO:0006929),0.36569666021289604,0.8997881990031115,0.5906542056074766,0.9855654836163422,1.0,5/14,16.83%,PTPRC;ITGA2;OPHN1;VEGFC;CD2AP
prerank,positive chemotaxis (GO:0050918),-0.3269640897630209,-0.8997410846660733,0.6162528216704289,0.8848355637024353,1.0,10/17,32.39%,NRP1;SCG2;TSC2;SEMA5A;MET;CX3CL1;VEGFA;SCRIB;FGF10;FGF7
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.2720331778506732,-0.8991755517094965,0.65,0.88551109647266,1.0,12/36,22.51%,CYLD;TAOK3;EZR;PER1;SIRPA;DLG1;FKTN;DACT1;PTPN22;PINK1;SH3RF2;DUSP1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.36971316086527717,-0.8991540032510686,0.6057494866529775,0.8841177295977491,1.0,2/12,2.87%,EFNA5;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.36971316086527717,-0.8991540032510686,0.6057494866529775,0.8841177295977491,1.0,2/12,2.87%,EFNA5;FBLN1
prerank,regulation of RNA metabolic process (GO:0051252),-0.24815131771446156,-0.8987933333514254,0.6912928759894459,0.8842886078659802,1.0,7/59,4.72%,HNRNPH1;SNRNP70;AHNAK;SON;AFF2;CLK4;MED1
prerank,amino acid import (GO:0043090),-0.3144701725940816,-0.8987813157281441,0.6179775280898876,0.8836055497732472,1.0,6/21,9.28%,SLC1A3;SLC6A13;SLC47A1;SLC6A1;SFXN2;SLC22A4
prerank,skeletal muscle contraction (GO:0003009),0.344036597385234,0.8987733210732323,0.613126079447323,0.9873523484623369,1.0,1/19,3.35%,STAC
prerank,gliogenesis (GO:0042063),-0.3430843629411523,-0.8986798166249036,0.5866666666666667,0.8831414384193109,1.0,4/15,11.85%,NFIB;RELN;CDK6;ANXA1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.40091178375611125,0.8985947066093832,0.5925925925925926,0.9870304051876241,1.0,4/10,17.41%,DCLRE1B;ACD;TERF2IP;DCLRE1C
prerank,histone H3 deacetylation (GO:0070932),0.3646249258783878,0.8985694358590883,0.5940409683426443,0.986310370734931,1.0,4/15,7.30%,HDAC9;HDAC3;SFPQ;SIRT1
prerank,lipid modification (GO:0030258),0.301114683632034,0.8983249556369568,0.6225490196078431,0.9861440487092725,1.0,6/37,8.19%,DGKB;PLPP6;LPCAT3;PLPP1;MBOAT1;SGPP2
prerank,positive regulation of cytokinesis (GO:0032467),-0.2759124928936396,-0.8983120840165049,0.6272040302267002,0.8833163666212289,1.0,3/32,6.06%,SVIL;RHOA;CIT
prerank,positive regulation of DNA recombination (GO:0045911),-0.29218289450837387,-0.898272615709682,0.6277372262773723,0.8826889828297843,1.0,7/27,19.19%,ERCC6;PAXIP1;SHLD1;MMS19;ACTR2;PARP1;RIF1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.31377130440790646,-0.8982495824322241,0.6059907834101382,0.8820286902415349,1.0,3/20,4.28%,AKAP6;AKAP12;ADGRV1
prerank,epithelial cell development (GO:0002064),-0.316773143069214,-0.8978990735101496,0.5783410138248848,0.882164699372877,1.0,2/20,4.42%,WNT5B;RILPL1
prerank,regulation of establishment of protein localization (GO:0070201),-0.34450255342819947,-0.897120400428242,0.6209150326797386,0.8833422422424403,1.0,4/14,15.15%,SPIDR;CEP120;CTSD;CEP295
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.2681837541773173,-0.8967574991626518,0.6365979381443299,0.8835245332127551,1.0,15/36,24.91%,OGT;WAC;FHIT;CAMLG;PSMF1;DDRGK1;TRIM39;MAP1A;USP7;EIF3H;BAG6;UBXN1;PRKCG;NOP53;AQP11
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3423967969959224,0.8966961803293807,0.5970149253731343,0.989409862075643,1.0,4/20,10.76%,TRIB3;PRMT3;ASXL3;ERLIN2
prerank,regulation of protein ubiquitination (GO:0031396),0.2483665904244977,0.8962781029048472,0.6520547945205479,0.9896605121720496,1.0,18/108,11.52%,GSK3A;TNFAIP3;PRMT3;BIRC2;HDAC3;UBE3A;WFS1;PTTG1IP;FOXF2;SMAD7;IVNS1ABP;AXIN1;SPRTN;MYCBP2;PARK7;SPOPL;UBQLN1;RPS3
prerank,positive regulation of cellular component organization (GO:0051130),0.25000891009527926,0.8961969978374434,0.6583679114799447,0.9891003282676921,1.0,26/107,17.79%,SURF4;TAL1;SLF1;ANAPC2;SHANK3;TIRAP;NEDD4L;APOE;ICE1;SYK;RAPGEF3;PARK7;RPS3;BMF;CDH5;FAF1;ATP10A;ASAP1;ADGRL1;LRP4;BNIP3;SLF2;WARS1;INSR;TMEM30A;BAX
prerank,mRNA destabilization (GO:0061157),0.3012272858651131,0.8961491597318788,0.59375,0.9884265662532761,1.0,12/38,20.12%,ZC3H12D;ZFP36L1;TARDBP;TUT7;CNOT1;TUT4;MOV10;FTO;RC3H1;DIS3L2;DHX36;METTL14
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3412021849635004,0.8960339542577993,0.6208695652173913,0.9871872123881845,1.0,3/20,5.63%,BCKDHB;SLC25A44;ACAT1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3412021849635004,0.8960339542577993,0.6208695652173913,0.9871872123881845,1.0,3/20,5.63%,BCKDHB;SLC25A44;ACAT1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.34712958296760943,0.8957535826982064,0.6039076376554174,0.9871445839712835,1.0,5/18,12.83%,RIPOR2;SCAI;RASIP1;ITGA3;CUL3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.24651802019411498,0.8954836310460846,0.6684420772303595,0.9870599478607428,1.0,29/124,16.84%,ROPN1;FAM161B;PTPRM;KIFAP3;MANF;CFAP126;APOE;CNTNAP2;DTNBP1;TMEM108;TTC17;MAP4;ODF2;CSF1R;LGI1;LYN;OPHN1;DOCK7;FRY;APP;TBC1D24;PLEK;SNAPIN;TBC1D23;LRP12;PLEKHA1;BLOC1S5;FRYL;CYFIP1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.2788955832592336,-0.895248676946014,0.6349614395886889,0.8864236919508697,1.0,4/32,8.60%,AKAP6;CEMIP;HTT;TRPC1
prerank,transition metal ion homeostasis (GO:0055076),0.31744138015380435,0.8952230116369694,0.610051993067591,0.9869326902514454,1.0,7/28,15.46%,HMOX2;FBXL5;B2M;PICALM;CUTC;TMPRSS6;BDH2
prerank,cytoplasmic microtubule organization (GO:0031122),0.2747886438630252,0.8950132911729444,0.6240126382306477,0.9866938461775883,1.0,9/54,7.89%,TUBGCP5;SLK;CIB1;DST;CRIPT;CCDC88C;CLIP2;CAMSAP2;TRPV4
prerank,pinocytosis (GO:0006907),0.3902605552134608,0.8949754110879483,0.6204819277108434,0.9860164086677524,1.0,1/10,3.22%,PPT1
prerank,positive regulation of transmembrane transport (GO:0034764),0.37235545139692355,0.8948007097842124,0.5957446808510638,0.9857082755923969,1.0,5/13,17.58%,ACSL5;CA2;P2RX7;BRAF;C2CD5
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.32056834272823276,0.8946882408310003,0.6243739565943238,0.9852180659503473,1.0,6/26,12.77%,TNFAIP3;CARD16;NLRC3;NFKBIL1;TRAF3IP1;MAPKBP1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3563023397814829,0.8942823071091708,0.5988700564971752,0.9854433781652372,1.0,5/17,15.22%,TDG;ACD;SMUG1;MPG;TERF2IP
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.3121665476672389,-0.8939776540361187,0.6320541760722348,0.8888012947726147,1.0,6/21,16.62%,MED13;MED1;MED17;PAXIP1;SETX;JUN
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3388422151415162,0.8936571440865305,0.6,0.9854875830750309,1.0,3/21,8.79%,ERCC3;ERCC4;GTF2H1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3388422151415162,0.8936571440865305,0.6,0.9854875830750309,1.0,3/21,8.79%,ERCC3;ERCC4;GTF2H1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3583317623183662,-0.8934520473757335,0.625250501002004,0.8893364313425809,1.0,5/12,28.88%,PPARA;ABCA5;ABCA1;NR1H2;ITGB3
prerank,long-term memory (GO:0007616),-0.3187850422212312,-0.8930234460630238,0.6153846153846154,0.8896701233684565,1.0,6/19,19.78%,RASGRF1;CAMK4;LDLR;SGK1;NFATC4;SHANK1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.40647274329508576,0.8928511410336878,0.586,0.9867885159521591,1.0,2/10,5.71%,LRCH1;RIPOR2
prerank,regulation of histone modification (GO:0031056),0.37663475632737997,0.8927367586311715,0.5872420262664165,0.9863121095001804,1.0,4/13,9.86%,HPF1;SETD5;PARK7;AKAP8L
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.36003020691837573,0.8925951875525763,0.5860869565217391,0.9858816937722926,1.0,4/16,14.25%,APOE;TERT;SCARB1;GCH1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.33238488580708236,0.892372435535787,0.6121739130434782,0.9856780201755951,1.0,3/22,6.91%,DUSP7;PPP2CA;PPP2CB
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.31990862339599274,-0.8922230373679394,0.6377440347071583,0.890909725837732,1.0,6/19,24.32%,ENPP1;SLC26A2;SLC35B3;PAPSS2;BPNT1;ABHD14B
prerank,positive regulation of cell population proliferation (GO:0008284),0.2167697357917763,0.8917554713594442,0.7877777777777778,0.9864262570794076,1.0,60/423,13.08%,MAZ;ROMO1;EZH2;LEF1;PTPRC;ACER2;TIAM1;RPL23;DERL2;PRKCH;GREM1;CRLF1;STOX1;MCTS1;TBC1D8;NME1;TSHR;SLC35F6;MEIS1;SINHCAF;CIB1;CDKN1A;TBX1;CHTOP;FBXO5;PIM1;SIRT1;BMI1;RNF187;IRS2;NOTCH1;CNOT7;CDK4;WNT5A;TJP1;RELA;CD47;CSF1R;LYN;MDM2;FZD9;PAK1;CLDN5;ESM1;TRPM4;BAD;TERT;SRPK2;RPS9;CD81;RBPJ;RHOG;FLT1;ACER3;CRKL;PRKCI;DHPS;DOT1L;CUL3;CNOT6
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2922301668511291,-0.8917049949811751,0.6164705882352941,0.8914364129839907,1.0,11/26,36.75%,SMAD3;P2RX4;DDAH1;PTGS2;AKT1;HSP90AA1;DDAH2;ASS1;EDN1;TMEM106A;CLU
prerank,negative regulation of defense response (GO:0031348),-0.23225381033969061,-0.8913879768961345,0.7515723270440252,0.8914465452245581,1.0,17/77,17.41%,LRFN5;PPM1B;SIRT2;ILRUN;PRKCD;PPARA;PTGIS;IRAK3;TRAFD1;OTULIN;SIRPA;RORA;SELENOS;CCN3;PTPN2;ENPP3;TNFAIP6
prerank,synaptonemal complex assembly (GO:0007130),-0.33633435130754574,-0.8913825947999746,0.6165919282511211,0.8900319973017892,1.0,12/15,64.39%,BAG6;RAD21;P3H4;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3;SYCP2;RAD21L1;HORMAD1
prerank,synaptonemal complex organization (GO:0070193),-0.33633435130754574,-0.8913825947999746,0.6165919282511211,0.8900319973017892,1.0,12/15,64.39%,BAG6;RAD21;P3H4;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3;SYCP2;RAD21L1;HORMAD1
prerank,response to growth factor (GO:0070848),-0.26931189085510393,-0.8913060328989392,0.6481012658227848,0.8895024507866149,1.0,26/41,36.62%,TGFBR1;TGFBR2;CTNNB1;ACVR1;ACVR1B;RACK1;BMPR1B;TWF2;RPS6KB1;BMPR1A;CPNE3;BMPR2;EMD;AKT1;ERBB2;SFRP1;HDAC6;TBC1D7;NOS1;GATA6;SPHK1;PLK5;MAPK7;EPHA2;URI1;HTRA2
prerank,cellular response to ionizing radiation (GO:0071479),-0.25218156884406073,-0.8910856265516242,0.6526610644257703,0.8892829113407105,1.0,19/47,23.18%,SPIDR;MAPK14;MAP3K20;NIPBL;TNKS1BP1;TP53;HSF1;NUCKS1;RHOB;GRB2;ATM;KDM1A;TANK;CRYAB;BLM;TMEM109;INTS7;YAP1;RAD9B
prerank,calcium ion homeostasis (GO:0055074),-0.22089120956443353,-0.8907929674025784,0.714765100671141,0.8892213495351492,1.0,7/95,3.53%,ANK2;SLC24A3;HTR2C;STIM2;ATP1B1;STIM1;ATP13A5
prerank,long-chain fatty acid import into cell (GO:0044539),-0.38701202291789594,-0.890662257911275,0.6380753138075314,0.8888249724457559,1.0,3/10,18.72%,ACSL1;SLC27A1;RPS6KB1
prerank,regulation of mast cell degranulation (GO:0043304),0.3646934128740348,0.8904736433257199,0.6181818181818182,0.9888140533852403,1.0,3/14,9.52%,SYK;LYN;CD84
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2621748242828205,0.8904271135226647,0.6681350954478708,0.9881701723232682,1.0,11/70,11.88%,GSK3A;BCL2L2;SORT1;TNFRSF10B;TNFRSF1B;CIB1;CRADD;BAD;DDX3X;P2RX7;IFI27
prerank,regulation of myoblast differentiation (GO:0045661),0.3026422464684662,0.8901959847487956,0.6233552631578947,0.9879949373238442,1.0,5/32,9.59%,XKR8;ZFP36L1;RIPOR2;NOTCH1;PLCB1
prerank,autophagy of nucleus (GO:0044804),-0.33168774558306546,-0.8900363149122255,0.6124197002141327,0.8896475216222738,1.0,2/16,5.34%,ULK2;WIPI1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.28133044581627165,-0.8897175656170895,0.6795180722891566,0.8897177601645807,1.0,14/30,27.38%,PARP14;PIBF1;PRKCZ;PRKCD;SRCIN1;SEMA4D;NF2;PTPN2;CADM4;SH3BP5;SH3BP5L;DMTN;SFRP1;INPP5F
prerank,generation of neurons (GO:0048699),0.2301219849935927,0.8893196996939853,0.7065491183879093,0.9893872134779521,1.0,23/190,10.55%,IRX1;EML1;NR4A2;PIN1;HES6;ASTN2;ADGRL3;HEY1;POMGNT2;IER2;MYEF2;FGF13;HEY2;WNT5A;ITM2C;NGRN;PRUNE1;FZD3;CELSR1;OPHN1;ACSL4;DOCK7;NAV1
prerank,regulation of lymphocyte activation (GO:0051249),0.37284198631426974,0.8888905672991136,0.6218809980806143,0.9896775302921859,1.0,12/12,62.74%,PAG1;SIT1;CD4;CD19;LCK;CRTAM;CCL5;THEMIS2;IKZF3;LAT;DCAF15;KAT2A
prerank,protein localization to phagophore assembly site (GO:0034497),-0.372552426674585,-0.8886811614453731,0.6119096509240246,0.8914449010873253,1.0,2/11,5.34%,PACS2;WIPI1
prerank,negative regulation of myotube differentiation (GO:0010832),0.3810041201648086,0.8885268569674674,0.596116504854369,0.9898360014986861,1.0,4/12,13.20%,HDAC3;BDNF;NOTCH1;HDAC5
prerank,N-glycan processing (GO:0006491),-0.31518761683943786,-0.8884388850190729,0.6055045871559633,0.8912591498987551,1.0,4/18,10.81%,MAN1C1;FUT8;GANC;MAN2A2
prerank,protein glycosylation (GO:0006486),-0.2110055710793164,-0.8882509425824403,0.7588652482269503,0.8910394352154076,1.0,37/125,26.24%,MGAT4C;MAN1C1;OGT;PLOD2;B4GALT1;TET1;FUT8;POFUT1;TRAK1;PMM2;ALG9;GOLGA2;PLOD1;FUT10;DPM1;LARGE1;FKTN;B3GALT5;SLC39A8;ST3GAL4;B3GALNT1;MAGT1;ENTPD5;B3GALT1;ST8SIA2;ALG5;ALG10B;C1GALT1C1;ALG11;GFPT1;STT3A;GAL3ST1;SERP1;AQP11;GFPT2;ALG12;KRTCAP2
prerank,positive regulation of ATPase activity (GO:0032781),-0.25572442462339084,-0.8882065528357874,0.6498740554156172,0.8904354081662023,1.0,8/41,9.90%,TOR1AIP2;ATP1B1;TPM1;DNAJC24;ATP1B3;TOR1AIP1;ATP1B2;PLSCR1
prerank,cellular response to hexose stimulus (GO:0071331),0.3273936090580091,0.8877838005402885,0.6106194690265486,0.9908985515703722,1.0,1/23,0.01%,PCK1
prerank,lytic vacuole organization (GO:0080171),0.30255212517999386,0.8877079663879742,0.6366612111292962,0.9903254987420684,1.0,10/32,16.65%,LAMTOR1;TPP1;AKTIP;ZKSCAN3;MBTPS1;CLVS1;SNAPIN;TFEB;HOOK3;VPS18
prerank,erythrocyte differentiation (GO:0030218),0.28717674718894226,0.8874155946887283,0.6623164763458401,0.99031135098738,1.0,7/44,10.57%,TAL1;ABCB10;HIPK2;RPS14;CEBPG;LYN;MFHAS1
prerank,protein localization to condensed chromosome (GO:1903083),0.37377342093953564,0.8872375085398024,0.600375234521576,0.9900037189503156,1.0,3/12,14.59%,CHAMP1;MIS12;MTBP
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.31677658566421163,0.8871525955615432,0.6194690265486725,0.9894410778633759,1.0,2/23,2.03%,CBL;PTPRC
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.23441864148616084,-0.8870306851359708,0.6858789625360231,0.8924526254071169,1.0,40/69,33.06%,RPRD1B;POU2F1;ELL;PHAX;SRRT;GTF2A1;CDK7;CCNT1;POLR2A;SNAPC3;TAF8;INTS10;INTS8;CCNK;INTS11;TAF6;CDK9;GTF2E2;NABP2;GTF2B;INTS7;SNAPC4;NCBP2;TAF13;POLR2K;INTS12;GTF2E1;INTS9;TAF11;POLR2H;INTS3;ZC3H8;NABP1;POLR2G;POLR2F;POU2F2;POLR2C;TAF5;GTF2F1;INTS1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.26465733618796233,-0.8870222708451072,0.6419098143236074,0.8917629907610124,1.0,15/40,26.64%,PID1;MAPT;VCP;AKT2;SPART;SLC25A36;ATP5IF1;SLC25A33;PINK1;BCL2;STOML2;AKT1;BCL2L1;PRDX3;RNF122
prerank,autophagy of mitochondrion (GO:0000422),0.29161951194143776,0.8867957804877391,0.63915857605178,0.9895717223984741,1.0,19/38,22.29%,MAP1LC3B;PHB2;FBXO7;CISD2;ATG7;ATG14;GABARAPL1;ATG13;BNIP3;BECN1;GABARAP;ULK1;WDR45B;ATG2B;FUNDC1;USP30;ATG12;SQSTM1;GABARAPL2
prerank,serine family amino acid metabolic process (GO:0009069),0.34713455761939727,0.8866266861160883,0.5799256505576208,0.9892143502543594,1.0,1/16,0.78%,GCLC
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3260012663994645,0.8861916535851265,0.6199324324324325,0.9895230448917902,1.0,4/24,8.15%,XRCC1;POLK;POLE;POLD3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.3899598158701365,0.8861840949948145,0.6331360946745562,0.9887810709204723,1.0,3/11,15.25%,CXCL12;MERTK;GAS6
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.38238342795767827,-0.8861129868611745,0.6265822784810127,0.8931621357688885,1.0,4/10,11.95%,RARB;SNW1;RXRA;RARA
prerank,aorta morphogenesis (GO:0035909),0.3478535350387146,0.8860660393737699,0.6186291739894552,0.9883212342401104,1.0,5/17,10.80%,HEY1;TBX1;HEY2;ACVRL1;RBPJ
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.36742537966993816,-0.8860223174402929,0.6307053941908713,0.8926643042232854,1.0,3/11,10.09%,CAB39;BIN1;ACTN2
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.2870782036428161,-0.8858409098884077,0.655940594059406,0.8923718412685028,1.0,5/25,11.34%,EGFR;NRP1;DSCAM;THBS1;ILK
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.31133373631760797,0.8852570216209535,0.6312178387650086,0.9895419289630222,1.0,8/28,17.79%,TRIB3;TNFRSF10B;SELENOK;AIFM1;DDIT3;DNAJC10;QRICH1;BAX
prerank,macrophage differentiation (GO:0030225),-0.34696766749164853,-0.8851672769091276,0.6192560175054704,0.8932050313295893,1.0,5/13,22.28%,BMP4;IL31RA;CDC42;PARP1;VEGFA
prerank,phosphatidic acid metabolic process (GO:0046473),-0.25240308092137853,-0.885122817075001,0.6479591836734694,0.8926107000702251,1.0,6/48,6.34%,PLD1;PLA2G4A;AGPAT4;ABHD5;AGPAT5;DGKH
prerank,regulation of response to oxidative stress (GO:1902882),0.38895909356682423,0.8850994597132431,0.6197183098591549,0.9891768972131024,1.0,2/11,10.97%,STOX1;MCTP1
prerank,gene silencing by miRNA (GO:0035195),-0.2744616310953027,-0.884965980607954,0.6522842639593909,0.8923109173398712,1.0,8/32,14.25%,ZC3H7A;PUM1;ZC3H7B;PUM2;AGO3;RBM4;LIMD1;DICER1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.33959511913470236,0.884826058308962,0.6103202846975089,0.9890962566911985,1.0,4/19,11.57%,RPTOR;ICE1;NAB2;POLR3F
prerank,neuron differentiation (GO:0030182),0.2323834147213397,0.8845386926018953,0.7128205128205128,0.98905258170202,1.0,17/165,10.10%,IRX1;ERCC3;NR4A2;PIN1;MANF;PPT1;HS6ST1;IER2;MYEF2;UGCG;EPHA5;WNT5A;ITM2C;NGRN;FZD3;OPHN1;ACSL4
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.24276870022591868,-0.8841762533227783,0.6905444126074498,0.8934677554557037,1.0,16/59,14.49%,TGFBR1;TGFBR2;WNK1;CDC42BPB;ROCK2;CIT;PRKCD;HIPK3;ROCK1;ACVR1;GSK3B;CAMK2D;HIPK1;ACVR1B;WNK3;MAP3K12
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.2902436300070021,0.8837941848830051,0.6093489148580968,0.9901182581961695,1.0,7/38,13.61%,TNFAIP3;RFFL;TNFRSF10B;ICAM1;DDX3X;NOS3;FAIM
prerank,negative regulation of stem cell differentiation (GO:2000737),0.37562218214611,0.8837195021213179,0.6155378486055777,0.9895449844891364,1.0,3/12,13.91%,NOTCH1;N4BP2L2;HES1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.34021133158361355,0.8836462519722742,0.6240875912408759,0.9889670369759473,1.0,5/19,12.43%,PRKCH;F11R;TJP1;CLDN5;IKBKB
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.2595933075363279,0.8836134728040664,0.6741405082212257,0.9882867109352047,1.0,13/75,14.05%,RGS2;SAG;RGS5;GNG7;METAP2;YWHAB;RGS3;PLCB1;METAP1;USP33;PLEK;RPGRIP1L;ZDHHC7
prerank,regulation of chromosome segregation (GO:0051983),0.34813351036240703,0.8833753307232668,0.6233766233766234,0.9881274806282229,1.0,1/16,0.79%,RAD18
prerank,tRNA transport (GO:0051031),0.2937042970786422,0.8832012312220899,0.6179966044142614,0.9877913503421734,1.0,11/35,19.26%,TOMM20;NUP54;NUP50;NUP35;YBX1;SSB;NDC1;NUP160;POM121;NUP42;NUP133
prerank,positive regulation of developmental process (GO:0051094),0.23410795810344473,0.8831834481882381,0.7203274215552524,0.9870892701724466,1.0,23/164,12.16%,LRP8;ANAPC2;RPS6KA1;SHANK3;SRC;CLASP2;APOE;CFL1;SLC6A6;RALA;ARHGEF7;RAPGEF3;FBXO5;SIRT1;DAG1;DDHD1;WNT5A;PLCB1;ZDHHC15;TRPM4;ZBED3;PA2G4;KMT5B
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.2643706172142416,-0.8830889432651816,0.6352040816326531,0.8952930654794287,1.0,17/39,23.22%,RIOK1;RIOK2;NOL11;DDX52;RPS7;RPS16;RPS6;NOM1;UTP4;RPS17;NOB1;RIOK3;NOP14;WDR3;LSM6;METTL17;RRP36
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.25052654635915833,0.8829676380596199,0.6927453769559033,0.9868656762504786,1.0,9/110,6.34%,PTGER2;ADGRE1;ADGRL4;GNAQ;ADGRL3;TSHR;RAMP2;GNB1;RXFP1
prerank,cilium movement (GO:0003341),0.277624670053767,0.8827757980002228,0.6437699680511182,0.9865906429261193,1.0,2/48,2.17%,CFAP73;CABYR
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.30662601291604635,0.8824453198667134,0.6224137931034482,0.9866699262719245,1.0,8/29,18.10%,UTP20;RPS21;RPS14;NGDN;HELB;HEATR1;DCAF13;RPS8
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3887077419170866,0.882226418683307,0.6052141527001862,0.9864643923089644,1.0,3/11,19.80%,SIRT1;HDAC2;XBP1
prerank,acylglycerol homeostasis (GO:0055090),0.3361372584221208,0.8821395409489688,0.6336448598130842,0.9859278487948194,1.0,3/20,11.85%,APOE;PNPLA8;SCARB1
prerank,negative regulation of blood pressure (GO:0045776),0.36930525245689205,0.8819024613209078,0.599250936329588,0.9857507195872159,1.0,2/13,11.15%,PRCP;NOS3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3598225910390658,0.8817558951493039,0.6165137614678899,0.9853640870083478,1.0,4/14,14.27%,RAP2A;MYO9A;OPHN1;PATJ
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2288347808463415,-0.8817308247585451,0.7134328358208956,0.8977861576318501,1.0,34/85,26.74%,DAB2;HECTD1;RNF14;SIRT2;RCHY1;NUPR1;USP13;VCP;CSNK1A1;CSNK1E;GSK3B;TMEM259;DDRGK1;RACK1;RNFT1;RNF19B;KEAP1;DVL1;SOCS5;USP5;STUB1;OSBPL7;PSMC5;DNAJB2;PSMC3;ARIH2;SH3RF2;BAG6;NKD2;NOP53;RNF185;RNF144A;HSPBP1;DDA1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3618498547649777,0.8816871713898694,0.6288848263254113,0.9847931673037889,1.0,1/14,0.61%,IMPDH1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.35694696240790497,0.8816755637979825,0.6435272045028143,0.9840795822001347,1.0,5/16,18.51%,CXCL12;CCAR2;RPS3;TMEM161A;FBH1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.31552676811764657,0.8815946132442669,0.6416382252559727,0.9835146110047689,1.0,6/22,17.30%,UTP20;RPS21;EXOSC9;WDR12;ERI2;URB1
prerank,positive regulation of protein processing (GO:0010954),-0.31484380537907386,-0.881366458971056,0.629976580796253,0.8979053077456791,1.0,4/19,8.97%,GSN;RHBDD1;CLEC3B;CCBE1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.3881958193417827,-0.8811566707917774,0.6075949367088608,0.8976783216047345,1.0,3/10,19.11%,ACTN2;WDR1;SEMA5A
prerank,aspartate family amino acid catabolic process (GO:0009068),0.33885376497863157,0.8806274550959656,0.6285211267605634,0.9851317041581584,1.0,3/19,9.70%,AASS;GOT2;PHYKPL
prerank,regulation of protein localization (GO:0032880),-0.243848065913201,-0.8796960765796048,0.6931818181818182,0.9003543027969992,1.0,17/58,21.08%,MAP2;UFL1;CSNK1E;DVL3;AFDN;RAB9A;DZIP1L;CTSD;DLG1;CAMK1;RACK1;KDM1A;DVL1;PARP1;TRIM5;PPM1F;VPS4A
prerank,homotypic cell-cell adhesion (GO:0034109),-0.2584774393582396,-0.879369834353894,0.6537467700258398,0.900396372898233,1.0,10/39,13.72%,MEGF11;TLN1;FLNA;PLPP3;VCL;PDGFRA;UBASH3B;FN1;ILK;STXBP1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.3781080535897523,0.8786303188142404,0.6160877513711152,0.98933498309065,1.0,2/11,8.56%,NR4A2;WNT5A
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.3987590756593491,0.8785998814952332,0.6060037523452158,0.9886742160284594,1.0,2/10,4.91%,PTPRJ;PTPN12
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2547278339368712,0.878590815147551,0.6915351506456241,0.9879528696413419,1.0,17/80,17.10%,CYCS;RPS6KA1;SRC;MAP2K5;SOX2;CARD16;SYK;SIRT1;USP47;BAD;DDX3X;NOD1;NDUFA13;CD44;GAS6;DELE1;BCAP31
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.2609369178782329,-0.8785707980040133,0.6957605985037406,0.9015244769723608,1.0,9/39,16.40%,MCU;NLGN2;GLUD1;RBP4;AIMP1;TM7SF3;NNAT;PSMD9;TCF7L2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.35664803014135504,-0.878426693257352,0.6575052854122622,0.9011255967766193,1.0,9/13,45.21%,SERTAD2;ARID1B;PADI2;SERTAD1;ZMIZ2;ELOF1;SPI1;CDCA4;CHEK1
prerank,hepaticobiliary system development (GO:0061008),-0.3065060846677705,-0.8782964388483481,0.615866388308977,0.9006802723813777,1.0,4/20,7.76%,TGFBR3;WNT4;COBL;NIPBL
prerank,mitochondrion localization (GO:0051646),-0.30860557179256454,-0.8782227823546671,0.6309794988610479,0.9001291556652973,1.0,13/19,48.70%,TRAK1;NECTIN2;MFN1;ATCAY;MARK2;MSTO1;BRAT1;MUL1;TRAK2;MEF2A;MTM1;TLE6;HAP1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.34379784043938116,-0.8782012023660255,0.64375,0.8994751555417081,1.0,4/13,10.62%,ADCY1;RELN;LGMN;EPHB2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.37746933461762516,-0.8780532047647551,0.609704641350211,0.8991003943857361,1.0,5/10,24.82%,BMP4;SALL1;FZD7;BASP1;PAX2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.23586094711693195,-0.8779230927620606,0.6889460154241646,0.8986801819912972,1.0,15/55,21.94%,TGFBR1;CYLD;NUPR1;PML;GSDME;FIS1;BCL2L11;TP53;TRIM39;RACK1;TRAF2;TRAF7;BCL2;LTBR;TNFSF12
prerank,sensory organ development (GO:0007423),0.2761234613720454,0.8775530331560778,0.6442748091603053,0.9896855007804946,1.0,5/51,4.88%,ATF6;HIPK2;PAX8;SOX2;MEIS1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.3369308764356028,-0.8775105498046598,0.6445396145610278,0.8989081894230772,1.0,3/14,13.39%,PRKCZ;RARA;IL18
prerank,regulation of viral life cycle (GO:1903900),-0.2999425385988212,-0.8775063255850256,0.6434782608695652,0.89821033718713,1.0,8/21,26.14%,HS3ST5;AXL;TSG101;TRIM5;VPS4A;NECTIN2;TRIM62;PPIA
prerank,negative regulation of developmental process (GO:0051093),-0.23252256060513504,-0.8774015899302265,0.7521865889212828,0.8977458738085453,1.0,12/69,9.85%,DCC;NFIB;PTPRS;MAPT;BMP4;ROCK2;ROCK1;FOXC1;ANP32B;BCL11A;HUWE1;CDK6
prerank,peptide catabolic process (GO:0043171),0.3206145364660833,0.8772022704172451,0.6347517730496454,0.989748705184789,1.0,1/23,0.22%,LVRN
prerank,regulation of wound healing (GO:0061041),-0.25894401384598187,-0.8771935115732409,0.7135135135135136,0.8975116054004132,1.0,16/42,31.77%,OCLN;SRSF6;VTN;EPHB2;ANXA1;PTK2;AJAP1;CD109;CADM4;ADRA2A;DMTN;SERPINE1;HBEGF;MYLK;CLDN1;CAV1
prerank,amino acid transmembrane transport (GO:0003333),-0.2564332207463975,-0.8770461694445922,0.6721311475409836,0.8971551194044365,1.0,8/45,11.39%,SLC7A11;SLC6A13;SLC47A1;LRRC8D;SLC25A13;SFXN2;SLC22A4;SLC38A11
prerank,regulation of interleukin-4 production (GO:0032673),0.3270024062061241,0.877043187103206,0.6499162479061976,0.9893674346535752,1.0,4/21,17.21%,LEF1;SYK;DDIT3;SLC7A5
prerank,fat cell differentiation (GO:0045444),-0.24433412832724954,-0.8769047046676789,0.7203389830508474,0.8968018322935364,1.0,18/57,23.88%,WNT5B;OSBPL11;PID1;MED1;PPARGC1A;PER2;AKT2;SMAD6;CLIP3;BBS9;BBS2;TMEM120B;TCF7L2;PRDM16;ATF5;OSBPL8;TMEM120A;C1QTNF3
prerank,global genome nucleotide-excision repair (GO:0070911),0.31357389446887535,0.8767960477740308,0.6311336717428088,0.9892138752489825,1.0,3/26,8.79%,ERCC3;ERCC4;GTF2H1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.3477177579684845,0.8767881690254765,0.6433691756272402,0.9884907384887399,1.0,3/16,9.59%,XKR8;RIPOR2;PLCB1
prerank,tRNA 5'-leader removal (GO:0001682),0.3697752250551018,0.8765198931429795,0.634862385321101,0.9884143465125811,1.0,3/13,14.97%,RPP25L;POP5;SSB
prerank,positive regulation of macroautophagy (GO:0016239),0.2816562919831636,0.8764746957063823,0.667741935483871,0.9877861285131969,1.0,16/48,19.38%,RALB;MAP3K7;EPM2A;SIRT1;FYCO1;PRKAA2;BNIP3L;SCOC;RAB3GAP1;SESN3;BNIP3;PIP4K2A;SH3GLB1;SESN1;LARP1;HSPB8
prerank,amyloid-beta metabolic process (GO:0050435),0.34772825481219793,0.8760221125168087,0.6102003642987249,0.9881408549422929,1.0,2/16,4.44%,PSEN2;MME
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.30005011232416956,-0.8760035215720194,0.6252873563218391,0.8981308842061049,1.0,4/21,10.62%,CGNL1;ARHGAP12;LZTR1;EPHB2
prerank,positive regulation of peptidase activity (GO:0010952),-0.3128398232595995,-0.8757176843902634,0.6417233560090703,0.8981029260515199,1.0,11/20,34.70%,VCP;DDRGK1;RCN3;TANK;PINK1;APH1B;PSME2;PSME3;PSME1;PRELID1;PSENEN
prerank,L-glutamate transmembrane transport (GO:0015813),0.39613984794058155,0.8753264112356717,0.6048387096774194,0.9890835417680294,1.0,3/10,12.49%,SLC1A1;SLC1A2;SLC25A12
prerank,mRNA 3'-end processing (GO:0031124),-0.2209257750386081,-0.8750720742333429,0.7610619469026548,0.8988609710495106,1.0,27/78,24.59%,SRSF5;SRSF11;PABPN1;CASC3;RPRD1B;SRSF2;SRSF6;SRSF1;POLDIP3;DDX39B;CSTF3;CDC73;SYMPK;CSTF2;THOC5;SLU7;PAF1;CDC40;RNPS1;GRSF1;CPSF3;PABPC1;EIF4A3;NCBP2;TUT1;THOC1;RBM8A
prerank,pentose-phosphate shunt (GO:0006098),0.38034715214854237,0.8748479225467369,0.6130268199233716,0.9895012784905474,1.0,3/11,11.57%,TALDO1;RPIA;PGLS
prerank,zinc ion transport (GO:0006829),-0.3085141816512311,-0.8747098903714844,0.6264236902050114,0.898969530320922,1.0,8/21,25.22%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,negative regulation of platelet activation (GO:0010544),0.3533914281051215,0.8746036050228098,0.592391304347826,0.9893565638120162,1.0,6/16,20.78%,PRKG1;APOE;NOS3;CD9;THBD;PDGFB
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3839343056963629,0.8745464708518872,0.6155339805825243,0.9887584628043857,1.0,5/11,20.29%,SRC;ARHGEF7;CD44;CORO1C;ENPP2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.329133942710631,0.874500324337064,0.6283662477558348,0.9881368622581819,1.0,2/19,6.21%,TNFAIP3;CARD16
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3099065083546889,-0.8743997992561039,0.6393805309734514,0.8989383532616841,1.0,3/18,7.23%,PLA2G4A;PTGDS;PTGIS
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.2858191922320903,0.874351525036649,0.6629032258064517,0.9877497594429855,1.0,8/39,13.12%,DYNC1I1;MYO5A;ACTN4;TANC2;RAB1A;MYO1D;PPFIA2;MYO1E
prerank,megakaryocyte differentiation (GO:0030219),0.378810480826565,0.8743306602754879,0.6307129798903108,0.9870621827534749,1.0,1/11,1.49%,TAL1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.217548948873571,-0.8742916070329101,0.740506329113924,0.8984958622822781,1.0,35/96,24.94%,SRSF5;SRSF11;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,cranial nerve development (GO:0021545),-0.36248866215152653,-0.874289944580331,0.6316916488222698,0.8978033990751877,1.0,9/11,59.66%,SALL1;PAX2;TMEM126A;ERBB3;CHRNB2;TFAP2A;POU4F1;TIFAB;ISL1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.21989979091471618,0.8741979899145763,0.772289156626506,0.9866440059170346,1.0,39/291,13.09%,CERS1;MAPK3;ROMO1;BRINP3;INSIG1;TNFAIP3;RUVBL2;ACTB;RPTOR;TIRAP;MTR;SBNO2;ZFP36L1;TSHR;CCDC62;TNFRSF1B;ZFAND1;MAPK8;TBX1;CARD16;RET;GNB1;LAMTOR1;RAPGEF3;WNT5A;RELA;LYN;NFKBIL1;ESR1;P2RX7;RPS3;IP6K2;PLAA;TNIP2;LARS1;CHUK;RRAGC;CD274;NDUFA13
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3206206014812455,-0.8741555353731095,0.6065217391304348,0.8973782349648406,1.0,7/16,29.43%,OGFOD1;IRAK3;UPF1;CLN3;SHFL;HDAC6;MTRF1
prerank,phagosome acidification (GO:0090383),0.309597956099237,0.873799483828447,0.6336283185840708,0.9868749414341091,1.0,4/26,8.45%,ATP6V1D;RAB7A;ATP6V0D1;ATP6V0E1
prerank,positive regulation of reproductive process (GO:2000243),-0.2712405059121287,-0.8736678938164029,0.6658653846153846,0.8977605430144139,1.0,5/31,12.18%,SMURF2;SIRT2;LHFPL2;GLRA1;ACVR1B
prerank,sulfur compound transport (GO:0072348),-0.28533130846771726,-0.873216734536617,0.6718346253229974,0.898072308672432,1.0,14/27,32.12%,SLC6A13;LRRC8D;SLC26A7;SLC13A4;SLC35F3;SLC27A1;SLC26A11;SLC5A6;SLC25A30;SLC19A2;SLC25A11;MGST1;SLC36A1;SLC25A19
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.35603927853172396,-0.8731683701576157,0.618,0.8974985159792925,1.0,6/12,21.49%,PARP6;PARP3;PARP12;PARP1;PARP16;PARP2
prerank,negative regulation of signal transduction (GO:0009968),0.22351704753493315,0.8731166985489198,0.7593052109181141,0.9877791939984928,1.0,21/249,7.11%,SOX30;RGS2;MAZ;SEMA6A;PTPN18;GSK3A;NR4A2;PTPRJ;EZH2;FRZB;PTPRC;TNFAIP3;PTPRE;HEY1;EGFL7;PTPN12;MMRN2;CARD16;YWHAB;PTPRT;BDNF
prerank,regulation of intracellular signal transduction (GO:1902531),0.21214744547793563,0.8725097676354756,0.8232662192393736,0.988483124725896,1.0,75/420,14.47%,RAC2;PRKAR1A;MAPK3;PIN1;TIAM1;VAV3;ARHGEF26;CHN2;HIPK2;MCF2L;RFFL;PRKD2;BIRC2;PPP1R16B;ITSN1;TEK;RAD1;SPRED1;SGMS1;ARAP2;EP300;ARHGAP25;RPL5;ARHGEF6;TRAF5;PAK3;ARHGEF7;TRIO;ATP6AP2;VWF;ARHGEF18;MINK1;GNA12;WNT5A;MYO9A;PHLPP1;TRAF3;RELA;LYN;MDM2;FAM13A;PJA2;TTC5;PAK1;RHOQ;OPHN1;TAF15;TMBIM4;PRKAA2;ING2;ARHGAP39;RHOG;HUS1;A2M;GNAI1;TOP3A;ARHGAP23;MYO9B;MAP4K4;PAK1IP1;TAF4B;NBN;CHD3;TBP;PTPMT1;RRAGC;ING5;DEPDC1B;CHEK2;MAP2K6;NFKBIA;ARHGAP15;CSNK2A2;RMI1;SYDE1
prerank,vascular process in circulatory system (GO:0003018),0.3662376028628126,0.8719459724353493,0.6292947558770343,0.9883589900500477,1.0,3/13,11.15%,GCLC;GCLM;NOS3
prerank,regulation of tube diameter (GO:0035296),0.3662376028628126,0.8719459724353493,0.6292947558770343,0.9883589900500477,1.0,3/13,11.15%,GCLC;GCLM;NOS3
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3012463304080375,0.871942078069439,0.648972602739726,0.9876395283930087,1.0,9/31,21.31%,PTPRC;PHB2;GPI;KMT5B;DNAJB9;TFRC;XBP1;KMT5C;STX4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.3712969508831037,0.8717223475459152,0.6273062730627307,0.9874288788094185,1.0,4/12,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,DNA geometric change (GO:0032392),-0.29115864635142796,-0.8714955511616644,0.642512077294686,0.9005173132390952,1.0,10/24,21.22%,DDX1;RAD50;HNRNPA2B1;MRE11;ANXA1;MCM9;BLM;SUPV3L1;RECQL;RTEL1
prerank,nucleotide catabolic process (GO:0009166),-0.3247982301266068,-0.8713846844895932,0.6341463414634146,0.9000576732248033,1.0,8/16,34.04%,VCP;XDH;DERA;NUDT3;ITPA;GPX1;GDA;NT5C
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.2944841926645201,-0.871134432127576,0.6704545454545454,0.8992432975587916,1.0,6/23,11.56%,DAB2;ZEB2;SMAD4;SNW1;THBS1;STK11
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.2944841926645201,-0.871134432127576,0.6704545454545454,0.8992432975587916,1.0,6/23,11.56%,DAB2;ZEB2;SMAD4;SNW1;THBS1;STK11
prerank,purine-containing compound salvage (GO:0043101),-0.3484778326945135,-0.8709338033481028,0.6236559139784946,0.8989893620510763,1.0,3/12,9.95%,AMPD3;DGUOK;ADK
prerank,histone H4-K16 acetylation (GO:0043984),0.33599353450288716,0.8709085212509787,0.6361940298507462,0.9886022227118255,1.0,7/19,18.81%,JADE3;ING4;KANSL2;KANSL3;HCFC1;MSL2;MSL3
prerank,response to interferon-beta (GO:0035456),0.32570762723933766,0.8704649919359957,0.6488970588235294,0.9889008571448377,1.0,5/22,13.09%,IFITM2;XAF1;IFITM3;IFITM1;NDUFA13
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.29826750722233053,0.870341110409167,0.6454248366013072,0.9884387798523483,1.0,9/29,16.09%,LEF1;EP300;RUVBL1;TERT;CREBBP;TLE4;TRRAP;SMARCA4;TCF7L1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3310291673652043,0.8702146287251832,0.6451612903225806,0.9879968294540271,1.0,3/20,15.93%,TSPO;STARD3NL;STARD3
prerank,Golgi inheritance (GO:0048313),-0.3608551413535217,-0.8701804189881202,0.6614481409001957,0.9000403505205041,1.0,2/11,11.61%,GOLGA2;STK25
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3702918172903418,0.8701092638793809,0.6195028680688337,0.9875133181720875,1.0,4/13,16.55%,PIK3AP1;EPG5;TNIP2;PIK3R4
prerank,ether lipid metabolic process (GO:0046485),0.36089689027412886,0.8698448642060341,0.6136363636363636,0.9873753332554009,1.0,5/14,14.30%,PLAAT3;PEDS1;PEX7;AGPS;GNPAT
prerank,microtubule polymerization (GO:0046785),-0.2827661272486174,-0.8697611568195959,0.6515513126491647,0.9003093436136471,1.0,10/29,13.33%,HDGFL3;MAPT;TUBGCP4;CCDC57;GOLGA2;AKAP9;SLAIN2;CKAP5;TUBGCP6;RANBP9
prerank,regulation of dendritic spine development (GO:0060998),0.331175079073248,0.869536831429454,0.6469565217391304,0.9873747065756548,1.0,5/19,15.57%,SHANK3;APOE;TANC2;PPFIA2;ARF6
prerank,interstrand cross-link repair (GO:0036297),-0.2411980796427122,-0.8688367862103697,0.7374301675977654,0.9016816019728263,1.0,34/53,45.05%,VCP;RNF168;RPA1;UBC;RNF8;NUCKS1;MCM9;FANCE;FAN1;USP1;ATRIP;SLX4;POLN;DCLRE1A;FAAP100;MSH6;FANCC;ERCC1;MUS81;FANCI;FAAP20;RPA3;XPA;FANCB;UBA52;FANCD2;FANCG;NEIL3;MCM8;RPA2;EXO5;RAD51;RAD51AP2;CENPX
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.22261512551079143,-0.8687632474787748,0.779874213836478,0.9011437091724969,1.0,18/76,21.70%,NTRK3;NRP1;DYNC1H1;FER;CTTN;BIN1;SYNPO2;BAIAP2L1;PFDN2;FCHSD2;WDR1;CDC42EP5;NES;CDC42EP1;CDC42;SEMA5A;CX3CL1;PFN2
prerank,renal absorption (GO:0070293),-0.37364881640725955,-0.8687560058814076,0.6441351888667992,0.9004722521084624,1.0,3/10,10.22%,GSN;WNK4;SGK1
prerank,response to steroid hormone (GO:0048545),0.2977526041483848,0.8683215150829497,0.6568144499178982,0.9894954142563008,1.0,3/31,5.00%,SOX30;PAQR8;UBE3A
prerank,cellular amide metabolic process (GO:0043603),0.24255029288011437,0.8682396244321318,0.7018544935805991,0.9889414078889858,1.0,10/102,6.76%,ALDH1L1;MLYCD;PPP2CA;PANK2;MME;PLAAT3;DBI;MTHFS;GPAT4;PLPP1
prerank,response to purine-containing compound (GO:0014074),-0.3255210031496588,-0.8681580785366384,0.6244635193133047,0.9011082934067812,1.0,9/17,40.76%,P2RX4;ABCC9;STAT1;DGKQ;TRPC3;P2RY1;TRPM2;P2RY6;VGF
prerank,histone H4 deacetylation (GO:0070933),-0.37101798928898044,-0.867708560552637,0.6544715447154471,0.901363320604666,1.0,3/10,4.58%,HDAC4;HDAC1;SIRT2
prerank,spliceosomal complex assembly (GO:0000245),0.2760847415954729,0.8676874300646945,0.6639072847682119,0.9895351104806378,1.0,8/46,10.59%,SNRPD2;NCBP1;SNRPD1;SF1;SRSF10;YTHDC1;SF3A1;SRPK2
prerank,regulation of organelle assembly (GO:1902115),0.2517107873249023,0.8675272107290328,0.7289719626168224,0.9891553303079386,1.0,14/73,13.25%,ALMS1;PLK2;TBC1D8;VPS11;TBC1D10B;USP6NL;PIKFYVE;TBC1D12;IFT140;CENPJ;ADPRH;TBC1D24;TBC1D14;RABGAP1
prerank,positive regulation of calcium ion import (GO:0090280),0.37657160349004326,0.8675221044611039,0.6546112115732369,0.9884394754746836,1.0,1/12,2.58%,CXCL12
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3070704047336891,0.8674653083028083,0.6847635726795096,0.9878385741050739,1.0,5/29,11.08%,PPP2CA;SPRED1;SMAD7;EFNA1;ADIPOR1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.27717090996079746,0.8670692885966261,0.6666666666666666,0.9880313072521125,1.0,9/44,13.79%,EBP;INSIG1;HMGCR;SC5D;OSBPL1A;PARK7;HSD17B4;ACOT8;OSBPL2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3432224860954376,-0.8670687031551755,0.6225596529284165,0.9020833465602027,1.0,3/13,13.36%,CYFIP2;LGMN;TBC1D10A
prerank,response to glucose (GO:0009749),0.2750702372127355,0.8669555390132632,0.6598101265822784,0.9875692663960011,1.0,6/46,11.50%,PCK1;SELENOT;IRS2;EIF2B3;PRKAA2;ZBED3
prerank,regulation of RNA splicing (GO:0043484),0.25986035092281445,0.8668457611249079,0.7103559870550162,0.9870932787830763,1.0,11/69,7.96%,KHDRBS3;RBM22;HNRNPH2;SF1;QKI;HNRNPK;FAM50A;SRSF10;RBM20;RPS26;YTHDC1
prerank,response to muramyl dipeptide (GO:0032495),-0.35409683586653434,-0.8664689051464407,0.6326530612244898,0.9027166993800289,1.0,4/12,18.85%,VIM;TRIM41;PTPN22;CHMP5
prerank,cellular response to purine-containing compound (GO:0071415),-0.38396612770706506,-0.8663539078517535,0.6443089430894309,0.902291899180153,1.0,6/10,41.43%,RYR3;P2RY1;GSTM2;TRPM2;P2RY6;CASQ2
prerank,protein-containing complex subunit organization (GO:0043933),0.23787612017136667,0.8662357714328686,0.7194767441860465,0.9878035165449605,1.0,27/109,17.73%,SH3BGR;CAPZA2;KIFAP3;SKAP2;NDUFAF1;KPNA3;NUP54;MAGI1;GEMIN5;SLC2A1;MDM2;TFAP4;CREBBP;ELOB;PICALM;NUP35;APC;HES1;PARD3;NDC1;DNM1L;PTK2B;TUBGCP2;LIN7A;CD2AP;CAPZA1;ST13
prerank,endocrine system development (GO:0035270),-0.2956853509133945,-0.8655541862162321,0.6658823529411765,0.9033513390750455,1.0,5/21,9.91%,GLI2;TGFBR1;WNT4;DKK3;SALL1
prerank,microtubule nucleation (GO:0007020),-0.3050721035632146,-0.8653955613464591,0.6593406593406593,0.9030025936946323,1.0,7/20,13.33%,TUBGCP4;CCDC57;GOLGA2;AKAP9;SLAIN2;TUBGCP6;RANBP9
prerank,positive regulation of neuron death (GO:1901216),-0.2486889573523591,-0.8651413145864699,0.7096774193548387,0.9028629207722884,1.0,9/46,10.96%,GRIN2B;EFNB2;MAPT;CTNNB1;EPHA7;NUPR1;BACE1;GSK3B;MAP3K5
prerank,regulation of multicellular organism growth (GO:0040014),0.34289431568559925,0.8648273242161975,0.6368515205724508,0.9903617234574689,1.0,3/15,11.27%,SOD1;PPIB;APP
prerank,regulation of neuron death (GO:1901214),0.24808627941953304,0.8646602819495259,0.7195301027900147,0.9900114105653307,1.0,14/82,11.93%,SNCG;EIF2S1;FCGR2B;SIGMAR1;FYN;TNFRSF1B;AKT1S1;WNT5A;TSC1;PARK7;NAE1;EGLN2;PICALM;PRNP
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2864604812344929,0.8646567414454303,0.6597774244833068,0.9892977804271103,1.0,5/39,8.79%,ERCC3;ERCC4;POLK;POLD3;GTF2H1
prerank,RNA export from nucleus (GO:0006405),-0.21277102115377156,-0.8644944937809588,0.7645161290322581,0.9036430990529863,1.0,36/100,24.94%,SRSF5;SRSF11;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;HNRNPA1;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3735409477029822,-0.8644069397352706,0.642578125,0.9031417708743511,1.0,4/10,31.59%,PLA2G4A;PLA2G6;PLA2G7;PLA2G15
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3183873628070153,0.8643436988227889,0.656084656084656,0.9893196001487669,1.0,6/22,12.41%,GSK3A;EFNA1;RELA;LYN;PICALM;SP1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.36313978850303297,0.8639673116707584,0.6411214953271028,0.9895260151230497,1.0,5/13,17.79%,BAD;BMF;BNIP3L;BNIP3;BAX
prerank,response to sterol (GO:0036314),-0.3619660073998847,-0.8639141555690705,0.6659751037344398,0.9035147372141329,1.0,4/11,16.22%,TGFBR1;TGFBR2;RORA;TGFB1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.24911866576379144,0.863735160290116,0.696969696969697,0.989361160585853,1.0,18/87,14.49%,CBL;MAP3K7;LRRC32;SRC;SMAD1;TGFBRAP1;F11R;SMAD7;SIRT1;ARHGEF18;ACVRL1;CLDN5;NLK;USP15;ZFYVE9;CDH5;USP9X;PARD3
prerank,regulation of myotube differentiation (GO:0010830),0.312409951528764,0.8636881045922017,0.6763698630136986,0.9887491950785334,1.0,5/24,8.04%,HDAC9;HDAC3;ATP11A;BDNF;NOTCH1
prerank,glycosphingolipid metabolic process (GO:0006687),0.2815972478180913,0.8635940993834932,0.6710743801652893,0.9882609349273379,1.0,6/42,6.57%,GLB1;SMPD4;ST6GALNAC3;ESYT2;UGCG;ST8SIA1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.32642369057500464,0.8635750724057529,0.6460980036297641,0.9875892923405475,1.0,4/22,6.40%,PFN1;CYRIB;KANK3;SSH2
prerank,glycolytic process (GO:0006096),0.3088622511631676,0.8634578179993683,0.6797945205479452,0.9871131309838477,1.0,3/28,10.85%,ENO4;TPI1;GPI
prerank,positive regulation of transport (GO:0051050),0.24793614927650753,0.8633569195890521,0.6920863309352518,0.9866297532951089,1.0,10/85,9.09%,GSK3A;FCGR2B;ACTB;CAMK1D;NEDD4L;LMAN2;APOE;ZNF205;MERTK;CD47
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.2514548397695222,0.86330401702285,0.7198838896952104,0.986035149122358,1.0,11/77,10.80%,MAZ;NR4A2;BCL2L2;SRC;SLC35F6;BDNF;ITGA6;RELA;FZD9;PARK7;DDX3X
prerank,lipid phosphorylation (GO:0046834),-0.3726887384450144,-0.8632467067618571,0.6431535269709544,0.9042548419697746,1.0,2/10,6.34%,DGKI;DGKH
prerank,positive regulation of protein sumoylation (GO:0033235),0.38645038398375586,0.8626259976244909,0.6673040152963671,0.9869092136199049,1.0,3/10,11.39%,SAE1;UBA2;PIAS1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.2827322743229359,-0.8623367350316509,0.6762589928057554,0.9055715749955116,1.0,7/27,17.82%,FGF12;SNTA1;PTPN3;CAMK2D;DLG1;COMMD1;GPD1L
prerank,cell cycle G2/M phase transition (GO:0044839),0.23379273090981398,0.8622504207305562,0.7333333333333333,0.9870049209733434,1.0,17/130,10.48%,FBXL6;ALMS1;HAUS4;HAUS5;CEP41;TUBB;CCNH;DCTN2;CDKN1A;ODF2;WEE1;CEP164;DCTN3;PLCB1;AKAP8L;PPP1R12A;DYNLL1
prerank,mRNA transport (GO:0051028),-0.21109880814591628,-0.8621416514435241,0.7603833865814696,0.9053002010139896,1.0,36/101,24.94%,SRSF5;SRSF11;CASC3;SRSF2;KIF5C;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,cellular biogenic amine catabolic process (GO:0042402),0.38851389157062133,0.8621038442624454,0.6377358490566037,0.9866393011743724,1.0,2/10,7.90%,SMOX;SLC44A1
prerank,response to muscle stretch (GO:0035994),-0.32626299945125026,-0.8620330576307335,0.6806167400881057,0.9048560896995627,1.0,2/15,3.91%,GSN;CTNNB1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.36339322986880085,-0.861842368134786,0.6639175257731958,0.9045676812427442,1.0,1/11,4.75%,P2RX4
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.37020165254292947,0.8616916540330535,0.6471734892787524,0.9868387905975659,1.0,2/12,9.31%,PTPRC;LYN
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.20172130571097205,-0.8613757343207089,0.8455598455598455,0.9048505770926715,1.0,12/140,8.11%,LPAR1;HTR2C;CACNA1C;ADCY5;DLG4;PLCE1;P2RX4;PDGFRA;EDNRA;ADRA1B;FIS1;CCR9
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.34149375619688194,0.8613647862569613,0.6397748592870544,0.9868897325029831,1.0,5/16,18.68%,MLYCD;SIRT1;ADIPOR1;FOXK2;PDK3
prerank,regulation of microtubule depolymerization (GO:0031114),0.3119708723428855,0.861131049809687,0.657608695652174,0.9867485267962076,1.0,6/25,7.89%,CLASP2;MAP1S;CIB1;FGF13;CAMSAP2;TRPV4
prerank,response to endoplasmic reticulum stress (GO:0034976),0.24183710018697754,0.8606735188551033,0.7254335260115607,0.9871053784406248,1.0,25/107,18.48%,ATF3;TRIB3;ATF6;EIF2S1;GORASP2;UFC1;ATP2A2;TNFRSF10B;WFS1;SELENOK;MBTPS1;AIFM1;HYOU1;UBQLN1;DDIT3;ERP44;DNAJC10;QRICH1;RASGRF2;TMTC3;BCAP31;BAX;DNAJB9;CCDC47;PDIA4
prerank,negative regulation of neuron differentiation (GO:0045665),-0.29937637139869927,-0.8605951969364791,0.6636363636363637,0.9058112403920751,1.0,4/22,10.56%,CNTN4;BMP7;MED1;GSK3B
prerank,carboxylic acid metabolic process (GO:0019752),-0.2654219173116852,-0.8605809757777152,0.673469387755102,0.9051612761767385,1.0,5/33,7.23%,PLA2G4A;DDO;GLUD1;CYB5A;PTGIS
prerank,cortical cytoskeleton organization (GO:0030865),-0.2527454933371666,-0.8604892397756521,0.7017994858611826,0.9046856420906928,1.0,12/41,12.92%,EPB41L3;RHOA;ROCK2;ROCK1;NLGN1;EZR;RND3;RHOBTB2;FHOD1;RHOB;RHOBTB1;DLG1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.30170760669092045,-0.8603542644506192,0.6561743341404358,0.9042858151167154,1.0,10/20,24.29%,BICD1;MGRN1;GRK3;RNF157;GPRASP1;CRY1;STMN1;MET;GRK2;APLP1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.32521856189668075,0.8600845931067961,0.6547008547008547,0.9877647957299738,1.0,6/20,17.01%,LCP1;RHOQ;IKBKB;PLEK;ARF6;STRIP1
prerank,myelination in peripheral nervous system (GO:0022011),0.34997278456101244,0.8600499871236582,0.6463878326996197,0.9871307065920659,1.0,5/13,14.63%,SOD1;NF1;ADGRG6;PARD3;ARHGEF10
prerank,positive regulation of double-strand break repair (GO:2000781),-0.2587532346855263,-0.8598271448822247,0.7190721649484536,0.9047622614691371,1.0,13/39,21.11%,SPIRE1;SPIDR;FMN2;ERCC6;SHLD1;MGMT;PARP3;MMS19;ACTR2;PARP1;RIF1;SMCHD1;DTX3L
prerank,positive regulation of lipid transport (GO:0032370),0.3741309069040927,0.8597816664820972,0.6704980842911877,0.9870439873244109,1.0,2/12,5.62%,APOE;DBI
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.36780196901829665,0.8597193924116713,0.634469696969697,0.9864825246042004,1.0,3/12,15.93%,TSPO;STARD3NL;STARD3
prerank,cellular response to DNA damage stimulus (GO:0006974),0.21375465006143285,0.859458370060612,0.8323563892145369,0.9863846462045515,1.0,60/336,15.85%,ERCC3;ZRANB3;RAD18;MAPK3;TRIM28;SLF1;ACER2;VAV3;PNKP;BCL2L2;UBA1;ERCC4;RAD1;RBBP6;YY1;TNFRSF1B;HPF1;CIB1;POLK;CDKN1A;APLF;SIRT1;USP47;AKTIP;GTF2H1;SPRTN;POLA1;LYN;RFWD3;MSH3;PAK1;PARK7;ALKBH7;SUSD6;CHCHD6;RAD51B;APTX;HUS1;RPS3;KMT5B;PWWP3A;NBN;MAPK12;DOT1L;HELB;TRRAP;CHEK2;DDIT3;TLK2;MAP2K6;APC;FANCL;UBA6;BACH1;INO80;UBQLN4;DYRK2;TAF1;BCL6;ATR
prerank,iron ion transport (GO:0006826),-0.2441010277409474,-0.859355022031992,0.7329700272479565,0.9051187092822455,1.0,9/47,12.83%,CP;ATP6V1E1;ATP6V0B;SLC39A14;SCARA5;TCIRG1;ATP6V0A4;STEAP3;ATP6V0C
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3591835451282014,0.859148564264488,0.6311926605504588,0.986421272015361,1.0,2/13,5.79%,ALG6;ALG8
prerank,adherens junction organization (GO:0034332),0.268614557428911,0.8589502103276893,0.6793650793650794,0.9861612836839225,1.0,7/48,8.66%,CADM1;ACTB;CDH2;RAMP2;CDH12;SMAD7;TJP1
prerank,sodium-independent organic anion transport (GO:0043252),-0.3721951241340027,-0.8588454431610639,0.6449579831932774,0.9055410272322858,1.0,1/10,0.94%,SLCO3A1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.2923923792104111,-0.8587280300300426,0.7049180327868853,0.9051119841912998,1.0,8/23,16.22%,PRKAG2;BMP7;CEMIP;CAB39;TNKS1BP1;WNK3;UBE2K;TGFB1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.27076520320563335,-0.8583001363323289,0.6771084337349398,0.9053806569891247,1.0,6/28,10.62%,ADCY1;RELN;YTHDF1;LGMN;GSK3B;EPHB2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.30010438602496065,-0.8580661736022326,0.6866666666666666,0.9051987186374428,1.0,7/20,20.30%,OSR1;HECW1;CAB39;ACTN2;CAMK2D;HECW2;NEDD4
prerank,receptor internalization (GO:0031623),0.2788251863072091,0.8576799549930358,0.6825885978428351,0.9883721128797027,1.0,9/44,14.38%,SAG;DNM3;RAMP2;SYK;SNX1;CD81;PICALM;LDLRAP1;AP2M1
prerank,carbohydrate derivative transport (GO:1901264),0.33244194479149786,0.8574909941650202,0.6379310344827587,0.9881006866966029,1.0,7/18,20.16%,SLC10A7;SLC29A1;SCARB1;NPC2;PLTP;ABCG1;SLC15A2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.2888109283414599,0.8570179084383445,0.6793388429752066,0.9884663758613752,1.0,7/33,13.49%,EZH2;RPTOR;PHB2;RGCC;PLCB1;DDX3X;ANKRD17
prerank,protein mannosylation (GO:0035268),0.3240223363386243,0.8569981396723849,0.6690017513134852,0.9878183165912473,1.0,5/22,12.45%,TMTC2;POMGNT2;DPY19L4;DPY19L1;CRPPA
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3228378101094138,-0.8569779294133288,0.6441048034934498,0.9067842784182222,1.0,8/16,21.76%,BMP7;RREB1;NAPEPLD;VSTM2A;SIX1;PTGS2;TFE3;FLCN
prerank,regulation of response to stress (GO:0080134),0.38183345897824367,0.8567521566594827,0.6477495107632094,0.9876719137019038,1.0,3/10,18.94%,STOX1;CORO2B;EIF4G1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.2827635442755815,-0.8566754610855556,0.6997635933806147,0.9067033416505987,1.0,9/25,33.24%,SMAD3;P2RX4;DDAH1;PTGS2;AKT1;HSP90AA1;DDAH2;ASS1;EDN1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.2920534637660055,0.8566723909657341,0.6709886547811994,0.9871415162848762,1.0,8/33,11.12%,GPAM;EP300;AXIN1;PKN1;PARK7;RNF6;ESR1;CARM1
prerank,vesicle transport along microtubule (GO:0047496),0.31702946143746,0.8562807768209797,0.6869409660107334,0.9873103418086688,1.0,6/23,13.20%,DYNC1I1;KIFAP3;FYCO1;RAB1A;KIF13A;KIF3B
prerank,positive regulation of myelination (GO:0031643),0.3679201921788503,0.8561874566021765,0.6373831775700934,0.9868321555115012,1.0,3/11,14.49%,TNFRSF1B;TENM4;PARD3
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3105405674832972,0.8560135139175151,0.6590909090909091,0.9865107233664304,1.0,7/24,17.08%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;LZTFL1;PPP2R5A
prerank,response to nutrient levels (GO:0031667),0.3419472321399244,0.8554604941583523,0.6853146853146853,0.9870167998000166,1.0,4/17,18.94%,RPTOR;PRKAA2;ULK1;EIF4G1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.332098334328593,-0.8553281265727958,0.6718403547671841,0.9088727440055848,1.0,8/15,45.88%,IL17RA;GBP5;APPL1;IL17D;TICAM1;NOD2;MYD88;TLR4
prerank,substantia nigra development (GO:0021762),-0.25378550007576595,-0.8549733165989548,0.6956521739130435,0.90893772670042,1.0,8/37,10.06%,PLP1;MBP;RHOA;SIRT2;GLUD1;NDRG2;NDUFS3;CKB
prerank,negative regulation of lipid storage (GO:0010888),-0.30652545382491814,-0.8541910735300459,0.6832579185520362,0.9099098156267369,1.0,8/19,28.88%,ABHD5;PPARA;ABCA1;TTC39B;PTPN2;OSBPL8;NR1H2;ITGB3
prerank,erythrocyte development (GO:0048821),0.389230178013937,0.8541726827509566,0.6308851224105462,0.9892235832786752,1.0,1/10,1.61%,ABCB10
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.3628183142765827,-0.8538835109472948,0.6302521008403361,0.9091988480341806,1.0,5/10,17.83%,AP2B1;AP2A2;AP2A1;VLDLR;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.3628183142765827,-0.8538835109472948,0.6302521008403361,0.9091988480341806,1.0,5/10,17.83%,AP2B1;AP2A2;AP2A1;VLDLR;MYLIP
prerank,protein autophosphorylation (GO:0046777),0.2247444239294967,0.8537465125609325,0.7850340136054422,0.9894381497035127,1.0,18/157,9.75%,PRKX;MAP3K11;MAPK3;OXSR1;SRC;MEX3B;PRKD2;MAP3K9;TEK;SMG1;SLK;PIM1;PIKFYVE;PEAK1;MINK1;CSF1R;LYN;PAK1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.33206906535504166,0.853598548484379,0.6649122807017543,0.9890589524691361,1.0,3/18,9.29%,POLE;POLD3;POLA1
prerank,regulation of monooxygenase activity (GO:0032768),-0.2895010631140912,-0.8535107305709392,0.6932084309133489,0.9093013903647542,1.0,12/23,31.77%,EGFR;WASL;ZDHHC21;DDAH1;NOSIP;AKT1;HSP90AA1;DDAH2;CYGB;SNCA;POR;CAV1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.32009229059998234,-0.853388789384897,0.6517857142857143,0.9088823437671851,1.0,1/16,0.30%,NOTCH2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.27397961628776557,-0.8532986260766886,0.7183770883054893,0.908400687767256,1.0,10/29,25.93%,DDO;GSTZ1;ALDH4A1;ACADSB;PRODH;KYAT1;FAH;SARDH;HOGA1;MTRR
prerank,cyclooxygenase pathway (GO:0019371),-0.36557981772471004,-0.8532456846732522,0.653276955602537,0.90783549994587,1.0,6/10,27.58%,PTGDS;PTGIS;PTGES;PTGS2;TBXAS1;HPGDS
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.3348611702557331,-0.8532104606462292,0.643312101910828,0.90723663674567,1.0,5/13,16.95%,BMP7;MED1;BMP4;NR3C2;NR3C1
prerank,response to iron ion (GO:0010039),-0.3506793582620217,-0.8531972022787682,0.6693711967545639,0.9065907134665977,1.0,1/12,0.22%,BMP6
prerank,regulation of developmental growth (GO:0048638),-0.27387455443694203,-0.8529176944111682,0.6859296482412061,0.9064946704300307,1.0,6/29,10.56%,IGF1;NRCAM;GHR;CTTN;NIPBL;GSK3B
prerank,regulation of leukocyte activation (GO:0002694),0.3573527100922409,0.8527056676176141,0.6382189239332097,0.9904052007038525,1.0,3/14,10.57%,LYN;PJA2;MFHAS1
prerank,nuclear transport (GO:0051169),0.3388309106155471,0.8523171163876438,0.6785046728971963,0.9905623706333566,1.0,4/16,12.89%,BANF1;NXT1;RSRC1;XPO1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2711879756327604,0.852307674769364,0.7190635451505016,0.9898822513812847,1.0,5/43,6.54%,CBL;PTPRJ;RAB7A;EPS15L1;ARHGEF7
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.38453539794295943,0.8522363017438539,0.6328413284132841,0.98933639033707,1.0,2/10,9.50%,UPP1;UPP2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.25843521522622903,0.8517335579095913,0.7156105100463679,0.9897919146081716,1.0,16/65,13.26%,HIPK2;ZFP36L1;SCN2A;CARD16;RGCC;SIRT1;TSC1;MDM2;BAD;TERT;HYOU1;HP1BP3;UBQLN1;EGLN2;BNIP3L;EPAS1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3042795317104062,0.8515682016893191,0.6523972602739726,0.9894758066990545,1.0,9/26,17.57%,BEND3;TET3;SETD5;SETD3;SETD1B;KMT5B;ETFBKMT;SETD2;TET2
prerank,nucleosome disassembly (GO:0006337),-0.3307439571396071,-0.8515355431897201,0.6666666666666666,0.9081345086449559,1.0,4/14,22.04%,SET;SMARCD3;SMARCD2;SMARCC1
prerank,chromatin disassembly (GO:0031498),-0.3307439571396071,-0.8515355431897201,0.6666666666666666,0.9081345086449559,1.0,4/14,22.04%,SET;SMARCD3;SMARCD2;SMARCC1
prerank,cholesterol homeostasis (GO:0042632),0.26016388509048743,0.8514593692653912,0.7032457496136012,0.9890187798962914,1.0,10/64,13.55%,INSIG1;HDAC9;APOE;SOAT1;LAMTOR1;SIRT1;SCARB1;LDLRAP1;NPC2;NPC1
prerank,neuron projection regeneration (GO:0031102),0.3829885313695254,0.8513675398845506,0.6522593320235757,0.9885309348530529,1.0,1/10,2.94%,MTR
prerank,folic acid metabolic process (GO:0046655),0.32966761072100115,0.8512187895370165,0.6460980036297641,0.9881900778462993,1.0,2/18,6.17%,ALDH1L1;MTHFS
prerank,cellular response to inorganic substance (GO:0071241),-0.2992000291892273,-0.8508819453588149,0.6943127962085308,0.9088116953889446,1.0,11/21,38.97%,KCNC2;SPIDR;DDI2;RTF2;BLM;GUCY1B1;CDK2;DDX11;NSMCE3;TIMELESS;MT3
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3370474056384225,-0.850821255775798,0.6630434782608695,0.908265058049995,1.0,5/14,28.73%,PAXIP1;SHLD1;RIF1;NECTIN2;SHLD2
prerank,inositol phosphate metabolic process (GO:0043647),0.27195081707938845,0.8505839688558812,0.7032967032967034,0.9888692284466243,1.0,12/46,18.82%,PPIP5K2;NUDT11;PLCG1;INPP5D;PLCB1;INPP4B;IP6K2;ITPK1;IMPA1;ITPKB;MINPP1;CALM1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3217382371391262,-0.850304899438202,0.6868250539956804,0.9086538824081394,1.0,3/16,20.38%,CLDN11;CLDN14;CLDN12
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.20719906121694204,-0.8498743883512733,0.8571428571428571,0.9089115778728416,1.0,22/101,19.58%,PABPN1;MAPK14;AXL;VIM;RHOA;LBP;IRAK1;CDC73;TRIM41;NFKB1;SIRPA;IL18;PTPN22;PAF1;PDE4B;SELENOS;UPF1;DEFA6;TGFB1;MTDH;CHMP5;IRGM
prerank,organelle transport along microtubule (GO:0072384),0.28684131860397244,0.849822991514665,0.655,0.9898761316920709,1.0,8/31,14.53%,DYNC1I1;MAP1S;COPG2;UXT;RAB6A;RAB1A;COPG1;BICD2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.30309683710624247,-0.8497739953456396,0.6558441558441559,0.9084421788106177,1.0,3/18,14.81%,WNK1;PPARA;PTPN22
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.37273552613224237,-0.8497639519565898,0.6895833333333333,0.907793809083297,1.0,4/10,19.26%,JARID2;KDM1A;RIF1;DNMT1
prerank,extracellular transport (GO:0006858),0.35303876195291173,0.8497414476493308,0.6812977099236641,0.9893602431980586,1.0,1/13,2.17%,CABYR
prerank,establishment of epithelial cell polarity (GO:0090162),0.3298634284743665,0.8497392795433142,0.6654804270462633,0.9886697596670924,1.0,7/19,18.46%,RAP2A;MYO9A;OPHN1;PARD3;CLASP1;MYO18A;CYTH1
prerank,mitotic spindle assembly (GO:0090307),0.2749889006406537,0.8495528416231922,0.6976744186046512,0.9884003384447155,1.0,11/42,17.19%,ABRAXAS1;CLASP2;MZT1;KIF2A;BCCIP;KIF3B;CHEK2;ARHGEF10;STAG2;KPNB1;CLASP1
prerank,placenta development (GO:0001890),0.3684852728584424,0.849126006322572,0.6763005780346821,0.9886335175267388,1.0,1/12,2.23%,SOD1
prerank,lipid homeostasis (GO:0055088),0.2619961393124361,0.8490300954555109,0.719047619047619,0.988146129694928,1.0,9/57,11.52%,FITM2;APOE;ACOX3;USF2;SIRT1;IRS2;PRKAA2;DDX3X;PNPLA8
prerank,histone H3-K9 demethylation (GO:0033169),0.3781225513923592,0.8486928416338534,0.659047619047619,0.9882234727617962,1.0,6/11,19.49%,KDM3A;KDM4D;JMJD1C;PHF8;KDM4C;KDM3B
prerank,sterol homeostasis (GO:0055092),0.25883942256934744,0.8482238354318002,0.6970633693972179,0.9885959229099864,1.0,10/65,13.55%,INSIG1;HDAC9;APOE;SOAT1;LAMTOR1;SIRT1;SCARB1;LDLRAP1;NPC2;NPC1
prerank,histone mRNA catabolic process (GO:0071044),-0.3148132115125278,-0.8480444693480218,0.6904761904761905,0.9106835829145786,1.0,6/15,23.78%,EXOSC10;DCP2;ATM;UPF1;ERI1;TUT1
prerank,protein sumoylation (GO:0016925),0.27040624461914825,0.8479103261693667,0.6866883116883117,0.9886097627659249,1.0,16/49,19.26%,TRIM28;SAE1;UBE2I;NUP54;UBA2;NUP50;PIAS2;TRPM4;PIAS1;NUP35;NDC1;NUP160;POM121;RANGAP1;NUP42;NUP133
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3189256623064124,0.8478182032252506,0.6678321678321678,0.9881313974600352,1.0,4/21,10.98%,PDE4D;CNKSR3;SMAD7;DMD
prerank,tRNA export from nucleus (GO:0006409),-0.264828238488366,-0.8474639256382561,0.7240566037735849,0.9105787395908527,1.0,16/32,33.22%,NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;SEC13;NUP153;RAN;NUP43;NUP210
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.264828238488366,-0.8474639256382561,0.7240566037735849,0.9105787395908527,1.0,16/32,33.22%,NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;SEC13;NUP153;RAN;NUP43;NUP210
prerank,glutamine family amino acid catabolic process (GO:0009065),0.35067691281807567,0.8474481359297948,0.65234375,0.9882142608247778,1.0,3/13,11.15%,GLS2;GLS;NOS3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2801888922183727,0.8474184091297454,0.6900311526479751,0.9875975941347171,1.0,8/40,10.35%,SMG1;FXR1;FBXO5;UBE2V2;BCLAF1;RFWD3;UBE2V1;ING2
prerank,thymus development (GO:0048538),0.34968986867438345,0.8472578800134112,0.6454033771106942,0.9872410270986727,1.0,2/13,5.97%,SOD1;TBX1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3181224416442267,-0.8465062507053538,0.6623655913978495,0.9119295175880116,1.0,7/16,24.48%,ABHD5;LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.3094818750724841,-0.8463027044466945,0.6923076923076923,0.9116556246648362,1.0,4/18,10.56%,RIMS1;NLGN1;SYN1;GSK3B
prerank,negative regulation of JNK cascade (GO:0046329),-0.2675419426580103,-0.8462873883183394,0.7111111111111111,0.9110177360833213,1.0,8/31,14.81%,CYLD;TAOK3;HIPK3;PER1;SIRPA;FKTN;DACT1;PTPN22
prerank,prostaglandin metabolic process (GO:0006693),-0.282100843385602,-0.8462178332313889,0.7073170731707317,0.9105038244808827,1.0,8/26,27.58%,PLA2G4A;PTGDS;PTGIS;PTGES;PTGS2;GSTM1;TBXAS1;HPGDS
prerank,arachidonic acid metabolic process (GO:0019369),-0.2555372779544591,-0.845697151402165,0.7051282051282052,0.9109418628052317,1.0,4/35,7.23%,PLA2G4A;PTGDS;EPHX1;PTGIS
prerank,nucleus organization (GO:0006997),0.2706870388562527,0.8455891169682446,0.7196850393700788,0.9901809472996387,1.0,12/47,19.26%,SYNE1;LEMD3;NUP54;CHMP1A;REEP3;CHMP2A;NUP35;NDC1;VPS4B;USP36;PITPNB;NUP133
prerank,response to nitric oxide (GO:0071731),0.35169199266033424,0.8451983606069424,0.6512915129151291,0.9903712831021491,1.0,2/13,7.36%,MTR;TXN
prerank,protein-containing complex disassembly (GO:0032984),0.2610100240268329,0.8451892796648853,0.7311475409836066,0.989700303400354,1.0,8/54,11.25%,MAP1LC3B;HSPA8;RPL23;AXIN1;PYM1;EPG5;TECPR1;UBQLN1
prerank,negative regulation of macrophage activation (GO:0043031),0.3416680701898521,0.8451046859249535,0.6730769230769231,0.9892095720815541,1.0,2/16,2.51%,PTPRC;FCGR2B
prerank,divalent inorganic cation homeostasis (GO:0072507),0.31050968552475666,0.8450804727438838,0.6775862068965517,0.9885719946018713,1.0,3/25,5.56%,TMTC2;WFS1;TRPM7
prerank,muscle tissue morphogenesis (GO:0060415),-0.31431206655585286,-0.8450322077669475,0.6821052631578948,0.9117138002584607,1.0,2/16,4.74%,TGFBR3;BMP4
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.29436889265478877,0.8448449903893176,0.6858108108108109,0.9884123857488676,1.0,2/27,4.64%,ZC3H12D;RNASE6
prerank,keratan sulfate catabolic process (GO:0042340),-0.34997381221269985,-0.8446558777383215,0.6942148760330579,0.9118342620423908,1.0,6/11,20.04%,OGN;HEXA;HEXB;PRELP;GNS;LUM
prerank,regulation of cell morphogenesis (GO:0022604),0.2954921208723554,0.844552995059087,0.6783831282952548,0.9883535335891795,1.0,10/30,17.01%,SH3D19;FITM2;ZMYM4;CFL1;MYO9A;CD44;MOV10;LARP4;WTIP;STRIP1
prerank,protein localization to cilium (GO:0061512),0.2876545249647565,0.8444807518182156,0.7051926298157454,0.9878347732581341,1.0,4/32,11.46%,ROPN1;ATP6V1D;RABEP1;IFT140
prerank,carboxylic acid transport (GO:0046942),0.2650449896591741,0.844273822979642,0.7078651685393258,0.9876090788331725,1.0,5/55,5.53%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3243507399824635,-0.8440129126339995,0.6889352818371608,0.9125240101726061,1.0,6/14,30.86%,NRP1;FOXC1;VEGFA;VEGFB;PGF;FLT4
prerank,regulation of translational initiation (GO:0006446),0.2567159352696859,0.843547994712377,0.7581903276131046,0.9885245047657271,1.0,8/63,11.42%,ATF3;NCBP1;EIF3B;PAIP2B;EIF4H;EIF4G2;DDX3X;EIF4B
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.32205101042524714,0.8434377123253722,0.6728624535315985,0.9880640842440985,1.0,4/18,7.16%,GRIK5;GRIK2;SLC17A6;NAPA
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2346946594222348,0.8433676689803408,0.7704011065006916,0.9875331002440554,1.0,19/112,12.62%,CBL;MAP3K7;LRRC32;SRC;SMAD1;ZFP36L1;TGFBRAP1;F11R;SMAD7;SIRT1;ARHGEF18;WNT5A;ACVRL1;CLDN5;NLK;USP15;ZFYVE9;CRKL;CDH5
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.2755665354372638,0.8432423599228872,0.7070552147239264,0.9871464156384808,1.0,7/42,9.29%,POLK;POLE;SIRT1;POLD3;TRIM25;SPRTN;POLA1
prerank,homocysteine metabolic process (GO:0050667),-0.3463433916960521,-0.842912682574599,0.660455486542443,0.9141603300563621,1.0,2/11,11.53%,MTHFR;NOX4
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.29907887006099076,-0.8428037690348675,0.6583710407239819,0.9136902432865475,1.0,3/19,5.55%,AXL;MMP14;ZBTB1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.33763648687539316,0.8426827724438806,0.6730769230769231,0.9876896400305807,1.0,4/14,13.20%,MAP2K5;MMRN2;NOTCH1;HDAC5
prerank,mitotic cytokinetic process (GO:1902410),-0.291120416830113,-0.8426277867876112,0.6788793103448276,0.9133912252761374,1.0,7/20,25.30%,RHOA;KLHDC8B;MITD1;CHMP2B;CHMP5;VPS4A;CNTROB
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.282747610535374,-0.8424250900290784,0.6956521739130435,0.9131323156508001,1.0,7/23,19.58%,JAK1;PARP14;IFNGR1;PTPN2;IFNGR2;STAT1;IRGM
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.22250962933672336,-0.8417440019438367,0.786144578313253,0.9138285096142466,1.0,16/66,27.68%,FOXP1;IGF1;MALT1;AIM2;SIRPA;USP50;GBP5;GSDMD;CX3CL1;HSPB1;PANX1;GIT1;TRIM16;CX3CR1;EGR1;ZC3H12A
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2713418140897183,-0.8414761493329109,0.7176781002638523,0.9136827227503751,1.0,16/29,34.28%,RFC1;RAD50;TNKS1BP1;MRE11;RPA1;PPP6C;PPP6R3;RTEL1;TELO2;PPIA;HSP90AA1;CDK2;TERF1;TERF2;GAR1;TINF2
prerank,primary miRNA processing (GO:0031053),-0.36296508915804215,-0.8414377634681403,0.6824457593688363,0.9130942934738248,1.0,3/10,9.20%,SMAD3;SRRT;HNRNPA2B1
prerank,ceramide catabolic process (GO:0046514),0.3486323312235111,0.8413094131471579,0.6887298747763864,0.9900273244596272,1.0,3/14,12.30%,ACER2;ACER3;GM2A
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.3525046848918287,-0.8412704221845497,0.6659959758551308,0.9127819649471626,1.0,3/11,8.63%,NUPR1;YBX3;BIRC3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3413379504820468,0.8410904056272466,0.6752767527675276,0.9898313679430839,1.0,1/13,5.41%,CYRIB
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.37610009351630247,0.8409794096374092,0.6455938697318008,0.9893700689302405,1.0,3/10,8.04%,NEXMIF;RGCC;NOTCH1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.35588106508880246,-0.8404399253005884,0.7265135699373695,0.9138280143223516,1.0,8/11,45.21%,SERTAD2;ARID1B;PADI2;SERTAD1;ZMIZ2;ELOF1;CDCA4;CHEK1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.32918137856354335,0.8404356331654884,0.698292220113852,0.989862569602489,1.0,3/17,9.19%,PRKG1;CDKN1A;SOD2
prerank,microglial cell activation (GO:0001774),-0.2880384010935989,-0.8402383259787077,0.7139423076923077,0.9135370014602284,1.0,13/21,50.18%,MAPT;IFNGR1;CX3CL1;CX3CR1;SNCA;C1QA;CLU;TYROBP;ITGB2;ITGAM;AGER;AIF1;TREM2
prerank,regulation of cellular catabolic process (GO:0031329),-0.22681106933742182,-0.8399470997408808,0.7987616099071208,0.9134634950755878,1.0,20/62,21.19%,ITPR1;PSAP;DEPDC5;MAPT;NUPR1;USP13;ROCK1;PIP4K2B;ATM;MTMR4;KEAP1;USP10;DAPK2;RAB8A;ABL2;FBXL2;DAPK1;OSBPL7;HSPB1;KAT8
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.36656320521867464,0.8399028849231791,0.6622641509433962,0.9903186484880151,1.0,4/12,17.96%,SIRT1;ING2;CD44;RPL26
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3638795405070572,-0.8399014085313187,0.689727463312369,0.912226391506591,1.0,4/10,49.08%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3638795405070572,-0.8399014085313187,0.689727463312369,0.912226391506591,1.0,4/10,49.08%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,mRNA metabolic process (GO:0016071),0.2392927762553501,0.8394674112465218,0.7888111888111888,0.9905948828916686,1.0,24/90,17.29%,ZC3H12D;NCBP1;PRPF3;NUDT12;SFPQ;SRSF4;PRMT9;SF3A1;DXO;AKAP8L;U2AF1;CPSF6;AGO4;PTBP1;PCBP3;SRSF7;USP39;SSB;TCERG1;RNASE4;SLBP;U2AF2;CNOT10;NONO
prerank,monocyte chemotaxis (GO:0002548),-0.2587346724390491,-0.839457821435499,0.7301980198019802,0.9124887582516319,1.0,6/32,22.11%,IL6R;ANXA1;CCL14;PTPRO;CX3CL1;CCL13
prerank,positive regulation of vasculature development (GO:1904018),0.23760198571582608,0.8393407474887836,0.7489539748953975,0.9902025843387811,1.0,16/94,12.62%,PDCL3;HIPK2;PRKD2;RAMP2;TEK;RAPGEF3;SIRT1;PLCG1;WNT5A;TIE1;CYP1B1;FLT1;NOS3;PIK3CD;SP1;CDH5
prerank,response to amino acid starvation (GO:1990928),0.2472309355476416,0.8392810596507498,0.7547723935389133,0.9896537584328654,1.0,20/72,19.34%,MAPK3;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;CDKN1A;MAPK8;LAMTOR1;ATP6V0E1;LARS1;RRAGC;ATP6V1B2;TFEB;KPTN;SESN3;DAPL1;ATP6V1A;SH3GLB1;SESN1;LARP1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3449516975532563,0.8391465024987682,0.6728971962616822,0.989267649445899,1.0,2/14,5.04%,PTPRC;TNFRSF1B
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.31781351159582916,0.838838405908824,0.7032967032967034,0.9892295189979408,1.0,7/21,18.20%,PSEN2;SPPL3;DAG1;APH1A;MYH9;ADAM9;SPPL2A
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3469101294914108,0.8387508455494284,0.6716417910447762,0.988738695152472,1.0,2/14,9.17%,MAPK3;CSF1R
prerank,polyol biosynthetic process (GO:0046173),0.3303567696782807,0.83855363832141,0.6907407407407408,0.9884707062568029,1.0,4/16,16.52%,PPIP5K2;ACER3;IP6K2;ITPKB
prerank,regulation of cell population proliferation (GO:0042127),0.19897438628495734,0.8383725014566876,0.9332627118644068,0.9881974723900061,1.0,79/691,11.39%,MAZ;ROMO1;JAG2;BNIPL;UTP20;PTPRJ;EZH2;FRZB;LEF1;ACER2;TIAM1;SHCBP1;RPL23;DERL2;IFNLR1;GREM1;DNAJA3;CRLF1;RERG;FABP7;ING4;STOX1;GNRH1;MCTS1;TBC1D8;BCL6B;BIRC2;NME1;CD164;IFI35;ZFP36L1;TSHR;SMARCA2;SLC35F6;MEIS1;SINHCAF;CIB1;TSPO;CDKN1A;P3H2;TBX1;CHTOP;TMEM115;PLPP1;RGCC;FBXO5;SIRT1;RNF187;IRS2;NOTCH1;CNOT7;CDK4;TJP1;IFITM1;TSC1;ACVRL1;RELA;CD47;CSF1R;SOD2;JUND;LYN;MDM2;TFAP4;PAK1;CLDN5;ESM1;TRPM4;SRPK2;RPS9;CD81;CYP1B1;RHOG;HP1BP3;FLT1;NOS3;CTBP1;APP;PIAS1
prerank,negative regulation of chemokine production (GO:0032682),0.34166332316114606,0.8382307978077426,0.6716141001855288,0.9878161775117581,1.0,1/14,3.42%,MAP2K5
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3181543319783081,0.8380881730502889,0.6894736842105263,0.9874565790004388,1.0,2/20,2.89%,GSK3A;BCL2L2
prerank,positive regulation of DNA binding (GO:0043388),-0.26506296636954485,-0.8380052755815202,0.7279411764705882,0.9147299894462789,1.0,7/31,16.22%,IGF1;SIRT2;SKI;FOXC1;NIBAN2;NGF;TGFB1
prerank,cellular response to alkaloid (GO:0071312),-0.3116012979674177,-0.8378764831177828,0.6948051948051948,0.9143142335597368,1.0,5/17,22.86%,RYR3;SPIDR;CASP7;BLM;CASP3
prerank,regulation of chromatin organization (GO:1902275),0.3501594975726085,0.8378641635333133,0.658,0.9872561693951573,1.0,3/14,13.46%,HPF1;SETD5;TLK2
prerank,response to retinoic acid (GO:0032526),-0.22973988173460877,-0.8377890344846596,0.7933884297520661,0.9138294884878033,1.0,15/59,17.61%,WNT5B;BRINP1;PTK7;RBP4;BRINP2;SNW1;RXRA;EPHA3;RARA;WNT9A;ATM;SETX;ABL2;FZD4;TWF2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3220611580647056,-0.8376808116369326,0.65625,0.9133879868686655,1.0,3/15,8.19%,MED1;BMP4;FOXC1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2470032046883961,-0.8376547522481523,0.7455470737913485,0.9127811640864922,1.0,10/42,21.22%,SPIDR;ERCC6;SHLD1;MMS19;KDM1A;ACTR2;PARP1;RIF1;SMCHD1;RTEL1
prerank,response to axon injury (GO:0048678),0.32334318534706435,0.836539461710383,0.6875,0.9893720420472045,1.0,2/18,2.94%,SOD1;MTR
prerank,regulation of microglial cell activation (GO:1903978),0.33065088573951584,0.8362912651576826,0.6752767527675276,0.9892047790371011,1.0,1/15,2.03%,PTPRC
prerank,atrioventricular valve development (GO:0003171),-0.32547449767509334,-0.8359996932728693,0.6770833333333334,0.9154013238564014,1.0,5/14,19.91%,TGFBR2;ACVR1;MDM4;BMPR1A;BMPR2
prerank,mesenchymal cell development (GO:0014031),0.3205059157569941,0.8358780420909339,0.6742957746478874,0.9893836774482504,1.0,3/18,8.04%,CDH2;HEY2;NOTCH1
prerank,O-glycan processing (GO:0016266),-0.23141798744691885,-0.835104200860031,0.7719298245614035,0.9164641826651994,1.0,9/54,22.22%,GALNT13;GXYLT2;POFUT1;XXYLT1;ST3GAL4;GALNT14;ST6GAL1;GALNT12;C1GALT1C1
prerank,positive regulation of insulin secretion (GO:0032024),-0.25419104474656734,-0.8349528587920351,0.7671568627450981,0.9160979208457303,1.0,15/36,27.15%,MCU;NLGN2;GLUD1;RBP4;ANO1;TM7SF3;NNAT;PSMD9;GPLD1;TCF7L2;PLA2G6;ADCY8;CAPN10;AACS;LRRC8A
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.30229510630536305,0.8349425577836925,0.6891651865008881,0.9906645892521436,1.0,4/23,10.98%,PLK2;PRCC;WEE1;CHFR
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3304941582453971,0.8346606136707617,0.7072310405643739,0.9905960215950541,1.0,6/17,13.84%,F11R;CLDN5;PPP1R12A;IKBKB;CDH5;PROC
prerank,organelle disassembly (GO:1903008),-0.26045622492590836,-0.8345484966744245,0.7252475247524752,0.9162555303253888,1.0,8/33,14.47%,ULK2;UFL1;VCP;GOLGA2;DDRGK1;MRRF;TEX264;EIF2D
prerank,mRNA catabolic process (GO:0006402),0.2725513891670506,0.8343268689058078,0.7251908396946565,0.9906081206923544,1.0,14/44,20.64%,ZC3H12D;NUDT12;EXOSC9;XRN2;DXO;AGO4;TUT7;TUT4;NBDY;CNOT10;RC3H1;DIS3L2;AGO1;ERN1
prerank,purine-containing compound catabolic process (GO:0072523),-0.32816527469769086,-0.8338011503547456,0.7133333333333334,0.9170132656807825,1.0,2/13,6.98%,DPYD;XDH
prerank,phospholipid biosynthetic process (GO:0008654),0.2774879037849661,0.8337743283354024,0.7265238879736409,0.9910853518388042,1.0,6/36,11.31%,GPAM;FITM2;SGMS1;MBOAT1;IDI1;AGPAT3
prerank,positive regulation of viral genome replication (GO:0045070),0.29357557145861857,0.8337582391118247,0.6925675675675675,0.9904447274417608,1.0,7/29,12.53%,IFIT1;ADAR;CNOT7;RAD23A;SRPK2;DDX3X;TMEM39A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3312188235593514,0.8334927597488871,0.6753246753246753,0.9903072206217145,1.0,5/17,20.22%,BACH2;CD55;STAT3;CD46;BTN3A3
prerank,DNA replication checkpoint signaling (GO:0000076),0.33047525249990195,0.8334067419848176,0.6715328467153284,0.9897996534384474,1.0,3/16,11.27%,CDC45;NAE1;HUS1
prerank,second-messenger-mediated signaling (GO:0019932),-0.2085662716407676,-0.8334054754277312,0.8830409356725146,0.917163477831195,1.0,10/82,10.84%,MCU;PPP1R9A;NUDT4;PLCE1;P2RX4;CHRM3;CCR9;KSR2;ACKR3;DDAH1
prerank,cellular response to amino acid starvation (GO:0034198),0.24650898427816867,0.8332562121620458,0.7628865979381443,0.9894342266970212,1.0,19/71,19.05%,MAPK3;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;CDKN1A;MAPK8;LAMTOR1;ATP6V0E1;LARS1;RRAGC;ATP6V1B2;TFEB;KPTN;SESN3;DAPL1;ATP6V1A;SH3GLB1;SESN1
prerank,polyol metabolic process (GO:0019751),0.2658508322303464,0.833163012807305,0.7261345852895149,0.9889569530192452,1.0,12/46,18.82%,PPIP5K2;NUDT11;PLCG1;INPP5D;PLCB1;INPP4B;IP6K2;ITPK1;IMPA1;ITPKB;MINPP1;CALM1
prerank,cilium-dependent cell motility (GO:0060285),0.30739081032478766,0.8330295127300225,0.6998191681735986,0.9885993791790525,1.0,2/22,5.93%,DNAH3;RFX3
prerank,lipid translocation (GO:0034204),0.3098505534099319,0.8326223817010637,0.6901669758812616,0.9888001618875082,1.0,7/21,18.56%,ATP8A1;ATP11A;TMEM30B;ATP11C;ATP10A;TMEM30A;ATP9B
prerank,response to hexose (GO:0009746),0.30001182966316436,0.832517695318099,0.680628272251309,0.9883587847116532,1.0,4/25,11.50%,SELENOT;IRS2;EIF2B3;ZBED3
prerank,positive regulation of translation (GO:0045727),0.2351751978956462,0.832450533630006,0.7983074753173484,0.9878330526635515,1.0,11/94,10.80%,JMJD4;EIF5AL1;EIF5A;FASTKD2;LARP4B;FXR1;RPL5;PYM1;NGRN;RPS9;DDX3X
prerank,fatty acid catabolic process (GO:0009062),-0.22524121519829735,-0.8323654042061622,0.8088235294117647,0.9185360423866351,1.0,25/67,31.59%,ACBD5;ECI2;PCCB;LPIN1;ALDH3A2;ABCD2;ACAD11;PCCA;CPT2;PEX2;PHYH;ABHD3;EHHADH;ACAD10;LPIN2;ECHDC2;NUDT7;ACAT2;ABCD3;ECI1;LPIN3;SLC27A4;PECR;MCEE;PLA2G15
prerank,cellular response to reactive oxygen species (GO:0034614),0.25592650503617936,0.831919276824801,0.7534246575342466,0.9882695608724421,1.0,10/59,12.87%,MAPK3;ROMO1;TNFAIP3;MAPK8;SIRT1;RELA;PARK7;CYP1B1;RPS3;CHUK
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.35423898566353756,0.8318899980231098,0.6871508379888268,0.9876634510134807,1.0,3/12,17.51%,ZNF205;CYBA;RAB27A
prerank,protein localization to microtubule organizing center (GO:1905508),0.33594068428455576,0.8317453325015913,0.6741573033707865,0.9873039003328643,1.0,6/15,21.08%,DCTN2;CEP83;HOOK3;CCDC14;CEP192;BBS4
prerank,regulation of B cell apoptotic process (GO:0002902),-0.3325923024162495,-0.8317330423171783,0.7103004291845494,0.9191580143859079,1.0,1/12,0.28%,FOXP1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.35407070247018835,0.83171271219732,0.6706349206349206,0.9866943495373552,1.0,1/12,0.88%,SEMA6A
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2687689974948731,-0.8316360490232254,0.7353629976580797,0.9186663096769505,1.0,5/27,14.90%,NFAT5;RHOA;IRAK1;SIRPA;HSPD1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.2524111066331087,-0.8315781038587996,0.775609756097561,0.9181233636613642,1.0,14/37,33.34%,DLG4;SIRT2;AATF;OPTN;NFKB1;RIN3;SIRT5;PINK1;PAX2;ITGB3;ANKRD13D;ABCA2;EDN1;ANKRD13B
prerank,striated muscle contraction (GO:0006941),-0.2324854830964088,-0.8308789550808793,0.8121212121212121,0.9188327023275069,1.0,3/53,4.07%,ATP1A2;ATP1B1;TPM1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2719337371646047,0.8304990610638885,0.7188498402555911,0.9886225314876924,1.0,5/40,9.71%,ZRANB3;POLE;RFWD3;EXD2;MSH3
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.31771651053463845,0.8302753240273756,0.7176258992805755,0.9884322791030221,1.0,6/20,17.08%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;PPP2R5A
prerank,positive regulation of isotype switching (GO:0045830),-0.3178705240568332,-0.8300114701515622,0.7048832271762208,0.9198352381947195,1.0,9/15,42.21%,PAXIP1;SHLD1;TGFB1;RIF1;SHLD2;CD40;MAD2L2;CLCF1;TNFSF13
prerank,negative regulation of synaptic transmission (GO:0050805),0.30476579539704535,0.8299211740334081,0.6845018450184502,0.988492262416658,1.0,3/23,9.28%,PLK2;PNKD;ARF1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.24450249472107496,0.829855053098982,0.7515060240963856,0.9879600884847319,1.0,13/74,11.15%,TNFAIP3;SRC;MAP2K5;RFFL;TNFRSF10B;ICAM1;EYA3;ITGA6;RELA;PARK7;TERT;DDX3X;NOS3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.26267934355145556,0.8298189920271073,0.7611464968152867,0.9873717269186741,1.0,9/54,12.87%,TNFAIP3;RFFL;BIRC2;SPATA2;CARD16;SYK;RBCK1;IKBKB;CHUK
prerank,positive regulation of macrophage activation (GO:0043032),-0.30583866124978076,-0.8295135701059967,0.6911111111111111,0.9201276542561848,1.0,6/17,27.48%,LBP;THBS1;IL33;HSPD1;TTBK1;KARS1
prerank,cell differentiation in hindbrain (GO:0021533),-0.3546345920033579,-0.8295001219101542,0.7,0.9194921416519247,1.0,2/11,5.67%,GRID2;ATP7A
prerank,negative regulation of ossification (GO:0030279),0.3031053008434641,0.8294424379584481,0.701067615658363,0.9874640982616265,1.0,6/23,16.35%,GREM1;NOTCH1;TRPM4;RBPJ;PTK2B;LRP4
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.3535480055954356,-0.8291510917173884,0.6852589641434262,0.9195037426612875,1.0,4/10,25.86%,GHR;STAT6;PRLR;STAT5A
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.28685181081076055,0.8288719589706214,0.7198067632850241,0.9880127977967955,1.0,8/32,16.91%,AEN;HIPK2;EP300;SIRT1;CDIP1;RRP8;DYRK2;USP28
prerank,toll-like receptor signaling pathway (GO:0002224),0.23785304792027986,0.8285617009305062,0.7873900293255132,0.9879971424279773,1.0,11/84,12.87%,PIK3AP1;MAP3K7;TAB2;TIRAP;BIRC2;TAB3;EPG5;TRAF3;TNIP2;IKBKB;CHUK
prerank,organelle assembly (GO:0070925),0.20273328401590046,0.8285184506504434,0.9010356731875719,0.9874109457147594,1.0,78/385,17.31%,ABCC4;MAP1LC3B;PATL2;EIF2S1;EIF2A;POC1B;GORASP2;HAUS4;HAUS5;CEP41;EHD4;EXOC8;FITM2;ATP6V1D;HDAC3;ATP2A2;TUBGCP5;PGM5;RAB7A;TMEM138;FLII;RAB43;ATP6V0D1;RFX3;SCLT1;CHMP1A;VMP1;NOTCH1;BBIP1;CEP164;CENPC;STARD9;AUP1;RAB1A;PATL1;CHMP2A;ABLIM1;DYNLL1;VPS37B;MIS12;TRAF3IP1;RPS23;DDX3X;NEK7;UBQLN1;IFT140;RPS3;TNKS;ATG7;CENPJ;PDE6D;KIF3B;POGZ;NEK6;SSX2IP;CEP83;ATG16L1;ASAP1;RCC1;LMOD1;INO80;LZTFL1;CLUAP1;ATG14;TMEM41B;GABARAPL1;ARMC9;ATG13;EXOC2;UNC119B;TP53INP2;TUBGCP2;UBQLN2;ZFYVE1;VPS37C;BECN1;IFT80;NPM1
prerank,apoptotic nuclear changes (GO:0030262),-0.27841997167824506,-0.8284266902109537,0.7396061269146609,0.9201643033707645,1.0,17/24,46.62%,DICER1;DFFA;CASP3;ACIN1;EXOG;H1-0;CDK5RAP3;DNASE2;DEDD2;HMGB1;GPER1;HMGB2;ACVR1C;DFFB;TOP2A;FOXL2;BLCAP
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.23749967375352093,0.8283574962711628,0.7763347763347763,0.9870828784466734,1.0,10/90,7.51%,ALMS1;UCP2;HDAC3;TSHR;KDM3A;ELOVL6;GATM;SYK;ADIPOR2;OMA1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.35457100919254936,0.8283392422521109,0.6973180076628352,0.9864602969318145,1.0,1/12,1.58%,ATF6
prerank,B cell proliferation (GO:0042100),0.32372296916540644,0.8280933629018051,0.6666666666666666,0.986309307147973,1.0,1/17,2.03%,PTPRC
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.33331463763442826,0.8279238778220442,0.6702898550724637,0.9860063711639454,1.0,3/14,12.57%,SYK;CD81;CD55
prerank,protein depolymerization (GO:0051261),-0.2739066898672702,-0.8274138248791272,0.7541766109785203,0.9214716265322598,1.0,8/27,17.61%,GSN;MICAL2;MICAL3;STMN2;CKAP5;WDR1;STMN1;TWF2
prerank,ncRNA export from nucleus (GO:0097064),-0.2503205096411846,-0.8270017881860648,0.7427884615384616,0.9216286715001429,1.0,14/36,24.94%,NUP205;NUP155;NUP188;PHAX;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;NCBP2;SEC13
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.338610602974234,-0.8268251940359851,0.6962305986696231,0.921309680313776,1.0,3/12,7.34%,DSCAM;NKD1;SDK2
prerank,DNA replication initiation (GO:0006270),0.27521598142888626,0.8266196588078055,0.7424242424242424,0.9880216381596458,1.0,6/37,11.47%,ORC3;POLE;CDC45;ORC4;POLA1;ORC2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3658687770293028,0.8265259284256417,0.6827309236947792,0.9862535746175849,1.0,4/11,16.92%,PANK2;ACAT1;PANK1;PANK4
prerank,coenzyme A biosynthetic process (GO:0015937),0.3658687770293028,0.8265259284256417,0.6827309236947792,0.9862535746175849,1.0,4/11,16.92%,PANK2;ACAT1;PANK1;PANK4
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3658687770293028,0.8265259284256417,0.6827309236947792,0.9862535746175849,1.0,4/11,16.92%,PANK2;ACAT1;PANK1;PANK4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.2965918663187257,0.8264954760134999,0.7249575551782682,0.9856617490086028,1.0,4/26,8.31%,EEF1A1;ZFP36L1;PTPN12;PLCG1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3285929056692313,0.8264825227207483,0.6807339449541284,0.9850373737587113,1.0,3/17,12.29%,PTPRC;TERT;N4BP2L2
prerank,regulation of cell size (GO:0008361),0.30697313059054315,0.8255876165805582,0.7019400352733686,0.9861929331939475,1.0,5/23,13.31%,VAV3;RPTOR;AKT1S1;LARS1;PLEK
prerank,insulin receptor signaling pathway (GO:0008286),0.2432149582534346,0.825527763357543,0.7916041979010495,0.9856677080287691,1.0,21/69,18.86%,GSK3A;BCAR3;ATP6V1D;ATP6V0D1;AP3S1;IRS2;ATP6V0E1;RHOQ;ATP6AP1;GRB14;APC;PIK3C2A;ATP6V1B2;NAMPT;SHC1;BAIAP2;INSR;C2CD5;ATP6V1A;IRS1;ZNF106
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.36656842162596726,0.825244787463828,0.6867704280155642,0.9855612015542375,1.0,3/11,14.70%,SIRT1;ING2;CD44
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3192097647387076,-0.8247979327361796,0.7164835164835165,0.9245515527189888,1.0,9/15,35.08%,NLGN2;NLGN1;STXBP1;ADRA1A;USP46;CLN3;DRD2;ZDHHC3;BAIAP3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24769634828422513,0.824508440581811,0.7581903276131046,0.9864021615706166,1.0,11/68,13.54%,MLYCD;DBI;ACAT1;GPAT4;SULT1A1;RHOQ;BAD;ACOT8;NT5C2;EFL1;GMPR2
prerank,regulation of protein kinase B signaling (GO:0051896),0.21239869006202378,0.8243062436903952,0.8435114503816794,0.9861466889235961,1.0,23/193,11.82%,RAC2;MAZ;PIK3CG;TRIB3;PIK3AP1;PTPRJ;SRC;TEK;FYN;CIB1;RET;SIRT1;TXN;IRS2;DAG1;PHLPP1;PARK7;ESR1;MFHAS1;OTUD3;RHOG;PIK3CD;PIK3R5
prerank,folic acid-containing compound metabolic process (GO:0006760),0.31629146718762685,0.8241081207241369,0.7090909090909091,0.9859283839315155,1.0,2/19,6.17%,ALDH1L1;MTHFS
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.2984135054794118,0.8237866929851846,0.7227036395147314,0.9859197287990604,1.0,2/25,1.61%,TAL1;ABCB10
prerank,Golgi localization (GO:0051645),-0.3476409106713034,-0.8236974376624212,0.7032520325203252,0.9259204830149964,1.0,5/11,24.81%,UVRAG;STK25;TBCCD1;CDC42;RIPOR1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3578149403435768,0.8235807077324948,0.6923076923076923,0.9856687019618382,1.0,2/11,6.27%,ATL1;LPCAT3
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.3316195050528,0.8230481055177766,0.6776556776556777,0.9860561015861669,1.0,2/15,4.96%,EZH2;PHB2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.22332755274828212,0.8228544986915755,0.8117489986648865,0.9858089297895744,1.0,16/129,10.48%,FBXL6;ALMS1;HAUS4;HAUS5;CEP41;TUBB;CCNH;DCTN2;CDKN1A;ODF2;WEE1;CEP164;DCTN3;PLCB1;PPP1R12A;DYNLL1
prerank,positive regulation of protein deacetylation (GO:0090312),0.33672814547662655,0.8226234143624198,0.7,0.9856535505687607,1.0,3/14,11.22%,AKAP8L;ING2;CTBP1
prerank,regulation of protein export from nucleus (GO:0046825),-0.2775074469542414,-0.8225613410789335,0.7637614678899083,0.9274170293010725,1.0,8/23,16.40%,PTPN14;BAG3;ANP32B;GSK3B;TP53;CAMK1;SIRT7;TCF7L2
prerank,negative regulation of complement activation (GO:0045916),0.3657183683463779,0.8221279675520489,0.6584362139917695,0.9859938877558575,1.0,3/10,18.17%,A2M;CD55;CD46
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.26900625776143594,0.8218858229955697,0.737649063032368,0.9858253707660037,1.0,4/37,9.23%,NCBP1;NUDT5;RNASE6;XRN2
prerank,C4-dicarboxylate transport (GO:0015740),0.34004364118170227,0.8218615207556059,0.7134831460674157,0.9852120660428204,1.0,3/14,12.49%,SLC1A1;SLC1A2;SLC25A12
prerank,recombinational repair (GO:0000725),0.2405281091162347,0.8218262756230816,0.7802359882005899,0.9846319794606391,1.0,15/77,14.94%,ZSWIM7;ERCC4;YY1;XRCC1;SFPQ;KDM4D;SEM1;RFWD3;EXD2;RAD51B;HUS1;NBN;PSMD14;RMI1;INO80
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3572554536879566,-0.8217776419566969,0.682092555331992,0.9282086047811896,1.0,3/10,13.63%,KMT2A;SMAD4;CAMK1
prerank,positive regulation of chemokine production (GO:0032722),0.262996348652029,0.821712496692516,0.7808219178082192,0.9842025985353243,1.0,6/44,11.27%,TIRAP;SYK;WNT5A;CSF1R;DDX3X;APP
prerank,autophagy of peroxisome (GO:0030242),0.3511180825584197,0.8212518425454981,0.6766355140186916,0.9844954205158698,1.0,3/12,11.64%,MAP1LC3B;TRAPPC8;NBR1
prerank,positive regulation of exocytosis (GO:0045921),0.2804097466868295,0.8212306931890598,0.6964856230031949,0.9838888007979678,1.0,6/35,10.69%,CLASP2;RAB7A;CADPS;RAB2B;CHMP2A;ATP6AP1
prerank,peptidyl-arginine modification (GO:0018195),0.33041125255872617,0.8212142095736926,0.6842105263157895,0.9832740011348896,1.0,2/15,9.76%,NDUFAF5;PARK7
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3133630754459293,0.8211008502582012,0.7246891651865008,0.982860999962128,1.0,5/18,12.41%,GSK3A;EFNA1;RELA;PICALM;SP1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3068596404764013,0.8210416996961711,0.7018181818181818,0.9823325706175666,1.0,4/21,9.35%,BIRC2;SOX2;FYN;PCID2
prerank,platelet aggregation (GO:0070527),0.2805375776315946,0.820965610095478,0.7375415282392026,0.9818400820909511,1.0,8/33,15.74%,PIK3CG;ACTB;MYL9;METAP1;PLEK;CSRP1;FIBP;MYH9
prerank,genitalia development (GO:0048806),-0.33898703613400966,-0.8209342325260959,0.724669603524229,0.9291870977129164,1.0,3/12,11.62%,PKD1;DNAJC19;TBX3
prerank,lipid oxidation (GO:0034440),0.3520961427746324,0.8208327570544911,0.7005649717514124,0.9814646562479314,1.0,2/12,11.08%,ADIPOR2;ADIPOR1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.23347239805485875,-0.8206503913018349,0.7864583333333334,0.9290439786265567,1.0,14/49,19.23%,LDLRAD4;PRKCZ;JAM3;SORL1;SMAD6;GSK3B;HSF1;PPM1A;DACT1;RAF1;PEX5;CDC42;CRYAB;RIOK3
prerank,cellular glucose homeostasis (GO:0001678),-0.24254239765125157,-0.8203975689755678,0.7872340425531915,0.9288617421143436,1.0,13/41,22.38%,ZBTB20;LRRC8D;PPARGC1A;SLC39A14;PRKACA;NUCKS1;UNC13B;RACK1;FOXK1;PIK3R1;PCK2;ADCY8;HK2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3669100658296345,0.8193563719582223,0.691699604743083,0.983727349738813,1.0,3/10,16.59%,EIF2S1;DDIT3;QRICH1
prerank,regulation of proteolysis (GO:0030162),-0.2353887459879409,-0.8186454396653338,0.8230563002680965,0.931452696325271,1.0,20/48,31.77%,OGT;CYFIP2;FBXW11;BTRC;IST1;CAMK2N1;NEDD8;GSAP;TBC1D10A;RNF139;STUB1;BAG6;CLN3;AKT1;PERP;HDAC6;DNAJC1;CDK5;FGFR4;CAV1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3056581798328904,0.8184784147369412,0.697463768115942,0.9848751219033236,1.0,6/20,16.80%,APOE;LPCAT3;MBTPS1;LDLRAP1;ACADL;KPNB1
prerank,error-prone translesion synthesis (GO:0042276),-0.2897816017169929,-0.8184718345246185,0.7396593673965937,0.9311424033039528,1.0,14/21,42.55%,RFC1;RPA1;UBC;PRIMPOL;RFC2;PCNA;POLE2;POLI;REV3L;RPA3;RFC3;MAD2L2;UBA52;RPA2
prerank,negative regulation of autophagy (GO:0010507),-0.2241115897924381,-0.8184520534843032,0.8028169014084507,0.9305258606763879,1.0,16/54,20.75%,SNRNP70;LEPR;SIRT2;NUPR1;KDM4A;KLHL22;GOLGA2;NRBP2;CTSA;MTMR9;PTPN22;QSOX1;FOXK1;MET;PINK1;BCL2
prerank,postreplication repair (GO:0006301),0.2661787987204335,0.8184401888774914,0.7383177570093458,0.9843089709116487,1.0,7/45,10.18%,RAD18;POLK;UBE2V2;POLD3;TRIM25;SPRTN;UBE2V1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.23001644163838122,0.8184057607451308,0.8198847262247838,0.9837280799745305,1.0,27/100,18.07%,GSK3A;TRIB3;ARIH1;COP1;FOXF2;SMAD7;DESI1;GNA12;MDM2;RAD23A;PARK7;RYBP;CCAR2;PIAS1;ELOB;XPO1;TLK2;GIPC1;RNF180;UCHL5;FBXO22;UBQLN4;TAF1;N4BP1;RAD23B;BBS7;GABARAP
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2260593477459835,-0.8182015338129166,0.7840909090909091,0.9303366901755905,1.0,20/56,30.97%,SFTPA2;SFTPA1;LBP;IRAK1;LGMN;UBC;TAB1;LACC1;IRAK4;IRAK2;CNPY3;CTSK;TLR3;BCL10;MAPKAPK2;CTSB;TIFA;CTSS;S100A1;TLR7
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.331699827445466,-0.8175703096775394,0.714902807775378,0.9308618497218424,1.0,1/12,3.91%,CTNNB1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.30133022411699373,-0.8171839635451305,0.7120535714285714,0.9309467858681768,1.0,6/17,16.41%,VCP;RHBDD1;HERPUD1;NPLOC4;SELENOS;HM13
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2805611355521874,0.8170946409312474,0.7419354838709677,0.9857465384620733,1.0,8/32,17.23%,PNKD;PREPL;DTNBP1;MCTP2;MCTP1;SNAPIN;VPS18;SLC30A1
prerank,protein destabilization (GO:0031648),0.2819238950648679,0.8168842426813423,0.7215619694397284,0.9855222644384101,1.0,8/32,12.83%,EP300;CCDC88C;SIRT1;MDM2;RAD23A;CREBBP;PRNP;CUL3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.2300293512547065,0.8166852129334152,0.801980198019802,0.9852887752078696,1.0,12/98,9.96%,ROMO1;CHCHD2;IFNLR1;GREM1;PAX8;APOE;CDKN1A;PPARD;ACACB;RAB1A;IL10RB;IFNAR1
prerank,tRNA 5'-end processing (GO:0099116),0.3356362174957984,0.8166733983408812,0.7078039927404719,0.9846648144582558,1.0,3/15,14.97%,RPP25L;POP5;SSB
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.25955570199761013,0.8160178853354237,0.75,0.9853544850961778,1.0,15/49,17.79%,BCL2L2;SRC;SGMS1;BCLAF1;BAD;DDX3X;UBQLN1;BMF;PTPMT1;NDUFA13;DDIT3;DNM1L;BECN1;BCAP31;BAX
prerank,autonomic nervous system development (GO:0048483),-0.2966880863981083,-0.8158684837965162,0.748314606741573,0.9327411770074702,1.0,3/17,11.11%,NRP1;SEMA3A;FN1
prerank,regulation of actin nucleation (GO:0051125),-0.3324335237642654,-0.8155992583375283,0.6997885835095138,0.9325924702378043,1.0,5/12,28.74%,GSN;WASHC5;ARFIP2;PICK1;ARPIN
prerank,cellular response to oxygen levels (GO:0071453),0.3657932361690336,0.8154099826900507,0.6967370441458733,0.9859086198825161,1.0,3/10,10.69%,ATP6V0D1;NDUFS2;ATP6AP1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3134704389960984,0.8151415593006186,0.7237762237762237,0.9858011450877782,1.0,6/17,18.94%,SPRED1;CALM3;SMAD7;PARD3;CALM1;EIF4G1
prerank,cellular glucan metabolic process (GO:0006073),-0.3439258853550231,-0.8149045592202809,0.719758064516129,0.9331942965423152,1.0,4/11,19.38%,PRKAG2;GSK3B;PYGM;PHKG2
prerank,heart morphogenesis (GO:0003007),-0.22713631208144308,-0.8137989107859119,0.8174386920980926,0.9345944723017574,1.0,11/50,19.70%,TGFBR3;FLRT2;TGFBR1;NIPBL;EPHB4;ACVR1;TBX3;PTK2;MDM4;BMPR1A;OLFM1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3031564329482646,0.813671461262778,0.7183098591549296,0.9880092584992627,1.0,5/22,11.77%,MAP3K4;MINK1;PJA2;MFHAS1;RELL1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2971632861546265,0.8136634539078617,0.7396551724137931,0.9873766784425512,1.0,5/26,14.25%,APOE;PARK7;TERT;SCARB1;GCH1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.3404289798337926,-0.8135440849062893,0.7051546391752578,0.9344041667181749,1.0,4/11,19.89%,THBS1;CD34;BMPR1A;PTGS2
prerank,regulation of autophagosome maturation (GO:1901096),0.3390434975305669,0.8131832800185345,0.7142857142857143,0.9876559346333403,1.0,4/13,15.33%,FYCO1;TBC1D25;TMEM39A;UBQLN4
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.36388620017784534,0.8131195811759271,0.6846153846153846,0.9871284549955116,1.0,3/10,14.72%,ATP5MG;ATP5MC2;ATP5F1C
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.25254060172248743,0.8130353773658275,0.7929984779299848,0.9866382903289186,1.0,20/57,21.15%,RPL35A;RPL5;EMG1;RPS28;RPS24;LTV1;RBIS;WDR12;PAK1IP1;XPO1;LTO1;NPM1;RPL38;RPL26;NVL;RPL7;RPL14;TGS1;GTF3A;SDAD1
prerank,cellular response to superoxide (GO:0071451),0.35976059868879084,0.8130344347780801,0.7033398821218074,0.9859976161144193,1.0,3/10,11.15%,SOD1;SOD2;NOS3
prerank,regulation of macrophage activation (GO:0043030),-0.24957820136594658,-0.8125550131714817,0.7690476190476191,0.9355286020542152,1.0,6/30,14.90%,LRFN5;LBP;IL31RA;THBS1;IL33;HSPD1
prerank,positive regulation of embryonic development (GO:0040019),-0.29489888776945583,-0.8124898554993746,0.7294372294372294,0.9349840760502891,1.0,5/19,14.15%,OSR1;WNT4;NIBAN2;NR2C2;RACK1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.24188039811226109,0.8124284678442517,0.8081570996978852,0.9865803184963854,1.0,6/66,4.67%,RBM22;TRIM28;DMAP1;CCT2;HDAC3;CCT5
prerank,carbohydrate derivative catabolic process (GO:1901136),0.31425683160536216,0.8122723596648322,0.7109929078014184,0.986268357561098,1.0,3/18,10.87%,BPGM;FUCA1;STT3B
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.27915273426187537,0.8122635924509476,0.7417763157894737,0.9856427218682153,1.0,5/34,10.57%,TNFAIP3;RAB7B;LYN;NFKBIL1;MFHAS1
prerank,protein hydroxylation (GO:0018126),0.326559730026431,0.8121751314504048,0.7200736648250461,0.9851710066793076,1.0,3/15,10.90%,JMJD4;P3H2;PLOD3
prerank,RNA biosynthetic process (GO:0032774),-0.25704745852797445,-0.8120647572389902,0.7884130982367759,0.9351045740597745,1.0,14/31,32.62%,NCOA6;POLR2A;SETX;TAF6;TAF12;PRIM2;GTF2B;TAF13;SMN1;PRMT5;POLA2;PRIM1;TAF7;TAF5
prerank,regulation of lipase activity (GO:0060191),-0.3236238167157642,-0.8119077406643288,0.7272727272727273,0.9347381742891996,1.0,3/13,13.46%,PCSK5;RHOA;PCSK6
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3179579929919829,0.8119008920113313,0.7267657992565055,0.9850859606345543,1.0,5/18,13.91%,TNFRSF1B;NOTCH1;NF1;TENM4;HES1
prerank,telomere maintenance (GO:0000723),0.25780161727568723,0.8118096498301901,0.765990639625585,0.9846322713871203,1.0,12/50,16.75%,CTC1;ERCC4;DCLRE1B;POLD3;ACD;TERT;HUS1;NBN;LTO1;TERF2IP;ATR;PRKDC
prerank,protein targeting to membrane (GO:0006612),0.2357568502440491,0.8111890712548431,0.8141843971631205,0.985165989166099,1.0,14/83,14.49%,RTP3;CHM;SGTB;ZDHHC14;PIKFYVE;PXMP2;ZDHHC15;ICMT;VPS37B;SEC62;PRKCI;ZDHHC9;ZDHHC7;PARD3
prerank,glycerolipid metabolic process (GO:0046486),0.3493788423869465,0.8109737315273858,0.7137254901960784,0.9849695121508268,1.0,2/11,11.01%,DGKB;PGP
prerank,macrophage chemotaxis (GO:0048246),0.36699496861904696,0.8109373105929849,0.7121212121212122,0.9844111196124447,1.0,1/10,8.25%,EDNRB
prerank,modulation by host of symbiont process (GO:0051851),0.278972980320891,0.8108930955589243,0.7324185248713551,0.9838599002402516,1.0,6/31,12.41%,LEF1;EP300;TFAP4;TARDBP;CHD1;SP1
prerank,positive regulation of cell death (GO:0010942),0.25182339017400845,0.8107832222184352,0.7853810264385692,0.9834254646488705,1.0,10/59,13.85%,ACER2;EIF2S1;FCGR2B;FYN;SLC6A6;WNT5A;PICALM;PRNP;FAF1;APC
prerank,peptidyl-amino acid modification (GO:0018193),0.37095021728780553,0.8105122339757792,0.6965376782077393,0.9833272806557147,1.0,2/10,10.71%,METAP2;METAP1
prerank,regulation of astrocyte differentiation (GO:0048710),0.3389290340899336,0.8104121660542993,0.6927374301675978,0.982889649199487,1.0,3/12,16.05%,NOTCH1;HES1;ID2
prerank,t-circle formation (GO:0090656),-0.34794173947830737,-0.8103902994271414,0.7379032258064516,0.9356070640482139,1.0,6/10,36.60%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.34794173947830737,-0.8103902994271414,0.7379032258064516,0.9356070640482139,1.0,6/10,36.60%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.34794173947830737,-0.8103902994271414,0.7379032258064516,0.9356070640482139,1.0,6/10,36.60%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,glial cell development (GO:0021782),-0.269821322229575,-0.8103683045721318,0.7505827505827506,0.9350030099732038,1.0,17/25,41.93%,CDK6;MXRA8;TPPP;NRROS;PICK1;EIF2B5;CSPG5;MDK;EIF2B2;EIF2B4;MYRF;NSUN5;SOX11;SOX10;MT3;SOX4;EIF2B1
prerank,cellular response to unfolded protein (GO:0034620),0.29073785882112224,0.8096676954837874,0.7303921568627451,0.9836561224237471,1.0,2/26,1.88%,ABCB10;HSPA8
prerank,positive regulation of chromatin organization (GO:1905269),0.3441115588221151,0.8087750627353358,0.6957364341085271,0.9847256638326075,1.0,5/12,18.79%,TAL1;ACD;TERF2IP;SIN3A;ATRX
prerank,integrated stress response signaling (GO:0140467),0.3349968925359082,0.808670287886801,0.7423664122137404,0.9843107668295961,1.0,4/14,16.59%,EIF2S1;OMA1;DDIT3;QRICH1
prerank,icosanoid metabolic process (GO:0006690),-0.23829129268931953,-0.8080227040283817,0.8226221079691517,0.9386455656082968,1.0,20/40,46.43%,PLA2G4A;EPHX1;PTGIS;GGT5;PTGS2;GPX1;TBXAS1;MAPKAPK2;ABCC10;FADS1;ALOX12;PTGS1;PLA2G4C;DAGLA;FAAH;CYP2S1;LTA4H;PTGR1;MGLL;GGT1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.23187303340451562,0.8079356168339143,0.8129713423831071,0.9850643390720363,1.0,11/83,12.08%,ALMS1;HAUS4;HAUS5;CEP41;TUBB;DCTN2;ODF2;CEP164;DCTN3;DYNLL1;CENPJ
prerank,cell junction maintenance (GO:0034331),-0.31143788609578477,-0.8074303681694998,0.7192622950819673,0.9390989552000995,1.0,3/14,15.73%,NLGN2;MYADM;DCTN1
prerank,protein localization to lysosome (GO:0061462),-0.2587329337881508,-0.8074296227556688,0.7927461139896373,0.9384439499698495,1.0,14/28,27.37%,SORL1;ZFYVE16;NCOA4;M6PR;AP4M1;GGA3;SZT2;NEDD4;MFSD1;VPS4A;HGS;LAMTOR5;LMBRD1;SH3BP4
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23855936693341717,0.807354357252926,0.8026124818577649,0.9855298160368829,1.0,9/72,9.68%,ERCC3;RNASE6;ERCC4;POLK;POLD3;GTF2H1;XRN2;DXO;EXD2
prerank,carbohydrate transport (GO:0008643),-0.3335652608708191,-0.8073251691171406,0.7347826086956522,0.9379872534493007,1.0,9/11,61.62%,AQP11;SLC50A1;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1;SLC2A5;AQP9
prerank,visual system development (GO:0150063),0.2720826247566036,0.8070029834041194,0.757328990228013,0.9855899418722408,1.0,4/37,4.88%,ATF6;HIPK2;SOX2;MEIS1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.25294741943156346,-0.8068944371178896,0.7791563275434243,0.9381150742577918,1.0,8/35,14.81%,SASH1;CYLD;XDH;EZR;ULK4;PER1;DLG1;PTPN22
prerank,positive regulation of interleukin-12 production (GO:0032735),0.27960367712087114,0.8068484044422224,0.761437908496732,0.985239667648163,1.0,3/31,9.59%,TIRAP;SYK;PLCB1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.33619412135366944,0.8067784366097117,0.702048417132216,0.9847541262868541,1.0,4/13,16.35%,SYK;CD81;CD9;CDH13
prerank,protein processing (GO:0016485),0.22625430720034562,0.8067490797946787,0.8569384835479256,0.9841830559869774,1.0,10/102,10.03%,PCSK1;PSEN2;MME;SEC11A;METAP2;SPCS3;SPPL3;OMA1;SPRTN;VSIR
prerank,positive regulation of leukocyte activation (GO:0002696),-0.28749858771839293,-0.8067479299085302,0.7397849462365591,0.9377302064216666,1.0,6/18,27.48%,LBP;THBS1;IL33;HSPD1;NECTIN2;KARS1
prerank,protein secretion (GO:0009306),-0.2189120714904995,-0.8064122471147529,0.8410958904109589,0.9376673494855386,1.0,14/56,18.71%,WLS;TANGO2;PCSK5;RAB3C;RAB8B;MON1A;ANXA1;ABCA1;STEAP3;RCN3;OLFM2;RAB8A;SCG2;MTTP
prerank,organonitrogen compound catabolic process (GO:1901565),0.24926433738330758,0.8062419267771468,0.7797147385103012,0.9845475507967638,1.0,3/57,3.22%,LVRN;AMDHD2;PPT1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.28989456592493335,0.8062205419297602,0.7451669595782073,0.9839761801383631,1.0,5/24,15.57%,PTPRJ;TEK;TSC1;MAP4K4;ARF6
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.2736525496950738,-0.8060925216560022,0.7793764988009593,0.9375699353000416,1.0,4/24,9.32%,CTNNB1;EPHA7;NUPR1;BACE1
prerank,regulation of superoxide anion generation (GO:0032928),0.3322865889488459,0.8060516836352445,0.7060931899641577,0.9836425807341693,1.0,2/14,6.70%,SOD1;SYK
prerank,endoplasmic reticulum organization (GO:0007029),0.23506318721897979,0.8057158754684398,0.8091603053435115,0.983644420513701,1.0,10/72,11.93%,REEP1;SMPD4;LMAN2;ATL1;LPCAT3;REEP3;DOP1B;APP;ZBED3;PRNP
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3235086299899798,0.805653392139175,0.7412844036697248,0.9831298430213906,1.0,1/16,0.61%,IMPDH1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.24783830294870213,-0.8049816895760508,0.7960687960687961,0.9389031185241046,1.0,15/33,37.14%,IFIH1;RNF135;POLR3C;MAVS;RIOK3;FLOT1;TLR3;OAS2;HSP90AA1;POLR3G;TOMM70;TLR7;POLR3D;ISG15;DHX58
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3113862790040528,0.8049287243123252,0.7283737024221453,0.9838812013497897,1.0,4/20,7.84%,ATP2A2;WFS1;RAP1GDS1;SELENOK
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.29936524603957115,0.8046772994917645,0.7440147329650092,0.9837438050818429,1.0,6/20,18.20%,PSEN2;RELA;MBTPS1;APH1A;ADAM9;SPPL2A
prerank,negative regulation of cholesterol transport (GO:0032375),-0.3400316882704846,-0.8046737656058807,0.7361963190184049,0.9387711706649448,1.0,2/10,31.25%,NFKB1;ABCA2
prerank,sister chromatid segregation (GO:0000819),0.27190165600890204,0.8044743248905428,0.7487266553480475,0.9835034982122733,1.0,4/31,10.51%,KIF18A;CHAMP1;CDCA8;MIS12
prerank,histone deubiquitination (GO:0016578),0.3150103190164867,0.8041512789626893,0.7287822878228782,0.9834776399904785,1.0,7/18,19.50%,ATXN7L3;USP22;USP15;TRRAP;BRCC3;USP36;UIMC1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3149473798801527,0.8036158399267114,0.7145593869731801,0.9838370263602172,1.0,5/17,15.81%,NCBP1;CPSF6;ZC3H14;RNF20;ZC3H3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.20307460637771993,-0.8032506737453738,0.882943143812709,0.9406155419608987,1.0,21/86,21.70%,NAV3;MAPT;OCLN;FER;CTTN;STMN2;AKAP9;SLAIN2;BIN1;SYNPO2;BAIAP2L1;FCHSD2;WDR1;CDC42EP5;DCTN1;CDC42EP1;SEMA5A;MET;CX3CL1;EFEMP2;PFN2
prerank,negative regulation of programmed cell death (GO:0043069),0.1987468416538008,0.8031335656209608,0.9409681227863046,0.9841682104308795,1.0,46/355,12.73%,HIGD2A;GCLC;MECOM;CBL;LEF1;PSEN2;PLK2;RPS6KA1;BCL2L2;GREM1;PPT1;SRC;BIRC2;HDAC3;TEK;RAB7A;CIAPIN1;HNRNPK;PHB2;WFS1;CFL1;CIB1;MAPK8;BAG1;PIM1;SIRT1;NAA35;USP47;WNT5A;TJP1;RELA;PCID2;PARK7;TMBIM4;CITED2;PRKAA2;DDX3X;HIGD1A;ANKLE2;PA2G4;BNIP3L;PRKCI;MAP4K4;IKBKB;API5;ERC1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3478678752181189,0.803063013205987,0.736936936936937,0.983668297168278,1.0,2/12,6.35%,PRPS1L1;PRPS1
prerank,telomere maintenance via telomerase (GO:0007004),-0.25962249647373664,-0.8028180015502266,0.7712082262210797,0.9407338511639003,1.0,15/28,34.28%,RFC1;RAD50;TNKS1BP1;MRE11;RPA1;PPP6C;PPP6R3;RTEL1;TELO2;HSP90AA1;CDK2;TERF1;TERF2;GAR1;TINF2
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.2846547900880432,-0.8024237243365939,0.7607223476297968,0.9407366527078975,1.0,4/19,9.34%,CBFB;IRAK1;IFIH1;ELF1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2996317707289592,0.8024133050862652,0.7522768670309654,0.9842837738722525,1.0,5/22,13.85%,CDK5RAP1;CDKN1A;LATS2;TFAP4;APC
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.26444116485007,0.8023096373983856,0.7744107744107744,0.9838674993115593,1.0,7/38,10.76%,TRIB3;PTPRJ;CIB1;SIRT1;DAG1;PHLPP1;OTUD3
prerank,vitamin transport (GO:0051180),0.2865367699254172,0.802296249014622,0.7768166089965398,0.9832718653120709,1.0,3/29,5.01%,ABCG2;SLC52A2;SLC52A3
prerank,regulation of histone deacetylation (GO:0031063),0.33515284548378554,0.8021820328060668,0.7145631067961165,0.9828486928552647,1.0,3/13,11.22%,AKAP8L;ING2;CTBP1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3393266450844985,-0.8020664873990964,0.726,0.9407112225398738,1.0,4/11,19.11%,STMN2;WDR1;NES;SEMA5A
prerank,cellular response to estrogen stimulus (GO:0071391),0.32202557781435126,0.8019324029285723,0.7408759124087592,0.9826817257177816,1.0,2/14,10.39%,ARID5A;WBP2
prerank,heterochromatin assembly (GO:0031507),-0.2796696508134823,-0.8017951482998154,0.7483731019522777,0.9404969888255444,1.0,10/20,29.75%,HDAC1;SIRT2;ZNFX1;CENPV;HELLS;SMCHD1;NRDE2;BAHD1;HMGA2;SUV39H1
prerank,regulation of mononuclear cell migration (GO:0071675),0.2987747146844377,0.8017822677729612,0.7313691507798961,0.9823354241183834,1.0,3/23,9.31%,MAPK3;CSF1R;LYN
prerank,histone H3-K4 trimethylation (GO:0080182),-0.3376673196043958,-0.8015426922849604,0.7659574468085106,0.9402807025651818,1.0,2/11,2.13%,OGT;KMT2A
prerank,regulation of endocytic recycling (GO:2001135),-0.32614022293978606,-0.8013185191130567,0.7139874739039666,0.9400232440378525,1.0,4/11,16.52%,ATP9A;SORL1;ACTN2;EHD1
prerank,negative regulation of hemostasis (GO:1900047),-0.32149970303507447,-0.8009036755120936,0.7331975560081466,0.9400890820973847,1.0,3/12,11.71%,TFPI;VTN;CD34
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.28645444921665814,0.800895587446642,0.7481884057971014,0.9833514053522898,1.0,9/26,19.35%,TRIB3;ADIPOR2;PRKAA2;ERLIN2;ADIPOR1;ACADL;EIF6;ELOVL5;NR1H3
prerank,regulation of plasminogen activation (GO:0010755),0.3391492491030893,0.8002727235937133,0.7281191806331471,0.9838407899555142,1.0,1/12,1.93%,PLGRKT
prerank,nucleosome organization (GO:0034728),0.24986533008207173,0.8001441668724417,0.806697108066971,0.9834427185415916,1.0,14/55,19.08%,DMAP1;NAP1L4;VPS72;RSF1;SMARCD1;ZNHIT1;BRD2;INO80;SMARCA4;SETD2;NPM1;ACTR6;ATRX;SMARCB1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.25916422807114337,-0.8000172761675912,0.7668997668997669,0.9409870189569078,1.0,11/27,27.55%,NAPEPLD;LPIN1;CHKA;SLC27A1;ETNK2;PCYT2;PLA2G6;LPIN2;CHKB;NAAA;LPIN3
prerank,steroid biosynthetic process (GO:0006694),0.24702375861756,0.799975271296052,0.7993680884676145,0.9831433061624147,1.0,9/56,13.79%,EBP;INSIG1;HMGCR;SC5D;OSBPL1A;HSD17B4;ACOT8;LSS;OSBPL2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.2841173053096623,-0.7999321651481438,0.7723214285714286,0.9404742649475373,1.0,7/20,26.70%,EGFR;PKD1;CCND3;CCNYL1;AKT1;SPDYA;TTBK1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.31386845629808624,0.7998760831090012,0.7293103448275862,0.9827266729318747,1.0,2/17,5.79%,ALG6;ALG8
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.36291293476144076,0.7995280520313888,0.7238658777120316,0.9827445458446328,1.0,4/10,21.13%,TXN;PARK7;PDE8A;LRRK2
prerank,organic substance transport (GO:0071702),-0.19403696870452714,-0.799163484486128,0.9120879120879121,0.9410702740365758,1.0,24/121,15.91%,CALCRL;ABCA9;SLC47A1;SNX4;ARRDC3;LRP1B;ABCA4;ABCA5;TCN2;SLC35F3;PLEKHA8;SLC22A4;SCAMP2;FLVCR1;KIF3A;ABCA1;CHKA;RAMP1;ABCD2;VAMP2;SLC22A6;RCN3;SCAMP5;SLC19A1
prerank,mitochondrion transport along microtubule (GO:0047497),0.33729984880171454,0.7989860879209173,0.7132352941176471,0.983151415061713,1.0,2/13,7.04%,MAP1S;UXT
prerank,arachidonate transport (GO:1903963),-0.3394303465356818,-0.7989033636568765,0.7330677290836654,0.9402306722627986,1.0,4/10,30.44%,ANXA1;ACE;BDKRB2;DRD2
prerank,arachidonic acid secretion (GO:0050482),-0.3394303465356818,-0.7989033636568765,0.7330677290836654,0.9402306722627986,1.0,4/10,30.44%,ANXA1;ACE;BDKRB2;DRD2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2606436041738797,0.7987390778040258,0.7766990291262136,0.9830103965842403,1.0,10/44,17.44%,VASP;EVL;ARPC4;PFN1;CDC42EP3;LMOD1;WHAMM;ARF6;PTK2B;BAIAP2
prerank,mitotic sister chromatid segregation (GO:0000070),0.22265850636872683,0.798554812408909,0.8593974175035868,0.9827230703684708,1.0,15/98,14.94%,KIF18A;NUDC;BOD1;DCTN2;TENT4A;CHMP1A;CDCA8;AKAP8L;CHMP2A;MIS12;CUL3;POGZ;PHF8;CSNK2A2;INO80
prerank,translesion synthesis (GO:0019985),-0.23227868695731912,-0.7981818373518323,0.8364116094986808,0.9408030358366511,1.0,30/42,46.52%,RFC1;RCHY1;ZBTB1;VCP;RPA1;UBC;NPLOC4;USP10;PRIMPOL;RFC2;POLN;PCNA;POLE2;POLI;UBE2L6;ISG15;REV3L;FAAP20;RPA3;RFC3;MAD2L2;UBA52;USP43;POLD2;RPA2;PCLAF;RFC4;POLDIP2;POLD4;POLD1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2259556187142766,0.797825246246814,0.8508771929824561,0.9834065317220017,1.0,15/88,14.53%,ILF3;PATL2;APOE;FXR1;PAIP2B;EDNRB;CNOT7;TSC1;DDX3X;NANOS3;RPS3;PLAT;YBX1;CNOT1;CAPRIN1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.29999445277981207,-0.7976117790025267,0.7428571428571429,0.9411567233017322,1.0,9/16,31.77%,PARP14;PIBF1;NF2;PTPN2;HGS;VHL;INPP5F;BCL3;CAV1
prerank,amide transport (GO:0042886),-0.2645562073096961,-0.7975891795924325,0.7755102040816326,0.9405464292497459,1.0,9/26,24.91%,PDPN;PLEKHA8;SLC25A32;SLC27A1;SLC19A1;SLC5A6;GLTP;ABCB9;AQP11
prerank,protein tetramerization (GO:0051262),0.238533927142777,0.7974771861669355,0.82574568288854,0.9834519240934428,1.0,11/67,14.95%,THG1L;GLS;B2M;SSBP1;ACACB;SOD2;CPSF6;TRPM4;CUTC;OSBPL2;HOMER1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.23488853186603761,0.7967490375289651,0.8365817091454273,0.9841060836514017,1.0,6/65,6.54%,CBL;PTPRJ;BCAR3;PTPN12;EPS15L1;ARHGEF7
prerank,positive regulation of intracellular transport (GO:0032388),0.2651268944380934,0.7966866675230608,0.7944535073409462,0.9835916241841474,1.0,5/38,9.94%,PRR5L;ZFAND1;ICE1;RUFY3;EIPR1
prerank,visual perception (GO:0007601),0.2307886253660817,0.7959131044065717,0.8184397163120567,0.9844285483274268,1.0,8/84,10.37%,RS1;ATF6;WFS1;DRAM2;EYA3;MYO9A;PITPNA;ABLIM1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2701852587064505,-0.7954487588971442,0.7589285714285714,0.9435722726384685,1.0,4/24,7.72%,ANK3;CEMIP;AKT2;FIS1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.29130967036257416,-0.7953471664014189,0.7473002159827213,0.9430799739588492,1.0,9/17,31.83%,SNAP25;STX3;STX1A;SNAP29;SYP;STX1B;AP3D1;SYNGR1;TOR1A
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.313491402920532,0.7953335700287296,0.7119266055045872,0.9848625339580125,1.0,2/16,10.76%,TRIB3;ERLIN2
prerank,vesicle transport along actin filament (GO:0030050),0.3031071531807998,0.7951526176257343,0.745945945945946,0.9845747377596152,1.0,4/19,13.12%,MYO5A;ACTN4;MYO1D;MYO1E
prerank,maturation of 5.8S rRNA (GO:0000460),-0.29345457329025687,-0.7950477883544165,0.7671840354767184,0.9429492089188498,1.0,8/17,23.70%,NSA2;EXOSC10;LAS1L;MTREX;C1D;RPF1;NOL9;MAK16
prerank,negative regulation of kinase activity (GO:0033673),0.2380992284516828,0.7948970128595787,0.8136094674556213,0.9844000316036048,1.0,8/62,9.76%,TRIB3;PTPRC;GNAQ;SPRED1;AKT1S1;DTNBP1;IRS2;PARK7
prerank,protein autoprocessing (GO:0016540),0.3142581151871191,0.7948079592763674,0.7486338797814208,0.9839370685878618,1.0,2/17,9.11%,OMA1;SPRTN
prerank,mitotic DNA replication (GO:1902969),0.3608571984277941,0.7941919171777311,0.708984375,0.9844134917771851,1.0,2/10,9.29%,CDC45;POLA1
prerank,vasoconstriction (GO:0042310),0.3533482390787064,0.7940027073153586,0.7196078431372549,0.9841340832827327,1.0,3/11,14.60%,EDNRB;ACTA2;PIK3C2A
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3225433155309429,0.7937576472059484,0.7226277372262774,0.9839527059085856,1.0,3/15,13.34%,NEK11;HUS1;CHEK2
prerank,negative regulation of phagocytosis (GO:0050765),-0.2952410217423501,-0.7929436509943557,0.7697368421052632,0.9458299188598833,1.0,7/17,22.55%,PIP4P2;PLSCR1;SYT11;SIRPA;RACK1;SNX3;APPL1
prerank,protein localization to Golgi apparatus (GO:0034067),0.27930143202159224,0.792393241930903,0.7421052631578947,0.9857824361770338,1.0,6/27,10.13%,ARL5C;RAB6A;TMED10;ARL5B;ZDHHC15;GCC2
prerank,regulation of mast cell activation (GO:0033003),0.3592110328428538,0.7923525378134759,0.7324478178368121,0.9852372420961382,1.0,2/10,9.52%,LYN;CD84
prerank,positive regulation of organelle assembly (GO:1902117),0.2531658441757768,0.7918449856893873,0.7960122699386503,0.9854936965578318,1.0,9/44,15.37%,LCP1;RALB;CNOT2;G3BP2;CNOT6;CNOT1;ASAP1;CNOT6L;RAB3GAP1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2692750107844581,0.7916212376551495,0.7529021558872305,0.985309091585036,1.0,4/33,9.19%,TNFAIP3;PRKG1;CDKN1A;SOD2
prerank,melanosome organization (GO:0032438),0.2864150437546611,0.7913771641572369,0.7698815566835872,0.9851484948458578,1.0,6/26,16.44%,DTNBP1;AP1G1;PIKFYVE;KIF13A;SNAPIN;BLOC1S5
prerank,gonad development (GO:0008406),-0.23395779800053768,-0.7913441412286464,0.8516624040920716,0.947778260946454,1.0,6/41,12.95%,NR2F2;KIT;WNT4;SALL1;NCOA4;MSH2
prerank,regulation of protein sumoylation (GO:0033233),0.3095670710427691,0.7909169226698827,0.7323135755258127,0.9853852886217427,1.0,4/17,11.39%,SAE1;UBA2;PARK7;PIAS1
prerank,protein localization to kinetochore (GO:0034501),0.3211712605400965,0.7908631599104414,0.7400379506641366,0.9848657855428398,1.0,3/14,14.59%,CHAMP1;MIS12;MTBP
prerank,histone H3-K4 methylation (GO:0051568),-0.26022266800337124,-0.7907424233124467,0.7801418439716312,0.9481161861780297,1.0,8/26,20.70%,OGT;KMT2A;PAXIP1;RBBP5;KMT2B;KMT2D;DPY30;SETD4
prerank,base-excision repair (GO:0006284),0.2519556534326069,0.7906958646989934,0.7800312012480499,0.984554318202185,1.0,8/48,13.19%,PNKP;XRCC1;TDG;POLE;POLD3;USP47;SMUG1;MPG
prerank,cellular response to hormone stimulus (GO:0032870),0.2330405314257804,0.7900517674416918,0.8422619047619048,0.9851095556171282,1.0,9/69,10.75%,ARID5A;GAS2L1;SRC;PAX8;ZFP36L1;RAMP2;LMO2;WBP2;THRB
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.25713763290902397,0.7899739565182147,0.7851239669421488,0.9846143312577008,1.0,12/39,18.36%,ACER2;NEXMIF;ACTN4;NOTCH1;HOXA7;MAP4K4;AP1AR;CORO2B;SEMA3E;MELTF;CORO1C;CASK
prerank,cellular defense response (GO:0006968),-0.23180482658185275,-0.7898608757242872,0.8284182305630027,0.9489195466830664,1.0,6/40,14.56%,DCDC2;LBP;CCR9;LSP1;TCIRG1;RAB23
prerank,glycoprotein biosynthetic process (GO:0009101),-0.20273071038757856,-0.7896666966049641,0.8984126984126984,0.9485818362094829,1.0,34/79,35.61%,IGF1;ATP7A;CSGALNACT2;PMM2;GOLGA2;FUT10;CHST11;LARGE1;B3GALT5;ST3GAL4;TNIP1;B3GALNT1;BMPR1B;B3GALT1;ST8SIA2;CHST8;BMPR2;ALG5;ALG10B;CANT1;SERP1;FOXL1;CHST12;B4GALT7;ALG1;B3GALT2;DDOST;CHST10;B4GALT5;GCNT1;TMEM106A;ST8SIA3;ST8SIA5;ST3GAL5
prerank,response to ketone (GO:1901654),-0.2669222453772276,-0.7887471773357807,0.7852193995381063,0.9494177869537093,1.0,9/24,33.80%,TGFBR3;THBS1;TGFB1;CATSPER2;YAP1;TGFB3;CAV1;ABCB4;CATSPER3
prerank,modulation by host of viral genome replication (GO:0044827),0.3262672946956129,0.7885638472716837,0.7335907335907336,0.9864994216023435,1.0,7/13,23.68%,PPIB;IFI27;YTHDC2;EIF2AK4;TBC1D20;VAPA;FMR1
prerank,phospholipid translocation (GO:0045332),0.2789976184128196,0.7884972340857437,0.76,0.9859938031271959,1.0,6/28,13.90%,ATP8A1;ATP11A;TMEM30B;P2RX7;ATP11C;ATP10A
prerank,response to lipopolysaccharide (GO:0032496),0.21059198354431025,0.7882035259639999,0.8883048620236531,0.9858837158557457,1.0,19/138,13.00%,TNFAIP3;TAB2;TIRAP;SBNO2;TNFRSF1B;MAPK8;CARD16;SELP;WNT5A;ERBIN;RELA;IFNAR1;NFKBIL1;NOS3;SCARB1;PLAA;TNIP2;OTUD5;CD274
prerank,lamellipodium assembly (GO:0030032),-0.2587061338185287,-0.7877823988936149,0.8023809523809524,0.9503738524960322,1.0,9/26,21.62%,KIT;VCL;SPATA13;ABLIM2;ABLIM3;PTPRO;ARFIP2;ARHGEF4;P2RY12
prerank,positive regulation of behavior (GO:0048520),-0.3372224340564355,-0.7877021122022588,0.7593360995850622,0.9498598696456918,1.0,4/10,23.35%,CFAP20;NLGN1;NPAS2;STRA6
prerank,protein monoubiquitination (GO:0006513),0.26565888340012506,0.7874492082265102,0.7860696517412935,0.9865501362887749,1.0,8/36,14.31%,RAD18;TRIM25;ATXN7L3;UBE3D;CUL3;UBE2R2;RNF20;FANCL
prerank,regulation of cell death (GO:0010941),0.22452319591868286,0.7874325214469691,0.8481894150417827,0.9859655291294914,1.0,18/94,17.16%,RAD18;SNCG;SLC25A24;TXNDC12;ACER2;TNFRSF1B;TSC1;PARK7;CHMP2A;ACER3;BNIP3L;FAF1;APC;SPEF1;VPS35;BNIP3;BECN1;PDE8A
prerank,embryonic heart tube development (GO:0035050),0.322661093883873,0.787378717538046,0.73992673992674,0.9854558685901927,1.0,5/14,19.21%,CITED2;HES1;SOX17;RYR2;IFT122
prerank,protein O-linked mannosylation (GO:0035269),-0.2880019278080359,-0.7872999281276034,0.7570093457943925,0.9498965090547133,1.0,6/18,13.05%,TMTC4;TMTC1;DPM1;RXYLT1;LARGE1;FKTN
prerank,acylglycerol catabolic process (GO:0046464),0.2741239257395577,0.7871150073850639,0.7750865051903114,0.985346947896019,1.0,29/30,65.45%,FABP7;ABHD12;ABHD16A;FABP2;PNLIPRP2;PNPLA1;PNPLA5;LIPI;ABHD12B;APOC3;FABP6;CPS1;APOA2;LIPG;ABHD6;FABP12;FABP4;ABHD2;LIPC;LIPH;FABP3;MGLL;FAAH;DAGLA;PNPLA3;FABP5;LPL;PNPLA2;LYPLA2
prerank,ruffle organization (GO:0031529),-0.296842858180528,-0.7862955100749938,0.7741176470588236,0.9509034766403207,1.0,3/16,6.02%,LIMA1;TPM1;PIP5K1A
prerank,positive regulation of MAP kinase activity (GO:0043406),0.23478338717605687,0.7858696169846406,0.841079460269865,0.9869094980797193,1.0,9/66,11.82%,MAP3K11;PIK3CG;EZH2;MAP3K7;MAP3K4;PAK1;FLT1;RPS3;PIK3R5
prerank,mitotic nuclear membrane organization (GO:0101024),-0.22294801452475269,-0.78583284546077,0.8558823529411764,0.9503494163512595,1.0,19/51,25.20%,SIRT2;PPP2R2A;LMNA;NUP205;IST1;NUP155;NUP188;AHCTF1;NUP93;SEH1L;CHMP2B;NUP85;CC2D1B;NUP37;VPS4A;EMD;LEMD2;SEC13;LBR
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.22294801452475269,-0.78583284546077,0.8558823529411764,0.9503494163512595,1.0,19/51,25.20%,SIRT2;PPP2R2A;LMNA;NUP205;IST1;NUP155;NUP188;AHCTF1;NUP93;SEH1L;CHMP2B;NUP85;CC2D1B;NUP37;VPS4A;EMD;LEMD2;SEC13;LBR
prerank,regulation of interleukin-10 production (GO:0032653),0.25246011246816125,0.7858010016882019,0.8084112149532711,0.9864159138911391,1.0,5/44,13.00%,FCGR2B;SYK;CD47;VSIR;CD274
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2263967373033917,0.7856778412681442,0.8660968660968661,0.9860244637683776,1.0,15/88,13.81%,TAL1;SLF1;TIRAP;PFN1;RAB7A;ICE1;SYK;RGCC;PARK7;CHMP2A;RPS3;BMF;CDH5;PLEK;FAF1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.31565097581014107,0.7856169980201568,0.7549549549549549,0.9855090506203983,1.0,2/15,8.11%,SMAD7;CUEDC2
prerank,regulation of mitotic spindle organization (GO:0060236),-0.23806709097778841,-0.785578415693056,0.8165374677002584,0.9500979495776356,1.0,8/35,20.56%,DYNC1H1;PARP3;EML3;DCTN1;CHMP2B;CHMP5;RAE1;MAP9
prerank,extracellular matrix disassembly (GO:0022617),0.2459674457537369,0.7854483254711209,0.8077519379844961,0.9851909101208539,1.0,4/53,4.44%,LCP1;BSG;EXOC8;MMP12
prerank,reverse cholesterol transport (GO:0043691),0.32561432004925794,0.7853456193096651,0.7485714285714286,0.984771264011872,1.0,2/13,11.85%,APOE;SCARB1
prerank,cellular component disassembly (GO:0022411),0.24616175399185602,0.7853122352512006,0.8116169544740973,0.9842139301520004,1.0,4/53,4.44%,LCP1;BSG;EXOC8;MMP12
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.24724973324674115,-0.7852757352070608,0.8133333333333334,0.9499129291117656,1.0,4/30,14.90%,PIBF1;PRKCZ;CD34;HSPD1
prerank,proton transmembrane transport (GO:1902600),0.263010757208611,0.7844609624069899,0.8153078202995009,0.9850507763578655,1.0,5/36,11.55%,UCP2;SLC25A27;ATP6V0D1;ATP6V0E1;COX15
prerank,cellular response to interferon-gamma (GO:0071346),0.2218181709213833,0.7844400598820137,0.8654970760233918,0.9844844554681194,1.0,15/88,15.68%,TRIM8;GBP3;IRF9;B2M;GBP4;ICAM1;TRIM25;CCL25;WNT5A;CD47;IRF2;MID1;MT2A;CD44;CAMK2G
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3065873210309246,0.7844195044729694,0.7743682310469314,0.9839098943002464,1.0,1/18,4.13%,ZFP36L1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.3260939677202591,-0.7843483811390372,0.7604166666666666,0.950773594024143,1.0,3/10,13.61%,ITGA5;VTN;GRB10
prerank,negative regulation of T cell activation (GO:0050868),0.26026635089294325,0.784171522488481,0.7922948073701842,0.9837217253141094,1.0,4/35,14.50%,FCGR2B;RIPOR2;CD274;PAG1
prerank,negative regulation of insulin secretion (GO:0046676),-0.2854410234643114,-0.7841465514352605,0.7606263982102909,0.950439448790936,1.0,8/17,40.78%,PSMD9;CCN3;ADRA2A;SFRP1;SIRT4;PIM3;CHGA;INHBB
prerank,regulation of monocyte chemotaxis (GO:0090025),0.28603023340169725,0.7837089297678701,0.7714776632302406,0.9839086388739128,1.0,3/24,9.31%,CXCL12;GREM1;LYN
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3522112475564415,0.7835635545468244,0.7281746031746031,0.9835679538049427,1.0,1/10,0.91%,NCBP1
prerank,linoleic acid metabolic process (GO:0043651),-0.28883400214910104,-0.7834812926402268,0.7505720823798627,0.9508797557353361,1.0,6/17,37.59%,ACSL1;FADS2;ELOVL1;FADS1;GSTM2;ALOX12
prerank,negative regulation of leukocyte activation (GO:0002695),-0.3010303437671798,-0.7833373003119207,0.7601713062098501,0.9504701003707069,1.0,2/15,7.05%,LRFN5;IL31RA
prerank,hippo signaling (GO:0035329),0.2850796830477529,0.7830696824773792,0.7953410981697171,0.9838143455843059,1.0,5/26,9.10%,AMOTL1;YWHAB;TJP1;LATS2;MOB1B
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3260711535580989,-0.7827625463679572,0.7510729613733905,0.9507918176402785,1.0,6/11,24.48%,LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2763156461477074,0.7827171917055114,0.7731958762886598,0.9838143343256803,1.0,2/27,3.86%,RRM2B;NME1
prerank,glycolipid biosynthetic process (GO:0009247),-0.232276257961523,-0.7825254128298889,0.8345679012345679,0.9505090899166382,1.0,19/38,35.61%,A4GALT;B4GALT6;DPM1;ST6GALNAC5;LARGE1;ST3GAL4;PIGV;PIGG;PIGA;PIGM;PGAP4;PIGF;MPPE1;DPM2;PIGC;DPM3;ST8SIA3;ST8SIA5;ST3GAL5
prerank,membrane raft organization (GO:0031579),-0.2969275195848112,-0.7825095480001115,0.7806451612903226,0.9498924305092526,1.0,7/15,28.71%,ANXA2;FLOT2;MYADM;FLOT1;CLN3;EMP2;ABCA7
prerank,negative regulation of endocytosis (GO:0045806),-0.2595443908615328,-0.7821347801853926,0.8113636363636364,0.9498614497590775,1.0,10/24,32.26%,EPHA3;SYT11;SCAMP5;LRSAM1;PRKD1;NR1H2;ABCA7;PACSIN3;CAV1;CD300A
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.29901836774328716,-0.7818178208328264,0.7505285412262156,0.9496998689846282,1.0,6/15,16.40%,BAG3;ANP32B;GSK3B;TP53;CAMK1;TCF7L2
prerank,negative regulation of histone modification (GO:0031057),0.31699530459422226,0.7818161870868869,0.75,0.9847786499875287,1.0,1/14,0.92%,AASS
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.2627083416163097,-0.7814406736979156,0.7802690582959642,0.9496873833050313,1.0,5/22,16.34%,MAN1C1;UGGT2;UBC;EDEM1;RNF139
prerank,regulation of erythrocyte differentiation (GO:0045646),0.26581311313504585,0.7813342058963705,0.7951219512195122,0.9849576721996872,1.0,5/35,10.55%,TAL1;ABCB10;ZFP36L1;LYN;ACVR2A
prerank,regulation of defense response to virus by host (GO:0050691),0.2686084990168279,0.7811124900680477,0.7838709677419354,0.9847357659653582,1.0,2/30,2.81%,TNFAIP3;IFNLR1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.3268943960772168,-0.7810243316604785,0.7304526748971193,0.9496932254359072,1.0,7/11,38.36%,EXOSC10;LARP7;EXOSC2;EXOSC3;EXOSC5;TENT4B;FBL
prerank,regulation of receptor recycling (GO:0001919),-0.29180177307802896,-0.7809294336952739,0.7833698030634574,0.9491935599529437,1.0,7/16,30.10%,ANXA2;OPTN;TBC1D16;RAB29;INPP5F;SNCA;SCRIB
prerank,regulation of centrosome cycle (GO:0046605),0.2939211688399897,0.7808025820993979,0.7800369685767098,0.9846690957292092,1.0,5/21,18.09%,CHMP1A;SIRT1;CHMP2A;NPM1;VPS4B
prerank,nuclear pore organization (GO:0006999),-0.30178307334772664,-0.7807847813124382,0.7680525164113785,0.9487913324815636,1.0,4/14,13.34%,NUP205;AHCTF1;NUP93;SEH1L
prerank,polyamine metabolic process (GO:0006595),0.33249434550715806,0.780258944640534,0.7707948243992606,0.9849644259717975,1.0,4/13,15.26%,SMOX;DHPS;AMD1;ODC1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3357330040740757,-0.7797675719739486,0.7563025210084033,0.949765526666452,1.0,9/10,51.67%,NAF1;RPUSD4;GAR1;NOP10;TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,positive regulation of mitochondrion organization (GO:0010822),0.23768306788471,0.7791806353689508,0.8262910798122066,0.9861675247425346,1.0,13/57,16.49%,GSK3A;RALA;ZNF205;DDHD1;PARK7;FBXO7;BAD;BMF;MIEF1;CAMKK2;VPS35;DNM1L;BNIP3
prerank,carboxylic acid catabolic process (GO:0046395),0.33722966446888125,0.7791786013437609,0.7381889763779528,0.9855689751494311,1.0,2/12,11.77%,AMDHD2;ACOT8
prerank,regulation of response to interferon-gamma (GO:0060330),-0.29531104873578956,-0.7791036987009475,0.7802690582959642,0.9502004508552001,1.0,5/14,19.49%,JAK1;IFNGR1;PTPN2;IFNGR2;STAT1
prerank,regulation of actin filament polymerization (GO:0030833),0.2336853426611626,0.7789703372880169,0.8516886930983847,0.9852858701123278,1.0,16/69,18.87%,VASP;EVL;PFN1;CYRIB;KANK3;SSH2;PAK3;ESAM;CDC42EP3;TWF1;LMOD1;ARF6;PTK2B;BAIAP2;ARFGEF1;PRKCE
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2698082330411396,-0.7786224093321267,0.7772511848341233,0.9503321538676853,1.0,5/21,20.01%,ZWINT;KLHL22;BUB3;ATM;ZW10
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.25268784405863115,-0.7783556884285424,0.7976470588235294,0.9501042554167124,1.0,1/26,0.15%,ATP1A2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.34570861840641504,0.7783137243797118,0.7235772357723578,0.9858187665300725,1.0,1/10,2.23%,SOD1
prerank,B cell homeostasis (GO:0001782),0.34322434844363037,0.7778629604206693,0.728515625,0.985945924475887,1.0,2/10,9.31%,TNFAIP3;LYN
prerank,response to interleukin-1 (GO:0070555),-0.20251682638104215,-0.777820220691961,0.9226006191950464,0.9502411618169754,1.0,13/73,16.27%,ADAMTS12;HDAC4;RBMX;IRAK1;PTGIS;IRAK3;NFKB1;ANXA1;SIRPA;CCL14;UPF1;USP10;TANK
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.28968018900895787,-0.7776891353176252,0.7757437070938215,0.9497965951306259,1.0,2/16,1.62%,DPYD;DPYSL3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2964579838678652,-0.7775948440796044,0.7777777777777778,0.9493192567634168,1.0,9/15,32.88%,RAB3GAP2;SEC61A1;EDEM1;SRPRB;SRP14;ZFAND2A;SEC61G;SRPRA;SPCS1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2778100403300294,0.7774936290416572,0.7742998352553542,0.9859551249415647,1.0,7/27,15.85%,SPRED1;PTTG1IP;SIRT1;YJU2;MDM2;CD44;ATR
prerank,P-body assembly (GO:0033962),0.333304122005318,0.7774416704993511,0.7339805825242719,0.9854353530304292,1.0,2/12,9.63%,PATL2;PATL1
prerank,catecholamine biosynthetic process (GO:0042423),-0.3263022382372326,-0.7765723500362153,0.7775510204081633,0.9502801934775216,1.0,1/11,2.84%,MOXD1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.28467385894363595,0.7763149461807746,0.8074866310160428,0.9867219844655951,1.0,2/23,6.21%,TNFAIP3;CARD16
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.33422597770898177,-0.7762133023605919,0.7670682730923695,0.9501379145624574,1.0,3/10,12.55%,MTHFD2L;MTHFR;MTHFD1
prerank,DNA alkylation (GO:0006305),0.297996544262934,0.7751226609874079,0.7814814814814814,0.987448362116545,1.0,2/19,5.83%,DMAP1;BEND3
prerank,DNA methylation or demethylation (GO:0044728),0.297996544262934,0.7751226609874079,0.7814814814814814,0.987448362116545,1.0,2/19,5.83%,DMAP1;BEND3
prerank,brain morphogenesis (GO:0048854),-0.31878627741489657,-0.7747762461651372,0.7620889748549323,0.9516283149804102,1.0,2/12,5.15%,CTNNA2;FBXW11
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2530784206405482,-0.7746279504453382,0.8177339901477833,0.9512017024293268,1.0,5/28,9.05%,EGFR;MMP14;WWP2;NOTCH3;NIBAN2
prerank,regulation of DNA metabolic process (GO:0051052),0.24926474754186284,0.773785370727049,0.8116883116883117,0.9890749466301829,1.0,13/44,18.25%,STOX1;SMG1;UBE2V2;UBE2V1;KPNA1;NBN;HELB;TERF2IP;WDR70;SMARCAD1;SMG6;POLH;SMG5
prerank,protein targeting to lysosome (GO:0006622),-0.2689703939958572,-0.7737417702998598,0.8146453089244852,0.9518912530557837,1.0,10/20,22.01%,SORL1;ZFYVE16;NCOA4;M6PR;AP4M1;GGA3;NEDD4;VPS4A;GNPTAB;HGS
prerank,response to amyloid-beta (GO:1904645),0.2509806256938999,0.7736065977292078,0.8252427184466019,0.9887455235238524,1.0,7/44,11.93%,CACNA1A;FCGR2B;MMP12;FYN;ICAM1;APP;PRNP
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2749703699225986,0.7732732535116845,0.7923875432525952,0.9886918593826963,1.0,5/28,12.78%,CXCL12;PFN1;PAK3;ESAM;NAA80
prerank,regulation of synapse maturation (GO:0090128),-0.33643677912269115,-0.7732634227184951,0.7560975609756098,0.9519846929337767,1.0,2/10,5.33%,NRXN1;RELN
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.2929840037930048,0.77325664298892,0.7692307692307693,0.9881159434719525,1.0,5/20,10.80%,HEY1;HEY2;NOTCH1;ACVRL1;RBPJ
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.33740430494546325,0.7731630429791639,0.7485265225933202,0.9876606360338814,1.0,2/10,8.04%,TNFRSF1B;NOTCH1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3340266604446878,0.7728887502645184,0.7447619047619047,0.9875142725880789,1.0,3/11,14.51%,TRIM28;PPHLN1;TASOR
prerank,protein complex oligomerization (GO:0051259),0.22406191062362105,0.7726326761766883,0.874095513748191,0.9873246843038809,1.0,13/85,12.33%,RS1;EHD4;ATL1;BEND3;LRRC8C;TRMT61B;CPSF6;CHMP2A;MAT2A;HGSNAT;G3BP2;LETM1;CUTC
prerank,positive regulation of signaling receptor activity (GO:2000273),0.25729661759509964,0.7725471604805777,0.7775947281713345,0.9868739738536999,1.0,4/36,9.86%,SHANK3;GREM1;PARK7;BUD31
prerank,cellular senescence (GO:0090398),-0.2521893802728303,-0.7723903718245095,0.8285024154589372,0.9526614790012012,1.0,5/27,11.62%,MAPK14;PRKCD;PML;SMC6;TBX3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.32903854717771724,0.7723113274765242,0.7648183556405354,0.9866586619917078,1.0,3/12,13.34%,NAE1;HUS1;CHEK2
prerank,positive regulation of bone resorption (GO:0045780),0.34227209924473445,0.7722485389736253,0.7585551330798479,0.986158993005851,1.0,2/11,10.69%,SYK;ATP6AP1
prerank,sulfur compound catabolic process (GO:0044273),0.25759001892330075,0.7720459404823513,0.8180272108843537,0.9858720272164176,1.0,7/38,14.21%,GLB1;MLYCD;FITM2;ACAT1;IDS;GALNS;TXN2
prerank,regulation of cell cycle process (GO:0010564),-0.18722858923925995,-0.7718786766556393,0.9608540925266904,0.9527859618422272,1.0,28/104,25.75%,DYNC1H1;CTNNB1;RPRD1B;CUL9;PIK3C3;AHCTF1;UVRAG;E4F1;OBSL1;SND1;RAB11A;USP19;ENTR1;CAV2;CCP110;TTL;CEP250;CDC42;ATF5;TXLNG;MAP9;MYO19;FLCN;RAB11FIP4;PRMT5;BCL2L1;GIT1;SFRP1
prerank,nucleoside catabolic process (GO:0009164),0.34084178043738944,0.7714938570518759,0.7454873646209387,0.9861879145494049,1.0,2/11,9.50%,UPP1;UPP2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.23785067363805723,-0.7712864551475834,0.8692307692307693,0.9530497332565501,1.0,5/30,11.56%,DDX5;FHIT;PAXIP1;TP53;STK11
prerank,positive regulation of neuron migration (GO:2001224),0.3346382609206368,0.7711540084781391,0.7813765182186235,0.986169504949749,1.0,1/11,0.88%,SEMA6A
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3221989775367904,0.7706553988498003,0.7706422018348624,0.9863896421408347,1.0,3/14,9.91%,TIRAP;HNRNPC;TARDBP
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.2768370057991501,-0.7703296201803811,0.7866108786610879,0.9537786964985356,1.0,5/19,18.37%,NFAT5;PLCE1;NFATC2;PPP3CC;NFATC4
prerank,regulation of nuclear division (GO:0051783),0.29219886212393914,0.7702832348074223,0.7843803056027164,0.9864061251147717,1.0,2/20,7.00%,PIN1;FBXO5
prerank,transferrin transport (GO:0033572),0.2612173977115489,0.7698540249580342,0.7989778534923339,0.9865111078823181,1.0,5/33,10.69%,ATP6V1D;RAB11B;ATP6V0D1;ATP6V0E1;ATP6AP1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.28628182801499535,0.7692026832453766,0.7647058823529411,0.9869414336691866,1.0,6/21,14.12%,CLASP2;CIB1;FGF13;CAMSAP2;APC;SPEF1
prerank,microtubule anchoring at centrosome (GO:0034454),-0.33006384499744673,-0.7691845320474875,0.7832310838445807,0.954827384536874,1.0,3/10,15.73%,NINL;KIF3A;DCTN1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.3029975763239262,-0.7687252760289094,0.7780126849894292,0.954859067404335,1.0,5/14,17.75%,DDX1;CSTF2;RTCB;RTRAF;ZBTB8OS
prerank,endothelial cell differentiation (GO:0045446),-0.31032554152651665,-0.7686845349810218,0.7780040733197556,0.9542870093097272,1.0,4/12,21.98%,FSTL1;SCUBE1;BMPR2;KDM6B
prerank,aminoglycan catabolic process (GO:0006026),0.2766516116519778,0.7686645591268536,0.8091993185689949,0.9872271618618373,1.0,6/28,12.35%,SGSH;GLB1;FUCA1;HGSNAT;AGRN;IDS
prerank,mRNA modification (GO:0016556),-0.26452996986963223,-0.7684166375127505,0.7947494033412887,0.9540387721138714,1.0,7/22,24.02%,PUS7;VIRMA;CBLL1;TRUB1;PCIF1;TRMT6;CMTR1
prerank,phospholipid metabolic process (GO:0006644),-0.19997828703050546,-0.7682833192937335,0.9166666666666666,0.9536159264356314,1.0,13/71,16.53%,PLA2G4A;PLPPR1;AGPAT4;PLPP3;AGPAT5;PIP5K1A;PLPPR5;PIP4K2B;SMPD3;PLPPR4;PCYT2;FDFT1;PLCD1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.24582015673936916,0.7681851784961321,0.8379705400981997,0.9874116419666997,1.0,5/42,8.86%,PTPRJ;TEK;CIB1;CCL25;TSC1
prerank,synaptic vesicle localization (GO:0097479),-0.30675990998002683,-0.7676750588141316,0.7737068965517241,0.9539544545573064,1.0,4/13,15.74%,KIF5C;SYNDIG1;NLGN1;KIF5A
prerank,negative regulation of hormone secretion (GO:0046888),0.3400225015907913,0.76726421656591,0.765625,0.9882958182100371,1.0,2/10,17.43%,RAB11FIP5;RAB11FIP1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.31507795552480533,0.7668366433793815,0.7761467889908257,0.9883781078050579,1.0,1/16,0.39%,BCAP29
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.33386773625974686,-0.7668031450624982,0.7828685258964143,0.9545804615980723,1.0,3/10,20.67%,ATP7A;KYAT1;QDPR
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.22438359768904162,-0.7664574605742026,0.8429319371727748,0.9544480821378114,1.0,3/41,4.84%,PLA2G4A;ACSL1;EPHX1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.23780425271966604,-0.7661863212853809,0.8497536945812808,0.9542125408789945,1.0,9/33,15.46%,PKD1;APPL2;CDKN1B;CDC73;DDRGK1;STXBP4;TRIM39;PAF1;MN1
prerank,lymphocyte chemotaxis (GO:0048247),0.25951834283485997,0.7658752319557789,0.8350340136054422,0.989366814989556,1.0,4/34,15.25%,PIK3CG;CCL25;PIK3CD;GAS6
prerank,negative regulation of cell cycle process (GO:0010948),0.23147810212920797,0.7654867975639885,0.8706070287539937,0.98941952636092,1.0,8/61,10.41%,EZH2;EED;FBXO5;UXT;BMI1;CHMP2A;RYBP;MGA
prerank,nucleotide metabolic process (GO:0009117),0.28008559671566996,0.7651470159728575,0.7867383512544803,0.9893394867783816,1.0,4/23,10.60%,REXO2;NUDT5;PARK7;PNP
prerank,negative regulation of transport (GO:0051051),0.23859787547326394,0.7649344954257118,0.8401976935749588,0.989077477806495,1.0,3/51,4.78%,RSC1A1;FCGR2B;RAB7A
prerank,regulation of activated T cell proliferation (GO:0046006),0.2670264825831571,0.7646100298108309,0.8130360205831904,0.9889928498022269,1.0,4/30,13.00%,PRKAR1A;RPS3;PRNP;CD274
prerank,establishment of protein localization to organelle (GO:0072594),0.2242140414915814,0.7643988868891656,0.8696969696969697,0.9887335319399299,1.0,19/72,19.26%,MMP12;PHB2;RALA;PTTG1IP;SYK;NXT1;NUP50;RANBP17;ZDHHC15;E2F3;TSPAN17;IPO8;HIKESHI;KPNB1;POM121;STAT3;RYR2;LAMP2;NUP133
prerank,response to estradiol (GO:0032355),-0.24017979865703473,-0.7642323825515641,0.8582677165354331,0.9563816753322898,1.0,6/31,16.22%,EGFR;CTNNB1;SOCS2;ANXA1;GGT5;TGFB1
prerank,excitatory postsynaptic potential (GO:0060079),-0.2759799005930594,-0.7641172742278242,0.8082788671023965,0.9559230621905384,1.0,7/19,24.52%,GRID2;GRIN2B;GSK3B;GRIN2D;GRIN1;MPP2;AKT1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.22585534312949992,0.763685756940248,0.8723404255319149,0.9892269779864636,1.0,6/69,11.27%,PTPRJ;PTPRC;TIRAP;SYK;WNT5A;APP
prerank,response to acidic pH (GO:0010447),0.31903857048566187,0.7635447608819678,0.7589641434262948,0.9888355374857398,1.0,2/13,8.00%,RAB11B;RAB11FIP5
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2149885678404854,0.7633292635681259,0.9044943820224719,0.9885448073467319,1.0,16/95,14.94%,ZSWIM7;ERCC4;YY1;XRCC1;SFPQ;CDC45;KDM4D;SEM1;RFWD3;EXD2;RAD51B;HUS1;NBN;PSMD14;RMI1;INO80
prerank,histone lysine methylation (GO:0034968),-0.24306317079050396,-0.763276432843167,0.8389610389610389,0.9564911460985203,1.0,11/33,19.77%,PRDM5;KMT2A;PAXIP1;RBBP5;EHMT2;SETDB2;KMT2B;SMYD2;KMT2D;DPY30;N6AMT1
prerank,regulation of mitochondrion organization (GO:0010821),0.24180367567450806,0.7628163219159397,0.844551282051282,0.9887353072070532,1.0,5/47,7.51%,GSK3A;STOX1;CYRIB;EP300;OMA1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.24411280510679148,0.7624059226425841,0.8467874794069192,0.98877349933339,1.0,9/50,11.52%,IFI35;PHB2;EP300;ACTN4;RELA;DDX3X;APP;NOD1;RPS3
prerank,ERAD pathway (GO:0036503),0.2193998318137464,0.7623575242260519,0.8829787234042553,0.9882653457256759,1.0,24/83,19.57%,DERL2;YOD1;WFS1;FAM8A1;SGTB;TRIM25;AUP1;RHBDD2;ERLIN2;STT3B;UBQLN1;PSMC6;DNAJC10;UFD1;UBQLN2;DNAJB14;ATXN3;UBXN4;UGGT1;DNAJB9;POMT2;CCDC47;DERL1;SEL1L
prerank,positive regulation of leukocyte migration (GO:0002687),-0.2515908258740039,-0.7622979301887779,0.8106060606060606,0.9572414563268417,1.0,8/27,35.10%,IL6R;JAM3;VEGFA;NCKAP1L;MDK;PTN;THY1;EDN3
prerank,negative regulation of GTPase activity (GO:0034260),-0.25755883774655486,-0.7622954853977908,0.8282608695652174,0.9566115232626182,1.0,4/22,11.61%,CPEB2;WNK1;GPSM1;GMIP
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.26956486498150833,0.7619196023494063,0.7966386554621848,0.9883394494526827,1.0,6/28,12.14%,GAS2L1;CLASP2;MAP1S;CAMSAP2;PRUNE1;FKBP4
prerank,cell-cell junction maintenance (GO:0045217),0.33658657730368785,0.7617758750547515,0.7509803921568627,0.9879882894621725,1.0,2/11,9.17%,TJP1;CSF1R
prerank,copper ion homeostasis (GO:0055070),-0.2825223295167353,-0.7608783489107213,0.8016877637130801,0.9579805723294752,1.0,6/17,18.69%,ATP7A;XIAP;SLC31A1;COMMD1;SLC31A2;COX19
prerank,endocardial cushion development (GO:0003197),0.281521770074178,0.7606098573213754,0.784070796460177,0.9892870259469037,1.0,4/21,11.15%,HEY1;NOTCH1;ACVRL1;NOS3
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.2340237878050208,-0.7603613110578533,0.8758949880668258,0.9580724965359118,1.0,20/33,40.89%,IGF1;MAPT;MPV17L;HUWE1;GHITM;PINK1;FLCN;AKT1;BCL2L1;GPX1;TMEM14A;FXN;SLC25A5;ADCK1;PRELID1;CLU;HGF;MUL1;OPA1;PPIF
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.2875759492668458,-0.7601271144054167,0.8100208768267223,0.9577382310753233,1.0,3/15,6.59%,LPGAT1;PPARGC1A;PPARA
prerank,mitotic chromosome condensation (GO:0007076),0.26379414509500854,0.759654405135803,0.7968476357267951,0.9902059561415536,1.0,5/26,14.34%,TENT4A;CHMP1A;AKAP8L;PHF8;CSNK2A2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.25650806789456976,-0.759487740319451,0.8283752860411899,0.9579991692010311,1.0,8/24,17.67%,SEC31A;SEC24D;PDIA3;TAPBP;SEC23A;SEC24C;SEC24A;ACE
prerank,cellular response to leucine (GO:0071233),0.3432410965348908,0.7594548430142757,0.7578558225508318,0.9893419372759941,1.0,4/10,19.05%,RPTOR;LARS1;SESN3;SESN1
prerank,response to leucine (GO:0043201),0.3432410965348908,0.7594548430142757,0.7578558225508318,0.9893419372759941,1.0,4/10,19.05%,RPTOR;LARS1;SESN3;SESN1
prerank,protein autoubiquitination (GO:0051865),0.22876921992472665,0.7594227818719531,0.8569277108433735,0.9888134696057667,1.0,11/61,13.34%,RAD18;UBE3A;NFX1;RNF187;MDM2;KLHL24;UBE3D;RNF13;RNF11;CUL3;RNF146
prerank,hemidesmosome assembly (GO:0031581),0.33062331635685577,0.7593802355960159,0.7660818713450293,0.9882910110056673,1.0,2/11,8.58%,DST;ITGA6
prerank,covalent chromatin modification (GO:0016569),0.3135904217748254,0.7590717646717581,0.7908366533864541,0.9881882811860667,1.0,4/14,10.39%,SIRT1;SETD5;PARK7;CHD1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.2128232587720808,-0.7584562616381183,0.9321148825065274,0.9588340517553915,1.0,20/49,33.50%,MAP2;CPEB2;WNK1;SLC39A14;GPSM1;GMIP;ECM1;ATP5IF1;SH3RF2;RRP1B;ZCCHC9;CAMK2A;EGLN1;SH3BP4;ARL2;NOS1;TERF2;CHP1;RASA4;MAPK7
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.309581071793819,0.758445358686483,0.7836812144212524,0.9885502393891635,1.0,1/13,1.17%,CBL
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.32953595871177443,0.7580499839783763,0.7821969696969697,0.9885839710279221,1.0,2/12,10.58%,ESR1;TERT
prerank,positive regulation of T cell activation (GO:0050870),0.22969874163052856,0.7579681030498562,0.8622291021671826,0.9881316257470977,1.0,14/62,21.75%,PTPRC;CYRIB;CD47;PNP;CD81;CD274;DOCK8;IL7;CD46;TFRC;XBP1;SLC7A1;VCAM1;IL15
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.3159111348701119,-0.7564613023148433,0.8050682261208577,0.9610238116253632,1.0,2/11,5.46%,NECAB1;BACE2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3300454250199696,0.7564156356325844,0.79,0.9899545207700541,1.0,4/11,20.30%,PARK7;FBXO7;NONO;REST
prerank,mitochondrion disassembly (GO:0061726),-0.23361272986659581,-0.7563588384716005,0.8491048593350383,0.9605146432257898,1.0,4/34,7.72%,AMBRA1;ULK2;WIPI1;FIS1
prerank,DNA modification (GO:0006304),0.2769292934202716,0.7561802446016779,0.8003597122302158,0.9897218344208862,1.0,5/22,15.22%,TDG;ACD;SMUG1;MPG;TERF2IP
prerank,regulation of cellular metabolic process (GO:0031323),0.24133575132994506,0.7561042854972754,0.8704,0.9892503184971778,1.0,15/45,21.30%,PANK2;LAMTOR1;ACACB;ARF1;CYP1B1;NPC2;VPS35;MBOAT7;ACACA;EIF6;KIF16B;PDK3;ABCG1;FASN;RNF41
prerank,negative regulation of telomere maintenance (GO:0032205),0.31037469359030845,0.7555782109190471,0.777988614800759,0.9894828527001285,1.0,6/15,18.15%,ERCC4;TNKS;NBN;TERF2IP;SMG6;TNKS2
prerank,pre-miRNA processing (GO:0031054),0.306554937699949,0.7555154577400061,0.7767527675276753,0.9889938267102295,1.0,4/14,15.07%,ADAR;AGO4;TUT7;TUT4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.25108450740240085,0.755386519099303,0.8394039735099338,0.988597959223574,1.0,6/37,7.73%,RPTOR;STOX1;SPRED1;CALM3;SMAD7;AXIN1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2889559651268053,-0.7550030237645401,0.8104575163398693,0.9617493719974255,1.0,5/15,17.75%,DDX1;CSTF2;RTCB;RTRAF;ZBTB8OS
prerank,atrioventricular valve morphogenesis (GO:0003181),0.2824593215925061,0.7549762257183537,0.8059149722735675,0.9885945996721708,1.0,4/19,8.68%,HEY1;HEY2;NOTCH1;EFNA1
prerank,miRNA metabolic process (GO:0010586),0.28217203489634307,0.7548773579415713,0.7982608695652174,0.9881475827652829,1.0,6/20,19.11%,BCDIN3D;XPO5;TUT7;TUT4;PARN;DIS3L2
prerank,negative regulation of histone methylation (GO:0031061),0.33898015091597,0.754462331353988,0.7689243027888446,0.9882139400698943,1.0,1/10,0.92%,AASS
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.27335174099782444,0.7536063383538039,0.8,0.9889267771164929,1.0,10/25,19.28%,LONP1;OMA1;AUP1;CUL3;UFD1;YME1L1;ATXN3;UGGT1;POMT2;DERL1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.31633040259044765,0.753108675736841,0.7792706333973128,0.9890790409431428,1.0,2/13,6.88%,PDE4D;CALM3
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3076839123864903,0.7530767108969325,0.8032490974729242,0.9885447978125662,1.0,2/15,11.10%,STOX2;USP22
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.32349740339366323,0.7526322363971972,0.7773359840954275,0.9886310193700124,1.0,2/12,10.53%,PPP3CB;TRPM4
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.22982913946875475,-0.7525713385829604,0.8746928746928747,0.9645012420047654,1.0,17/32,32.19%,TAOK3;MRE11;BRSK1;TAOK1;ATM;TRIM39;RINT1;FOXN3;BABAM1;BLM;NOP53;CDC14B;TOPBP1;TAOK2;HMGA2;CDK5RAP3;CLSPN
prerank,positive regulation of lamellipodium organization (GO:1902745),0.2562040273551512,0.7525265082890462,0.8216666666666667,0.9882169788825551,1.0,3/32,6.54%,RAC2;SRC;ARHGEF7
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.2859303321655755,-0.7524050251706672,0.8296460176991151,0.96408421955904,1.0,7/16,30.06%,KCNC2;DDAH1;GUCY1A1;GUCY1B1;DDAH2;NDNF;NOS1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.2994290355332208,-0.7523171609010247,0.8098290598290598,0.9635669710093966,1.0,3/13,10.09%,CAB39;BIN1;ACTN2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.21234686518907367,0.7522003763916816,0.8920118343195266,0.9881052605612418,1.0,15/95,14.75%,ALMS1;HAUS4;HAUS5;CEP41;TUBB;DCTN2;SCLT1;ODF2;CEP164;DCTN3;DYNLL1;CENPJ;RPGRIP1L;CEP83;DYNC1I2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.3053550949691404,-0.7520551965877508,0.7963709677419355,0.9632888365843318,1.0,5/13,22.40%,NIBAN2;NEDD4;CADM4;HGS;EMILIN1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.2451095742091265,-0.7515848014104559,0.8317972350230415,0.9632678472156188,1.0,8/27,24.48%,PPARA;ABCA5;NFKB1;ABCA1;IL18;AGTR1;MAPK9;NR1H2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.2406259049424845,0.7515660335394325,0.8692185007974481,0.9884586667615731,1.0,10/45,15.68%,TRIM8;IRF9;B2M;ICAM1;TRIM25;IRF2;MID1;MT2A;CD44;CAMK2G
prerank,regulation of stem cell proliferation (GO:0072091),0.2970909936885434,0.7514420958424495,0.7981981981981981,0.9880528975090976,1.0,3/17,10.58%,PTPRC;ZFP36L1;TERT
prerank,xenobiotic transport (GO:0042908),-0.2769867174159809,-0.7513630204206742,0.8235294117647058,0.9629251941174909,1.0,3/17,10.60%,SLC47A1;SLC22A4;GJA1
prerank,mitochondrial protein processing (GO:0034982),0.3261697971592593,0.7504942694256537,0.7690763052208835,0.9888964104327591,1.0,4/11,17.39%,IMMP2L;OMA1;YME1L1;MIPEP
prerank,negative regulation of bone mineralization (GO:0030502),0.307467251010469,0.7501310857053374,0.8056603773584906,0.9888456324496188,1.0,3/13,16.34%,GREM1;TRPM4;PTK2B
prerank,regulation of T cell activation (GO:0050863),0.24097219897830374,0.7499372368517746,0.839546191247974,0.9885454437852136,1.0,3/42,9.09%,TNFRSF1B;CYRIB;CD47
prerank,protein localization to vacuole (GO:0072665),0.3179401392504879,0.7495826360101379,0.7916666666666666,0.9884991736374865,1.0,5/13,18.85%,GLMP;CD81;KPTN;RNF128;SH3GLB1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.26459374226756155,0.7492792778679045,0.826530612244898,0.9883808545780723,1.0,5/28,17.85%,CYRIB;CD47;TNIP2;PRKDC;SH3KBP1
prerank,early endosome to late endosome transport (GO:0045022),-0.2565122104914037,-0.7492283216547861,0.8250591016548463,0.9651459685819659,1.0,8/20,23.93%,PIK3C3;EEA1;STX8;SNF8;PTPN23;HOOK2;LMTK2;EMP2
prerank,male gonad development (GO:0008584),0.2511785835473177,0.7486787791555758,0.8277591973244147,0.9886876205089873,1.0,4/34,10.35%,NR5A1;MAMLD1;WNT5A;ING2
prerank,endocardial cushion morphogenesis (GO:0003203),0.28701778436213043,0.7480670273189709,0.8092592592592592,0.9889844972009668,1.0,4/18,11.15%,HEY1;NOTCH1;ACVRL1;NOS3
prerank,female gonad development (GO:0008585),0.2873421596624497,0.7475164991361117,0.8057553956834532,0.9891852354146581,1.0,2/19,4.24%,SOD1;NR5A1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.23558386774204532,0.7470973482479903,0.8488745980707395,0.9892090759520482,1.0,7/47,13.31%,TRIB3;PRMT3;FYN;EP300;ERLIN2;PGP;PLEK
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.2798823376200967,0.7469632916780008,0.7942754919499105,0.9888237314831219,1.0,4/23,13.31%,GSK3A;EP300;PGP;PLEK
prerank,positive regulation of vacuole organization (GO:0044090),-0.3229122191501887,-0.7468563529925212,0.7942386831275721,0.9677604476254184,1.0,4/10,16.47%,ANXA2;RAB3GAP2;PIP4K2B;LRSAM1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.2712419943632555,-0.746853869134834,0.806941431670282,0.9671306384168984,1.0,3/18,7.72%,MCU;SPIRE1;FIS1
prerank,C-terminal protein amino acid modification (GO:0018410),0.33369900374912526,0.7468137526917258,0.8086785009861933,0.9884504578648466,1.0,5/11,19.25%,AGTPBP1;ICMT;ATG7;LCMT1;FOLH1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.2681538680394533,-0.7462574324300772,0.821505376344086,0.9672680079922028,1.0,7/18,40.78%,PSMD9;CCN3;ADRA2A;SFRP1;SIRT4;CHGA;INHBB
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2633005917776635,0.7450972920572726,0.8545454545454545,0.9903005525716486,1.0,3/29,8.79%,ERCC3;CCNH;GTF2H1
prerank,signal transduction in response to DNA damage (GO:0042770),0.23530338355050529,0.7441318051064654,0.877488514548239,0.9910846433172521,1.0,11/49,16.91%,TIPRL;ACER2;RAD1;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.2851004418752439,0.7438795589419634,0.8095238095238095,0.9908705101557209,1.0,3/20,5.51%,ZFP36L1;MEIS1;CIB1
prerank,myelination (GO:0042552),0.2386794041186585,0.7434295913236185,0.8790322580645161,0.990912793303677,1.0,12/46,14.63%,MAL;MPZ;SCN2A;NFASC;PMP22;MARVELD1;ACER3;SBF2;NF1;ADGRG6;PARD3;ARHGEF10
prerank,regulation of gene silencing by miRNA (GO:0060964),0.22716411241925716,0.7433781306936642,0.883177570093458,0.990399791485788,1.0,19/62,21.38%,POLR2J;POLR2B;FXR1;NUP54;NUP50;NUP35;IPO8;NDC1;WTIP;NUP160;POM121;STAT3;NUP42;EIF4G1;NUP133;AGO1;TNRC6A;PPARG;DHX9
prerank,cellular response to amyloid-beta (GO:1904646),0.25046895279216896,0.7431046829947191,0.8535773710482529,0.9901890592758312,1.0,7/35,14.37%,CACNA1A;FCGR2B;FYN;ICAM1;APP;PRNP;GRIN2A
prerank,microtubule bundle formation (GO:0001578),0.2414130437030755,0.7422768786330889,0.87,0.9907604739076242,1.0,7/42,17.27%,GAS2L1;MAP1S;NAV1;SPEF1;CLIP1;CLASP1;NCKAP5
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.315046413473528,-0.7420527493544988,0.8153526970954357,0.9721499824988077,1.0,7/10,46.57%,SIRT2;CDC42;RCC2;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.2707730382481478,-0.7419032965996517,0.8099547511312217,0.9717152261395653,1.0,6/16,27.46%,THBS1;JCAD;AGTR1;VEGFA;GATA2;FGFBP1
prerank,diacylglycerol metabolic process (GO:0046339),0.27480470734608836,0.7416639829657331,0.800718132854578,0.991003081369107,1.0,2/23,2.68%,DGKB;GPAM
prerank,positive regulation of protein transport (GO:0051222),-0.1964448024664346,-0.7411485683877127,0.9365994236311239,0.9720208681682826,1.0,21/67,26.14%,BMP6;IGF1;EZR;PPID;UNC13B;VAMP2;RACK1;ARHGEF5;OAZ1;EXOC1;TGFB1;CNST;OAZ2;RAB29;CLN3;TGFB3;IER3IP1;RIPOR1;APBB1;SYTL4;PPIA
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.26358071853589343,0.7407374187577899,0.8369747899159664,0.9917284084169488,1.0,4/27,8.56%,CDKN1A;BMI1;CDK4;WNT5A
prerank,cellular response to pH (GO:0071467),0.29133730613082587,0.7404776098026398,0.8393194706994329,0.9915252746403065,1.0,2/17,8.00%,RAB11B;RAB11FIP5
prerank,pancreas development (GO:0031016),0.30985397795965197,0.7404258377689139,0.787109375,0.9910352198803879,1.0,1/12,4.00%,SELENOT
prerank,protein-DNA complex disassembly (GO:0032986),0.29360998545101663,0.7403994874589717,0.8082706766917294,0.9905042824171132,1.0,4/16,19.08%,RPL23;SMARCD1;SMARCA4;SMARCB1
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.25263062033289163,-0.7402436375700631,0.8451025056947609,0.9725652065543775,1.0,5/22,11.30%,BMP7;BMP4;ROCK1;CDKN1B;TP53
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3234605642767381,0.7402285365809067,0.8078358208955224,0.9901711163017652,1.0,2/12,8.02%,INSIG1;KDELR2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.31558972014256287,-0.7396016331102806,0.809322033898305,0.9727772644926304,1.0,2/10,7.24%,DGKH;GAP43
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3254933177556549,0.7395563754471133,0.776,0.9905369018483973,1.0,1/10,1.77%,AMDHD2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2666966851756206,-0.7386066368380164,0.8259911894273128,0.9734291430204549,1.0,6/18,26.99%,ROCK1;SLC39A8;ITGA4;ADD2;PODXL2;CX3CR1
prerank,myelin assembly (GO:0032288),-0.32298362658955515,-0.7385699805048539,0.8181818181818182,0.9728407765833538,1.0,6/10,32.25%,EPB41L3;DICER1;TPPP;CNTNAP1;ABCA2;GPC1
prerank,regulation of glucose metabolic process (GO:0010906),0.2500505565466131,0.738371818592868,0.8432055749128919,0.9916229526495608,1.0,5/34,11.08%,SDHAF3;MLYCD;SIRT1;IRS2;ADIPOR1
prerank,glycerophospholipid metabolic process (GO:0006650),0.2141178912106677,0.7383468270535652,0.907624633431085,0.9910892353061537,1.0,12/75,14.23%,SERINC1;SMPD4;PLCG1;PIGH;CSF1R;PLCB1;SERINC5;PGP;PIGB;ABHD12;PLEK;PNPLA6
prerank,lipid transport (GO:0006869),0.2102504687586459,0.7377838212494318,0.9234104046242775,0.9913037165377794,1.0,16/97,15.55%,ATP8A1;ABCC4;GOT2;APOE;PRELID3B;UGCG;PPARD;PRELID2;PITPNA;SCARB1;GM2A;NPC2;OSBPL2;SPNS2;SLCO1C1;CERT1
prerank,regulation of spindle assembly (GO:0090169),-0.2439244362182676,-0.7373786404002429,0.8561151079136691,0.9737375796684927,1.0,5/25,18.85%,DYNC1H1;RNF4;EML3;CHMP2B;CHMP5
prerank,regulation of hemopoiesis (GO:1903706),-0.3105609578740256,-0.7372422737557167,0.8170212765957446,0.9732707687082442,1.0,5/10,33.68%,CBFB;MYSM1;IL17D;MAFB;PTN
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3070325697150011,0.7363159115702265,0.8273921200750469,0.9927639057452255,1.0,5/14,13.32%,PPP2R2D;PPP2CA;PPP2CB;PPP3CA;PPP5C
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.25579573967146074,-0.736089204499052,0.8421052631578947,0.9740686673196637,1.0,4/23,10.60%,WNT5B;BMP4;SMO;GJA1
prerank,macrophage activation (GO:0042116),0.2494202670501481,0.7358609507147766,0.8406504065040651,0.992789582251391,1.0,6/34,14.77%,IFI35;SBNO2;SYK;APP;CD93;CRTC3
prerank,synaptic vesicle transport (GO:0048489),0.32564241000040356,0.7357663124382646,0.7895752895752896,0.9923378921519944,1.0,5/11,19.66%,TMEM230;SPG11;SNAPIN;RAB27A;KIF5B
prerank,negative regulation of macroautophagy (GO:0016242),0.26285634101134026,0.7357586266116697,0.8374125874125874,0.9917838963197128,1.0,11/26,21.33%,SMG1;TSC1;SCFD1;FEZ2;TMEM39A;UBQLN4;USP36;LZTS1;RUBCN;LRRK2;PIK3CA
prerank,positive regulation of glial cell differentiation (GO:0045687),0.28653277204824107,0.7350534276790262,0.8208409506398537,0.9921841149488235,1.0,5/17,16.05%,TNFRSF1B;NOTCH1;TENM4;HES1;ID2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.2607412766157263,-0.7347504318816976,0.8422273781902552,0.9751467516578975,1.0,2/20,3.31%,TGFBR1;DCUN1D5
prerank,carnitine metabolic process (GO:0009437),0.31093385293141124,0.7344586575534539,0.8,0.9924170418757301,1.0,1/12,1.43%,CRAT
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.33109783665629655,0.7343968237192274,0.7919847328244275,0.991921790055682,1.0,3/10,18.42%,PRKG1;CD9;RDX
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.21426320916341246,0.7341892319736044,0.9096385542168675,0.9916317622900432,1.0,15/84,14.53%,ILF3;PIN1;PATL2;APOE;FXR1;PAIP2B;CNOT7;TSC1;DDX3X;NANOS3;RPS3;PRNP;YBX1;CNOT1;CAPRIN1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.29068246653085744,0.7341048185052275,0.8178368121442126,0.9911692748238998,1.0,3/18,9.76%,SIRT1;SOD2;PARK7
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2765715143004158,0.7339288340853034,0.8106194690265487,0.9908399571344328,1.0,2/22,8.79%,ERCC3;GTF2H1
prerank,establishment of melanosome localization (GO:0032401),0.28459362309137054,0.7339145315431752,0.8227848101265823,0.9902942336234486,1.0,5/19,17.83%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7
prerank,regulation of B cell differentiation (GO:0045577),0.28932554865031185,0.7332611163241478,0.8037735849056604,0.9905570570698792,1.0,2/17,6.70%,ZFP36L1;SYK
prerank,cellular response to virus (GO:0098586),0.25232171214563415,0.7328847906534594,0.8467741935483871,0.9904830946014328,1.0,5/30,14.22%,EIF5A;ARF1;DDX3X;CHUK;LGALS8
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.23160133088939744,-0.7326350393688977,0.9086538461538461,0.9771170502167312,1.0,7/30,17.67%,UFL1;BMP4;KIT;TP53;LMBR1L;TGFB1;ACE
prerank,organic hydroxy compound transport (GO:0015850),-0.22566428796347768,-0.7321142179710725,0.8962962962962963,0.977110770925868,1.0,7/36,15.65%,RBP4;OSBP;RXRA;RALBP1;NCOA1;STARD5;ATP8B1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.31536879817914193,0.7318387791580869,0.8233009708737864,0.9913366189849531,1.0,1/11,3.08%,GREM1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.23601091564888665,-0.7308637491064794,0.8789237668161435,0.9779721028016143,1.0,4/28,7.72%,ANK3;CEMIP;AKT2;FIS1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.3193873929044893,0.7308084516110424,0.8018518518518518,0.9921725719606549,1.0,1/11,1.77%,AMDHD2
prerank,melanosome localization (GO:0032400),0.27817592790311724,0.7307429891751549,0.8249097472924187,0.9916758536805219,1.0,6/21,18.03%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7;VPS33A
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.3282709798090096,0.7306809364836278,0.7784200385356455,0.9911879908141379,1.0,1/10,2.74%,PRKCH
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2926593459937761,0.730299798380704,0.8409090909090909,0.9910859190088047,1.0,2/16,14.45%,ERCC4;RMI1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.31644018209537916,0.7301663258180499,0.8022181146025879,0.9907008937219818,1.0,5/12,16.45%,APOE;TMED10;PICALM;PRNP;FKBP1A
prerank,amino sugar biosynthetic process (GO:0046349),0.31060458503540533,0.7301266496461285,0.8091743119266055,0.9901906267496087,1.0,1/12,1.77%,AMDHD2
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.28747007313836936,-0.7301223029798594,0.8329764453961456,0.9782297021489308,1.0,3/13,16.22%,BMP4;TBX3;TGFB1
prerank,carbohydrate catabolic process (GO:0016052),0.24087163250465785,0.7297380360745783,0.8896,0.9901301316434888,1.0,2/38,5.68%,ENO4;TPI1
prerank,cellular macromolecule catabolic process (GO:0044265),0.23106186054599262,0.7291842780392209,0.8824476650563607,0.9902727340859887,1.0,8/49,15.43%,NCBP1;RNASE6;MAGEC2;XRN2;STT3B;CHEK2;UBE2G1;PPP1R8
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.2905523269494351,-0.7291348573773996,0.8687872763419483,0.9788096192668424,1.0,4/12,35.40%,BMP7;FLOT1;THY1;SKAP1
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.2699351046362129,-0.7285801279972158,0.8414376321353065,0.978849682854415,1.0,5/16,22.62%,RPA1;PURA;BLM;RECQL;MCM6
prerank,cellular response to fatty acid (GO:0071398),-0.2970256462819917,-0.7285199914270626,0.8323108384458078,0.9782882392577341,1.0,6/12,43.17%,PID1;ZC3H12A;LPL;NR1H4;DGAT2;PDK4
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.2604274171995038,0.7279881271557969,0.8178571428571428,0.9912397366061791,1.0,2/25,3.34%,GSK3A;INSYN2A
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.31407125621704535,-0.7279411761701451,0.8283898305084746,0.9783191155958318,1.0,5/10,39.32%,HIPK3;PTPN22;DNAJA1;MAPK8IP1;DUSP19
prerank,zinc ion transmembrane transport (GO:0071577),-0.25328514267310975,-0.7278743402089757,0.8663594470046083,0.9777703855784089,1.0,8/22,25.22%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.2738046712126378,0.7273177943618754,0.8382899628252788,0.9915492560030439,1.0,3/18,9.18%,CLASP2;RGCC;COLGALT1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.2597596577540444,-0.7271019179503541,0.8306264501160093,0.9780358522613686,1.0,9/18,30.95%,NELL1;VGLL4;EZR;DACT1;MSN;AMER1;HSP90AA1;RGP1;CDK5RAP3
prerank,carboxylic acid transmembrane transport (GO:1905039),0.24243875703408752,0.7266240925274471,0.8818770226537217,0.9918450151971471,1.0,2/40,1.30%,SLC7A8;SLC36A4
prerank,negative regulation of blood coagulation (GO:0030195),0.24143237661028452,0.72653947065082,0.8858075040783034,0.9913930492133983,1.0,6/38,13.84%,APOE;F8;NOS3;A2M;PLAT;PROC
prerank,tryptophan catabolic process (GO:0006569),-0.3078468298807282,-0.7264424315720602,0.84375,0.9782086280384154,1.0,11/11,69.24%,KYAT1;AFMID;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.21281495155061364,0.726334204258747,0.9223880597014925,0.9910925341000563,1.0,6/73,11.27%,PTPRJ;PTPRC;TIRAP;SYK;WNT5A;APP
prerank,positive regulation of exosomal secretion (GO:1903543),-0.27769489498676714,-0.7262956674861959,0.8558758314855875,0.9777489564673324,1.0,6/15,22.01%,SMPD3;SNF8;TSG101;STAM;VPS4A;HGS
prerank,fatty acid metabolic process (GO:0006631),0.2021907402087127,0.7259811157951768,0.9590395480225988,0.9909972726207109,1.0,12/115,11.77%,CRAT;ACSL5;MLYCD;GPAM;PPARD;ADIPOR2;NUDT19;ALKBH7;ACSL4;ADIPOR1;PNPLA8;ACOT8
prerank,melanosome transport (GO:0032402),0.2852932658304723,0.7254224016225805,0.8342541436464088,0.9905777062444616,1.0,5/18,17.83%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7
prerank,pigment granule transport (GO:0051904),0.2852932658304723,0.7254224016225805,0.8342541436464088,0.9905777062444616,1.0,5/18,17.83%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7
prerank,negative regulation of TOR signaling (GO:0032007),0.24466956822106734,0.725122903869287,0.853225806451613,0.9904201912468588,1.0,9/36,16.18%,GSK3A;EPM2A;AKT1S1;SIRT1;TSC1;PRKAA2;TMEM127;KPTN;SESN3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3104143348323142,-0.7249503601744439,0.8170731707317073,0.9780441334342905,1.0,4/10,18.37%,NFAT5;NFATC2;PPP3CC;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),-0.3104143348323142,-0.7249503601744439,0.8170731707317073,0.9780441334342905,1.0,4/10,18.37%,NFAT5;NFATC2;PPP3CC;NFATC4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.2941369047898277,-0.7248628385151411,0.826722338204593,0.977523075631061,1.0,3/11,11.96%,PUM1;PUM2;LIMD1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3129666565570467,0.72474052402738,0.7879377431906615,0.9903101140818936,1.0,2/12,7.54%,MLYCD;IRS2
prerank,negative regulation of cell death (GO:0060548),0.20721924777778128,0.7237648610186114,0.9276218611521418,0.9909240608092206,1.0,6/88,5.19%,RAD18;MECOM;TXNDC12;FYN;TNFRSF1B;WFS1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.27565062239245247,-0.7235008152703303,0.8574660633484162,0.9784182857344776,1.0,6/16,18.88%,A4GALT;B4GALT6;ST6GALNAC5;LARGE1;ST6GALNAC6;ST8SIA2
prerank,ceramide transport (GO:0035627),-0.29280869699938905,-0.7233435259907427,0.8523908523908524,0.9779592269896925,1.0,2/12,8.49%,PSAP;PLEKHA8
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.27665275032023556,-0.7232642131391444,0.8682008368200836,0.9774204020574278,1.0,2/15,9.88%,MOXD1;SAT1
prerank,cellular response to acid chemical (GO:0071229),-0.2382941669128552,-0.7226954694036669,0.8613861386138614,0.9774393175798507,1.0,3/27,2.38%,CPEB4;CPEB1;CAPN2
prerank,phosphate ion homeostasis (GO:0055062),0.32254335909233955,0.7221791529179143,0.8158914728682171,0.9923552186725586,1.0,1/10,5.33%,XPR1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.31134172561309836,-0.7221759815737078,0.8181818181818182,0.977378681003818,1.0,8/10,52.69%,AKT1;TICAM1;MYD88;TLR4;CD68;TREM2;CD36;TLR6
prerank,response to organic cyclic compound (GO:0014070),-0.19828914444417645,-0.7214595056018958,0.952513966480447,0.9775572758120438,1.0,10/52,17.43%,IGFBP5;CTNNB1;HLCS;SOCS2;ANXA1;IL18;GGT5;SPP1;TGFB1;ALPL
prerank,positive regulation of sodium ion transport (GO:0010765),0.30827332011639336,0.7213406400211322,0.8157894736842105,0.9928227027773084,1.0,2/12,6.92%,AHCYL1;CNKSR3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.302769361910069,0.7209189377342022,0.8239700374531835,0.9927771240980726,1.0,2/14,9.76%,TXNDC12;PARK7
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3232148971527875,0.7208341674434431,0.8046875,0.9923269216515125,1.0,1/10,1.75%,PDE4D
prerank,cell projection assembly (GO:0030031),0.2632687503380443,0.7198421857668837,0.8382608695652174,0.9929769131862706,1.0,3/22,11.04%,RAC2;RHOQ;RHOG
prerank,filopodium assembly (GO:0046847),0.2852904239826578,0.7196276601408127,0.8326996197718631,0.9926974912723657,1.0,3/16,14.12%,DNM3;FGD5;SPEF1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.2754395212291294,-0.7191428845403705,0.8580645161290322,0.9795552297941303,1.0,6/14,36.47%,ACE;ENPEP;AGTR1;EDN1;EDN3;ACE2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.256005404912642,-0.7186558900510328,0.8415178571428571,0.979476041448928,1.0,8/20,28.63%,GLI2;NBL1;ACVR1;BMPR1B;BMPR1A;PTCH1;SFRP1;MDFI
prerank,urogenital system development (GO:0001655),-0.3049173004261889,-0.7180328845512772,0.8382978723404255,0.9795599312271542,1.0,3/11,11.85%,OSR1;EPHB2;ANXA1
prerank,protein import into peroxisome matrix (GO:0016558),0.3068769065513751,0.7179553294987204,0.8099808061420346,0.9942000409368031,1.0,2/12,6.57%,PEX1;PEX7
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.25746187135538556,0.7176560891155489,0.8450946643717728,0.993984643618632,1.0,6/24,16.34%,APOE;UBE3A;EFNA1;PSMD14;UCHL5;PTK2B
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.2902864584735395,0.7176358267760417,0.8410351201478743,0.9934568737652705,1.0,1/15,2.74%,PRKCH
prerank,glial cell differentiation (GO:0010001),-0.23011078308610067,-0.7175178346650054,0.8924205378973105,0.9795327296271578,1.0,19/28,41.73%,NFIB;RELN;TPPP;PAX2;PICK1;EIF2B5;CDK5;MYRF;FGF10;GPC1;SOX11;SOX9;ERBB3;GPR157;SOX10;METRN;SOX4;SOX8;PTPRZ1
prerank,glycoprotein metabolic process (GO:0009100),-0.1965436174222957,-0.7174711514028206,0.9570200573065902,0.9789668381624513,1.0,12/53,18.88%,MAN1C1;NGLY1;FUT8;ADAMTS9;GANC;MAN2A2;LARGE1;PCSK6;ST3GAL4;TNIP1;ST6GALNAC6;ST8SIA2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.25646807687498063,0.7174320624052656,0.859375,0.9931344156145195,1.0,8/27,18.81%,RUVBL2;EP300;RUVBL1;CREBBP;TRRAP;TAF6L;NAA50;MSL3
prerank,superoxide metabolic process (GO:0006801),-0.23152511650859864,-0.7172351145798709,0.9176755447941889,0.9786154359032998,1.0,10/29,23.35%,ATP7A;SH3PXD2A;CCS;NOX4;PREX1;SOD3;PRDX1;PRDX2;SH3PXD2B;NRROS
prerank,negative regulation of protein processing (GO:0010955),-0.2944030828482309,-0.7165634006244069,0.8442982456140351,0.9787054139016723,1.0,4/12,25.85%,GAS1;THBS1;CTSZ;SERPINE1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.279362970050404,0.716112882355572,0.8385899814471243,0.9941557675936011,1.0,4/17,10.80%,HEY1;HEY2;NOTCH1;RBPJ
prerank,negative regulation of cell division (GO:0051782),-0.3023005206397398,-0.7159048488478198,0.8221258134490239,0.978808216819157,1.0,3/11,21.08%,ORC6;BLM;VPS4A
prerank,regulation of lymphocyte proliferation (GO:0050670),0.2859297394000809,0.7150042998208126,0.8389380530973451,0.9949383378546296,1.0,1/16,5.04%,TNFRSF1B
prerank,response to unfolded protein (GO:0006986),0.22914302740273373,0.7143576353033966,0.8992125984251969,0.9951655176833518,1.0,15/48,20.74%,HSPA8;HSPA4L;DNAJB5;STT3B;HSPE1;DDIT3;ERP44;HSPA13;HSPA14;SERPINH1;BAX;DERL1;HSPB8;ERN1;HSP90AB1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.23960054483276141,-0.7136451944939802,0.8701594533029613,0.9799941304149972,1.0,11/24,31.59%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,canonical glycolysis (GO:0061621),-0.23960054483276141,-0.7136451944939802,0.8701594533029613,0.9799941304149972,1.0,11/24,31.59%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,negative regulation of cyclase activity (GO:0031280),-0.2788033206888997,-0.7134397913248359,0.8672199170124482,0.9796044469782973,1.0,2/14,7.83%,ADGRV1;GABBR2
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3042083599503866,-0.7132112440602031,0.8350100603621731,0.9792224276871583,1.0,6/10,33.08%,EPB41L4B;IQSEC1;MAPRE2;FGF10;FGF7;MTOR
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.3031777248689045,0.712656627954863,0.8486590038314177,0.9966872799658778,1.0,5/13,18.22%,TMEM30B;CD81;BCAP31;TMEM30A;EDEM2
prerank,positive regulation of secretion by cell (GO:1903532),-0.18714628212899712,-0.7120587542977531,0.9626168224299065,0.9798555566932505,1.0,13/70,16.63%,BMP6;IGF1;P2RX4;SLC12A2;RAB27B;EZR;STXBP5;PPID;RAB9A;UNC13B;EXOC1;TGFB1;STX1A
prerank,regulation of transposition (GO:0010528),-0.28393021136013163,-0.7117442191797488,0.8530020703933747,0.9795554994235256,1.0,9/13,58.60%,SIRT7;UBR2;TEX15;SMYD5;PIWIL2;TDRD9;DDX4;PIWIL4;SPOCD1
prerank,regulation of macrophage migration (GO:1905521),0.31072262071417756,0.7114973110468306,0.8235294117647058,0.9974727183116548,1.0,3/10,16.34%,CD81;MTUS1;PTK2B
prerank,cellular response to misfolded protein (GO:0071218),0.27182597306001405,0.7113892669064842,0.8620071684587813,0.9970351227800353,1.0,9/20,20.98%,AUP1;CUL3;UFD1;DNAJB14;ATXN3;UGGT1;POMT2;DERL1;KLHL15
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.20845444528466905,0.7113388396427477,0.9382530120481928,0.9965420792427667,1.0,10/76,11.60%,GSK3A;TRIB3;ARIH1;COP1;SMAD7;AXIN1;MDM2;RAD23A;PIAS1;ELOB
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.19051028792710048,0.7110129016634997,0.9828947368421053,0.996357071102634,1.0,30/148,16.22%,PIN1;RPL23;HIPK2;RFFL;RAD1;EP300;RPL5;MDM2;TTC5;TAF15;PRKAA2;ING2;HUS1;TOP3A;PAK1IP1;TAF4B;NBN;CHD3;TBP;ING5;CHEK2;MAP2K6;CSNK2A2;RMI1;BRIP1;DYRK2;TAF1;ATR;RBBP4;TAF3
prerank,regulation of lipid storage (GO:0010883),0.26862202771237603,0.7104612047190503,0.8718381112984823,0.996433358247037,1.0,5/22,15.61%,SIRT1;ALKBH7;MEST;NFKBIA;FTO
prerank,regulation of cell-substrate adhesion (GO:0010810),0.23172856375611084,0.7104583244561202,0.9032258064516129,0.9958795407338076,1.0,10/42,17.73%,RAC2;NOTCH1;MINK1;TSC1;NPNT;NF1;CORO2B;ATXN3;CORO1C;FBLN2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.2936787628430396,-0.7102771302447644,0.8651452282157677,0.9804280800882255,1.0,6/12,24.35%,TET1;MPHOSPH8;SETDB2;RESF1;DNMT1;ATF7IP
prerank,regulation of cytokinesis (GO:0032465),0.20836464582613828,0.7098717251534775,0.9578947368421052,0.9959950780532635,1.0,20/78,20.21%,PIN1;PLK2;CSPP1;PRPF40A;CALM3;KIF13A;CUL3;GIPC1;PIK3R4;KLHL13;SETD2;BECN1;KLHL9;ZFYVE19;CALM1;SH3GLB1;PRKCE;PKN2;CDC14A;ZFYVE26
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.27169339454578456,-0.7094775096550949,0.851380042462845,0.9806387016714779,1.0,10/15,39.84%,PRKCD;SMPD3;RACK1;PLA2G6;ORMDL3;SMPD2;SPHK1;ORMDL1;ORMDL2;SPHK2
prerank,microtubule depolymerization (GO:0007019),0.2799904999384774,0.7091327335340916,0.8584729981378026,0.9962758025713867,1.0,4/17,18.21%,KIF18A;KIF2A;NCKAP5;KIF24
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.2798785547728185,-0.7089998908852356,0.8464818763326226,0.9805388512001341,1.0,8/13,36.62%,TOB1;PABPC1;BTG2;POLR2G;TNRC6C;TNRC6B;EIF4ENIF1;ZFP36
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.21690006861045402,0.7087087024291614,0.9282442748091603,0.9962085343366143,1.0,13/58,17.41%,ABRAXAS1;ERCC4;KDM2A;DCLRE1B;UBE2V2;POLA1;NBN;PSMD14;BRCC3;NSD2;XRCC4;PRKDC;DCLRE1C
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.2574097548687053,-0.7084549316717342,0.8704545454545455,0.9804841282706582,1.0,4/18,11.77%,PUM1;PUM2;BIRC3;NPLOC4
prerank,cholesterol transport (GO:0030301),0.2291144271416829,0.7083166041727683,0.9048387096774193,0.9960719451404045,1.0,9/45,15.93%,APOE;SOAT1;SCARB1;LDLRAP1;NPC2;NPC1;OSBPL2;SERAC1;STARD3
prerank,histone H2A monoubiquitination (GO:0035518),-0.2586143891009783,-0.7082295430915292,0.8684807256235828,0.980083966951587,1.0,6/17,19.06%,DDB1;DDB2;RNF168;PCGF2;BCOR;PCGF6
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3152019711373374,0.7079192049524764,0.8490566037735849,0.9959608209213225,1.0,4/10,19.11%,CHFR;TUT7;TUT4;DIS3L2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.26919972650903834,0.7076492944058674,0.8673835125448028,0.9956767766755401,1.0,7/20,20.58%,IMPDH1;NT5C2;GMPR2;HPRT1;GART;ATIC;PPAT
prerank,negative regulation of protein ubiquitination (GO:0031397),0.22645354409744575,0.7070073768654848,0.9276729559748428,0.9958785149451357,1.0,8/50,11.52%,TNFAIP3;PRMT3;FBXO5;SMAD7;IVNS1ABP;PARK7;SPOPL;RPS3
prerank,negative regulation of protein secretion (GO:0050709),0.23767874248560497,0.7069993958131172,0.9013157894736842,0.9953294902818505,1.0,4/38,10.01%,HMGCR;APOE;RAB11FIP5;RHBDF2
prerank,Golgi ribbon formation (GO:0090161),0.2946700472048763,0.7062784750515956,0.8477842003853564,0.9955635258115192,1.0,3/13,10.13%,TRIP11;TMED5;GCC2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.28494266104667565,0.7058574223453746,0.8500881834215167,0.9954817689604701,1.0,2/15,7.11%,SORT1;BDNF
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.23699276363693814,0.7058211132478235,0.8989113530326595,0.9949681893759275,1.0,7/36,14.25%,SPR;APOE;TERT;NOSTRIN;NOS3;SCARB1;GCH1
prerank,cell proliferation in forebrain (GO:0021846),-0.3088266680863573,-0.7057338659504021,0.8688524590163934,0.9820364172449596,1.0,2/10,10.88%,CEP120;NUMBL
prerank,regulation of microtubule nucleation (GO:0010968),-0.3010557743763352,-0.7047970116688979,0.8556263269639066,0.9823694166157507,1.0,3/10,15.73%,EML2;CKAP5;DCTN1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.2822453048632487,-0.7044554757214098,0.865979381443299,0.9821113260095542,1.0,2/13,7.83%,ADGRV1;GABBR2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2509793278056124,0.7036027035737005,0.8723404255319149,0.9968677122402975,1.0,6/26,14.59%,RPTOR;RGCC;PLCB1;DDX3X;ANKRD17;MTBP
prerank,mRNA methylation (GO:0080009),-0.2663647671075695,-0.7028387656979442,0.8584269662921349,0.9831245897563324,1.0,5/15,24.02%,VIRMA;CBLL1;PCIF1;TRMT6;CMTR1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.2561903371580004,0.702239345208055,0.8767361111111112,0.9978558907929063,1.0,6/26,13.91%,TAL1;MDM2;USP22;APP;CUL3;HES1
prerank,coenzyme A metabolic process (GO:0015936),0.29016391013500176,0.7021443665303857,0.8582089552238806,0.9974123721470908,1.0,2/14,5.63%,PANK2;ACAT1
prerank,DNA double-strand break processing (GO:0000729),-0.2587945033021774,-0.7010020801495859,0.8920086393088553,0.9843721230295907,1.0,10/18,36.60%,UBE2N;RAD50;MRE11;ATM;BLM;SLX4;KAT5;BARD1;SETMAR;DNA2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.22480930912409455,-0.7007977552833667,0.8923766816143498,0.9839688935626304,1.0,8/28,20.63%,NUPR1;DDRGK1;PTK2;RNF139;ATP5IF1;OSBPL7;PSMC5;PSMC3
prerank,negative regulation of anoikis (GO:2000811),0.2920062892298476,0.700724950235294,0.8403846153846154,0.9983865684309973,1.0,2/14,8.04%,SRC;NOTCH1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.2299821788808015,-0.7007175143078628,0.8992805755395683,0.9834247374800819,1.0,9/27,27.68%,IRAK3;SYT11;SIRPA;PTPN22;SELENOS;CX3CL1;C1QTNF3;NCKAP1L;ZC3H12A
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.275860924641699,-0.7003456567610739,0.8435517970401691,0.983184551311563,1.0,7/13,34.21%,RAB23;ENTPD7;AK3;GTPBP1;MFN1;RAN;AK4
prerank,negative regulation of gluconeogenesis (GO:0045721),0.30871366293586044,0.7001992434772956,0.8183556405353728,0.9984192511665118,1.0,2/11,11.01%,EP300;PGP
prerank,mitochondrial membrane organization (GO:0007006),0.24392141679864102,0.7001577011129633,0.8869565217391304,0.9979117859936,1.0,9/32,17.58%,IMMT;BAD;MAIP1;CHCHD6;CHCHD3;DNAJC11;MICOS10;BNIP3;RCC1L
prerank,positive regulation of vasculogenesis (GO:2001214),-0.29501014818531746,-0.7000701746777106,0.8585657370517928,0.9828211564720533,1.0,6/10,35.71%,CD34;RAPGEF2;HIF1AN;CEACAM1;RRAS;RIN2
prerank,B cell activation involved in immune response (GO:0002312),0.2861307592211267,0.6992664111877794,0.8354661791590493,0.998324675282661,1.0,1/13,2.51%,FCGR2B
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.24125043855268083,0.6982950996188448,0.9234608985024958,0.9988511398980338,1.0,5/33,10.58%,CTC1;ANKRD28;DCLRE1B;ACD;TERT
prerank,cellular copper ion homeostasis (GO:0006878),0.2899312537347796,0.6971921614586728,0.8735177865612648,0.9994287357265809,1.0,4/14,14.67%,ARF1;APP;PRNP;MT2A
prerank,indolalkylamine catabolic process (GO:0046218),-0.3078275061201431,-0.6971192603901792,0.8684759916492694,0.9851240776649293,1.0,10/10,69.24%,KYAT1;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.23572245854691165,-0.6965843317619143,0.9030837004405287,0.9850009619778392,1.0,11/23,36.13%,DICER1;DNASE1L1;DFFA;CASP3;EXOG;H1-0;DNASE2;HMGB1;HMGB2;SETMAR;MUS81
prerank,rRNA 3'-end processing (GO:0031125),0.3059966662716363,0.6963883302088222,0.8303747534516766,0.9997146574548001,1.0,2/10,8.81%,RPS21;EXOSC9
prerank,release of cytochrome c from mitochondria (GO:0001836),0.2728337010240953,0.6963588186821854,0.8685185185185185,0.9991968440604561,1.0,5/17,17.79%,SOD2;FZD9;BAD;DNM1L;BAX
prerank,bile acid and bile salt transport (GO:0015721),0.2536219773576107,0.6962562863611578,0.8763837638376384,0.9987557891364522,1.0,1/24,1.40%,ABCC4
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.21997568559330205,0.6962483032775264,0.9235772357723577,0.9976638487379368,1.0,13/50,20.07%,POLR2J;POLR2B;NUP54;NUP50;NUP35;IPO8;NDC1;NUP160;POM121;NUP42;EIF4G1;NUP133;AGO1
prerank,regulation of gene silencing by RNA (GO:0060966),0.21997568559330205,0.6962483032775264,0.9235772357723577,0.9976638487379368,1.0,13/50,20.07%,POLR2J;POLR2B;NUP54;NUP50;NUP35;IPO8;NDC1;NUP160;POM121;NUP42;EIF4G1;NUP133;AGO1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.203743064592876,0.6955701195638738,0.9418960244648318,0.9978473716792428,1.0,17/78,18.07%,GSK3A;TRIB3;ARIH1;COP1;SMAD7;MDM2;RAD23A;UBQLN1;PIAS1;ELOB;RNF180;FBXO22;TAF1;UBQLN2;BCAP31;BBS7;GABARAP
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.22396459287709097,0.6949358694113678,0.9429967426710097,0.997975678299841,1.0,7/43,13.29%,ABRAXAS1;CDKN1A;NAE1;CHFR;HUS1;NBN;BRCC3
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.22219376444818437,-0.6947850081567316,0.9311224489795918,0.9861171570983138,1.0,2/34,1.84%,IGF1;PDGFRB
prerank,neuron apoptotic process (GO:0051402),-0.24625251970618448,-0.6944884216452937,0.8739316239316239,0.9857762023930234,1.0,9/19,29.67%,TRPC5;CIT;FAM162A;TNFRSF21;ATN1;BCL2;GAPDH;BID;CDK5
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.27906170347529247,0.6943864091468798,0.868421052631579,0.9980083713142479,1.0,3/15,14.50%,TENT4A;CNOT7;CNOT1
prerank,histone mRNA metabolic process (GO:0008334),0.24481082684515426,0.6942182560877259,0.9113712374581939,0.9976298727913266,1.0,7/27,18.64%,NCBP1;TUT7;SSB;TUT4;SLBP;LSM1;SNRPD3
prerank,cobalamin metabolic process (GO:0009235),0.26775423677719146,0.6940649081730995,0.8644688644688645,0.997252289279639,1.0,1/17,2.94%,MTR
prerank,steroid metabolic process (GO:0008202),-0.18296293413130335,-0.693589504252418,0.9704142011834319,0.9859670878919337,1.0,18/72,30.36%,CYP27A1;CYP7B1;LGMN;MSMO1;CYP26B1;FDX1;FDFT1;CYP51A1;PIAS4;ARV1;PRLR;DHRS4;LIPA;CUBN;GBA2;AMACR;DHCR24;DHRS11
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2792647497006122,-0.6934121345123873,0.8604166666666667,0.9855198711183996,1.0,7/13,35.78%,UFL1;DDRGK1;RACK1;PPP1R15B;ABCA7;NCK1;ATF6B
prerank,hydrogen peroxide metabolic process (GO:0042743),0.26651312345277545,0.6932236873277721,0.8615107913669064,0.9975632869618124,1.0,3/19,14.46%,SOD1;PARK7;CYBA
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.2387963595780682,-0.6930212947465636,0.9074889867841409,0.9852710957993024,1.0,7/20,23.59%,MCU;MICU2;AFG3L2;MCUR1;SPG7;MCUB;STOML2
prerank,cochlea morphogenesis (GO:0090103),0.3122170537835642,0.6928064461612516,0.8411552346570397,0.9974674545287977,1.0,1/10,5.97%,TBX1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.302295789365865,0.6919878737347159,0.8336557059961315,0.9977575553165373,1.0,2/11,7.30%,NR5A1;SIRT1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.2767531418127698,0.6917381972241714,0.8776290630975143,0.996909707664496,1.0,3/16,8.88%,SRC;CLASP2;ACVRL1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.2767531418127698,0.6917381972241714,0.8776290630975143,0.996909707664496,1.0,3/16,8.88%,SRC;CLASP2;ACVRL1
prerank,RNA methylation (GO:0001510),0.21185503484356674,0.6911446442368424,0.9428571428571428,0.9969224366130498,1.0,15/60,20.59%,TRMO;BCDIN3D;THUMPD2;TRMT61B;METTL2A;METTL2B;NSUN6;ZC3H13;NSUN2;TFB1M;FTSJ1;TFB2M;METTL14;TGS1;ALKBH8
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.22514065822778198,-0.6908470964840242,0.9377880184331797,0.9866703894692995,1.0,9/28,21.11%,ERCC6;SHLD1;HSF1;PARP3;SIRT7;ACTR2;RIF1;SMCHD1;DTX3L
prerank,lysosome localization (GO:0032418),0.229921793541627,0.6905207736737928,0.9098639455782312,0.9969804145974163,1.0,10/37,19.66%,PIK3CG;LAMTOR1;PIK3CD;SNAPIN;S100A13;TFEB;MYH9;VPS33A;PLEKHM2;KIF5B
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.22919787142425216,-0.6905138118891838,0.9166666666666666,0.9863400349248987,1.0,13/26,35.42%,FBN1;CDK6;RARA;PTPN2;TCTA;TLR3;INHBA;GPR137B;CEACAM1;TMEM178A;MAFB;ZFPM1;GPR137
prerank,phosphate ion transport (GO:0006817),0.27943792812242774,0.690487463436294,0.8663003663003663,0.9964711115634984,1.0,2/16,9.67%,XPR1;SLC37A3
prerank,Golgi to endosome transport (GO:0006895),0.2717079140652962,0.6903206852230295,0.8457350272232305,0.9960930371132148,1.0,6/16,17.75%,SORT1;RAB14;DOP1B;AP1AR;CORO7;KIF16B
prerank,endodermal cell fate commitment (GO:0001711),0.3062354658414474,0.6902543475658207,0.8330170777988615,0.9956185424875285,1.0,1/10,4.86%,SOX2
prerank,adipose tissue development (GO:0060612),-0.2881898133203329,-0.690155141016714,0.8481561822125814,0.9860418354028084,1.0,6/11,41.46%,LRP5;PGRMC2;SH3PXD2B;DYRK1B;DGAT2;SOX8
prerank,regulation of exocytosis (GO:0017157),0.22164135669837445,0.6901494596801442,0.919558359621451,0.9951783148930489,1.0,6/46,10.69%,CLASP2;STXBP5L;RALA;CADPS;RAB2B;ATP6AP1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2698327741857124,-0.6888699041659326,0.8657718120805369,0.9866026523021022,1.0,7/13,28.63%,PKD1;FLNA;KEAP1;SUFU;DBN1;GET4;MDFI
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.25018143390976133,-0.6879514717593589,0.899103139013453,0.9868464395405673,1.0,9/18,31.23%,USP13;BCL2L11;TMEM259;RNFT1;PIK3R1;BAG6;RNF185;NCK1;BOK
prerank,vesicle organization (GO:0016050),0.22095642299422985,0.6876320630247205,0.9424,0.9971562588579591,1.0,12/46,19.20%,SORT1;EXOC8;VPS11;LAMTOR1;AKTIP;RAB22A;LAPTM4B;HOOK3;VPS18;FNBP1L;ALS2;PI4K2B
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.25346716894498417,-0.6875141934246554,0.8786516853932584,0.9866421249612763,1.0,6/17,28.76%,ANXA4;ANXA1;PTPN22;SSC5D;OTUD7B;BCL3
prerank,quinone biosynthetic process (GO:1901663),0.283920194674317,0.6874914570940865,0.8517110266159695,0.9967449231964363,1.0,6/14,19.46%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.27755089495917007,0.6862854121145101,0.8549618320610687,0.9973944010880289,1.0,6/15,21.07%,PPARD;IRS2;LDLRAP1;IRS1;PRKCE;PPARG
prerank,positive regulation of type I interferon production (GO:0032481),0.2048004066520079,0.6862681963080877,0.9539877300613497,0.9968689861543104,1.0,16/73,19.12%,LRRFIP1;POLR1C;EP300;RELA;DDX3X;CREBBP;POLR3F;CHUK;POLR3B;SETD2;PRKDC;PTPN11;POLR3K;POLR3GL;TRIM56;DHX36
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.28229006566119824,-0.6862396162624604,0.8757637474541752,0.987174783633842,1.0,5/11,28.50%,NBL1;RIN3;CCN3;DUSP1;PADI2
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.2470419167965932,-0.6856404295051103,0.9036697247706422,0.9870837358212969,1.0,10/18,33.30%,MMP14;STX8;VPS4A;APPL1;CLN3;VAMP8;SPTBN1;CDK5;ABCA2;VTI1B
prerank,DNA replication (GO:0006260),0.1917561285000693,0.6855893851266297,0.9737931034482759,0.9970009529302863,1.0,19/105,15.85%,PNKP;ING4;ORC3;RAD1;POLE;CDC45;ORC4;CDK2AP1;POLA1;HUS1;ORC2;TOP3A;NBN;HELB;ING5;RMI1;BRIP1;TOP1;ATR
prerank,regulation of glycogen metabolic process (GO:0070873),-0.28464324926414136,-0.6854114680475119,0.8777292576419214,0.9866828779578141,1.0,9/12,56.67%,PPP1R3B;AKT1;INPP5K;PPP1R3C;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,sterol transport (GO:0015918),0.2637156125643747,0.6853568403398117,0.8670309653916212,0.9966865666160032,1.0,5/19,15.93%,LDLRAP1;NPC2;NPC1;OSBPL2;STARD3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2549903189860825,-0.6850238945707191,0.9008810572687225,0.9863906776982916,1.0,8/16,31.77%,PIGV;PIGG;PIGX;PIGA;PIGM;PIGF;DPM2;PIGC
prerank,mesoderm development (GO:0007498),0.2644014851914018,0.6846467473406416,0.8653465346534653,0.996818489066795,1.0,3/18,10.46%,TBX1;TIE1;MEST
prerank,phosphate ion transmembrane transport (GO:0035435),0.29324472288570036,0.6839081150298906,0.8589981447124304,0.9970085779782101,1.0,2/12,9.67%,XPR1;SLC37A3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2561781873218364,0.6836881566636424,0.8770053475935828,0.9966882793524428,1.0,4/20,13.85%,CDK5RAP1;LATS2;TFAP4;APC
prerank,positive regulation of vasoconstriction (GO:0045907),-0.26973483513764906,-0.6836265381460049,0.8991228070175439,0.9870590414462885,1.0,4/13,32.23%,ADRA1B;ADRA1A;CAV1;TBXA2R
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.23494777462871494,0.6836077568998052,0.8879598662207357,0.9962227121415126,1.0,3/31,13.00%,FCGR2B;LYN;CD274
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.27456076533657736,0.6826843595178003,0.8986866791744841,0.9965721659562421,1.0,4/16,16.75%,PNKP;KDM4D;KMT5B;PRKDC
prerank,regulation of cholesterol storage (GO:0010885),-0.2577160814233379,-0.682613020818927,0.9220489977728286,0.9873302478942734,1.0,4/15,16.52%,PPARA;ABCA1;TTC39B;EHD1
prerank,phasic smooth muscle contraction (GO:0014821),0.3045006590923357,0.6817818366346571,0.8623481781376519,0.996929130024193,1.0,10/10,69.57%,EDNRB;EDN2;HTR1D;TIFAB;GDNF;HTR2B;EDN3;PTGER3;EDN1;DRD2
prerank,regulation of myelination (GO:0031641),-0.22285640302938284,-0.6807064657596609,0.9119638826185101,0.9883315935117253,1.0,12/25,35.78%,SIRT2;TNFRSF21;DICER1;TPPP;RNF10;EIF2AK3;LGI4;MYRF;PTN;NSUN5;ZPR1;TMEM98
prerank,GPI anchor metabolic process (GO:0006505),-0.2178189024099673,-0.6803578205244281,0.9251700680272109,0.9880292877220073,1.0,12/26,33.84%,DPM1;GPLD1;PIGV;PIGG;PIGA;PIGM;PGAP4;PIGF;MPPE1;DPM2;PIGC;DPM3
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.2711255949722026,-0.680244421998327,0.8804123711340206,0.987513805966645,1.0,1/12,1.66%,ACSL1
prerank,cellular lipid catabolic process (GO:0044242),0.24107383971134436,0.6781905980477146,0.8832752613240418,0.9997270985137607,1.0,5/27,12.52%,PPARD;NUDT19;CYP1B1;ACOT8;ABHD12
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2914935314725007,-0.6771702436302173,0.9125799573560768,0.9894424234241654,1.0,3/10,15.30%,DNAJC19;MTMR9;MTMR4
prerank,protein catabolic process (GO:0030163),0.20392913610537544,0.6766937219837206,0.952887537993921,1.0,1.0,8/59,15.10%,HSPA8;PPT1;APOE;MAGEC2;TPP1;STT3B;CHEK2;UBE2G1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.20012074243845418,0.6763656569276515,0.9415481832543444,1.0,1.0,13/67,15.63%,TBC1D8;PPP1R16B;TBC1D10B;FXR1;USP6NL;PODXL;IFT140;TBC1D24;TBC1D14;RABGAP1;TWF1;ARF6;CDKL5
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.28341755753937703,0.6763500682131653,0.8943533697632058,0.9997568336466617,1.0,1/13,1.77%,AMDHD2
prerank,rRNA modification (GO:0000154),0.2499190923239955,0.675971390519236,0.8971119133574007,0.9995451103708543,1.0,1/21,1.09%,THUMPD1
prerank,regulation of T cell differentiation (GO:0045580),-0.20614087757431537,-0.6755785632712307,0.9437340153452686,0.9901169120510365,1.0,3/33,6.99%,CBFB;ZBTB1;CAMK4
prerank,protein localization to centrosome (GO:0071539),-0.2497164392259948,-0.6755684946681059,0.8808988764044944,0.9895123399341561,1.0,3/17,10.50%,PIBF1;NUDCD3;GOLGB1
prerank,regulation of interferon-beta production (GO:0032648),0.21625573249731347,0.6747145453811638,0.9521531100478469,1.0,1.0,8/46,13.47%,TIRAP;YY1;NLRC3;TRAF3;DDX3X;POLR3F;RNF216;POLR3B
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2105376012573244,0.6745885268609262,0.9254185692541856,0.9997447191438538,1.0,10/49,18.08%,RAB7B;MYL9;CIB1;EP300;MTURN;AGO4;PITHD1;MOV10;EIF6;SIN3A
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.2253640414129287,-0.6739875050514019,0.9318181818181818,0.99019852453937,1.0,6/25,15.83%,AMPD3;DGUOK;ADK;GMPS;MTHFD1;PRPSAP2
prerank,protein localization to chromatin (GO:0071168),0.2625574183164532,0.6735899843778704,0.8854545454545455,1.0,1.0,4/18,14.51%,RUVBL2;ESR1;PPHLN1;TASOR
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.2773685528408746,-0.6734399732636034,0.9083503054989817,0.9900162427882966,1.0,4/12,26.38%,BTRC;GOLGA2;CDC14B;UBE2S
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.21905160284727695,-0.6733040416349708,0.933806146572104,0.9895000477188168,1.0,5/26,12.90%,GRIN2B;MBP;ROCK2;AIM2;USP50
prerank,tetrapyrrole metabolic process (GO:0033013),0.2597595075262503,0.6728000963904788,0.8823529411764706,1.0,1.0,1/18,2.94%,MTR
prerank,high-density lipoprotein particle assembly (GO:0034380),0.30100721715459167,0.6726883505908656,0.8496993987975952,0.9998621146881927,1.0,1/10,4.59%,APOE
prerank,regulation of T cell proliferation (GO:0042129),0.20208938098417217,0.6725417342273564,0.9559939301972686,0.9994446640203416,1.0,4/61,13.00%,PTPRC;TNFRSF1B;PNP;CD274
prerank,long-chain fatty acid metabolic process (GO:0001676),0.20295985156855584,0.6723635945919019,0.9573529411764706,0.9990693039592979,1.0,12/64,18.12%,ACSL5;ELOVL6;ACSL4;CYP1B1;PNPLA8;HSD17B4;ACOT8;DAGLB;HPGD;ACADL;AIG1;ELOVL5
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.2610589367126599,-0.6708971384588202,0.8969957081545065,0.9908186758617311,1.0,10/15,44.02%,BMP4;SMO;SIX1;VEGFA;PAX2;SOX9;AGT;SIX4;SOX8;GDNF
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.2820761870139178,-0.6705007294916503,0.8734177215189873,0.9899125356249624,1.0,5/10,33.55%,CDC42EP5;CDC42EP1;CDC42;CDC42EP2;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.2820761870139178,-0.6705007294916503,0.8734177215189873,0.9899125356249624,1.0,5/10,33.55%,CDC42EP5;CDC42EP1;CDC42;CDC42EP2;WASHC1
prerank,inhibitory synapse assembly (GO:1904862),-0.28291082026939113,-0.670250510338081,0.9006085192697769,0.9895250162447062,1.0,5/11,24.46%,GABRA2;GABRG2;LGI2;GABRA1;PLXNB1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.2411131206015278,0.6700429335500285,0.9142367066895368,1.0,1.0,5/23,15.25%,VSIR;PRNP;CD274;DDIT3;GAS6
prerank,NAD biosynthetic process (GO:0009435),0.25244699995666325,0.6691427812297521,0.8864468864468864,1.0,1.0,5/20,16.87%,NUDT12;NADSYN1;NAMPT;NAXD;NMNAT1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.23385060525148868,0.6686627202680842,0.9123434704830053,1.0,1.0,5/29,11.27%,GRIK2;NETO1;APOE;MCTP1;APP
prerank,negative regulation of neurogenesis (GO:0050768),0.2248553718583838,0.6684951712103062,0.9455445544554455,1.0,1.0,8/34,17.53%,B2M;RUFY3;NOTCH1;NF1;YWHAH;HOOK3;LRP4;LINGO1
prerank,piRNA metabolic process (GO:0034587),0.25725411380479835,0.667991834888569,0.8874045801526718,1.0,1.0,19/19,74.31%,MYBL1;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;PIWIL4;TDRD12;DDX4;TDRD9;PIWIL2;EXD1;TEX15;TDRKH
prerank,potassium ion export across plasma membrane (GO:0097623),-0.262177872078428,-0.6675640611459696,0.8849372384937239,0.9910079859365475,1.0,5/13,45.89%,KCNK5;KCNQ1;KCNIP2;KCNE4;KCNH2
prerank,positive regulation of cell development (GO:0010720),0.23127217467207117,0.6670608852862265,0.9333333333333333,1.0,1.0,5/31,13.61%,MME;RFX3;BAD;ATP6AP1;FAIM
prerank,regulation of stem cell population maintenance (GO:2000036),0.2518536164284636,0.6666153309303362,0.9081081081081082,1.0,1.0,5/18,20.30%,CNOT2;CNOT1;TAF6L;ZC3H13;REST
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2300190346234433,-0.6658093592699149,0.9186046511627907,0.9917447851917902,1.0,14/21,43.67%,COX16;COX19;COX17;COX18;PET100;COX20;COX14;BCS1L;COA5;SCO1;COA3;SURF1;COA6;FASTKD3
prerank,RNA polyadenylation (GO:0043631),0.23669233845588192,0.6651856156036411,0.9176276771004942,1.0,1.0,9/26,21.52%,AHCYL1;PAPOLA;APP;SCAF8;WDR33;CLP1;PAPOLG;TENT2;MTPAP
prerank,mRNA polyadenylation (GO:0006378),0.23669233845588192,0.6651856156036411,0.9176276771004942,1.0,1.0,9/26,21.52%,AHCYL1;PAPOLA;APP;SCAF8;WDR33;CLP1;PAPOLG;TENT2;MTPAP
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.22042432845898113,-0.6651754334338776,0.9123595505617977,0.9916159318234564,1.0,11/25,31.59%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.29535162763822387,0.6647489358762116,0.8732673267326733,0.9996767076138973,1.0,3/11,18.82%,CALM3;FKBP1A;CALM1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.29535162763822387,0.6647489358762116,0.8732673267326733,0.9996767076138973,1.0,3/11,18.82%,CALM3;FKBP1A;CALM1
prerank,positive regulation of TOR signaling (GO:0032008),0.22182493243435467,0.6640957063283819,0.9300155520995335,0.9996784277740991,1.0,7/40,15.25%,RPTOR;HDAC3;LAMTOR1;SIK3;LARS1;RRAGC;GAS6
prerank,steroid hormone biosynthetic process (GO:0120178),0.22997605874427368,0.6630512601215159,0.9139966273187183,0.9999924687578818,1.0,4/29,15.93%,TSPO;HSD17B11;STARD3NL;STARD3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.20781590752945986,0.6625525778293808,0.9655172413793104,0.9998661413761333,1.0,8/54,11.52%,TNFAIP3;PRMT3;RPL5;SMAD7;IVNS1ABP;PARK7;SPOPL;RPS3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.2852453867745972,0.6622564729985537,0.8925143953934741,0.9995538248674531,1.0,3/12,13.63%,SGTB;SEC62;SEC61A2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.2716743404647721,0.6621116566170449,0.8855534709193246,0.9991301300460506,1.0,2/13,8.20%,RIC3;TMEM35A
prerank,cellular response to interleukin-15 (GO:0071350),-0.2636696733286461,-0.661563771076315,0.8784067085953878,0.9931727899893467,1.0,2/13,12.24%,JAK1;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.2636696733286461,-0.661563771076315,0.8784067085953878,0.9931727899893467,1.0,2/13,12.24%,JAK1;GRB2
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.23181628872786508,-0.6612236768680381,0.9471264367816092,0.9928318420029045,1.0,7/21,27.55%,ACBD5;LPIN1;CYP26B1;LPIN2;FAH;HOGA1;LPIN3
prerank,regulation of cell aging (GO:0090342),0.2925229835797607,0.6611723934686738,0.8685258964143426,0.9993612674548169,1.0,4/11,18.90%,ING2;NEK6;RSL1D1;NUAK1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.2866805318673257,-0.6603275706096841,0.8863157894736842,0.9922834561860864,1.0,4/10,21.46%,PRKCD;SMPD3;RACK1;PLA2G6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.2866805318673257,-0.6603275706096841,0.8863157894736842,0.9922834561860864,1.0,4/10,21.46%,PRKCD;SMPD3;RACK1;PLA2G6
prerank,mitochondrial transcription (GO:0006390),-0.28630829356580484,-0.6596961027025395,0.8803245436105477,0.9921374455163223,1.0,7/10,41.26%,SLC25A33;FOXO3;MTERF2;MRPL12;TEFM;POLRMT;TWNK
prerank,intracellular cholesterol transport (GO:0032367),0.2689510524366904,0.659546357933246,0.9021113243761996,1.0,1.0,5/15,13.98%,LDLRAP1;NPC2;NPC1;OSBPL2;SERAC1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.19994675185272123,-0.6590807793968906,0.9689737470167065,0.9919653323606277,1.0,4/35,8.39%,CDH10;CDH11;CDH7;NLGN1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.2727416401397582,0.6587683689084721,0.8973384030418251,1.0,1.0,3/15,11.85%,FITM2;CNEP1R1;SCARB1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.2705609435990495,0.6585909032294848,0.8888888888888888,0.9998540023699997,1.0,3/13,15.95%,NUDT12;NAMPT;NAXD
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.26939228829213646,0.658530807332334,0.904424778761062,0.9993668496839179,1.0,2/15,6.97%,RIPOR2;RAPGEF3
prerank,positive regulation of macrophage migration (GO:1905523),0.253012643404274,0.6579922634090261,0.8884955752212389,0.9992346154333621,1.0,2/19,9.17%,MAPK3;CSF1R
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.23369462346130226,-0.6579047514899143,0.9267734553775744,0.9922558304657025,1.0,12/19,37.44%,PMM2;RENBP;UGDH;NAGK;GFPT1;GNPDA2;GFPT2;GNPDA1;GNPNAT1;PMM1;UAP1;NANS
prerank,hexose transmembrane transport (GO:0008645),0.2394102819552545,0.6574166384076761,0.911190053285968,0.9991649443671948,1.0,2/21,8.35%,PPARD;SLC2A1
prerank,oligodendrocyte differentiation (GO:0048709),-0.23586714402551706,-0.6559567582697798,0.9030023094688222,0.9930205262447928,1.0,13/19,41.93%,SOX6;TPPP;EIF2B5;EIF2B2;CDK5;EIF2B4;MYRF;NSUN5;SOX9;SOX10;SOX8;PTPRZ1;EIF2B1
prerank,positive regulation of cholesterol transport (GO:0032376),0.23212215678666986,0.6556361055594265,0.9045936395759717,1.0,1.0,3/27,7.30%,APOE;LPCAT3;SIRT1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.1790000100569795,-0.6547498634754736,0.9680232558139535,0.9932713670850136,1.0,6/55,14.13%,IGF1;IGFBP2;ANXA1;IL18;IL6ST;IGF2
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2175241782648058,0.6539153063280047,0.9438202247191011,1.0,1.0,10/39,19.57%,MIA2;ARL4D;COPG2;PPY;COPG1;TANGO6;TVP23B;MIA3;PDIA4;SEL1L
prerank,mesoderm formation (GO:0001707),0.2594317210767082,0.6538591936286956,0.921146953405018,1.0,1.0,2/17,12.25%,ITGA2;ITGA3
prerank,development of primary male sexual characteristics (GO:0046546),-0.2019408303757211,-0.6537490921042604,0.9600997506234414,0.9933542519533769,1.0,5/34,12.95%,KIT;LHFPL2;WNT4;NCOA4;MSH2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.25827111312861384,0.653663916981854,0.8976234003656307,0.999917920977679,1.0,1/17,2.58%,CXCL12
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.27077240609561265,-0.6527591929904486,0.8991935483870968,0.9934563417356731,1.0,4/11,20.48%,EFNB2;TGFB1;SOX6;FZD7
prerank,ncRNA 3'-end processing (GO:0043628),0.26872893115341207,0.6523945246171634,0.8992395437262357,1.0,1.0,6/14,20.27%,PTCD1;INTS14;SSB;INTS6;TRNT1;INTS2
prerank,regulation of membrane depolarization (GO:0003254),0.2526377288962892,0.6523660363320275,0.9104991394148021,0.9998308740328556,1.0,2/18,7.28%,NEDD4L;SMAD7
prerank,glycerophospholipid catabolic process (GO:0046475),0.23156194138539826,0.6523590326736199,0.9236111111111112,0.9993055620021415,1.0,4/27,14.23%,SMPD4;PNPLA8;ABHD12;PNPLA6
prerank,glycerolipid catabolic process (GO:0046503),0.24692151155838593,0.6514521297189906,0.9195804195804196,0.999430331583258,1.0,3/19,14.23%,SMPD4;ABHD12;PNPLA6
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.26988575904951806,-0.6513414768440272,0.905982905982906,0.9938415180792393,1.0,4/12,22.90%,ATP7A;HNMT;SMS;OAZ2
prerank,histone H3-K36 demethylation (GO:0070544),-0.2761599631297977,-0.6497772465186562,0.9012096774193549,0.9942840728450906,1.0,2/10,5.28%,KDM4A;KDM7A
prerank,negative regulation of organelle assembly (GO:1902116),-0.19574286263014382,-0.64937835542952,0.95,0.9939497552426854,1.0,17/35,32.79%,SMAD4;NUPR1;FEZ1;CCP110;LIMK2;PINK1;PHF23;RBM14;YAP1;MDM1;CDK10;TBC1D7;CEP97;KAT2B;TCHP;TRIM37;SMCR8
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.2663248151831443,-0.6491143930883995,0.9077868852459017,0.9935346812319575,1.0,1/11,3.95%,SCARA3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.2621314029257146,-0.649104014900103,0.9082969432314411,0.9929386371487692,1.0,2/13,15.92%,IL33;SELENOS
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.2030558689727218,0.6489387803957569,0.9522342064714946,1.0,1.0,2/51,2.58%,MAPK3;CXCL12
prerank,cell projection organization (GO:0030030),0.22122750249240786,0.6485748004552149,0.9366666666666666,1.0,1.0,6/30,16.84%,RAC2;RHOQ;RHOG;PLEK;PACSIN2;CYFIP1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.23588737701939724,0.6481885106923345,0.9245901639344263,1.0,1.0,4/25,12.73%,HEY1;HEY2;PARK7;DOT1L
prerank,lymphocyte migration (GO:0072676),0.2216522685261476,0.6479143892933986,0.9418803418803419,0.9999050107351543,1.0,2/32,8.51%,RET;CCL25
prerank,regulation of keratinocyte migration (GO:0051547),-0.26277463053541283,-0.6477127237361817,0.9201680672268907,0.9932934181111185,1.0,6/12,33.08%,EPB41L4B;IQSEC1;MAPRE2;FGF10;FGF7;MTOR
prerank,myelin maintenance (GO:0043217),0.2840102629490491,0.6466389710735562,0.8870056497175142,1.0,1.0,1/10,2.23%,SOD1
prerank,ganglioside biosynthetic process (GO:0001574),0.26034553441157876,0.646299933345579,0.9026217228464419,1.0,1.0,3/15,14.61%,ST6GALNAC3;ST3GAL1;ST8SIA6
prerank,regulation of cilium assembly (GO:1902017),0.1949109242917475,0.6454179795203251,0.9754601226993865,1.0,1.0,9/62,13.25%,EVI5L;TBC1D30;TBC1D8;TBC1D10B;USP6NL;IFT140;TBC1D24;TBC1D14;RABGAP1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.27906095370751094,0.6453022311754181,0.888030888030888,0.9991561428916849,1.0,3/11,16.71%,SYK;PTK2B;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),0.27906095370751094,0.6453022311754181,0.888030888030888,0.9991561428916849,1.0,3/11,16.71%,SYK;PTK2B;SHC1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.2566966846424337,0.644055383173208,0.9160447761194029,0.9995209437882528,1.0,5/15,19.57%,DERL2;AUP1;UFD1;DERL1;SEL1L
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.2599394545385575,-0.6438242985113652,0.926829268292683,0.9951602797138106,1.0,3/13,17.63%,AXL;IFIH1;MAVS
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.1950133820266836,0.6433648692456578,0.9664634146341463,0.999494454829801,1.0,8/57,13.34%,ABRAXAS1;NEK11;CDKN1A;RFWD3;HUS1;NBN;BRCC3;CHEK2
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.25337930297467676,-0.6425607153250528,0.9057017543859649,0.9954041848628464,1.0,4/13,22.00%,NUPR1;FEZ1;PINK1;PHF23
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.28645147077163235,0.6420772094222582,0.877431906614786,0.9998826332970892,1.0,1/10,6.88%,CALM3
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.25773930745410173,-0.6413175164925844,0.9260869565217391,0.9955901924901855,1.0,8/14,40.70%,PPARA;AKT2;ABCD2;AKT1;MFSD2A;TWIST1;TYSND1;MTLN
prerank,protein alkylation (GO:0008213),-0.22008609631471424,-0.6407774694045243,0.9341176470588235,0.9953284599751205,1.0,8/22,28.28%,CAMKMT;FAM98A;EEF1AKMT1;PRMT2;METTL21A;PRMT8;PRMT1;EEF2KMT
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.2831586215554579,0.6399076424475373,0.8924528301886793,1.0,1.0,10/10,71.70%,ETFBKMT;OXA1L;GZMA;DRD5;PRKN;HP;AOC3;MT3;SNCA;HDAC6
prerank,regulation of mitochondrial fusion (GO:0010635),0.2775674895507953,0.6386354605954472,0.903921568627451,1.0,1.0,4/11,19.06%,OMA1;VAT1;BNIP3;TFRC
prerank,macrophage migration (GO:1905517),-0.25588309146562055,-0.6383199201703887,0.9175475687103594,0.9962457683558406,1.0,3/13,24.19%,P2RX4;P2RY12;CKLF
prerank,macromolecule catabolic process (GO:0009057),-0.20548166880605934,-0.636738576367793,0.9577777777777777,0.9966472287877706,1.0,12/26,33.08%,LGMN;UVRAG;SNX25;UCHL3;TGFB1;LRSAM1;NEDD4;CLPX;CLN5;SMURF1;MVB12A;MTOR
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.24779310277838418,-0.6360603273332726,0.9094827586206896,0.996425692539148,1.0,9/14,38.47%,ZNHIT6;NOL9;RPF2;FTSJ3;BOP1;NIFK;RPL7L1;PES1;DDX18
prerank,regulation of telomere maintenance (GO:0032204),0.22731106099615137,0.6341310143439315,0.9438596491228071,1.0,1.0,8/26,19.12%,ERCC4;SMG1;NBN;TERF2IP;SMG6;SMG5;ATRX;DHX36
prerank,ubiquinone metabolic process (GO:0006743),0.2560717336680431,0.6335617097595846,0.9089184060721063,1.0,1.0,6/15,19.46%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.22706057960141582,-0.6335313282073761,0.9172413793103448,0.9973290528407723,1.0,6/17,36.25%,PRKCZ;RARA;CEBPB;CD86;HAVCR2;FCER1G
prerank,GPI anchor biosynthetic process (GO:0006506),-0.19932165772021596,-0.6334000011574541,0.9606879606879607,0.9968108410059086,1.0,14/30,33.84%,DPM1;PIGV;PIGG;PIGX;PIGA;PIGM;PGAP4;PIGS;PIGF;GPAA1;MPPE1;DPM2;PIGC;DPM3
prerank,DNA methylation (GO:0006306),0.23249288463966888,0.6330391392824516,0.9553072625698324,1.0,1.0,2/23,5.83%,DMAP1;BEND3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.2774151241039719,0.6311987933620364,0.9148936170212766,1.0,1.0,2/11,13.00%,VSIR;CD274
prerank,cellular response to interferon-beta (GO:0035458),0.2600507242171339,0.6306609418882209,0.9119850187265918,1.0,1.0,2/14,13.09%,IFITM2;NDUFA13
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2700383560922188,-0.6305093905893406,0.9229166666666667,0.9978528606646686,1.0,1/10,3.09%,STIM1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.21882271266816367,0.6304132583826147,0.9480069324090121,1.0,1.0,6/32,16.60%,LPCAT3;GPAT4;SLC44A1;CEPT1;CSNK2A2;SLC44A2
prerank,negative regulation of secretion (GO:0051048),-0.2700384284590389,-0.6300757096559743,0.9156862745098039,0.9975239905393377,1.0,6/10,50.19%,VAMP8;PTGER3;EGF;ERBB3;SPX;NRG1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.26452326677900306,0.6299904437292171,0.9059040590405905,1.0,1.0,2/13,12.41%,PLCG1;SP1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.24061195328109253,-0.6299160672397612,0.9131403118040089,0.997009326359528,1.0,6/15,26.97%,ALDH4A1;GGT5;PRODH;SARDH;HOGA1;CHAC2
prerank,ovarian follicle development (GO:0001541),0.25610178412629,0.6288738383648841,0.9055555555555556,1.0,1.0,1/13,2.23%,SOD1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.2587148365946462,0.6277961256644975,0.9310344827586207,1.0,1.0,1/14,2.47%,PSEN2
prerank,chromosome organization (GO:0051276),0.17670110788692042,0.6276121505556151,0.9985569985569985,1.0,1.0,16/99,16.09%,EZH2;HDAC3;SOX2;FAM50A;SIRT1;CDCA8;RFWD3;MSH3;COPS7B;PWWP3A;DOT1L;HDAC5;COPS8;EZH1;SMARCA4;TCF7L1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.2263326693263591,0.6270182321281523,0.9412780656303973,1.0,1.0,3/24,10.98%,PDE4D;CALM3;DMD
prerank,organophosphate catabolic process (GO:0046434),0.2684243565599498,0.6268779487575853,0.9096153846153846,1.0,1.0,11/11,73.18%,ABHD12;ENPP2;PNLIPRP2;APOA2;LIPG;PON1;PDXP;NUDT15;PLBD1;ANGPTL3;PLBD2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.2448195915694174,0.6268666449100714,0.9305301645338209,1.0,1.0,1/18,2.43%,DERL2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.272574066091112,-0.6257926546546606,0.93125,0.9987432178957062,1.0,4/10,23.57%,EMC7;EMC1;EMC8;EMC9
prerank,defense response to fungus (GO:0050832),0.2433964212374771,0.6253190825323004,0.937037037037037,1.0,1.0,1/17,6.03%,FAM3A
prerank,actin filament-based transport (GO:0099515),0.23494401758835787,0.6252940627749932,0.9485815602836879,1.0,1.0,4/21,13.12%,MYO5A;ACTN4;MYO1D;MYO1E
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.2647232564869561,0.6251998842950353,0.9261363636363636,1.0,1.0,1/13,3.56%,EXTL2
prerank,intracellular sterol transport (GO:0032366),0.2654813857510894,0.6251745630208603,0.9224652087475149,1.0,1.0,4/13,13.98%,NPC2;NPC1;OSBPL2;SERAC1
prerank,regulation of DNA recombination (GO:0000018),0.21783210349896573,0.6243552386311383,0.9645868465430016,1.0,1.0,6/32,16.84%,ZRANB3;MSH3;KPNA1;TERF2IP;SETD2;SMARCAD1
prerank,neuromuscular process (GO:0050905),0.25486241916080815,0.6243456686847273,0.9061913696060038,1.0,1.0,5/16,17.78%,AGTPBP1;TPP1;MYCBP2;GCH1;PAFAH1B1
prerank,purine nucleotide metabolic process (GO:0006163),0.22835397484475112,0.6241684575579116,0.9332161687170475,0.99981862483755,1.0,4/24,12.02%,PRPS1L1;PRPS1;PNP;NT5C2
prerank,striated muscle cell differentiation (GO:0051146),0.25257571759514225,0.6240751795490392,0.9166666666666666,0.9993570883849353,1.0,2/16,5.82%,SORT1;MYEF2
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2572296965902504,-0.6240399321146235,0.940552016985138,0.9991255736683435,1.0,5/12,29.16%,HDAC1;JUN;PSMC3;INPP5K;HMGA2
prerank,neural crest cell differentiation (GO:0014033),-0.2250480094918597,-0.6234121581636722,0.9475982532751092,0.9988709348938272,1.0,13/18,50.33%,TAPT1;LRP6;PEF1;TCOF1;NOLC1;FBXL17;SOX11;SOX8;KBTBD8;HTR2B;SNAI2;NRG1;MEF2C
prerank,muscle tissue development (GO:0060537),0.25537246541460246,0.6228381574842541,0.9149722735674677,0.9995575111675302,1.0,3/13,13.39%,PGM5;NF1;CSRP1
prerank,RNA interference (GO:0016246),-0.23058854475202067,-0.6215185570317652,0.9361702127659575,0.9992724849361213,1.0,6/17,28.59%,TSN;AGO3;DICER1;NRDE2;CELF1;DROSHA
prerank,regulation of ruffle assembly (GO:1900027),0.2271035756103524,0.621328472063861,0.9466911764705882,0.9999174566825635,1.0,2/23,4.76%,EVL;PFN1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.26395491766035817,-0.6211944847477601,0.9256198347107438,0.9988405924809777,1.0,1/10,3.61%,TGFBR2
prerank,cardiac cell development (GO:0055006),-0.26251537824085935,-0.6200926333435364,0.9240506329113924,0.9988285066248767,1.0,3/11,24.77%,CXADR;VEGFA;MYH11
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.21189930975969642,-0.6194318560169935,0.9544419134396356,0.998578732445219,1.0,12/22,34.57%,LMAN1;GDI1;RAB23;APOD;CABP1;ITGB1BP1;DMTN;SUFU;INPP5K;CHP1;SIAH3;BARD1
prerank,positive regulation of innate immune response (GO:0045089),0.21273215966981726,0.6180620631242421,0.962171052631579,1.0,1.0,5/30,13.47%,IFI35;WNT5A;POLR3F;NLRC5;POLR3B
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.26318229398377624,0.6174229983357958,0.9122137404580153,1.0,1.0,3/13,17.67%,CRLF1;TYK2;STAT3
prerank,cellular response to leucine starvation (GO:1990253),-0.26567750517145194,-0.6169643286863364,0.9296066252587992,0.9992761051737672,1.0,5/10,33.64%,GCN1;IMPACT;SESN2;MTOR;RRAGD
prerank,negative regulation of translational initiation (GO:0045947),0.25613515371866447,0.6169250138292178,0.9323583180987203,1.0,1.0,7/13,23.68%,PAIP2B;EIF3E;LARP1;EIF2AK4;PAIP2;AGO2;FMR1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.21289244093203966,0.6164114249335343,0.9534109816971714,1.0,1.0,4/29,12.87%,BIRC2;TRAF3;IKBKB;CHUK
prerank,fibrinolysis (GO:0042730),0.25860120542440984,0.6156307343838401,0.9049360146252285,1.0,1.0,13/13,74.16%,PLAT;FGG;SERPINF2;KRT1;F2;GP1BA;CPB2;SERPINB2;PLG;HRG;PLAU;PLAUR;SERPINE1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.20222432490426903,-0.6149371161661936,0.9595505617977528,0.9996945237097827,1.0,4/25,13.07%,FAM162A;BCL2L11;TP53;PDCD5
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.20388457563605522,0.6145217379111927,0.9606557377049181,1.0,1.0,5/35,12.83%,RIPOR2;SCAI;RASIP1;ITGA3;CUL3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.26758577112284465,0.6143897666458,0.9166666666666666,1.0,1.0,2/11,11.08%,PTPRT;ADIPOR1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.2588894947993975,-0.6142053689433377,0.924643584521385,0.9994623057961468,1.0,2/10,14.25%,TSN;DICER1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.226236374975966,0.6139935820488945,0.9553719008264463,0.9993739000737468,1.0,4/22,14.05%,ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.226236374975966,0.6139935820488945,0.9553719008264463,0.9993739000737468,1.0,4/22,14.05%,ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.23863326450509348,0.6132267613188496,0.9325259515570934,0.9992605353665104,1.0,6/19,18.52%,POLD3;TERT;PNP;GMPR2;GMPR;HPRT1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.2376177677284797,0.6130632035726934,0.9520426287744227,0.998847967487116,1.0,3/18,12.41%,PLCG1;FLT1;SP1
prerank,snRNA 3'-end processing (GO:0034472),0.2324837758714909,0.61267558920092,0.943289224952741,0.998549010967592,1.0,6/19,20.27%,USB1;EXOSC9;INTS14;INTS6;EXOSC7;INTS2
prerank,iron-sulfur cluster assembly (GO:0016226),0.21798284483771097,0.6121129509955962,0.9585492227979274,0.9983301620592386,1.0,4/24,13.46%,CIAPIN1;ISCU;GLRX3;HSCB
prerank,mitochondrial genome maintenance (GO:0000002),-0.25420902172992554,-0.6115627060081119,0.934640522875817,1.0,1.0,4/11,19.81%,SLC25A36;MPV17;PARP1;SLC25A33
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.20999315104151792,0.6114864628320148,0.96,0.9981288980420144,1.0,4/30,12.87%,BIRC2;TRAF3;IKBKB;CHUK
prerank,regulation of RNA export from nucleus (GO:0046831),0.2692588273916037,0.61108834850687,0.9172932330827067,0.9978209275629141,1.0,5/11,21.38%,AKAP8L;CPSF6;SETD2;NSUN2;DHX9
prerank,regulation of acrosome reaction (GO:0060046),-0.26560595274008164,-0.6095619272645393,0.921161825726141,1.0,1.0,1/10,7.73%,GLRA1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.24427416022535803,-0.6092746275491623,0.9410569105691057,1.0,1.0,5/13,24.16%,NLGN1;FAM98A;PLEKHM1;P2RY12;EPS8L2
prerank,regulation of interleukin-6 production (GO:0032675),0.17260435131290058,0.6092235031597244,0.9957325746799431,0.9982519136178518,1.0,7/96,9.09%,TNFAIP3;TIRAP;RAB7B;SYK;NLRC3;WNT5A;CD47
prerank,ESCRT complex disassembly (GO:1904896),0.26880085907503015,0.6056257883437408,0.9257731958762887,0.9990231285429948,1.0,2/10,10.23%,CHMP1A;CHMP2A
prerank,ESCRT III complex disassembly (GO:1904903),0.26880085907503015,0.6056257883437408,0.9257731958762887,0.9990231285429948,1.0,2/10,10.23%,CHMP1A;CHMP2A
prerank,ubiquinone biosynthetic process (GO:0006744),0.2472931237020874,0.6051666065525566,0.9407265774378585,0.9987452810230775,1.0,6/15,19.46%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.2197419492485847,-0.6051163070798177,0.9694323144104804,1.0,1.0,13/18,45.29%,ATP7A;ABL2;AGTR1;RFK;PDP1;POR;FXN;EDN1;EDN3;AGT;NOD2;GDNF;PDP2
prerank,negative regulation of receptor internalization (GO:0002091),-0.2501797866379116,-0.6050193917431576,0.9277899343544858,1.0,1.0,2/12,15.60%,DLG4;RIN3
prerank,ncRNA metabolic process (GO:0034660),0.1977062581549346,0.6045396560065797,0.9717607973421927,0.9985500372353113,1.0,6/37,16.46%,BCDIN3D;XPO5;TUT7;TUT4;DTD1;PARN
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.2432171341479957,-0.6039410883137316,0.937246963562753,1.0,1.0,7/12,31.27%,CLCN2;MBTPS2;SREBF1;DGKQ;H6PD;ABCA2;RAN
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.2064095998883038,-0.6036791302579183,0.9643705463182898,1.0,1.0,18/22,66.03%,IL18;TGFB1;SPHK1;ZBTB7B;NR1H4;NOD2;MYD88;LY9;SLAMF6;PRKCQ;CARD9;IL23A;IL6;IL23R;CCL1;IL12B;IL2;OSM
prerank,peptidyl-lysine methylation (GO:0018022),-0.19896751709857435,-0.6028405150407851,0.9570135746606335,1.0,1.0,17/26,43.87%,SETD7;EHMT2;ATPSCKMT;EEF1AKMT1;SMYD2;N6AMT1;SETD4;METTL21A;EEF2KMT;SUV39H1;EEF1AKMT2;SMYD1;ANTKMT;SUV39H2;VCPKMT;SETD6;TRMT112
prerank,electron transport chain (GO:0022900),0.24283629871291007,0.6026621015318065,0.9474671669793621,0.9989767356447937,1.0,3/15,13.86%,ETFA;SDHA;PDIA5
prerank,modulation by symbiont of host process (GO:0044003),0.26939391810399904,0.6022909862420003,0.937007874015748,0.9986432721568334,1.0,1/10,5.45%,B2M
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2581303356804209,-0.6022556738733417,0.9364754098360656,0.9997468518417493,1.0,3/10,20.70%,SETD7;SMYD2;SETD4
prerank,fatty acid biosynthetic process (GO:0006633),-0.16031204546560662,-0.6020382494713513,0.9938837920489296,0.9992491244105831,1.0,24/63,39.24%,HACD3;HACD1;HACD4;TECR;ACLY;ABHD3;ACOT7;PTGS2;DEGS1;EPHX2;ABCD3;ELOVL4;FADS3;DECR2;CBR4;SCD;ELOVL1;LIAS;FADS1;ACSBG1;LPL;ALOX12;HSD17B8;OXSM
prerank,protein localization to mitochondrion (GO:0070585),0.26159912350044046,0.5998357198992521,0.9365079365079365,0.9993221284237291,1.0,2/11,10.66%,RALA;MAIP1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.22158318573296407,-0.5994447552129897,0.949290060851927,0.9997851252559073,1.0,4/16,20.38%,TMEM50A;SNF8;CHMP5;STAM
prerank,modulation by symbiont of entry into host (GO:0052372),-0.22671019175662196,-0.5981183407424082,0.9446902654867256,0.9998237474411908,1.0,9/16,35.43%,HS3ST5;EXOC7;TRIM5;NECTIN2;TRIM62;FUCA2;CAV1;TRIM21;TRIM68
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2519563193026526,-0.597956029492984,0.9463220675944334,0.999307354009853,1.0,7/11,43.94%,RBM14;MDM1;KAT2B;TRIM37;KAT2A;CCNF;BRCA1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.1932852080047559,-0.5969275989661419,0.9949238578680203,0.9991754523058943,1.0,9/32,25.51%,ERBB4;FIS1;HSPD1;THEM4;BCL2;HK2;CAMK2A;AIFM2;BCL2L1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.25511767927948126,-0.596360151390146,0.9100204498977505,0.9988031700560881,1.0,1/10,3.66%,BMP5
prerank,apoptotic DNA fragmentation (GO:0006309),-0.22035373750721016,-0.5962751505577569,0.9483471074380165,0.9982459976528234,1.0,8/16,35.82%,DICER1;DFFA;CASP3;EXOG;H1-0;DNASE2;HMGB1;HMGB2
prerank,negative regulation of histone acetylation (GO:0035067),0.2586326931323079,0.5962526496720404,0.9313543599257885,1.0,1.0,2/11,11.22%,SIRT1;CTBP1
prerank,homologous chromosome segregation (GO:0045143),-0.20879613424163682,-0.5961365034491226,0.9711538461538461,0.9977055924597473,1.0,11/20,53.29%,FMN2;SIRT7;PTTG1;PRDM9;TERB1;MEI4;FANCD2;ZCWPW1;SGO1;MAJIN;MEIOB
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.2108397075187391,0.5952759271830064,0.9714285714285714,1.0,1.0,1/26,1.17%,CBL
prerank,fatty acid oxidation (GO:0019395),0.1825992263622058,0.5947438163871438,0.9922239502332815,1.0,1.0,11/57,17.50%,ACAT1;PPARD;ADIPOR2;ADIPOR1;HSD17B4;BDH2;ECHDC1;ECHS1;ACAA2;ACADL;PEX13
prerank,regulation of mitotic spindle assembly (GO:1901673),0.22248055780093395,0.5942281810949197,0.9397590361445783,0.999856531292082,1.0,2/19,10.23%,CHMP1A;CHMP2A
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.19411563526929074,0.5934124462395768,0.9749216300940439,0.9997067008372357,1.0,12/44,20.81%,PRR5L;ZFP36L1;CNOT7;NANOS3;CNOT1;MOV10;FTO;RC3H1;DHX36;METTL14;CNOT8;TNRC6A
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.23319883266842006,0.5923804455856929,0.9520295202952029,0.9996468768719704,1.0,6/16,19.12%,ERCC4;TNKS;SMG6;TNKS2;SMG5;DHX36
prerank,ureteric bud morphogenesis (GO:0060675),0.24268320496858348,0.592277182860021,0.9430604982206405,0.9991915907771948,1.0,2/16,11.08%,PAX8;NPNT
prerank,leukocyte tethering or rolling (GO:0050901),-0.21629717393504222,-0.5900576152218822,0.9686800894854586,0.999594421007813,1.0,5/17,26.99%,ROCK1;ITGA4;ADD2;PODXL2;CX3CR1
prerank,RNA stabilization (GO:0043489),0.20162000468088584,0.5897606829758469,0.9782608695652174,0.9997892546033065,1.0,10/33,19.34%,TAF15;YBX1;FUS;NOCT;DKC1;ZCCHC17;PARN;NSUN2;DHX36;LARP1
prerank,eye photoreceptor cell development (GO:0042462),-0.22461549025751631,-0.5895423597712371,0.9517819706498952,0.9991885874669565,1.0,8/15,49.39%,TOPORS;VEGFA;RP1;THY1;RPGRIP1;TULP1;MYO7A;RORB
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.24634260524949442,-0.5891874985803618,0.9364406779661016,0.998739020915596,1.0,3/10,27.39%,SORL1;HSP90AA1;EGR1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.266652114234179,0.588147371754635,0.9272030651340997,0.9999688757809754,1.0,2/10,11.22%,SIRT1;CTBP1
prerank,cGMP biosynthetic process (GO:0006182),0.2657417861434774,0.5868328763341367,0.9410681399631676,1.0,1.0,2/10,14.18%,NPPC;NPR2
prerank,negative regulation of DNA replication (GO:0008156),-0.23428756503254794,-0.5866245493398403,0.9568034557235421,0.9991482933472167,1.0,9/13,54.19%,S100A11;TSPYL2;CDAN1;TERF1;PDS5A;GMNC;RAD17;GMNN;CDC6
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2240561206193854,-0.5855868306302937,0.9402985074626866,0.9989408311520265,1.0,10/16,44.29%,SHLD1;RIF1;SMCHD1;SHLD2;POLQ;FANCB;CGAS;MAD2L2;RMI2;PARPBP
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.24131423613186603,-0.5843721684615614,0.9440993788819876,0.9988051666701826,1.0,6/11,33.08%,NOL11;SIRT7;NOP53;PIH1D1;DDX11;MTOR
prerank,negative regulation of transposition (GO:0010529),0.23188431493630665,0.5843542962335672,0.9525547445255474,1.0,1.0,4/16,19.15%,TUT7;TUT4;MOV10;MYBL1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.2495984190292442,-0.5838998878313493,0.9322033898305084,0.9983776066852422,1.0,7/10,46.96%,NPLOC4;RIOK3;GPATCH3;DHX58;C1QBP;TKFC;TSPAN6
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.2518788138560291,0.5838889560755587,0.933852140077821,1.0,1.0,1/12,3.46%,PAX8
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.24250692659523937,-0.5837999233642489,0.9527720739219713,0.9978329966383827,1.0,5/11,32.12%,ENPP3;NT5C3A;SLC19A2;DCK;SLC25A19
prerank,respiratory electron transport chain (GO:0022904),0.2400433607165911,0.5834858596466822,0.946969696969697,0.9998319568697004,1.0,3/14,12.49%,ETFA;SDHA;SLC25A12
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.2169721454025635,-0.5832300611836292,0.9732360097323601,0.997444563982342,1.0,8/18,43.78%,GPLD1;SPG21;BAG6;CMKLR1;SH2B2;FCER1G;BCAR1;C3AR1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.17536599566977917,-0.5823309337453372,0.9897172236503856,0.9971946868806175,1.0,18/36,49.18%,AXL;PARP14;UBE2K;MAVS;IRGM;AGPAT1;PARP9;EDN1;LAPTM5;AGPAT2;TRIM6;HSPA1A;ZBP1;TXK;CASP1;HSPA1B;CXCR4;CD300LF
prerank,positive regulation of cholesterol efflux (GO:0010875),0.21883774565374145,0.5821369280583415,0.960820895522388,0.9998483534220409,1.0,7/21,21.07%,APOE;SIRT1;NFKBIA;PLTP;EEPD1;NR1H3;PPARG
prerank,muscle filament sliding (GO:0030049),-0.17397152748890074,-0.5814053338828045,0.9922680412371134,0.9963533107718551,1.0,3/38,10.09%,TPM1;VIM;ACTN2
prerank,actin-myosin filament sliding (GO:0033275),-0.17397152748890074,-0.5814053338828045,0.9922680412371134,0.9963533107718551,1.0,3/38,10.09%,TPM1;VIM;ACTN2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.22264050448767153,-0.5812326520976332,0.9576837416481069,0.9958261460379769,1.0,1/14,1.93%,PKD1
prerank,chromatin assembly (GO:0031497),0.19144649894004118,0.5811652120016737,0.9797507788161994,0.9997516577392712,1.0,8/38,18.79%,NAP1L4;SIRT1;RSF1;BRD2;EZH1;RBBP4;NPM1;ATRX
prerank,regulation of cholesterol efflux (GO:0010874),0.20426316525183708,0.5807182847167068,0.9712230215827338,0.9994267087987068,1.0,3/30,7.30%,APOE;LAMTOR1;SIRT1
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.24666447730987157,-0.5803339568821176,0.9318181818181818,0.9955585074229397,1.0,5/11,52.63%,AGTR1;PLA2G7;AGT;LIPC;PLA2G5
prerank,plasma membrane tubulation (GO:0097320),-0.23411266984089962,-0.579823989404443,0.9576612903225806,0.9951581481616928,1.0,5/13,32.59%,BIN3;PACSIN1;PACSIN3;CAVIN2;MICALL1
prerank,regulation of anoikis (GO:2000209),0.22256013025326632,0.5797418278858799,0.9632352941176471,0.9992951418923041,1.0,2/19,8.04%,SRC;NOTCH1
prerank,regulation of interferon-alpha production (GO:0032647),-0.19861030298583807,-0.5788852012711841,0.9765807962529274,0.9948852334513366,1.0,5/23,19.49%,PTPRS;IFIH1;HSPD1;MAVS;STAT1
prerank,negative regulation of cell activation (GO:0050866),0.2375808221722968,0.5780741925308316,0.9521072796934866,0.9994251438590774,1.0,2/14,11.15%,APOE;NOS3
prerank,regulation of transferase activity (GO:0051338),0.22512770289004164,0.5764213879959335,0.9570661896243292,0.9995679630545194,1.0,1/17,1.41%,JMJD8
prerank,sulfur amino acid catabolic process (GO:0000098),0.2593685267717032,0.5749975024640306,0.9484732824427481,0.9995867550346964,1.0,10/10,74.08%,TXN2;BLMH;MAT1A;GADL1;TST;MPST;ADO;CTH;CBS;MTRR
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.20691148360836892,0.573962335462268,0.9732142857142857,0.9994636904213728,1.0,9/25,22.03%,APP;PICALM;ARF6;MTMR2;UBQLN2;RAC1;ANKRD13A;PSEN1;ATXN2
prerank,negative regulation of biosynthetic process (GO:0009890),-0.21476353798117498,-0.5737944279532986,0.9632829373650108,0.9960550418127367,1.0,3/16,13.86%,SLC30A10;PPARA;ABCD2
prerank,secretory granule organization (GO:0033363),0.2590952179735669,0.5734467302798554,0.9417670682730924,0.9991454192471305,1.0,1/10,6.05%,DTNBP1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.22100537611905155,-0.5730071060909773,0.9662447257383966,0.9957075524555303,1.0,6/14,37.04%,SLC24A2;CACNA2D1;TRPV2;SLC8A2;TRPM2;ATP2B4
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.21848272248800749,0.5717667046224317,0.964349376114082,0.9992696287529316,1.0,3/21,13.40%,TXNDC12;PARK7;DDIT3
prerank,maturation of LSU-rRNA (GO:0000470),0.20585787143493933,0.5717647440086746,0.9690346083788707,0.9987626426399163,1.0,7/26,17.53%,RRP15;SNU13;WDR12;RPL35;RSL1D1;URB1;EIF6
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.23142792002112067,0.5717114438357263,0.9575289575289575,0.9982806076465699,1.0,1/14,3.76%,NUDT5
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.23957944307782908,0.5716403753848553,0.9473684210526315,0.9978032088497172,1.0,2/13,9.76%,TXN;PARK7
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.2275732730040825,-0.5702139501540557,0.9698924731182795,0.9960055055777249,1.0,1/12,7.87%,RBP4
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.2479873797487065,-0.5700017117131888,0.9607843137254902,0.9955072368447951,1.0,5/10,30.04%,AKT2;GPLD1;AKT1;SNCA;SLC45A3
prerank,ganglioside metabolic process (GO:0001573),-0.1980375473108888,-0.5686321866737127,0.9861111111111112,0.9953542279760665,1.0,10/20,35.61%,HEXA;HEXB;ST6GALNAC5;ST6GALNAC6;ST8SIA2;ST6GALNAC4;ABCA2;NEU1;ST8SIA3;ST3GAL5
prerank,tyrosine metabolic process (GO:0006570),0.248603221348407,0.5681611276001195,0.9476861167002012,0.9985146600512905,1.0,1/11,9.16%,THAP4
prerank,replication fork processing (GO:0031297),0.18672473108647167,0.5680144787581209,0.9849749582637729,0.9980624863781645,1.0,3/38,9.68%,ZRANB3;RFWD3;EXD2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.2508944824555898,0.565850445073352,0.9518304431599229,0.9983028222783483,1.0,10/10,74.93%,FBXW7;ADAM17;AREG;EPGN;TGFA;NCF1;BTC;EGF;HBEGF;ADRA2A
prerank,mRNA stabilization (GO:0048255),0.18747064339362512,0.5657750873850187,0.9805194805194806,0.9978208592526784,1.0,7/40,15.50%,TIRAP;HNRNPC;TARDBP;TAF15;YBX1;FUS;NOCT
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.23096259493574886,-0.5642648529422308,0.9671772428884027,0.9955353636514845,1.0,5/11,36.62%,AGO3;RBM4;NOTCH4;TNRC6C;ZFP36
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.23096259493574886,-0.5642648529422308,0.9671772428884027,0.9955353636514845,1.0,5/11,36.62%,AGO3;RBM4;NOTCH4;TNRC6C;ZFP36
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.224040878968264,-0.5602483789791092,0.9676724137931034,0.9960892764405057,1.0,7/13,34.57%,RAB23;APOD;CABP1;SUFU;NUP153;CHP1;BARD1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.24795982423101082,0.5582663775326984,0.965183752417795,0.9992635804259704,1.0,11/11,75.22%,SYNJ2;IMPA1;INPP5B;SYNJ1;INPP5J;PTEN;IMPA2;INPP1;INPP5K;OCRL;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.24795982423101082,0.5582663775326984,0.965183752417795,0.9992635804259704,1.0,11/11,75.22%,SYNJ2;IMPA1;INPP5B;SYNJ1;INPP5J;PTEN;IMPA2;INPP1;INPP5K;OCRL;INPP5A
prerank,ribosomal subunit export from nucleus (GO:0000054),0.23597428140127644,0.5577850316522757,0.964221824686941,0.9989049310492729,1.0,6/13,21.76%,LTV1;XPO1;NPM1;EIF6;SDAD1;NMD3
prerank,phospholipid catabolic process (GO:0009395),0.20374839331495526,0.5564087028668336,0.9876106194690265,0.9988380957510572,1.0,3/24,14.23%,SMPD4;ABHD12;PNPLA6
prerank,midbody abscission (GO:0061952),0.21832611833865218,0.5548417921135731,0.966796875,0.9987988527713234,1.0,2/17,10.23%,CHMP1A;CHMP2A
prerank,female gamete generation (GO:0007292),-0.17389311948812658,-0.5537243840130536,0.995049504950495,0.9973441693879131,1.0,2/29,5.66%,DIAPH2;FMN2
prerank,regulation of chromosome organization (GO:0033044),-0.19230206297492902,-0.5535957598606346,0.9837209302325581,0.9967926709698487,1.0,4/22,17.68%,MAPT;CENPV;UPF1;YLPM1
prerank,protein deneddylation (GO:0000338),-0.23372030621017917,-0.5519908850951448,0.9619450317124736,0.9966222741948452,1.0,6/10,38.79%,COPS2;COPS5;COPS7A;TOR1A;COPS6;GPS1
prerank,prostanoid metabolic process (GO:0006692),0.23005178355517836,0.5512992129908417,0.9688715953307393,0.9993318780832512,1.0,3/13,15.80%,PLAA;PTGR2;HPGD
prerank,positive regulation of immune system process (GO:0002684),-0.2039829916870822,-0.5498257375466618,0.9763948497854077,0.996646815057408,1.0,6/16,41.20%,ANXA1;VEGFA;NCKAP1L;RSAD2;PIK3CB;TGFB2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.22186273060472267,0.5488075449959605,0.9717514124293786,0.99955089879666,1.0,1/15,4.13%,ZFP36L1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.25352735953357375,0.5484281734587371,0.9606299212598425,0.9991526992680136,1.0,1/10,7.28%,SMAD7
prerank,negative regulation of cation channel activity (GO:2001258),0.19715302546854732,0.5454391412170051,0.975,0.9994691061439817,1.0,5/26,18.82%,CALM3;KCNAB1;UBQLN1;FKBP1A;CALM1
prerank,regulation of sensory perception of pain (GO:0051930),0.24009180840542066,0.5436852163208585,0.9504950495049505,0.9994387962154393,1.0,1/11,7.31%,TMEM100
prerank,L-serine metabolic process (GO:0006563),0.23993619448312317,0.5435681367178412,0.9610894941634242,0.9989648742957468,1.0,2/10,11.35%,SERINC5;SERINC3
prerank,cGMP metabolic process (GO:0046068),-0.22334994354597543,-0.5428464715535041,0.986046511627907,0.9978206059422488,1.0,4/12,26.25%,GUCY1A1;NPR1;GUCY1B1;PDE2A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.2329847930793426,-0.5428392821213195,0.9647749510763209,0.9972404441269935,1.0,6/10,43.17%,FN1;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.23218701995632235,-0.5427714248010204,0.9643605870020965,0.996678750507224,1.0,5/10,37.75%,SRI;PDE4B;CACNA2D1;NIPSNAP2;CACNB3
prerank,endoderm development (GO:0007492),0.2252009040683074,0.541888096427968,0.9633699633699634,0.9989462766909699,1.0,13/13,77.50%,SOX17;KIF16B;APELA;EOMES;GATA4;DUSP2;DUSP5;TBX20;DUSP4;LHX1;LAMC1;SOX7;DUSP1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2252009040683073,0.5410759614332316,0.9704797047970479,0.9986562969652506,1.0,13/13,77.50%,PCID2;LCMT1;CDK5RAP2;USP44;TPR;CCNB1;XRCC3;NDC80;GEN1;MAD2L1;DYNC1LI1;ANAPC15;DUSP1
prerank,calcium ion import into cytosol (GO:1902656),-0.20406410700882563,-0.539816053428342,0.9739130434782609,0.9968112108688046,1.0,6/15,37.04%,SLC24A2;CACNA2D1;TRPV2;SLC8A2;TRPM2;ATP2B4
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2262540021344719,0.5394314946106832,0.9709302325581395,0.99856480514995,1.0,12/12,77.39%,CDC45;MCM2;GINS2;MCM5;MCM7;MCM3;GINS4;MCMDC2;MUS81;MCM4;CDC7;MCM6
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.20401823538498998,0.5391219506159111,0.9848771266540642,0.998142482579609,1.0,3/20,11.27%,TXN;P2RX7;APP
prerank,oxoacid metabolic process (GO:0043436),-0.17593028567951735,-0.5357733245863214,0.9906759906759907,0.9971449298207398,1.0,2/27,5.42%,DDO;ENPP1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.22664837015754855,-0.5354377624166646,0.9669421487603306,0.996638213389751,1.0,1/10,4.76%,KIT
prerank,androgen metabolic process (GO:0008209),0.20776949679271164,0.5349056803612218,0.9711375212224108,0.9987082913710587,1.0,2/18,11.73%,HSD17B11;HSD17B4
prerank,lymphocyte mediated immunity (GO:0002449),0.22882857483645463,0.5321377873818448,0.9621513944223108,0.9988727199315737,1.0,3/12,20.22%,CD55;CD46;BTN3A3
prerank,regulation of multicellular organismal development (GO:2000026),0.18866415485677918,0.5318514817130968,0.9890909090909091,0.9984408514002785,1.0,5/25,19.12%,TDG;RAB14;SOX17;INSR;DHX36
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.2318357880950857,0.5315351202282051,0.9711711711711711,0.9980130598451092,1.0,1/11,7.28%,SMAD7
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.15055436290903748,-0.5287291735992253,0.9973684210526316,0.997494972483103,1.0,21/45,47.58%,MALT1;AIM2;USP50;GBP5;GSDMD;HSPB1;PANX1;TRIM16;EGR1;TMEM106A;LPL;TYROBP;CASP8;CCL19;NOD2;PYCARD;MYD88;TLR4;CASP1;FZD5;AGER
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.1897911265749444,-0.5285930498841318,0.984304932735426,0.9969400185053778,1.0,5/19,25.11%,IFIH1;HSPD1;MAVS;STAT1;TLR3
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.2140197944395251,0.5271114679170802,0.9704251386321626,0.9985436524656901,1.0,2/15,10.80%,NLRC3;DDX3X
prerank,neutrophil activation (GO:0042119),0.22966611822663374,0.5252860425196326,0.9617486338797814,0.9984156765542682,1.0,1/12,6.70%,SYK
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.18337991228477896,0.5247474162262131,0.9914965986394558,0.9980290209511017,1.0,1/29,2.58%,CXCL12
prerank,response to fatty acid (GO:0070542),-0.19125143950324072,-0.5237391153661606,0.9887133182844243,0.9972715745934657,1.0,1/17,3.56%,PID1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.22095016236089537,-0.5237113067609515,0.9770833333333333,0.9967016427353883,1.0,5/11,31.83%,VCP;UGGT2;BAG6;RNF185;TOR1A
prerank,regulation of interleukin-17 production (GO:0032660),0.1817707063501065,0.5216684649042362,0.9902439024390244,0.9981860219538603,1.0,4/31,17.21%,VSIR;PRNP;DDIT3;SLC7A5
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.20717373714167903,-0.5214205069575354,0.986870897155361,0.9965751190304575,1.0,3/13,24.32%,ENPP1;BPNT1;ABHD14B
prerank,inositol phosphate catabolic process (GO:0071545),-0.2124113712602409,-0.5192927909390104,0.9698275862068966,0.9963615548494442,1.0,6/12,36.34%,NUDT3;INPP5A;OCRL;INPP5K;INPP1;IMPA2
prerank,mitotic sister chromatid cohesion (GO:0007064),0.20785710219246775,0.5184936040003981,0.9761029411764706,0.998326053529734,1.0,1/16,3.93%,BOD1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.2059872420924435,-0.5135689298296332,0.9865470852017937,0.9967902971541773,1.0,4/14,33.39%,IL18;IL17D;CD80;PAEP
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.16561677620370174,-0.5116008472064306,0.9974811083123426,0.9965284016679314,1.0,7/26,29.08%,SLC30A10;PPARA;ABCD2;SLC25A33;GRIN1;SLC5A3;SNCA
prerank,oogenesis (GO:0048477),0.20668553594697175,0.5114617880720129,0.9849056603773585,0.9991767135019153,1.0,2/15,11.15%,MARF1;NANOS3
prerank,outer dynein arm assembly (GO:0036158),0.20607865305349526,0.5114311976912478,0.9814814814814815,0.9986851364180747,1.0,1/15,6.62%,DNAL1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.18964335284119005,0.5094748290399901,0.9870609981515711,0.9985411394431474,1.0,5/22,18.09%,UBAP1;VPS37B;PLAA;VPS37C;VPS4B
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.19832946052879485,0.5014907023206525,0.9855334538878843,0.9994403027366923,1.0,18/18,80.19%,ALKBH7;BAD;BNIP3;SLC25A4;TMEM102;SLC25A31;HEBP2;NAIF1;PMAIP1;PPIF;BAK1;MUL1;SLC25A5;BCL2L1;CAMK2A;BCL2;THEM4;SPG7
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.21425047409791037,-0.4997008505417122,0.9834710743801653,0.9976737789275661,1.0,7/10,41.68%,ACAD11;ETFB;ACADS;ACADVL;IVD;ACADM;GCDH
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.20044217032161105,-0.49893222967816653,0.9877049180327869,0.9972115434827403,1.0,9/12,46.43%,SRR;MTHFD1;PSPH;PSAT1;CBS;PHGDH;SEPHS2;CTH;GGT1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.2073730028990183,-0.49683963295797573,0.9870689655172413,0.9969027958447986,1.0,3/11,27.26%,BMP4;BMPR1A;ZFPM2
prerank,zymogen activation (GO:0031638),0.16424586326809554,0.49477312623524516,0.9920255183413078,0.999997265207827,1.0,5/39,14.37%,OMA1;VSIR;BAD;PLAT;GRIN2A
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.19127791400643418,-0.493496533303279,0.9914712153518124,0.9967564159521529,1.0,4/13,22.97%,NFU1;MMS19;ISCA1;CIAO1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.14683816580842474,0.4910795310940134,1.0,1.0,1.0,5/68,11.27%,TIRAP;RAB7B;SYK;WNT5A;APP
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.1680929511534334,-0.48908121745904676,0.9955056179775281,0.9967094448956725,1.0,9/22,33.08%,NOL11;WDR43;ATF4;UTP15;EIF2AK3;ERBB2;PIH1D1;DDX11;MTOR
prerank,defense response to protozoan (GO:0042832),0.2080803299113852,0.48660477339774527,0.9900990099009901,1.0,1.0,1/12,6.26%,GBP4
prerank,metallo-sulfur cluster assembly (GO:0031163),0.1784529790743437,0.48589327573547825,0.9945454545454545,0.9997092164730107,1.0,2/22,7.13%,CIAPIN1;ISCU
prerank,lipoxygenase pathway (GO:0019372),0.19897030200288815,0.4810176621987092,0.994413407821229,0.9998333877962273,1.0,14/14,80.12%,HPGD;ALOX12B;ALOX15;GPX4;PON3;PON1;LTC4S;PON2;ALOX5;ALOXE3;ALOX5AP;ALOX12;GPX1;PTGS2
prerank,meiosis I (GO:0007127),0.1758180015074411,0.47818812784572257,0.9913941480206541,0.9996545068679593,1.0,21/23,57.78%,ING2;FOXJ3;ZSCAN21;MYBL1;BRDT;BTBD18;MEIOC;DNMT3L;MEI1;CCNA1;MEIKIN;MOV10L1;FOXJ2;SLC25A31;MEIOB;DDX4;TDRD9;SGO1;SYCP3;ZCWPW1;HSF2BP
prerank,mitochondrial RNA metabolic process (GO:0000959),0.19601933823067758,0.46879351856812046,0.98635477582846,1.0,1.0,14/14,80.42%,EARS2;TFAM;TFB1M;TFB2M;PNPT1;FASTKD5;TWNK;POLRMT;TEFM;MRPL12;MTERF2;FOXO3;SLC25A33;FASTKD1
prerank,response to glucocorticoid (GO:0051384),0.17267519233945178,0.46837373792584236,0.9982014388489209,0.999744896303254,1.0,1/26,4.13%,ZFP36L1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.2028281501671862,-0.4675257057905113,0.9957627118644068,0.9981770213168265,1.0,1/10,13.42%,IL33
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.17125266993340882,0.4629403089779963,0.9949238578680203,0.999792958183521,1.0,23/23,82.90%,ELOVL6;HPGD;ALOX12B;ALOX15;GPX4;ACSBG2;GSTP1;LTC4S;CYP1A1;GSTM4;CYP2E1;ALOX5;ALOXE3;ASAH2;LTA4H;ALOX12;ACSBG1;GSTM2;FADS1;EPHX2;GSTM1;PTGS2;ACOT7
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.17747514302421216,-0.46221637802138654,0.991304347826087,0.9980647236055991,1.0,4/15,25.07%,RIOK2;PTTG1;HECW2;CDC27
prerank,sensory perception of pain (GO:0019233),0.17368260324922688,0.458067445180152,0.9965928449744463,0.9997547864855341,1.0,2/21,10.95%,MME;P2RX7
prerank,DNA catabolic process (GO:0006308),0.1949185298493051,0.4547292041815082,0.9924528301886792,0.9995182077650969,1.0,2/11,18.51%,XRN2;FBH1
prerank,negative regulation of immune effector process (GO:0002698),0.18747954960469448,0.44395749846717836,0.9961464354527938,0.9998372338435078,1.0,4/13,20.44%,CD47;CD55;RC3H1;GRN
prerank,superoxide anion generation (GO:0042554),-0.17570042351588755,-0.43799596769648036,1.0,0.9990651195426886,1.0,9/13,60.94%,NOX4;NCF2;ALOX12;CYBB;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,regulation of phosphate metabolic process (GO:0019220),0.16869578335529525,0.42774398308701667,1.0,1.0,1.0,6/16,21.48%,IKBKB;SMG6;SMG5;IGBP1;SMG7;PSEN1
prerank,purine nucleotide catabolic process (GO:0006195),0.17786411202045008,0.42538245326615143,0.9927140255009107,1.0,1.0,2/13,12.02%,PNP;NT5C2
prerank,pseudouridine synthesis (GO:0001522),-0.16713224512657998,-0.4126331725402701,0.9978540772532188,0.9995256635824697,1.0,10/13,50.83%,PUS7;TRUB1;PUS3;GAR1;NOP10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,toxin transport (GO:1901998),0.18482350273583503,0.40929801043469294,0.9944029850746269,1.0,1.0,2/10,15.83%,RAB40B;ANTXR1
prerank,inorganic ion transmembrane transport (GO:0098660),0.16997371468789874,0.3873299142270458,0.9981412639405205,1.0,1.0,1/12,10.53%,TRPM4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.12930031209377096,0.3716703890577607,1.0,1.0,1.0,4/29,15.50%,TAF15;YBX1;FUS;NOCT
prerank,positive regulation of interleukin-1 production (GO:0032732),0.11391232522319318,0.3604252494179463,1.0,0.9997685329800053,1.0,4/51,11.27%,TMED10;WNT5A;P2RX7;APP
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.11601507732039872,-0.34407614443206275,1.0,0.99992773724481,1.0,1/22,5.12%,CBFB
